name,id,shortName,numerator,denominator
 % of Malaria confirmed cases over suspected Malaria Case (>5Years MoH 705B),RWVSZXQF8DO,"Malaria confirmed cases ,suspected Malaria",#{OoakJhWiyZp.SeDaCnHi3m5},#{Lt0FqtnHraW.SeDaCnHi3m5}
 MOH-729B Total Number of Pregnant women or HEI Mothers,zTzQGHbaGQl, Total No. ofPregnant women or HEI Mothers,(#{PUElM9fX05X} + #{FJsr7NuAZzG} + #{yow23Z4qoyH} + #{u5zeltl5rfV} + #{eSvJ0iwxW8S} + #{Cfiqv92r3sT} + #{hzYT4vfNzQv} + #{C6Letuzs5lf} + #{qamQo2MgLMc} + #{j02efZsr6h9} + #{xYA6HgnX7kr} + #{Ea0QdQ5Zo8c} + #{NhuwyxsOnxc}),1
 MOS-MoH 730A Revision 2017 Paediatric preparations Efavirenz (EFV) 200mg Tablets 90s,dJNY6TQ0xX2, MOS-MoH 730A Revision 2017 Efavirenz Tablets 90s,(#{H5eOAm3h1dr.GvjV9gy3OOc} + #{FWfv9nwqQNj.GvjV9gy3OOc}),#{FWfv9nwqQNj.yP6vevc91WZ}
 MoH 730B Revision 2017 Adult preparations Dolutegravir(DTG) 50mg tabs 30s-QR,VmmPXNwflUH, MoH730BRevision2017Adult prep(DTG)50mg tabs30s-QR,(#{L806dq5McGs.b11dZBeBzRE} * 3) - #{L806dq5McGs.GvjV9gy3OOc},1
%  Active at 18 months but no AB test done,pbk71OFmLLZ,%  Active at 18 months but no AB test do,#{xz6EklggPTY.C0JkKJwjz0z},#{xz6EklggPTY.kKduCnnIOk7}
%  Lost to Follow‐Up between 0 and 18 months,CV0ofpZFEz2,%  Lost to Follow‐Up between 0 and 18 mo,#{UOXvN7hJUAh.C0JkKJwjz0z},#{UOXvN7hJUAh.kKduCnnIOk7}
%  Transferred out between 0 and 18 month,aDxr9ADYIWg,%  Transferred out between 0 and 18 mont,#{YEZKh5z5uIX.C0JkKJwjz0z},#{YEZKh5z5uIX.kKduCnnIOk7}
% 10-14 year-old girls of total Population,LXNNyU4iJmu,% 10-14 year-old girls of total Population,#{dRhugDCanvB},#{NLKRV7bYbVy}
% AB negative at 18 months,XwR9InaSBqH,% AB negative at 18 months% AB negative ,#{uM0kppDX04I.C0JkKJwjz0z},#{uM0kppDX04I.kKduCnnIOk7}
% Active in follow‐up ,nU2bjLqwN2p,% Active in follow‐up ,#{s3FoQN5Ml6T.C0JkKJwjz0z},#{s3FoQN5Ml6T.kKduCnnIOk7}
% Died between 0 and 18 months,Qlu7OyTuhTJ,% Died between 0 and 18 months,#{XiuOw6frDEi.C0JkKJwjz0z},#{XiuOw6frDEi.kKduCnnIOk7}
% Died between 0 and 9 months,N06PQGwcwG5,% Died between 0 and 9 months,#{uSwAblfq472.C0JkKJwjz0z},#{uSwAblfq472.kKduCnnIOk7}
% HEI Identified as positive between 0 and 18 months,MPcutumFZm7,%HEI Identified as positive btw 0 an18mt,#{P2p3i9vmOV8.C0JkKJwjz0z},#{P2p3i9vmOV8.kKduCnnIOk7}
% HEI tested with PCR at age 6‐8 weeks and results available,hkhajO6SfQO,% HEI tested with PCR at age 6‐8 weeks,#{IiRdyJ8sDTC.C0JkKJwjz0z},#{IiRdyJ8sDTC.kKduCnnIOk7}
% Identified as positive between 0 and 9 months,MPW7HIS4TgK,% Identified as positive between 0 and 9,#{izPvSZbsRA7.C0JkKJwjz0z},#{izPvSZbsRA7.kKduCnnIOk7}
% Infants who received ARVs at 0‐6 weeks ,mmfbBoNavHH,% Infants who received ARVs at 0‐6 weeks,#{QmSAEKTjdCB.C0JkKJwjz0z},#{QmSAEKTjdCB.kKduCnnIOk7}
% Latrine Coverage,rc63pQlR7fm,Latrine Coverage,#{UUa3P9X0iUs.NhSoXUMPK2K},#{duLaKUuuAwV.NhSoXUMPK2K}
% Missing 9 month follow‐up visit,lcBztrKYmJf,% Missing 9 month follow‐up visit,#{EULfPdQNJ6i.C0JkKJwjz0z},#{EULfPdQNJ6i.kKduCnnIOk7}
% Outcomes for birth cohort at 18 Months ,S1YSQs5d9Bb,% Outcomes for birth cohort at 18 Months,#{uM0kppDX04I.C0JkKJwjz0z}+#{xz6EklggPTY.C0JkKJwjz0z}+#{P2p3i9vmOV8.C0JkKJwjz0z}+#{YEZKh5z5uIX.C0JkKJwjz0z}+#{UOXvN7hJUAh.C0JkKJwjz0z}+#{XiuOw6frDEi.C0JkKJwjz0z},#{XiuOw6frDEi.kKduCnnIOk7}
% Outcomes for birth cohort at 9 Months,xLqVwGVw57y,% Outcomes for birth cohort at 9 Months,#{s3FoQN5Ml6T.C0JkKJwjz0z}+#{izPvSZbsRA7.C0JkKJwjz0z}+#{roL580fLVfT.C0JkKJwjz0z}+#{EULfPdQNJ6i.C0JkKJwjz0z}+#{uSwAblfq472.C0JkKJwjz0z},#{s3FoQN5Ml6T.kKduCnnIOk7}
% RDT Positivity (MoH 706),vAiDHQiMcEm,% RDT Positivity ,#{vORT3FUaS6P.nwpzSJ8o7hD},#{vORT3FUaS6P.TZ7UnG134RW}
% RDT uptake among Suspected Malaria patient (MOH 705A&B),qXatLmgS87P,% RDT uptake among Suspected Malaria ,#{c0MB4RmVjxk.w77uMi1KzOH} + #{qnZmg5tNSMy.w77uMi1KzOH} + #{gVp1KSFI69G.w77uMi1KzOH} + #{BnGDrFwyQp9.w77uMi1KzOH},#{Lt0FqtnHraW}
% Transferred out between 0 and 9 months,Wku2axMvLmx,% Transferred out between 0 and 9 months,#{roL580fLVfT.C0JkKJwjz0z},#{roL580fLVfT.kKduCnnIOk7}
% of Malaria confirmed cases over suspected Malaria Case (<5Years MoH 705A),NLghrsU5KlN,% of Malaria confirmed/ suspected Malaria,#{OoakJhWiyZp.lHl2rmXpHse},#{Lt0FqtnHraW.lHl2rmXpHse}
% of Malaria confirmed cases over suspected Malaria Case (<5Years MoH 705A+>5Years MoH 705B),tZZFufLIT9p,% of Mal confirmed/suspected Mal,#{OoakJhWiyZp.lHl2rmXpHse} + #{OoakJhWiyZp.SeDaCnHi3m5},#{Lt0FqtnHraW.lHl2rmXpHse} + #{Lt0FqtnHraW.SeDaCnHi3m5}
% of Patients treated with AL as a proportion of confirmed malaria cases.,tdhIKc7sGAj,Patients on AL vs confirmed malaria cases MOH 705,#{zB1NW37bi46.LGF6iqCIERd} + #{zB1NW37bi46.Y91nbvpppbG} + #{zB1NW37bi46.lBMSm0aBgXs} + #{zB1NW37bi46.abmGKYBTUWU},#{OoakJhWiyZp.lHl2rmXpHse} + #{OoakJhWiyZp.SeDaCnHi3m5}
% of RDT tests positive  among over 5 Years(IDSR),BihtPNae8lw,% of RDT tests positive  among over 5 Years(IDSR),#{IYnqoV2vlRq.ROXPeIvP89X},#{IYnqoV2vlRq.dbZfB6Oub9K}
% of Under Five Treated for Malaria,Wce6aGcFE0B,% of Under Five Treated for Malaria,#{Lt0FqtnHraW.lHl2rmXpHse}+#{OoakJhWiyZp.lHl2rmXpHse},#{BwROYFIiXKG.lHl2rmXpHse}+#{IxhbkNwhcvE.lHl2rmXpHse}
% of women (15-49) yrs provided with FP commodities - Community unit,GC3uAyQE12s,% of women (15-49) yrs provided with FP commodit,#{bbrNRV9zwVa},#{ddd4ahrnB2S}
% tested by AB test at >= 18 months and results are available,dXokgBJjDdf,% tested by AB test at >= 18 months,#{PkjZxAyJmzw.C0JkKJwjz0z},#{PkjZxAyJmzw.kKduCnnIOk7}
%HEI tested positive by first PCR at age 6‐8 weeks,PH6o4APFqWg,%HEI tested positive by first PCR at age,#{tYL0A1JspLB.C0JkKJwjz0z},#{tYL0A1JspLB.kKduCnnIOk7}
%HEI tested with PCR and results available between 0 and 9 months,kw3icxbznx4,%HEI tested with PCR and results availab,#{E3RbPoXM0ie.C0JkKJwjz0z},#{E3RbPoXM0ie.kKduCnnIOk7}
%HEI who tested AB positive with confirmatory PCR and results available,Eyr7p3PxARt,%HEI who tested AB positive with confirm,#{bsMZvAiHQIH.C0JkKJwjz0z},#{bsMZvAiHQIH.kKduCnnIOk7}
%HEI who were Exclusively Breastfed at 6 months among HEI assessed,jpgJZYKSyHR,HEI who were Exclusively Breastfed at 6,#{GjLqj024iQY.C0JkKJwjz0z},#{GjLqj024iQY.kKduCnnIOk7}
%HIV positive infants identified between 0 and 9 months linked to CCC,dWcHTmlsLZu,%HIV positive infants identified btw 0-9,#{q8kmDg03bi3.C0JkKJwjz0z},#{q8kmDg03bi3.kKduCnnIOk7}
%HIV positive infants linked to CCC among those testing positive,zuFauObBeOK,%HIV positive infants linked to CCC,#{HGIGKgY3L1c.C0JkKJwjz0z},#{HGIGKgY3L1c.kKduCnnIOk7}
%Mothers who received PMTCT ARVs ,travzZ9fbHI,%Mothers who received PMTCT ARVs ,#{NU2ICgX42vu.C0JkKJwjz0z},#{NU2ICgX42vu.kKduCnnIOk7}
%Patient treated for malaria managed according to national treatment guidelines,IDM2apaGrH5,%Pt Tx Mlr guidelines,#{zB1NW37bi46.LGF6iqCIERd} + #{zB1NW37bi46.Y91nbvpppbG} + #{zB1NW37bi46.lBMSm0aBgXs} + #{zB1NW37bi46.abmGKYBTUWU}, #{OoakJhWiyZp.lHl2rmXpHse} + #{OoakJhWiyZp.SeDaCnHi3m5}
%eligible HEI tested with 1st AB test and results available,A0utHTE9eDJ,%eligible HEI tested with 1st AB test,#{EmDUlUXSdWw.C0JkKJwjz0z},#{EmDUlUXSdWw.kKduCnnIOk7}
%eligible HEI tested with 1st AB test and results available,FXkV1sRbgE1,%eligible HEI tested with 1st AB test,#{EmDUlUXSdWw.C0JkKJwjz0z},#{EmDUlUXSdWw.kKduCnnIOk7}
(%) of  Adolescents (10-19 years) pregnant at 1st ANC visit,eKn1rzinNH6,(%) Adolescents (10-19 years) pregnant at 1st ANC,#{chMsCa5zcn7} + #{uHBmKxktYk0},#{f9vesk5d4IY}
(%) of Deliveries conducted by Skilled Birth Attendants,sAWX6GB722p,(%) Skilled Birth Attendants ,#{jaPrPmor6WV.NhSoXUMPK2K}+#{Kx64gGqaFVq.NhSoXUMPK2K}+#{sMqM8DwiAaj.NhSoXUMPK2K}+#{rAZBTMa7Jy3.NhSoXUMPK2K},#{tmlMpIqHimf.NhSoXUMPK2K}
(%) of HIV  positive pregnant women on ARVs ,d238y0wRpFZ,(%) of HIV  positive pregnant women on ARVs ,#{PyDKoTxqKB9}+#{UMyB7dSIdz1},#{KYpWTsp2yHv}
(%) of pregnant women who are  Adolescents (10-14 years),CMe87oOgEj8,(%) of pregnant Adolescents (10-14 years),#{chMsCa5zcn7},#{f9vesk5d4IY}
(%) of pregnant women who are  Adolescents (10-19 years),nD5xOBIMJY8,(%) of pregnant women Adolescents (10-19 years) ,#{chMsCa5zcn7}+#{uHBmKxktYk0} ,#{f9vesk5d4IY}
(%) of pregnant women who are  Adolescents (15-19 years),GOsFZKRCBqa,(%) of pregnant  Adolescents (15-19 years),#{uHBmKxktYk0},#{f9vesk5d4IY}
(Delete) % Squint Surgery,osILr6BaJGa,% Squint Surgery,#{OT56W5Vx666},#{gleQTAUHvlQ}
(Delete)%  Low vision due to refractive errors total ophthalmic patient,I6BundIAWjD,Low vision due to refractive errors ,#{txuFX4UOFHg}+#{aWFczgLX3bN},#{JGbmLfjZPEf.wBWcFk7k1qY}+#{JGbmLfjZPEf.K4WLOEhtcvC}
(Delete)% Blind due to Cataract,zyqXdGCwzeS,% Blind due to Cataract,#{UE9gZpb7nH1.hP7wPVD9mnT}+#{UE9gZpb7nH1.OdPRuXx7Vyj}+#{UE9gZpb7nH1.eZJz06Qw9vU}+#{UE9gZpb7nH1.rf4rzMwjMWT}+#{UE9gZpb7nH1.ts1WNZMlFaC}+#{UE9gZpb7nH1.jvRuY1CUNpS},#{keO7GNuBNYc.NhSoXUMPK2K}+#{nyZxBa6yi5A.NhSoXUMPK2K}
(Delete)% Blind due to Glaucoma,lFbtFS3MFSq,% Blind due to Glaucoma,#{GfoLOw33bHh},#{keO7GNuBNYc.NhSoXUMPK2K}+#{nyZxBa6yi5A.NhSoXUMPK2K}
(Delete)% Cataract operation with IOL implantation,laPCZlja6ot,% Cataract operation with IOL implantati,#{HLAZb7bcag7},#{UE9gZpb7nH1}
(Delete)% Diabetes screened,t4uWUzcb0ho,% Diabetes screened,#{HYdMSUkzDdF}+#{qzLSvOgBb2S}+#{e4TLO34L0eJ},#{JGbmLfjZPEf.wBWcFk7k1qY}+#{JGbmLfjZPEf.K4WLOEhtcvC}
(Delete)% Entropion surgery,gb2ZTI1mWSG,% Entropion surgery,#{kk3EU5RSYTx},#{coruNdbeHV5}
(Delete)% Retinal Laser Treatment,BzeXeSDyTeG,% Retinal Laser Treatment,#{PC441DEoi0l},#{HYdMSUkzDdF}
(Delete)Cataract  <5 Years,FShKdZtuG3e,Cataract  <5 Years,#{HLAZb7bcag7.j6fkKnPByyc}+#{HLAZb7bcag7.eEbWx72xgGq}+#{vedTHAMWMLk.j6fkKnPByyc}+#{vedTHAMWMLk.eEbWx72xgGq},1
(Delete)Cataract Adult >16 years,C1LC6BSlNJC,Cataract Adult >16 years,#{HLAZb7bcag7.pyoB2N4B1cY}+#{HLAZb7bcag7.yulOlF1vNjn}+#{vedTHAMWMLk.pyoB2N4B1cY}+#{vedTHAMWMLk.yulOlF1vNjn},1
(Delete)Cataract operation  5-16 years,cD88FSxgYIV,Cataract operation  5-16 years,#{vedTHAMWMLk.ffVheqj92lv}+#{vedTHAMWMLk.kd0FPFnQwOQ}+#{HLAZb7bcag7.ffVheqj92lv}+#{HLAZb7bcag7.kd0FPFnQwOQ},1
(Delete)Glaucoma,nm0sliRQ4Iz,Glaucoma,#{GfoLOw33bHh},1
(Delete)Total Entropion Surgeries,RCfjFyGHXs8,Total Entropion Surgeries,#{kk3EU5RSYTx},1
(Delete)Total Injury eye,W0TBrKZshOL,Total Injury eye,#{tCG2GSIgk4q},1
(Delete)Total Ophthalmia Neonatorum,vDbSJRMq0rG,Total Ophthalmia Neonatorum,#{VkgodRyl3Xl},1
(Delete)Total Purulent Conjunctivitis,MaVH5dXyr92,Total Purulent Conjunctivitis,#{xFN2gtOlIC3},1
(Delete)Total Retinoblastoma,MGVaup6dY3i,Total Retinoblastoma,#{DRuEFY7qxsz},1
(Delete)Total ophthalmic patients,n1PIFBHf1rg,Total ophthalmic pts,#{keO7GNuBNYc.NhSoXUMPK2K}+#{nyZxBa6yi5A.NhSoXUMPK2K},1
(Duplicate)Female Infants below 6 months on exclusive breastfeeding,xZ7KQVYNZoM,Female <6months exclusive breastfed ,#{QUueF25THDC.a57uWFr3dUy},#{twpy25QKLk9.a57uWFr3dUy} + #{AIduSzrilaz.a57uWFr3dUy} + #{ENjll6PbaI8.a57uWFr3dUy} + #{QCNHvzgxurQ.a57uWFr3dUy} + #{lvyOQjZaXZ3.a57uWFr3dUy}
(Duplicate)Proportion of pregnant women attending ANC who were issued with combined  Iron/folate supplements.,vgeqxprCL8x,No. combined Iron and Folate,#{NTLdyLadTk1.NhSoXUMPK2K},(#{f9vesk5d4IY} + #{hxXwYIgT8rI})
"(Not collected) Vitamin A coverage for Lactating Mothers (200,000IU)",zP2866sBSiM,Vit A cov Lact. Mothers,#{vfyid8wVnVz.NhSoXUMPK2K},#{tmlMpIqHimf.NhSoXUMPK2K}
0-5 Female Population(PMI),OB4T5ljkyTg,0-5 Female Population(PMI),#{KNrK5VWTZkx}*0.51,1
0-5 Male Population(PMI),IJvgIozpTF9,0-5 Male Population(PMI),#{KNrK5VWTZkx}*0.49,1
18-25_covid_vaccine,mSZ0ei6bhME,18-25_covid_vaccine,#{myQD3R0GBUq.OfZG3d4UTEe} + #{myQD3R0GBUq.LkGt7Z4CeY8} + #{qRQ3LIl7SmG.OfZG3d4UTEe} + #{qRQ3LIl7SmG.LkGt7Z4CeY8} + #{LTJsHtrbyML.OfZG3d4UTEe} + #{LTJsHtrbyML.LkGt7Z4CeY8} + #{UoaXvx7kTB7.OfZG3d4UTEe} + #{UoaXvx7kTB7.LkGt7Z4CeY8} + #{gOksPnou3je.OfZG3d4UTEe} + #{gOksPnou3je.LkGt7Z4CeY8} + #{ZWMO83OyDwx.OfZG3d4UTEe} + #{ZWMO83OyDwx.LkGt7Z4CeY8} + #{jm6G9QtE6Th.OfZG3d4UTEe} + #{jm6G9QtE6Th.LkGt7Z4CeY8} + #{pkrY92yugfK.OfZG3d4UTEe} + #{pkrY92yugfK.LkGt7Z4CeY8} + #{NHd2e6QGCkk.OfZG3d4UTEe} + #{NHd2e6QGCkk.LkGt7Z4CeY8},1
25-35_covid_vaccine,h0oEWJpgQoi,25-35_covid_vaccine,#{myQD3R0GBUq.x4bdfcs1Eyf} + #{myQD3R0GBUq.gVnIpfiEjnG} + #{qRQ3LIl7SmG.x4bdfcs1Eyf} + #{qRQ3LIl7SmG.gVnIpfiEjnG} + #{LTJsHtrbyML.x4bdfcs1Eyf} + #{LTJsHtrbyML.gVnIpfiEjnG} + #{UoaXvx7kTB7.x4bdfcs1Eyf} + #{UoaXvx7kTB7.gVnIpfiEjnG} + #{gOksPnou3je.x4bdfcs1Eyf} + #{gOksPnou3je.gVnIpfiEjnG} + #{ZWMO83OyDwx.x4bdfcs1Eyf} + #{ZWMO83OyDwx.gVnIpfiEjnG} + #{jm6G9QtE6Th.x4bdfcs1Eyf} + #{jm6G9QtE6Th.gVnIpfiEjnG} + #{pkrY92yugfK.x4bdfcs1Eyf} + #{pkrY92yugfK.gVnIpfiEjnG} + #{NHd2e6QGCkk.x4bdfcs1Eyf} + #{NHd2e6QGCkk.gVnIpfiEjnG},1
35-45_covid_vaccine,OCdXMaq0Od4,35-45_covid_vaccine,#{myQD3R0GBUq.wM9T6slu124} + #{myQD3R0GBUq.D7GeTJKDFQa} + #{qRQ3LIl7SmG.wM9T6slu124} + #{qRQ3LIl7SmG.D7GeTJKDFQa} + #{LTJsHtrbyML.wM9T6slu124} + #{LTJsHtrbyML.D7GeTJKDFQa} + #{UoaXvx7kTB7.wM9T6slu124} + #{UoaXvx7kTB7.D7GeTJKDFQa} + #{gOksPnou3je.wM9T6slu124} + #{gOksPnou3je.D7GeTJKDFQa} + #{ZWMO83OyDwx.wM9T6slu124} + #{ZWMO83OyDwx.D7GeTJKDFQa} + #{jm6G9QtE6Th.wM9T6slu124} + #{jm6G9QtE6Th.D7GeTJKDFQa} + #{pkrY92yugfK.wM9T6slu124} + #{pkrY92yugfK.D7GeTJKDFQa} + #{NHd2e6QGCkk.wM9T6slu124} + #{NHd2e6QGCkk.D7GeTJKDFQa},1
45-55_covid_vaccine,E4TGjFuvtUd,45-55_covid_vaccine,#{myQD3R0GBUq.KMGJlmXh7fa} + #{myQD3R0GBUq.F4aAJxbU3Np} + #{qRQ3LIl7SmG.KMGJlmXh7fa} + #{qRQ3LIl7SmG.F4aAJxbU3Np} + #{LTJsHtrbyML.KMGJlmXh7fa} + #{LTJsHtrbyML.F4aAJxbU3Np} + #{UoaXvx7kTB7.KMGJlmXh7fa} + #{UoaXvx7kTB7.F4aAJxbU3Np} + #{gOksPnou3je.KMGJlmXh7fa} + #{gOksPnou3je.F4aAJxbU3Np} + #{ZWMO83OyDwx.KMGJlmXh7fa} + #{ZWMO83OyDwx.F4aAJxbU3Np}  + #{jm6G9QtE6Th.KMGJlmXh7fa} + #{jm6G9QtE6Th.F4aAJxbU3Np} + #{pkrY92yugfK.KMGJlmXh7fa} + #{pkrY92yugfK.F4aAJxbU3Np} + #{NHd2e6QGCkk.KMGJlmXh7fa} + #{NHd2e6QGCkk.F4aAJxbU3Np},1
4th Antenatal Care (ANC) Coverage (%),pGF8aDdlSxY,4th Antenatal Care (ANC) Coverage (%),#{Fz0LzxMT1vV.NhSoXUMPK2K},#{pct05jgGcLt}
5+ Female Population(PMI),xvyuglWHmNX,5+ Female Population(PMI),(#{w5ltvnNihEZ})- (#{KNrK5VWTZkx}*0.51),1
5+ Male Population(PMI),xwr1h5Uijmi,5+ Male Population(PMI),(#{Mpv8crmnOzy})- (#{KNrK5VWTZkx}*0.49),1
5+ Total Population(PMI),un1m78MSdkP,5+ Total Population(PMI),(#{w5ltvnNihEZ}+#{Mpv8crmnOzy})-(#{KNrK5VWTZkx}),1
55+_covid_vaccine,nGaZDxg99pi,55+_covid_vaccine,#{myQD3R0GBUq.hsgnO0aLtTH} + #{myQD3R0GBUq.IWjT8EE7a5u} + #{qRQ3LIl7SmG.hsgnO0aLtTH} + #{qRQ3LIl7SmG.IWjT8EE7a5u} + #{LTJsHtrbyML.hsgnO0aLtTH} + #{LTJsHtrbyML.IWjT8EE7a5u} + #{UoaXvx7kTB7.hsgnO0aLtTH} + #{UoaXvx7kTB7.IWjT8EE7a5u} + #{gOksPnou3je.hsgnO0aLtTH} + #{gOksPnou3je.IWjT8EE7a5u} + #{ZWMO83OyDwx.hsgnO0aLtTH} + #{ZWMO83OyDwx.IWjT8EE7a5u} + #{jm6G9QtE6Th.hsgnO0aLtTH} + #{jm6G9QtE6Th.IWjT8EE7a5u} + #{pkrY92yugfK.hsgnO0aLtTH} + #{pkrY92yugfK.IWjT8EE7a5u} + #{NHd2e6QGCkk.hsgnO0aLtTH} + #{NHd2e6QGCkk.IWjT8EE7a5u} ,1
711 cervical screen 25-49Years,qVThi5c3M5l,711 cervical screen 25-49Yrs,#{ommbnTANmGo.FqagtL5h8ni}+#{kl4RvWOGb7x.FqagtL5h8ni}+#{G9COyloYLYa.FqagtL5h8ni},1
751_Proportion of   Pregnant and lactating women  who were malnourished,HF5476rrjpk,751_%  Pregnant and lactating  malnourished,#{AOCwxxHypQm.Py6gFedDbBe},#{AOCwxxHypQm.Py6gFedDbBe} + #{AOCwxxHypQm.UTTzAxNTKtm}
751_Proportion of Children 0-23 months  given prelacteal feeds,cZUX2iePpiO,751_% Children 0-23 months  given prelacteal feeds,#{wOFNSW7kg9v.Py6gFedDbBe},#{wOFNSW7kg9v.Py6gFedDbBe} + #{wOFNSW7kg9v.UTTzAxNTKtm}
751_Proportion of Children 0-23 months on early  initiation to breastfeeding,PN6Jy45bSaL,751_% early  initiation to breastfeeding,#{FokMFvh3FGp.U2xjqZYwbEi},#{FokMFvh3FGp.U2xjqZYwbEi} + #{FokMFvh3FGp.yVYqreHYU8q} + #{FokMFvh3FGp.fJXvzwsjETC}
751_Proportion of Children 0-5 months exclusively breastfed,SV0hUIEMH5P,751_% Children 0-5 months exclusively breastfed,#{Vw9Phs0bGSW.Py6gFedDbBe},#{Vw9Phs0bGSW.Py6gFedDbBe} + #{Vw9Phs0bGSW.UTTzAxNTKtm}
751_Proportion of Children 6-23 months consuming at least 4 food groups,pU7kY4we07g,751_% 6-23 months consuming at least 4 food groups,#{Oe0LkadAdFP.Py6gFedDbBe},#{Oe0LkadAdFP.Py6gFedDbBe} + #{Oe0LkadAdFP.UTTzAxNTKtm}
751_Proportion of Children 6-23 months consuming iron- rich foods,Tk5a82bPAJU,751_% 6-23 months consuming iron- rich foods,#{RAWb16mKoXy.Py6gFedDbBe},#{RAWb16mKoXy.Py6gFedDbBe} + #{RAWb16mKoXy.UTTzAxNTKtm}
751_Proportion of Mother/caregivers (NICHE beneficiaries) who received positive parenting sessions during home visit,OUcgDI5nEMf,751_% Mother/caregivers nutrition counse parenting,#{Ayzl7c5BUA6.Py6gFedDbBe},#{Ayzl7c5BUA6.Py6gFedDbBe} + #{Ayzl7c5BUA6.UTTzAxNTKtm}
751_Proportion of Mother/caregivers who received nutrition counselling during home visit,EMzugXW9R79,751_% Mother/caregivers nutrition counselling,#{OpfNItK9k9d.Py6gFedDbBe},#{OpfNItK9k9d.Py6gFedDbBe} + #{OpfNItK9k9d.UTTzAxNTKtm}
751_Proportion of Mothers/caregivers (NICHE beneficiaries) who received at least two nutrition counselling sessions during home visit,Wie6bIYavZw,751_% Mother/caregivers nutrition counsel NICHE,#{QnCht96qmEU.Py6gFedDbBe},#{QnCht96qmEU.Py6gFedDbBe} + #{QnCht96qmEU.UTTzAxNTKtm}
751_Proportion of Percentage of pregnant and lactating women &  caregivers with children less than 2 years who  received BFCI services (coverage),W4kOEwuChrI,751_%  P&L caregivers  received BFCI services ,#{X2LMKZ504Wv},#{Ysa9yZQFuLA}
751_Proportion of Pregnant and lactating  women consuming ≥ 5  food groups in a day,V25lkkbWTwO,751_% P&L consuming ≥ 5  food groups in a day,#{NxPuJeBdAd5.Py6gFedDbBe},#{NxPuJeBdAd5.Py6gFedDbBe} +#{NxPuJeBdAd5.UTTzAxNTKtm}
751_Proportion of Pregnant and lactating women  consuming the recommended  number of meals per day,WRdQhocJDlA,751_% P&Lwomen  consuming the recommended,#{rGCGEOaFEEE.Py6gFedDbBe},#{rGCGEOaFEEE.Py6gFedDbBe} + #{rGCGEOaFEEE.UTTzAxNTKtm}
751_Proportion of Pregnant and lactating women received  nutrition counselling  in BFCI,j07A702YXfE,751_% P&L women receive  nutri counselling in BFCI,#{uc4oYYirXma.Py6gFedDbBe},#{uc4oYYirXma.Py6gFedDbBe} + #{uc4oYYirXma.UTTzAxNTKtm}
751_Proportion of Pregnant and lactating women who received nutrition  counselling during home visit,jPBLPT332i4,751_% P&l received nutrition  counselling ,#{hDzaai04ezp.Py6gFedDbBe},#{hDzaai04ezp.Py6gFedDbBe} + #{hDzaai04ezp.UTTzAxNTKtm}
751_Proportion of Pregnant and lactating women who received positive parenting sessions  during home visi,ccxh1GghmgJ,751_% P&L received positive parenting sessions,#{vobFwVJchh2.Py6gFedDbBe},#{vobFwVJchh2.Py6gFedDbBe} + #{vobFwVJchh2.UTTzAxNTKtm}
751_Proportion of Pregnant women who consumed IFAS,I5n7y93g6ve,751_% Pregnant women who consumed IFAS,#{BKdA4Xrx7dL.Py6gFedDbBe},#{BKdA4Xrx7dL.Py6gFedDbBe} + #{BKdA4Xrx7dL.UTTzAxNTKtm}
751_Proportion of Pregnant women who had IFA,sWIsmN3wrFg,751_% Pregnant women who had IFA,#{ltSt3VLhOcq.Py6gFedDbBe},#{ltSt3VLhOcq.Py6gFedDbBe} + #{ltSt3VLhOcq.UTTzAxNTKtm}
751_Total  Pregnant and lactating women  who were malnourished,vBF9T10RPWf,51_Total  Pregnant and lactating  malnourished,#{AOCwxxHypQm.Py6gFedDbBe} + #{AOCwxxHypQm.UTTzAxNTKtm},1
751_Total Children 0-23 months  given prelacteal feeds,VAn6lvMkfYs,51_Total 0-23 months  given prelacteal feeds,#{wOFNSW7kg9v.Py6gFedDbBe} + #{wOFNSW7kg9v.UTTzAxNTKtm},1
751_Total Children 0-23 months on early initiation to breastfeeding,e5cjQFloOMF,51_0-23 months early initiation to breastfeeding,#{FokMFvh3FGp.U2xjqZYwbEi} + #{FokMFvh3FGp.yVYqreHYU8q} + #{FokMFvh3FGp.fJXvzwsjETC},1
751_Total Children 0-5 months exclusively breastfed,X1CXeVDk9A1,51_Total Children 0-5 months exclusively breastfed,#{Vw9Phs0bGSW.Py6gFedDbBe} + #{Vw9Phs0bGSW.UTTzAxNTKtm},1
751_Total Children 6-23 months consuming at least 4 food groups,wmOpZfcRPKi,51_6-23 months consuming at least 4 food groups,#{Oe0LkadAdFP.Py6gFedDbBe} + #{Oe0LkadAdFP.UTTzAxNTKtm},1
751_Total Children 6-23 months consuming iron- rich foods,ES4YlGuu1tv,751_Total 6-23 months consuming iron- rich foods,#{RAWb16mKoXy.Py6gFedDbBe} + #{RAWb16mKoXy.UTTzAxNTKtm},1
751_Total Mother/caregivers (NICHE beneficiaries) who received at least two nutrition counselling sessions during home visit,u4kzYywsFrw,751_Total Mother/caregivers  nutr counsellin NICHE,#{QnCht96qmEU.Py6gFedDbBe} + #{QnCht96qmEU.UTTzAxNTKtm},1
751_Total Mother/caregivers (NICHE beneficiaries) who received positive parenting sessions during home visit,V2H52eO9FQa,751_Total Mother/caregivers  nutr c parenting,#{Ayzl7c5BUA6.Py6gFedDbBe} + #{Ayzl7c5BUA6.UTTzAxNTKtm},1
751_Total Mother/caregivers who received nutrition counselling during home visit,LAEF1fXLZqi,751_Total Mother/caregivers  nutrition counsellin,#{OpfNItK9k9d.Py6gFedDbBe} + #{OpfNItK9k9d.UTTzAxNTKtm},1
751_Total Pregnant and lactating  women consuming ≥ 5  food groups in a day,W0snpiBeX1u,51_Total  P&l  women consuming ≥ 5  food ,#{NxPuJeBdAd5.Py6gFedDbBe} + #{NxPuJeBdAd5.UTTzAxNTKtm},1
751_Total Pregnant and lactating women  consuming the recommended  number of meals per day,vuT0WxBenRP,51_Total P&L consuming the recommended ,#{rGCGEOaFEEE.Py6gFedDbBe} + #{rGCGEOaFEEE.UTTzAxNTKtm},1
751_Total Pregnant and lactating women received  nutrition counselling,Bn4fro5Vzd3,51_Total P&L women received  nutrition counselling,#{uc4oYYirXma.Py6gFedDbBe} + #{uc4oYYirXma.UTTzAxNTKtm},1
751_Total Pregnant and lactating women who received nutrition  counselling during home visit,kvwFR5UKsI6,51_Total P&l received nutrition  counselling,#{hDzaai04ezp.Py6gFedDbBe} + #{hDzaai04ezp.UTTzAxNTKtm},1
751_Total Pregnant and lactating women who received positive parenting sessions  during home visi,mgIpQF6Prfj,51_Total CP&L positive parenting sessions,#{vobFwVJchh2.Py6gFedDbBe} + #{vobFwVJchh2.UTTzAxNTKtm},1
751_Total Pregnant women who consumed IFAS,XKOeNdUfien,51_Total Pregnant women who consumed IFAS,#{BKdA4Xrx7dL.Py6gFedDbBe} + #{BKdA4Xrx7dL.UTTzAxNTKtm},1
751_Total Pregnant women who had IFA,SD1aG8GXi5n,51_Total Pregnant women who had IFA,#{ltSt3VLhOcq.Py6gFedDbBe} + #{ltSt3VLhOcq.UTTzAxNTKtm},1
ACT_Percentage Samples Resistant for Amikacin,FOp6nYuntiv,Percentage Samples Resistant for Amikacin,#{vFiiT9A7QmW.pSCWLB1tEMy} + #{P8DS3GTrwon.pSCWLB1tEMy} + #{wxb1U2pT4pV.pSCWLB1tEMy} + #{ZPduJkyoE4m.pSCWLB1tEMy} + #{Wzq3BlPHzj4.pSCWLB1tEMy} + #{NRalulUvSUv.pSCWLB1tEMy},#{vFiiT9A7QmW.ARNjLL9Y0fV} + #{P8DS3GTrwon.ARNjLL9Y0fV} + #{Wzq3BlPHzj4.ARNjLL9Y0fV} + #{wxb1U2pT4pV.ARNjLL9Y0fV} + #{ZPduJkyoE4m.ARNjLL9Y0fV} + #{NRalulUvSUv.ARNjLL9Y0fV}
ACT_Percentage Samples Resistant for Imipenem,VX5MeqENnsY,Percentage Samples Resistant for Imipenem,#{vFiiT9A7QmW.NRyCpmtFS6D} + #{P8DS3GTrwon.NRyCpmtFS6D} + #{wxb1U2pT4pV.NRyCpmtFS6D} + #{ZPduJkyoE4m.NRyCpmtFS6D} + #{Wzq3BlPHzj4.NRyCpmtFS6D} + #{NRalulUvSUv.NRyCpmtFS6D},#{vFiiT9A7QmW.ARNjLL9Y0fV} + #{P8DS3GTrwon.ARNjLL9Y0fV} + #{Wzq3BlPHzj4.ARNjLL9Y0fV} + #{wxb1U2pT4pV.ARNjLL9Y0fV} + #{ZPduJkyoE4m.ARNjLL9Y0fV} + #{NRalulUvSUv.ARNjLL9Y0fV}
ACT_Percentage Samples Resistant for Tigecycline/Minocycline,gjxcAqafWR6,Samples Resistant for Tigecycline/Minocycline,#{vFiiT9A7QmW.aG662VU09Gv} + #{P8DS3GTrwon.aG662VU09Gv} + #{wxb1U2pT4pV.aG662VU09Gv} + #{ZPduJkyoE4m.aG662VU09Gv} + #{Wzq3BlPHzj4.aG662VU09Gv} + #{NRalulUvSUv.aG662VU09Gv},#{vFiiT9A7QmW.ARNjLL9Y0fV} + #{P8DS3GTrwon.ARNjLL9Y0fV} + #{Wzq3BlPHzj4.ARNjLL9Y0fV} + #{wxb1U2pT4pV.ARNjLL9Y0fV} + #{ZPduJkyoE4m.ARNjLL9Y0fV} + #{NRalulUvSUv.ARNjLL9Y0fV}
ACT_Percentage Samples Resistant to Gentamicin,NTEllTwnxHY,Percentage Samples Resistant to Gentamicin,#{vFiiT9A7QmW.xAwiYqKIyxg} + #{P8DS3GTrwon.xAwiYqKIyxg} + #{Wzq3BlPHzj4.xAwiYqKIyxg} + #{wxb1U2pT4pV.xAwiYqKIyxg} + #{ZPduJkyoE4m.xAwiYqKIyxg} + #{NRalulUvSUv.xAwiYqKIyxg},#{vFiiT9A7QmW.ARNjLL9Y0fV} + #{P8DS3GTrwon.ARNjLL9Y0fV} + #{Wzq3BlPHzj4.ARNjLL9Y0fV} + #{wxb1U2pT4pV.ARNjLL9Y0fV} + #{ZPduJkyoE4m.ARNjLL9Y0fV} + #{NRalulUvSUv.ARNjLL9Y0fV}
ACT_Percentage Samples Resistant to Meropenem,u9J0BiQKCIo,Percentage Samples Resistant to Meropenem,#{vFiiT9A7QmW.Ud3t1nnq02A} + #{P8DS3GTrwon.Ud3t1nnq02A} + #{Wzq3BlPHzj4.Ud3t1nnq02A} + #{wxb1U2pT4pV.Ud3t1nnq02A} + #{ZPduJkyoE4m.Ud3t1nnq02A} + #{NRalulUvSUv.Ud3t1nnq02A},#{vFiiT9A7QmW.ARNjLL9Y0fV} + #{P8DS3GTrwon.ARNjLL9Y0fV} + #{Wzq3BlPHzj4.ARNjLL9Y0fV} + #{wxb1U2pT4pV.ARNjLL9Y0fV} + #{ZPduJkyoE4m.ARNjLL9Y0fV} + #{NRalulUvSUv.ARNjLL9Y0fV}
ACT_Percentage Samples Resistant to Piperacillin/Tazobactam,Q2pgaOXj1RJ,Samples Resistant to Piperacillin/Tazobactam,#{vFiiT9A7QmW.qZcD3UI8L8q} + #{P8DS3GTrwon.qZcD3UI8L8q} + #{wxb1U2pT4pV.qZcD3UI8L8q} + #{ZPduJkyoE4m.qZcD3UI8L8q} + #{Wzq3BlPHzj4.qZcD3UI8L8q} + #{NRalulUvSUv.qZcD3UI8L8q},#{vFiiT9A7QmW.ARNjLL9Y0fV} + #{P8DS3GTrwon.ARNjLL9Y0fV} + #{Wzq3BlPHzj4.ARNjLL9Y0fV} + #{wxb1U2pT4pV.ARNjLL9Y0fV} + #{ZPduJkyoE4m.ARNjLL9Y0fV} + #{NRalulUvSUv.ARNjLL9Y0fV}
ACT_Total Samples Intermediate for Amikacin,WaBsE4UxtvZ,Total Samples Intermediate for Amikacin,#{vFiiT9A7QmW.PpEWoGYIRTp} + #{P8DS3GTrwon.PpEWoGYIRTp} + #{wxb1U2pT4pV.PpEWoGYIRTp} + #{ZPduJkyoE4m.PpEWoGYIRTp} + #{Wzq3BlPHzj4.PpEWoGYIRTp} + #{NRalulUvSUv.PpEWoGYIRTp},1
ACT_Total Samples Intermediate for Gentamicin,yggrj7flLJG,Total Samples Intermediate for Gentamicin,#{vFiiT9A7QmW.G2OsZxpAyBI} + #{P8DS3GTrwon.G2OsZxpAyBI} + #{wxb1U2pT4pV.G2OsZxpAyBI} + #{ZPduJkyoE4m.G2OsZxpAyBI} + #{Wzq3BlPHzj4.G2OsZxpAyBI} + #{NRalulUvSUv.G2OsZxpAyBI},1
ACT_Total Samples Intermediate for Imipenem,nlJCbCZeuxZ,Total Samples Intermediate for Imipenem,#{vFiiT9A7QmW.tmajheS6Ck6} + #{P8DS3GTrwon.tmajheS6Ck6} + #{wxb1U2pT4pV.tmajheS6Ck6} + #{ZPduJkyoE4m.tmajheS6Ck6} + #{Wzq3BlPHzj4.tmajheS6Ck6} + #{NRalulUvSUv.tmajheS6Ck6},1
ACT_Total Samples Intermediate for Meropenem,UrH2l2imiyw,Total Samples Intermediate for Meropenem,#{vFiiT9A7QmW.WfSrGP6z6wt} + #{P8DS3GTrwon.WfSrGP6z6wt} + #{Wzq3BlPHzj4.WfSrGP6z6wt} + #{wxb1U2pT4pV.WfSrGP6z6wt} + #{ZPduJkyoE4m.WfSrGP6z6wt} + #{NRalulUvSUv.WfSrGP6z6wt},1
ACT_Total Samples Intermediate for Piperacillin/Tazobactam,JYTAWKlDtlQ,Samples Intermediate for Piperacillin/Tazobactam,#{vFiiT9A7QmW.LnuIxJw9y6F} + #{P8DS3GTrwon.LnuIxJw9y6F} + #{wxb1U2pT4pV.LnuIxJw9y6F} + #{ZPduJkyoE4m.LnuIxJw9y6F} + #{Wzq3BlPHzj4.LnuIxJw9y6F} + #{NRalulUvSUv.LnuIxJw9y6F},1
ACT_Total Samples Intermediate for Tigecycline/Minocycline,He1EkHaB3cl,Samples Intermediate for Tigecycline/Minocycline,#{vFiiT9A7QmW.SErt6P6YrN8} + #{P8DS3GTrwon.SErt6P6YrN8} + #{wxb1U2pT4pV.SErt6P6YrN8} + #{ZPduJkyoE4m.SErt6P6YrN8} + #{Wzq3BlPHzj4.SErt6P6YrN8} + #{NRalulUvSUv.SErt6P6YrN8},1
ACT_Total Samples Resistant for Amikacin,rkudyuX7GKY,Total Samples Resistant for Amikacin,#{vFiiT9A7QmW.pSCWLB1tEMy} + #{P8DS3GTrwon.pSCWLB1tEMy} + #{wxb1U2pT4pV.pSCWLB1tEMy} + #{ZPduJkyoE4m.pSCWLB1tEMy} + #{Wzq3BlPHzj4.pSCWLB1tEMy} + #{NRalulUvSUv.pSCWLB1tEMy},1
ACT_Total Samples Resistant for Imipenem,BfHrOLdBn5d,Total Samples Resistant for Imipenem,#{vFiiT9A7QmW.NRyCpmtFS6D} + #{P8DS3GTrwon.NRyCpmtFS6D} + #{wxb1U2pT4pV.NRyCpmtFS6D} + #{ZPduJkyoE4m.NRyCpmtFS6D} + #{Wzq3BlPHzj4.NRyCpmtFS6D} + #{NRalulUvSUv.NRyCpmtFS6D},1
ACT_Total Samples Resistant for Meropenem,zqADvONQWc8,Total Samples Resistant for Meropenem,#{vFiiT9A7QmW.Ud3t1nnq02A} + #{P8DS3GTrwon.Ud3t1nnq02A} + #{Wzq3BlPHzj4.Ud3t1nnq02A} + #{wxb1U2pT4pV.Ud3t1nnq02A} + #{ZPduJkyoE4m.Ud3t1nnq02A} + #{NRalulUvSUv.Ud3t1nnq02A},1
ACT_Total Samples Resistant for Tigecycline/Minocycline,WLYhZyN3VGY,Samples Resistant for Tigecycline/Minocycline,#{vFiiT9A7QmW.aG662VU09Gv} + #{P8DS3GTrwon.aG662VU09Gv} + #{wxb1U2pT4pV.aG662VU09Gv} + #{ZPduJkyoE4m.aG662VU09Gv} + #{Wzq3BlPHzj4.aG662VU09Gv} + #{NRalulUvSUv.aG662VU09Gv},1
ACT_Total Samples Resistant to Gentamicin ,A2ZFMXzNXNp,Total Samples Resistant to Gentamicin ,#{vFiiT9A7QmW.xAwiYqKIyxg} + #{P8DS3GTrwon.xAwiYqKIyxg} + #{Wzq3BlPHzj4.xAwiYqKIyxg} + #{wxb1U2pT4pV.xAwiYqKIyxg} + #{ZPduJkyoE4m.xAwiYqKIyxg} + #{NRalulUvSUv.xAwiYqKIyxg},1
ACT_Total Samples Resistant to Piperacillin/Tazobactam,W48SIgA3ZDl,Total Samples Resistant to Piperacillin/Tazobactam,#{vFiiT9A7QmW.qZcD3UI8L8q} + #{P8DS3GTrwon.qZcD3UI8L8q} + #{wxb1U2pT4pV.qZcD3UI8L8q} + #{ZPduJkyoE4m.qZcD3UI8L8q} + #{Wzq3BlPHzj4.qZcD3UI8L8q} + #{NRalulUvSUv.qZcD3UI8L8q},1
ACT_Total Samples Susceptible to Amikacin,u1jOvQO6pYu,Total Samples Susceptible to Amikacin,#{vFiiT9A7QmW.WFxU8392Wwp} + #{P8DS3GTrwon.WFxU8392Wwp} + #{wxb1U2pT4pV.WFxU8392Wwp} + #{ZPduJkyoE4m.WFxU8392Wwp} + #{Wzq3BlPHzj4.WFxU8392Wwp} + #{NRalulUvSUv.WFxU8392Wwp},1
ACT_Total Samples Susceptible to Gentamicin,cdeTr52Eiwb,Total Samples Susceptible to Gentamicin,#{vFiiT9A7QmW.BhOwjz6RPEV} + #{P8DS3GTrwon.BhOwjz6RPEV} + #{wxb1U2pT4pV.BhOwjz6RPEV} + #{ZPduJkyoE4m.BhOwjz6RPEV} + #{Wzq3BlPHzj4.BhOwjz6RPEV} + #{NRalulUvSUv.BhOwjz6RPEV},1
ACT_Total Samples Susceptible to Imipenem,Q64DkGjWlrf,Total Samples Susceptible to Imipenem,#{vFiiT9A7QmW.zIl9NFPK5SN} + #{P8DS3GTrwon.zIl9NFPK5SN} + #{wxb1U2pT4pV.zIl9NFPK5SN} + #{ZPduJkyoE4m.zIl9NFPK5SN} + #{Wzq3BlPHzj4.zIl9NFPK5SN} + #{NRalulUvSUv.zIl9NFPK5SN},1
ACT_Total Samples Susceptible to Meropenem,kWTjp8uQYBQ,Total Samples Susceptible to Meropenem,#{vFiiT9A7QmW.GQsIcaV9Uor} + #{P8DS3GTrwon.GQsIcaV9Uor} + #{wxb1U2pT4pV.GQsIcaV9Uor} + #{ZPduJkyoE4m.GQsIcaV9Uor} + #{Wzq3BlPHzj4.GQsIcaV9Uor} + #{NRalulUvSUv.GQsIcaV9Uor},1
ACT_Total Samples Susceptible to Piperacillin/Tazobactam,cSQ7dnxm7Dm,Samples Susceptible to Piperacillin/Tazobactam,#{vFiiT9A7QmW.LRRsvxMFLAB} + #{P8DS3GTrwon.LRRsvxMFLAB} + #{wxb1U2pT4pV.LRRsvxMFLAB} + #{ZPduJkyoE4m.LRRsvxMFLAB} + #{Wzq3BlPHzj4.LRRsvxMFLAB} + #{NRalulUvSUv.LRRsvxMFLAB},1
ACT_Total Samples Susceptible to Tigecycline/Minocycline,HP2dYD6zHWP,Samples Susceptible to Tigecycline/Minocycline,#{vFiiT9A7QmW.NQ4K2bbvuVp} + #{P8DS3GTrwon.NQ4K2bbvuVp} + #{wxb1U2pT4pV.NQ4K2bbvuVp} + #{ZPduJkyoE4m.NQ4K2bbvuVp} + #{Wzq3BlPHzj4.NQ4K2bbvuVp} + #{NRalulUvSUv.NQ4K2bbvuVp},1
AEFI Deaths,AoNid8qa4iP,AEFI Deaths,#{AyO5TjcPFNa.GR4pbqLKhMV} + #{AyO5TjcPFNa.EqEj84xFkHz},1
AEFI Total,duEwnPpZTeJ,AEFI Total,#{AyO5TjcPFNa.dCd7yKlyqk4} + #{AyO5TjcPFNa.PTWBeC1K2HJ},1
ALOS-Eye Ward,VGyf4CdHaIC,ALOS-Eye Ward,#{bRP7RnMWTK8.CFyfkW0xUuP},#{bRP7RnMWTK8.n46ELgn5X5P}+#{bRP7RnMWTK8.IBZaTcO3Odv}
ALOS-Gynacology Ward,SuxFlDE6wcc,ALOS-Gynacology Ward,#{zqqP41WTYNk.CFyfkW0xUuP},#{zqqP41WTYNk.n46ELgn5X5P}+#{zqqP41WTYNk.IBZaTcO3Odv}
ALOS-Isolation Ward,GaOtmeGwMoJ,ALOS-Isolation Ward,#{ndneSgDusqj.CFyfkW0xUuP},#{ndneSgDusqj.n46ELgn5X5P}+#{ndneSgDusqj.IBZaTcO3Odv}
ALOS-Labour Ward,F8I8mCXTA6x,ALOS-Labour Ward,#{KcmpbSvRETO.CFyfkW0xUuP},#{KcmpbSvRETO.n46ELgn5X5P}+#{KcmpbSvRETO.IBZaTcO3Odv}
ALOS-Maternity Ward,D86kACPy6yN,ALOS-Maternity Ward,#{C3srxhSBods.CFyfkW0xUuP},#{C3srxhSBods.n46ELgn5X5P}+#{C3srxhSBods.IBZaTcO3Odv}
ALOS-Medical ward Female,sbyH9ladTCm,ALOS-Medical ward Female,#{S9BU0xS5QRf.CFyfkW0xUuP},#{S9BU0xS5QRf.n46ELgn5X5P}+#{S9BU0xS5QRf.IBZaTcO3Odv}
ALOS-Medical ward Male,dLgwSdyCt0Q,ALOS-Medical ward Male,#{OdXZaAsAGRU.CFyfkW0xUuP},#{OdXZaAsAGRU.n46ELgn5X5P}+#{OdXZaAsAGRU.IBZaTcO3Odv}
ALOS-Nursery/Neonatal Ward,NVc6l6PY8z8,ALOS-Neonatal Ward,#{VuMnNeKMui9.CFyfkW0xUuP},#{VuMnNeKMui9.n46ELgn5X5P}+#{VuMnNeKMui9.IBZaTcO3Odv}
ALOS-Orthopaedic Ward,YuInOYoV6gJ,ALOS-Orthopaedic Ward,#{Y1sxN73phAf.CFyfkW0xUuP},#{Y1sxN73phAf.n46ELgn5X5P}+#{Y1sxN73phAf.IBZaTcO3Odv}
ALOS-Paediatric Ward,Q8eF9CGeVTS,ALOS-Paediatric Ward,#{IgnbdUEWMd4.CFyfkW0xUuP},#{IgnbdUEWMd4.n46ELgn5X5P}+#{IgnbdUEWMd4.IBZaTcO3Odv}
ALOS-Psychastric Ward,Z7FHK3rpzuz,ALOS-Psychastric Ward,#{BcVftn5I5NL.CFyfkW0xUuP},#{BcVftn5I5NL.n46ELgn5X5P}+#{BcVftn5I5NL.IBZaTcO3Odv}
ALOS-Surgical Female,jo06euHLqwf,ALOS-Surgical Female,#{rAvVxANpmvq.CFyfkW0xUuP},#{rAvVxANpmvq.n46ELgn5X5P}+#{rAvVxANpmvq.IBZaTcO3Odv}
ALOS-Surgical Male,VlECsNIaGD7,ALOS-Surgical Male,#{slxcaBIJQFz.CFyfkW0xUuP},#{slxcaBIJQFz.n46ELgn5X5P}+#{slxcaBIJQFz.IBZaTcO3Odv}
ALOS-Surgical Ward,GJLCZvnaYD0,ALOS-Surgical Ward,#{knorevTYX7E.CFyfkW0xUuP},#{knorevTYX7E.n46ELgn5X5P}+#{knorevTYX7E.IBZaTcO3Odv}
AMR2022_Total Antibiotics prescribed (A+W+R),BZsZ1Pr2mSP,Total Antibiotics prescribed (A+W+R),#{zYtdGkdOanM} + #{N8XqxpY3jSl} + #{fLo8zLS5Jhk},1
ANC,okee8vB9sHU,ANC 4th visit Perf,#{Fz0LzxMT1vV.NhSoXUMPK2K},#{gZi8zx858OK.ea7VHlwMkhH}
ANC 1 Eligibility CD4 Proportion,DlIKY5bdQVp,ANC 1 Eligibility CD4,#{BhaetsBTxPa.NhSoXUMPK2K},#{BhaetsBTxPa.NhSoXUMPK2K}+#{HYyJiuoyiLb.NhSoXUMPK2K}
ANC 1 Eligibility WHO Staging Done Proportion,lcjsabkMhcj,ANC 1 Elig WHO Stag Done,#{HYyJiuoyiLb.NhSoXUMPK2K},#{BhaetsBTxPa.NhSoXUMPK2K}+#{HYyJiuoyiLb.NhSoXUMPK2K}
ANC Attendance New Clients,twcLHU9joUY,ANC Att New Clients,#{uTQOSp7rx5h.wBWcFk7k1qY},1
ANC Coverage,xBL1QPNXkFe,ANC Coverage,#{uSxBUWnagGg},#{IDeJME1RKqM}
ANC Partners Tested among New ANC Clients Coverage,enq4ZMlxJ0o,ANC Partners tested Cov,#{N9VDFWZAumw.NhSoXUMPK2K},#{f9vesk5d4IY.NhSoXUMPK2K}
ANC Testing for Syphilis Missed Opportunities,sf0cYtioY7t,ANC Testing for Syphilis Missed Opportunities,#{uSxBUWnagGg} - #{i5jVVTm1vI8},1
ANC Testing for Syphilis Missed Opportunity,xNTM673ne69,ANC Testing for Syphilis Missed Opportunity,#{uSxBUWnagGg} - #{i5jVVTm1vI8},1
ANC Unreached Mothers,RSzsd0SElQl,ANC Unreached Mothers,#{pct05jgGcLt} - #{uSxBUWnagGg},1
ANC clients Tested HIV among New ANC Clients Coverage,tO5gJgq9Ns5,ANC clients Test HIV Cov,#{nspwXhqQaAz.NhSoXUMPK2K},#{uTQOSp7rx5h.wBWcFk7k1qY}
ART Uptake,PPCY2IpH927,ART Uptake,#{sEtNuNusKTT},#{NYkr7LlxmUg}
Accounting Rate of fund  from Partners,WdZV67bSOL0,Accounting Rate partners ,#{oMWJpAyAIUh.ho19GFuJL4X},#{uq2Izs9ZGT7.ho19GFuJL4X}
Adrenaline Injection 1mg/ml (Ampoule) MoS,SFwHgXxyaBX,Adrenaline Injection 1mg/ml (Ampoule) MoS,#{PcX1hwl7aQD.n8XlCFUpWOG},#{SNj7ETKcFO3.QvctQfKAQn3}
Adults >15 Years Tested,pIgWDXbG9zG,Adults >15 Years Tested,#{YXJf27jfkvS} + #{XiRbc0DSMOH} + #{JiuqbydCIcy} + #{pkShOkgNQt2} + #{atSQz5O7e2A} + #{gTkVw97FnQK},1
Adults >15 years New ART,t2cMsNss42N,Adults >15 years New ART,#{DaNcGZnkclz} + #{yWkSi8L3qGm} + #{zNCSlBKbS6d} + #{K59f8nZ5vhy} + #{Nv4OkbdDvmm} + #{SCMKsiNj6c5},1
Adults >15 years on ART,wgmEn2Gip5h,Adults >15 years on ART,#{AQsTt7jtKbt} + #{oOOnacUi9Jm} + #{EhZQp3PTA3C} + #{e93GKJTHKAX} + #{yNCUlEYkmyA} + #{pR7VzBydoj3},1
Adults >15+ years Positive,BO7eh2rJdtZ,Adults >15+ years Positive,#{xMNhnyu7vm1} + #{kLXGWRLzCAw} + #{oCFXmpol7D8} + #{F9OR49Lc1aR} + #{cBTa1jVzT8f} + #{J4vNm7YEkdj},1
Albendazole Tab. 400mg (Tablet) MoS,uHSqkMzQWbJ,Albendazole Tab. 400mg (Tablet) MoS,#{Klw6Oa18M4Y.n8XlCFUpWOG},#{Rmx1tNUwJyb.QvctQfKAQn3}
All Other Family planning Methods CYP,Kr3A94oQ66i,All Other CYP,#{M9wNpvfC8wb.wBWcFk7k1qY}+#{M9wNpvfC8wb.K4WLOEhtcvC},
"Amoxicillin Capsules, 500mg (Capsule) MoS",m2Dxu9fe9Ps,"Amoxicillin Capsules, 500mg (Capsule) MoS",#{QGugDSQXwPR.n8XlCFUpWOG},#{TjTv4RDUy8A.QvctQfKAQn3}
"Amoxicillin Dispersible Tablets, 250mg (Tablet) MoS",VA3KZphR8Dc,"Amoxicillin Dispersible Tablets, 250mg (Tablet) ",#{t8vd4GgcRmh.n8XlCFUpWOG},#{DJC8qxQeJA6.QvctQfKAQn3}
Artemether-Lumefantrine 20/120 Tabs 12s Adjusted Consumption,nnA359PSbbZ,Artemether-Lumefant 12s,#{c0MB4RmVjxk.w77uMi1KzOH}*31,31-#{c0MB4RmVjxk.DV8l1KuASLR}
Artemether-Lumefantrine 20/120 Tabs 12s MOS,bJILAolJsSJ,AL 20/120 Tabs 12s MOS,#{c0MB4RmVjxk.rPAsF4cpNxm},#{c0MB4RmVjxk.w77uMi1KzOH}
Artemether-Lumefantrine 20/120 Tabs 12s Quantity for resupply,iPZNMIfNg6i,Artemether-Lumefantrine 20/120 Tabs 12s Resupply,(((#{c0MB4RmVjxk.w77uMi1KzOH}*[days])/([days]-#{c0MB4RmVjxk.DV8l1KuASLR}))*3)-#{c0MB4RmVjxk.rPAsF4cpNxm},1
Artemether-Lumefantrine 20/120 Tabs 18s Adjusted Consumption,GCY4FVWIs0Y,Artemether-Lumefant 18s,#{qnZmg5tNSMy.w77uMi1KzOH}*31,31-#{qnZmg5tNSMy.DV8l1KuASLR}
Artemether-Lumefantrine 20/120 Tabs 18s MOS,jtGNoWcdNcx,AL 20/120 Tabs 18s MOS,#{qnZmg5tNSMy.rPAsF4cpNxm},(#{qnZmg5tNSMy.w77uMi1KzOH})
Artemether-Lumefantrine 20/120 Tabs 18s Quantity for Resupply,CMI1h51t2A0,Artemether-Lumefantrine 20/120 Tabs 18s,((#{qnZmg5tNSMy.w77uMi1KzOH}*[days]/[days]-#{qnZmg5tNSMy.DV8l1KuASLR})*3)-#{qnZmg5tNSMy.rPAsF4cpNxm},1
Artemether-Lumefantrine 20/120 Tabs 24s Adjusted Consumption,y4m0W9q3PTQ,Artemether-Lumefant 24s,#{gVp1KSFI69G.w77uMi1KzOH}*31,31-#{gVp1KSFI69G.DV8l1KuASLR}
Artemether-Lumefantrine 20/120 Tabs 24s MOS,p2aNqT2HVyr,AL 20/120 Tabs 24s MOS,#{gVp1KSFI69G.rPAsF4cpNxm},#{gVp1KSFI69G.w77uMi1KzOH}
Artemether-Lumefantrine 20/120 Tabs 24s Quantity for Resupply,meGWfNwmwmP,Artemether-Lumefantrine 20/120 Tabs 24s,((#{gVp1KSFI69G.w77uMi1KzOH}*[days]/[days]-#{gVp1KSFI69G.DV8l1KuASLR})*3)-#{gVp1KSFI69G.rPAsF4cpNxm},1
Artemether-Lumefantrine 20/120 Tabs 6s Adj. Consumption,hTw8knRVCg1,Artemether-Lumefantrine 20/120 Tabs	6s,(#{BnGDrFwyQp9.w77uMi1KzOH})*(31/(31-(#{BnGDrFwyQp9.DV8l1KuASLR}))),1
Artemether-Lumefantrine 20/120 Tabs 6s Adjusted Consumption,KQIGSNSVcUV,Artemether-Lumefant 6s,#{BnGDrFwyQp9.w77uMi1KzOH}*31,31-#{BnGDrFwyQp9.DV8l1KuASLR}
Artemether-Lumefantrine 20/120 Tabs 6s MOS (PeriodOffset),zLR3PBVPgN5,Artemether-Lumefantrine 20/120 Tabs 6s,#{BnGDrFwyQp9.rPAsF4cpNxm},(#{BnGDrFwyQp9.w77uMi1KzOH}+#{BnGDrFwyQp9.w77uMi1KzOH}.periodOffset(-1)+#{BnGDrFwyQp9.w77uMi1KzOH}.periodOffset(-2))/3
Artemether-Lumefantrine 20/120 Tabs 6s Quantity for Resupply,XXCjzZhZ1P3,Artemether-Lumefantrine 20/120 Tabs 6s,((#{BnGDrFwyQp9.w77uMi1KzOH}*[days]/[days]-#{BnGDrFwyQp9.DV8l1KuASLR})*3)-#{BnGDrFwyQp9.rPAsF4cpNxm},1
Artesunate  Injection 60mg Adjusted Consumption,nqQqZv3NUYF,Artesunate  Injection 60mg Adjusted Consumption,#{iOARK31NdLp.w77uMi1KzOH}*31,31-#{iOARK31NdLp.DV8l1KuASLR}
Artesunate Injection 60mg Quantity for Resupply,XO9ObBjwNY3,Artesunate Injection 60mg Quantity for Resupply,((#{iOARK31NdLp.w77uMi1KzOH}*[days]/[days]-#{iOARK31NdLp.DV8l1KuASLR})*3)-#{iOARK31NdLp.rPAsF4cpNxm},1
Assessed for Eligibility in ANC (Sum HV02-18 to HV02-19),FJcNQJIxxbW, (Sum HV02-18 to HV02-19),#{BhaetsBTxPa.NhSoXUMPK2K}+#{HYyJiuoyiLb.NhSoXUMPK2K},1
Astrazeneca_Vaccine_Type,FJ5pE7FXWwq,Astrazeneca_Vaccine_Type,#{myQD3R0GBUq} + #{ZWMO83OyDwx},1
Available Bed Days - Medical Ward Male,U0ML2A0jzg5,ABD-Male,(#{OdXZaAsAGRU.fgY5yxfRFHN}+#{OdXZaAsAGRU.ERX6phnRjMW})*[days],1
Available Bed Days -Amenity Ward,ZuriRAmTbqe,ABD Amenity ward,(#{zTIGTbphtuA.fgY5yxfRFHN}+#{zTIGTbphtuA.ERX6phnRjMW})*[days],1
Available Bed Days -Eye Ward,jzzmWpiuiOM,ABD - Eye,(#{bRP7RnMWTK8.fgY5yxfRFHN}+#{bRP7RnMWTK8.ERX6phnRjMW})*[days],1
Available Bed Days -Gynaecology Ward,y8K4w6WcxoM,ABD-Gynaecology Ward,(#{zqqP41WTYNk.fgY5yxfRFHN}+#{zqqP41WTYNk.ERX6phnRjMW})*[days],1
Available Bed Days -Isolation ward,g9ctORNwWSV,Available Bed Days -Isola,(#{ndneSgDusqj.fgY5yxfRFHN}+#{ndneSgDusqj.ERX6phnRjMW})*[days],1
Available Bed Days -Orthopaedic ward,OTT6wcpQsex,Available Bed Days -Ortho,(#{Y1sxN73phAf.fgY5yxfRFHN}+#{Y1sxN73phAf.ERX6phnRjMW})*[days],1
Available Bed Days -Psychatric ward,XROBhcooEd3,Available Bed Days -Psych,(#{BcVftn5I5NL.fgY5yxfRFHN}+#{BcVftn5I5NL.ERX6phnRjMW})*[days],1
Available Bed Days -Surgical Ward,j9wSbrgcajj,ABD -Surgical Ward,(#{knorevTYX7E.fgY5yxfRFHN}+#{knorevTYX7E.ERX6phnRjMW})*[days],1
Available Bed Days -Surgical Ward Female,on2WNNeK59j,ABD -Surgical Female,(#{rAvVxANpmvq.fgY5yxfRFHN}+#{rAvVxANpmvq.ERX6phnRjMW})*[days],1
Available Bed Days -Surgical Ward Male,DqytHkP6XNm,ABD S Male,(#{slxcaBIJQFz.fgY5yxfRFHN}+#{slxcaBIJQFz.ERX6phnRjMW})*[days],1
Available Bed Days= Labour Ward,iTGkpgO5j2l,ABD labour,(#{KcmpbSvRETO.fgY5yxfRFHN}+#{KcmpbSvRETO.ERX6phnRjMW})*[days],1
Available Bed Days= Maternity ward,xmQceOIOmeH,ABD -Maternity,(#{C3srxhSBods.fgY5yxfRFHN}+#{C3srxhSBods.ERX6phnRjMW})*[days],1
Available Bed Days= Medical Ward Female,B5aFsyZtDAa,ABD-Female,(#{S9BU0xS5QRf.fgY5yxfRFHN}+#{S9BU0xS5QRf.ERX6phnRjMW})*[days],1
Available Bed Days= Nursery/Newborn Ward,srcNPwcFD0X,ABD- Newborn,(#{VuMnNeKMui9.fgY5yxfRFHN}+#{VuMnNeKMui9.ERX6phnRjMW})*[days],1
Available Bed Days= paediatric ward,t8W9dUGRkFx,ABD _Paedriatric,(#{IgnbdUEWMd4.fgY5yxfRFHN}+#{IgnbdUEWMd4.ERX6phnRjMW})*[days],1
Average Daily Attendace of Outpatient ,B5qDJwsJnYo,Average daily OPD,#{rIkD2jIDqPh}+#{zXzBILTVJzD}+#{Ha96SBKI06u}+#{F6AwnxbwiK2}+#{x13zGZKuxzs}+#{uTQOSp7rx5h}+#{EsfvxFcltV0}+#{aq64ukEqs2N}+#{JQkE0bN9OTB}+#{d3jNYZueSmn}+#{hAH08l33p9B}+#{JGbmLfjZPEf}+#{SyUQl638r5P}+#{T22hPVk4yGZ}+#{T22hPVk4yGZ}+#{QStt76mU06X}+#{DpR59HXC0jW}+#{GAeKNgKXNDm}+#{WEW9Bjga52F},
Average Length of Stay(ALOS) in the Out patient Therapeutic Program (OTP Nutrition) for children aged 6-59 months ,GVBWxeRKGDs,ALOS Out Patient Nutrition <5years,#{amZpTJLE3oC.g3NguFeSV2h} + #{amZpTJLE3oC.J4oQVAR80oo}, #{d0mQHTddjre.g3NguFeSV2h} + #{d0mQHTddjre.J4oQVAR80oo}
Average Length of Stay(ALOS) in the SFP program (Nutrition) for Pregnant & Lactating mothers,cLy4vKhH9HQ,ALOS Supplementary Nutrition PLW,#{uK4Xo8S4bF4.RxueJ9pzyTM},#{myEpgfhSPLZ.RxueJ9pzyTM}
Average Length of Stay(ALOS) in the SFP program (Nutrition) for children aged 6-59 months ,Rj70cn4Z0TO,ALOS Supplementary 6-59 months,#{uK4Xo8S4bF4.g3NguFeSV2h} + #{uK4Xo8S4bF4.J4oQVAR80oo},#{myEpgfhSPLZ.g3NguFeSV2h} + #{myEpgfhSPLZ.J4oQVAR80oo}
Average Length of Stay(ALOS) in the inpatient / Stabilization Centre Nutrition <5years,EL9fHM8H6N2,ALOS Stabilization Centre Nutrition <5years,#{pmkDjxnh6gS.KfdnIJGDpJ4} + #{pmkDjxnh6gS.g3NguFeSV2h} + #{pmkDjxnh6gS.J4oQVAR80oo},#{kXsIskFokOj.KfdnIJGDpJ4} + #{kXsIskFokOj.g3NguFeSV2h} + #{kXsIskFokOj.J4oQVAR80oo}
Average Monthly Consumption -Artemether ,sHEyyFyUMuI,Average Monthly Consumption -Artemether ,#{c0MB4RmVjxk.w77uMi1KzOH},[days]-#{c0MB4RmVjxk.DV8l1KuASLR}
Average Occupancy,eZmygU9T4Se,Average Occupancy,#{R6Z03VUZ0YU.JUI7tesx6as}+#{KeluwzeRirR.JUI7tesx6as}+#{R6Z03VUZ0YU.Lj5arkL7GL8}+#{KeluwzeRirR.Lj5arkL7GL8}+#{R6Z03VUZ0YU.ObiJr399QRt}+#{KeluwzeRirR.ObiJr399QRt}+#{R6Z03VUZ0YU.bPNw3Km3Ug7}+#{KeluwzeRirR.bPNw3Km3Ug7},1
Average length of stay (ALOS) medical wards scorecard,lQuPyRjlcfC,Average length of stay (ALOS) medical wards,(#{R6Z03VUZ0YU.Lj5arkL7GL8}+#{KeluwzeRirR.Lj5arkL7GL8})/(#{o6RJFSXIelv.Lj5arkL7GL8}+#{JbfEjiVnE6z.Lj5arkL7GL8}+#{GM77KVNoX6u.Lj5arkL7GL8}),1
BCG Wastage Rate,t33qItEEF1p,BCG Wastage Rate,#{d8MsenqQaMv.NhSoXUMPK2K}+#{mRVVnw1KKSL.NhSoXUMPK2K}-#{iIlheePZjCc.NhSoXUMPK2K}-#{O3qECFGrzeF.bCfwecaPx2W}+#{O3qECFGrzeF.ieuodyY5ybC},#{d8MsenqQaMv.NhSoXUMPK2K}+#{mRVVnw1KKSL.NhSoXUMPK2K}
BCG Wastage Rate (WR),Jzllq7K3gyH,BCG Wastage Rate,((#{d8MsenqQaMv.NhSoXUMPK2K}+#{mRVVnw1KKSL.NhSoXUMPK2K})-#{iIlheePZjCc.NhSoXUMPK2K})-#{O3qECFGrzeF},(#{d8MsenqQaMv.NhSoXUMPK2K}+#{mRVVnw1KKSL.NhSoXUMPK2K})-#{iIlheePZjCc.NhSoXUMPK2K}
BTL Couple year protection,N3FFtxkRDCy,BTL CYP,(#{PggNwT09D3U} + #{g6Wk32DjOez})*10,1
Bacteriologically confirmed TB cases,ktg50fndz9b,Bacteriologically  confirmed TB cases,#{z8QuJHnjbnq.WwOVo8ccFpn},1
Bed Occupancy Rate,MRllWHKmVua,Bed Occ Rate,#{R6Z03VUZ0YU} + #{R6Z03VUZ0YU.Lj5arkL7GL8} + #{R6Z03VUZ0YU.KFmqREu0VSL} + #{R6Z03VUZ0YU.rYfAgBnJKnj} + #{R6Z03VUZ0YU.ObiJr399QRt} + #{R6Z03VUZ0YU.bPNw3Km3Ug7} + #{R6Z03VUZ0YU.oJ6IUNugflo} + #{R6Z03VUZ0YU.vr2WcWaojbO} + #{R6Z03VUZ0YU.B0ji6ZY2zJ3} + #{R6Z03VUZ0YU.szjWdpjHTDe} + #{R6Z03VUZ0YU.JUI7tesx6as} + #{R6Z03VUZ0YU.O68sxX0pJMT} + #{R6Z03VUZ0YU.tMEFFDHQCAW} + #{R6Z03VUZ0YU.R99ctw9w6Kt} + #{R6Z03VUZ0YU.Qy5yADe3SiB} + #{KeluwzeRirR} + #{KeluwzeRirR.Lj5arkL7GL8} + #{KeluwzeRirR.KFmqREu0VSL} + #{KeluwzeRirR.rYfAgBnJKnj} + #{KeluwzeRirR.rYfAgBnJKnj} + #{KeluwzeRirR.ObiJr399QRt} + #{KeluwzeRirR.bPNw3Km3Ug7} + #{KeluwzeRirR.oJ6IUNugflo} + #{KeluwzeRirR.vr2WcWaojbO} + #{KeluwzeRirR.B0ji6ZY2zJ3} + #{KeluwzeRirR.szjWdpjHTDe} + #{KeluwzeRirR.JUI7tesx6as} + #{KeluwzeRirR.O68sxX0pJMT} + #{KeluwzeRirR.tMEFFDHQCAW} + #{KeluwzeRirR.R99ctw9w6Kt} + #{KeluwzeRirR.Qy5yADe3SiB},#{K3i0LumP9MU} + #{K3i0LumP9MU.Lj5arkL7GL8} + #{K3i0LumP9MU.KFmqREu0VSL} + #{K3i0LumP9MU.rYfAgBnJKnj} + #{K3i0LumP9MU.ObiJr399QRt} + #{K3i0LumP9MU.bPNw3Km3Ug7} + #{K3i0LumP9MU.oJ6IUNugflo} + #{K3i0LumP9MU.vr2WcWaojbO} + #{K3i0LumP9MU.B0ji6ZY2zJ3} + #{K3i0LumP9MU.szjWdpjHTDe} + #{K3i0LumP9MU.JUI7tesx6as} + #{K3i0LumP9MU.O68sxX0pJMT} + #{K3i0LumP9MU.tMEFFDHQCAW} + #{K3i0LumP9MU.R99ctw9w6Kt} + #{K3i0LumP9MU.Qy5yADe3SiB} + #{Q9bZ7fvL0c3} + #{Q9bZ7fvL0c3.Lj5arkL7GL8} + #{Q9bZ7fvL0c3.KFmqREu0VSL} + #{Q9bZ7fvL0c3.rYfAgBnJKnj} + #{Q9bZ7fvL0c3.ObiJr399QRt} + #{Q9bZ7fvL0c3.bPNw3Km3Ug7} + #{Q9bZ7fvL0c3.oJ6IUNugflo} + #{Q9bZ7fvL0c3.vr2WcWaojbO} + #{Q9bZ7fvL0c3.B0ji6ZY2zJ3} + #{Q9bZ7fvL0c3.szjWdpjHTDe} + #{Q9bZ7fvL0c3.JUI7tesx6as} + #{Q9bZ7fvL0c3.O68sxX0pJMT} + #{Q9bZ7fvL0c3.tMEFFDHQCAW} + #{Q9bZ7fvL0c3.R99ctw9w6Kt} + #{Q9bZ7fvL0c3.Qy5yADe3SiB} * 30.5
Benzyl penicillin Injection 1 MU (Vial) MoS,h1NaQphYTFv,Benzyl penicillin Injection 1 MU (Vial),#{QYT9nPwdqOz.n8XlCFUpWOG},#{G8JcgB3ZHT8.QvctQfKAQn3}
Benzyl penicillin Injection 5 MU (Vial) MoS,rdUP34gG5z7,Benzyl penicillin Injection 5 MU (Vial),#{xvX0hsq7F8j.n8XlCFUpWOG},#{Slds2fjm6k5.QvctQfKAQn3}
C&T ART Retention Rate,lcNiLGUuIHs,C&T ART Retention Rate,#{p1wJaxpErlY.NhSoXUMPK2K},#{RwTKRWWKGhn.NhSoXUMPK2K}
C&T Proportion receiving CTX,L7hQb27Pvym,Proportion receiving CTX ,#{F9ZGgbM0Bg1.NhSoXUMPK2K},#{koLybf8Nw4h.NhSoXUMPK2K}
C&T TB Screening Rate,XfNWNKLW8iJ,C&T TB Screening Rate,#{RZzhjN1F54S.NhSoXUMPK2K},#{uBEYxUvmeys.NhSoXUMPK2K}
C&T_1st 90 Uptake Adults,XGy0MSNVXhL,C&T_1st 90 Uptake Adults,(#{oOOnacUi9Jm} + #{AQsTt7jtKbt} + #{e93GKJTHKAX} + #{EhZQp3PTA3C} + #{pR7VzBydoj3} + #{yNCUlEYkmyA}),(#{oOOnacUi9Jm} + #{AQsTt7jtKbt} + #{e93GKJTHKAX} + #{EhZQp3PTA3C} + #{pR7VzBydoj3} + #{yNCUlEYkmyA}) + (#{kLXGWRLzCAw} + #{xMNhnyu7vm1} + #{F9OR49Lc1aR} + #{oCFXmpol7D8} + #{J4vNm7YEkdj} + #{cBTa1jVzT8f}) - (#{yWkSi8L3qGm} + #{DaNcGZnkclz} + #{Nv4OkbdDvmm} + #{K59f8nZ5vhy} + #{zNCSlBKbS6d} + #{SCMKsiNj6c5})
C&T_1st 90 coverage Overall,pw8L0GLvlfW,C&T_1st 90 coverage Overall,(#{GSEmLUnrvzj} + #{Jbu4if6gtDp} + #{AQsTt7jtKbt} + #{oOOnacUi9Jm} + #{EhZQp3PTA3C} + #{e93GKJTHKAX} + #{yNCUlEYkmyA} + #{pR7VzBydoj3} + #{wbJOu4h2SSz} + #{SJL4k6Gl53C} ),(#{G1x3DL1qaEa} + #{QVW8F6CrQE1})
C&T_1st 90 coverage of Adults,NKf30SkTi47,C&T_1st 90 coverage of Adults,(#{oOOnacUi9Jm} + #{AQsTt7jtKbt} + #{EhZQp3PTA3C} + #{e93GKJTHKAX} + #{yNCUlEYkmyA} + #{pR7VzBydoj3}),#{QVW8F6CrQE1}
C&T_1st 90 coverage of adolescents,BFUhCMyvQg9,C&T_1st 90 coverage of adolescents,(#{Jbu4if6gtDp} + #{GSEmLUnrvzj} + #{oOOnacUi9Jm} + #{AQsTt7jtKbt}),#{chNcH4HrZyF}
C&T_1st 90 coverage of young adults,BvOQZuISXdw,C&T_1st 90 coverage of young adults,(#{oOOnacUi9Jm} + #{AQsTt7jtKbt} + #{EhZQp3PTA3C} + #{e93GKJTHKAX}),#{ircjJjsE4UL}
C&T_1st 90 uptake adolescents,JgvGOrW0rYU,C&T_1st 90 uptake adolescents,(#{Jbu4if6gtDp} + #{GSEmLUnrvzj} + #{oOOnacUi9Jm} + #{AQsTt7jtKbt}),(#{Jbu4if6gtDp} + #{GSEmLUnrvzj} + #{oOOnacUi9Jm} + #{AQsTt7jtKbt}) + (#{D9YwtS6RhQ1} + #{wu0ITFRjUzF} + #{kLXGWRLzCAw} + #{xMNhnyu7vm1}) - (#{LC2OqnUC5Sn} + #{jthpt5cVV9c} + #{yWkSi8L3qGm} + #{DaNcGZnkclz})
C&T_1st 90 uptake children,xv44jZswxKI,C&T_1st 90 uptake children,(#{SJL4k6Gl53C} + #{wbJOu4h2SSz} + #{Jbu4if6gtDp} + #{GSEmLUnrvzj}),(#{SJL4k6Gl53C} + #{wbJOu4h2SSz} + #{Jbu4if6gtDp} + #{GSEmLUnrvzj}) + (#{du5RMT3aecB} + #{D9YwtS6RhQ1} + #{wu0ITFRjUzF} + #{DMr8fYCKJzF}) - (#{mACm1JUzeLT} + #{Hbc2qRi0U5x} + #{LC2OqnUC5Sn} + #{jthpt5cVV9c})
C&T_1st 90 uptake overall,VZEqI3QOvkm,C&T_1st 90 uptake overall,(#{SJL4k6Gl53C} + #{wbJOu4h2SSz} + #{Jbu4if6gtDp} + #{GSEmLUnrvzj} + #{oOOnacUi9Jm} + #{AQsTt7jtKbt} + #{e93GKJTHKAX} + #{EhZQp3PTA3C} + #{pR7VzBydoj3} + #{yNCUlEYkmyA}),(#{SJL4k6Gl53C} + #{wbJOu4h2SSz} + #{Jbu4if6gtDp} + #{GSEmLUnrvzj} + #{oOOnacUi9Jm} + #{AQsTt7jtKbt} + #{e93GKJTHKAX} + #{EhZQp3PTA3C} + #{pR7VzBydoj3} + #{yNCUlEYkmyA}) + (#{du5RMT3aecB} + #{D9YwtS6RhQ1} + #{wu0ITFRjUzF} + #{kLXGWRLzCAw} + #{xMNhnyu7vm1} + #{F9OR49Lc1aR} + #{oCFXmpol7D8} + #{J4vNm7YEkdj} + #{cBTa1jVzT8f}) - (#{mACm1JUzeLT} + #{Hbc2qRi0U5x} + #{LC2OqnUC5Sn} + #{jthpt5cVV9c} + #{yWkSi8L3qGm} + #{DaNcGZnkclz} + #{K59f8nZ5vhy} + #{zNCSlBKbS6d} + #{SCMKsiNj6c5} + #{Nv4OkbdDvmm})
C&T_90% of all children living with HIV will know their HIV status,hkPl9f69N8X,C&T_90% of all child HIV will HIV status,(#{SJL4k6Gl53C} + #{wbJOu4h2SSz} + #{Jbu4if6gtDp} + #{GSEmLUnrvzj}),#{G1x3DL1qaEa}
C&T_Proportion NEW TB cases co-infected with HIV on HAART,SNRPuAe6zlJ,C&T_Proportion NEW TB cases HIV positive on HAART,(#{IOy5jgQqfHU} + #{PIxcR1T5ORh}),(#{TXJ3QlKmD10} + #{jjXPL4ZIuIU})
C&T_Proportion of malnourished HIV positive adults and children receiving food by prescription,MbAzzUwU2d0,C&T_Proportion of malnourished HIV + fBP,(#{rwTvrrkKot4} + #{PXMPO6t3FIh}),(#{FuDzKYjF69C} + #{j0x31E1xybY})
C&T_Proportion of newly diagnosed TB patients co-infected with HIV,CsEOWuMUq1X,C&T_%of newly diag TB patients WITH HIV,(#{TXJ3QlKmD10} + #{jjXPL4ZIuIU}),#{Vb9I1VRoaZt}
C&T_Proportion of persons newly enrolled into HIV care,xJ1IGcwqOOM,Percentage of HIV+ enrolled in care,(#{Nj4fdwBMPSv} + #{Qx6MQyeLsbW} + #{voKyCW93y78} + #{fEreYoprpD1} + #{k3XKbFkk2ZR} + #{tCuuWVCan0K} + #{IEPIbqqB7FP} + #{nNE84uVg0xN} + #{LGMBmncr1Qw} + #{FsnRF3p3qVc}),(#{du5RMT3aecB} + #{D9YwtS6RhQ1} + #{wu0ITFRjUzF} + #{kLXGWRLzCAw} + #{xMNhnyu7vm1} + #{F9OR49Lc1aR} + #{oCFXmpol7D8} + #{J4vNm7YEkdj} + #{cBTa1jVzT8f})
CDF Accounting rate,g7Y61bux7hW,CDF Accounting rate,#{oMWJpAyAIUh.VCWJK5P18lI},#{uq2Izs9ZGT7}
CDF Fund utilization rate,n7xdGBfniY0,CDF Fund utilization rate,#{uq2Izs9ZGT7.VCWJK5P18lI},#{QLC6ejj76za.VCWJK5P18lI}
CHEW Malaria Test Positivity Rate (by RDT),kZBu57noYNb,CHEW Malaria Test Positivity Rate (by RDT),#{CVHsV294PjK} + #{NeUMw0K561Q} + #{TZHFXJrxbUU},#{CVHsV294PjK} + #{NeUMw0K561Q} + #{TZHFXJrxbUU} + #{EA3C82Tnftk} + #{vmQj5H8ImG4} + #{nqa34Xgoq3T}
CHEW Malaria Test Positivity Rate (by RDT)  < 5,AmZFKhvuKkU,CHEW Malaria Test Positivity Rate (by RDT)  < 5,#{NeUMw0K561Q},#{NeUMw0K561Q} + #{vmQj5H8ImG4}
CHEW Malaria Test Positivity Rate (by RDT) > 5,mzSmiyUC53J,CHEW Malaria Test Positivity Rate (by RDT) > 5,#{TZHFXJrxbUU},#{TZHFXJrxbUU} + #{nqa34Xgoq3T}
CHEW Malaria Testing Rate - Community,H13apJacejH,CHEW Malaria Testing Rate - Community,#{CVHsV294PjK} + #{NeUMw0K561Q} + #{TZHFXJrxbUU} + #{EA3C82Tnftk} + #{vmQj5H8ImG4} + #{nqa34Xgoq3T},#{M48SVvFpwHM} + #{UB5wMmYe9kL} + #{l2S58qxe2bt}
CHEW Malaria Testing Rate < 5 - Community,TSbD6ZBlBcx,CHEW Malaria Testing Rate < 5 - Community,#{NeUMw0K561Q} + #{vmQj5H8ImG4},#{UB5wMmYe9kL}
CHEW Malaria Testing Rate > 5 - Community,kdheIY1GEDW,CHEW Malaria Testing Rate > 5 - Community,#{TZHFXJrxbUU} + #{nqa34Xgoq3T},#{l2S58qxe2bt}
CHEW Patients on AL,gvf1aAKQvrU,CHEW Patients on AL,#{qsxgiW5M2ic} + #{aPTi7dw2PkL} + #{nqjuVL8kW6Y} + #{eIfWFxJK8mg},1
CHEW Percentage of Fever Cases Tested,m9aom6xjB9r,Fever Cases Tested %,#{RXgNfdYSJPh} + #{ZAsCMIJLkvj},#{gpYrkLhO4wB} + #{YCWGGPn7tdl}
CHEW Percentage of Fever Cases Tested < 5,pLucEvEEUTm,Fever Cases Tested % < 5,#{RXgNfdYSJPh},#{gpYrkLhO4wB}
CHEW Percentage of Fever Cases Tested > 5,UU5TE9ut9OA,Fever Cases Tested % > 5,#{ZAsCMIJLkvj},#{YCWGGPn7tdl}
CHEW Proportion of Confirmed Malaria Cases Treated with AL,O2t0kGFmgxt,CHEW - Confirmed Malaria Cases Treated with AL,#{qsxgiW5M2ic} + #{aPTi7dw2PkL} + #{nqjuVL8kW6Y} + #{eIfWFxJK8mg},#{CVHsV294PjK} + #{NeUMw0K561Q} + #{TZHFXJrxbUU}
CHEW RDT positives receiving ACT,ZWVMavkPreK,RDT positives receiving ACT %,#{V9SqzZHKoP7} + #{oVxxa344TPs},#{QfBRPj1q0W1} + #{eUakxWsxkcq}
CHEW RDT positives receiving ACT < 5,WcCD7CWF0QE,RDT positives receiving ACT % < 5,#{V9SqzZHKoP7},#{eUakxWsxkcq}
CHEW RDT positives receiving ACT > 5,rbimG60NhBC,RDT positives receiving ACT % > 5,#{oVxxa344TPs},#{QfBRPj1q0W1}
CHEW Suspected malaria cases tested in the community,aJoI9KvZXHE,CHEW Suspected malaria cases tested,#{CVHsV294PjK} + #{EA3C82Tnftk} + #{jUPlf5USqBU},#{M48SVvFpwHM}
CHEW Testing Rate,nx64ZdZwUFh,Chew Testing Rate,#{NeUMw0K561Q}+#{TZHFXJrxbUU}+#{vmQj5H8ImG4} + #{nqa34Xgoq3T} + #{CVHsV294PjK} + #{EA3C82Tnftk},#{M48SVvFpwHM}
CHEW Total Malaria Positive Cases - Community,jDc1xXvLisc,CHEW Total Malaria Positive Cases - Community,#{CVHsV294PjK} + #{NeUMw0K561Q} + #{TZHFXJrxbUU},1
CHEW Total Suspected Cases - Community,g2Ctqza7hbi,CHEW Total Suspected Cases,#{M48SVvFpwHM} + #{UB5wMmYe9kL} + #{l2S58qxe2bt},1
CHEW Total Tests,Ra10oGAxowh,CHEW Total Tests,#{NeUMw0K561Q}+#{TZHFXJrxbUU}+#{vmQj5H8ImG4} + #{nqa34Xgoq3T} + #{jUPlf5USqBU} + #{aUpuJYJ41hM} + #{g3InB3mkDmC},1
CHEW Total deaths,CoR5moMDod0,CHEW Total deaths,#{bWTVzXQoxpt} + #{sXPwrF8r04E} + #{I9yVwu1FWu6} + #{zW17XEoFhAN} + #{jBYvAmDdyfY},1
COVID 19 - Doses Received,Lk4hW6JbZNm,COVID 19 - Doses Received,#{iY0BIv0KvVB.jO9s1Z5pyvK} + #{QAJYBsTwYJ1.jO9s1Z5pyvK} + #{HpAFxzo7qYL.jO9s1Z5pyvK} + #{R9TUyxDL5a0.jO9s1Z5pyvK} + #{RvSYwi63b5r.jO9s1Z5pyvK},1
COVID 19 - Doses administered,a4FtRrd4mYn,COVID 19 - Doses administered,#{iY0BIv0KvVB.go3XWpQGS2G} + #{QAJYBsTwYJ1.go3XWpQGS2G} + #{HpAFxzo7qYL.go3XWpQGS2G} + #{R9TUyxDL5a0.go3XWpQGS2G} + #{RvSYwi63b5r.go3XWpQGS2G},1
COVID 19 - Fully vaccinated,jjVxHi8D30p,COVID 19 - Fully vaccinated,#{ZWMO83OyDwx} + #{jm6G9QtE6Th} + #{pkrY92yugfK} + #{NHd2e6QGCkk} + #{qRQ3LIl7SmG},1
COVID 19 - Partially Vaccinated,fProGjda4Mq,COVID 19 - Partially Vaccinated,(#{myQD3R0GBUq} + #{LTJsHtrbyML} + #{UoaXvx7kTB7} + #{gOksPnou3je}) - (#{NHd2e6QGCkk} + #{pkrY92yugfK} + #{jm6G9QtE6Th} + #{ZWMO83OyDwx}),1
COVID 19 - Severe number of AEFI per 100000 doses administered,zYCvS1dfiOJ,COVID 19 - Severe number of AEFI,#{BAqNYvjMM06.dUL0Oh2ivqk} + #{dJruyJIjeV1.dUL0Oh2ivqk} + #{cll5lwGYIwo.dUL0Oh2ivqk} + #{Ojoh1BOou9Y.dUL0Oh2ivqk} + #{oI9F4BBqNqM.dUL0Oh2ivqk},#{myQD3R0GBUq} + #{ZWMO83OyDwx} + #{UoaXvx7kTB7} + #{pkrY92yugfK} + #{LTJsHtrbyML} + #{jm6G9QtE6Th} + #{gOksPnou3je} + #{NHd2e6QGCkk} + #{qRQ3LIl7SmG} 
CS_Assessment of NHIF services,TfyAxfk0gy7,CS_Assessment of NHIF services,#{bN8m9ABVXer},3
CS_Availability of medicines and diagnostic services,CHOmEkZmEOh,Availability of medicines and diagnostic services,#{xSRVXr852es},3
CS_Cleanliness of the facility,xvPzXu0SiK7,Cleanliness of the facility,#{Gr5PBDmLazA},3
CS_Emergency and referral services,W5k1IuIATr0,CS_Emergency and referral services,#{Hgniu7KGUnU},3
CS_Home visits by Community Health Volunteers,aJ3T2Bupq9I,CS_Home visits by Community Health Volunteers,#{WcHZ6sIUYFD},3
CS_Respectful and compassionate care,QHVNJYKf4wN,CS_Respectful and compassionate care,#{iMp57k6VRXr},3
CS_Responsiveness to community health needs,EmotZy9nTxd,Responsiveness to community health needs,#{TtfzPKQH7sX},3
CS_Safety and security of the facility,wAh2tIp7VxL,CS_Safety and security of the facility,#{WVoTxGXF298},3
CS_Waiting time for provision of health care services,IhWIQjuK0FQ,Waiting time for provision of health care services,#{jYwvl9KGwx2},3
CU Children under 1 year (12 months) of the total Population,W3kCf9HauEz,CHIS Children < 1 yrs,#{fql7YMti688.NhSoXUMPK2K},#{rcf6uBJpXTd.NhSoXUMPK2K}
CU Children under five year old of the total Population,EtyiFYuh4pX,CU <5yrs,#{HT7SV4XRpXJ.NhSoXUMPK2K},#{rcf6uBJpXTd.NhSoXUMPK2K}
CU Estimated Deliveries of the total Population,FtBkQRkGC9Q,CU Estimated Deliveries,#{Q6ycIK7qAwi.NhSoXUMPK2K},#{rcf6uBJpXTd.NhSoXUMPK2K}
CU Estimated live births of the total CU Population,IkxXBiZaLWj,Live birth CU,#{EBrjMtVka7K.NhSoXUMPK2K},#{rcf6uBJpXTd.NhSoXUMPK2K}
CU Household Size,CfrnMVrNiHZ,CU Household Size,#{rcf6uBJpXTd.NhSoXUMPK2K},#{vMj9ZXCqkXk.NhSoXUMPK2K}
CU Population 25-59 years of the total Population,ejhgnOFjttm,CU Popn 25-59 year,#{IkPLWQZ6ozA.NhSoXUMPK2K},#{rcf6uBJpXTd.NhSoXUMPK2K}
CU Population of female of the total CU Population,ynNNZZL8xiG,CU female Popn,#{F1batWPfTob.NhSoXUMPK2K},#{rcf6uBJpXTd.NhSoXUMPK2K}
CU Population of male of the total CU Population,hpyM8tZejc3,CU Male of Popn,#{xveEJRFGfpZ.NhSoXUMPK2K},#{rcf6uBJpXTd.NhSoXUMPK2K}
CU Population under 15 years of  the total CU Population,RTlcX5CmE2x,CU Population < 15 yrs,#{IHPSoXP2ePe.NhSoXUMPK2K},#{rcf6uBJpXTd.NhSoXUMPK2K}
CU Women of childbearing age (15–49yrs) of the total Population,LpufemQRCkf,CU WRA (15-49yrs) ,#{KGdrH5y2o4v.NhSoXUMPK2K},#{rcf6uBJpXTd.NhSoXUMPK2K}
CU population 60+ years of the total Population,yXc6QtBKyGT, % CU  Population 60+ yr,#{dfidnbIDfRM.NhSoXUMPK2K},#{rcf6uBJpXTd.NhSoXUMPK2K}
CWC population under 5yrs,plFreC3I5LF,CWC <5 Population,#{ENjll6PbaI8.a57uWFr3dUy} + #{ENjll6PbaI8.MJAGUpeHkpn} + #{HlZXTFN2B61.a57uWFr3dUy} + #{HlZXTFN2B61.MJAGUpeHkpn} + #{Ype6qUApdlR.a57uWFr3dUy} + #{Ype6qUApdlR.MJAGUpeHkpn}  + #{AIduSzrilaz.a57uWFr3dUy} + #{AIduSzrilaz.MJAGUpeHkpn} + #{uYBa6RU8wUZ.a57uWFr3dUy} + #{uYBa6RU8wUZ.MJAGUpeHkpn} + #{AYT1IPxFRZx.a57uWFr3dUy} + #{AYT1IPxFRZx.MJAGUpeHkpn} + #{QCNHvzgxurQ.a57uWFr3dUy} + #{QCNHvzgxurQ.MJAGUpeHkpn} + #{k3xX4NKJaaY.a57uWFr3dUy} + #{k3xX4NKJaaY.MJAGUpeHkpn} + #{mv0ICssqScK.a57uWFr3dUy} + #{mv0ICssqScK.MJAGUpeHkpn} + #{lvyOQjZaXZ3.a57uWFr3dUy} + #{lvyOQjZaXZ3.MJAGUpeHkpn} + #{PW4W1Fa7b5b.a57uWFr3dUy} + #{PW4W1Fa7b5b.MJAGUpeHkpn} + #{zels3jARvGQ.a57uWFr3dUy} + #{zels3jARvGQ.MJAGUpeHkpn} + #{twpy25QKLk9.a57uWFr3dUy} + #{twpy25QKLk9.MJAGUpeHkpn} + #{ikI4r8YuZZ0.a57uWFr3dUy} + #{ikI4r8YuZZ0.MJAGUpeHkpn} + #{qoEPwxCNrll.a57uWFr3dUy} + #{qoEPwxCNrll.MJAGUpeHkpn},1
Caesarean section rate,hWR4NCWDpez,CS rate,#{rAZBTMa7Jy3.NhSoXUMPK2K},#{jaPrPmor6WV.NhSoXUMPK2K}+#{rAZBTMa7Jy3.NhSoXUMPK2K}+#{sMqM8DwiAaj.NhSoXUMPK2K}+#{Kx64gGqaFVq.NhSoXUMPK2K}
Cascade Adolesents Currently on ART,ZvW3UZpOAJw,Cascade Adolesents Currently on ART,#{AQsTt7jtKbt} + #{oOOnacUi9Jm} + #{GSEmLUnrvzj} + #{Jbu4if6gtDp},1
Cascade Adolesents VL Suppressed,CkihSEjFODg,Cascade Adolesents VL suppressed,#{H3JxUdxxNoe.zIYfBTRncpm} + #{H3JxUdxxNoe.IqQ9Pgr5mZI}+ #{H3JxUdxxNoe.gKLYDFU4mSV} + #{H3JxUdxxNoe.KwQazknW2Lt},1
Cascade Adolesents estimates,aEgq9k5jJOP,Cascade Adolesents estimates,#{chNcH4HrZyF},1
Cascade Adult currently on ART,iXiUj2pCJon,Cascade Adult currently on ART,#{AQsTt7jtKbt} + #{oOOnacUi9Jm} + #{EhZQp3PTA3C} + #{e93GKJTHKAX} + #{yNCUlEYkmyA} + #{pR7VzBydoj3},1
Cascade Adults Currently on Care,taOwegTT6B1,Cascade Adults Currently on Care, #{yNCUlEYkmyA} + #{pR7VzBydoj3} + #{AQsTt7jtKbt} + #{oOOnacUi9Jm} + #{EhZQp3PTA3C} + #{e93GKJTHKAX} + #{Vhx18QRosUs},1
Cascade Children Currently on Care,MOJxAdu6Cmb,Cascade Children Currently on Care,#{SJL4k6Gl53C} + #{wbJOu4h2SSz} + #{GSEmLUnrvzj} + #{Jbu4if6gtDp} + #{KknDtmFfDBM},1
Cascade Children VL suppressed,yanhryQN8u2,Cascade Children VL suppressed,#{H3JxUdxxNoe.Z9cc22tdFtK} + #{H3JxUdxxNoe.fQaGWZ8R25L}+#{H3JxUdxxNoe.Yg1zqrAT9mS} + #{H3JxUdxxNoe.gTzKy4LS0l7} + #{H3JxUdxxNoe.gKLYDFU4mSV} + #{H3JxUdxxNoe.KwQazknW2Lt} ,1
Cascade FLHIV,vt5fShXJZ9n,Cascade FLHIV,#{GSEmLUnrvzj} + #{AQsTt7jtKbt} + #{EhZQp3PTA3C} + #{yNCUlEYkmyA} + #{wu0ITFRjUzF} + #{xMNhnyu7vm1} + #{oCFXmpol7D8} + #{cBTa1jVzT8f},1
Cascade FLHIV Currently on care,UUiHHIgoYKt,Cascade FLHIV Currently on care,#{GSEmLUnrvzj} + #{AQsTt7jtKbt} + #{EhZQp3PTA3C} + #{yNCUlEYkmyA},1
Cascade FLHIV VL suppressed,vpckcvOXWwH,Cascade FLHIV VL suppressed,#{H3JxUdxxNoe.fQaGWZ8R25L} + #{H3JxUdxxNoe.gTzKy4LS0l7} + #{H3JxUdxxNoe.KwQazknW2Lt} + #{H3JxUdxxNoe.IqQ9Pgr5mZI} + #{H3JxUdxxNoe.hipCW8yhAri} + #{H3JxUdxxNoe.HlFzCSip1te},1
Cascade MHLIV VL suppressed,sRcIF9NRZvr,Cascade MHLIV VL suppressed,#{H3JxUdxxNoe.Z9cc22tdFtK} + #{H3JxUdxxNoe.Yg1zqrAT9mS} + #{H3JxUdxxNoe.gKLYDFU4mSV} + #{H3JxUdxxNoe.zIYfBTRncpm} + #{H3JxUdxxNoe.GFh2Bue6iwS} + #{H3JxUdxxNoe.CbHPjpgsMT0},1
Cascade MLHIV,PmUnWXUQxHi,Cascade MLHIV,#{Jbu4if6gtDp} + #{oOOnacUi9Jm} + #{e93GKJTHKAX} + #{pR7VzBydoj3} + #{D9YwtS6RhQ1} + #{kLXGWRLzCAw} + #{F9OR49Lc1aR} + #{J4vNm7YEkdj},1
Cascade Male Currently on care,pso1gdHKhiB,Cascade Male Currently on care,#{Jbu4if6gtDp} + #{oOOnacUi9Jm} + #{e93GKJTHKAX} + #{pR7VzBydoj3},1
Cascade Overall PLHIV (estimates),ZYXTdVBPmVw,Cascade Overall PLHIV (estimates),#{G1x3DL1qaEa} + #{QVW8F6CrQE1},1
Cascade Overall currently on care,xzxXd3Ia6C7,Cascade overall Currently on Care,#{GSEmLUnrvzj} + #{Jbu4if6gtDp} + #{AQsTt7jtKbt} + #{oOOnacUi9Jm} + #{wbJOu4h2SSz} + #{SJL4k6Gl53C} + #{EhZQp3PTA3C} + #{e93GKJTHKAX} + #{yNCUlEYkmyA} + #{pR7VzBydoj3} + #{KknDtmFfDBM} + #{Vhx18QRosUs},1
Cascade YAdult Currently on ART,iQ7XNIj9bFr,Cascade YAdult Currently on ART,#{EhZQp3PTA3C} + #{e93GKJTHKAX} + #{AQsTt7jtKbt} + #{oOOnacUi9Jm} ,1
Cascade YAdult currently on care,ncOm8ACs7Yu,Cascade YAdult currently on care,#{EhZQp3PTA3C} + #{e93GKJTHKAX} + #{AQsTt7jtKbt} + #{oOOnacUi9Jm} ,1
Cascade YAdults VL suppressed,EEYGxhBKDu6,Cascade YAdults VL suppressed,#{H3JxUdxxNoe.GFh2Bue6iwS} + #{H3JxUdxxNoe.hipCW8yhAri} + #{H3JxUdxxNoe.zIYfBTRncpm} + #{H3JxUdxxNoe.IqQ9Pgr5mZI},1
Cascade Yadult LHIV (estimates),rast2THwKSh,Cascade Yadult LHIV (estimates),#{ircjJjsE4UL},1
Cascade adolesent currently on care,pHMm7OaoCdF,Cascade adolesent currently on care,#{AQsTt7jtKbt} + #{oOOnacUi9Jm}  + #{GSEmLUnrvzj} + #{Jbu4if6gtDp},1
Cascade adult ALHIV ( Estimates),jRO2cj8LlNZ,Cascade adult ALHIV (estimates),#{QVW8F6CrQE1},1
Cascade adult VL suppressed ,Z655hAUelBN,Cascade adult VL suppressed ,#{H3JxUdxxNoe.CbHPjpgsMT0} + #{H3JxUdxxNoe.HlFzCSip1te} + #{H3JxUdxxNoe.zIYfBTRncpm} + #{H3JxUdxxNoe.IqQ9Pgr5mZI} + #{H3JxUdxxNoe.GFh2Bue6iwS} + #{H3JxUdxxNoe.hipCW8yhAri},1
Cascade children CHLIV (estimates),EpZYkbBwJLF,Cascade children CHLIV (estimates),#{G1x3DL1qaEa},1
Cascade children currently on ART,jVTiH06lamG,Cascade children currently on ART,#{SJL4k6Gl53C} + #{wbJOu4h2SSz} + #{GSEmLUnrvzj} + #{Jbu4if6gtDp},1
Cascade overall VL suppressed,wolRW9OOtxf,Cascade overall VL suppressed,#{H3JxUdxxNoe.Z9cc22tdFtK} + #{H3JxUdxxNoe.fQaGWZ8R25L} + #{H3JxUdxxNoe.Yg1zqrAT9mS} + #{H3JxUdxxNoe.gTzKy4LS0l7} + #{H3JxUdxxNoe.gKLYDFU4mSV} + #{H3JxUdxxNoe.KwQazknW2Lt} + #{H3JxUdxxNoe.zIYfBTRncpm} + #{H3JxUdxxNoe.IqQ9Pgr5mZI} + #{H3JxUdxxNoe.GFh2Bue6iwS} + #{H3JxUdxxNoe.hipCW8yhAri} + #{H3JxUdxxNoe.CbHPjpgsMT0} + #{H3JxUdxxNoe.HlFzCSip1te},1
Cascade overall currently on ART,Tk1yaa1L16g,Cascade overall currently on ART,#{GSEmLUnrvzj} + #{Jbu4if6gtDp} + #{AQsTt7jtKbt} + #{oOOnacUi9Jm} + #{wbJOu4h2SSz} + #{SJL4k6Gl53C} + #{EhZQp3PTA3C} + #{e93GKJTHKAX} + #{yNCUlEYkmyA} + #{pR7VzBydoj3},1
Chew Total RDT +ve,KrwPdf0P0JZ,Chew Total RDT +ve,#{NeUMw0K561Q} + #{TZHFXJrxbUU},1
Chew Total RDT -ve,qS9iUj9xEb3,Chew Total RDT -ve,#{vmQj5H8ImG4} + #{nqa34Xgoq3T},1
Chew Total RDT Invalid,HPQs3e9pu7n,Chew Total RDT Invalid,#{aUpuJYJ41hM} + #{g3InB3mkDmC},1
Children 0-14 Years Positive,PqYuHnTOd97,Children 0-14 Years Positive,#{du5RMT3aecB} + #{wu0ITFRjUzF} + #{D9YwtS6RhQ1},1
Children 0-14 Years Tested,JJDEmJTb5I0,Children 0-14 Years Tested,#{gMICOUtzqRb} + #{lj9QYJqS7bN} + #{OePJt8CcZ0d},1
Children 0-14 years New ART,vT8LEAdf9TD,Children 0-14 years New ART,#{mACm1JUzeLT} + #{Hbc2qRi0U5x} + #{jthpt5cVV9c} + #{LC2OqnUC5Sn},1
Children 0-14 years on ART,PsC3cNUieWl,Children 0-14 years on ART,#{SJL4k6Gl53C} + #{wbJOu4h2SSz} + #{GSEmLUnrvzj} + #{Jbu4if6gtDp},1
Children under 1 year (12 months) of the total Population,rG80XGagRlg,<1yrs of the total Popn,#{pMbuvKvH4rg.NhSoXUMPK2K},#{NLKRV7bYbVy.NhSoXUMPK2K}
Children under 5 years (60 months) of the total Population,VdShlsQiR5A,< 5yrs of popn,#{KNrK5VWTZkx.NhSoXUMPK2K},#{NLKRV7bYbVy.NhSoXUMPK2K}
"Chlorhexidine gel, 7.1% (as digluconate) (20 g tube) (Tube) MoS",gkY7xYvyV01,"Chlorhexidine gel, 7.1% ",#{GOFxghdlf5n.n8XlCFUpWOG},#{mp0OYo756gW.QvctQfKAQn3}
Cohort analysis,oGT24hOvr7l,Cohort analysis,(#{m3sannZJcUn.NhSoXUMPK2K}/#{RwTKRWWKGhn.NhSoXUMPK2K})*100,1
Combined Contraceptive Pills Ending Balance,YYNfhajyjnz,Comb Cont EB,#{vCYikXcYEa6.NvpLpQxmzkZ},1
Combined contraceptive Pills Dispensed,I4oqVMRU58z,Combined contrac Disp,#{vCYikXcYEa6.LkO5M9beZqG},1
Condom Couple year protection (Male +Female),YW8qksk9vDB,Condom CYP,#{Fxb4iVJdw2g} + #{Fxb4iVJdw2g.wBWcFk7k1qY} + #{Fxb4iVJdw2g.K4WLOEhtcvC} + #{cV4qoKSYiBs} + #{cV4qoKSYiBs.wBWcFk7k1qY} + #{cV4qoKSYiBs.K4WLOEhtcvC},120
Confirmatory test (First Response) MoS,SgDX5MWDF0b,Confirmatory test (First Response) MoS,#{faa0mAwNa26.CGnwPpnZ7n7},#{ARTk5FR9rmY.QvctQfKAQn3}
Confirmed Malaria Cases in the Community,MOOmJaQP7K7,Total Malaria Positive Cases at CU,#{eUakxWsxkcq} + #{QfBRPj1q0W1},1
Confirmed Malaria Cases(MOH 706),HZpxIY9iIIO,Confirmed Malaria Cases(MOH 706),#{t9yAWC8wK4k.nwpzSJ8o7hD} + #{CceLQEL5Q4p.nwpzSJ8o7hD} + #{qi4TilPOx6o.nwpzSJ8o7hD} + #{pacXvg8XEYT.nwpzSJ8o7hD},1
Confirmed Malaria cases Per 1000 Population,FkJJBNUGH5W,Confirmed Malaria cases Per 1000 Population,#{OoakJhWiyZp.lHl2rmXpHse}+#{OoakJhWiyZp.SeDaCnHi3m5}+#{gvZmXInRLuD.SeDaCnHi3m5} + #{CVHsV294PjK} + #{NeUMw0K561Q} + #{TZHFXJrxbUU},#{Mpv8crmnOzy} + #{w5ltvnNihEZ}
Confirmed Malaria cases Per 1000 Population - Yearly,D2xeHYyU5s6,Confirmed Malaria cases / 1000 Population - Yearly,#{OoakJhWiyZp.lHl2rmXpHse}+#{OoakJhWiyZp.SeDaCnHi3m5}+#{gvZmXInRLuD.SeDaCnHi3m5},#{Mpv8crmnOzy} + #{w5ltvnNihEZ}
Confirmed Malaria cases Per 1000 Population < 5,qMYm7fGXkXP,Confirmed Malaria cases / 1000 Population < 5,#{OoakJhWiyZp.lHl2rmXpHse},#{KNrK5VWTZkx}
Confirmed Malaria cases Per 1000 Population > 5,rfmxXpWFwMq,Confirmed Malaria cases / 1000 Population > 5,#{OoakJhWiyZp.SeDaCnHi3m5}+#{gvZmXInRLuD.SeDaCnHi3m5},(#{Mpv8crmnOzy} + #{w5ltvnNihEZ}) - #{KNrK5VWTZkx}
Confirmed malaria cases (MOH 505),cFQoDfmMP5E,Confirmed malaria cases (MOH 505),#{bB8vhQefDlH.lHl2rmXpHse} + #{bB8vhQefDlH.SeDaCnHi3m5} + #{q40X71immxZ.lHl2rmXpHse} + #{q40X71immxZ.SeDaCnHi3m5},1
Confirmed malaria cases (MOH 705 A/B),Rjk83gmqVwz,Confirmed malaria cases (MOH 705 A/B),#{OoakJhWiyZp.lHl2rmXpHse} + #{OoakJhWiyZp.SeDaCnHi3m5},1
Contraceptive Prevalence Rate,emd3tpLQRTR,Contraceptive Prevalence Rate,#{BQmcVE8fex4}+#{uHM6lzLXDBd}+#{yQFyyQBhXQf}+#{DuBH6qPPdaO}+#{otgQMOXuyIn}+#{PggNwT09D3U}+#{cV4qoKSYiBs}+#{OiuBpHJw4kf}+#{Fxb4iVJdw2g}+#{paDQStynGGD},#{bPQDV3mud0v}
Cov-19_Proportion of vaccine doses administered_Astrazeneca,uGF3DRedNRr,Proportion of vaccine administered_Astrazeneca,(#{myQD3R0GBUq} + #{ZWMO83OyDwx})/(#{myQD3R0GBUq} + #{LTJsHtrbyML} + #{UoaXvx7kTB7} + #{gOksPnou3je} + #{qRQ3LIl7SmG} + #{ZWMO83OyDwx} + #{jm6G9QtE6Th} + #{pkrY92yugfK} + #{NHd2e6QGCkk}),1
Cov-19_Proportion of vaccine doses administered_J&J,dUA1jGE3L2w,Proportion of vaccine administered_J&J   ,(#{qRQ3LIl7SmG})/(#{myQD3R0GBUq} + #{LTJsHtrbyML} + #{UoaXvx7kTB7} + #{gOksPnou3je} + #{qRQ3LIl7SmG} + #{ZWMO83OyDwx} + #{jm6G9QtE6Th} + #{pkrY92yugfK} + #{NHd2e6QGCkk}),1
Cov-19_Proportion of vaccine doses administered_Moderna    ,fFdbBkXjqGH,Proportion of vaccine administered_Moderna    ,(#{LTJsHtrbyML} + #{jm6G9QtE6Th})/(#{myQD3R0GBUq} + #{LTJsHtrbyML} + #{UoaXvx7kTB7} + #{gOksPnou3je} + #{qRQ3LIl7SmG} + #{ZWMO83OyDwx} + #{jm6G9QtE6Th} + #{pkrY92yugfK} + #{NHd2e6QGCkk}),1
Cov-19_Proportion of vaccine doses administered_Pfizer  ,YotkQfYf5ly,Proportion of vaccine administered_Pfizer    ,(#{UoaXvx7kTB7} + #{pkrY92yugfK})/(#{myQD3R0GBUq} + #{LTJsHtrbyML} + #{UoaXvx7kTB7} + #{gOksPnou3je} + #{qRQ3LIl7SmG} + #{ZWMO83OyDwx} + #{jm6G9QtE6Th} + #{pkrY92yugfK} + #{NHd2e6QGCkk}),1
Cov-19_Proportion of vaccine doses administered_Sinopharm ,J0X2UiQ9MbL,Proportion of vaccine administered_Sinopharm   ,(#{gOksPnou3je} + #{NHd2e6QGCkk})/(#{myQD3R0GBUq} + #{LTJsHtrbyML} + #{UoaXvx7kTB7} + #{gOksPnou3je} + #{qRQ3LIl7SmG} + #{ZWMO83OyDwx} + #{jm6G9QtE6Th} + #{pkrY92yugfK} + #{NHd2e6QGCkk}),1
Coverage of Targeted Under 1s provided with LLITNs,X74moZtF5v5,Coverage of Targeted Under 1s provided with LLITNs,#{adV5ma0IRHU},#{pMbuvKvH4rg}
Covid 19 - Total ever  Vaccinated Female,Puk3ssY5rRs,Covid 19 - Total ever  Vaccinated Female,#{myQD3R0GBUq.LkGt7Z4CeY8} + #{myQD3R0GBUq.gVnIpfiEjnG} + #{myQD3R0GBUq.D7GeTJKDFQa} + #{myQD3R0GBUq.F4aAJxbU3Np} + #{myQD3R0GBUq.IWjT8EE7a5u} + #{LTJsHtrbyML.LkGt7Z4CeY8} + #{LTJsHtrbyML.gVnIpfiEjnG} + #{LTJsHtrbyML.D7GeTJKDFQa} + #{LTJsHtrbyML.F4aAJxbU3Np} + #{LTJsHtrbyML.IWjT8EE7a5u} + #{LTJsHtrbyML.IWjT8EE7a5u} + #{UoaXvx7kTB7.LkGt7Z4CeY8} + #{UoaXvx7kTB7.gVnIpfiEjnG} + #{UoaXvx7kTB7.D7GeTJKDFQa} + #{UoaXvx7kTB7.F4aAJxbU3Np} + #{UoaXvx7kTB7.IWjT8EE7a5u} ,1
Covid 19 - Total ever  Vaccinated Male,J4h0iw98w4v,Total ever  Vaccinated Male,#{myQD3R0GBUq.OfZG3d4UTEe} + #{myQD3R0GBUq.x4bdfcs1Eyf} + #{myQD3R0GBUq.wM9T6slu124} + #{myQD3R0GBUq.KMGJlmXh7fa} + #{myQD3R0GBUq.hsgnO0aLtTH} + #{qRQ3LIl7SmG.OfZG3d4UTEe} + #{qRQ3LIl7SmG.x4bdfcs1Eyf} + #{qRQ3LIl7SmG.wM9T6slu124} + #{qRQ3LIl7SmG.KMGJlmXh7fa} + #{qRQ3LIl7SmG.hsgnO0aLtTH} + #{LTJsHtrbyML.OfZG3d4UTEe} + #{LTJsHtrbyML.x4bdfcs1Eyf} + #{LTJsHtrbyML.wM9T6slu124} + #{LTJsHtrbyML.KMGJlmXh7fa} + #{LTJsHtrbyML.hsgnO0aLtTH} + #{UoaXvx7kTB7.OfZG3d4UTEe} + #{UoaXvx7kTB7.x4bdfcs1Eyf} + #{UoaXvx7kTB7.wM9T6slu124} + #{UoaXvx7kTB7.KMGJlmXh7fa} + #{UoaXvx7kTB7.hsgnO0aLtTH} + #{gOksPnou3je.OfZG3d4UTEe} + #{gOksPnou3je.x4bdfcs1Eyf},1
Covid _Vaccine_AEFI Total(Mild+Severe),xgqw09vIa1u,Covid _Vaccine_AEFI Total(Mild+Severe),#{BAqNYvjMM06.zQoY624Edct} + #{BAqNYvjMM06.dUL0Oh2ivqk} + #{Ojoh1BOou9Y.zQoY624Edct} + #{Ojoh1BOou9Y.dUL0Oh2ivqk} + #{cll5lwGYIwo.zQoY624Edct} + #{cll5lwGYIwo.dUL0Oh2ivqk} + #{dJruyJIjeV1.zQoY624Edct} + #{dJruyJIjeV1.dUL0Oh2ivqk} + #{oI9F4BBqNqM.zQoY624Edct} + #{oI9F4BBqNqM.dUL0Oh2ivqk},1
Covid-19 drop out rate_Astrazeneca,uwdG4NsbIrD,Covid-19 drop out rate_Astrazeneca,(#{myQD3R0GBUq} - #{ZWMO83OyDwx}) / #{myQD3R0GBUq},1
Covid-19 drop out rate_Moderna    ,cWE8flkLkWH,Covid-19 drop out rate_Moderna,(#{LTJsHtrbyML} - #{jm6G9QtE6Th}) / #{LTJsHtrbyML},1
Covid-19 drop out rate_Pfizer,wJ1hYn4Se42,Covid-19 drop out rate_Pfizer,(#{UoaXvx7kTB7} - #{pkrY92yugfK}) / #{UoaXvx7kTB7},1
Covid-19 drop out rate_Sinopharm,KK2aFWRVrjY,Covid-19 drop out rate_Sinopharm,(#{gOksPnou3je} - #{NHd2e6QGCkk}) / #{gOksPnou3je},1
Covid-19 people fully vaccinated_Astrazeneca    ,hO9LARFUMqm,Covid-19 people fully vaccinated_Astrazeneca    ,#{ZWMO83OyDwx},1
Covid-19 people fully vaccinated_Johnson and Johnson,cxkrEwagrME,Covid-19 people fully vaccinated_J&J,#{fh9tgtMnVsZ},1
Covid-19 people fully vaccinated_Moderna    ,kwvavfkHs3N,Covid-19 people fully vaccinated_Moderna ,#{jm6G9QtE6Th},1
Covid-19 people fully vaccinated_Pfizer     ,IBkI6RZgL22,Covid-19 people fully vaccinated_Pfizer ,#{pkrY92yugfK},1
Covid-19 people fully vaccinated_Sinopharm,mfdeRruY3Aq,Covid-19 people fully vaccinated_Sinopharm,#{NHd2e6QGCkk},1
Covid-19 proportion of target population fully vaccinated,ctnDw4Qk1ei,Cov-19 proportion of target population fully-vacc,(#{ZWMO83OyDwx} + #{jm6G9QtE6Th} + #{pkrY92yugfK} + #{NHd2e6QGCkk} + #{fh9tgtMnVsZ}) / #{mhND31WZvDX},1
Covid-19_vaccinated_1st-dose_Astrazeneca,UxMkIWab214,Covid-19_vaccinated_1st-dose_Astrazeneca,#{myQD3R0GBUq},1
Covid-19_vaccinated_1st-dose_Moderna    ,kpzwUdfAGgx,Covid-19_vaccinated_1st-dose_Moderna  ,#{LTJsHtrbyML},1
Covid-19_vaccinated_1st-dose_Pfizer,Q3VLWP4neMn,Covid-19_vaccinated_1st-dose_Pfizer,#{UoaXvx7kTB7},1
Covid-19_vaccinated_1st-dose_Sinopharm,ZgiZb56pKQp,Covid-19_vaccinated_1st-dose_Sinopharm,#{gOksPnou3je},1
Covid-19_vaccine_overall_drop_out_rate,JE8r64gDkq9,Covid-19_vaccine_overall_drop_out_rate,(#{myQD3R0GBUq} + #{LTJsHtrbyML} + #{UoaXvx7kTB7} + #{gOksPnou3je})-(#{ZWMO83OyDwx} + #{jm6G9QtE6Th} + #{pkrY92yugfK} + #{NHd2e6QGCkk}),#{myQD3R0GBUq} + #{LTJsHtrbyML} + #{UoaXvx7kTB7} + #{gOksPnou3je}
Covid_vaccine_Others Fully Vaccinated,tlTlbj1GnZs,Covid_vaccine_Others Fully Vaccinated,#{eXSwuieh7QF.EKbkjqMMi9J},1
Covid_vaccine_Security officers Fully Vaccinated,amizM6oV7CN,Covid_vaccine_Security officers Fully Vaccinated,#{nxGoa1VLytI.EKbkjqMMi9J},1
Covid_vaccine_Teachers Fully Vaccinated,KKHzubwyZFw,Covid_vaccine_Teachers Fully Vaccinated,#{Pe3BHI9Cskn.EKbkjqMMi9J},1
Cumulative doses of COVID-19 doses administered,YWcQV3Hes1p,Cumulative doses of COVID-19 doses administered,#{myQD3R0GBUq} + #{LTJsHtrbyML} + #{UoaXvx7kTB7} + #{gOksPnou3je} + #{qRQ3LIl7SmG} + #{ZWMO83OyDwx} + #{jm6G9QtE6Th} + #{pkrY92yugfK} + #{NHd2e6QGCkk},1
Currently On ART,CoaZWJlOWNf,On ART,(#{GSEmLUnrvzj} + #{Jbu4if6gtDp} + #{AQsTt7jtKbt} + #{oOOnacUi9Jm} + #{wbJOu4h2SSz} + #{SJL4k6Gl53C} + #{EhZQp3PTA3C} + #{e93GKJTHKAX} + #{yNCUlEYkmyA} + #{pR7VzBydoj3}),1
Currently in Care,PE07jfUeam4,Currently in Care,(#{KknDtmFfDBM} + #{Vhx18QRosUs} + #{GSEmLUnrvzj} + #{Jbu4if6gtDp} + #{AQsTt7jtKbt} + #{oOOnacUi9Jm} + #{wbJOu4h2SSz} + #{SJL4k6Gl53C} + #{EhZQp3PTA3C} + #{e93GKJTHKAX} + #{yNCUlEYkmyA} + #{pR7VzBydoj3}),1
DPT+HIB+HEP B Wastage Rate (WR),L5QrK4H2pOl,DPT+HIB+HEP B Wastage Rate (WR),((#{s5PaJNvYa6i.NhSoXUMPK2K}+#{byrpD40AkQG.NhSoXUMPK2K})-#{BkGKNzv3Vn6.NhSoXUMPK2K})-(#{ku80YRejJPg}+#{K1Zzhafeukq}+#{OyddF1qflzP}),(#{s5PaJNvYa6i.NhSoXUMPK2K}+#{byrpD40AkQG.NhSoXUMPK2K})-#{BkGKNzv3Vn6.NhSoXUMPK2K}
DPT/HIB/HEP B Wastage Rate,qMgtqhTwlZ6,DPT/HIB/HEP B,#{s5PaJNvYa6i.NhSoXUMPK2K}+#{byrpD40AkQG.NhSoXUMPK2K}-#{BkGKNzv3Vn6.NhSoXUMPK2K}-#{ku80YRejJPg.bCfwecaPx2W}-#{ku80YRejJPg.ieuodyY5ybC}-#{K1Zzhafeukq.bCfwecaPx2W}-#{K1Zzhafeukq.ieuodyY5ybC}-#{OyddF1qflzP.bCfwecaPx2W}-#{OyddF1qflzP.ieuodyY5ybC},#{s5PaJNvYa6i.NhSoXUMPK2K}+#{byrpD40AkQG.NhSoXUMPK2K}
DPT/Hep+HiB2 Coverage,NJnUbIgLpef,DPT/Hep+HiB2 Coverage,#{K1Zzhafeukq.ieuodyY5ybC},#{pMbuvKvH4rg.NhSoXUMPK2K}
DPT/Hep+HiB3 dropout rate ,J5r47eAXjG0,DPT/Hep+HiB3 dropout rate,#{ku80YRejJPg.ieuodyY5ybC}-#{OyddF1qflzP.ieuodyY5ybC},#{ku80YRejJPg.ieuodyY5ybC}
DVI Doses used in the month [E=C-D],TPAblyrRjIh,DVI Doses used in the month [E=C-D],(#{mhzuV7H3wkD} + #{NsOeLT1oeMy}) - #{nUMKWMZkWM5},1
DVI Doses wasted in the month[G=E-F],ixdiWdzHQ8U,DVI Doses wasted in the month[G=E-F],((#{mhzuV7H3wkD} + #{NsOeLT1oeMy}) - #{nUMKWMZkWM5}) - #{crzUGZA2wOd},1
DVI Total doses stocked in the month (C=A+B),VaRpSbksAWN,DVI Total doses stocked in the month (C=A+B),#{mhzuV7H3wkD} + #{NsOeLT1oeMy},1
DVI Wastage rate  in the month[(G/E) x 100],eMHXx07nWko,DVI Wastage rate  in the month[(G/E) x 100],(((#{mhzuV7H3wkD} + #{NsOeLT1oeMy}) - #{nUMKWMZkWM5}) - #{crzUGZA2wOd})/((#{mhzuV7H3wkD} + #{NsOeLT1oeMy}) - #{nUMKWMZkWM5})*100,1
Death rate among TB cases notified,A5We2TRBbmR,TB_CT Death rate among TB cases notified,#{YpM2CXCPZbf.Xc27LcZstD5} + #{m7BMQu4HYRT.rf6Umm9tJJo} + #{yEyrFyJryXL.OMQWRyqq6aA} + #{H61J8pIAjLQ.Lf8OCNIaUZ2} + #{Z9AVW5bKTaG.rH2x9vLTldI},#{YpM2CXCPZbf.oTxLi0v4fb1} + #{m7BMQu4HYRT.W1sDC9IzJ1d} + #{yEyrFyJryXL.ufORzeLtcEl} + #{H61J8pIAjLQ.Z5hHUGiaOh4} + #{Z9AVW5bKTaG.wiD5SVABQHR}
Deaths and discharges Total,a7ULYdqwVak,Deaths and discharges,#{o6RJFSXIelv}+#{JbfEjiVnE6z},1
Deliveries in health facilities Performance ,qfk2lsjOrIs,Deliveries in HF Perf,#{jaPrPmor6WV.NhSoXUMPK2K}+#{Kx64gGqaFVq.NhSoXUMPK2K}+#{sMqM8DwiAaj.NhSoXUMPK2K}+#{rAZBTMa7Jy3.NhSoXUMPK2K},#{GszVZNtYTql.ea7VHlwMkhH}
Delivery to HIV+ Mothers,KsxPBOVAyjJ,Delivery to HIV+ Mothers,#{KuMX8VqCejs},1
Delivery to HIV+ Mothers Missed Opportunity,ivtLMB7qdKg,Delivery to HIV+ Mothers Missed Opportunity,(#{nwXS5vxrrr7} + #{hn3aChn4sVx} + #{AfHArvGun12}+#{hHLR1HP8xzI} + #{qSgLzXh46n9}) - #{C8xdcRWT9d2},1
Dihydroartemesinin/piperaquine 160mg Adjusted Consumption,uMn3tNEMuHd,Dihydroartemesinin/piperaquine 160mg,#{lRdys3z7YNI.w77uMi1KzOH}*31,31-#{lRdys3z7YNI.DV8l1KuASLR}
Dihydroartemesinin/piperaquine 160mg Tabs Quantity for Resupply,QY4uDjQe9aV,Dihydroartemesinin/piperaquine 160mg	Tabs,((#{lRdys3z7YNI.w77uMi1KzOH}*[days]/[days]-#{lRdys3z7YNI.DV8l1KuASLR})*3)-#{lRdys3z7YNI.rPAsF4cpNxm},1
Dihydroartemesinin/piperaquine 320mg	Tabs Quantity for Resupply,OR5WGacLxqa,Dihydroartemesinin/piperaquine 320mg	Tabs,((#{wja80wk33jw.w77uMi1KzOH}*[days]/[days]-#{wja80wk33jw.DV8l1KuASLR})*3)-#{wja80wk33jw.rPAsF4cpNxm},1
Dihydroartemesinin/piperaquine 320mg Adjusted consumption,zWIud6VUvEQ,Dihydroartemesinin/piperaquine 320mg,#{wja80wk33jw.w77uMi1KzOH}*31,31-#{wja80wk33jw.DV8l1KuASLR}
EAC ANC  IPT two dose given,rBp8VVdqBRB,ANC IPT 2 dose given,#{EHGBrVPiG3N.NhSoXUMPK2K},1
EAC ANC HIV test done,Uk8ZveDUEFA,ANC HIV test done,#{ETX9cUWF43c} + #{eIvn8VgI5Zx},1
EAC ANC HIV tests positive,JRHNj57QFfT,ANC HIV tests +ve,#{oZc8MNc0nLZ},1
EAC ANC HIV tests positive (15-24 years),Bl0U4pKt1By,ANC HIV test +ve 15-24 yrs,0,1
EAC ANC clients screened for Anaemia,G6nItHvBE7C,ANC clients screened for anaemic,1,1
EAC ANC clients screened for syphilis,qqGkR7Qn53Z,EAC ANC clients screened for syphilis ,#{i5jVVTm1vI8},1
EAC ANC first visit,soUwg5kvxKs,ANC first visit,#{f9vesk5d4IY.NhSoXUMPK2K},1
EAC ANC first visit before 16 weeks,opoux8es9hJ,ANC 1 Visit < 16 weeks,0,1
EAC ANC fourth visit,iwEQZAI0Qxn,ANC 4 visit,#{Fz0LzxMT1vV.NhSoXUMPK2K},1
EAC ANC tetanus two doses or booster given,qykYUy6NhPb,ANC TT 2 or booster dose,#{au9lav766rM.Qzjct1emaaj}+#{au9lav766rM.B4gIWbNNUFc}+#{au9lav766rM.kHFI1LYOvZF}+#{au9lav766rM.WmSjcUiJumX},1
EAC ARVs to HIV positive mother during pregnancy,AWdUkET6dFs,ARV-HIV +ve ANC,#{UsyFvMBxvn0.NhSoXUMPK2K}+#{tF5z3LnQvWu.NhSoXUMPK2K} + #{PyDKoTxqKB9},1
EAC Admitted children under 1 year,aiSoF0KXchu,Admitted < 1 yr,0,1
EAC BCG dose given under one year,zIAxcoxZ3Pl,BCG dose < 1 yr,#{O3qECFGrzeF.ieuodyY5ybC},1
EAC Caesarean Sections performed,SIy8Bs77TiI,C section done,#{rAZBTMa7Jy3.NhSoXUMPK2K},1
EAC Children who are fully immunized at 12 months,YWQosOfGti1,fully immunized children at 12 months,#{Zr2nN9vy2ig},1
EAC Deaths in admitted children under 1 year,YNkZMV2g1cZ,Deaths < 1yr admitted ,0,1
EAC Deliveries by skilled birth attendants,s2rzbCX6URx,Deliveries by skilled birth attendants,#{jaPrPmor6WV.NhSoXUMPK2K}+#{Kx64gGqaFVq.NhSoXUMPK2K}+#{sMqM8DwiAaj.NhSoXUMPK2K}+#{rAZBTMa7Jy3.NhSoXUMPK2K},1
EAC Deliveries in facilities,rISK7Y8sj9n,Deliveries in facilities,#{jaPrPmor6WV.NhSoXUMPK2K}+#{Kx64gGqaFVq.NhSoXUMPK2K}+#{rAZBTMa7Jy3.NhSoXUMPK2K}+#{sMqM8DwiAaj.NhSoXUMPK2K},1
EAC Deliveries in facilities 16 year and below,gGlMqSv5KBN,Deliveries in facilities <= 16 yrs,0,1
EAC Delivery Expected,gZ46TSUOkQN,Delivery Expected,#{tmlMpIqHimf.NhSoXUMPK2K},1
EAC EAC DPT- Hepatitis third dose given under one year,OiGbaV8TGcU,DPT-Hep 3 dose < 1 yr,#{OyddF1qflzP.ieuodyY5ybC},1
EAC FP Injections given,tejkv4WNvzT,FP Injections given,#{yQFyyQBhXQf},1
EAC Facilities reporting on time,siMyi09NhXY,Facilities reporting on time,0,1
EAC Government and Development Partner direct expenditure RMNCH,ciw7elaTb7j,Govt DevPart direct expenditure RMNCH,0,1
EAC Government and development partner direct budget support to RMNCH,LmiRNT80zJF,Govt Devpart budget support RMNCH,0,1
EAC HIV Exposed infants with documented outcome by 18 months of age,dZpR5oJbiYb,EAC HIV Exposed infants by 18 months of age,1,1
EAC HIV exposed infants who are born 24 months,X7FxfS7iMzN,EAC HIV exposed infants born 24 months,1,1
EAC IUD Inserted,TMsBdhmgFrw,IUD Inserted,#{DuBH6qPPdaO},1
EAC Implants inserted,PvuUWCBoNsQ,Implants inserted,#{otgQMOXuyIn},1
EAC Live birth,U3CYJ5CZnBt,Live birth,#{UqKC1DJnymn.NhSoXUMPK2K},1
EAC Live births under 2500 grams,cWb0LtxTkIX,Live birth < 2500 grms,#{syjjPqXbjTm.NhSoXUMPK2K},1
EAC Malaria Admission,yNumMEiRLdo,Malaria Admission,0,1
EAC Malaria Admission under 5 years,WSz4ziNcO6i,Malaria Admission < 5 yrs,0,1
EAC Malaria Death,mGQFs1QdnQo,Malaria Death,0,1
EAC Malaria Death under 5 years,nTvpyYu7sxX,Malaria Death < 5 yrs,0,1
EAC Measles dose given under one year,AjxP6vi5PUZ,Measles dose < 1 yr,#{sRbqc5gBQhI.ieuodyY5ybC},1
EAC Number of facilities,nHvQ3zTSZGs,Number of facilities ,0,1
EAC Oral contraceptive cycles distributed,okTis86OqVE,OP cycles distributed,#{vCYikXcYEa6.LkO5M9beZqG},1
EAC PNC before 7 days,KYnnfHQ5R0D,PNC 2-7 days,0,1
EAC Population 6 to 59 months,l1KLdM4G6BD,Population 6 to 59 months,#{pkgghI15gSL.NhSoXUMPK2K},1
EAC Population Total,IsRmTJ69mcS,EAC Population Total,#{NLKRV7bYbVy.NhSoXUMPK2K},1
EAC Population under five year,SAlx0xFvHuP,Population under five year,#{KNrK5VWTZkx.NhSoXUMPK2K},1
EAC Population under one year,a77XVF0FRdn,Population < 1 yr,#{pMbuvKvH4rg.NhSoXUMPK2K},1
EAC Post natal care within 2 days (baby),I8jDNCf7fGo,Post natal care within 2 days (baby),#{wxg6cuH9cXF},1
EAC Post partum care  within 2 days (mother),Pdgt6CuCpBJ,Post partum care < 2 days (mother),#{wAeGJlvuydG} + #{qahRo2120r8},#{tmlMpIqHimf}
EAC Pregnancies Expected,zhF84oke5hj,Pregnancies Expected,#{IDeJME1RKqM.NhSoXUMPK2K},1
EAC Stillbirths,UjXNTMSefdE,Stillbirths,#{rYn8RCcHJg1} + #{wZtDYVBa41h},1
EAC Vitamin A dose administered,JkAWzYX2lLN,Vitamin A dose administered,#{KXifjlklHaU.NhSoXUMPK2K}+#{lxEQY7XM7Oy.NhSoXUMPK2K},1
EAC Women in reproductive age (15-45 years),JNV1acB8vyw,Women 15-45 yrs old,#{bPQDV3mud0v.NhSoXUMPK2K},1
EPTB <15 yrs  HIV+ out of Tested EPTB <15 yrs,gkIUXN3JZeG,EPTB <15 yrs HIV+,#{Vri74blSuoL.G7Yo01Xihi1},#{CQVzChlE9qw.G7Yo01Xihi1}
EPTB <15 yrs out of total TB cases,VXqQjXAisjX,EPTB <15 yrs,#{MmsSJfunbRu.G7Yo01Xihi1},#{MmsSJfunbRu}
EPTB >15 yrs  HIV+ out of Tested EPTB >15 yrs,JnxWIH3v4tq,EPTB >15 yrs HIV+,#{Vri74blSuoL.ylAZAGPSH8q},#{CQVzChlE9qw.ylAZAGPSH8q}
EPTB >15 yrs  out of total TB cases,LO5jAYF9SkQ,EPTB >15 yrs,#{MmsSJfunbRu.ylAZAGPSH8q},#{MmsSJfunbRu}
EPTB >15 yrs tested for HIV out of the registered EPTB >15 yrs,K6GsaCh443J,EPTB >15 yrs tested,#{CQVzChlE9qw.ylAZAGPSH8q},#{MmsSJfunbRu.ylAZAGPSH8q}
Emergency Pill Dispensed,di6qWEf5ylj,Emergency Pill Dispensed,#{Y3I8QGTED4x.LkO5M9beZqG},1
Emergency Pills Ending Balance,RKGJ5hkRIIH,Emergency Pills EB,#{Y3I8QGTED4x.NvpLpQxmzkZ},1
Enrolled and eligible but not started on ART,ry2Lh86t9o5,Eligible but not ART,#{kMe8cor2UxQ.j03wX0lCHZc}+#{kMe8cor2UxQ.vVketPHJwSY}+#{kMe8cor2UxQ.omEDL5LVgDJ}+#{kMe8cor2UxQ.g6112VF7T29},1
Essenetial - Diabetes cases - new cases,A9KOgWrbCCY,Essenetial - Diabetes cases - new cases,#{X1nfVRZfgoj.QOIpb8LBRtm}+#{X1nfVRZfgoj.EynBGhY9Yg4},1
Essential - Children under 5 years presenting with symptoms of Pneumonia,fzQbGiENdJo,Essential - Children under 5 years prese,#{QgiADNKtauy.lHl2rmXpHse} + #{EEVfLW0M8vU},#{BwROYFIiXKG.lHl2rmXpHse} + #{IxhbkNwhcvE.lHl2rmXpHse}
Essential - DPT3 doses administered,Cblp7TAdj9W,Essential - DPT3 doses administered,#{OyddF1qflzP.ieuodyY5ybC},1
Essential - Diabetes cases - total,i37mflclEU6,Essential - Diabetes cases - total,#{D923dTnerdk.SeDaCnHi3m5},1
Essential - HIV positive pregnant women on HAART,xfdnpoNEkKG,Essential - HIV positive pregnant women on HAART,#{lJpaBye9B0H} + #{WNFWVHMqPv9} + #{ckPCoAwmWmT} + #{vkOYqEesPAi} + #{UMyB7dSIdz1},#{qSgLzXh46n9} + #{hn3aChn4sVx} + #{nwXS5vxrrr7} + #{AfHArvGun12} + #{hHLR1HP8xzI}
Essential - HIV tests performed ,BmWlyhX3ERL,Essential - HIV tests performed ,#{gMICOUtzqRb} + #{lj9QYJqS7bN} + #{YXJf27jfkvS} + #{XiRbc0DSMOH} + #{OePJt8CcZ0d} + #{JiuqbydCIcy} + #{pkShOkgNQt2} + #{atSQz5O7e2A} + #{gTkVw97FnQK},1
Essential - Hypertension cases - total,hNyiGOxeAE0,Essential - Hypertension cases - total,#{lVNKL5UQ8Sb.SeDaCnHi3m5},1
Essential - Newly Enrolled on ART,RsGHNwSlhrR,Essential - Newly Enrolled on ART,#{mACm1JUzeLT} + #{Hbc2qRi0U5x} + #{jthpt5cVV9c} + #{LC2OqnUC5Sn} + #{DaNcGZnkclz} + #{yWkSi8L3qGm} + #{zNCSlBKbS6d} + #{K59f8nZ5vhy} + #{Nv4OkbdDvmm} + #{SCMKsiNj6c5},1
Essential - No. of PLWHIV currently ART ,nVx4FiV8hXq,Essential - No. of PLWHIV currently ART ,#{SJL4k6Gl53C} + #{wbJOu4h2SSz} +   #{GSEmLUnrvzj} + #{Jbu4if6gtDp} + #{AQsTt7jtKbt} + #{oOOnacUi9Jm} + #{EhZQp3PTA3C} + #{e93GKJTHKAX} + #{yNCUlEYkmyA} + #{pR7VzBydoj3},1
Essential - Number of patients tested for malaria,lQgReolCDjX,Essential - Number of patients tested for malaria,#{IYnqoV2vlRq.dbZfB6Oub9K} + #{IYnqoV2vlRq.Gs4AqH6n3mV},1
Essential - OPD Visits for Children Under 5 Years,r7WOa2TrWSr,Essential - OPD Visits for Children < 5 yrs,#{Ha96SBKI06u} + #{F6AwnxbwiK2},1
Essential - Penta 3 dropout rate,Q1bg0sgLYcB,Essential - Penta 3 dropout rate,#{ku80YRejJPg.ieuodyY5ybC} - #{OyddF1qflzP.ieuodyY5ybC},#{ku80YRejJPg.ieuodyY5ybC}
Essential - Proportion of Adolescent Pregnancy among ANC Clients,mNYjNlj6kgW,E-Proportion of Adol Pregnancy among ANC Clients,#{chMsCa5zcn7} + #{uHBmKxktYk0},#{f9vesk5d4IY}
Essential - TB number of notified cases,OVMhCuFXB7s,Essential - TB number of notified cases,#{DBa1E1JSJ5K.WwOVo8ccFpn} + #{z8QuJHnjbnq.WwOVo8ccFpn} + #{dANzI9yMtIC.Se28qOAkpKc} + #{dANzI9yMtIC.sPdWr6ACTiU},1
Essential - Violence cases,Mg8KT0bPzOu,Essential - Violence cases,#{IJcsSSeoIok.SeDaCnHi3m5},1
Essential - Women aged 25-49 screened for cervical cancer ,C6fThjYiDZA,Essential - Women aged 25-49 screened for,#{kl4RvWOGb7x.FqagtL5h8ni} + #{G9COyloYLYa.FqagtL5h8ni},1
Essential - vitamin A supplementation for children aged between 6 to 59 months,MifkeL55fBg,Essential - vit A suppl children 6 to 59 months,#{MAGmTkOIZus.ieuodyY5ybC} + #{UTXjB4dxdrp} + #{Oaysbgtl1gF} + #{lxEQY7XM7Oy} + #{KXifjlklHaU} + #{cPeaV6caNqJ},1
Essential Malaria Tests Done (Revised),q3zSDDKBjqL,Essential Malaria Tested,#{XLT68mdLbJT.lHl2rmXpHse} + #{XLT68mdLbJT.SeDaCnHi3m5} + #{YjZ3XFV2Zum.lHl2rmXpHse} + #{YjZ3XFV2Zum.SeDaCnHi3m5},1
Essential services - OPD visits ,Rsus0ojKqPe,Essential services - OPD visits ,#{IxhbkNwhcvE.lHl2rmXpHse} + #{IxhbkNwhcvE.SeDaCnHi3m5} + #{BwROYFIiXKG.lHl2rmXpHse} + #{BwROYFIiXKG.SeDaCnHi3m5},1
Essetial - Hypertension cases - new,MsSSJrdOw0a,Essetial - Hypertension cases - new,#{s7cDALEmOP0.EynBGhY9Yg4}+#{s7cDALEmOP0.QOIpb8LBRtm},1
Estimated Emergency obstetric complications of the total pregnancy,gJNxVZDLTa8,Estimated Emergency obst,#{OjsW4KS6M5O.NhSoXUMPK2K},#{IDeJME1RKqM.NhSoXUMPK2K}
Estimated Total Deliveries ,K6RJMez0s1Z,Estimated Deliveries,#{tmlMpIqHimf.NhSoXUMPK2K},#{NLKRV7bYbVy.NhSoXUMPK2K}
Estimated live births of the total Population,UUAtEhT1ylT,Estimated live births,#{JOnT3OiMd5o.NhSoXUMPK2K},#{NLKRV7bYbVy.NhSoXUMPK2K}
Estimated number of Pregnant Women of the total Population,BLQqoPPTxQu,Est Pregnant Women,#{pct05jgGcLt},#{NLKRV7bYbVy.NhSoXUMPK2K}
Estimated post abortion cases of the total pregnancies  ,IPaGq1MqHNk,Estimated post abortion,#{a73BxXAmC08.NhSoXUMPK2K},#{pct05jgGcLt}
Expected Number of CHWs,pnNRuQJgUCx,Expected Number of CHWs,#{vMj9ZXCqkXk.NhSoXUMPK2K},1
Expected Population for Vitamin A  6-59 Months (90% of < 5yrs)*2,uxelbeGZ3M2,Expected Population for Vitamin A  6-59 Months*2,(#{KNrK5VWTZkx.NhSoXUMPK2K}*90/100)*2,1
Extra Pulmonary TB,nUXm8M3dfPX,Extra Pulmonary TB,#{BgFeMs6gQ7E.vVketPHJwSY}+#{BgFeMs6gQ7E.g6112VF7T29}+#{BgFeMs6gQ7E.omEDL5LVgDJ}+#{BgFeMs6gQ7E.j03wX0lCHZc},#{VihTrdMMli8.vVketPHJwSY}+#{VihTrdMMli8.g6112VF7T29}+#{VihTrdMMli8.omEDL5LVgDJ}+#{VihTrdMMli8.j03wX0lCHZc}
FP Combined Oral contraceptive Pills Stock MOS,CSjSohGxnxq,FP Combined Oral contraceptive Pills Stock MOS,#{i3ZaXmQj0jL.HMTuusGLTUj},#{m1U1MJZoK9Q.QvctQfKAQn3}
FP Cycle Beads Stock MOS,KucK2GDza8l,FP Cycle Beads Stock MOS,#{yqVMu78CyA2.HMTuusGLTUj},#{CxoGtEwF44m.QvctQfKAQn3}
FP Emergency Contraceptive pills Stock MOS,VInUQaQtrrt,FP Emergency Contraceptive pills Stock MOS,#{BIte0mKNt8v.HMTuusGLTUj},#{nGR47qCgOfQ.QvctQfKAQn3}
FP Female Condoms Stock MOS,J4Pzryd1EYO,FP Female Condoms Stock MOS,#{zgKc5Q0QOb6.HMTuusGLTUj},#{RXJmB0afFhv.QvctQfKAQn3}
FP IUCDs Stock MOS,Eut7pOhH1P6,FP IUCDs Stock MOS,#{mlMAWuMkAzX.HMTuusGLTUj},#{ri9reJBhA2Y.QvctQfKAQn3}
FP Implants (1-Rod) Stock MOS,iORtndG8LNB,FP Implants (1-Rod) Stock MOS,#{dxx7yqS7BpR.HMTuusGLTUj},#{QZpWVTFZEE7.QvctQfKAQn3}
FP Implants (2-Rod) Stock MOS,jVgFM6chs6l,FP Implants (2-Rod) Stock MOS,#{DtcvkNfutb4.HMTuusGLTUj},#{WLS1R40DxXt.QvctQfKAQn3}
"FP Implants (2-Rod, 3 years) Stock MOS",aldjeFPIbbt,"FP Implants (2-Rod, 3 years) Stock MOS",#{DtcvkNfutb4.HMTuusGLTUj},#{WLS1R40DxXt.QvctQfKAQn3}
FP Injectables DMPA SC Stock MOS,UTNuw3gPqdi,FP Injectables DMPA SC Stock MOS,#{hXa1xyUMfTa.i9dqmLZr7fd},#{CH3syaQ3wJ3.QvctQfKAQn3}
FP Injectables Stock MOS,t5DOInBnxIC,FP Injectables Stock MOS,#{WJFb0MNwc3u.HMTuusGLTUj},#{CH3syaQ3wJ3.QvctQfKAQn3}
FP Male Condoms Stock MOS,qBORbeFTtW3,FP Male Condoms Stock MOS,#{r9qspMRFu7n.HMTuusGLTUj},#{YSjqRqkkQdi.QvctQfKAQn3}
FP Progestin only pills Stock MOS,nSfd4EGB2ca,FP Progestin only pills Stock MOS,#{ZbzBYUMlTJK.HMTuusGLTUj},#{uiU7PDbqn74.QvctQfKAQn3}
FPCOCMOS,Qc07k3H7f55,FPCOCMOS,#{vCYikXcYEa6.NvpLpQxmzkZ},#{vCYikXcYEa6.LkO5M9beZqG}
FPInjectablesMOS,eLtUQoaqlb8,FPInjectablesMOS,#{J6qnTev1LXw.i9dqmLZr7fd},#{J6qnTev1LXw.to0Pssxkq4S}
FP_Combined Oral contraceptive Pills MoS,vBtxrMus3Qf,FP_Combined Oral contraceptive Pills MoS,#{hH9gmEmEhH4.i9dqmLZr7fd},#{m1U1MJZoK9Q.QvctQfKAQn3}
FP_Cycle Beads MoS,E5ehG5Qmk5Y,FP_Cycle Beads MoS,#{bGGT0F7iRxt.i9dqmLZr7fd},#{CxoGtEwF44m.QvctQfKAQn3}
FP_Emergency Contraceptive pills MoS,KWavo9MWGBT,FP_Emergency Contraceptive pills MoS,#{qaBPR9wbWku.i9dqmLZr7fd},#{nGR47qCgOfQ.QvctQfKAQn3}
FP_Female Condoms MoS,z5rdAD1Z9rH,FP_Female Condoms MoS,#{AR7RhdC90IV.i9dqmLZr7fd},#{RXJmB0afFhv.QvctQfKAQn3}
FP_IUCDs MoS,HP1u3rO8rM7,FP_IUCDs MoS,#{tfPZ6sGgh4q.i9dqmLZr7fd},#{ri9reJBhA2Y.QvctQfKAQn3}
FP_Implants (1-Rod) MoS,ZbLcoTanQnP,FP_Implants (1-Rod) MoS,#{XgJfT71Unkn.i9dqmLZr7fd},#{QZpWVTFZEE7.QvctQfKAQn3}
FP_Implants (2-Rod) MoS,Zz6gJ3FAKjr,FP_Implants (2-Rod) MoS,#{MsS41X1GEFr.i9dqmLZr7fd},#{WLS1R40DxXt.QvctQfKAQn3}
FP_Injectables MoS,xvxsOVLQWqh,FP_Injectables MoS,#{J6qnTev1LXw.i9dqmLZr7fd},#{CH3syaQ3wJ3.QvctQfKAQn3}
FP_Male Condoms MoS,DWMK6mvF9LH,FP_Male Condoms MoS,#{AVDzuypqGt9.i9dqmLZr7fd},#{YSjqRqkkQdi.QvctQfKAQn3}
FP_Others MoS,VHtSG6l59rb,FP_Others MoS,#{QKvDccYJ18W.i9dqmLZr7fd},#{FyLIhJocwlR.QvctQfKAQn3}
FP_Progestin only pills MoS,H7CkBPdObiC,FP_Progestin only pills MoS,#{dl4JcBnxu0X.i9dqmLZr7fd},#{uiU7PDbqn74.QvctQfKAQn3}
Facility Based Perinatal Mortality Rate (per 1000 Births),NEuqNomnNqa,Perinatal Mortality Rate (per 1000),#{Sw2AEIBtrFz} + #{rYn8RCcHJg1} + #{wZtDYVBa41h},#{UqKC1DJnymn} + #{rYn8RCcHJg1} + #{wZtDYVBa41h}
Facility Maternal Mortality Ratio,fCUaxiQYZzm,FMMR,#{eBHhfupqMHz.NhSoXUMPK2K} + #{CoAXLBxR0Ik} + #{KDFtI6rqYwI} + #{BYMSIbnUzXQ} + #{AC1Iorxdijc} + #{dPRCstLVkZu},#{UqKC1DJnymn.NhSoXUMPK2K}
Facility _TB_2017  Gloves  ,f7UMIUzG4f5, Gloves  ,(#{XDfVSKTx8fb.e2os98CantY} * 2) - #{XDfVSKTx8fb.TRw8Amoledr},1
Facility _TB_2017  Nirmatrevir/ritonavir 150mg/100mg,nT9l0Co1HMX,Nirmatrevir/ritonavir 150mg/100mg,(#{M9ExhULkaGz.ShAXH8W58Ju} * 2) - (#{M9ExhULkaGz.dRvK7VxuTSd}),1
Facility _TB_2017  Patients Packs,mYUXGeP8SBi,TB Patients Packs,(#{kiSFcMKPA8R.e2os98CantY} * 2) - #{kiSFcMKPA8R.TRw8Amoledr},1
Facility _TB_2017  Salbutamol inhaler ,cdlQij9Z2l8,Salbutamol inhaler  ,(#{uJxT82ybnOf.e2os98CantY} * 2) - #{uJxT82ybnOf.TRw8Amoledr},1
Facility _TB_2017 Amoxiclavulin 1gm ,cfqv5RThagj,Amoxiclavulin 1gm ,(#{mHP7rUjFTTY.e2os98CantY} * 2) - #{mHP7rUjFTTY.TRw8Amoledr},1
Facility _TB_2017 Azithromycin 500mg,dc9th47eoH8,Azithromycin 500mg,(#{DNptgVt8nv9.pD4OtrJ3XTJ} * 2) - #{DNptgVt8nv9.wGSba4uJwJ8},1
Facility _TB_2017 Beclomethasone inhaler,v6IJQ0GBDFr,Beclomethasone inhaler,(#{Y7gPHtYCDr3.e2os98CantY} * 2) - #{Y7gPHtYCDr3.TRw8Amoledr},1
Facility _TB_2017 Bedaquiline 100mg,xR6XA2nryZ4,Bedaquiline 100mg,(#{Sqdwoopw1nD.ShAXH8W58Ju} * 2) - #{Sqdwoopw1nD.dRvK7VxuTSd},1
Facility _TB_2017 Capreomycin 1gm vial,qMahMfdBp6H,Capreomycin 1gm vial,(#{XUq7mFujyzS.e2os98CantY} * 2) - #{XUq7mFujyzS.TRw8Amoledr},1
Facility _TB_2017 Carbamazipine 200mg,zzYlyLMK90b,Carbamazipine 200mg,(#{nADIXnQjn5X.e2os98CantY} * 2) - #{nADIXnQjn5X.TRw8Amoledr},1
Facility _TB_2017 Clofazimine 100mg,zBkbd9x8oQ2,Clofazimine 100mg,(#{ZrXmJW51TgK.ShAXH8W58Ju} * 2) - #{ZrXmJW51TgK.dRvK7VxuTSd},1
Facility _TB_2017 Cycloserine 250mg,WsU034Nd8dw,Cycloserine 250mg,(#{wMqBG6RUQlh.e2os98CantY} * 2) - #{wMqBG6RUQlh.TRw8Amoledr},1
Facility _TB_2017 Delaminid 50mg,SMpPTgiNGiN,Delaminid 50mg,(#{xAdz2MrUUsc.ShAXH8W58Ju} * 2) - #{xAdz2MrUUsc.dRvK7VxuTSd},1
Facility _TB_2017 Dexamethazone 6mg  ,Sg1GfiLrK8D,Dexamethazone 6mg  ,(#{LsESMSgHcBJ.e2os98CantY} * 2) - #{LsESMSgHcBJ.TRw8Amoledr},1
Facility _TB_2017 Ethambutol 100 mg,c1ClO9BAXHJ,Ethambutol 100 mg,(#{leD1F35SGYm.e2os98CantY} * 2) - #{leD1F35SGYm.TRw8Amoledr},1
Facility _TB_2017 FBF(Fortified Blended Foods),uga5ZeJ8D2t,FBF(Fortified Blended Foods),(#{k1mVrXUuOnL.e2os98CantY} * 2) - #{k1mVrXUuOnL.TRw8Amoledr},1
Facility _TB_2017 Fluoxetine 20mg,QfveipyaGED,Fluoxetine 20mg,(#{rEATKgNCxVW.e2os98CantY} *2 ) - #{rEATKgNCxVW.TRw8Amoledr},1
Facility _TB_2017 Formoterol fumarate tubohaler    ,fNCBYWR2JWo,Formoterol fumarate tubohaler    ,(#{jlOADslbCdY.e2os98CantY} * 2) - #{jlOADslbCdY.TRw8Amoledr},1
Facility _TB_2017 Haloperidol 5mg,Wl9Zyglt43P,Haloperidol 5mg,(#{RsgBr5i55fn.e2os98CantY} * 2) - #{RsgBr5i55fn.TRw8Amoledr},1
Facility _TB_2017 Hydrocortisone 20mg,TRIKIncGBvR,Hydrocortisone 20mg,(#{t5DU9lxKgcW.e2os98CantY} * 2) - #{t5DU9lxKgcW.TRw8Amoledr},1
Facility _TB_2017 Hydroxyquinolone (HCQ) 600mg,wYgUPjgPkYO,Hydroxyquinolone (HCQ) 600mg,(#{TKDMm5FgSRr.e2os98CantY} * 2) - #{TKDMm5FgSRr.TRw8Amoledr},1
Facility _TB_2017 Inhalers  ,IgyuSXk3FsX,Inhalers  ,(#{tqvroR4eECO.e2os98CantY} * 2) - #{tqvroR4eECO.TRw8Amoledr},1
Facility _TB_2017 Ipratropium bromide inhaler    ,kzGgOEJGAD4,Ipratropium bromide inhaler    ,(#{Zvq6hyfQSzm.e2os98CantY} * 2) - #{Zvq6hyfQSzm.TRw8Amoledr},1
Facility _TB_2017 Isoniazid 100 mg,wwNHp7umVqy,Isoniazid 100 mg,(#{SDdm1ePFws5.e2os98CantY} * 2) - #{SDdm1ePFws5.TRw8Amoledr},1
Facility _TB_2017 Isoniazid 100mg/5ml,mmJVG58PP80,Isoniazid 100mg/5ml,(#{FdzG6oQZ2yh.e2os98CantY} * 2) -#{FdzG6oQZ2yh.TRw8Amoledr},1
Facility _TB_2017 Isoniazid 300 mg,XjaYTym85bv,Isoniazid 300 mg,(#{foBquRqvLR5.e2os98CantY} * 2) - #{foBquRqvLR5.TRw8Amoledr},1
Facility _TB_2017 Isoniazid syrup 50mg/5ml,f8e2vc7W6PW,Isoniazid syrup 50mg/5ml,(#{OhBNKe1NTeq.e2os98CantY} * 2) - #{OhBNKe1NTeq.TRw8Amoledr},1
Facility _TB_2017 Kanamycin 1gm vial,NWHtk99D8oD,Kanamycin 1gm vial,(#{ATZnUs2RmVd.e2os98CantY} * 2) - #{ATZnUs2RmVd.TRw8Amoledr},1
Facility _TB_2017 Levofloxacin 250mg,PpwBSzJeZs2,Levofloxacin 250mg,(#{FoWAp7gEibO.e2os98CantY} * 2) - #{FoWAp7gEibO.TRw8Amoledr},1
Facility _TB_2017 Levofloxacin 500mg,lPJl3gGKLPR,Levofloxacin 500mg,(#{zm2U9nJQ2x2.e2os98CantY} * 2) - #{zm2U9nJQ2x2.TRw8Amoledr},1
Facility _TB_2017 Linezolid 600mg,Bc5cJSAGUHl,Linezolid 600mg,(#{z9QMZREIpkY.ShAXH8W58Ju} * 2) - #{z9QMZREIpkY.dRvK7VxuTSd},1
Facility _TB_2017 MB Adult Blister,ynsYJTOns6a,MB Adult Blister,(#{MgQ2Bq8EEAq.e2os98CantY} * 2) - #{MgQ2Bq8EEAq.TRw8Amoledr},1
Facility _TB_2017 MB Child Blister Packs,hlo21GQPJgK,MB Child Blister Packs,(#{i8PkCUh5Fik.e2os98CantY} *2 ) - #{i8PkCUh5Fik.TRw8Amoledr},1
Facility _TB_2017 Masks KN95,dRRos8vwIig,Masks KN95,(#{gAq62iuXlyH.e2os98CantY} * 2) - #{gAq62iuXlyH.TRw8Amoledr},1
Facility _TB_2017 Masks N95,jTD2HD5xA42,Masks N95,(#{ycKXmDGOcVQ.e2os98CantY} * 2 ) - #{ycKXmDGOcVQ.TRw8Amoledr},1
Facility _TB_2017 Masks surgical ,Q4RcXiXHw9u,Masks surgical ,(#{tCc5Bh2goul.e2os98CantY} * 2) - #{tCc5Bh2goul.TRw8Amoledr},1
Facility _TB_2017 Methyl -prednisolone 5mg  ,POxg2PEcZnU,Methyl -prednisolone 5mg  ,(#{Rp647ZSkkff.e2os98CantY} * 2) - #{Rp647ZSkkff.TRw8Amoledr},1
Facility _TB_2017 Montelukast 5mg   ,NfRp1sWcXAA,Montelukast 5mg   ,(#{wzdknuko9QA.e2os98CantY} * 2) - #{wzdknuko9QA.TRw8Amoledr},1
Facility _TB_2017 Moxifloxacin 400mg,sgZwaq5appn,Moxifloxacin 400mg,(#{ZIDG9tCleKX.e2os98CantY} * 2) - #{ZIDG9tCleKX.TRw8Amoledr},1
Facility _TB_2017 Nebulizers    ,yFoCREXkItS,Nebulizers    ,(#{L4jPNf5l1tv.e2os98CantY} * 2) - #{L4jPNf5l1tv.TRw8Amoledr},1
Facility _TB_2017 Omeprazole 20mg,q1aB0Bwi4bP,Omeprazole 20mg,(#{XWIm2t6lglg.e2os98CantY} * 2) - #{XWIm2t6lglg.TRw8Amoledr},1
Facility _TB_2017 PB Adult Blister Packs,vkf7Bf70v2M,PB Adult Blister Packs,(#{NuM1I0MnmoP.e2os98CantY} *2) - #{NuM1I0MnmoP.TRw8Amoledr},1
Facility _TB_2017 PB Child Blister Packs,waCo8cUrhsI,PB Child Blister Packs,(#{zstDvWVPooz.e2os98CantY} * 2) - #{zstDvWVPooz.TRw8Amoledr},1
Facility _TB_2017 Para-aminosalicylic acid 4mg,pSoF8k32DcI,Para-aminosalicylic acid 4mg,(#{GRycZaWtmu3.ShAXH8W58Ju} * 2) - #{GRycZaWtmu3.dRvK7VxuTSd},1
Facility _TB_2017 Peakfow meters    ,Leeoim6eXU8,Peakfow meters    ,(#{IBcqtCtwUCZ.e2os98CantY} * 2) - #{IBcqtCtwUCZ.TRw8Amoledr},1
Facility _TB_2017 Prednisolone 5mg,vwzv4sN2MVj,Prednisolone 5mg,(#{wXP4iP9414P.e2os98CantY} * 2) - #{wXP4iP9414P.TRw8Amoledr},1
Facility _TB_2017 Prothionamide 250mg,me3n0b1zNPU,Prothionamide 250mg,(#{qqTaOHPl8MN.e2os98CantY} * 2) - #{qqTaOHPl8MN.TRw8Amoledr},1
Facility _TB_2017 Prothionamide 250mg,qdcUItv1dRu,Prothionamide 250mg,(#{qqTaOHPl8MN.e2os98CantY} * 2) - #{qqTaOHPl8MN.TRw8Amoledr},1
Facility _TB_2017 Pyrazinamide 500mg,X7EAU5Uy06N,Pyrazinamide 500mg,(#{j6EB9U0HB4P.e2os98CantY} * 2) - #{j6EB9U0HB4P.TRw8Amoledr},1
Facility _TB_2017 Pyridoxine 25mg,BuInnbuTF9m,Pyridoxine 25mg,(#{bpUp4QMn3Iu.e2os98CantY} * 2) - #{bpUp4QMn3Iu.TRw8Amoledr},1
Facility _TB_2017 Pyridoxine 50mg,TdUxGbBIurw,Pyridoxine 50mg,(#{WgmhbXVnUdP} * 2) - #{WgmhbXVnUdP.dRvK7VxuTSd},1
Facility _TB_2017 R/H 75/50 mg,Qf3iAwghHGe,R/H 75/50 mg,(#{VfvEWB7ukWJ.e2os98CantY} *2 ) - #{VfvEWB7ukWJ.TRw8Amoledr},1
Facility _TB_2017 R/H/Z 75/50/150 mg,Dqmqh5EhguC,R/H/Z 75/50/150 mg,(#{Xwat5Cw8bo0.e2os98CantY} * 2) - #{Xwat5Cw8bo0.TRw8Amoledr},1
Facility _TB_2017 R/H/Z/E 150/75/400/275 mg,Pi8VxbYS30b,R/H/Z/E 150/75/400/275 mg,(#{WoHyCSyeiPI.e2os98CantY} * 2) - #{Yut9Dn6gydL.i65ATXAav6k},1
Facility _TB_2017 RUTF(Ready to Use Therapeutic Feed),ZUVy4gxvc7l,RUTF(Ready to Use Therapeutic Feed),(#{txAzEoC1TDB.e2os98CantY} * 2) - #{txAzEoC1TDB.TRw8Amoledr},1
Facility _TB_2017 Redemsavir 100mg  ,aRTNiBclNVk,Redemsavir 100mg  ,(#{hGzJIJhxjZy.e2os98CantY} * 2) - #{hGzJIJhxjZy.TRw8Amoledr},1
Facility _TB_2017 Rifampicin 150mg,Ghopc1r646b,Rifampicin 150mg,(#{DNnJnuCr44Y.e2os98CantY} * 2) - #{DNnJnuCr44Y.TRw8Amoledr},1
Facility _TB_2017 Rifampicin 300mg,k8xznD7yosO,Rifampicin 300mg,(#{VOOsfe4pPxC.e2os98CantY} * 2)  - #{VOOsfe4pPxC.TRw8Amoledr},1
Facility _TB_2017 Rifapentine + Isoniazid 300/300mg,JJ06c39Uto3,Rifapentine + Isoniazid 300/300mg,(#{Ak39JAb6v08.e2os98CantY}*2) - #{Ak39JAb6v08.TRw8Amoledr},1
Facility _TB_2017 Rifapentine 150mg tabs,JU5yBFisKfh,Facility _TB_2017 Rifapentine 150mg tabs,(#{BfXSH6Bcgd8.e2os98CantY}*2) - #{BfXSH6Bcgd8.TRw8Amoledr},1
Facility _TB_2017 Salbutamol inhaler  ,QV3XBPmX6Mp,Salbutamol inhaler  ,(#{uJxT82ybnOf.e2os98CantY} * 2) - #{uJxT82ybnOf.TRw8Amoledr},1
Facility _TB_2017 Sanitizers 0.5 Ltr ,pcMVAWdVlXU,Sanitizers 0.5 Ltr ,(#{iPgIJNN8V5F.e2os98CantY} * 2) - #{iPgIJNN8V5F.TRw8Amoledr},1
Facility _TB_2017 Spacers  ,K5G70bfZzS6,Spacers  ,(#{eDaqTtzslrs.e2os98CantY} * 2) - #{eDaqTtzslrs.TRw8Amoledr},1
Facility _TB_2017 Spirometer  ,Uldl1r7a9eU,Spirometer  ,(#{TFoxzxJVEun.e2os98CantY} * 2) - #{TFoxzxJVEun.TRw8Amoledr},1
Facility _TB_2017 Valproic Acid 200mg,S4ZRjiv04Ds,Valproic Acid 200mg,(#{gyDc2CtG70j.e2os98CantY} * 2) - #{gyDc2CtG70j.TRw8Amoledr},1
Facility _TB_2017Ethambutol 400 mg,geoJ42MLt4I,Ethambutol 400 mg, (#{EG8iaqKX2eq.e2os98CantY} * 2) - #{EG8iaqKX2eq.TRw8Amoledr},1
Facility based  <5yrs death rate,kSLNDPeUUEI,< 5yrs death rate,#{BA4dSFQINJq},#{cvJuw6Fbuiw} + #{F6AwnxbwiK2} + #{Ha96SBKI06u}
Facility based Under 1 deaths Scorecard,HVuKAubYkTm,Facility based Under 1 deaths Scorecard,#{z3ws0gAzoqL.NhSoXUMPK2K},#{GmQrYAEymfD.NhSoXUMPK2K}
Facility based Under 1 deaths ratio scorecard per 1000,Z3L0o3uPKX2,Facility based Under 1 deaths ratio scorecard,#{z3ws0gAzoqL.NhSoXUMPK2K},#{GmQrYAEymfD.NhSoXUMPK2K}
Facility based neonatal death rate  (per 1000 live births),kKpGBaLJwEp,Neonatal death rate (per 1000 live births),#{GAr6xu6f1n7.NhSoXUMPK2K},#{UqKC1DJnymn}
Facility supervised during last quarter,AYBdBp0d1d4,Facility supervised during last quarter,#{NOfWraFeclb.NhSoXUMPK2K},1
Family Planning New Cases,fJ7CyT97iJC,FP New Cases,#{M9wNpvfC8wb.wBWcFk7k1qY}+#{cV4qoKSYiBs.wBWcFk7k1qY}+#{yQFyyQBhXQf.wBWcFk7k1qY}+#{otgQMOXuyIn.wBWcFk7k1qY}+#{DuBH6qPPdaO.wBWcFk7k1qY}+#{BQmcVE8fex4.wBWcFk7k1qY}+#{uHM6lzLXDBd.wBWcFk7k1qY}+#{PggNwT09D3U.wBWcFk7k1qY}+#{Nqt6rz4tqnm.wBWcFk7k1qY},1
Family Planning Revisits,MVIKFGNvNJp,FP Revisits,#{M9wNpvfC8wb.K4WLOEhtcvC}+#{cV4qoKSYiBs.K4WLOEhtcvC}+#{yQFyyQBhXQf.K4WLOEhtcvC}+#{otgQMOXuyIn.K4WLOEhtcvC}+#{DuBH6qPPdaO.K4WLOEhtcvC}+#{BQmcVE8fex4.K4WLOEhtcvC}+#{uHM6lzLXDBd.K4WLOEhtcvC}+#{PggNwT09D3U.K4WLOEhtcvC}+#{Nqt6rz4tqnm.K4WLOEhtcvC},1
Female 0-4 yrs tested HIV+ (Tested for HIV) (PTB-),s0Q9Gjpj5oA,Female 0-4 yrs HIV+,#{pRlwE15DsEF.mShPtMKrbn3},#{DGOE9qBg0S9.mShPtMKrbn3}
Female 0-4 yrs tested for HIV (EPTB),T8oRvVljaeE,Female 0-4yr tested ,#{tZYhz9UkfxJ.mShPtMKrbn3},#{jJSUs0JbSra.mShPtMKrbn3}
Female 0-4 yrs tested for HIV (PTB+),Pcx5XRsreeK,Female 0-4yrs tested,#{NNkcO5xJ4D8.mShPtMKrbn3},#{mYcTFL89KEW.mShPtMKrbn3}
Female 0-4yrs tested HIV+ (Tested for HIV) (EPTB),zwdO3xBGYjE,Female 0-4yrs HIV+,#{F7BQXT7ExEh.mShPtMKrbn3},#{tZYhz9UkfxJ.mShPtMKrbn3}
Female 0-4yrs tested HIV+ (Tested for HIV) (PTB+),rQqPQcjbuzg,Female 0-4yrs tested HIV+,#{m9rOYAy4LZT.mShPtMKrbn3},#{NNkcO5xJ4D8.mShPtMKrbn3}
Female 0-4yrs tested for HIV (PTB-),KqF8UAuN3UE,Female 0-4yrs tested HIV,#{DGOE9qBg0S9.mShPtMKrbn3},#{u8dU1LPUUWD.mShPtMKrbn3}
Female 10-14 yrs tested HIV+ (Tested for HIV) (PTB+),HxisVJpBMu3,% Female 10-14yrs,#{m9rOYAy4LZT.evzSmUUZM1g},#{NNkcO5xJ4D8.evzSmUUZM1g}
Female 10-14 yrs tested HIV+ (Tested for HIV) (PTB-),Vm5lYOlhVGc,Female 10-14yrs HIV+,#{pRlwE15DsEF.evzSmUUZM1g},#{DGOE9qBg0S9.evzSmUUZM1g}
Female 10-14yrs tested HIV+ (Tested for HIV) (EPTB),ykuozW4clWL,Female 10-14yrs test HIV+,#{F7BQXT7ExEh.evzSmUUZM1g},#{tZYhz9UkfxJ.evzSmUUZM1g}
Female 10-14yrs tested for HIV (EPTB),A3jk19TU6zN,Female 10-14yrs,#{tZYhz9UkfxJ.evzSmUUZM1g},#{jJSUs0JbSra.evzSmUUZM1g}
Female 10-14yrs tested for HIV (PTB+),Vzw1vUjeXrR,Female 10-14 yrs,#{NNkcO5xJ4D8.evzSmUUZM1g},#{mYcTFL89KEW.evzSmUUZM1g}
Female 10-14yrs tested for HIV (PTB-),aJmN2NwbmzR,Female 10-14yrs HIV,#{DGOE9qBg0S9.evzSmUUZM1g},#{u8dU1LPUUWD.evzSmUUZM1g}
Female 15-24 yrs tested HIV+ (Tested for HIV) (EPTB),XY0qOVh6IW7,% Female 15-24yrs,#{F7BQXT7ExEh.WDafWKWrI84},#{tZYhz9UkfxJ.WDafWKWrI84}
Female 15-24 yrs tested for HIV (EPTB),vS0JFGGd3aB,% of Female 15-24yrs,#{tZYhz9UkfxJ.WDafWKWrI84},#{jJSUs0JbSra.WDafWKWrI84}
Female 15-24 yrs tested for HIV (PTB+),kW730g6Wqob,% of Female 15-24 yrs,#{NNkcO5xJ4D8.WDafWKWrI84},#{mYcTFL89KEW.WDafWKWrI84}
Female 15-24 yrs tested for HIV (PTB-),Q0PSStsWR0q,%  Female 15-24 yrs,#{DGOE9qBg0S9.WDafWKWrI84},#{u8dU1LPUUWD.WDafWKWrI84}
Female 15-24yrs tested HIV+ (Tested for HIV) (PTB+),Nkwr3M305LE,%  Female 15-24yrs,#{m9rOYAy4LZT.WDafWKWrI84},#{NNkcO5xJ4D8.WDafWKWrI84}
Female 15-24yrs tested HIV+ (Tested for HIV) (PTB-),lAxJM7zuQ0m,% Female15-24yrs,#{pRlwE15DsEF.WDafWKWrI84},#{DGOE9qBg0S9.WDafWKWrI84}
Female 25-34 yrs tested HIV+ (Tested for HIV) (EPTB),TFrIstPN6xr,% of Female 25-34 yrs ,#{F7BQXT7ExEh.g6eOWUrsZRD},#{tZYhz9UkfxJ.g6eOWUrsZRD}
Female 25-34 yrs tested HIV+ (Tested for HIV) (PTB+),kiExw53Ho61,% of Female 25-34 yrs,#{m9rOYAy4LZT.g6eOWUrsZRD},#{NNkcO5xJ4D8.g6eOWUrsZRD}
Female 25-34 yrs tested HIV+ (Tested for HIV) (PTB-),urDjkbPROeO,% of Female 25-34 yr,#{pRlwE15DsEF.g6eOWUrsZRD},#{DGOE9qBg0S9.g6eOWUrsZRD}
Female 25-34 yrs tested for HIV (EPTB),xCWlRsQwDyS,% of Female 25-34 yrs tes,#{tZYhz9UkfxJ.g6eOWUrsZRD},#{jJSUs0JbSra.g6eOWUrsZRD}
Female 25-34 yrs tested for HIV (PTB+),oE8Lu8oWUV7,% of Female 25-34 yrs te,#{NNkcO5xJ4D8.g6eOWUrsZRD},#{mYcTFL89KEW.g6eOWUrsZRD}
Female 25-34 yrs tested for HIV (PTB-),veJngOfUilu,% of Female 25-34 yrs t,#{DGOE9qBg0S9.g6eOWUrsZRD},#{u8dU1LPUUWD.g6eOWUrsZRD}
Female 35-44 yrs tested HIV+ (Tested for HIV) (EPTB),NBwRqEiRbA5,% of Female 35-44 yrs t,#{F7BQXT7ExEh.ppw89viJsQm},#{tZYhz9UkfxJ.ppw89viJsQm}
Female 35-44 yrs tested HIV+ (Tested for HIV) (PTB+),oWE42MLR5Mt,% of Female 35-44 yrs ,#{m9rOYAy4LZT.ppw89viJsQm},#{NNkcO5xJ4D8.ppw89viJsQm}
Female 35-44 yrs tested HIV+ (Tested for HIV) (PTB-),EcHU7Y5uHW9,% of Female 35-44 yrs,#{pRlwE15DsEF.ppw89viJsQm},#{DGOE9qBg0S9.ppw89viJsQm}
Female 35-44 yrs tested for HIV (PTB+),Ye948QJrqKq,% of Female 35-44 yrs tes,#{NNkcO5xJ4D8.ppw89viJsQm},#{mYcTFL89KEW.ppw89viJsQm}
Female 35-44 yrs tested for HIV (PTB-),JIGeDMAiMhc,% of Female 35-44 yrs te,#{DGOE9qBg0S9.ppw89viJsQm},#{u8dU1LPUUWD.ppw89viJsQm}
Female 35-44yrs tested for HIV (EPTB),mY2T4kAutEm,% of Female yrs 35-44 tes,#{tZYhz9UkfxJ.ppw89viJsQm},#{jJSUs0JbSra.ppw89viJsQm}
Female 45-54 yrs tested HIV+ (Tested for HIV) (EPTB),WBgp7CgMeMD,% of Female 45-54 yrs ,#{F7BQXT7ExEh.ePIPTGN08C1},#{tZYhz9UkfxJ.ePIPTGN08C1}
Female 45-54 yrs tested HIV+ (Tested for HIV) (PTB+),JV2GHgYE6Ps,% of Female 45-54 yrs,#{m9rOYAy4LZT.ePIPTGN08C1},#{NNkcO5xJ4D8.ePIPTGN08C1}
Female 45-54 yrs tested HIV+ (Tested for HIV) (PTB-),pK5KVgXHAYo,% of Female 45-54 yr,#{pRlwE15DsEF.ePIPTGN08C1},#{DGOE9qBg0S9.ePIPTGN08C1}
Female 45-54 yrs tested for HIV (EPTB),Y2DW2YPIYxI,% of Female 45-54 yrs tes,#{tZYhz9UkfxJ.ePIPTGN08C1},#{jJSUs0JbSra.ePIPTGN08C1}
Female 45-54 yrs tested for HIV (PTB+),rCNE4hjm4Yw,% of Female 45-54 yrs te,#{NNkcO5xJ4D8.ePIPTGN08C1},#{mYcTFL89KEW.ePIPTGN08C1}
Female 45-54 yrs tested for HIV (PTB-),VQ2PpA9Bq10,% of Female 45-54 yrs t,#{DGOE9qBg0S9.ePIPTGN08C1},#{u8dU1LPUUWD.ePIPTGN08C1}
Female 5-9 yrs tested HIV+ (Tested for HIV) (EPTB),AKI5OvFDZnP,% of Female 5-9yrs HIV+,#{F7BQXT7ExEh.XDU1Bi82Hgl},#{tZYhz9UkfxJ.XDU1Bi82Hgl}
Female 5-9yrs  tested HIV+ (Tested for HIV) (PTB-),wzwEoYouXSg,% of Female 5-9 yr tested,#{pRlwE15DsEF.XDU1Bi82Hgl},#{DGOE9qBg0S9.XDU1Bi82Hgl}
Female 5-9yrs  tested for HIV (PTB-),EzPB0Cc6Bli,%  Female 5-9yrs tested,#{DGOE9qBg0S9.XDU1Bi82Hgl},#{u8dU1LPUUWD.XDU1Bi82Hgl}
Female 5-9yrs tested HIV+ (Tested for HIV) (PTB+),ndO0TaOIA2J,% Female 5-9yrs tested,#{m9rOYAy4LZT.XDU1Bi82Hgl},#{NNkcO5xJ4D8.XDU1Bi82Hgl}
Female 5-9yrs tested for HIV (EPTB),NcO3No5qf7j,% of Female 5-9yr tested ,#{tZYhz9UkfxJ.XDU1Bi82Hgl},#{jJSUs0JbSra.XDU1Bi82Hgl}
Female 5-9yrs tested for HIV (PTB+),g1IfgPlZV0r,% of Female 5-9yrs tested,#{NNkcO5xJ4D8.XDU1Bi82Hgl},#{mYcTFL89KEW.XDU1Bi82Hgl}
Female 55-64 yrs tested HIV+ (Tested for HIV) (EPTB),RYgJtaJ6Sow,% of Female 55-64 yrs ,#{F7BQXT7ExEh.MlP8UmeTtS7},#{tZYhz9UkfxJ.MlP8UmeTtS7}
Female 55-64 yrs tested HIV+ (Tested for HIV) (PTB+),CxnwAvWS8Vp,% of Female 55-64 yrs,#{m9rOYAy4LZT.MlP8UmeTtS7},#{NNkcO5xJ4D8.MlP8UmeTtS7}
Female 55-64 yrs tested HIV+ (Tested for HIV) (PTB-),LRrLx30zkoz,% of Female 55-64 yr,#{pRlwE15DsEF.MlP8UmeTtS7},#{DGOE9qBg0S9.MlP8UmeTtS7}
Female 55-64 yrs tested for HIV (EPTB),uOelB2ooU7O,% of Female 55-64 yrs tes,#{tZYhz9UkfxJ.MlP8UmeTtS7},#{jJSUs0JbSra.MlP8UmeTtS7}
Female 55-64 yrs tested for HIV (PTB+),BqP7AUXI7bj,% of Female 55-64 yrs te,#{NNkcO5xJ4D8.MlP8UmeTtS7},#{mYcTFL89KEW.MlP8UmeTtS7}
Female 55-64 yrs tested for HIV (PTB-),ApR1RDYz238,% of Female 55-64 yrs t,#{DGOE9qBg0S9.MlP8UmeTtS7},#{u8dU1LPUUWD.MlP8UmeTtS7}
Female 65+ yrs tested HIV+ (Tested for HIV) (EPTB),Kpj3swsJvLv,% of Female 65+ yrs te,#{F7BQXT7ExEh.XIQ1SeOshtt},#{tZYhz9UkfxJ.XIQ1SeOshtt}
Female 65+ yrs tested HIV+ (Tested for HIV) (PTB+),CasrDIuGFuA,% of Female 65+ yrs t,#{m9rOYAy4LZT.XIQ1SeOshtt},#{NNkcO5xJ4D8.XIQ1SeOshtt}
Female 65+ yrs tested HIV+ (Tested for HIV) (PTB-),pRvX3EBUfsP,% of Female 65+ yrs ,#{pRlwE15DsEF.XIQ1SeOshtt},#{DGOE9qBg0S9.XIQ1SeOshtt}
Female 65+ yrs tested for HIV (EPTB),L4rJIYh5Wuq,% of Female 65+ yrs teste,#{tZYhz9UkfxJ.XIQ1SeOshtt},#{jJSUs0JbSra.XIQ1SeOshtt}
Female 65+ yrs tested for HIV (PTB+),DcgiNjJYLqO,% of Female 65+ yrs test,#{NNkcO5xJ4D8.XIQ1SeOshtt},#{mYcTFL89KEW.XIQ1SeOshtt}
Female 65+ yrs tested for HIV (PTB-),sZnixc1Mxnx,% of Female 65+ yrs tes,#{DGOE9qBg0S9.XIQ1SeOshtt},#{u8dU1LPUUWD.XIQ1SeOshtt}
Female Condom Dispensed,r8aBmbnY22K,Female Condom Dispensed,#{r5OyMeSK4c3.LkO5M9beZqG},1
Female Condom Ending Balance,ROE4SGMZ1jM,Female Condom EB,#{r5OyMeSK4c3.NvpLpQxmzkZ},1
Female Infants <6 Months Exclusive Breastfeeding(EBF),u9OdDYPBIRS,Female Infants <6 Months EBF,#{QUueF25THDC.a57uWFr3dUy},#{twpy25QKLk9.a57uWFr3dUy} + #{AIduSzrilaz.a57uWFr3dUy} + #{ENjll6PbaI8.a57uWFr3dUy} + #{QCNHvzgxurQ.a57uWFr3dUy} + #{lvyOQjZaXZ3.a57uWFr3dUy}
Females_Vaccinated,j4DLK581S2A,Females_Vaccinated,#{myQD3R0GBUq.LkGt7Z4CeY8} + #{myQD3R0GBUq.gVnIpfiEjnG} + #{myQD3R0GBUq.D7GeTJKDFQa} + #{myQD3R0GBUq.F4aAJxbU3Np} + #{myQD3R0GBUq.IWjT8EE7a5u} + #{qRQ3LIl7SmG.LkGt7Z4CeY8} + #{qRQ3LIl7SmG.gVnIpfiEjnG} + #{qRQ3LIl7SmG.D7GeTJKDFQa} + #{qRQ3LIl7SmG.F4aAJxbU3Np} + #{qRQ3LIl7SmG.IWjT8EE7a5u} + #{LTJsHtrbyML.LkGt7Z4CeY8} + #{LTJsHtrbyML.gVnIpfiEjnG} + #{LTJsHtrbyML.D7GeTJKDFQa} + #{LTJsHtrbyML.F4aAJxbU3Np} + #{LTJsHtrbyML.IWjT8EE7a5u} + #{UoaXvx7kTB7.LkGt7Z4CeY8} + #{UoaXvx7kTB7.gVnIpfiEjnG} + #{UoaXvx7kTB7.D7GeTJKDFQa} + #{UoaXvx7kTB7.F4aAJxbU3Np} + #{UoaXvx7kTB7.IWjT8EE7a5u} + #{gOksPnou3je.LkGt7Z4CeY8} + #{gOksPnou3je.D7GeTJKDFQa} + #{gOksPnou3je.F4aAJxbU3Np} + #{gOksPnou3je.IWjT8EE7a5u} + #{gOksPnou3je.gVnIpfiEjnG} + #{ZWMO83OyDwx.LkGt7Z4CeY8} + #{ZWMO83OyDwx.gVnIpfiEjnG} + #{ZWMO83OyDwx.D7GeTJKDFQa} + #{ZWMO83OyDwx.F4aAJxbU3Np} + #{ZWMO83OyDwx.IWjT8EE7a5u} + #{jm6G9QtE6Th.LkGt7Z4CeY8} + #{jm6G9QtE6Th.gVnIpfiEjnG} + #{jm6G9QtE6Th.D7GeTJKDFQa} + #{jm6G9QtE6Th.F4aAJxbU3Np} + #{jm6G9QtE6Th.IWjT8EE7a5u} + #{pkrY92yugfK.LkGt7Z4CeY8} + #{pkrY92yugfK.gVnIpfiEjnG} + #{pkrY92yugfK.D7GeTJKDFQa} + #{pkrY92yugfK.F4aAJxbU3Np} + #{pkrY92yugfK.IWjT8EE7a5u}  + #{NHd2e6QGCkk.LkGt7Z4CeY8} + #{NHd2e6QGCkk.gVnIpfiEjnG} + #{NHd2e6QGCkk.D7GeTJKDFQa} + #{NHd2e6QGCkk.F4aAJxbU3Np} + #{NHd2e6QGCkk.IWjT8EE7a5u},1
First Time Testers Proportion,HMbM0RhPwjZ,First Time Testers,#{Aioi6LxPb3N.NhSoXUMPK2K},#{Aioi6LxPb3N.NhSoXUMPK2K}+#{jbzrwpsfYMN.NhSoXUMPK2K}
Fresh still Birth Rate,YHHOt4ktnD4,Fresh still Birth Rate,#{rYn8RCcHJg1.NhSoXUMPK2K},#{mmqXlRfsXlf.NhSoXUMPK2K}+#{UqKC1DJnymn.NhSoXUMPK2K}
Fresh still births in health facility Perfomance,g4Hl19CHWZK,Fresh still birth,#{mmqXlRfsXlf.NhSoXUMPK2K},#{uIVSw3JGaGK.ea7VHlwMkhH}
Fully immunized Child Performance,tYSU89UkhMn,FIC Performance,#{tBPGQFhWB7M.ieuodyY5ybC},#{knYEO8oH2cu.ea7VHlwMkhH}
Funds utilization rate Scorecard,jTZ4ZEQnbGk,Funds utilization rate Scorecard,#{QLC6ejj76za},#{LwS5qdivh4n}
GF Number of HIV-positive women who received ART during pregnancy and/or labour and delivery,wgF81tPbyM7,GF # of HIV-positive women who received ART,#{WNFWVHMqPv9} + #{ckPCoAwmWmT} + #{vkOYqEesPAi} + #{UMyB7dSIdz1} + #{lJpaBye9B0H},1
GF Number of PLHIV on ART who initiated TB preventive therapy among those eligible during the reporting period,bYbcJx2rrLL,GF PLHIV on ART who initiated,#{HkupH0VZK2I} + #{tmSTLmcpAGb} + #{HNMPXD5GbCn} + #{BQ1kgSFRLHZ} + #{Ue4hEtq10cK} + #{W1Y1DC0wDUd},1
GF Number of Pregnant women who know their HIV status,kOQPx5zfBp5,GF #Pregnant women who know their HIV status,(#{qSgLzXh46n9} + #{ETX9cUWF43c} + #{mQz4DhBSv9V} + #{LQpQQP3KnU1}) + #{UMyB7dSIdz1},1
GF Number of f people on ART among all people living with HIV at the end of the reporting period,hxJPUTTSmRT,GF # of people on ART among all people living,#{wbJOu4h2SSz} + #{SJL4k6Gl53C} + #{Jbu4if6gtDp} + #{GSEmLUnrvzj} + #{oOOnacUi9Jm} + #{AQsTt7jtKbt} + #{e93GKJTHKAX} + #{EhZQp3PTA3C} + #{pR7VzBydoj3} + #{yNCUlEYkmyA},1
GF Number of medical male circumcisions performed according to national standards,ywdewF3RMlp,Gf Number of medical MC performed ,#{ZPcn7zMAZ1V} + #{GGKtWopm7vD} + #{hx68TrqkSh1} + #{i99a9CT4YeV} + #{WyVWHKRa4i8} + #{yivJXC2pAOM},1
GF Percentage of HIV-positive results among the total HIV tests performed during the reporting period,LOXYP44hz2Q,#HIV-positive results among the total HIV tests,#{OePJt8CcZ0d} + #{lj9QYJqS7bN} + #{gMICOUtzqRb} + #{XiRbc0DSMOH} + #{YXJf27jfkvS} + #{pkShOkgNQt2} + #{JiuqbydCIcy} +#{gTkVw97FnQK} + #{atSQz5O7e2A},#{du5RMT3aecB} + #{D9YwtS6RhQ1} + #{wu0ITFRjUzF} + #{kLXGWRLzCAw} + #{xMNhnyu7vm1} + #{F9OR49Lc1aR} + #{oCFXmpol7D8} + #{J4vNm7YEkdj} + #{cBTa1jVzT8f}
Gap / surplus (kshs) for Non pharmaceuticals,a9FoevajZZW,Non pharma gaps/Suppliers,#{yM9I4mtTWWT.mkunaICeJrU}-#{xifB1WtH7Ng.mkunaICeJrU}-#{RbeH1QkzW1n.mkunaICeJrU}-#{xgjUzJuRc9y.mkunaICeJrU}-#{wvsz8rHyZjm.mkunaICeJrU},1
Gaps/Surplus for Pharmaceuticals,mNWkxaY4O3i,Gaps/Surplus for Pharmace,#{yM9I4mtTWWT.uatqPaQgSUj}-#{xgjUzJuRc9y.uatqPaQgSUj}-#{xifB1WtH7Ng.uatqPaQgSUj}-#{RbeH1QkzW1n.uatqPaQgSUj}-#{wvsz8rHyZjm.uatqPaQgSUj},1
"Gentamicin Injection, 40mg/2ml (Ampoule)  MoS",snkYSLUGXk6,"Gentamicin Injection, 40mg/2ml (Ampoule)",#{BT8vV7Z7anH.n8XlCFUpWOG},#{BG8rAWc2pPP.QvctQfKAQn3}
HCD - R/H 75/50 mg - Adjusted Consumption - HF,EJbp4GVNpfK,R/H 75/50 mg ,(#{D25RrfG5JlP.wGSba4uJwJ8}+#{L9uipIDbAd1.dRvK7VxuTSd})/#{L9uipIDbAd1.ShAXH8W58Ju},1
HCD - R/H/Z 75/50/150 mg Adjusted Consumption - HF,zaGvKUA5dOL,R/H/Z 75/50/150,(#{FFklDDzQwaA.wGSba4uJwJ8}+#{MfT3krz1tyl.dRvK7VxuTSd})/#{MfT3krz1tyl.ShAXH8W58Ju},1
HCD - R/H/Z/E 150/75/400/275 mg adjusted Consumption - hf,meI8kaOWV52,HCD - R/H/Z/E 150/75/400/275 mg,(#{Vp6ycWrIssj.wGSba4uJwJ8}+#{yrbLuCsTfPQ.dRvK7VxuTSd})/#{yrbLuCsTfPQ.ShAXH8W58Ju},1
HCT Couples Discordancy Rate-MOH711,gGNIPUcSNon,HCT Couples Discordancy -MOH711,#{f1yrtCEf1HP.NhSoXUMPK2K},#{OPII6vOKimx.NhSoXUMPK2K}
HCT Couples Discordancy Rate-MOH731,YHzlBaOHxUp,HCT Couples Discordancy,#{ahFBu9QDdwt.NhSoXUMPK2K},#{jgTfzqHhC3P.NhSoXUMPK2K}
HIV + pregnant mothers receiving preventive ARV’s,fECDc5w8IPz,HIV + pregnant mothers ,#{tF5z3LnQvWu.NhSoXUMPK2K},#{FCmhDa4kaMp.NhSoXUMPK2K}
HIV Positivity,bEmCLebFq1P,HIV Positivity,#{W8KZcGSjbkY},#{c2pgDecBILP} + #{NMWgSKFW6U7} + #{QXQFd2JB10B} + #{RCFqEXIiqed} + #{xN6GhQGgaoI} + #{DBZH3aC9gwQ}
HIV Tests Done,CD61huCGvgG,HIV Tests Done,#{rxhsRqFckMf}+#{s0Zi5NpklJN}+#{szTUYhNllEM.NhSoXUMPK2K}+#{NeH2XNZ4B78}+#{DrYHirleKid.NhSoXUMPK2K}+#{jnRAS7B3piw}+#{BnPSZj7YWX4.NhSoXUMPK2K},1
HIV positive cases receiving ART treatment Total,mdLI9UKDIiS,HIV+ cases ART treatment,#{qa1IrxISrSJ}+#{qMybCnYBkNY},1
HIV+  - PMTCT-ANC Prevalence,sJfbqsQl8Xn,HIV+  - PMTCT-ANC Prevale,#{FCmhDa4kaMp.NhSoXUMPK2K},#{nspwXhqQaAz.NhSoXUMPK2K}
HIV+ patients starting ART Total,VucGcubk3qj,HIV+ patients start ART,#{cTY2tTKwUqd}+#{eNcsljfoUKW}+#{jFrSw8UkNQ4}+#{GlGolXdf6gr},1
HIV+ pregnant women received ARV for PMTCT,vl3c901RTVh,Pregnant Women - ARV,#{g62PclQcVba.NhSoXUMPK2K},#{A00MjWUoJu7.NhSoXUMPK2K}
HIV+ test rate - DTC inpatients,LrYZHxOgLHQ,HIV+ test rate - DTC IPD,#{JglserSm6IQ},#{rxhsRqFckMf}
HIV+ test rate - DTC outpatients,mj5WBkEgqcF,HIV+ test rate - DTC OPD,#{SI8igpKYhVG},#{s0Zi5NpklJN}
HIV+ test rate - PMTCT -ANC,bK9Y9gimhnI,HIV+ test rate - PMTCT -A,#{A00MjWUoJu7.NhSoXUMPK2K},#{Du49LE8Qndk.NhSoXUMPK2K}
HIV+ test rate - PMTCT-Maternity,iMdf7hcQ5ux,HIV+ test rate maternity,#{pSIDJ79UquD.NhSoXUMPK2K},#{cKxrOyX8yfM.NhSoXUMPK2K}
HIV+ test rate - TB patients,Bd9BzNGrWBy,HIV+ test rate - TB,#{bhFvc6EeCTC},#{jnRAS7B3piw}
HIV+ test rate - VCT,e76jzkp4Mff,HIV+ test rate - VCT,#{sdA7bJkZc9E},#{NeH2XNZ4B78}
HIV-Abacavir (ABC) 300mg Tablets MoS,zlCkaws4enU,HIV-Abacavir (ABC) 300mg Tablets MoS,#{Bv08ScvBzZy.GvjV9gy3OOc},#{EfRYfSRQUJ7.QvctQfKAQn3}
HIV-Abacavir/Lamivudine (ABC/3TC) 120mg/60mg FDC Tablets MoS,dBYqllZ8cAI,HIV-Abacavir/Lamivudine (ABC/3TC) 120mg/60mg FDC T,#{KnOB8nSo99l.GvjV9gy3OOc},#{qJNU0TdxOwf.QvctQfKAQn3}
HIV-Abacavir/Lamivudine (ABC/3TC) 600mg/300mg FDC Tablets MoS,uQCflTtzKo6,HIV-Abacavir/Lamivudine (ABC/3TC) 600mg/300mg FDC ,#{WeA3sq0ELOE.GvjV9gy3OOc},#{sl7iwGHnE0z.QvctQfKAQn3}
HIV-Abacavir/Lamivudine/Dolutegravir (ABC/3TC/DTG) 60mg/30mg /5mg FDC Tablets MoS,Y9NJQTP4CtZ,HIV-Abacavir/Lamivudine/Dolutegravir (ABC/3TC/DTG),#{y849186w1rj.GvjV9gy3OOc},#{xvv9A6gWeZS.QvctQfKAQn3}
HIV-Abacavir/Lamivudine/Lopinavir/ritonavir (ABC/3TC/LPV/r) 30/15/40/10mg FDC Tablets MoS,CX2q4dCIdkn,HIV-Abacavir/Lamivudine/Lopinavir/ritonavir (ABC/3,#{orN14YLwwZM.GvjV9gy3OOc},#{Cx2c0PSSID2.QvctQfKAQn3}
HIV-Acyclovir 400mg Tablets MoS,xeSDrPDoOrS,HIV-Acyclovir 400mg Tablets MoS,#{ZYYcDSXFHcq.GvjV9gy3OOc},#{tn30gfgNC7L.QvctQfKAQn3}
HIV-Amphotericin B 50mg IV Injection MoS,uAYoiQaC29j,HIV-Amphotericin B 50mg IV Injection MoS,#{Ywi6QrCf4wp.GvjV9gy3OOc},#{XiEveLkBID9.QvctQfKAQn3}
HIV-Atazanavir/Ritonavir (ATV/r) 300/100mg Tablets MoS,mpXPU0FBDeH,HIV-Atazanavir/Ritonavir (ATV/r) 300/100mg Tablets,#{hnMei2LGuhw.GvjV9gy3OOc},#{B936SWYOedE.QvctQfKAQn3}
HIV-Cotrimoxazole 960mg Tablets MoS,rq2MP7baB0o,HIV-Cotrimoxazole 960mg Tablets MoS,#{uYwZjUIeoY2.GvjV9gy3OOc},#{VbdCdregf9D.QvctQfKAQn3}
HIV-Cotrimoxazole suspension 240mg/5ml MoS,Zs5HYTbY8g8,HIV-Cotrimoxazole suspension 240mg/5ml MoS,#{rS62iKZ6Idq.GvjV9gy3OOc},#{uZwzgzmrIg8.QvctQfKAQn3}
HIV-Darunavir (DRV) 150mg Tablets MoS,OvYg8OqlW6K,HIV-Darunavir (DRV) 150mg Tablets MoS,#{Fmu24faR6RP.GvjV9gy3OOc},#{eZtUCnV7519.QvctQfKAQn3}
HIV-Darunavir (DRV) 600mg Tablets MoS,dOJpd8Sira6,HIV-Darunavir (DRV) 600mg Tablets MoS,#{Lo1lUEHEXap.GvjV9gy3OOc},#{R9x82Bcjk8T.QvctQfKAQn3}
HIV-Darunavir (DRV) 75mg Tablets MoS,fsWfAYksyYX,HIV-Darunavir (DRV) 75mg Tablets MoS,#{YvUG4Tj5pBB.GvjV9gy3OOc},#{H5S8Oy18dRW.QvctQfKAQn3}
HIV-Darunavir (DRV) susp 100mg/ml (200ml Bottles) MoS,cBNrzYufrS5,HIV-Darunavir (DRV) susp 100mg/ml (200ml Bottles) ,#{Zp4GO6RalC3.GvjV9gy3OOc},#{Hwk74KlJ8XC.QvctQfKAQn3}
HIV-Dolutegravir(DTG) 10mg Dispersible Scored Tablets MoS,QUtewe4qTGm,HIV-Dolutegravir(DTG) 10mg Dispersible Scored Tabl,#{ms3ICb7Ic6Z.GvjV9gy3OOc},#{FSOX0zGcw4b.QvctQfKAQn3}
HIV-Dolutegravir(DTG) 50mg tabs MoS,DlRkPKWsWlT,HIV-Dolutegravir(DTG) 50mg tabs MoS,#{Qr8Hx7Nl02R.GvjV9gy3OOc},#{Qfr7PEnW4Aj.QvctQfKAQn3}
HIV-Efavirenz (EFV) 200mg Tablets MoS,kNOK2MiIkqQ,HIV-Efavirenz (EFV) 200mg Tablets MoS,#{FWfv9nwqQNj.GvjV9gy3OOc},#{TO9DMIsX7Eb.QvctQfKAQn3}
HIV-Efavirenz (EFV) 600mg Tablets MoS,BGdbr7oIKMv,HIV-Efavirenz (EFV) 600mg Tablets MoS,#{JfkxhCPe29t.GvjV9gy3OOc},#{hLdzVlYVlFT.QvctQfKAQn3}
HIV-Ethambutol 400mg Tab (for Pack of 28 tabs) MoS,KU4BL5zs6Lw,HIV-Ethambutol 400mg Tab (for Pack of 28 tabs) MoS,#{XYarFhtrZnM.GvjV9gy3OOc},#{zobz6USsiVU.QvctQfKAQn3}
HIV-Etravirine (ETV) 100mg Tablets MoS,sTYY0uvGcmf,HIV-Etravirine (ETV) 100mg Tablets MoS,#{CUkg2rMIBqV.GvjV9gy3OOc},#{wLJeSZ0EdNC.QvctQfKAQn3}
HIV-Fluconazole 200mg Tablets MoS,FRNwpYUk9Yi,HIV-Fluconazole 200mg Tablets MoS,#{BHlhxD6Wjct.GvjV9gy3OOc},#{xShLoYJeWD1.QvctQfKAQn3}
HIV-Isoniazid (H) 100mg Tablets MoS,Mc0uBfTXfOv,HIV-Isoniazid (H) 100mg Tablets MoS,#{ow27FKynLOP.GvjV9gy3OOc},#{YKO2r4iQcBA.QvctQfKAQn3}
HIV-Isoniazid (H) 10mg/ml (120ml Bottles) MoS,TL7PYii2VHT,HIV-Isoniazid (H) 10mg/ml (120ml Bottles) MoS,#{hI5dsFlNwro.GvjV9gy3OOc},#{eZU4HYSr66K.QvctQfKAQn3}
HIV-Isoniazid (H) 300mg Tabs (for Pack of 100 tabs) MoS,qCfoqQgVpXd,HIV-Isoniazid (H) 300mg Tabs (for Pack of 100 tabs,#{bjqajaEgKDD.GvjV9gy3OOc},#{z6zCzrZ7zyF.QvctQfKAQn3}
HIV-Isoniazid (H) 300mg Tabs (for Pack of 672 tabs) MoS,MCVZftLNBmX,HIV-Isoniazid (H) 300mg Tabs (for Pack of 672 tabs,#{ScMZvEURp0k.GvjV9gy3OOc},#{wWF0cC258Cl.QvctQfKAQn3}
HIV-Lamivudine (3TC) 150mg Tablets MoS,nWH2InzCwwm,HIV-Lamivudine (3TC) 150mg Tablets MoS,#{jC1clm8DHjU.GvjV9gy3OOc},#{uTdA3gypldw.QvctQfKAQn3}
HIV-Lamivudine (3TC) liquid 10mg/ml (240ml Bottles) MoS,JFxdleJLsdI,HIV-Lamivudine (3TC) liquid 10mg/ml (240ml Bottles,#{k820rGmrG7y.GvjV9gy3OOc},#{ek66G8H0atW.QvctQfKAQn3}
HIV-Lopinavir/ritonavir (LPV/r) 100/25mg Tabs MoS,dNSmKDj3oj8,HIV-Lopinavir/ritonavir (LPV/r) 100/25mg Tabs MoS,#{bNwb0BQTiXu.GvjV9gy3OOc},#{Z7SGfocyEgp.QvctQfKAQn3}
HIV-Lopinavir/ritonavir (LPV/r) 200/50mg Tablets MoS,wO4xohNGRrx,HIV-Lopinavir/ritonavir (LPV/r) 200/50mg Tablets M,#{GjYg7sEHVAx.GvjV9gy3OOc},#{aeLZtD1DrdS.QvctQfKAQn3}
HIV-Lopinavir/ritonavir (LPV/r) 40/10mg Caps(pellets) MoS,qDEImjg7kfY,HIV-Lopinavir/ritonavir (LPV/r) 40/10mg Caps(pelle,#{qvS7TkgQO1f.GvjV9gy3OOc},#{DZLxyL4mOyx.QvctQfKAQn3}
HIV-Lopinavir/ritonavir (LPV/r) liquid 80/20mg/ml (60ml Bottles) MoS,BoBsS7v3Hmh,HIV-Lopinavir/ritonavir (LPV/r) liquid 80/20mg/ml ,#{GTqdnEoYWpl.GvjV9gy3OOc},#{P8DZsEc9sX3.QvctQfKAQn3}
HIV-Nevirapine (NVP) 200mg Tablets MoS,sUnzO1dgLhh,HIV-Nevirapine (NVP) 200mg Tablets MoS,#{Fo2gnhRx1eB.GvjV9gy3OOc},#{TvuY7HgQqxf.QvctQfKAQn3}
HIV-Nevirapine (NVP) Susp 10mg/ml (100 ml Bottles) MoS,OeSxhWKAX7L,HIV-Nevirapine (NVP) Susp 10mg/ml (100 ml Bottles),#{w96pwQ6povd.GvjV9gy3OOc},#{UQ0VP5vLjho.QvctQfKAQn3}
HIV-Nevirapine (NVP) Susp 10mg/ml (240 ml Bottles) MoS,FtbXvNYEa9Q,HIV-Nevirapine (NVP) Susp 10mg/ml (240 ml Bottles),#{SeDTXsB8p8g.GvjV9gy3OOc},#{KZKyE8XPwqM.QvctQfKAQn3}
HIV-Pyrazinamide 500mg Tab (for Pack of 28 tabs) MoS,eG0NxIQTrDu,HIV-Pyrazinamide 500mg Tab (for Pack of 28 tabs) M,#{rgrECRA0XVz.GvjV9gy3OOc},#{PrgwmD5lX6p.QvctQfKAQn3}
HIV-Pyridoxine 25mg Tabs MoS,tq31BSuoWZo,HIV-Pyridoxine 25mg Tabs MoS,#{noIMGcbffat.GvjV9gy3OOc},#{kuQDtoisudv.QvctQfKAQn3}
HIV-Pyridoxine 50mg Tablets MoS,woYtouduDMj,HIV-Pyridoxine 50mg Tablets MoS,#{nReJj3EEIHt.GvjV9gy3OOc},#{NjGpeXQ11wG.QvctQfKAQn3}
HIV-Raltegravir (RAL) 100mg Chewable Tablets MoS,YjHq66bzXlZ,HIV-Raltegravir (RAL) 100mg Chewable Tablets MoS,#{aGYM59Vptun.GvjV9gy3OOc},#{FKoLBdRGDIm.QvctQfKAQn3}
HIV-Raltegravir (RAL) 25mg Chewable Tablets MoS,lla3LZfauvE,HIV-Raltegravir (RAL) 25mg Chewable Tablets MoS,#{q7xXQuGgvgB.GvjV9gy3OOc},#{pPxbwhzYcYS.QvctQfKAQn3}
HIV-Raltegravir (RAL) 400mg Tablets MoS,SQf8nn0ft4L,HIV-Raltegravir (RAL) 400mg Tablets MoS,#{dsZqocFWAqm.GvjV9gy3OOc},#{OrcW22xjYyI.QvctQfKAQn3}
HIV-Rifabutin 150mg Tab MoS,BZbR8OONjOc,HIV-Rifabutin 150mg Tab MoS,#{gjOJC5nWO9W.GvjV9gy3OOc},#{ErRbt8Bd5ej.QvctQfKAQn3}
HIV-Rifapentine (P) 150mg Tab MoS,vWjTvmK3nZm,HIV-Rifapentine (P) 150mg Tab MoS,#{POCEHFzbrPN.GvjV9gy3OOc},#{yyDjYmmbEnj.QvctQfKAQn3}
HIV-Rifapentine/isoniazid (P) 300/300mg Tab MoS,B08VqeJVlhW,HIV-Rifapentine/isoniazid (P) 300/300mg Tab MoS,#{i7MzGhzg6VJ.GvjV9gy3OOc},#{P35q614oPCt.QvctQfKAQn3}
HIV-Ritonavir (RTV) 100mg Tablets MoS,mwDdIBXWwuj,HIV-Ritonavir (RTV) 100mg Tablets MoS,#{FE6o5uZ6Ey3.GvjV9gy3OOc},#{pDpymgPmheM.QvctQfKAQn3}
HIV-Ritonavir liquid 80mg/ml (90ml Bottles) MoS,CoF8wn0j8ns,HIV-Ritonavir liquid 80mg/ml (90ml Bottles) MoS,#{LdqZPGOt7px.GvjV9gy3OOc},#{gkE2EpTDu6P.QvctQfKAQn3}
HIV-Tenofovir (TDF) 300mg Tablets MoS,w1ZJxBM0JmM,HIV-Tenofovir (TDF) 300mg Tablets MoS,#{lMHWiV1wfzU.GvjV9gy3OOc},#{CvUJslAXr1o.QvctQfKAQn3}
HIV-Tenofovir/Emtricitabine (TDF/FTC) FDC (300/200mg) Tablets MoS,Mbc2bBQJiUS,HIV-Tenofovir/Emtricitabine (TDF/FTC) FDC (300/200,#{Ovk1BBcACSN.GvjV9gy3OOc},#{gDIKqyYAHUq.QvctQfKAQn3}
HIV-Tenofovir/Lamivudine (TDF/3TC) FDC (300/300mg) Tablets MoS,muJNLZJen0M,HIV-Tenofovir/Lamivudine (TDF/3TC) FDC (300/300mg),#{VJMNX2JtVAL.GvjV9gy3OOc},#{oFSBUuHRlmU.QvctQfKAQn3}
HIV-Tenofovir/Lamivudine/Dolutegravir (TDF/3TC/DTG) FDC (300/300/50mg) FDC Tablets(30s) MoS,JV3v7fSrW7f,HIV-Tenofovir/Lamivudine/Dolutegravir (TDF/3TC/DTG,#{YpjdjMD6yeC.GvjV9gy3OOc},#{s5HpBTQ3z4T.QvctQfKAQn3}
HIV-Tenofovir/Lamivudine/Dolutegravir (TDF/3TC/DTG) FDC (300/300/50mg) FDC Tablets(90s) MoS,wQq1PZOPs2v,HIV-Tenofovir/Lamivudine/Dolutegravir (TDF/3TC/DTG,#{EqZyS1EUSQc.GvjV9gy3OOc},#{S8cf1r3Qakt.QvctQfKAQn3}
HIV-Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/400mg) FDC Tablets(30s) MoS,e2oxSJFSAvy,HIV-Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) F,#{wJTbaU9jnf2.GvjV9gy3OOc},#{xjqgb03P3WP.QvctQfKAQn3}
HIV-Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/400mg) FDC Tablets(90s) MoS,cjtAB7uQ35P,HIV-Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) F,#{H6HgMLW2tWl.GvjV9gy3OOc},#{jqdQjZRS1tZ.QvctQfKAQn3}
HIV-Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/600mg) FDC Tablets MoS,sWVoL2uVUXU,HIV-Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) F,#{MtiBOPPd7Ke.GvjV9gy3OOc},#{PIoKmxtkg4G.QvctQfKAQn3}
HIV-Zidovudine (AZT) 300mg Tablets MoS,XbAT4zkOnKf,HIV-Zidovudine (AZT) 300mg Tablets MoS,#{L9VlZFQZGbv.GvjV9gy3OOc},#{P3rGuKcGoYz.QvctQfKAQn3}
HIV-Zidovudine (AZT) liquid 10mg/ml (100ml Bottles) MoS,ImIgmYDxZKA,HIV-Zidovudine (AZT) liquid 10mg/ml (100ml Bottles,#{KRY9yB58imr.GvjV9gy3OOc},#{YZdwXItCbkj.QvctQfKAQn3}
HIV-Zidovudine (AZT) liquid 10mg/ml (240ml Bottles) MoS,Judt7Df32vB,HIV-Zidovudine (AZT) liquid 10mg/ml (240ml Bottles,#{U3h59Gd6zNP.GvjV9gy3OOc},#{ccghB3xlLBM.QvctQfKAQn3}
HIV-Zidovudine/Lamivudine (AZT/3TC) FDC (300/150mg) Tablets MoS,QGHquSwFDUv,HIV-Zidovudine/Lamivudine (AZT/3TC) FDC (300/150mg,#{YUbsR6vuIVF.GvjV9gy3OOc},#{Xk6AeYQXS58.QvctQfKAQn3}
HIV-Zidovudine/Lamivudine (AZT/3TC) FDC (60/30mg) Tablets MoS,Wo5jzTF0hVB,HIV-Zidovudine/Lamivudine (AZT/3TC) FDC (60/30mg) ,#{cgSXbyWnsji.GvjV9gy3OOc},#{ja9xLKh1g57.QvctQfKAQn3}
HIV-Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (300/150/200mg) Tablets MoS,EuThKHrDN0x,HIV-Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP),#{ZPdNDKh0jtf.GvjV9gy3OOc},#{c8ezq9xdh7R.QvctQfKAQn3}
HIV-Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (60/30/50mg) Tablets MoS,VeF7s6CU72J,HIV-Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP),#{CV5vmItEeGO.GvjV9gy3OOc},#{xhpU07mm81R.QvctQfKAQn3}
HIV/SYPHILIS DUO TEST MoS,B1P7n2CFPuG,HIV/SYPHILIS DUO TEST MoS,#{QySiuXrDb3l.CGnwPpnZ7n7},#{O4lHxC6JQGW.QvctQfKAQn3}
HSF Accounting rate,yGsklLz1k0s,HSF Accounting rate,#{oMWJpAyAIUh.PbvwbLA3fbd},#{uq2Izs9ZGT7.PbvwbLA3fbd}
HSF utilization Rate,VQkd3wXvWWG,HSF utilization Rate,#{uq2Izs9ZGT7.PbvwbLA3fbd},#{QLC6ejj76za.PbvwbLA3fbd}
HSSF Utilization rate,QR0uquWjuRv,HSSF Utilization rate1,#{kQ4NVgc2MYs.NhSoXUMPK2K}+#{jY3JFizFzQN.NhSoXUMPK2K}+#{usMDjlboKn4.NhSoXUMPK2K}+#{WuEJXcFURTY.NhSoXUMPK2K}+#{KAVPEvsu7GB.NhSoXUMPK2K}+#{sW1FEKkUlno.NhSoXUMPK2K}+#{JgjYnWEbbXI.NhSoXUMPK2K}+#{GeLsHQnBJSl.NhSoXUMPK2K}+#{Anntg74AWAc.NhSoXUMPK2K}+#{NAWDpCTju9c.NhSoXUMPK2K}+#{uIKFwsGjL8l.NhSoXUMPK2K}+#{zfE43ojuX27.NhSoXUMPK2K}+#{Jm0j7eIJw22.NhSoXUMPK2K}+#{Kvrh6Edh4ux.NhSoXUMPK2K}+#{kZVa4Dfz3oW.NhSoXUMPK2K}+#{ozuOGiiROjR.NhSoXUMPK2K}+#{zq5cC1mHOjZ.NhSoXUMPK2K}+#{kkKxlgb0SIK.NhSoXUMPK2K}+#{ChuFUyaFoat.NhSoXUMPK2K}+#{Ta4fC50ws12.NhSoXUMPK2K}+#{pMp1v17OVlZ.NhSoXUMPK2K}+#{ktAiKqEgewS.NhSoXUMPK2K}+#{eWJI88NUHju.NhSoXUMPK2K}+#{ZL5umjFvNZT.NhSoXUMPK2K}+#{kMyKJqs4tP6.NhSoXUMPK2K}+#{JfMlkDb7sfP.NhSoXUMPK2K}+#{ERUP9jd5kr8.NhSoXUMPK2K}+#{VE7bP4Hd0Y8.NhSoXUMPK2K}+#{G10FiANc4uK.NhSoXUMPK2K}+#{jER1yfrClYQ.NhSoXUMPK2K}+#{zmTKl26bqXb.NhSoXUMPK2K}+#{JqVPN31hItf.NhSoXUMPK2K}+#{FNaQfndi92d.NhSoXUMPK2K}+#{pwYhMY7SObK.NhSoXUMPK2K}+#{T6Zosl4H5TG.NhSoXUMPK2K}+#{W53qF6leiPm.NhSoXUMPK2K}+#{MxceLE1Wgwj.NhSoXUMPK2K}+#{HGfobnG3qSX.NhSoXUMPK2K}+#{WypNzlF1rxb.NhSoXUMPK2K}+#{kltZozM5rkg.NhSoXUMPK2K}+#{SWHhf1eE89t.NhSoXUMPK2K}+#{qLWHhVTIp0l.NhSoXUMPK2K}+#{s2Ha3e0xwwp.NhSoXUMPK2K}+#{RMsgMQj2SBM.NhSoXUMPK2K}+#{X3nuiSHRJJP.NhSoXUMPK2K}+#{bDSQEZM3rtd.NhSoXUMPK2K}+#{dvo26Xu2g3G.NhSoXUMPK2K}+#{dvo26Xu2g3G.NhSoXUMPK2K}+#{ksAM140tLvc.NhSoXUMPK2K}+#{mYIZtgEPa5S.NhSoXUMPK2K}+#{RWwJcCEIcZw.NhSoXUMPK2K}+#{u9TiVtfs3or.NhSoXUMPK2K}+#{BsyP5AnR1pE.NhSoXUMPK2K}+#{p4Vk0aCXUKj.NhSoXUMPK2K}+#{ZysDicYyDxN.NhSoXUMPK2K}+#{Mnz4Ts6dMVo.NhSoXUMPK2K},#{RvNJvXCx4El.NhSoXUMPK2K}+#{zo5v2sL2Pcz.NhSoXUMPK2K}+#{QokZ5jjGLRz.NhSoXUMPK2K}+#{YkVzbDfJKMy.NhSoXUMPK2K}+#{H5NKPaRikyM.NhSoXUMPK2K}+#{FLT5619aj9V.NhSoXUMPK2K}+#{cKGenTODtq8.NhSoXUMPK2K}+#{nspiDhcn12j.NhSoXUMPK2K}
HTC Couples both HIV +ve rate (MOH 711),MlSa8hnRcAa,HTC Couples both HIV +ve rate (MOH 711),#{MKICatwGRPz.NhSoXUMPK2K},#{OPII6vOKimx.NhSoXUMPK2K}
HTC positivity rate (VCT&DTC-MOH 711),OMVrIqyNa0i,HTC positivity rate (VCT&DTC-MOH 711),#{sdA7bJkZc9E}+#{JglserSm6IQ}+#{SI8igpKYhVG},#{NeH2XNZ4B78}+#{rxhsRqFckMf}+#{s0Zi5NpklJN}
HTS_Adolescent Newly identified as HIV positive,y7E7ibjeroR,HTS_Adolescent,(#{wu0ITFRjUzF} + #{D9YwtS6RhQ1} + #{xMNhnyu7vm1} + #{kLXGWRLzCAw}),1
HTS_Adults Newly Identified as HIV positive,oRwSMGu83Ds,HTS_Adults,(#{kLXGWRLzCAw} + #{xMNhnyu7vm1} + #{F9OR49Lc1aR} + #{oCFXmpol7D8} + #{J4vNm7YEkdj} + #{cBTa1jVzT8f}),1
HTS_Children Newly identified as HIV positive,N6fSTAQgiLp,HTS_Children Identified.,(#{du5RMT3aecB} + #{D9YwtS6RhQ1} + #{wu0ITFRjUzF}),1
HTS_Efficiency,Z34438YtULH,HTS_effncy,(#{gMICOUtzqRb} + #{lj9QYJqS7bN} + #{YXJf27jfkvS} + #{XiRbc0DSMOH} + #{OePJt8CcZ0d} + #{JiuqbydCIcy} + #{pkShOkgNQt2} + #{atSQz5O7e2A} + #{gTkVw97FnQK}),(#{wu0ITFRjUzF} + #{D9YwtS6RhQ1} + #{xMNhnyu7vm1} + #{kLXGWRLzCAw} +  #{du5RMT3aecB} + #{oCFXmpol7D8} + #{F9OR49Lc1aR} + #{cBTa1jVzT8f} + #{J4vNm7YEkdj})
HTS_Linked,ANKboc5nOjW,Total number linked ,(#{EXmKDudsMNb} + #{fuX0Qzg218I} + #{fXErbzykgKz} + #{kAvepmaQr9c} + #{WOjriy3w7Fh}),1
HTS_Maternal Positivity rate,gSXmvbYI8du,HTS_Maternal Positivity rate,#{nwXS5vxrrr7}+#{hn3aChn4sVx}+#{AfHArvGun12},#{ETX9cUWF43c}+#{mQz4DhBSv9V}+#{LQpQQP3KnU1}
HTS_Number of  discordant couples ,AEGpotBQAeP,HTS_Number of discordant couples ,#{W0ChhvyVtSX},1
HTS_Proportion of HIV positive clients linked to treatment within 1 month,t8fnPRZBENL,HTS_Prop of HIV + clnts lnkd to trmt within 1 mnth,(#{jthpt5cVV9c} + #{LC2OqnUC5Sn} + #{DaNcGZnkclz} + #{yWkSi8L3qGm} + #{Hbc2qRi0U5x} +  #{mACm1JUzeLT} + #{zNCSlBKbS6d} + #{K59f8nZ5vhy} + #{Nv4OkbdDvmm} + #{SCMKsiNj6c5}),(#{wu0ITFRjUzF} + #{D9YwtS6RhQ1} + #{xMNhnyu7vm1} + #{kLXGWRLzCAw} + #{du5RMT3aecB} + #{oCFXmpol7D8} + #{F9OR49Lc1aR} + #{cBTa1jVzT8f} + #{J4vNm7YEkdj})
HTS_proportion of New diagnosed HIV clients,bM9J1FhdPRN,HTS_prop of HIV+ clnts,(#{wu0ITFRjUzF} + #{D9YwtS6RhQ1} + #{xMNhnyu7vm1} + #{kLXGWRLzCAw} + #{du5RMT3aecB} + #{oCFXmpol7D8} + #{F9OR49Lc1aR} + #{cBTa1jVzT8f} + #{J4vNm7YEkdj}),(#{YXJf27jfkvS} + #{XiRbc0DSMOH} + #{OePJt8CcZ0d} + #{JiuqbydCIcy} + #{pkShOkgNQt2} + #{atSQz5O7e2A} + #{gTkVw97FnQK} + #{gMICOUtzqRb} + #{lj9QYJqS7bN})
HV01-01 First Testing,iOPjrFDls4p,HV01-01 First Testing,#{Aioi6LxPb3N.NhSoXUMPK2K},1
HV01-02 Repeat Testing,d06EKU1S16R,HV01-02 Repeat Testing,#{jbzrwpsfYMN.NhSoXUMPK2K},1
HV01-03 Total Tested,VKbfAAbwxAG,HV01-03 Total Tested,#{h4pR1wz1JQb.NhSoXUMPK2K},1
HV01-10 Positive| Males - Below 15 year,uwQNmhpN4L8,Positive| Males - Below 15 year,#{DBZH3aC9gwQ.NhSoXUMPK2K},1
HV01-11 Positive| Females - Below 15 year,D2s7e1eCedC,HV01-11,#{QXQFd2JB10B.NhSoXUMPK2K},1
HV01-12 Positive Males 15-24 years,K1n4OqdgxdT,HV01-12 Positive Males 15-24 years,#{RCFqEXIiqed.NhSoXUMPK2K},1
HV01-13 Positive Female 15-24 years,mWJBu5l1Krj,HV01-13,#{c2pgDecBILP.NhSoXUMPK2K},1
HV01-14 Positive Males 25 years & older,iAF4i51JpUm,HV01-14,#{xN6GhQGgaoI.NhSoXUMPK2K},1
HV01-15 Positive Females 25 years & older,WQ6JZCOeSME,HV01-15,#{NMWgSKFW6U7.NhSoXUMPK2K},1
HV02-01 Testing for HIV Antenatal,eJ1syjWGqMO,HV02-01 Testing for HIV Antenatal,#{DrYHirleKid.NhSoXUMPK2K},1
HV02-05 Known positive status (at entry into ANC),wOfwMMoUpnP,HV02-05,#{TJMdle70A7X.NhSoXUMPK2K},1
HV02-06 HIV positive results Antenatal,rRJfQIyFAyP,HV02-06 HIV positive results Antenatal,#{GCAkHwMAWM6.NhSoXUMPK2K},1
HV02-13 Prophylaxis – NVP Only,gMaosZAfyyU,HV02-13 Prophylaxis – NVP Only,#{BZ9EGLQPnvl.NhSoXUMPK2K},1
HV02-14 Prophylaxis – (AZT + SdNVP),gZaJOLoWDub,HV02-14 Prophylaxis – (AZT + SdNVP),#{dba7gHtgiLi.NhSoXUMPK2K},1
HV02-15 Prophylaxis – Interrupted HAART,g2eipuUpQPB,HV02-15 Prophylaxis – Interrupted HAART,#{JZDDuahVatz.NhSoXUMPK2K},1
HV02-16 HAART (ART),nL5pCjFP2vb,HV02-16 HAART (ART),#{FRRDdqayYnU.NhSoXUMPK2K},1
HV02-17 Total PMTCT prophylaxis,dibw98D5VRQ,HV02-17 Total PMTCT prophylaxis,#{g62PclQcVba.NhSoXUMPK2K},1
HV03-21 (M) Starting ART - Below 15 years,R1xQIfrkJDQ,HV03-21 (M) Starting ART - Below 15 years,#{Ivi4xwwsjNN.NhSoXUMPK2K},1
HV03-22 (F) Starting ART - Below 15 years,Mj3Lm3dGqO5,HV03-22 (F) Starting ART - Below 15 years,#{QTfUGmnpzCm.NhSoXUMPK2K},1
HV03-23 (M) Starting ART - 15 years & older ,AemzmLNt6Q7,HV03-23 (M) Starting ART - 15 years & older ,#{yPGhCvz2bX2.NhSoXUMPK2K},1
HV03-24 (F) Starting ART - 15 years & older ,id6jSGcewy5,HV03-24 (F) Starting ART - 15 years & older ,#{CNK6qMLzi8b.NhSoXUMPK2K},1
HV03-35 Currently on ART - Below 15 years,ObhXYrRVf3Y,HV03-35 Currently on ART - Below 15 years,#{QISrDYwXnMw.NhSoXUMPK2K},1
HV03-36 Currently on ART - Below 15 years ,neF3KHwg8BY,HV03-36 Currently on ART - Below 15 years ,#{cbUoZG6mlS7.NhSoXUMPK2K},1
HV03-37 Currently on ART - 15 years & older,szxPSXHHXYC,HV03-37 Currently on ART - 15 years & older,#{oTjp04eBIaV.NhSoXUMPK2K},1
HV03-38 Currently on ART - 15 years & older,ZyiQZGfHInx,HV03-38 Currently on ART - 15 years & older,#{ISGNo6jMJlI.NhSoXUMPK2K},1
HWO2022_Total number of occupational incidents,pqDkyyMal5Z,Total number of occupational incidents,#{yCXLaSKG8Cg} + #{OEoiIeGG0nt},1
Hand Hygience Compliance Rate for Clinical Officers,NGAoqeH5UYM,HH Compliance Rate for Clinical Officers,#{yVJt3G51ur3.Ce06pMO8es6} + #{yVJt3G51ur3.jzjIo1V9O9L},#{yVJt3G51ur3.Ce06pMO8es6} + #{yVJt3G51ur3.VIbTo0yPdUk} + #{yVJt3G51ur3.jzjIo1V9O9L} + #{yVJt3G51ur3.YSgir3rUw0H}
Hand Hygience Compliance Rate for Doctors,x6G3U4erdxr,Hand Hygience Compliance Rate for Doctors,#{iv99y7nzJvR.Ce06pMO8es6} + #{iv99y7nzJvR.jzjIo1V9O9L},#{iv99y7nzJvR.Ce06pMO8es6} + #{iv99y7nzJvR.VIbTo0yPdUk} + #{iv99y7nzJvR.jzjIo1V9O9L} + #{iv99y7nzJvR.YSgir3rUw0H}
Hand Hygience Compliance Rate for Laboratory,qoIMBKMbjXK,HH Compliance Rate for Laboratory,#{Zks2R3Cy3Kn.Ce06pMO8es6} + #{Zks2R3Cy3Kn.jzjIo1V9O9L},#{Zks2R3Cy3Kn.Ce06pMO8es6} + #{Zks2R3Cy3Kn.VIbTo0yPdUk} + #{Zks2R3Cy3Kn.jzjIo1V9O9L} + #{Zks2R3Cy3Kn.YSgir3rUw0H}
Hand Hygience Compliance Rate for Nurses,Vb6mjpRxBAm,Hand Hygience Compliance Rate for Nurses,#{zgRORDnvTSE.Ce06pMO8es6} + #{zgRORDnvTSE.jzjIo1V9O9L},#{zgRORDnvTSE.Ce06pMO8es6} + #{zgRORDnvTSE.VIbTo0yPdUk} + #{zgRORDnvTSE.jzjIo1V9O9L} + #{zgRORDnvTSE.YSgir3rUw0H}
Hand Hygience Compliance Rate for Others,uFlZ5HgS2eG,Hand Hygience Compliance Rate for Others,#{MKTbL1B1Wn0.Ce06pMO8es6} + #{MKTbL1B1Wn0.jzjIo1V9O9L},#{MKTbL1B1Wn0.Ce06pMO8es6} + #{MKTbL1B1Wn0.VIbTo0yPdUk} + #{MKTbL1B1Wn0.jzjIo1V9O9L} + #{MKTbL1B1Wn0.YSgir3rUw0H}
Hand Hygience Compliance Rate for Students,uismOafrcrl,HH Compliance Rate for Students,#{AbKF3pgBBMB.Ce06pMO8es6} + #{AbKF3pgBBMB.jzjIo1V9O9L},#{AbKF3pgBBMB.Ce06pMO8es6} + #{AbKF3pgBBMB.VIbTo0yPdUk} + #{AbKF3pgBBMB.jzjIo1V9O9L} + #{AbKF3pgBBMB.YSgir3rUw0H}
Health Facility Attendance (Total),C6uw9Wtisfa,Health Facility Attendanc,#{rIkD2jIDqPh}+#{zXzBILTVJzD}+#{Ha96SBKI06u}+#{F6AwnxbwiK2}+#{x13zGZKuxzs}+#{uTQOSp7rx5h}+#{EsfvxFcltV0}+#{aq64ukEqs2N}+#{JQkE0bN9OTB}+#{d3jNYZueSmn}+#{hAH08l33p9B}+#{JGbmLfjZPEf}+#{SyUQl638r5P}+#{T22hPVk4yGZ}+#{T22hPVk4yGZ}+#{QStt76mU06X}+#{DpR59HXC0jW}+#{GAeKNgKXNDm}+#{WEW9Bjga52F},1
House to House Vaccination Strategy,tI46ulV5g4Y,House to House ,#{sgEpaCzTzvY.bUz00a8pctE} + #{sgEpaCzTzvY.oip6bIFCwOB} + #{sgEpaCzTzvY.Lvd1oGx0HHb} + #{sgEpaCzTzvY.sqjrYVS6XdS} + #{ocZqT75qL0Q.bUz00a8pctE} + #{ocZqT75qL0Q.oip6bIFCwOB} + #{ocZqT75qL0Q.Lvd1oGx0HHb} + #{ocZqT75qL0Q.sqjrYVS6XdS} + #{xpZcEqvnYoc.bUz00a8pctE} + #{xpZcEqvnYoc.oip6bIFCwOB} + #{xpZcEqvnYoc.Lvd1oGx0HHb} + #{xpZcEqvnYoc.sqjrYVS6XdS} + #{OoQXhDZC2rl.bUz00a8pctE} + #{OoQXhDZC2rl.oip6bIFCwOB} + #{OoQXhDZC2rl.Lvd1oGx0HHb} + #{OoQXhDZC2rl.sqjrYVS6XdS} + #{MERTp2n8Kl8.vhe85utpULd} + #{MERTp2n8Kl8.jg9pthd0JoS} + #{CAa7cjb9ur4.vhe85utpULd} + #{CAa7cjb9ur4.jg9pthd0JoS} + #{JFPzGka2cDN.vhe85utpULd} + #{JFPzGka2cDN.jg9pthd0JoS} + #{aT4Yb7Gd9JA.vhe85utpULd} + #{aT4Yb7Gd9JA.jg9pthd0JoS} + #{JveFJDlz6oV.bUz00a8pctE} + #{JveFJDlz6oV.oip6bIFCwOB} + #{JveFJDlz6oV.Lvd1oGx0HHb} + #{JveFJDlz6oV.sqjrYVS6XdS},1
Household size,jMbilBMV2Pe,Household size,#{NLKRV7bYbVy.NhSoXUMPK2K},#{duLaKUuuAwV.NhSoXUMPK2K}
Hydrocortisone Injection 100mg (Vial) MoS,tFikgcVkTSr,Hydrocortisone Injection 100mg (Vial),#{Ss60yT7k8lU.n8XlCFUpWOG},#{C5HRQXl977d.QvctQfKAQn3}
IDSR - Malaria Incidence Rate (per 1000 population),eCcSxVr5BYD,Malaria Incidence Rate (per 1000 population),(#{IYnqoV2vlRq.FIYMDBzdabP} + #{IYnqoV2vlRq.ROXPeIvP89X}),#{NLKRV7bYbVy}
IDSR Acute Flaccid Paralysis (AFP for Poliomyelitis) Cases,YrVngLCNhCN,IDSR Acute Flaccid Paralysis ,#{ZQiG8Aidl8J.dCd7yKlyqk4} + #{ZQiG8Aidl8J.PTWBeC1K2HJ},1
IDSR Acute Flaccid Paralysis (AFP for Poliomyelitis) Deaths,IPzqbhBXzYI,IDSR Acute Flaccid Paralysis,#{ZQiG8Aidl8J.GR4pbqLKhMV} + #{ZQiG8Aidl8J.EqEj84xFkHz},1
IDSR Acute Jaundice Cases,QcCSmjw0E1t,IDSR Acute Jaundice ,#{RGozddXpuwI.dCd7yKlyqk4}  + #{RGozddXpuwI.PTWBeC1K2HJ},1
IDSR Acute Jaundice Deaths,mdLORcOXNVC,IDSR Acute Jaundice Deaths,#{RGozddXpuwI.GR4pbqLKhMV} + #{RGozddXpuwI.EqEj84xFkHz},1
IDSR Acute Malnutrition Cases,XUmIT8vmtB8,IDSR Acute Malnutrition Total,#{ycHTiTrGfHi.dCd7yKlyqk4} + #{ycHTiTrGfHi.PTWBeC1K2HJ} ,1
IDSR Acute Malnutrition Deaths,SvGX6aqR44S,IDSR Acute Malnutrition Deaths, #{ycHTiTrGfHi.GR4pbqLKhMV} + #{ycHTiTrGfHi.EqEj84xFkHz},1
IDSR Anthrax Cases,VIbr1Dhv7Zt,IDSR Anthrax Cases,#{YjkS8YBwtM3.dCd7yKlyqk4} + #{YjkS8YBwtM3.PTWBeC1K2HJ},1
IDSR Anthrax Deaths,RLzaFBwaWFN,IDSR Anthrax Deaths,#{YjkS8YBwtM3.GR4pbqLKhMV} + #{YjkS8YBwtM3.EqEj84xFkHz},1
IDSR Cholera Cases,mxWEOiayWem,IDSR Cholera Total,#{wajkorhT4I5.dCd7yKlyqk4} + #{wajkorhT4I5.PTWBeC1K2HJ},1
IDSR Cholera Deaths,MqEYVvHFn4C,IDSR Cholera Deaths,#{wajkorhT4I5.GR4pbqLKhMV} + #{wajkorhT4I5.EqEj84xFkHz},1
IDSR Dengue Deaths,aoDMYH6STyu,IDSR Dengue Deaths,#{TVbSuL9AdcI.GR4pbqLKhMV} + #{TVbSuL9AdcI.EqEj84xFkHz},1
IDSR Dengue Total,rNvGKtwbte6,IDSR Dengue Total,#{TVbSuL9AdcI.dCd7yKlyqk4} + #{TVbSuL9AdcI.PTWBeC1K2HJ},1
IDSR Dummy1,k99fKerg18p,IDSR Dummy1,0,1
IDSR Dummy2,aS7l3UKgTEL,IDSR Dummy2,0,1
IDSR Dysentry Deaths,ZpEL8teGmpy,IDSR Dysentry Deaths,#{tn0o15uvfgP.GR4pbqLKhMV} + #{tn0o15uvfgP.EqEj84xFkHz},1
IDSR Dysentry Total,SvFYd0EZdF1,IDSR Dysentry Total,#{tn0o15uvfgP.dCd7yKlyqk4}  + #{tn0o15uvfgP.PTWBeC1K2HJ},1
IDSR Guinea Worm Disease Deaths,hInp9Yu39ap,IDSR Guinea Worm Disease Deaths,#{sL7vw21TOKw.GR4pbqLKhMV} + #{sL7vw21TOKw.EqEj84xFkHz},1
IDSR Guinea Worm Disease Total,DyCmCMGhcaT,IDSR Guinea Worm Disease Total,#{sL7vw21TOKw.dCd7yKlyqk4} + #{sL7vw21TOKw.PTWBeC1K2HJ},1
IDSR Malaria Cases,aqtAtDtbywp,IDSR Malaria Total,#{GJDppyWOYYM.dCd7yKlyqk4} + #{GJDppyWOYYM.PTWBeC1K2HJ}  ,1
IDSR Malaria Deaths,vqyFNp0Tyjj,IDSR Malaria Deaths,#{GJDppyWOYYM.GR4pbqLKhMV} + #{GJDppyWOYYM.EqEj84xFkHz},1
IDSR Malaria Incidence Rate (per 1000 population),nWOrfKtYJpz,IDSR Malaria Incidence Rate (per 1000 population),#{IYnqoV2vlRq.FIYMDBzdabP} + #{IYnqoV2vlRq.ROXPeIvP89X},(#{Mpv8crmnOzy} + #{w5ltvnNihEZ})
IDSR Malaria Positivity,cILf2i4484b,IDSR malaria positivity ,((#{IYnqoV2vlRq.FIYMDBzdabP} + #{IYnqoV2vlRq.ROXPeIvP89X}) /(#{IYnqoV2vlRq.Gs4AqH6n3mV} + #{IYnqoV2vlRq.dbZfB6Oub9K})) * 100,1
IDSR Malaria Positivity (revised),V78EpwfHA2V,IDSR malaria positivity (revised),"((#{bB8vhQefDlH.lHl2rmXpHse} + #{bB8vhQefDlH.SeDaCnHi3m5} + #{q40X71immxZ.lHl2rmXpHse} + #{q40X71immxZ.SeDaCnHi3m5}) /(#{XLT68mdLbJT.lHl2rmXpHse} + #{XLT68mdLbJT.SeDaCnHi3m5} + #{YjZ3XFV2Zum.lHl2rmXpHse} + #{YjZ3XFV2Zum.SeDaCnHi3m5})) * 100


",1
IDSR Malaria Tested Positive,gzxF71bqYP8,IDSR Malaria Tested +ve,#{IYnqoV2vlRq.FIYMDBzdabP} + #{IYnqoV2vlRq.ROXPeIvP89X},1
IDSR Malaria Tested Positive (Revised),Ak6JvvdNbSB,IDSR Malaria Tested +ve,#{bB8vhQefDlH.lHl2rmXpHse} + #{bB8vhQefDlH.SeDaCnHi3m5} + #{q40X71immxZ.lHl2rmXpHse} + #{q40X71immxZ.SeDaCnHi3m5},1
IDSR Maternal deaths,Iq9dK8PQGks,IDSR Maternal deaths,#{lJotmrRnSnD.dCd7yKlyqk4} + #{lJotmrRnSnD.PTWBeC1K2HJ},1
IDSR Maternal deaths Deaths,ODPXXGbNVz3,IDSR Maternal deaths Deaths,#{lJotmrRnSnD.dCd7yKlyqk4} + #{lJotmrRnSnD.PTWBeC1K2HJ},1
IDSR Measles Deaths,iZa8X0R8DC2,IDSR Measles Deaths, #{Tz0tiCQ8o6X.EqEj84xFkHz}+ #{Tz0tiCQ8o6X.GR4pbqLKhMV} ,1
IDSR Measles Total,MjpTjUPSLY6,IDSR Measles,#{Tz0tiCQ8o6X.dCd7yKlyqk4} + #{Tz0tiCQ8o6X.PTWBeC1K2HJ} ,1
IDSR Meningococcal Meningitis Deaths,pxZwZGa3S79,IDSR Meningococcal Meningitis Deaths,#{IVT5avXg4CC.EqEj84xFkHz}+ #{IVT5avXg4CC.GR4pbqLKhMV},1
IDSR Meningococcal Meningitis Total,rQT7Z4eJmQp,IDSR Meningococcal,#{IVT5avXg4CC.dCd7yKlyqk4}  + #{IVT5avXg4CC.PTWBeC1K2HJ},1
IDSR Neonatal Tetanus Deaths,Uaezmz9SzNy,IDSR Neonatal Tetanus Deaths,#{SLnpLPVE4RI.GR4pbqLKhMV} + #{SLnpLPVE4RI.EqEj84xFkHz},1
IDSR Neonatal Tetanus Total,hUIVHkS4Zt4,IDSR Neonatal Tetanus Total,#{SLnpLPVE4RI.dCd7yKlyqk4} + #{SLnpLPVE4RI.PTWBeC1K2HJ},1
IDSR Neonatal deaths Deaths,o6UNt4eaw0C,IDSR Neonatal deaths Deaths,#{eH7m94f1Mrv.GR4pbqLKhMV} + #{eH7m94f1Mrv.EqEj84xFkHz},1
IDSR Neonatal deaths Total,WNovNDcvhHl,IDSR Neonatal deaths Total,#{eH7m94f1Mrv.dCd7yKlyqk4} + #{eH7m94f1Mrv.PTWBeC1K2HJ} ,1
IDSR Other Viral Haemorrhagic Fevers Deaths,QMk6rJZtBT9,IDSR Other Viral Haemorrhagic Fevers Deaths,#{rnUg5fAPgxU.GR4pbqLKhMV} + #{rnUg5fAPgxU.EqEj84xFkHz},1
IDSR Other Viral Haemorrhagic Fevers Total,ntWgkwXCFp2,IDSR Other Viral Haemorrhagic Fevers Total,#{rnUg5fAPgxU.dCd7yKlyqk4} + #{rnUg5fAPgxU.PTWBeC1K2HJ},1
IDSR Plague Deaths,bZNWTQiGyPx,IDSR Plague Deaths,#{WXmC1SmmY8j.GR4pbqLKhMV} + #{WXmC1SmmY8j.EqEj84xFkHz},1
IDSR Plague Total,dwFMOqpWdJw,IDSR Plague Total,#{WXmC1SmmY8j.dCd7yKlyqk4} + #{WXmC1SmmY8j.PTWBeC1K2HJ},1
IDSR Rabies Deaths,rl6ivYvMVKJ,IDSR Rabies Deaths, #{S8DADvgv6Gy.GR4pbqLKhMV} + #{S8DADvgv6Gy.EqEj84xFkHz},1
IDSR Rabies Total,WnKnWVYZ6eX,IDSR Rabies Total,#{S8DADvgv6Gy.dCd7yKlyqk4} + #{S8DADvgv6Gy.PTWBeC1K2HJ},1
IDSR Suspected MDR/XDR TB Deaths,WQNqVsRWbje,IDSR Suspected MDR/XDR TB Deaths,#{dvgrSof8WCi.GR4pbqLKhMV} + #{dvgrSof8WCi.EqEj84xFkHz},1
IDSR Suspected MDR/XDR TB Total,FL1TjrtvExn,IDSR Suspected MDR/XDR TB Total,#{dvgrSof8WCi.dCd7yKlyqk4} + #{dvgrSof8WCi.PTWBeC1K2HJ},1
IDSR Tested for malaria  Positives,piQnwzWtwea,IDSR Tested for malaria  Positives,#{IYnqoV2vlRq.FIYMDBzdabP} + #{IYnqoV2vlRq.ROXPeIvP89X},1
IDSR Tested for malaria No. Tested,SpdUqIVx8ik,IDSR Tested for malaria No. Tested,#{IYnqoV2vlRq.Gs4AqH6n3mV} + #{IYnqoV2vlRq.dbZfB6Oub9K},1
IDSR Tested for malaria No. Tested (Revised),ej0bzHKeyEW,IDSR Tested for malaria No. Tested (revised),#{XLT68mdLbJT.lHl2rmXpHse} + #{XLT68mdLbJT.SeDaCnHi3m5} + #{YjZ3XFV2Zum.lHl2rmXpHse} + #{YjZ3XFV2Zum.SeDaCnHi3m5},1
IDSR Total Malaria Cases,lVdrgTPxzHO,IDSR Total Malaria Cases,(#{GJDppyWOYYM.dCd7yKlyqk4} + #{GJDppyWOYYM.PTWBeC1K2HJ}),1
IDSR Total Malaria Tests Performed,NEuSmgwbwzR,IDSR Total Malaria Tests Performed,(#{IYnqoV2vlRq.Gs4AqH6n3mV} + #{IYnqoV2vlRq.dbZfB6Oub9K}),1
IDSR Typhoid Deaths,vzVMT5xJLQR,IDSR Typhoid Deaths, #{LwwVppGxNJk.GR4pbqLKhMV} + #{LwwVppGxNJk.EqEj84xFkHz},1
IDSR Typhoid Total,SIKZR5L29QV,IDSR Typhoid Total,#{LwwVppGxNJk.dCd7yKlyqk4} + #{LwwVppGxNJk.PTWBeC1K2HJ} ,1
IDSR Yellow Fever Deaths,kUMdI6Ip4rm,IDSR Yellow Fever Deaths,#{NQwgklXIeG2.GR4pbqLKhMV} + #{NQwgklXIeG2.EqEj84xFkHz},1
IDSR Yellow Fever Total,DHf4qRMuNVZ,IDSR Yellow Fever Total,#{NQwgklXIeG2.dCd7yKlyqk4} + #{NQwgklXIeG2.PTWBeC1K2HJ},1
IHRIS All Nurses Total,AYtbeQ0IsCM,IHRIS All Nurses Total,#{pfIYHskfyhQ}+#{oGRUr2UiR8E}+#{CGN15kwiEla.NhSoXUMPK2K}+#{qrQRIOl3Y7W}+#{tdkj2HWk7GG}+#{e4SD2TEWunw}+#{aOH63LerJKG}+#{LJVhaEUREt1}+#{YBRNewyiKTG}+#{FheKkDXpzuB}+#{YFJwW8QWT0s}+#{N6JCCDgmijq}+#{D1YK6LDr1uo}+#{yut0lbk8fLZ}+#{v5YHnZPeu3Y}+#{T0ncWxRLsyF}+#{fDNhtWxxkDD}+#{nW6QimezeUY},1
IHRIS BSN Nurses Total Using Male and Female,MZ8QvOEjliE,IHRIS BSN Nurses Total Using Male and Female,#{CGN15kwiEla.Lt6CjodPpWZ}+#{CGN15kwiEla.MJAGUpeHkpn},1
IHRIS Nurses + COs +  Med Lab Techs,FPZJrNixn1d,IHRIS Nurses + COs +  Med Lab Techs,#{pfIYHskfyhQ}+#{oGRUr2UiR8E}+#{CGN15kwiEla.NhSoXUMPK2K}+#{qrQRIOl3Y7W}+#{tdkj2HWk7GG}+#{e4SD2TEWunw}+#{aOH63LerJKG}+#{LJVhaEUREt1}+#{YBRNewyiKTG}+#{FheKkDXpzuB}+#{YFJwW8QWT0s}+#{N6JCCDgmijq}+#{D1YK6LDr1uo}+#{yut0lbk8fLZ}+#{v5YHnZPeu3Y}+#{T0ncWxRLsyF}+#{fDNhtWxxkDD}+#{nW6QimezeUY}+#{uAk9AD2NGFv.NhSoXUMPK2K}+#{KRxsqqbdAGH.NhSoXUMPK2K}+#{QWymS3dj4uU.NhSoXUMPK2K}+#{J8mzCuLBAH1.NhSoXUMPK2K}+#{YOMA61T94eU.NhSoXUMPK2K}+#{pjEN2QceKNH.NhSoXUMPK2K}+#{ShtwHIW1rOC.NhSoXUMPK2K}+#{H1dgcVTwWQM.NhSoXUMPK2K}+#{arRbatxU74M.NhSoXUMPK2K}+#{Y0SDd8s2bK4.NhSoXUMPK2K}+#{GpYmbmcP4Oa.NhSoXUMPK2K}+#{RGMaEjZKHk9.NhSoXUMPK2K}+#{gUIhX5nb9V9.NhSoXUMPK2K}+#{uAk9AD2NGFv.NhSoXUMPK2K}+#{KRxsqqbdAGH.NhSoXUMPK2K}+#{UBCpnu7mV2S.NhSoXUMPK2K}+#{QWymS3dj4uU.NhSoXUMPK2K}+#{J8mzCuLBAH1.NhSoXUMPK2K}+#{YOMA61T94eU.NhSoXUMPK2K}+#{pjEN2QceKNH.NhSoXUMPK2K}+#{ShtwHIW1rOC.NhSoXUMPK2K}+#{H1dgcVTwWQM.NhSoXUMPK2K}+#{arRbatxU74M.NhSoXUMPK2K}+#{Y0SDd8s2bK4.NhSoXUMPK2K}+#{GpYmbmcP4Oa.NhSoXUMPK2K}+#{UQe25w2sxfL.NhSoXUMPK2K},1
IHRIS Total Key Care Cadres,rriLl3OQSsX,IHRIS Total Key Care Cadres,(#{CGN15kwiEla.NhSoXUMPK2K}+#{y90HxYFJReg.NhSoXUMPK2K}),1
IP - Average Length of Stay,Em1rmsuYowk,IP - ALS,#{reLgVCOeKpf.NhSoXUMPK2K},#{q7rflJEG37X.NhSoXUMPK2K}+#{tYh26gn0BnE.NhSoXUMPK2K}+#{RI5o1xdFSxs.NhSoXUMPK2K}+#{eN1h5cQerWI.NhSoXUMPK2K}+#{s2YDJjTnKyA.NhSoXUMPK2K}
IP - Bed Turn Over Rate,KGdpODkowXM,IP - Bed Turn Over Rate,#{q7rflJEG37X.NhSoXUMPK2K}+#{tYh26gn0BnE.NhSoXUMPK2K}+#{RI5o1xdFSxs.NhSoXUMPK2K}+#{eN1h5cQerWI.NhSoXUMPK2K}+#{s2YDJjTnKyA.NhSoXUMPK2K},(#{ykDnv6TyXP3.NhSoXUMPK2K}+#{JrCrKtM8Hw2.NhSoXUMPK2K}) * [days]
IP - Crude Death Rate,SS9GbDzYop9,IP - Crude Death Rate,#{tYh26gn0BnE.NhSoXUMPK2K},#{c7ZM3GXISND.NhSoXUMPK2K}+#{oyWx4OFwc6Z.NhSoXUMPK2K}
IP - Turn over interval,tEFy7fdmBpw,IP - ToI,( [days] * (#{ykDnv6TyXP3.NhSoXUMPK2K}+#{JrCrKtM8Hw2.NhSoXUMPK2K}) ) - #{reLgVCOeKpf.NhSoXUMPK2K},#{q7rflJEG37X.NhSoXUMPK2K}+#{tYh26gn0BnE.NhSoXUMPK2K}+#{RI5o1xdFSxs.NhSoXUMPK2K}+#{eN1h5cQerWI.NhSoXUMPK2K}+#{s2YDJjTnKyA.NhSoXUMPK2K}
IP - Vacant Beds,p81yBiB9oRj,IP - Vacant Beds,( [days] * (#{ykDnv6TyXP3.NhSoXUMPK2K}+#{JrCrKtM8Hw2.NhSoXUMPK2K}) ) - #{reLgVCOeKpf.NhSoXUMPK2K},1
IPD Percentage Occupancy,ZB7Pwo4NNx1,IPD Percentage Occupancy,#{reLgVCOeKpf.NhSoXUMPK2K},( #{ykDnv6TyXP3.NhSoXUMPK2K} + #{JrCrKtM8Hw2.NhSoXUMPK2K} ) * [days]
IPD Utilization Rate (MOH 717),MCtkH3YaeKe,IPD Utilization Rate,#{r7LJ3kCX8EZ.Lj5arkL7GL8} + #{r7LJ3kCX8EZ.KFmqREu0VSL} + #{r7LJ3kCX8EZ.rYfAgBnJKnj} + #{r7LJ3kCX8EZ.ObiJr399QRt} + #{r7LJ3kCX8EZ.bPNw3Km3Ug7} + #{r7LJ3kCX8EZ.oJ6IUNugflo} + #{r7LJ3kCX8EZ.vr2WcWaojbO} + #{r7LJ3kCX8EZ.B0ji6ZY2zJ3} + #{r7LJ3kCX8EZ.szjWdpjHTDe} + #{r7LJ3kCX8EZ.JUI7tesx6as} + #{r7LJ3kCX8EZ.O68sxX0pJMT} + #{r7LJ3kCX8EZ.Qy5yADe3SiB} + #{cvJuw6Fbuiw.Lj5arkL7GL8} + #{cvJuw6Fbuiw.KFmqREu0VSL} + #{cvJuw6Fbuiw.rYfAgBnJKnj} + #{cvJuw6Fbuiw.bPNw3Km3Ug7} + #{cvJuw6Fbuiw.ObiJr399QRt} ,#{w5ltvnNihEZ} + #{Mpv8crmnOzy}
IPD Utilization Rate Surgery,Mweo9JqA2Yr,IPD Utilization Rate Surgery,#{r7LJ3kCX8EZ.KFmqREu0VSL} + #{cvJuw6Fbuiw.KFmqREu0VSL},#{w5ltvnNihEZ} + #{Mpv8crmnOzy}
IPD Workload,ivoTTshfz2k,IPD Workload,#{cvJuw6Fbuiw.Lj5arkL7GL8} + #{cvJuw6Fbuiw.KFmqREu0VSL} + #{cvJuw6Fbuiw.rYfAgBnJKnj} + #{cvJuw6Fbuiw.ObiJr399QRt} + #{cvJuw6Fbuiw.bPNw3Km3Ug7} + #{cvJuw6Fbuiw.oJ6IUNugflo} + #{cvJuw6Fbuiw.vr2WcWaojbO} + #{cvJuw6Fbuiw.B0ji6ZY2zJ3} + #{cvJuw6Fbuiw.szjWdpjHTDe} + #{cvJuw6Fbuiw.JUI7tesx6as} + #{cvJuw6Fbuiw.O68sxX0pJMT} + #{cvJuw6Fbuiw.Qy5yADe3SiB} +  #{r7LJ3kCX8EZ.Lj5arkL7GL8} + #{r7LJ3kCX8EZ.KFmqREu0VSL} + #{r7LJ3kCX8EZ.rYfAgBnJKnj} + #{r7LJ3kCX8EZ.ObiJr399QRt} + #{r7LJ3kCX8EZ.bPNw3Km3Ug7} + #{r7LJ3kCX8EZ.oJ6IUNugflo} + #{r7LJ3kCX8EZ.vr2WcWaojbO} + #{r7LJ3kCX8EZ.B0ji6ZY2zJ3} + #{r7LJ3kCX8EZ.szjWdpjHTDe} + #{r7LJ3kCX8EZ.JUI7tesx6as} + #{r7LJ3kCX8EZ.O68sxX0pJMT} + #{r7LJ3kCX8EZ.Qy5yADe3SiB},1
IPT2 utilization,lX2cPNU4LFL,IPT 2 utilization,#{EHGBrVPiG3N.NhSoXUMPK2K},#{gAKCshSgSH3.NhSoXUMPK2K}
IPTp1 issued to Pregnant Women in Malaria Endemic areas,FKkcp7WWnEN,IPTp1 given to ANC clients,#{gAKCshSgSH3.NhSoXUMPK2K},#{pct05jgGcLt} / 12
IPTp2 issued to Pregnant Women in Malaria Endemic areas,NLDYChGtAx2,IPTp2 given to ANC clients,#{EHGBrVPiG3N.NhSoXUMPK2K},#{pct05jgGcLt} / 12
IPTp3 issued to Pregnant Women in Malaria Endemic areas,WWTomET64nI,IPTp3 given to ANC clients,#{N931F2wuVVO},#{pct05jgGcLt} / 12
IPV Wastage Rate (WR),zb0bzY0zWiR,IPV Wastage Rate (WR),((#{MJQFsY7Dp8G.NhSoXUMPK2K}+#{KUNmx9W9U2D.NhSoXUMPK2K})-#{IFQwJq7fgld.NhSoXUMPK2K})-#{gw4Zog5qvBy},(#{MJQFsY7Dp8G.NhSoXUMPK2K}+#{KUNmx9W9U2D.NhSoXUMPK2K})-#{IFQwJq7fgld.NhSoXUMPK2K}
IUCD  Couple year protection,dcfWn8ZS2ie,IUCD CYP,(#{DuBH6qPPdaO} + #{Wv02gixbRpT} + #{hRktPfPEegP})*4.6,1
IUCD Copper T Dispensed,JrfHpxf0fZB,IUCD Copper T Dispensed,#{bUlHHuXjVGE.LkO5M9beZqG},1
IUCD Copper T Ending Balance,z6zEiA849Fq,IUCD Copper T EB,#{bUlHHuXjVGE.NvpLpQxmzkZ},1
Ihris Nurse Midwives,hkuuc1hS9cv,Ihris Nurse Midwives,#{OR7PhOwj9Hl.NhSoXUMPK2K},1
Implants Dispensed,xM9vMDt6xSq,Implants Dispensed,#{ZvgVEwt6iEm.LkO5M9beZqG},1
Implants Ending Balance,jx7NXfCFBfO,ImplaImnts EB,#{ZvgVEwt6iEm.NvpLpQxmzkZ},1
Implants couple year protection,MRM3kDTz5Oq,Implants CYP,(#{otgQMOXuyIn} + #{CJdFYcZ1zOq} + #{TUHzoPGLM3t})*2.5,1
Incidence of Outpatient Malaria (per 1000 population),V5vHLgHhPwg,Malaria Incidence Rate (per 1000 population),#{OoakJhWiyZp.lHl2rmXpHse}+#{OoakJhWiyZp.SeDaCnHi3m5} + #{gvZmXInRLuD.SeDaCnHi3m5},#{w5ltvnNihEZ}+#{Mpv8crmnOzy}
Infant Prophylaxis Missed Opportunity,xvUt174iyYS,Infant Prophylaxis Missed Opportunity,#{nwXS5vxrrr7} + #{hn3aChn4sVx} + #{AfHArvGun12}+#{hHLR1HP8xzI} + #{qSgLzXh46n9}-(#{HAumxpKBaoK} + #{Jn6ATTfXp02} + #{RY1js5pK2Ep}),1
Infants tested for HIV at 6 wks Coverage,WiTsFtstIEO,Infants tested 6wks Cov,#{YZdSnMLgiAV.NhSoXUMPK2K},#{JOnT3OiMd5o.NhSoXUMPK2K}
Injectables Dispensed,dakp92oAECd,Injectables Dispensed,#{U7mQ95egBfs.LkO5M9beZqG},1
Injectables Ending Balance,QSRvXP8v6T5,Injectables EB,#{U7mQ95egBfs.NvpLpQxmzkZ},1
Injectables couple year protection,LBQ3CeEIrwx,Injectable CYP,#{PgQIx7Hq1kp} + #{NMCIxSeGpS3} + #{yQFyyQBhXQf},4
Inpatient Actual Physical Beds Total,vKONA0y47d1,Inpatient Actual Beds,#{K3i0LumP9MU},1
Inpatient Admission,h14HsnrOBCE,Inpatient Admission,#{cvJuw6Fbuiw} + #{r7LJ3kCX8EZ},1
Inpatient Occupied Bed Days Total,WgkuCjT99x4,Inpatient Occup Bed Days,#{R6Z03VUZ0YU}+#{KeluwzeRirR},1
Inpatient Physical  Beds,qMlNgrNUclZ,Inpatient Physical Beds,#{K3i0LumP9MU.Lj5arkL7GL8} + #{K3i0LumP9MU.KFmqREu0VSL} + #{K3i0LumP9MU.rYfAgBnJKnj} + #{K3i0LumP9MU.ObiJr399QRt} + #{K3i0LumP9MU.bPNw3Km3Ug7} + #{K3i0LumP9MU.oJ6IUNugflo} + #{K3i0LumP9MU.vr2WcWaojbO} + #{K3i0LumP9MU.B0ji6ZY2zJ3} + #{K3i0LumP9MU.szjWdpjHTDe} + #{K3i0LumP9MU.JUI7tesx6as} + #{K3i0LumP9MU.O68sxX0pJMT} + #{K3i0LumP9MU.Qy5yADe3SiB},1
Inpatients Authorized Beds,jsXZJdXTPuS,Inpatients Authorized Beds,#{nyP99EFVQ4O.Lj5arkL7GL8} + #{nyP99EFVQ4O.KFmqREu0VSL} + #{nyP99EFVQ4O.rYfAgBnJKnj} + #{nyP99EFVQ4O.ObiJr399QRt} + #{nyP99EFVQ4O.bPNw3Km3Ug7} + #{nyP99EFVQ4O.oJ6IUNugflo} + #{nyP99EFVQ4O.vr2WcWaojbO} + #{nyP99EFVQ4O.B0ji6ZY2zJ3} + #{nyP99EFVQ4O.szjWdpjHTDe} + #{nyP99EFVQ4O.JUI7tesx6as} + #{nyP99EFVQ4O.O68sxX0pJMT} + #{nyP99EFVQ4O.Qy5yADe3SiB},1
"Insulin, Premix (short acting +intermediate acting) Human [30 regular + 70 NPH) Injection 10ml Bottle (Vial /Bottle) MoS",n8B0vvf1PCW,"Insulin, Premix  Human [30 regular + 70 NPH) ",#{WiygygYRqs7.n8XlCFUpWOG},#{lcqBs8Qopdx.QvctQfKAQn3}
J&j_Vaccine_Type,TpFsAEwwq7m,J&j_Vaccine_Type,#{qRQ3LIl7SmG},1
KHIS_HTS_TST(<15-Female-Positive),h4KK9IBSToB,KHIS_HTS_TST(<15-Female-Positive),(#{QXQFd2JB10B} + #{wu0ITFRjUzF}),1
KHIS_HTS_TST(<15-Male-Positive),boYFCqSHIve,KHIS_HTS_TST(<15-Male-Positive),(#{DBZH3aC9gwQ} + #{D9YwtS6RhQ1}),1
KHIS_HTS_TST(<15-Unknown-Positive),suM4VZ0pEXs,KHIS_HTS_TST(<15-Unknown-Positive),#{du5RMT3aecB},1
KHIS_HTS_TST(>=15-Female-Positive),KG9pnNKlzof,KHIS_HTS_TST(>=15-Female-Positive),#{c2pgDecBILP} + #{NMWgSKFW6U7}+#{xMNhnyu7vm1} + #{oCFXmpol7D8} + #{cBTa1jVzT8f},1
KHIS_HTS_TST(>=15-Male-Positive),ZPUms4f6vKP,KHIS_HTS_TST(>=15-Male-Positive),(#{RCFqEXIiqed} + #{xN6GhQGgaoI}+#{kLXGWRLzCAw} + #{F9OR49Lc1aR} + #{J4vNm7YEkdj}),1
KHIS_HTS_TST(Total-Unknown-Negative),DWFWspkG4Yu,KHIS_HTS_TST(Total-Unknown-Negative),#{qw7eJpLE3vK} + ((#{jbzrwpsfYMN} + #{Aioi6LxPb3N})-(#{c2pgDecBILP} + #{NMWgSKFW6U7} + #{QXQFd2JB10B} + #{RCFqEXIiqed} + #{xN6GhQGgaoI} + #{DBZH3aC9gwQ})),1
KHIS_PMTCT_ART(N/A),FGATEY1l3k4,KHIS_PMTCT_ART(N/A),#{FRRDdqayYnU}+(#{lJpaBye9B0H}+#{WNFWVHMqPv9}),1
KHIS_PMTCT_STAT,mWln8PQom4I,KHIS_PMTCT_STAT,(#{TJMdle70A7X} + #{DrYHirleKid})+(#{qSgLzXh46n9} + #{ETX9cUWF43c}),1
KHIS_TX_CURR(<15-Female),FoJ0GHjlsZe,KHIS_TX_CURR(<15-Female),#{cbUoZG6mlS7}+#{GSEmLUnrvzj},1
KHIS_TX_CURR(<15-Male),KAO9ne0crno,KHIS_TX_CURR(<15-Male),#{QISrDYwXnMw} + #{Jbu4if6gtDp},1
KHIS_TX_CURR(<15-Unknown),qCZO3NEtLQy,KHIS_TX_CURR(<15-Unknown),#{SJL4k6Gl53C} + #{wbJOu4h2SSz},1
KHIS_TX_CURR(>=15-Female),YvS2nhm984D,KHIS_TX_CURR(>=15-Female),#{ISGNo6jMJlI} + #{AQsTt7jtKbt} + #{EhZQp3PTA3C} + #{yNCUlEYkmyA},1
KHIS_TX_CURR(>=15-Male),y1gxe1pTRk9,KHIS_TX_CURR(>=15-Male),#{oTjp04eBIaV} + #{oOOnacUi9Jm}+#{e93GKJTHKAX} + #{pR7VzBydoj3},1
KHIS_TX_NEW(<15-Female),f3tsgSHljrx,KHIS_TX_NEW(<15-Female),#{QTfUGmnpzCm} + #{jthpt5cVV9c},1
KHIS_TX_NEW(<15-Male),VPjGyHmiJhX,KHIS_TX_NEW(<15-Male),#{Ivi4xwwsjNN} + #{LC2OqnUC5Sn},1
KHIS_TX_NEW(<15-Unknown),MA3cbk0FFUE,KHIS_TX_NEW(<15-Unknown),#{mACm1JUzeLT} + #{Hbc2qRi0U5x},1
KHIS_TX_NEW(>=15-Female),vz2Uz2NXFXF,KHIS_TX_NEW(>=15-Female),#{CNK6qMLzi8b} + #{DaNcGZnkclz} + #{zNCSlBKbS6d} + #{Nv4OkbdDvmm},1
KHIS_TX_NEW(>=15-Male),O3loSMi9lDy,KHIS_TX_NEW(>=15-Male),#{yPGhCvz2bX2} + #{yWkSi8L3qGm} + #{K59f8nZ5vhy} + #{SCMKsiNj6c5},1
KP_Proportion of HIV Positive  Key Population  Currently on ART,flR1rC14m3S,KP_Proportion of HIV +ve  KP  Currently on ART,#{Jjl0ei5K2XL},(#{SJL4k6Gl53C} + #{wbJOu4h2SSz} + #{Jbu4if6gtDp} + #{GSEmLUnrvzj} + #{oOOnacUi9Jm} + #{AQsTt7jtKbt} + #{e93GKJTHKAX} + #{EhZQp3PTA3C} + #{pR7VzBydoj3} + #{yNCUlEYkmyA})
KP_Proportion of HIV Positive Key Population  starting ART,R8wFNRMazP3,KP_Proportion of HIV +ve KP  starting ART,#{tLrIZPv43Tk},(#{mACm1JUzeLT} + #{Hbc2qRi0U5x} + #{LC2OqnUC5Sn} + #{jthpt5cVV9c} + #{yWkSi8L3qGm} + #{DaNcGZnkclz} + #{K59f8nZ5vhy} + #{zNCSlBKbS6d} + #{SCMKsiNj6c5} + #{Nv4OkbdDvmm})
KP_Proportion of HIV positive  Key Population  Newly Enrolled in Care,yjZflaODVo5,KP_Prop HIV +ve KP  Newly Enrolled in Care,#{tLrIZPv43Tk},#{M5zablilTPO}
LATF Accounting Rate,XSh4BF8QIpE,LATF Accounting Rate,#{oMWJpAyAIUh.VNcrvgnT5bL},#{uq2Izs9ZGT7.VNcrvgnT5bL}
LATF Utilzation Rate,m0jrH6oVaJS,LATF Utilzation Rate,#{uq2Izs9ZGT7.VNcrvgnT5bL},#{QLC6ejj76za.VNcrvgnT5bL}
LLIN % variance between Expected & Closing SOH,c6A37DQWMIt,LLIN % variance between Expected & Closing SOH,"
((#{f0AIAR5pJ2F.HWtHCLAwprR} + #{f0AIAR5pJ2F.yuvCdaFqdCW} + #{f0AIAR5pJ2F.CckV73xy6HB}) - (#{f0AIAR5pJ2F.w77uMi1KzOH} + #{f0AIAR5pJ2F.rqzfl66VFyd} + #{f0AIAR5pJ2F.unVIt2C0cdW}))-(#{f0AIAR5pJ2F.rPAsF4cpNxm})",(#{f0AIAR5pJ2F.HWtHCLAwprR} + #{f0AIAR5pJ2F.yuvCdaFqdCW} + #{f0AIAR5pJ2F.CckV73xy6HB}) - (#{f0AIAR5pJ2F.w77uMi1KzOH} + #{f0AIAR5pJ2F.rqzfl66VFyd} + #{f0AIAR5pJ2F.unVIt2C0cdW})
LLIN -ve Adjustments as a % of available stock,RURwrNJC9h6,LLIN -ve Adjustments as a % of available stock,#{f0AIAR5pJ2F.unVIt2C0cdW},#{f0AIAR5pJ2F.rPAsF4cpNxm}
LLIN Adjusted Consumption,of9iOuMdstM,LLIN Adj Consumption,#{OyddF1qflzP.ieuodyY5ybC} + #{f9vesk5d4IY},1
LLIN CWC and ANC Issued,fgJI8Sl3xPq,LLIN CWC and ANC Issued,#{EsfvxFcltV0.wBWcFk7k1qY} + #{uTQOSp7rx5h.wBWcFk7k1qY},1
LLIN Losses as a % of available stock,Bi2Lyr2ZZk0,LLIN Losses as a % of available stock,#{f0AIAR5pJ2F.rqzfl66VFyd},#{f0AIAR5pJ2F.rPAsF4cpNxm}
LLIN Risk 10 - Discrepancies between service & commodity reports,xKXO1rvSnRh,LLIN Risk 10,(#{adV5ma0IRHU} + #{eIvn8VgI5Zx}) - #{f0AIAR5pJ2F.w77uMi1KzOH},1
LLIN dispensed nets issued,GmFCplHDQZR,LLIN dispensed nets,(#{adV5ma0IRHU} + #{eIvn8VgI5Zx}),1
LLINs Total dispensed minus Sum of ANC & CWC clients,mXWDzCMWWaW,LLIN Risk 10,#{f0AIAR5pJ2F.w77uMi1KzOH} - (#{f9vesk5d4IY} + #{ku80YRejJPg}),1
Latrine Coverage,wFgO9wjUjhY,Latrine Coverage,#{Sz30p2DryRZ.NhSoXUMPK2K},#{duLaKUuuAwV.NhSoXUMPK2K}
"Loratadine Tablets, 10mg (Tablet) MoS",aAHIH8QcdoF,"Loratadine Tablets, 10mg (Tablet)",#{hBItOmE0ybe.n8XlCFUpWOG},#{QqXgC8XD3IF.QvctQfKAQn3}
MDR TB death rate,Whhup3uA5cU,MDR TB death rate,#{dSpjJg77lqe.Boypl7fVVdU},#{dSpjJg77lqe.j0Q6xdnrEuX}
MDR TB-2⁽ᴹ⁾ Number of TB cases with RR-TB and/or MDR-TB notified,nNGYNZpAWst,RR + MDR TB cases,#{zVIv5xsY92B.pX5gB1XXBi0},1
MLR Total Confirmed Cases,mWd60Ulyh47,MLR Total Confirmed Cases,#{OoakJhWiyZp},1
MLR Total Patients Diagnosed,ZGGTobpFTwU,MLR Total Patients Diagnosed,#{Lt0FqtnHraW}+#{OoakJhWiyZp},1
MOH 643 Acetone MOS,J2LvmCLK1HA,MOH 643 Acetone MOS,#{TQscCW3V7Za.B1sPPfIobef}/#{TQscCW3V7Za.OV0KZq0N7Pf},1
MOH 643 Anti Human Globulin MOS,xm1YnAc6ejt,MOH 643 Anti Human Globulin MOS,#{HoExlPhOLOz.B1sPPfIobef}/#{HoExlPhOLOz.OV0KZq0N7Pf},1
MOH 643 Anti sera A MOS,cr5ZPGBDPPv,MOH 643 Anti sera A MOS,#{BIvgkNrIju1.B1sPPfIobef}/#{BIvgkNrIju1.OV0KZq0N7Pf},1
MOH 643 Anti sera B MOS,GVvl3E7J523,MOH 643 Anti sera B MOS,#{KQMyPkAZrAf.B1sPPfIobef}/#{KQMyPkAZrAf.OV0KZq0N7Pf},1
MOH 643 Anti sera D MOS,ygu40mAa0wo,MOH 643 Anti sera D MOS,#{pvOidoknd96.B1sPPfIobef}/#{pvOidoknd96.OV0KZq0N7Pf},1
MOH 643 Auramine-O MOS,oqcoJtSuTXy,MOH 643 Auramine-O MOS,#{WTyC4SVjGfq.qPAeQirUKSq}/#{WTyC4SVjGfq.qv44xZjRAB8},1
MOH 643 Autoclavable bags (for culture plates) MOS,bbtYOF2S2T5,MOH 643 Autoclavable bags (for culture plates) MOS,#{dxy8GfNgK3E.B1sPPfIobef}/#{dxy8GfNgK3E.OV0KZq0N7Pf},1
MOH 643 Basic Fuschin MOS,Nb4Rairq9K4,MOH 643 Basic Fuschin MOS,#{QmmftXddAw6.qPAeQirUKSq}/#{QmmftXddAw6.qv44xZjRAB8},1
MOH 643 Blood agar MOS,zHUi5OIuyxJ,MOH 643 Blood agar MOS,#{WzUK4ZdEv8x.GdkXfx3sa8f}/#{WzUK4ZdEv8x.BUq6w4krOnU},1
MOH 643 Blood collection  bags (Single) MOS,QA7UFbtErUS,MOH 643 Blood collection  bags (Single) MOS,#{WG9joWKNXX3.sP2bvbL3o9h}/#{WG9joWKNXX3.J9VBXro3Uyj},1
MOH 643 Blood collection bags (Double) MOS,Lu0vhvKkGpI,MOH 643 Blood collection bags (Double) MOS,#{KzdX7jf5Thz.sP2bvbL3o9h}/#{KzdX7jf5Thz.J9VBXro3Uyj},1
MOH 643 Blood collection bags (Quadruple with SAG-M) MOS,s9xt2ibuvDR,MOH 643 Blood collection bags (Quadruple with SAG-,#{ulLKnuzI3r7.sP2bvbL3o9h}/#{ulLKnuzI3r7.J9VBXro3Uyj},1
MOH 643 Blood collection bags (Triple with SAG-M) MOS,pJC19J4D7IM,MOH 643 Blood collection bags (Triple with SAG-M),#{vAkGAnWZrjL.sP2bvbL3o9h}/#{vAkGAnWZrjL.J9VBXro3Uyj},1
MOH 643 Blood screening Automated (Architect) MOS,FywnZpoXhUI,MOH 643 Blood screening Automated (Architect) MOS,#{EXCl93LMilM.sP2bvbL3o9h}/#{EXCl93LMilM.J9VBXro3Uyj},1
MOH 643 CLED MOS,KOgxNR7Q8Qt,MOH 643 CLED MOS,#{cMFxRO3Ehii.GdkXfx3sa8f}/#{cMFxRO3Ehii.BUq6w4krOnU},1
MOH 643 Cover slips MOS,Wo53nyQ7tlk,MOH 643 Cover slips MOS,#{zxMEsDqAfWS.B1sPPfIobef}/#{zxMEsDqAfWS.OV0KZq0N7Pf},1
MOH 643 Culture Plates MOS,BTRsTpaislQ,MOH 643 Culture Plates MOS,#{r3yJiFSdsos.GdkXfx3sa8f}/#{r3yJiFSdsos.BUq6w4krOnU},1
MOH 643 Di-Ethyl ether MOS,aXqPkd8kpQU,MOH 643 Di-Ethyl ether MOS,#{kPsb6Xekp0d.NHGvTtWMqW5}/#{kPsb6Xekp0d.oaVjwFy2Ayv},1
"MOH 643 Dried Blood spot (DBS) collection kit, 20s MOS",fWo8CHFKLjo,"MOH 643 Dried Blood spot (DBS) collection kit, 20s",#{cqX9v1wWNsx.K8shOw0pNhd}/#{cqX9v1wWNsx.R0j6FcLUYwb},1
"MOH 643 Dried Blood spot (DBS) collection kit, 50s MOS",Z94pxpjnQXp,"MOH 643 Dried Blood spot (DBS) collection kit, 50s",#{M5ZDXIkiWEb.K8shOw0pNhd}/#{M5ZDXIkiWEb.R0j6FcLUYwb},1
MOH 643 FCDRR-Qty for resupply_Acetone,Gs9B3WUIhoN,MOH 643 FCDRR-Qty for resupply_Acetone,(#{TQscCW3V7Za.OV0KZq0N7Pf}*4)-#{TQscCW3V7Za.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Anti Human Globulin,JCalXNngec7,MOH 643 FCDRR-Qty for resupply_Anti Human Globulin,(#{HoExlPhOLOz.OV0KZq0N7Pf}*4)-#{HoExlPhOLOz.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Anti sera A,wRJtyugeH6B,MOH 643 FCDRR-Qty for resupply_Anti sera A,(#{BIvgkNrIju1.OV0KZq0N7Pf}*4)-#{BIvgkNrIju1.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Anti sera B,ofaCBRt09rc,MOH 643 FCDRR-Qty for resupply_Anti sera B,(#{KQMyPkAZrAf.OV0KZq0N7Pf}*4)-#{KQMyPkAZrAf.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Anti sera D,F2KQoLbNQQP,MOH 643 FCDRR-Qty for resupply_Anti sera D,(#{pvOidoknd96.OV0KZq0N7Pf}*4)-#{pvOidoknd96.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Applicator sticks,BCfNLGb2EQU,MOH 643 FCDRR-Qty for resupply_Applicator sticks,(#{MAJFIOUSZQC.OV0KZq0N7Pf}*4)-#{MAJFIOUSZQC.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Auramine-O,Urj3W2p06Df,MOH 643 FCDRR-Qty for resupply_Auramine-O,(#{WTyC4SVjGfq.qv44xZjRAB8}*4)-#{WTyC4SVjGfq.qPAeQirUKSq},1
MOH 643 FCDRR-Qty for resupply_Autoclavable bags (for culture plates),nU8HOHfem6V,MOH 643 FCDRR-Qty for resupply_Autoclavable bags (,(#{dxy8GfNgK3E.OV0KZq0N7Pf}*4)-#{dxy8GfNgK3E.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Basic Fuschin,XtZXhN9A0X7,MOH 643 FCDRR-Qty for resupply_Basic Fuschin,(#{QmmftXddAw6.qv44xZjRAB8}*4)-#{QmmftXddAw6.qPAeQirUKSq},1
MOH 643 FCDRR-Qty for resupply_Blood agar,vLvjKTFBdMp,MOH 643 FCDRR-Qty for resupply_Blood agar,(#{WzUK4ZdEv8x.BUq6w4krOnU}*4)-#{WzUK4ZdEv8x.GdkXfx3sa8f},1
MOH 643 FCDRR-Qty for resupply_Blood collection  bags (Double),jM22iEcwy31,MOH 643 FCDRR-Qty for resupply_Blood collection  b,(#{KzdX7jf5Thz.J9VBXro3Uyj}*4)-#{KzdX7jf5Thz.sP2bvbL3o9h},1
MOH 643 FCDRR-Qty for resupply_Blood collection  bags (Single),llF0W0e7PPX,MOH 643 FCDRR-Qty for resupply_Blood collection  b,(#{WG9joWKNXX3.J9VBXro3Uyj}*4)-#{WG9joWKNXX3.sP2bvbL3o9h},1
MOH 643 FCDRR-Qty for resupply_Blood collection bags (Quadruple with SAG-M),zTLqVqrkETt,MOH 643 FCDRR-Qty for resupply_Blood collection ba,(#{ulLKnuzI3r7.J9VBXro3Uyj}*4)-#{ulLKnuzI3r7.sP2bvbL3o9h},1
MOH 643 FCDRR-Qty for resupply_Blood collection bags (Triple with SAG-M),gjCuoCeVJFc,MOH 643 FCDRR-Qty for resupply_Blood collection ba,(#{vAkGAnWZrjL.J9VBXro3Uyj}*4)-#{vAkGAnWZrjL.sP2bvbL3o9h},1
MOH 643 FCDRR-Qty for resupply_Blood screening Automated (Architect),Ioj8CAH1G0N,MOH 643 FCDRR-Qty for resupply_Blood screening Aut,(#{EXCl93LMilM.J9VBXro3Uyj}*4)-#{EXCl93LMilM.sP2bvbL3o9h},1
MOH 643 FCDRR-Qty for resupply_Blue tips,PV6JWqLmWbs,MOH 643 FCDRR-Qty for resupply_Blue tips,(#{fnfC3UpbPzc.OV0KZq0N7Pf}*4)-#{fnfC3UpbPzc.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_CLED,yYsVvtw8OkC,MOH 643 FCDRR-Qty for resupply_CLED,(#{cMFxRO3Ehii.BUq6w4krOnU}*4)-#{cMFxRO3Ehii.GdkXfx3sa8f},1
MOH 643 FCDRR-Qty for resupply_Colour coded bin liners,N64GogXbXrr,MOH 643 FCDRR-Qty for resupply_Colour coded bin li,(#{qYeR3AbhFUu.OV0KZq0N7Pf}*4)-#{qYeR3AbhFUu.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Cover slips,cX3UQkyZKuo,MOH 643 FCDRR-Qty for resupply_Cover slips,(#{zxMEsDqAfWS.OV0KZq0N7Pf}*4)-#{zxMEsDqAfWS.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Culture plates,GughEwSqx2F,MOH 643 FCDRR-Qty for resupply_Culture plates,(#{r3yJiFSdsos.BUq6w4krOnU}*4)-#{r3yJiFSdsos.GdkXfx3sa8f},1
MOH 643 FCDRR-Qty for resupply_Di-Ethyl ether,dh7NYUT37eM,MOH 643 FCDRR-Qty for resupply_Di-Ethyl ether,(#{kPsb6Xekp0d.oaVjwFy2Ayv}*4)-#{kPsb6Xekp0d.NHGvTtWMqW5},1
"MOH 643 FCDRR-Qty for resupply_Dried Blood spot (DBS) collection kit, 20s",oESDgvdukF9,MOH 643 FCDRR-Qty for resupply_Dried Blood spot (D,(#{cqX9v1wWNsx.R0j6FcLUYwb}*4)-#{cqX9v1wWNsx.K8shOw0pNhd},1
"MOH 643 FCDRR-Qty for resupply_Dried Blood spot (DBS) collection kit, 50s",fkseVoAfISC,MOH 643 FCDRR-Qty for resupply_Dried Blood spot (D,(#{M5ZDXIkiWEb.R0j6FcLUYwb}*4)-#{M5ZDXIkiWEb.K8shOw0pNhd},1
MOH 643 FCDRR-Qty for resupply_Falcon tubes,BaQnT5yvmzf,MOH 643 FCDRR-Qty for resupply_Falcon tubes,(#{MuAP2lHEsbC.qv44xZjRAB8}*4)-#{MuAP2lHEsbC.qPAeQirUKSq},1
MOH 643 FCDRR-Qty for resupply_Giemsa Stain (powder),YBoPD45FL4h,MOH 643 FCDRR-Qty for resupply_Giemsa Stain (powde,(#{z9D1b54J4zL.OV0KZq0N7Pf}*4)-#{z9D1b54J4zL.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Glycerol,E3PFX9VH6BB,MOH 643 FCDRR-Qty for resupply_Glycerol,(#{t9i4HMEoNlf.OV0KZq0N7Pf}*4)-#{t9i4HMEoNlf.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Gram's Iodine,zy0Nhk4uDNh,MOH 643 FCDRR-Qty for resupply_Gram's Iodine,(#{s6BqBvyGJXy.BUq6w4krOnU}*4)-#{s6BqBvyGJXy.GdkXfx3sa8f},1
"MOH 643 FCDRR-Qty for resupply_HIV Confirmatory (ELISA) Test, Semi-automated",bW26FBteUen,MOH 643 FCDRR-Qty for resupply_HIV Confirmatory (E,(#{XbsWL3J4crS.J9VBXro3Uyj}*4)-#{XbsWL3J4crS.sP2bvbL3o9h},1
"MOH 643 FCDRR-Qty for resupply_HIV Screening (ELISA) test, Semi-automated",mtrGQygcgha,MOH 643 FCDRR-Qty for resupply_HIV Screening (ELIS,(#{PUqGLFe1wxI.J9VBXro3Uyj}*4)-#{PUqGLFe1wxI.sP2bvbL3o9h},1
"MOH 643 FCDRR-Qty for resupply_Hepatitis B (ELISA) Test, Semi-automated",wZ9h0qz8e85,MOH 643 FCDRR-Qty for resupply_Hepatitis B (ELISA),(#{kmtShHYOOIj.J9VBXro3Uyj}*4)-#{kmtShHYOOIj.sP2bvbL3o9h},1
"MOH 643 FCDRR-Qty for resupply_Hepatitis C (ELISA) Test, Semi-automated",GiYCwG3z0CL,MOH 643 FCDRR-Qty for resupply_Hepatitis C (ELISA),(#{bwI50Zp7CQc.J9VBXro3Uyj}*4)-#{bwI50Zp7CQc.sP2bvbL3o9h},1
MOH 643 FCDRR-Qty for resupply_Hydrochloric acid,tlTk4iNZhbK,MOH 643 FCDRR-Qty for resupply_Hydrochloric acid,(#{RJhl5k2JlrI.OV0KZq0N7Pf}*4)-#{RJhl5k2JlrI.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Immersion Oil,aIXY3yQodkA,MOH 643 FCDRR-Qty for resupply_Immersion Oil,(#{OZ2mmwc0LT1.OV0KZq0N7Pf}*4)-#{OZ2mmwc0LT1.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Lancets,xuYRJR86SNf,MOH 643 FCDRR-Qty for resupply_Lancets,(#{dVdVwOEsfZE.OV0KZq0N7Pf}*4)-#{dVdVwOEsfZE.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Latex Gloves,BHbkkOOg8Q4,MOH 643 FCDRR-Qty for resupply_Latex Gloves,(#{xijDshi6dgl.OV0KZq0N7Pf}*4)-#{xijDshi6dgl.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_MacConkey agar,DfL5PMhc9j2,MOH 643 FCDRR-Qty for resupply_MacConkey agar,(#{NMkQWArQQ39.BUq6w4krOnU}*4)-#{NMkQWArQQ39.GdkXfx3sa8f},1
MOH 643 FCDRR-Qty for resupply_Malaria Rapid Diagnostic Test (mRDT),svqm1seDsHw,MOH 643 FCDRR-Qty for resupply_Malaria Rapid Diagn,(#{EUJgcU6Kff6.lhc54L6Gqhe}*4)-#{EUJgcU6Kff6.rAR5dJZG3DK},1
MOH 643 FCDRR-Qty for resupply_Methanol (Absolute),PKdHcBCcx1g,MOH 643 FCDRR-Qty for resupply_Methanol (Absolute),(#{Bp5H6BLUW8i.OV0KZq0N7Pf}*4)-#{Bp5H6BLUW8i.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Methylene Blue,kmqsKMtUA2z,MOH 643 FCDRR-Qty for resupply_Methylene Blue,(#{KG2Z91loRtE.qv44xZjRAB8}*4)-#{KG2Z91loRtE.qPAeQirUKSq},1
MOH 643 FCDRR-Qty for resupply_Methylene Blue/malachite green,XfNoYwIHJQW,MOH 643 FCDRR-Qty for resupply_Methylene Blue/mala,(#{KG2Z91loRtE.qv44xZjRAB8}*4)-#{KG2Z91loRtE.qPAeQirUKSq},1
MOH 643 FCDRR-Qty for resupply_Microscope slides,ByK0QBW506W,MOH 643 FCDRR-Qty for resupply_Microscope slides,(#{RBY9hSkxhzx.OV0KZq0N7Pf}*4)-#{RBY9hSkxhzx.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Mueller Hinton agar,PfrorDZNlzK,MOH 643 FCDRR-Qty for resupply_Mueller Hinton agar,(#{aF69pOSK5AJ.BUq6w4krOnU}*4)-#{aF69pOSK5AJ.GdkXfx3sa8f},1
MOH 643 FCDRR-Qty for resupply_Neutral red,h8ysXeLlNaH,MOH 643 FCDRR-Qty for resupply_Neutral red,(#{vvJUNYqC6B2.BUq6w4krOnU}*4)-#{vvJUNYqC6B2.GdkXfx3sa8f},1
MOH 643 FCDRR-Qty for resupply_Phenol crystals,RAAElv4hWZp,MOH 643 FCDRR-Qty for resupply_Phenol crystals,(#{qWhR66Qg4HV.qv44xZjRAB8}*4)-#{qWhR66Qg4HV.qPAeQirUKSq},1
MOH 643 FCDRR-Qty for resupply_Phosphate Buffer tablet pH 6.8,gM8xl6dkJUY,MOH 643 FCDRR-Qty for resupply_Phosphate Buffer ta,(#{NqFdHwFjqRg.OV0KZq0N7Pf}*4)-#{NqFdHwFjqRg.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Phosphate Buffer tablet pH 7.2,uVXnbUFhgD2,MOH 643 FCDRR-Qty for resupply_Phosphate Buffer ta,(#{Tc6SNNew9sb.OV0KZq0N7Pf}*4)-#{Tc6SNNew9sb.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Potassium Permanganate,S6NCbqQxjYK,MOH 643 FCDRR-Qty for resupply_Potassium Permangan,(#{BBDw9rdUkSk.qv44xZjRAB8}*4)-#{BBDw9rdUkSk.qPAeQirUKSq},1
MOH 643 FCDRR-Qty for resupply_Rapid HBV screening test,bV2pP6XAEt0,MOH 643 FCDRR-Qty for resupply_Rapid HBV screening,(#{MglrUDAeEyA.R0j6FcLUYwb}*4)-#{MglrUDAeEyA.K8shOw0pNhd},1
MOH 643 FCDRR-Qty for resupply_Rapid HIV 1+2 Test 1 - Screening,xhF3SXG4yjo,MOH 643 FCDRR-Qty for resupply_Rapid HIV 1+2 Test,(#{CzrZlb2oGMv.R0j6FcLUYwb}*4)-#{CzrZlb2oGMv.K8shOw0pNhd},1
MOH 643 FCDRR-Qty for resupply_Rapid HIV 1+2 Test 2 - Confirmatory,x5qYbvg72j8,MOH 643 FCDRR-Qty for resupply_Rapid HIV 1+2 Test,(#{rTFvDwdftfT.R0j6FcLUYwb}*4)-#{rTFvDwdftfT.K8shOw0pNhd},1
MOH 643 FCDRR-Qty for resupply_Safety boxes,rPOXdRvPyRf,MOH 643 FCDRR-Qty for resupply_Safety boxes,(#{LgXrtboIuB8.OV0KZq0N7Pf}*4)-#{LgXrtboIuB8.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Slide boxes,MnbjCecplGN,MOH 643 FCDRR-Qty for resupply_Slide boxes,(#{Gg3ooTfBlUI.OV0KZq0N7Pf}*4)-#{Gg3ooTfBlUI.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Slide mailers,C0x9KDd9uar,MOH 643 FCDRR-Qty for resupply_Slide mailers,(#{xrcG2HgpfJy.OV0KZq0N7Pf}*4)-#{xrcG2HgpfJy.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Sputum mugs,vZeHNwe7xeq,MOH 643 FCDRR-Qty for resupply_Sputum mugs,(#{AyUDGqkojEL.qv44xZjRAB8}*4)-#{AyUDGqkojEL.qPAeQirUKSq},1
MOH 643 FCDRR-Qty for resupply_Stool collection containers (e.g. Polypots),zzAJXbbVuqu,MOH 643 FCDRR-Qty for resupply_Stool collection co,(#{JZytHU04nrM.OV0KZq0N7Pf}*4)-#{JZytHU04nrM.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Sulphuric acid,ehFcb77mu4V,MOH 643 FCDRR-Qty for resupply_Sulphuric acid,(#{L0lHsGSNk7d.OV0KZq0N7Pf}*4)-#{L0lHsGSNk7d.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Syphilis Screening Test (e.g. RPR),maiU8YlNP5r,MOH 643 FCDRR-Qty for resupply_Syphilis Screening,(#{huXBGY0iBjF.J9VBXro3Uyj}*4)-#{huXBGY0iBjF.sP2bvbL3o9h},1
MOH 643 FCDRR-Qty for resupply_TB molecular test (Gene Xpert) cartridge,KPHSXASEVux,MOH 643 FCDRR-Qty for resupply_TB molecular test (,(#{Pg1f9xaHehS.qv44xZjRAB8}*4)-#{Pg1f9xaHehS.qPAeQirUKSq},1
MOH 643 FCDRR-Qty for resupply_Vacutainer holders,GHA1xRNTUar,MOH 643 FCDRR-Qty for resupply_Vacutainer holders,(#{XsXucJHGUJH.OV0KZq0N7Pf}*4)-#{XsXucJHGUJH.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Vacutainer holders,yV0GNmyC4Ke,MOH 643 FCDRR-Qty for resupply_Vacutainer holders,(#{XsXucJHGUJH.OV0KZq0N7Pf}*4)-#{XsXucJHGUJH.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Vacutainer needles,xZwor6bJ20y,MOH 643 FCDRR-Qty for resupply_Vacutainer needles,(#{z9FJsG5tRgB.OV0KZq0N7Pf}*4)-#{z9FJsG5tRgB.B1sPPfIobef},1
"MOH 643 FCDRR-Qty for resupply_Vacutainer tubes, EDTA",KeY73ATP5EC,"MOH 643 FCDRR-Qty for resupply_Vacutainer tubes, E",(#{FUI0WGRxsA7.OV0KZq0N7Pf}*4)-#{FUI0WGRxsA7.B1sPPfIobef},1
"MOH 643 FCDRR-Qty for resupply_Vacutainer tubes, Plain",qMxGDNuHZxv,"MOH 643 FCDRR-Qty for resupply_Vacutainer tubes, P",(#{qZXlxHNxgsc.OV0KZq0N7Pf}*4)-#{qZXlxHNxgsc.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_White tips,VLdMUMAatju,MOH 643 FCDRR-Qty for resupply_White tips,(#{afsmWDJVenz.OV0KZq0N7Pf}*4)-#{afsmWDJVenz.B1sPPfIobef},1
MOH 643 FCDRR-Qty for resupply_Yellow tips,iJLfwwKJSVh,MOH 643 FCDRR-Qty for resupply_Yellow tips,(#{PfGYqI66BCy.OV0KZq0N7Pf}*4)-#{PfGYqI66BCy.B1sPPfIobef},1
MOH 643 Falcon tubes MOS,gbFczbdk7Vb,MOH 643 Falcon tubes MOS,#{MuAP2lHEsbC.qPAeQirUKSq}/#{MuAP2lHEsbC.qv44xZjRAB8},1
MOH 643 Falcon tubes MOS,ZEA1Ir2Y8SD,MOH 643 Falcon tubes MOS,#{MuAP2lHEsbC.qPAeQirUKSq}/#{MuAP2lHEsbC.qv44xZjRAB8},1
MOH 643 Glycerol MOS,L9MoSLOXkET,MOH 643 Glycerol MOS,#{t9i4HMEoNlf.B1sPPfIobef}/#{t9i4HMEoNlf.OV0KZq0N7Pf},1
MOH 643 Grams Iodine MOS,XaP21BMHeJ0,MOH 643 Grams Iodine MOS,#{s6BqBvyGJXy.GdkXfx3sa8f}/#{s6BqBvyGJXy.BUq6w4krOnU},1
MOH 643 HIV confirmatory  (ELISA) Test -Semi-automated MOS,VFgTUQPCWW0,MOH 643 HIV confirmatory  (ELISA) Test -Semi-autom,#{XbsWL3J4crS.sP2bvbL3o9h}/#{XbsWL3J4crS.J9VBXro3Uyj},1
MOH 643 HIV screening  (ELISA) test  -Semi-automated MOS,kqGswiLsU2D,MOH 643 HIV screening  (ELISA) test  -Semi-automat,#{PUqGLFe1wxI.sP2bvbL3o9h}/#{PUqGLFe1wxI.J9VBXro3Uyj},1
MOH 643 Hepatitis B (ELISA) Test Semi-automated MOS,DNBmRfLXXJu,MOH 643 Hepatitis B (ELISA) Test Semi-automated,#{kmtShHYOOIj.sP2bvbL3o9h}/#{kmtShHYOOIj.J9VBXro3Uyj},1
MOH 643 Hepatitis C  (ELISA) Test semi-automated MOS,BBbfKvfchCl,MOH 643 Hepatitis C  (ELISA) Test semi-automated,#{bwI50Zp7CQc.sP2bvbL3o9h}/#{bwI50Zp7CQc.J9VBXro3Uyj},1
MOH 643 Hydrochloric acid MOS,EyEB5gE5pQZ,MOH 643 Hydrochloric acid MOS,#{RJhl5k2JlrI.B1sPPfIobef}/#{RJhl5k2JlrI.OV0KZq0N7Pf},1
MOH 643 Immersion oil MOS,XV408MW7rz9,MOH 643 Immersion oil MOS,#{OZ2mmwc0LT1.B1sPPfIobef}/#{OZ2mmwc0LT1.OV0KZq0N7Pf},1
MOH 643 Latex gloves MOS,YBseQGsm7i6,MOH 643 Latex gloves MOS,#{xijDshi6dgl.B1sPPfIobef}/#{xijDshi6dgl.OV0KZq0N7Pf},1
MOH 643 Mac Conkey agar MOS,UUSU43qjXbi,MOH 643 Mac Conkey agar MOS,#{NMkQWArQQ39.GdkXfx3sa8f}/#{NMkQWArQQ39.BUq6w4krOnU},1
MOH 643 Malaria Rapid Diagnostic Test (mRDT) MOS,iPF0WpjibM9,MOH 643 Malaria Rapid Diagnostic Test (mRDT) MOS,#{EUJgcU6Kff6.rAR5dJZG3DK}/#{EUJgcU6Kff6.lhc54L6Gqhe},1
MOH 643 Methylene Blue/malachite green MOS,vWZSbZCZYdj,MOH 643 Methylene Blue/malachite green MOS,#{KG2Z91loRtE.qPAeQirUKSq}/#{KG2Z91loRtE.qv44xZjRAB8},1
MOH 643 Methylene blue MOS,S1tMR3mezpt,MOH 643 Methylene blue MOS,#{YGx9Ev7DYiJ.B1sPPfIobef}/#{YGx9Ev7DYiJ.OV0KZq0N7Pf},1
MOH 643 Microscope slides MOS,NnBT64Pjyk9,MOH 643 Microscope slides MOS,#{RBY9hSkxhzx.B1sPPfIobef}/#{RBY9hSkxhzx.OV0KZq0N7Pf},1
MOH 643 Muller Hinton agar MOS,TA7ZFFdg3Jv,MOH 643 Muller Hinton agar MOS,#{aF69pOSK5AJ.GdkXfx3sa8f}/#{aF69pOSK5AJ.BUq6w4krOnU},1
MOH 643 Neutral red MOS,X0fDHR2rFN9,MOH 643 Neutral red MOS,#{vvJUNYqC6B2.GdkXfx3sa8f}/#{vvJUNYqC6B2.BUq6w4krOnU},1
MOH 643 Phenol crystals MOS,Pe89Vs51504,MOH 643 Phenol crystals MOS,#{qWhR66Qg4HV.qPAeQirUKSq}/#{qWhR66Qg4HV.qv44xZjRAB8},1
MOH 643 Phosphate buffer tablets pH 6.8 MOS,wHpCJi6B3Gp,MOH 643 Phosphate buffer tablets pH 6.8 MOS,#{NqFdHwFjqRg.B1sPPfIobef}/#{NqFdHwFjqRg.OV0KZq0N7Pf},1
MOH 643 Phosphate buffer tablets pH 7.2 MOS,SjsUXQxiUy1,MOH 643 Phosphate buffer tablets pH 7.2 MOS,#{Tc6SNNew9sb.B1sPPfIobef}/#{Tc6SNNew9sb.OV0KZq0N7Pf},1
MOH 643 Potassium Permanganate MOS,Yl8wxJ13Aaw,MOH 643 Potassium Permanganate MOS,#{BBDw9rdUkSk.qPAeQirUKSq}/#{BBDw9rdUkSk.qv44xZjRAB8},1
MOH 643 Rapid HBV screening  MOS,awxzVTcESLZ,MOH 643 Rapid HBV screening  MOS,#{MglrUDAeEyA.K8shOw0pNhd}/#{MglrUDAeEyA.R0j6FcLUYwb},1
MOH 643 Rapid HIV 1+2 Test  (Confirmatory) MOS,kuLISweFEND,MOH 643 Rapid HIV 1+2 Test  (Confirmatory) MOS,#{rTFvDwdftfT.K8shOw0pNhd}/#{rTFvDwdftfT.R0j6FcLUYwb},1
MOH 643 Rapid HIV 1+2 Test  (Screening) MOS,xwbc8oyFpnw,MOH 643 Rapid HIV 1+2 Test  (Screening) MOS,(#{CzrZlb2oGMv.K8shOw0pNhd})/(#{CzrZlb2oGMv.R0j6FcLUYwb}),1
MOH 643 Slide boxes MOS,eUPNyEzjB88,MOH 643 Slide boxes MOS,#{Gg3ooTfBlUI.B1sPPfIobef}/#{Gg3ooTfBlUI.OV0KZq0N7Pf},1
MOH 643 Sputum mugs MOS,wWJrjrWjuss,MOH 643 Sputum mugs MOS,#{AyUDGqkojEL.qPAeQirUKSq}/#{AyUDGqkojEL.qv44xZjRAB8},1
MOH 643 Stool collection containers (e.g. polypots) MOS,tPmPGWOsfLB,MOH 643 Stool collection containers (e.g. polypots,#{JZytHU04nrM.B1sPPfIobef}/#{JZytHU04nrM.OV0KZq0N7Pf},1
MOH 643 Sulphuric acid MOS,zDrvm5AMQLX,MOH 643 Sulphuric acid MOS,#{L0lHsGSNk7d.B1sPPfIobef}/#{L0lHsGSNk7d.OV0KZq0N7Pf},1
MOH 643 Syphilis screening (eg RPR) MOS,sVqiPEVKuXc,MOH 643 Syphilis screening (eg RPR) MOS,#{huXBGY0iBjF.sP2bvbL3o9h}/#{huXBGY0iBjF.J9VBXro3Uyj},1
MOH 643 TB molecular (Gene Xpert) cartridge MOS,aeNficZ7N4J,MOH 643 TB molecular (Gene Xpert) cartridge MOS,#{Pg1f9xaHehS.qPAeQirUKSq}/#{Pg1f9xaHehS.qv44xZjRAB8},1
MOH 643 Vacutainer holders MOS,JvTK5Kvlwiz,MOH 643 Vacutainer holders MOS,#{XsXucJHGUJH.B1sPPfIobef}/#{XsXucJHGUJH.OV0KZq0N7Pf},1
MOH 643 Vacutainer needles MOS,byOxsV6TJ3H,MOH 643 Vacutainer needles MOS,#{z9FJsG5tRgB.B1sPPfIobef}/#{z9FJsG5tRgB.OV0KZq0N7Pf},1
"MOH 643 Vacutainer tubes, EDTA MOS",rqEaPlkfSZM,"MOH 643 Vacutainer tubes, EDTA MOS",#{FUI0WGRxsA7.B1sPPfIobef}/#{FUI0WGRxsA7.OV0KZq0N7Pf},1
"MOH 643 Vacutainer tubes, plain MOS",pvXshPvIjcv,"MOH 643 Vacutainer tubes, plain MOS",#{qZXlxHNxgsc.B1sPPfIobef}/#{qZXlxHNxgsc.OV0KZq0N7Pf},1
MOH 643 White tips MOS,ihJIMTyoeIx,MOH 643 White tips MOS,#{afsmWDJVenz.B1sPPfIobef}/#{afsmWDJVenz.OV0KZq0N7Pf},1
MOH 643 Yellow tips MOS,GiTyb2GVtL1,MOH 643 Yellow tips MOS,#{PfGYqI66BCy.B1sPPfIobef}/#{PfGYqI66BCy.OV0KZq0N7Pf},1
MOH 643B FCDRR-Qty for resupply_Falcon Tubes,IoeWKgAJBGR,MOH 643B FCDRR-Qty for resupply_Falcon Tubes,(#{SUSYZJx6V88.U3zV9xMKzOt}*4)-#{SUSYZJx6V88.aD8QjuYyQyY},1
MOH 643Blue tips MOS,PItEa2rfwdB,MOH 643Blue tips MOS,#{fnfC3UpbPzc.B1sPPfIobef}/#{fnfC3UpbPzc.OV0KZq0N7Pf},1
MOH 643Colour coded bin liners MOS,g14KJay7CzO,MOH 643Colour coded bin liners MOS,#{qYeR3AbhFUu.B1sPPfIobef}/#{qYeR3AbhFUu.OV0KZq0N7Pf},1
MOH 643Giemsa Stain (powder) MOS,Uf7UahM2Hxe,MOH 643Giemsa Stain (powder) MOS,#{z9D1b54J4zL.B1sPPfIobef}/#{z9D1b54J4zL.OV0KZq0N7Pf},1
MOH 643Lancets MOS,aLU3dgKIlFv,MOH 643Lancets MOS,#{dVdVwOEsfZE.B1sPPfIobef}/#{dVdVwOEsfZE.OV0KZq0N7Pf},1
MOH 643Methanol (absolute) MOS,WpCwpPEPDV3,MOH 643Methanol (absolute) MOS,#{Bp5H6BLUW8i.B1sPPfIobef}/#{Bp5H6BLUW8i.OV0KZq0N7Pf},1
MOH 643Safety boxes MOS,YddIwpFu5qC,MOH 643Safety boxes MOS,#{LgXrtboIuB8.B1sPPfIobef}/#{LgXrtboIuB8.OV0KZq0N7Pf},1
MOH 643Slide mailers MOS,GRMVAMPexGf,MOH 643Slide mailers MOS,#{xrcG2HgpfJy.B1sPPfIobef}/#{xrcG2HgpfJy.OV0KZq0N7Pf},1
MOH 729B Adult OIs Universal prophylaxis,KraXFxQLXKf,MOH 729B Adult OIs Universal prophylaxis,#{BNmsizbHkbN.NhSoXUMPK2K}+#{AfFiACJQkMf.NhSoXUMPK2K},1
MOH 729B Paediatric - OIs Universal prophylaxis,nFRdXmJCNZy,MOH 729B Paediatric - OIs Universal prophylaxis,#{W2Fzg2Q8m7j.NhSoXUMPK2K}+#{llU9TW7jQ2w.NhSoXUMPK2K},1
MOH 729B Total - Adult ART Patients,vAQhkgvi8n0,MOH 729B Total - Adult ART Patients,#{aU4Uta9JX46.NhSoXUMPK2K}+#{ICeAvxmW1YJ.NhSoXUMPK2K}+#{dFW9Sq24ImN.NhSoXUMPK2K}+#{PlyjfbfXufu.NhSoXUMPK2K}+#{yq5Vs7DinZv.NhSoXUMPK2K}+#{clnJBLRW5Al.NhSoXUMPK2K}+#{XFI89451TA3.NhSoXUMPK2K}+#{oKOQremhrvN.NhSoXUMPK2K}+#{tJTnLw6GtHq.NhSoXUMPK2K}+#{g3saIK0dKkg.NhSoXUMPK2K}+#{jibdDtF1tAB.NhSoXUMPK2K}+#{kSAEsxbq1v3.NhSoXUMPK2K}+#{ZEQvD8DJa6g.NhSoXUMPK2K}+#{FYO3TF1Y2k3.NhSoXUMPK2K}+#{NSR40bbdMHr.NhSoXUMPK2K}+#{KIHJJlkyiDZ.NhSoXUMPK2K}++#{fLapmacPPFn.NhSoXUMPK2K}+#{BilZg5vO0Pf.NhSoXUMPK2K}+#{ByU3Gd9aDmh.NhSoXUMPK2K}+#{wSFPAmi4aqd.NhSoXUMPK2K}+#{NZoCQGgPdFj.NhSoXUMPK2K}+#{rE0lUqEFCqe.NhSoXUMPK2K},1
MOH 729B Total - Adult PEP,T58D2PSCiK2,MOH 729B Total - Adult PEP,#{LjoptxNJo91.NhSoXUMPK2K}+#{dCaa2nTxEGV.NhSoXUMPK2K}+#{hYDtZ4Vm3d1.NhSoXUMPK2K}+#{K5WLTcE6M3O.NhSoXUMPK2K}+#{lGxT5bZaN2U.NhSoXUMPK2K},1
MOH 729B Total - OIs IPT,D0BjN2EVs4K,MOH 729B Total - OIs IPT,#{uZn6HAl0krd.NhSoXUMPK2K}+#{ow3BwSKt0dv.NhSoXUMPK2K},1
MOH 729B Total - OIs Universal prophylaxis,D7GoyD7xlFv,MOH 729B Total - OIs Universal prophylaxis,#{BNmsizbHkbN.NhSoXUMPK2K}+#{W2Fzg2Q8m7j.NhSoXUMPK2K}+#{AfFiACJQkMf.NhSoXUMPK2K}+#{llU9TW7jQ2w.NhSoXUMPK2K},1
MOH 729B Total - PMTCT - Women,stEn1ckekNH,MOH 729B Total - PMTCT - Women,#{wlJ0Tv4jHks.NhSoXUMPK2K}+#{la5EU6sF7H6.NhSoXUMPK2K}+#{E6Oh5KvWIls.NhSoXUMPK2K}+#{Y9S9AxGgFMs.NhSoXUMPK2K}+#{zkYS2haOdDn.NhSoXUMPK2K}+#{FaLaBoUyE0Z.NhSoXUMPK2K}+#{frs6D2j48Py.NhSoXUMPK2K}+#{lXgr5RUap30.NhSoXUMPK2K}+#{VeFJAceo4FL.NhSoXUMPK2K},1
MOH 729B Total - Paediatric ART,rDyrVr6mOrX,MOH 729B Total - Paediatric ART,#{YitEiiFUpku.NhSoXUMPK2K}+#{BuSD0IsQTBA.NhSoXUMPK2K}+#{iDITgYLzOD7.NhSoXUMPK2K}+#{IVdLKFlGSST.NhSoXUMPK2K}+#{aqu3Ngg2wvJ.NhSoXUMPK2K}+#{VKvszpkrfxT.NhSoXUMPK2K}+#{fyTwNAVHyJY.NhSoXUMPK2K}+#{xoNh8hOrKVU.NhSoXUMPK2K}+#{kyU008u8sKN.NhSoXUMPK2K}+#{SKZIVXE0sDo.NhSoXUMPK2K}+#{WOidHO1vrLG.NhSoXUMPK2K}+#{wqTCvOif1Jn.NhSoXUMPK2K}+#{ME6C1Od3OrH.NhSoXUMPK2K}+#{pi6OsoghsbU.NhSoXUMPK2K}+#{Fab79894AZm.NhSoXUMPK2K}+#{v1nikfkOjpH.NhSoXUMPK2K}+#{ixD4GVzHNc7.NhSoXUMPK2K}+#{syOUiJd8s9j.NhSoXUMPK2K}+#{ldZQDawylt9.NhSoXUMPK2K}+#{HRUyRlJ7G7c.NhSoXUMPK2K}+#{yqN4DKYHtPP.NhSoXUMPK2K}+#{ujCQ0yxm8Q6.NhSoXUMPK2K}+#{lNUvpIQ3LEA.NhSoXUMPK2K}+#{sg3ieRfu6Xg.NhSoXUMPK2K}+#{isNcp0vyeC8.NhSoXUMPK2K}+#{Doa6BoB4qoP.NhSoXUMPK2K},1
MOH 729B Total - Paediatric PEP,xPmFmkaTCmh,MOH 729B Total - Paediatric PEP,#{NMeMN1lH3Ff.NhSoXUMPK2K}+#{zjdclnhvCWK.NhSoXUMPK2K}+#{DUj0UyuAh0z.NhSoXUMPK2K},1
MOH 729B Total - Paediatric PMTCT (Infants),ILZEyfef9Wd,MOH 729B Total - Paediatric PMTCT,#{axvTDBWGhf3.NhSoXUMPK2K}+#{owwzy85184b.NhSoXUMPK2K}+#{L9btjT9eDql.NhSoXUMPK2K}+#{yUokXNjdtXU.NhSoXUMPK2K},1
MOH 729B Total ART Patients,Rz4WeVyteu5,MOH 729B Total ART Patients,#{aU4Uta9JX46.NhSoXUMPK2K}+#{ICeAvxmW1YJ.NhSoXUMPK2K}+#{dFW9Sq24ImN.NhSoXUMPK2K}+#{PlyjfbfXufu.NhSoXUMPK2K}+#{yq5Vs7DinZv.NhSoXUMPK2K}+#{clnJBLRW5Al.NhSoXUMPK2K}+#{XFI89451TA3.NhSoXUMPK2K}+#{oKOQremhrvN.NhSoXUMPK2K}+#{tJTnLw6GtHq.NhSoXUMPK2K}+#{g3saIK0dKkg.NhSoXUMPK2K}+#{jibdDtF1tAB.NhSoXUMPK2K}+#{kSAEsxbq1v3.NhSoXUMPK2K}+#{ZEQvD8DJa6g.NhSoXUMPK2K}+#{FYO3TF1Y2k3.NhSoXUMPK2K}+#{NSR40bbdMHr.NhSoXUMPK2K}+#{KIHJJlkyiDZ.NhSoXUMPK2K}+#{fLapmacPPFn.NhSoXUMPK2K}+#{BilZg5vO0Pf.NhSoXUMPK2K}+#{ByU3Gd9aDmh.NhSoXUMPK2K}+#{wSFPAmi4aqd.NhSoXUMPK2K}+#{NZoCQGgPdFj.NhSoXUMPK2K}+#{rE0lUqEFCqe.NhSoXUMPK2K}+#{YitEiiFUpku.NhSoXUMPK2K}+#{BuSD0IsQTBA.NhSoXUMPK2K}+#{iDITgYLzOD7.NhSoXUMPK2K}+#{IVdLKFlGSST.NhSoXUMPK2K}+#{aqu3Ngg2wvJ.NhSoXUMPK2K}+#{VKvszpkrfxT.NhSoXUMPK2K}+#{fyTwNAVHyJY.NhSoXUMPK2K}+#{xoNh8hOrKVU.NhSoXUMPK2K}+#{kyU008u8sKN.NhSoXUMPK2K}+#{SKZIVXE0sDo.NhSoXUMPK2K}+#{WOidHO1vrLG.NhSoXUMPK2K}+#{wqTCvOif1Jn.NhSoXUMPK2K}+#{ME6C1Od3OrH.NhSoXUMPK2K}+#{pi6OsoghsbU.NhSoXUMPK2K}+#{Fab79894AZm.NhSoXUMPK2K}+#{v1nikfkOjpH.NhSoXUMPK2K}+#{ixD4GVzHNc7.NhSoXUMPK2K}+#{syOUiJd8s9j.NhSoXUMPK2K}+#{ldZQDawylt9.NhSoXUMPK2K}+#{yqN4DKYHtPP.NhSoXUMPK2K}+#{HRUyRlJ7G7c.NhSoXUMPK2K}+#{ujCQ0yxm8Q6.NhSoXUMPK2K}+#{lNUvpIQ3LEA.NhSoXUMPK2K}+#{sg3ieRfu6Xg.NhSoXUMPK2K}+#{isNcp0vyeC8.NhSoXUMPK2K}+#{Doa6BoB4qoP.NhSoXUMPK2K},1
MOH 730A Abacavir (ABC) 300mg Tabs Quantity Required,qta8HzU3R6N,MOH 730A Abacavir (ABC) 300mg Tabs Quantity Requir,(#{cWzuTozjBUb.YS0bTLh3Q4O}*3)-#{T8vIpv842eX.hC4WAv2wKep},1
MOH 730A Abacavir/Lamivudine (ABC/3TC) 60mg/30mg FDC Tabs Quantity Required,ebj2gF1IU51,MOH 730A Abacavir/Lamivudine (ABC/3TC) 60mg/30mg,(#{VRFyixZiNKq.YS0bTLh3Q4O}*3)-#{v70T2bzhYBH.hC4WAv2wKep},1
MOH 730A Acyclovir 400mg Tabs Quantity Required,WvXKLf2MDjm,MOH 730A Acyclovir 400mg Tabs Quantity Required,(#{fCU7NkQ7egO.YS0bTLh3Q4O}*3)-#{kMTppRz9Dy6.hC4WAv2wKep},1
MOH 730A Amphotericin B 50mg IV Injection Quantity Required,Esh5wxRu0Os,MOH 730A Amphotericin B 50mg IV Injection Quantity,(#{nfjDbwayZ4s.YS0bTLh3Q4O}*3)-#{OzHa7Wm9wWb.hC4WAv2wKep},1
MOH 730A Atazanavir/Ritonavir (ATV/r) 300/100mg tabs Quantity Required,cQl5K5dTM5s,MOH 730A Atazanavir/Ritonavir (ATV/r) 300/100mg ta,(#{AqK0pDHRkop.YS0bTLh3Q4O}*3)-#{HKNzvgOEXdV.hC4WAv2wKep},1
MOH 730A Cotrimoxazole 960mg Tabs (for Pack of 100 tabs) Quantity Required,WdH9qLMnhFj,MOH 730A Cotrimoxazole 960mg Tabs (for Pack of 100,(#{HUgqq26kDtr.YS0bTLh3Q4O}*3)-#{zX3RWIpPsU5.hC4WAv2wKep},1
MOH 730A Cotrimoxazole 960mg Tabs (for Pack of 500 tabs) Quantity Required,U3EG8a8jYtK,MOH 730A Cotrimoxazole 960mg Tabs (for Pack of 500,(#{kys6ug1qM84.YS0bTLh3Q4O}*3)-#{anJTqZAje6a.hC4WAv2wKep},1
MOH 730A Cotrimoxazole Suspension 240mg/5ml Quantity Required,fGxczRODhzz,MOH 730A Cotrimoxazole Suspension 240mg/5ml Quanti,(#{Gy2ZzJ3KmeP.YS0bTLh3Q4O}*3)-#{Ptvb1N5gQ54.hC4WAv2wKep},1
MOH 730A Dapsone 100mg Tabs (for Pack of 100 tabs) Quantity Required,gXum2akYVUq,MOH 730A Dapsone 100mg Tabs (for Pack of 100 tabs),(#{eM1HEGwGk3v.YS0bTLh3Q4O}*3)-#{g2J7NpW2ZM8.hC4WAv2wKep},1
MOH 730A Dapsone 100mg Tabs (for Pack of 1000 tabs) Quantity Required,NBeg84agViS,MOH 730A Dapsone 100mg Tabs (for Pack of 1000 tabs,(#{Ql68yXdB6hp.YS0bTLh3Q4O}*3)-#{ZcZwhTRfWkK.hC4WAv2wKep},1
MOH 730A Darunavir (DRV) 150mg Tabs Quantity Required,UkN3R5zEWiR,MOH 730A Darunavir (DRV) 150mg Tabs Quantity Requi,(#{FfZQ3UNST1x.YS0bTLh3Q4O}*3)-#{onTjG9ODh1k.hC4WAv2wKep},1
MOH 730A Darunavir (DRV) 600mg tabs Quantity Required,ugCV2tyS4bZ,MOH 730A Darunavir (DRV) 600mg tabs Quantity Requi,(#{OacLjYDR3Il.YS0bTLh3Q4O}*3)-#{BDKBvFhIQJf.hC4WAv2wKep},1
MOH 730A Darunavir (DRV) 75mg Tabs Quantity Required,aiIRN4gMMJr,MOH 730A Darunavir (DRV) 75mg Tabs Quantity Requir,(#{pZzARIwJbxo.YS0bTLh3Q4O}*3)-#{bZplX60YbPf.hC4WAv2wKep},1
MOH 730A Darunavir (DRV) susp 100mg/ml Quantity Required,sMAK1cfYdxi,MOH 730A Darunavir (DRV) susp 100mg/ml Quantity Re,(#{cn6LzRf2hyu.YS0bTLh3Q4O}*3)-#{wxA11VC6wRx.hC4WAv2wKep},1
MOH 730A Diflucan 200mg Tabs Quantity Required,WxtTX5VPCZS,MOH 730A Diflucan 200mg Tabs Quantity Required,(#{WzN4siZiJPD.YS0bTLh3Q4O}*3)-#{U3PLl3ULQt8.hC4WAv2wKep},1
MOH 730A Diflucan IV Infusion 2mg/ml Quantity Required,yEE6glDCXcC,MOH 730A Diflucan IV Infusion 2mg/ml Quantity Requ,(#{eKlDRNeQjyH.YS0bTLh3Q4O}*3)-#{piEFmBh6Uql.hC4WAv2wKep},1
MOH 730A Diflucan Suspension 50mg/5ml Quantity Required,bG990dDWGIm,MOH 730A Diflucan Suspension 50mg/5ml Quantity Req,(#{sYnSgRVCFYA.YS0bTLh3Q4O}*3)-#{zbrSNo8bSST.hC4WAv2wKep},1
MOH 730A Efavirenz (EFV) 200mg Tabs Quantity Required,GYZR2tHRbyW,MOH 730A Efavirenz (EFV) 200mg Tabs Quantity Requi,(#{iPjFiQJ13HN.YS0bTLh3Q4O}*3)-#{UMqyIpzJRCJ.hC4WAv2wKep},1
MOH 730A Efavirenz (EFV) 600mg Tabs Quantity Required,IaiZUTgMat2,MOH 730A Efavirenz (EFV) 600mg Tabs Quantity Requi,(#{B8QWYS3EJqZ.YS0bTLh3Q4O}*3)-#{ugsQqSyyZy2.hC4WAv2wKep},1
MOH 730A Etravirine (ETV) 100mg tabs Quantity Required,ZhHZvde3k75,MOH 730A Etravirine (ETV) 100mg tabs Quantity Requ,(#{Mf64ObujNcj.YS0bTLh3Q4O}*3)-#{wFFhejJhg1B.hC4WAv2wKep},1
MOH 730A Etravirine (ETV) 200mg tabs Quantity Required,KEwW4cfbCVa,MOH 730A Etravirine (ETV) 200mg tabs Quantity Requ,(#{RLZg91zBBJu.YS0bTLh3Q4O}*3)-#{LI1E9Xrvpwr.hC4WAv2wKep},1
MOH 730A Etravirine (ETV) 25mg tabs Quantity Required,AIInSLuuJmc,MOH 730A Etravirine (ETV) 25mg tabs Quantity Requi,(#{aNq0Dcj4SSu.YS0bTLh3Q4O}*3)-#{fWTJUSnntn6.hC4WAv2wKep},1
MOH 730A Fluconazole 200mg Tabs Quantity Required,EC5EW0rX6lZ,MOH 730A Fluconazole 200mg Tabs Quantity Required,(#{U5fGoqB4cNy.YS0bTLh3Q4O}*3)-#{HkZ39x8BCEK.hC4WAv2wKep},1
MOH 730A Isoniazid (H) 100mg tabs Quantity Required,xYg6ATVxgLr,MOH 730A Isoniazid (H) 100mg tabs Quantity Require,(#{s7bYJGXvjD5.YS0bTLh3Q4O}*3)-#{siZ3FslqDHV.hC4WAv2wKep},1
MOH 730A Isoniazid (H) 300mg Tabs (for Pack of 100 tabs) Quantity Required,BIgQhfAUfch,MOH 730A Isoniazid (H) 300mg Tabs (for Pack of 100,(#{UVibZfH0On0.YS0bTLh3Q4O}*3)-#{ymWk2uW4f1s.hC4WAv2wKep},1
MOH 730A Isoniazid (H) 300mg Tabs (for Pack of 672 tabs) Quantity Required,mQnpibIrzVi,MOH 730A Isoniazid (H) 300mg Tabs (for Pack of 672,(#{mrp5wgn0b1a.YS0bTLh3Q4O}*3)-#{y8vOQhrlRLj.hC4WAv2wKep},1
MOH 730A Lamivudine (3TC) 150mg Tabs Quantity Required,RvDOuQoA3BC,MOH 730A Lamivudine (3TC) 150mg Tabs Quantity Requ,(#{Ps9oJAmKFkg.YS0bTLh3Q4O}*3)-#{iKalfg97rtZ.hC4WAv2wKep},1
MOH 730A Lamivudine (3TC) liquid 10mg/ml Quantity Required,ymWpL733i5Y,MOH 730A Lamivudine (3TC) liquid 10mg/ml Quantity,(#{doDTLd8jMF9.YS0bTLh3Q4O}*3)-#{r9fSbflgQgC.hC4WAv2wKep},1
MOH 730A Lopinavir/ritonavir (LPV/r) 200/50mg Tabs Quantity Required,Ylsrxs02QD1,MOH 730A Lopinavir/ritonavir (LPV/r) 200/50mg Tabs,(#{fDZu3xtV92b.YS0bTLh3Q4O}*3)-#{VJ9VJ6dxwVD.hC4WAv2wKep},1
MOH 730A Lopinavir/ritonavir (LPV/r) liquid 80/20mg/ml Quantity Required,QYr8UJYaVev,MOH 730A Lopinavir/ritonavir (LPV/r) liquid 80/20m,(#{YQX1UdOAzRq.YS0bTLh3Q4O}*3)-#{OnFFuii2sYi.hC4WAv2wKep},1
MOH 730A Nevirapine (NVP) 200mg Tabs Quantity Required,KjA3pcDLtPC,MOH 730A Nevirapine (NVP) 200mg Tabs Quantity Requ,(#{PAmdoz5hPPQ.YS0bTLh3Q4O}*3)-#{JrfpoCr2vII.hC4WAv2wKep},1
MOH 730A Nevirapine (NVP) Susp 10mg/ml Quantity Required,TuadPP5C7q6,MOH 730A Nevirapine (NVP) Susp 10mg/ml Quantity Re,(#{DXeeHS2yDKf.YS0bTLh3Q4O}*3)-#{rNmSAnjCmWK.hC4WAv2wKep},1
MOH 730A Pyridoxine 25mg Tabs Quantity Required,sWoW8b8kZG1,MOH 730A Pyridoxine 25mg Tabs Quantity Required,(#{cKTjRDIAujO.YS0bTLh3Q4O}*3)-#{AUsGmP0j5eC.hC4WAv2wKep},1
MOH 730A Pyridoxine 50mg Tabs Quantity Required,RjTpSgEWK0s,MOH 730A Pyridoxine 50mg Tabs Quantity Required,(#{H0jATZHahed.YS0bTLh3Q4O}*3)-#{wWKgpcMkHnJ.hC4WAv2wKep},1
MOH 730A Pyridoxine 50mg Tabs Quantity Required,tLVRJYoCqSs,MOH 730A Pyridoxine 50mg Tabs Quantity Required,(#{H0jATZHahed.YS0bTLh3Q4O}*3)-#{wWKgpcMkHnJ.hC4WAv2wKep},1
MOH 730A Raltegravir (RAL) 100mg tabs Quantity Required,PiyTAQaOI3B,MOH 730A Raltegravir (RAL) 100mg tabs Quantity Req,(#{tUwIDx2oFjO.YS0bTLh3Q4O}*3)-#{pCPSqHPI4iN.hC4WAv2wKep},1
MOH 730A Raltegravir (RAL) 25mg tabs Quantity Required,MpbVc7SglEO,MOH 730A Raltegravir (RAL) 25mg tabs Quantity Requ,(#{L2IwQNujxtP.YS0bTLh3Q4O}*3)-#{kwhxIWspmVw.hC4WAv2wKep},1
MOH 730A Raltegravir (RAL) 400mg tabs Quantity Required,VYBkgepUrTd,MOH 730A Raltegravir (RAL) 400mg tabs Quantity Req,(#{knkLSijGwES.YS0bTLh3Q4O}*3)-#{VfUQzXlpKQl.hC4WAv2wKep},1
MOH 730A Ritonavir (RTV) 100mg tabs Quantity Required,N3Jt0YsMVoG,MOH 730A Ritonavir (RTV) 100mg tabs Quantity Requi,(#{KC0hUg3FCmM.YS0bTLh3Q4O}*3)-#{xUayEnX8Blt.hC4WAv2wKep},1
MOH 730A Ritonavir (RTV) liquid 80mg/ml Quantity Required,RYoY2KIOmcP,MOH 730A Ritonavir (RTV) liquid 80mg/ml Quantity R,(#{H6pU48yXxLu.YS0bTLh3Q4O}*3)-#{NWL4ULZezMy.hC4WAv2wKep},1
MOH 730A Tenofovir (TDF) 300mg Tabs Quantity Required,rjxkwwOMV01,MOH 730A Tenofovir (TDF) 300mg Tabs Quantity Requi,(#{slIsNAnY5WS.YS0bTLh3Q4O}*3)-#{u66LdVsKCvV.hC4WAv2wKep},1
MOH 730A Tenofovir/Lamivudine (TDF/3TC) FDC (300/300mg) Tabs Quantity Required,GkGs8gBiiOY,MOH 730A Tenofovir/Lamivudine (TDF/3TC) FDC (300/3,(#{yUt1DYxSUNy.YS0bTLh3Q4O}*3)-#{aYXQcIen2Wl.hC4WAv2wKep},1
MOH 730A Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/600mg) Tabs Quantity Required,W5Cc2iJUrJX,MOH 730A Tenofovir/Lamivudine/Efavirenz (TDF/3TC/E,(#{EIWAIlQBKU6.YS0bTLh3Q4O}*3)-#{LK4JkwJDx2c.hC4WAv2wKep},1
MOH 730A Zidovudine/Lamivudine (AZT/3TC) FDC (300/150mg) Tabs Quantity Required,dT45nP0KYGp,MOH 730A Zidovudine/Lamivudine (AZT/3TC) FDC (300/,(#{fFYWgW7OUjv.YS0bTLh3Q4O}*3)-#{ijmmJw97V6g.hC4WAv2wKep},1
MOH 730A Zidovudine/Lamivudine (AZT/3TC) FDC (60/30mg) Tabs Quantity Required,O4bEKXjn7yO,MOH 730A Zidovudine/Lamivudine (AZT/3TC) FDC (60/3,(#{yJYXWEpLfcZ.YS0bTLh3Q4O}*3)-#{eb9fVoSbFIr.hC4WAv2wKep},1
MOH 730A Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (300/150/200mg) Tabs Quantity Required,uly0BTFX0AQ,MOH 730A Zidovudine/Lamivudine/Nevirapine (AZT/3TC,(#{vVwNDHLP9NT.YS0bTLh3Q4O}*3)-#{c4V5Fav5ovZ.hC4WAv2wKep},1
MOH 730A Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (60/30/50mg) tabs Quantity Required,T9CnfyrkZpM,MOH 730A Zidovudine/Lamivudine/Nevirapine (AZT/3TC,(#{C5WLL3Js7oC.YS0bTLh3Q4O}*3)-#{in4iMk8Fjj1.hC4WAv2wKep},1
MOH 730Ba Abacavir (ABC) 300mg Tabs Quantity Required,xzNuJKZyNER,MOH 730Ba Abacavir (ABC) 300mg T Quantity Required,(#{cWzuTozjBUb.YS0bTLh3Q4O}*2)-#{cWzuTozjBUb.D7WnuXFK7PR},1
MOH 730Ba Abacavir/Lamivudine (ABC/3TC) 60mg/30mg FDC Tabs Quantity Required,sWQpQqvjHCz,MOH 730Ba Abacavir/Lamivudine (ABC/3TC) 60mg/30mg,(#{VRFyixZiNKq.YS0bTLh3Q4O}*2)-#{VRFyixZiNKq.D7WnuXFK7PR},1
MOH 730Ba Acyclovir 400mg Tabs Quantity Required,f2vdBV321gZ,MOH 730Ba Acyclovir 400mg Tabs Quantity Required,(#{fCU7NkQ7egO.YS0bTLh3Q4O}*2)-#{fCU7NkQ7egO.D7WnuXFK7PR},1
MOH 730Ba Amphotericin B 50mg IV Injection Quantity Required,Pd81ho48pH1,MOH 730Ba Amphotericin B 50mg IV Quantity Required,(#{nfjDbwayZ4s.YS0bTLh3Q4O}*2)-#{nfjDbwayZ4s.D7WnuXFK7PR},1
MOH 730Ba Atazanavir/Ritonavir (ATV/r) 300/100mg tabs Quantity Required,TQBTyWl69T3,MOH 730Ba Atazanavir/Ritonavir ( Quantity Required,(#{AqK0pDHRkop.YS0bTLh3Q4O}*2)-#{AqK0pDHRkop.D7WnuXFK7PR},1
MOH 730Ba Atazanavir/Ritonavir (ATV/r) 300/100mg tabs Quantity Required,WWpt84C0kWH,MOH 730Ba Atazanavir/Ritonavir ( Quantity Required,(#{AqK0pDHRkop.YS0bTLh3Q4O}*2)-#{AqK0pDHRkop.D7WnuXFK7PR},1
MOH 730Ba Cotrimoxazole 960mg Tabs (for Pack of 100 tabs) Quantity Required,F0RjXg6PgC3,MOH 730Ba Cotrimoxazole 960mg Tabs (for Pack of 10,(#{HUgqq26kDtr.YS0bTLh3Q4O}*2)-#{HUgqq26kDtr.D7WnuXFK7PR},1
MOH 730Ba Cotrimoxazole 960mg Tabs (for Pack of 500 tabs) Quantity Required,hk6y4eLAHsh,MOH 730Ba Cotrimoxazole 960mg Tabs (for Pack of 50,(#{kys6ug1qM84.YS0bTLh3Q4O}*2)-#{kys6ug1qM84.D7WnuXFK7PR},1
MOH 730Ba Cotrimoxazole Suspension 240mg/5ml Quantity Required,BWet5D2cPHe,MOH 730Ba Cotrimoxazole Suspension 240mg/5ml Quant,(#{Gy2ZzJ3KmeP.YS0bTLh3Q4O}*2)-#{Gy2ZzJ3KmeP.D7WnuXFK7PR},1
MOH 730Ba Dapsone 100mg Tabs (for Pack of 100 tabs) Quantity Required,lgjPXu2tGln,MOH 730Ba Dapsone 100mg Tabs (for Pack of 100 tabs,(#{eM1HEGwGk3v.YS0bTLh3Q4O}*2)-#{eM1HEGwGk3v.D7WnuXFK7PR},1
MOH 730Ba Dapsone 100mg Tabs (for Pack of 1000 tabs) Quantity Required,jIelnnREVpS,MOH 730Ba Dapsone 100mg Tabs (for Pack of 1000 tab,(#{Ql68yXdB6hp.YS0bTLh3Q4O}*2)-#{Ql68yXdB6hp.D7WnuXFK7PR},1
MOH 730Ba Darunavir (DRV) 150mg Tabs Quantity Required,ZSKpwuQDSg6,MOH 730Ba Darunavir (DRV) 150mg Tabs Quantity Requ,(#{FfZQ3UNST1x.YS0bTLh3Q4O}*2)-#{FfZQ3UNST1x.D7WnuXFK7PR},1
MOH 730Ba Darunavir (DRV) 600mg tabs Quantity Required,W50mk4WrtuW,MOH 730Ba Darunavir (DRV) 600mg tabs Quantity Requ,(#{OacLjYDR3Il.YS0bTLh3Q4O}*2)-#{OacLjYDR3Il.D7WnuXFK7PR},1
MOH 730Ba Darunavir (DRV) 75mg Tabs Quantity Required,ZXiRQqAtzcD,MOH 730Ba Darunavir (DRV) 75mg Tabs Quantity Requi,(#{pZzARIwJbxo.YS0bTLh3Q4O}*2)-#{pZzARIwJbxo.D7WnuXFK7PR},1
MOH 730Ba Darunavir (DRV) susp 100mg/ml Quantity Required,D322p81ojHQ,MOH 730Ba Darunavir (DRV) susp 100mg/ml Quantity R,(#{cn6LzRf2hyu.YS0bTLh3Q4O}*2)-#{cn6LzRf2hyu.D7WnuXFK7PR},1
MOH 730Ba Diflucan 200mg Tabs Quantity Required,Sdn23ugsxSQ,MOH 730Ba Diflucan 200mg Tabs Quantity Required,(#{WzN4siZiJPD.YS0bTLh3Q4O}*2)-#{WzN4siZiJPD.D7WnuXFK7PR},1
MOH 730Ba Diflucan IV Infusion 2mg/ml Quantity Required,eqYt14MOtbT,MOH 730Ba Diflucan IV Infusion 2 Quantity Required,(#{eKlDRNeQjyH.YS0bTLh3Q4O}*2)-#{eKlDRNeQjyH.D7WnuXFK7PR},1
MOH 730Ba Diflucan Suspension 50mg/5ml Quantity Required,EIyvwZ643pp,MOH 730Ba Diflucan Suspension 50mg/5ml Quantity Re,(#{sYnSgRVCFYA.YS0bTLh3Q4O}*2)-#{sYnSgRVCFYA.D7WnuXFK7PR},1
MOH 730Ba Efavirenz (EFV) 200mg Tabs Quantity Required,hRPBm8uLFcH,MOH 730Ba Efavirenz (EFV) 200mg Tabs Quantity,(#{iPjFiQJ13HN.YS0bTLh3Q4O}*2)-#{iPjFiQJ13HN.D7WnuXFK7PR},1
MOH 730Ba Efavirenz (EFV) 600mg Tabs Quantity Required,mKfEKGXTLDT,MOH 730Ba Efavirenz (EFV) 600mg  Quantity Required,(#{B8QWYS3EJqZ.YS0bTLh3Q4O}*2)-#{B8QWYS3EJqZ.D7WnuXFK7PR},1
MOH 730Ba Etravirine (ETV) 100mg tabs Quantity Required,G5rbDSB6jzu,MOH 730Ba Etravirine (ETV) 100mg tabs Quantity Req,(#{Mf64ObujNcj.YS0bTLh3Q4O}*2)-#{Mf64ObujNcj.D7WnuXFK7PR},1
MOH 730Ba Etravirine (ETV) 200mg tabs Quantity Required,j44Xaf7AlAR,MOH 730Ba Etravirine (ETV) 200mg tabs Quantity Req,(#{RLZg91zBBJu.YS0bTLh3Q4O}*2)-#{RLZg91zBBJu.D7WnuXFK7PR},1
MOH 730Ba Etravirine (ETV) 25mg tabs Quantity Required,mVKgWCo4ru4,MOH 730Ba Etravirine (ETV) 25mg tabs Quantity Requ,(#{aNq0Dcj4SSu.YS0bTLh3Q4O}*2)-#{aNq0Dcj4SSu.D7WnuXFK7PR},1
MOH 730Ba Etravirine (ETV) 25mg tabs Quantity Required,xKlSpy5Xgs8,MOH 730Ba Etravirine (ETV) 25mg tabs Quantity Requ,(#{aNq0Dcj4SSu.YS0bTLh3Q4O}*2)-#{aNq0Dcj4SSu.D7WnuXFK7PR},1
MOH 730Ba Fluconazole 200mg Tabs Quantity Required,BRdXxYi4OLP,MOH 730Ba Fluconazole 200mg Tabs Quantity Required,(#{U5fGoqB4cNy.YS0bTLh3Q4O}*2)-#{U5fGoqB4cNy.D7WnuXFK7PR},1
MOH 730Ba Fluconazole 200mg Tabs Quantity Required,JWnn6B6IoHI,MOH 730Ba Fluconazole 200mg Tabs Quantity Required,(#{U5fGoqB4cNy.YS0bTLh3Q4O}*2)-#{U5fGoqB4cNy.D7WnuXFK7PR},1
MOH 730Ba Isoniazid (H) 100mg tabs Quantity Required,phvQfcpzWJC,MOH 730Ba Isoniazid (H) 100mg tabs Quantity Requir,(#{s7bYJGXvjD5.YS0bTLh3Q4O}*2)-#{s7bYJGXvjD5.D7WnuXFK7PR},1
MOH 730Ba Isoniazid (H) 300mg Tabs (for Pack of 100 tabs) Quantity Required,WU4CzYAMJvt,MOH 730Ba Isoniazid (H) 300mg Tabs (for Pack of 10,(#{UVibZfH0On0.YS0bTLh3Q4O}*2)-#{UVibZfH0On0.D7WnuXFK7PR},1
MOH 730Ba Isoniazid (H) 300mg Tabs (for Pack of 672 tabs) Quantity Required,ArqITfvluOj,MOH 730Ba Isoniazid (H) 300mg Tabs (for Pack of 67,(#{mrp5wgn0b1a.YS0bTLh3Q4O}*2)-#{mrp5wgn0b1a.D7WnuXFK7PR},1
MOH 730Ba Lamivudine (3TC) 150mg Tabs Quantity Required,jkkRUQMlCZw,MOH 730Ba Lamivudine (3TC) 150mg Quantity Required,(#{Ps9oJAmKFkg.YS0bTLh3Q4O}*2)-#{Ps9oJAmKFkg.D7WnuXFK7PR},1
MOH 730Ba Lamivudine (3TC) liquid 10mg/ml Quantity Required,YiHR4C1OyKF,MOH 730Ba Lamivudine (3TC) liqui Quantity Required,(#{doDTLd8jMF9.YS0bTLh3Q4O}*2)-#{doDTLd8jMF9.D7WnuXFK7PR},1
MOH 730Ba Lopinavir/ritonavir (LPV/r) 200/50mg Tabs Quantity Required,jwH61BXf5P3,MOH 730Ba Lopinavir/ritonavir (LPV/r) 200/50mg Tab,(#{fDZu3xtV92b.YS0bTLh3Q4O}*2)-#{fDZu3xtV92b.D7WnuXFK7PR},1
MOH 730Ba Lopinavir/ritonavir (LPV/r) liquid 80/20mg/ml Quantity Required,XHr2AWvrvy0,MOH 730Ba Lopinavir/ritonavir (L Quantity Required,(#{YQX1UdOAzRq.YS0bTLh3Q4O}*2)-#{YQX1UdOAzRq.D7WnuXFK7PR},1
MOH 730Ba Nevirapine (NVP) 200mg Tabs Quantity Required,Trd9QkOl2WK,MOH 730Ba Nevirapine (NVP) 200mg Tabs Quantity Req,(#{PAmdoz5hPPQ.YS0bTLh3Q4O}*2)-#{PAmdoz5hPPQ.D7WnuXFK7PR},1
MOH 730Ba Nevirapine (NVP) Susp 10mg/ml Quantity Required,doj8dm8FOBV,MOH 730Ba Nevirapine (NVP) Susp 10mg/ml,(#{DXeeHS2yDKf.YS0bTLh3Q4O}*2)-#{DXeeHS2yDKf.D7WnuXFK7PR},1
MOH 730Ba Pyridoxine 25mg Tabs Quantity Required,mgZ7fYHAV4L,MOH 730Ba Pyridoxine 25mg Tabs Quantity Required,(#{cKTjRDIAujO.YS0bTLh3Q4O}*2)-#{cKTjRDIAujO.D7WnuXFK7PR},1
MOH 730Ba Pyridoxine 50mg Tabs Quantity Required,xSJwR444vpe,MOH 730Ba Pyridoxine 50mg Tabs Quantity Required,(#{H0jATZHahed.YS0bTLh3Q4O}*2)-#{H0jATZHahed.D7WnuXFK7PR},1
MOH 730Ba Raltegravir (RAL) 100mg tabs Quantity Required,PHQXlPOxQYl,MOH 730Ba Raltegravir (RAL) 100mg tabs Quantity Re,(#{tUwIDx2oFjO.YS0bTLh3Q4O}*2)-#{tUwIDx2oFjO.D7WnuXFK7PR},1
MOH 730Ba Raltegravir (RAL) 25mg tabs Quantity Required,jgUHBbpQeFk,MOH 730Ba Raltegravir (RAL) 25mg tabs Quantity Req,(#{L2IwQNujxtP.YS0bTLh3Q4O}*2)-#{L2IwQNujxtP.D7WnuXFK7PR},1
MOH 730Ba Raltegravir (RAL) 400mg tabs Quantity Required,NjnWIfixuaX,MOH 730Ba Raltegravir (RAL) 400mg tabs Quantity Re,(#{knkLSijGwES.YS0bTLh3Q4O}*2)-#{knkLSijGwES.D7WnuXFK7PR},1
MOH 730Ba Ritonavir (RTV) 100mg tabs Quantity Required,dN4IFqc3OZe,MOH 730Ba Ritonavir (RTV) 100mg tabs Quantity Requ,(#{KC0hUg3FCmM.YS0bTLh3Q4O}*2)-#{KC0hUg3FCmM.D7WnuXFK7PR},1
MOH 730Ba Ritonavir (RTV) liquid 80mg/ml Quantity Required,UkgTjcNiNUX,MOH 730Ba Ritonavir (RTV) liquid 80mg/ml Quantity,(#{H6pU48yXxLu.YS0bTLh3Q4O}*2)-#{H6pU48yXxLu.D7WnuXFK7PR},1
MOH 730Ba Tenofovir (TDF) 300mg Tabs Quantity Required,A1yLvYomOz3,MOH 730Ba Tenofovir (TDF) 300mg Tabs Quantity Requ,(#{slIsNAnY5WS.YS0bTLh3Q4O}*2)-#{slIsNAnY5WS.D7WnuXFK7PR},1
MOH 730Ba Tenofovir/Lamivudine (TDF/3TC) FDC (300/300mg) Tabs Quantity Required,SeuefYGBOGg,MOH 730Ba Tenofovir/Lamivudine ( Quantity Required,(#{yUt1DYxSUNy.YS0bTLh3Q4O}*2)-#{yUt1DYxSUNy.D7WnuXFK7PR},1
MOH 730Ba Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/600mg) Tabs Quantity Required,ZROhmzWv2XW,MOH 730Ba Tenofovir/Lamivudine/Efavirenz,(#{EIWAIlQBKU6.YS0bTLh3Q4O}*2)-#{EIWAIlQBKU6.D7WnuXFK7PR},1
MOH 730Ba Zidovudine/Lamivudine (AZT/3TC) FDC (300/150mg) Tabs Quantity Required,RvtRvr6llHy,MOH 730Ba Zidovudine/Lamivudine  Quantity Required,(#{fFYWgW7OUjv.YS0bTLh3Q4O}*2)-#{fFYWgW7OUjv.D7WnuXFK7PR},1
MOH 730Ba Zidovudine/Lamivudine (AZT/3TC) FDC (60/30mg) Tabs Quantity Required,HWa4i1g8ltm,MOH 730Ba Zidovudine/Lamivudine  Quantity Required,(#{yJYXWEpLfcZ.YS0bTLh3Q4O}*2)-#{yJYXWEpLfcZ.D7WnuXFK7PR},1
MOH 730Ba Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (300/150/200mg) Tabs Quantity Required,UYABfY02Ba7,MOH 730Ba Zidovudine/Lamivudine/ Quantity Required,(#{vVwNDHLP9NT.YS0bTLh3Q4O}*2)-#{vVwNDHLP9NT.D7WnuXFK7PR},1
MOH 730Ba Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (60/30/50mg) tabs Quantity Required,MIuwjOYAy4t,MOH 730Ba Zidovudine/Lamivudine/ Quantity Required,(#{C5WLL3Js7oC.YS0bTLh3Q4O}*2)-#{C5WLL3Js7oC.D7WnuXFK7PR},1
MOH 730Bb Abacavir (ABC) 300mg Tabs Quantity Required,Fc7RQKFTXtm,MOH 730Bb Abacavir (ABC) 300mg Tabs Quantity Requi,(#{cWzuTozjBUb.YS0bTLh3Q4O}*3)-#{cWzuTozjBUb.D7WnuXFK7PR},1
MOH 730Bb Abacavir/Lamivudine (ABC/3TC) 60mg/30mg FDC Tabs Quantity Required,XuIZ0dMGnGt,MOH 730Bb Abacavir/Lamivudine (ABC/3TC) 60mg/30mg,(#{VRFyixZiNKq.YS0bTLh3Q4O}*3)-#{VRFyixZiNKq.D7WnuXFK7PR},1
MOH 730Bb Acyclovir 400mg Tabs Quantity Required,ebFkM2M95jT,MOH 730Bb Acyclovir 400mg Tabs Quantity Required,(#{fCU7NkQ7egO.YS0bTLh3Q4O}*3)-#{fCU7NkQ7egO.D7WnuXFK7PR},1
MOH 730Bb Amphotericin B 50mg IV Injection Quantity Required,YO56ukB8TtP,MOH 730Bb Amphotericin B 50mg IV Injection Quantit,(#{nfjDbwayZ4s.YS0bTLh3Q4O}*3)-#{nfjDbwayZ4s.D7WnuXFK7PR},1
MOH 730Bb Atazanavir/Ritonavir (ATV/r) 300/100mg tabs Quantity Required,cPpvVY9H1RF,MOH 730Bb  Atazanavir/Ritonavir (ATV/r) 300/100mg,(#{AqK0pDHRkop.YS0bTLh3Q4O}*3)-#{AqK0pDHRkop.D7WnuXFK7PR},1
MOH 730Bb Cotrimoxazole 960mg Tabs (for Pack of 100 tabs) Quantity Required,RoDwv5XO88B,MOH 730Bb Cotrimoxazole 960mg Tabs (for Pack of 10,(#{HUgqq26kDtr.YS0bTLh3Q4O}*3)-#{HUgqq26kDtr.D7WnuXFK7PR},1
MOH 730Bb Cotrimoxazole 960mg Tabs (for Pack of 500 tabs Quantity Required,yK01glupXmO,MOH 730Bb Cotrimoxazole 960mg Tabs (for Pack of 50,"(#{kys6ug1qM84.YS0bTLh3Q4O}*3)-
#{kys6ug1qM84.D7WnuXFK7PR}",1
MOH 730Bb Cotrimoxazole Suspension 240mg/5ml Quantity Required,MlDijc8RfyC,MOH 730Bb Cotrimoxazole Suspension 240mg/5ml Quant,(#{Gy2ZzJ3KmeP.YS0bTLh3Q4O}*3)-#{Gy2ZzJ3KmeP.D7WnuXFK7PR},1
MOH 730Bb Dapsone 100mg Tabs (for Pack of 100 tabs) Quantity Required,hsrZflK9D0n,MOH 730Bb Dapsone 100mg Tabs (for Pack of 100 tabs,(#{eM1HEGwGk3v.YS0bTLh3Q4O}*3)-#{eM1HEGwGk3v.D7WnuXFK7PR},1
MOH 730Bb Dapsone 100mg Tabs (for Pack of 1000 tabs) Quantity Required,hD6QKvsaKOs,MOH 730Bb Dapsone 100mg Tabs (for Pack of 1000 tab,(#{Ql68yXdB6hp.YS0bTLh3Q4O}*3)-#{Ql68yXdB6hp.D7WnuXFK7PR},1
MOH 730Bb Darunavir (DRV) 150mg Tabs Quantity Required,Ai7ps1wbRAi,MOH 730Bb Darunavir (DRV) 150mg Tabs Quantity Requ,(#{FfZQ3UNST1x.YS0bTLh3Q4O}*3)-#{FfZQ3UNST1x.D7WnuXFK7PR},1
MOH 730Bb Darunavir (DRV) 600mg tabs Quantity Required,kWjo34dIjB4,MOH 730Bb Darunavir (DRV) 600mg tabs Quantity Requ,(#{OacLjYDR3Il.YS0bTLh3Q4O}*3)-#{OacLjYDR3Il.D7WnuXFK7PR},1
MOH 730Bb Darunavir (DRV) 75mg Tabs Quantity Required,IIYQkp7iyLI,MOH 730Bb Darunavir (DRV) 75mg Tabs Quantity Requi,(#{pZzARIwJbxo.YS0bTLh3Q4O}*3)-#{pZzARIwJbxo.D7WnuXFK7PR},1
MOH 730Bb Darunavir (DRV) susp 100mg/ml Quantity Required,bKVn06RQbYm,MOH 730Bb Darunavir (DRV) susp 100mg/ml Quantity R,(#{cn6LzRf2hyu.YS0bTLh3Q4O}*3)-#{cn6LzRf2hyu.D7WnuXFK7PR},1
MOH 730Bb Diflucan 200mg Tabs Quantity Required,M806Tv6bsrH,MOH 730Bb Diflucan 200mg Tabs Quantity Required,(#{WzN4siZiJPD.YS0bTLh3Q4O}*3)-#{WzN4siZiJPD.D7WnuXFK7PR},1
MOH 730Bb Diflucan IV Infusion 2mg/ml Quantity Required,oRD8wgYsuwU,MOH 730Bb Diflucan IV Infusion 2 Quantity Required,(#{eKlDRNeQjyH.YS0bTLh3Q4O}*3)-#{eKlDRNeQjyH.D7WnuXFK7PR},1
MOH 730Bb Diflucan Suspension 50mg/5ml Quantity Required,nYHfake6cll,MOH 730Bb Diflucan Suspension 50mg/5ml Quantity Re,(#{sYnSgRVCFYA.YS0bTLh3Q4O}*3)-#{sYnSgRVCFYA.D7WnuXFK7PR},1
MOH 730Bb Efavirenz (EFV) 200mg Tabs Quantity Required,KtDOGpPvH7H,MOH 730Bb Efavirenz (EFV) 200mg Tabs Quantity Requ,(#{iPjFiQJ13HN.YS0bTLh3Q4O}*3)-#{iPjFiQJ13HN.D7WnuXFK7PR},1
MOH 730Bb Efavirenz (EFV) 600mg Tabs Quantity Required,Qo3ckcB1nsZ,MOH 730Bb Efavirenz (EFV) 600mg Tabs Quantity Requ,(#{B8QWYS3EJqZ.YS0bTLh3Q4O}*3)-#{B8QWYS3EJqZ.D7WnuXFK7PR},1
MOH 730Bb Etravirine (ETV) 100mg tabs Quantity Required,H0LVLv9oNJD,MOH 730Bb Etravirine (ETV) 100mg tabs Quantity Req,(#{Mf64ObujNcj.YS0bTLh3Q4O}*3)-#{Mf64ObujNcj.D7WnuXFK7PR},1
MOH 730Bb Etravirine (ETV) 200mg tabs Quantity Required,lcSxmxN4w03,MOH 730Bb Etravirine (ETV) 200mg tabs Quantity Req,(#{RLZg91zBBJu.YS0bTLh3Q4O}*3)-#{RLZg91zBBJu.D7WnuXFK7PR},1
MOH 730Bb Etravirine (ETV) 25mg tabs Quantity Required,b9ZJVJpuDR7,MOH 730Bb Etravirine (ETV) 25mg tabs Quantity Requ,(#{aNq0Dcj4SSu.YS0bTLh3Q4O}*3)-#{aNq0Dcj4SSu.D7WnuXFK7PR},1
MOH 730Bb Fluconazole 200mg Tabs Quantity Required,l72C1CUI8bu,MOH 730Bb Fluconazole 200mg Tabs Quantity Required,(#{U5fGoqB4cNy.YS0bTLh3Q4O}*3)-#{U5fGoqB4cNy.D7WnuXFK7PR},1
MOH 730Bb Isoniazid (H) 100mg tabs Quantity Required,dlmzks1383r,MOH 730Bb Isoniazid (H) 100mg tabs Quantity Requir,(#{s7bYJGXvjD5.YS0bTLh3Q4O}*3)-#{s7bYJGXvjD5.D7WnuXFK7PR},1
MOH 730Bb Isoniazid (H) 300mg Tabs (for Pack of 100 tabs) Quantity Required,Xr0DrKhTT9M,MOH 730Bb Isoniazid (H) 300mg Tabs (for Pack of 10,(#{UVibZfH0On0.YS0bTLh3Q4O}*3)-#{UVibZfH0On0.D7WnuXFK7PR},1
MOH 730Bb Isoniazid (H) 300mg Tabs (for Pack of 672 tabs) Quantity Required,RZvVZZw25Pf,MOH 730Bb  Quantity Required,(#{mrp5wgn0b1a.YS0bTLh3Q4O}*3)-#{mrp5wgn0b1a.D7WnuXFK7PR},1
MOH 730Bb Lamivudine (3TC) 150mg Tabs Quantity Required,q5kiTSXWHX6,MOH 730Bb Lamivudine (3TC) 150mg Tabs Quantity Req,(#{Ps9oJAmKFkg.YS0bTLh3Q4O}*3)-#{Ps9oJAmKFkg.D7WnuXFK7PR},1
MOH 730Bb Lamivudine (3TC) liquid 10mg/ml Quantity Required,jsYnIZWeiqo,MOH 730Bb Lamivudine (3TC) liquid 10mg/ml Quantity,(#{doDTLd8jMF9.YS0bTLh3Q4O}*3)-#{doDTLd8jMF9.D7WnuXFK7PR},1
MOH 730Bb Lopinavir/ritonavir (LPV/r) 200/50mg Tabs Quantity Required,fduRtV6Y5Iy,MOH 730Bb Lopinavir/ritonavir (LPV/r) 200/50mg Tab,(#{fDZu3xtV92b.YS0bTLh3Q4O}*3)-#{fDZu3xtV92b.D7WnuXFK7PR},1
MOH 730Bb Lopinavir/ritonavir (LPV/r) liquid 80/20mg/ml Quantity Required,Hw38Dxs643f,MOH 730Bb Lopinavir/ritonavir (L Quantity Required,(#{YQX1UdOAzRq.LGfBi5YpYbo}*3)-#{YQX1UdOAzRq.D7WnuXFK7PR},1
MOH 730Bb Nevirapine (NVP) 200mg Tabs Quantity Required,h9Q7nObEIUd,MOH 730Bb Nevirapine (NVP) 200mg Tabs Quantity Req,(#{PAmdoz5hPPQ.YS0bTLh3Q4O}*3)-#{PAmdoz5hPPQ.D7WnuXFK7PR},1
MOH 730Bb Nevirapine (NVP) Susp 10mg/ml Quantity Required,l9BGnjIDc53,MOH 730Bb Nevirapine (NVP) Susp 10mg/ml Quantity R,(#{DXeeHS2yDKf.YS0bTLh3Q4O}*3)-#{DXeeHS2yDKf.D7WnuXFK7PR},1
MOH 730Bb Pyridoxine 25mg Tabs Quantity Required,L4ExksQLwc0,MOH 730Bb Pyridoxine 25mg Tabs Quantity Required,(#{cKTjRDIAujO.YS0bTLh3Q4O}*3)-#{cKTjRDIAujO.D7WnuXFK7PR},1
MOH 730Bb Pyridoxine 50mg Tabs Quantity Required,LtnWzAWHclu,MOH 730Bb Pyridoxine 50mg Tabs Quantity Required,(#{H0jATZHahed.YS0bTLh3Q4O}*3)-#{H0jATZHahed.D7WnuXFK7PR},1
MOH 730Bb Raltegravir (RAL) 100mg tabs Quantity Required,AFOLTw9ppnz,MOH 730Bb Raltegravir (RAL) 100mg tabs Quantity Re,(#{tUwIDx2oFjO.YS0bTLh3Q4O}*3)-#{tUwIDx2oFjO.D7WnuXFK7PR},1
MOH 730Bb Raltegravir (RAL) 25mg tabs Quantity Required,lgaH1H7kYPM,MOH 730Bb Raltegravir (RAL) 25mg tabs Quantity Req,(#{L2IwQNujxtP.YS0bTLh3Q4O}*3)-#{L2IwQNujxtP.D7WnuXFK7PR},1
MOH 730Bb Raltegravir (RAL) 400mg tabs Quantity Required,Qj5HMdMuv3V,MOH 730Bb Raltegravir (RAL) 400mg tabs Quantity Re,(#{knkLSijGwES.YS0bTLh3Q4O}*3)-#{knkLSijGwES.D7WnuXFK7PR},1
MOH 730Bb Ritonavir (RTV) 100mg tabs Quantity Required,WJRxfoJH2E7,MOH 730Bb Ritonavir (RTV) 100mg tabs Quantity Requ,(#{KC0hUg3FCmM.YS0bTLh3Q4O}*3)-#{KC0hUg3FCmM.D7WnuXFK7PR},1
MOH 730Bb Ritonavir (RTV) liquid 80mg/ml Quantity Required,WZjsCjdZsz8,MOH 730Bb Ritonavir (RTV) liquid 80mg/ml Quantity,(#{H6pU48yXxLu.YS0bTLh3Q4O}*3)-#{H6pU48yXxLu.D7WnuXFK7PR},1
MOH 730Bb Tenofovir (TDF) 300mg Tabs Quantity Required,rSF3xSPb3DZ,MOH 730Bb Tenofovir (TDF) 300mg Tabs Quantity Requ,(#{slIsNAnY5WS.YS0bTLh3Q4O}*3)-#{slIsNAnY5WS.D7WnuXFK7PR},1
MOH 730Bb Tenofovir/Lamivudine (TDF/3TC) FDC (300/300mg) Tabs Quantity Required,NKAVjoFDgQE,MOH 730Bb Tenofovir/Lamivudine ( Quantity Required,(#{yUt1DYxSUNy.YS0bTLh3Q4O}*3)-#{yUt1DYxSUNy.D7WnuXFK7PR},1
MOH 730Bb Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/600mg) Tabs Quantity Required,C1yAK22kMsV,MOH 730Bb Tenofovir/Lamivudine/Efavirenz (TDF/3TC/,(#{EIWAIlQBKU6.YS0bTLh3Q4O}*3)-#{EIWAIlQBKU6.D7WnuXFK7PR},1
MOH 730Bb Zidovudine/Lamivudine (AZT/3TC) FDC (300/150mg) Tabs Quantity Required,KEB50uBDZsa,MOH 730Bb Zidovudine/Lamivudine (AZT/3TC) FDC (300,(#{fFYWgW7OUjv.YS0bTLh3Q4O}*3)-#{fFYWgW7OUjv.D7WnuXFK7PR},1
MOH 730Bb Zidovudine/Lamivudine (AZT/3TC) FDC (60/30mg) Tabs Quantity Required,OJ0HaDG6bja,MOH 730Bb Zidovudine/Lamivudine (AZT/3TC) FDC (60/,(#{yJYXWEpLfcZ.YS0bTLh3Q4O}*3)-#{yJYXWEpLfcZ.D7WnuXFK7PR},1
MOH 730Bb Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (300/150/200mg) Tabs Quantity Required,JZSZxAVSC5o,MOH 730Bb Zidovudine/Lamivudine/Nevirapine (AZT/3T,(#{vVwNDHLP9NT.YS0bTLh3Q4O}*3)-#{vVwNDHLP9NT.D7WnuXFK7PR},1
MOH 730Bb Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (60/30/50mg) tabs Quantity Required,qdFqr6sLvpH,MOH 730Bb Zidovudine/Lamivudine/Nevirapine (AZT/3T,(#{C5WLL3Js7oC.LGfBi5YpYbo}*3)-#{C5WLL3Js7oC.D7WnuXFK7PR},1
MOH 730_Abacavir (ABC) 300mg SoH,OWYwPVhDKTJ,MOH 730_Abacavir (ABC) 300mg SoH,#{T8vIpv842eX.hC4WAv2wKep}+#{cWzuTozjBUb.D7WnuXFK7PR},1
MOH 730_Abacavir (ABC) 300mg Tabs MoS,pPMBY4Du0q1,MOH 730_Abacavir (ABC) 300mg Tabs MoS,(#{T8vIpv842eX.hC4WAv2wKep}+#{cWzuTozjBUb.D7WnuXFK7PR})/#{cWzuTozjBUb.YS0bTLh3Q4O},1
MOH 730_Abacavir/Lamivudine (ABC/3TC) 60mg/30mg FDC Tabs MoS,qDWLlNFCNB8,MOH 730_Abacavir/Lamivudine (ABC/3TC) 60mg/30mg FD,(#{v70T2bzhYBH.hC4WAv2wKep}+#{VRFyixZiNKq.D7WnuXFK7PR})/#{VRFyixZiNKq.YS0bTLh3Q4O},1
MOH 730_Abacavir/Lamivudine (ABC/3TC) 60mg/30mg FDC Tabs SoH,T5Vew5VPotC,MOH 730_Abacavir/Lamivudine (ABC/3TC) 60mg/30mg,#{v70T2bzhYBH.hC4WAv2wKep}+#{VRFyixZiNKq.D7WnuXFK7PR},1
MOH 730_Acyclovir 400mg Tabs MoS,ihZupI2ZfxR,MOH 730_Acyclovir 400mg Tabs MoS,(#{kMTppRz9Dy6.hC4WAv2wKep}+#{fCU7NkQ7egO.D7WnuXFK7PR})/#{fCU7NkQ7egO.YS0bTLh3Q4O},1
MOH 730_Acyclovir 400mg Tabs SoH,BVuBRPl6VjD,MOH 730_Acyclovir 400mg Tabs SoH,#{kMTppRz9Dy6.hC4WAv2wKep}+#{fCU7NkQ7egO.D7WnuXFK7PR},1
MOH 730_Amphotericin B 50mg IV Injection MoS,gdd1Lwfz7Uy,MOH 730_Amphotericin B 50mg IV Injection MoS,(#{OzHa7Wm9wWb.hC4WAv2wKep}+#{nfjDbwayZ4s.D7WnuXFK7PR})/#{nfjDbwayZ4s.YS0bTLh3Q4O},1
MOH 730_Amphotericin B 50mg IV Injection SoH,u0EHSOm5YgO,MOH 730_Amphotericin B 50mg IV Injection SoH,#{OzHa7Wm9wWb.hC4WAv2wKep}+#{nfjDbwayZ4s.D7WnuXFK7PR},1
MOH 730_Atazanavir/Ritonavir (ATV/r) 300/100mg tabs MoS,UhLSHRtFTAE,MOH 730_Atazanavir/Ritonavir (ATV/r) 300/100mg tab,(#{HKNzvgOEXdV.hC4WAv2wKep}+#{AqK0pDHRkop.D7WnuXFK7PR})/#{AqK0pDHRkop.YS0bTLh3Q4O},1
MOH 730_Atazanavir/Ritonavir (ATV/r) 300/100mg tabs SoH,QWHepteNufL,MOH 730_Atazanavir/Ritonavir (ATV/r) 300/100mg SoH,#{HKNzvgOEXdV.hC4WAv2wKep}+#{AqK0pDHRkop.D7WnuXFK7PR},1
MOH 730_Cotrimoxazole 960mg Tabs (for Pack of 100 tabs) MoS,Y6SRMYIJ6BB,Cotrimoxazole 960mg Tabs (for Pack of 100 tabs),(#{zX3RWIpPsU5.hC4WAv2wKep}+#{HUgqq26kDtr.D7WnuXFK7PR})/#{HUgqq26kDtr.YS0bTLh3Q4O},1
MOH 730_Cotrimoxazole 960mg Tabs (for Pack of 100 tabs) SoH,z84l6QNbWjg,MOH 730_Cotrimoxazole 960mg Tabs (for Pack of 100,#{zX3RWIpPsU5.hC4WAv2wKep}+#{HUgqq26kDtr.D7WnuXFK7PR},1
MOH 730_Cotrimoxazole 960mg Tabs (for Pack of 500 tabs) MoS,BajnJpvr9xH,Cotrimoxazole 960mg Tabs (for Pack of 500 tabs),(#{anJTqZAje6a.hC4WAv2wKep}+#{kys6ug1qM84.D7WnuXFK7PR})/#{kys6ug1qM84.YS0bTLh3Q4O},1
MOH 730_Cotrimoxazole 960mg Tabs (for Pack of 500 tabs) SoH,Oo2q0G08ACn,MOH 730_Cotrimoxazole 960mg Tabs (for Pack of 500,#{anJTqZAje6a.hC4WAv2wKep}+#{kys6ug1qM84.D7WnuXFK7PR},1
MOH 730_Cotrimoxazole Suspension 240mg/5ml MoS,DRdf5eCd1I1,MOH 730_Cotrimoxazole Suspension 240mg/5ml MoS,(#{Ptvb1N5gQ54.hC4WAv2wKep}+#{Gy2ZzJ3KmeP.D7WnuXFK7PR})/#{Gy2ZzJ3KmeP.YS0bTLh3Q4O},1
MOH 730_Cotrimoxazole Suspension 240mg/5ml SoH,etusgCszrAA,MOH 730_Cotrimoxazole Suspension 240mg/5ml SoH,#{Ptvb1N5gQ54.hC4WAv2wKep}+#{Gy2ZzJ3KmeP.D7WnuXFK7PR},1
MOH 730_Dapsone 100mg Tabs (for Pack of 100 tabs) MoS,ImvwUwtWd6P,Dapsone 100mg Tabs (for Pack of 100 tabs),(#{g2J7NpW2ZM8.hC4WAv2wKep}+#{eM1HEGwGk3v.D7WnuXFK7PR})/#{eM1HEGwGk3v.YS0bTLh3Q4O},1
MOH 730_Dapsone 100mg Tabs (for Pack of 100 tabs) SoH,eVS8E80m6nY,MOH 730_Dapsone 100mg Tabs (for Pack of 100 tabs),#{g2J7NpW2ZM8.hC4WAv2wKep}+#{eM1HEGwGk3v.D7WnuXFK7PR},1
MOH 730_Dapsone 100mg Tabs (for Pack of 1000 tabs) MoS,J6vJ8KEeQMf,Dapsone 100mg Tabs (for Pack of 1000 tabs),(#{ZcZwhTRfWkK.hC4WAv2wKep}+#{Ql68yXdB6hp.D7WnuXFK7PR})/#{Ql68yXdB6hp.YS0bTLh3Q4O},1
MOH 730_Dapsone 100mg Tabs (for Pack of 1000 tabs) SoH,buVcKi7ijJO,MOH 730_Dapsone 100mg Tabs (for Pack of 1000 tabs),#{ZcZwhTRfWkK.hC4WAv2wKep}+#{Ql68yXdB6hp.D7WnuXFK7PR},1
MOH 730_Darunavir (DRV) 150mg Tabs MoS,OPIoa0N6B5Q,MOH 730_Darunavir (DRV) 150mg Tabs MoS,(#{onTjG9ODh1k.hC4WAv2wKep}+#{FfZQ3UNST1x.D7WnuXFK7PR})/#{FfZQ3UNST1x.YS0bTLh3Q4O},1
MOH 730_Darunavir (DRV) 150mg Tabs SoH,wVCDQUkNOkl,MOH 730_Darunavir (DRV) 150mg Tabs SoH,#{onTjG9ODh1k.hC4WAv2wKep}+#{FfZQ3UNST1x.D7WnuXFK7PR},1
MOH 730_Darunavir (DRV) 600mg SoH,Tp1845AeTig,MOH 730_Darunavir (DRV) 600mg SoH,#{BDKBvFhIQJf.hC4WAv2wKep}+#{OacLjYDR3Il.D7WnuXFK7PR},1
MOH 730_Darunavir (DRV) 600mg tabs MoS,blamPkQzSDd,MOH 730_Darunavir (DRV) 600mg tabs MoS,(#{BDKBvFhIQJf.hC4WAv2wKep}+#{OacLjYDR3Il.D7WnuXFK7PR})/#{OacLjYDR3Il.YS0bTLh3Q4O},1
MOH 730_Darunavir (DRV) 75mg Tabs MoS,qXbgNoOOOwz,MOH 730_Darunavir (DRV) 75mg Tabs MoS,(#{bZplX60YbPf.hC4WAv2wKep}+#{pZzARIwJbxo.D7WnuXFK7PR})/#{pZzARIwJbxo.YS0bTLh3Q4O},1
MOH 730_Darunavir (DRV) 75mg Tabs SoH,VoaFrF9P0zE,MOH 730_Darunavir (DRV) 75mg Tabs SoH,#{bZplX60YbPf.hC4WAv2wKep}+#{pZzARIwJbxo.D7WnuXFK7PR},1
MOH 730_Darunavir (DRV) susp 100mg/ml MoS,IzvSs8FlyrU,MOH 730_Darunavir (DRV) susp 100mg/ml MoS,(#{wxA11VC6wRx.hC4WAv2wKep}+#{cn6LzRf2hyu.D7WnuXFK7PR})/#{cn6LzRf2hyu.YS0bTLh3Q4O},1
MOH 730_Darunavir (DRV) susp 100mg/ml SoH,JkInihsxZ9W,MOH 730_Darunavir (DRV) susp 100mg/ml SoH,#{wxA11VC6wRx.hC4WAv2wKep}+#{cn6LzRf2hyu.D7WnuXFK7PR},1
MOH 730_Efavirenz (EFV) 200mg Tabs MoS,sfMOTVPnyWr,MOH 730_Efavirenz (EFV) 200mg Tabs MoS,(#{iPjFiQJ13HN.D7WnuXFK7PR}+#{UMqyIpzJRCJ.hC4WAv2wKep})/#{iPjFiQJ13HN.YS0bTLh3Q4O},1
MOH 730_Efavirenz (EFV) 200mg Tabs SoH,XKj0zWHVCS0,MOH 730_Efavirenz (EFV) 200mg Tabs SoH,#{UMqyIpzJRCJ.hC4WAv2wKep}+#{iPjFiQJ13HN.D7WnuXFK7PR},1
MOH 730_Efavirenz (EFV) 600mg Tabs MoS,AiDyE4D8uAb,MOH 730_Efavirenz (EFV) 600mg Tabs MoS,(#{ugsQqSyyZy2.hC4WAv2wKep}+#{B8QWYS3EJqZ.D7WnuXFK7PR})/#{B8QWYS3EJqZ.YS0bTLh3Q4O},1
MOH 730_Efavirenz (EFV) 600mg Tabs SoH,UUiNAujKbjt,MOH 730_Efavirenz (EFV) 600mg SoH,#{ugsQqSyyZy2.hC4WAv2wKep}+#{B8QWYS3EJqZ.D7WnuXFK7PR},1
MOH 730_Etravirine (ETV) 100mg tabs MoS,UmjwQi0g9mj,MOH 730_Etravirine (ETV) 100mg tabs MoS,(#{wFFhejJhg1B.hC4WAv2wKep}+#{Mf64ObujNcj.D7WnuXFK7PR})/#{Mf64ObujNcj.YS0bTLh3Q4O},1
MOH 730_Etravirine (ETV) 100mg tabs SoH,E18VXNqBf2c,MOH 730_Etravirine (ETV) 100mg tabs SoH,#{wFFhejJhg1B.hC4WAv2wKep}+#{Mf64ObujNcj.D7WnuXFK7PR},1
MOH 730_Etravirine (ETV) 200mg SoH,o8aPt9RH6GZ,MOH 730_Etravirine (ETV) 200mg SoH,#{LI1E9Xrvpwr.hC4WAv2wKep}+#{RLZg91zBBJu.D7WnuXFK7PR},1
MOH 730_Etravirine (ETV) 200mg tabs MoS,rHg1Y2i2LM3,MOH 730_Etravirine (ETV) 200mg tabs MoS,(#{LI1E9Xrvpwr.hC4WAv2wKep}+#{RLZg91zBBJu.D7WnuXFK7PR})/#{RLZg91zBBJu.YS0bTLh3Q4O},1
MOH 730_Etravirine (ETV) 25mg tabs MoS,kZfNcGiMmom,MOH 730_Etravirine (ETV) 25mg tabs MoS,(#{fWTJUSnntn6.hC4WAv2wKep}+#{aNq0Dcj4SSu.D7WnuXFK7PR})/#{aNq0Dcj4SSu.YS0bTLh3Q4O},1
MOH 730_Etravirine (ETV) 25mg tabs SoH,xudZ5kNaJ2B,MOH 730_Etravirine (ETV) 25mg tabs SoH,#{fWTJUSnntn6.hC4WAv2wKep}+#{aNq0Dcj4SSu.D7WnuXFK7PR},1
MOH 730_Fluconazole 200mg Tabs MoS,tCy58P3zeXe,MOH 730_Fluconazole 200mg Tabs MoS,(#{HkZ39x8BCEK.hC4WAv2wKep}+#{U5fGoqB4cNy.D7WnuXFK7PR})/#{U5fGoqB4cNy.YS0bTLh3Q4O},1
MOH 730_Fluconazole 200mg Tabs SoH,dj1jTQ6ldXc,MOH 730_Fluconazole 200mg Tabs SoH,#{HkZ39x8BCEK.hC4WAv2wKep}+#{U5fGoqB4cNy.D7WnuXFK7PR},1
MOH 730_Isoniazid (H) 100mg tabs MoS,fMKnBagYHrh,MOH 730_Isoniazid (H) 100mg tabs MoS,(#{siZ3FslqDHV.hC4WAv2wKep}+#{s7bYJGXvjD5.D7WnuXFK7PR})/#{s7bYJGXvjD5.YS0bTLh3Q4O},1
MOH 730_Isoniazid (H) 100mg tabs SoH,ujDCkCZitLX,MOH 730_Isoniazid (H) 100mg tabs SoH,#{siZ3FslqDHV.hC4WAv2wKep}+#{s7bYJGXvjD5.D7WnuXFK7PR},1
MOH 730_Isoniazid (H) 300mg Tabs (for Pack of 100 tabs) MoS,wUrGoGN4nOt,Isoniazid (H) 300mg Tabs (for Pack of 100 tabs),(#{ymWk2uW4f1s.hC4WAv2wKep}+#{UVibZfH0On0.D7WnuXFK7PR})/#{UVibZfH0On0.YS0bTLh3Q4O},1
MOH 730_Isoniazid (H) 300mg Tabs (for Pack of 100 tabs) SoH,RpAFoZFi3nM,MOH 730_Isoniazid (H) 300mg Tabs (for Pack of 100,#{ymWk2uW4f1s.hC4WAv2wKep}+#{UVibZfH0On0.D7WnuXFK7PR},1
MOH 730_Isoniazid (H) 300mg Tabs (for Pack of 672 tabs) MoS,bkPmTvbhTeP,Isoniazid (H) 300mg Tabs (for Pack of 672 tabs),(#{y8vOQhrlRLj.hC4WAv2wKep}+#{mrp5wgn0b1a.D7WnuXFK7PR})/#{mrp5wgn0b1a.YS0bTLh3Q4O},1
MOH 730_Isoniazid (H) 300mg Tabs (for Pack of 672 tabs) SoH,dOVdkHCclJp,MOH 730_Isoniazid (H) 300mg Tabs (for Pack of 672,#{y8vOQhrlRLj.hC4WAv2wKep}+#{mrp5wgn0b1a.D7WnuXFK7PR},1
MOH 730_Lamivudine (3TC) 150mg SoH,xfD6PofCptw,MOH 730_Lamivudine (3TC) 150mg SoH,#{iKalfg97rtZ.hC4WAv2wKep}+#{Ps9oJAmKFkg.D7WnuXFK7PR},1
MOH 730_Lamivudine (3TC) 150mg Tabs MoS,kXcCixWIidO,MOH 730_Lamivudine (3TC) 150mg Tabs MoS,(#{iKalfg97rtZ.hC4WAv2wKep}+#{Ps9oJAmKFkg.D7WnuXFK7PR})/#{Ps9oJAmKFkg.YS0bTLh3Q4O},1
MOH 730_Lamivudine (3TC) liquid 10mg/ml MoS,qkvqedWi9Ot,MOH 730_Lamivudine (3TC) liquid 10mg/ml MoS,(#{r9fSbflgQgC.hC4WAv2wKep}+#{doDTLd8jMF9.D7WnuXFK7PR})/#{doDTLd8jMF9.YS0bTLh3Q4O},1
MOH 730_Lamivudine (3TC) liquid 10mg/ml SoH,yzphCM4eypm,MOH 730_Lamivudine (3TC) liquid 10mg/ml SoH,#{r9fSbflgQgC.hC4WAv2wKep}+#{doDTLd8jMF9.D7WnuXFK7PR},1
MOH 730_Lopinavir/ritonavir (LPV/r) 200/50mg SoH,fztT1ouwfQu,MOH 730_Lopinavir/ritonavir (LPV/r) 200/50mg,#{VJ9VJ6dxwVD.hC4WAv2wKep}+#{fDZu3xtV92b.D7WnuXFK7PR},1
MOH 730_Lopinavir/ritonavir (LPV/r) 200/50mg Tabs MoS,mJefQgZdhJB,MOH 730_Lopinavir/ritonavir (LPV/r) 200/50mg Tabs,(#{VJ9VJ6dxwVD.hC4WAv2wKep}+#{fDZu3xtV92b.D7WnuXFK7PR})/#{fDZu3xtV92b.YS0bTLh3Q4O},1
MOH 730_Lopinavir/ritonavir (LPV/r) liquid 80/20mg/ml SoH,E5SnmraKHZ5,MOH 730_Lopinavir/ritonavir (LPV/r) liquid 80/20mg,#{OnFFuii2sYi.hC4WAv2wKep}+#{YQX1UdOAzRq.D7WnuXFK7PR},1
MOH 730_Lopinavir/ritonavir (LPV/r) liquid 80/20mg/mlMoS,OoYebQXfbqL,Lopinavir/ritonavir (LPV/r) liquid 80/20mg/ml,(#{OnFFuii2sYi.QDGwAPfi7tu}+#{YQX1UdOAzRq.D7WnuXFK7PR})/#{YQX1UdOAzRq.YS0bTLh3Q4O},1
MOH 730_Nevirapine (NVP) 200mg SoH,DIt0F6baThs,MOH 730_Nevirapine (NVP) 200mg SoH,#{JrfpoCr2vII.hC4WAv2wKep}+#{PAmdoz5hPPQ.D7WnuXFK7PR},1
MOH 730_Nevirapine (NVP) 200mg Tabs MoS,K8IIKurfci1,MOH 730_Nevirapine (NVP) 200mg Tabs MoS,(#{JrfpoCr2vII.hC4WAv2wKep}+#{PAmdoz5hPPQ.D7WnuXFK7PR})/#{PAmdoz5hPPQ.YS0bTLh3Q4O},1
MOH 730_Nevirapine (NVP) Susp 10mg/ml MoS,yHtXmUxHfmC,MOH 730_Nevirapine (NVP) Susp 10mg/ml MoS,(#{rNmSAnjCmWK.hC4WAv2wKep}+#{DXeeHS2yDKf.D7WnuXFK7PR})/#{DXeeHS2yDKf.YS0bTLh3Q4O},1
MOH 730_Nevirapine (NVP) Susp 10mg/ml SoH,KTsqr32JjHC,MOH 730_Nevirapine (NVP) Susp 10mg/ml SoH,#{rNmSAnjCmWK.hC4WAv2wKep}+#{DXeeHS2yDKf.D7WnuXFK7PR},1
MOH 730_Pyridoxine 25mg Tabs MoS,LWT6k1M31gk,MOH 730_Pyridoxine 25mg Tabs MoS,(#{AUsGmP0j5eC.hC4WAv2wKep}+#{cKTjRDIAujO.D7WnuXFK7PR})/#{cKTjRDIAujO.YS0bTLh3Q4O},1
MOH 730_Pyridoxine 25mg Tabs SoH,VA5uMhhd53n,MOH 730_Pyridoxine 25mg Tabs SoH,#{AUsGmP0j5eC.hC4WAv2wKep}+#{cKTjRDIAujO.D7WnuXFK7PR},1
MOH 730_Pyridoxine 50mg Tabs MoS,Zb1YGeL354O,MOH 730_Pyridoxine 50mg Tabs MoS,(#{wWKgpcMkHnJ.hC4WAv2wKep}+#{H0jATZHahed.D7WnuXFK7PR})/#{H0jATZHahed.YS0bTLh3Q4O},1
MOH 730_Pyridoxine 50mg Tabs SoH,iYlQkwBiIXY,MOH 730_Pyridoxine 50mg Tabs SoH,#{wWKgpcMkHnJ.hC4WAv2wKep}+#{H0jATZHahed.D7WnuXFK7PR},1
MOH 730_Raltegravir (RAL) 100mg tabs MoS,C8XFAAXWUCy,MOH 730_Raltegravir (RAL) 100mg tabs MoS,(#{pCPSqHPI4iN.hC4WAv2wKep}+#{tUwIDx2oFjO.D7WnuXFK7PR})/#{tUwIDx2oFjO.YS0bTLh3Q4O},1
MOH 730_Raltegravir (RAL) 100mg tabs SoH,TmxlNu4glOL,MOH 730_Raltegravir (RAL) 100mg tabs SoH,#{pCPSqHPI4iN.hC4WAv2wKep}+#{tUwIDx2oFjO.D7WnuXFK7PR},1
MOH 730_Raltegravir (RAL) 25mg tabs MoS,ka5RlIqgTSB,MOH 730_Raltegravir (RAL) 25mg tabs MoS,(#{kwhxIWspmVw.hC4WAv2wKep}+#{L2IwQNujxtP.D7WnuXFK7PR})/#{L2IwQNujxtP.YS0bTLh3Q4O},1
MOH 730_Raltegravir (RAL) 25mg tabs SoH,unrYffZJYzk,MOH 730_Raltegravir (RAL) 25mg tabs SoH,#{kwhxIWspmVw.hC4WAv2wKep}+#{L2IwQNujxtP.D7WnuXFK7PR},1
MOH 730_Raltegravir (RAL) 400mg SoH,aLtBsrYGXHU,MOH 730_Raltegravir (RAL) 400mg SoH,#{VfUQzXlpKQl.hC4WAv2wKep}+#{knkLSijGwES.D7WnuXFK7PR},1
MOH 730_Raltegravir (RAL) 400mg tabs MoS,NJEtVJcYwsq,MOH 730_Raltegravir (RAL) 400mg tabs MoS,(#{VfUQzXlpKQl.hC4WAv2wKep}+#{knkLSijGwES.D7WnuXFK7PR})/#{knkLSijGwES.YS0bTLh3Q4O},1
MOH 730_Ritonavir (RTV) 100mg SoH,YpgGYH9cPYs,MOH 730_Ritonavir (RTV) 100mg SoH,#{xUayEnX8Blt.hC4WAv2wKep}+#{KC0hUg3FCmM.D7WnuXFK7PR},1
MOH 730_Ritonavir (RTV) 100mg tabs MoS,sIUIpqSrUPm,MOH 730_Ritonavir (RTV) 100mg tabs MoS,(#{xUayEnX8Blt.hC4WAv2wKep}+#{KC0hUg3FCmM.D7WnuXFK7PR})/#{KC0hUg3FCmM.YS0bTLh3Q4O},1
MOH 730_Ritonavir (RTV) liquid 80mg/ml MoS,cAbsKLEztWi,MOH 730_Ritonavir (RTV) liquid 80mg/ml MoS,(#{NWL4ULZezMy.hC4WAv2wKep}+#{H6pU48yXxLu.D7WnuXFK7PR})/#{H6pU48yXxLu.YS0bTLh3Q4O},1
MOH 730_Ritonavir (RTV) liquid 80mg/ml SoH,pxApH04cww9,MOH 730_Ritonavir (RTV) liquid 80mg/ml SoH,#{NWL4ULZezMy.hC4WAv2wKep}+#{H6pU48yXxLu.D7WnuXFK7PR},1
MOH 730_Tenofovir (TDF) 300mg SoH,YI6dQSTxgFg,MOH 730_Tenofovir (TDF) 300mg,#{u66LdVsKCvV.hC4WAv2wKep}+#{slIsNAnY5WS.D7WnuXFK7PR},1
MOH 730_Tenofovir (TDF) 300mg Tabs MoS,n22XLEH1aBr,MOH 730_Tenofovir (TDF) 300mg Tabs MoS,(#{u66LdVsKCvV.hC4WAv2wKep}+#{slIsNAnY5WS.D7WnuXFK7PR})/#{slIsNAnY5WS.YS0bTLh3Q4O},1
MOH 730_Tenofovir/Lamivudine (TDF/3TC) FDC (300/300mg) SoH,JdyaQns9LE4,MOH 730_Tenofovir/Lamivudine (TDF/3TC) FDC (300/30,#{aYXQcIen2Wl.hC4WAv2wKep}+#{yUt1DYxSUNy.D7WnuXFK7PR},1
MOH 730_Tenofovir/Lamivudine (TDF/3TC) FDC (300/300mg) Tabs MoS,Pw0x6gCNCji,MOH 730_Tenofovir/Lamivudine (TDF/3TC) FDC (300/30,(#{aYXQcIen2Wl.hC4WAv2wKep}+#{yUt1DYxSUNy.D7WnuXFK7PR})/#{yUt1DYxSUNy.YS0bTLh3Q4O},1
MOH 730_Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/600mg) SoH,b84v49tRV1o,MOH 730_Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EF,#{LK4JkwJDx2c.hC4WAv2wKep}+#{EIWAIlQBKU6.D7WnuXFK7PR},1
MOH 730_Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/600mg) Tabs MoS,U0Wdtq2e0cS,MOH 730_Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EF,(#{LK4JkwJDx2c.hC4WAv2wKep}+#{EIWAIlQBKU6.D7WnuXFK7PR})/#{EIWAIlQBKU6.YS0bTLh3Q4O},1
MOH 730_Zidovudine/Lamivudine (AZT/3TC) FDC (300/150mg) SoH,PPQluSGRmC8,MOH 730_Zidovudine/Lamivudine (AZT/3TC) FDC (300/1,#{ijmmJw97V6g.hC4WAv2wKep}+#{fFYWgW7OUjv.D7WnuXFK7PR},1
MOH 730_Zidovudine/Lamivudine (AZT/3TC) FDC (300/150mg) Tabs MoS,u2YN2upzW1S,MOH 730_Zidovudine/Lamivudine (AZT/3TC) FDC (300/1,(#{ijmmJw97V6g.hC4WAv2wKep}+#{fFYWgW7OUjv.D7WnuXFK7PR})/#{fFYWgW7OUjv.YS0bTLh3Q4O},1
MOH 730_Zidovudine/Lamivudine (AZT/3TC) FDC (60/30mg) Tabs MoS,m6qp5zS2fK8,MOH 730_Zidovudine/Lamivudine (AZT/3TC) FDC (60/30,(#{eb9fVoSbFIr.hC4WAv2wKep}+#{yJYXWEpLfcZ.D7WnuXFK7PR})/#{yJYXWEpLfcZ.YS0bTLh3Q4O},1
MOH 730_Zidovudine/Lamivudine (AZT/3TC) FDC (60/30mg) Tabs SoH,Y7eSDWLrXv9,MOH 730_Zidovudine/Lamivudine (AZT/3TC) FDC (60/30,#{eb9fVoSbFIr.hC4WAv2wKep}+#{yJYXWEpLfcZ.D7WnuXFK7PR},1
MOH 730_Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (300/150/200mg) SoH,abK8XwK3iMP,MOH_Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP),#{c4V5Fav5ovZ.hC4WAv2wKep}+#{vVwNDHLP9NT.D7WnuXFK7PR},1
MOH 730_Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (300/150/200mg) Tabs MoS,y9IjEycvVfO,MOH 730_Zidovudine/Lamivudine/Nevirapine (AZT/3TC/,(#{c4V5Fav5ovZ.hC4WAv2wKep}+#{vVwNDHLP9NT.D7WnuXFK7PR})/#{vVwNDHLP9NT.YS0bTLh3Q4O},1
MOH 730_Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (60/30/50mg)  Tabs MoS,uDak7OFKiHM,MOH 730_Zidovudine/Lamivudine/Nevirapine (AZT/3TC/,(#{C5WLL3Js7oC.D7WnuXFK7PR}+#{in4iMk8Fjj1.hC4WAv2wKep})/#{C5WLL3Js7oC.YS0bTLh3Q4O},1
MOH 730_Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (60/30/50mg) SoH,bqiFqviuPOT,MOH 730_Zidovudine/Lamivudine/Nevirapine (AZT/3TC/,#{in4iMk8Fjj1.hC4WAv2wKep}+#{C5WLL3Js7oC.D7WnuXFK7PR},1
MOH 733B Nutrition Diagnosis HIV Positive SAM Total,VTarbQSHxTl,MOH 733B Nutrition Diagnosis HIV Positive SAM,#{V3ULwnX5N4u.eEGOD8fIUdA} + #{q55MGZQLMBj.eEGOD8fIUdA} + #{yopMbinIiwm} + #{dfbF6bR9IIz.eEGOD8fIUdA} + #{Pmi8KM4jUVP},1
MOH 733B Rev.2019 ART and Co-existing infections New Art Initiated,CYZlnqbe50S,MOH 733B Rev.2019 ART and Co-existing infect,#{jvy2f4IKWkg} + #{UheiRMqTnBL} + #{GjXRIgL7zDi.PRZ0mmlSEwX} + #{lrlh76SBavS.PRZ0mmlSEwX} + #{o6cxRvb7g2O.PRZ0mmlSEwX},1
MOH 733B Rev.2019 Nutrition Diagnosis HIV Negative MAM Total,iMMUDTgdOb6,MOH 733B Rev.2019 Nutrition Diag HIV Neg MAM Tot,#{UN6ybZnP5in} + #{tBSFFtbpSTO} + #{dfbF6bR9IIz.UpLAmG5b9J5} +#{q55MGZQLMBj.UpLAmG5b9J5},1
MOH 733B Rev.2019 Nutrition Diagnosis HIV Negative SAM Total,CLMlc60Az7J,MOH 733B Rev.2019 Nutrition Diagnosis HIV Neg Tot,#{yopMbinIiwm} + #{usPqcFie91u} + #{dfbF6bR9IIz.Oz4jK0cumb4} + #{V3ULwnX5N4u.Oz4jK0cumb4}  + #{q55MGZQLMBj.Oz4jK0cumb4}  ,1
MOH 733B Rev.2019 Nutrition Diagnosis HIV Positive MAM Total,rMahmEXWhFt,MOH 733B Nutrition Diagnosis HIV Positive MAM Tota,#{cytFmUhOvnD} + #{BTLgjHe4WMo} + #{dfbF6bR9IIz.a6fhsBFtV1z} + #{V3ULwnX5N4u.a6fhsBFtV1z} + #{q55MGZQLMBj.a6fhsBFtV1z}  , 1 
MOH 734 FCDRR-Qty for resupply_Combined Iron (60mg) Folic Acid (400µg),fHqLxjuLxpK,MOH 734 FCDRR-Qty for resupply_Combined Iron (60mg,(#{zcyp7uXmQXc.RWCHIdXizft}*2)-#{zcyp7uXmQXc.OmTneOE9mMF},1
"MOH 734 FCDRR-Qty for resupply_Corn Soy Blend flour, 390kcal/100g",k2e7ar7ubNo,MOH 734 FCDRR-Qty for resupply_Corn Soy Blend,(#{cg4oKr1jQfU.RWCHIdXizft}*2)-#{cg4oKr1jQfU.OmTneOE9mMF},1
"MOH 734 FCDRR-Qty for resupply_Corn Soy Blend flour, 390kcal/100g Packet",fNFtD5WUN6B,MOH 734 FCDRR-Qty for resupply_Corn Soy Blend flou,(#{m8D0XjDlZJe.RWCHIdXizft}*2)-#{m8D0XjDlZJe.OmTneOE9mMF},1
"MOH 734 FCDRR-Qty for resupply_Fortified Blended Food (FBF) flour, 415kcal/100g",VyWRmo15vbC,MOH 734 FCDRR-Qty for resupply_Fortified Blended F,(#{Ob6FVyEzsLj.RWCHIdXizft}*2)-#{Ob6FVyEzsLj.OmTneOE9mMF},1
"MOH 734 FCDRR-Qty for resupply_Fortified Blended Food (FBF) flour, 435kcal/100g",t4LyvCfXPiH,MOH 734 FCDRR-Qty for resupply_Fortified Blended,(#{At9UpdKiMHM.RWCHIdXizft}*2)-#{At9UpdKiMHM.OmTneOE9mMF},1
"MOH 734 FCDRR-Qty for resupply_Fortified Blended Food (FBF) flour, 450kcal/100g",pLlsp0btodv,MOH 734 FCDRR-Qty for resupply_Fortified Blended,(#{wC17jUUFLCI.RWCHIdXizft}*2)-#{wC17jUUFLCI.OmTneOE9mMF},1
MOH 734 FCDRR-Qty for resupply_Micronutrient powder,JTtYXN2Zebs,MOH 734 FCDRR-Qty for resupply_Micronutrient powde,(#{xzJK2XKtIeG.RWCHIdXizft}*2)-#{xzJK2XKtIeG.OmTneOE9mMF},1
MOH 734 FCDRR-Qty for resupply_Multiple Vitamin and Mineral mix,HRFDQ79z9yK,MOH 734 FCDRR-Qty for resupply_Multiple Vitamin,(#{IYPPF6UKQnN.RWCHIdXizft}*2)-#{IYPPF6UKQnN.OmTneOE9mMF},1
MOH 734 FCDRR-Qty for resupply_Point of use Water treatment solution,EXE2xHV9gHX,MOH 734 FCDRR-Qty for resupply_Point of use Water,(#{XYpQMOdr73k.RWCHIdXizft}*2)-#{XYpQMOdr73k.OmTneOE9mMF},1
MOH 734 FCDRR-Qty for resupply_Ready to use supplemental food (RUSF) paste,h1jX4BYTTnc,MOH 734 FCDRR-Qty for resupply_Ready to use supple,(#{JnkzH5vxNNZ.RWCHIdXizft}*2)-#{JnkzH5vxNNZ.OmTneOE9mMF},1
MOH 734 FCDRR-Qty for resupply_Ready to use therapeutic food (RUTF) bar,LncMrasVpVG,MOH 734 FCDRR-Qty for resupply_Ready to use therap,(#{O6xf51NhlfJ.RWCHIdXizft}*2)-#{O6xf51NhlfJ.OmTneOE9mMF},1
MOH 734 FCDRR-Qty for resupply_Ready to use therapeutic food (RUTF) paste,HXHjdDqbXyg,MOH 734 FCDRR-Qty for resupply_Ready to use therap,(#{h6iFBcUZqo3.RWCHIdXizft}*2)-#{h6iFBcUZqo3.OmTneOE9mMF},1
MOH 734 FCDRR-Qty for resupply_Therapeutic Vitamin A 100 000 IU (30 mg RE),T24kzKnvN3Q,MOH 734 FCDRR-Qty for resupply_Therapeutic Vitamin,(#{GJtBIca5AB1.RWCHIdXizft}*2)-#{GJtBIca5AB1.OmTneOE9mMF},1
MOH 734 FCDRR-Qty for resupply_Therapeutic Vitamin A 200 000 IU (60 mg RE),oLQ3XiU2OFM,MOH 734 FCDRR-Qty for resupply_Therapeutic Vitamin,(#{WdfXBF664rN.RWCHIdXizft}*2)-#{WdfXBF664rN.OmTneOE9mMF},1
"MOH 734 FCDRR-Qty for resupply_Therapeutic diet milk (F-100), 100kcal/100ml",dTo28qHlNx0,MOH 734 FCDRR-Qty for resupply_Therapeutic diet mi,(#{bVKrRr27csC.RWCHIdXizft}*2)-#{bVKrRr27csC.OmTneOE9mMF},1
"MOH 734 FCDRR-Qty for resupply_Therapeutic diet milk (F-75), 75kcal/100ml",hjtgbL8XUTh,MOH 734 FCDRR-Qty for resupply_Therapeutic diet,(#{zQh34c0l2SY.RWCHIdXizft}*2)-#{zQh34c0l2SY.OmTneOE9mMF},1
MOH 743 Rev2020_Total Tested Microscopy,Z8wQFRAWfTA,MOH 743 Rev2020_Total Tested Microscopy,(#{E64sUrp6DrX.QKy6jjocOLj} + #{TSgMfWzStx6.QKy6jjocOLj}),1
MOH 743 Rev2020_Total Tested RDT,Lj9cGix66ks,MOH 743 Rev2020_Total Tested RDT,#{E64sUrp6DrX.hH6R0ZkxiK0}+#{TSgMfWzStx6.hH6R0ZkxiK0},1
MOH 747A_QR Hormonal IUCD,m9UY6CK5CyT,MOH 747A_QR Hormonal IUCD,(4* #{zXbxl6y97mi.to0Pssxkq4S})-(#{zXbxl6y97mi.i9dqmLZr7fd}),1
MOH 747A_QR Progestin Only Pills (POP),ZhwGbFzterD,MOH 747A_QR Progestin Only Pills (POP),( 4 * #{dl4JcBnxu0X.to0Pssxkq4S}) - (#{dl4JcBnxu0X.i9dqmLZr7fd}),1
MOH 747A_QR_Cycle Beads,zumb8mmPZH2,MOH 747A_QR_Cycle Beads,4*#{bGGT0F7iRxt.to0Pssxkq4S}-#{bGGT0F7iRxt.i9dqmLZr7fd},1
"MOH 747A_QR_DMPA Injection-104mg/0.65mL, SC",pkMT0NnXXg6,"MOH 747A_QR_DMPA Injection-104mg/0.65mL, SC",(4 * #{hXa1xyUMfTa.to0Pssxkq4S}) - (#{hXa1xyUMfTa.i9dqmLZr7fd}),1
"MOH 747A_QR_DMPA Injection-150mg/mL, IM",tH8HI5TYEgG,"MOH 747A_QR_DMPA Injection-150mg/mL, IM",(4 *#{J6qnTev1LXw.to0Pssxkq4S}) - (#{J6qnTev1LXw.i9dqmLZr7fd}),1
MOH 747A_QR_Implant 2 rod_3 years,wvRIfs4A8Qy,MOH 747A_QR_Implant 2 rod_3 years,(4*#{APbXNRovb5w.to0Pssxkq4S})-(#{APbXNRovb5w.i9dqmLZr7fd}),1
MOH 750 Total Cash,tOjPKQvBynR,Total Cash,#{Ia9YuRUiALo} + #{ifj8uDDgInG} + #{WTdZAlpShoA} + #{QnnD1TUcpvs} + #{RFs1SYFReY7},1
MOH 753_Number of liters of oxygen produced per month,soF3hmL7Uza,MOH 753_Number of liters of oxygen prod per month,#{Von49zRgyH9.RAmW6yU4wTy},1
MOH 753_Stock on Hand (SOH) Cylinders 1.84Kgs /1.36 M3,MX4Rs91pPMG,MOH 753_Cylinders 1.84Kgs /1.36 M3,#{bqU51dNlyxM.zqzh5Mz8BI0},1
MOH 753_Stock on Hand (SOH) Cylinders 9.2Kgs/6.8 M3,OPkORTTnSqn,MOH 753_ (SOH) Cylinders 9.2Kgs/6.8 M3,#{vzoL9sYvu1k.zqzh5Mz8BI0},1
MOH 753_Stock on Hand (SOH) Liquid (Cryogenic) gas (Tank),MneFGvrPjZi,MOH 753_ (SOH) Liquid (Cryogenic) gas (Tank),#{NDdYTYmWgxS.zqzh5Mz8BI0},1
MOH 753_Stock on Hand (SOH) Medical oxygen (Production),dquX9D0Ziw3,MOH 753_ Medical oxygen (Production),#{Von49zRgyH9.zqzh5Mz8BI0},1
MOH 753_Stock on Hand (SOH) cylinders 11.5Kgs /8.5 M3,nPmjaktNO1r,MOH 753_(SOH) cylinders 11.5Kgs /8.5 M3,#{BYejriGfzNE.zqzh5Mz8BI0},1
MOH 753_Stock on Hand (SOH) cylinders 4.6Kgs /3.4 M3,fmPUo7aJW2c,MOH 753_(SOH) cylinders 4.6Kgs /3.4 M3,#{KJB2UVPg38r.zqzh5Mz8BI0},1
MOH 754_Oxygen consumption by patients per month,Qs1BzI27fyZ,MOH 754_Oxygen consumption by patients per month,(#{n7nzx8vRQjh.oWuH3CZm3Id} + #{n7nzx8vRQjh.Tkgd8NYOiLa}),(#{JF1ahLRjj8p.NqEtKTNqN3n} + #{JF1ahLRjj8p.iAJuNkr5Qnn} + #{JF1ahLRjj8p.dSsztAUjPTV} + #{JF1ahLRjj8p.msXVfmB2LaF} + #{JF1ahLRjj8p.uGyC3lJJZYm} + #{JF1ahLRjj8p.RAgZQ8P3VQc} + #{JF1ahLRjj8p.VghORdqEVGa} + #{JF1ahLRjj8p.sYUYGmPFwQc}) + (#{DuuqEzlLWPT.NqEtKTNqN3n} +  + #{DuuqEzlLWPT.dSsztAUjPTV} + #{DuuqEzlLWPT.msXVfmB2LaF} + #{DuuqEzlLWPT.uGyC3lJJZYm} + #{DuuqEzlLWPT.RAgZQ8P3VQc} + #{DuuqEzlLWPT.VghORdqEVGa} + #{DuuqEzlLWPT.sYUYGmPFwQc})
MOH 754_Proportion of OPD patients managed with Oxygen,o0xLfv3LUfs,MOH 754_Prop of OPD patients managed with Oxygen,( + #{DuuqEzlLWPT.NqEtKTNqN3n} + #{DuuqEzlLWPT.iAJuNkr5Qnn} + #{DuuqEzlLWPT.dSsztAUjPTV} + #{DuuqEzlLWPT.msXVfmB2LaF} + #{DuuqEzlLWPT.uGyC3lJJZYm} + #{DuuqEzlLWPT.RAgZQ8P3VQc} + #{DuuqEzlLWPT.VghORdqEVGa} + #{DuuqEzlLWPT.sYUYGmPFwQc}),(#{zXzBILTVJzD.wBWcFk7k1qY} + #{zXzBILTVJzD.K4WLOEhtcvC} + #{Ha96SBKI06u.wBWcFk7k1qY} + #{Ha96SBKI06u.K4WLOEhtcvC} + #{rIkD2jIDqPh.wBWcFk7k1qY} + #{rIkD2jIDqPh.K4WLOEhtcvC} + #{F6AwnxbwiK2.wBWcFk7k1qY} + #{F6AwnxbwiK2.K4WLOEhtcvC})
MOH 754_Proportion of clients  Oxygen  delivered through Face mask  ,lSqt5zBL8WM,MOH 754_Propn  delivered through Face mask  ,#{QgQAWHfwtJ1.VI5KQOSFVn7},(#{QgQAWHfwtJ1.YGjCP0RaG05} + #{QgQAWHfwtJ1.VI5KQOSFVn7} + #{QgQAWHfwtJ1.OtpfBVIOrjT} + #{QgQAWHfwtJ1.bOp7ApOw8MI} + #{QgQAWHfwtJ1.aJgw2GjTZvs} + #{QgQAWHfwtJ1.GEx2aE5Yg1X} + #{QgQAWHfwtJ1.PEt9kMn1JVe})
MOH 754_Proportion of clients  Oxygen  delivered through Face mask with reservoir,XE06mH6tps5,MOH 754_Prop Face mask with reservoir,#{QgQAWHfwtJ1.OtpfBVIOrjT},(#{QgQAWHfwtJ1.YGjCP0RaG05} + #{QgQAWHfwtJ1.VI5KQOSFVn7} + #{QgQAWHfwtJ1.OtpfBVIOrjT} + #{QgQAWHfwtJ1.bOp7ApOw8MI} + #{QgQAWHfwtJ1.aJgw2GjTZvs} + #{QgQAWHfwtJ1.GEx2aE5Yg1X} + #{QgQAWHfwtJ1.PEt9kMn1JVe})
MOH 754_Proportion of clients  Oxygen  delivered through High-flow nasal cannula oxygen ,KOLnUn9HLUq,MOH 754_PropHigh-flow nasal cannula oxygen ,#{QgQAWHfwtJ1.bOp7ApOw8MI},(#{QgQAWHfwtJ1.YGjCP0RaG05} + #{QgQAWHfwtJ1.VI5KQOSFVn7} + #{QgQAWHfwtJ1.OtpfBVIOrjT} + #{QgQAWHfwtJ1.bOp7ApOw8MI} + #{QgQAWHfwtJ1.aJgw2GjTZvs} + #{QgQAWHfwtJ1.GEx2aE5Yg1X} + #{QgQAWHfwtJ1.PEt9kMn1JVe})
MOH 754_Proportion of clients  Oxygen  delivered through Invasive ventilation (ETT/Tracheostomy),ngruulxu75K,MOH 754_Prop (ETT/Tracheostomy),#{QgQAWHfwtJ1.PEt9kMn1JVe},(#{QgQAWHfwtJ1.YGjCP0RaG05} + #{QgQAWHfwtJ1.VI5KQOSFVn7} + #{QgQAWHfwtJ1.OtpfBVIOrjT} + #{QgQAWHfwtJ1.bOp7ApOw8MI} + #{QgQAWHfwtJ1.aJgw2GjTZvs} + #{QgQAWHfwtJ1.GEx2aE5Yg1X} + #{QgQAWHfwtJ1.PEt9kMn1JVe})
MOH 754_Proportion of clients  Oxygen  delivered through Nasal cannula,djiP2OBxBxM,MOH 754_Prop Oxygen  delivd through Nasal cannula,#{QgQAWHfwtJ1.YGjCP0RaG05},(#{QgQAWHfwtJ1.YGjCP0RaG05} + #{QgQAWHfwtJ1.VI5KQOSFVn7} + #{QgQAWHfwtJ1.OtpfBVIOrjT} + #{QgQAWHfwtJ1.bOp7ApOw8MI} + #{QgQAWHfwtJ1.aJgw2GjTZvs} + #{QgQAWHfwtJ1.GEx2aE5Yg1X} + #{QgQAWHfwtJ1.PEt9kMn1JVe})
"MOH 754_Proportion of clients  Oxygen  delivered through Non-invasive positive pressure ventilation (""BiPAP"") ",YCDqHgTxpIr,"MOH 754_Propo (""BiPAP"")",#{QgQAWHfwtJ1.GEx2aE5Yg1X},(#{QgQAWHfwtJ1.YGjCP0RaG05} + #{QgQAWHfwtJ1.VI5KQOSFVn7} + #{QgQAWHfwtJ1.OtpfBVIOrjT} + #{QgQAWHfwtJ1.bOp7ApOw8MI} + #{QgQAWHfwtJ1.aJgw2GjTZvs} + #{QgQAWHfwtJ1.GEx2aE5Yg1X} + #{QgQAWHfwtJ1.PEt9kMn1JVe})
MOH 754_Proportion of clients  Oxygen  delivered through Non-invasive positive pressure ventilation (“CPAP”) ,OV3CElBgLtf,MOH 754_Propn (“CPAP”) ,#{QgQAWHfwtJ1.aJgw2GjTZvs},(#{QgQAWHfwtJ1.YGjCP0RaG05} + #{QgQAWHfwtJ1.VI5KQOSFVn7} + #{QgQAWHfwtJ1.OtpfBVIOrjT} + #{QgQAWHfwtJ1.bOp7ApOw8MI} + #{QgQAWHfwtJ1.aJgw2GjTZvs} + #{QgQAWHfwtJ1.GEx2aE5Yg1X} + #{QgQAWHfwtJ1.PEt9kMn1JVe})
MOH-729 Total NO.  Paediatric ART 3rd Line regimens,VIQGBLVYi9s,Total No. Paedio.atric ART 3rd Line regimens,(#{sTEo59iQRXO.a57uWFr3dUy} + #{sTEo59iQRXO.MJAGUpeHkpn} + #{r2mTYlQii3q.a57uWFr3dUy} + #{r2mTYlQii3q.MJAGUpeHkpn} + #{uQ5vj1f05GN.a57uWFr3dUy} + #{uQ5vj1f05GN.MJAGUpeHkpn}),1
MOH-729B Total NO. Adult ART 3rd Line regimens,E2JZFHKZIut,Total No. Adult ART 3rd Line regimens,(#{xnLIj77k06T.a57uWFr3dUy} + #{xnLIj77k06T.MJAGUpeHkpn} + #{Ktn04AHeUc9.a57uWFr3dUy} + #{Ktn04AHeUc9.MJAGUpeHkpn} + #{WTMsR364r6Z.a57uWFr3dUy} + #{WTMsR364r6Z.MJAGUpeHkpn} + #{NsHgkn00d3Q.a57uWFr3dUy} + #{NsHgkn00d3Q.MJAGUpeHkpn}),1
MOH-729B Total NO. of Paediatric ART 1st Line regimens,koMgytX9Cjt,Total No. of Paediatric ART 1st Line regimens,(#{QTlvmY9tdwa.a57uWFr3dUy} + #{QTlvmY9tdwa.MJAGUpeHkpn} + #{U7OmEOz4E93.a57uWFr3dUy} + #{U7OmEOz4E93.MJAGUpeHkpn} + #{wJu0yBF0WBw.a57uWFr3dUy} + #{wJu0yBF0WBw.MJAGUpeHkpn} + #{RgCuLOzFgB4.a57uWFr3dUy} + #{RgCuLOzFgB4.MJAGUpeHkpn} + #{Y1Gjp8rIaBm.a57uWFr3dUy} + #{Y1Gjp8rIaBm.MJAGUpeHkpn} + #{WpoSwaP2fhO.a57uWFr3dUy} + #{WpoSwaP2fhO.MJAGUpeHkpn} + #{Dr60nYrX84f.a57uWFr3dUy} + #{Dr60nYrX84f.MJAGUpeHkpn} + #{KxYCpbMqCgS.a57uWFr3dUy} + #{KxYCpbMqCgS.MJAGUpeHkpn} + #{afSlkJRXW2Y.a57uWFr3dUy} + #{afSlkJRXW2Y.MJAGUpeHkpn}),1
MOH-729B Total NO.Paediatric ART 2nd Line regimens,nPPsW9NSHsu,Total no.Paediatric ART 2nd Line regimens,(#{eQiycM3ONY8.a57uWFr3dUy} + #{eQiycM3ONY8.MJAGUpeHkpn} + #{MnF88CgHUO1.a57uWFr3dUy} + #{MnF88CgHUO1.MJAGUpeHkpn} + #{xEXJBRpH2tR.a57uWFr3dUy} + #{xEXJBRpH2tR.MJAGUpeHkpn} + #{bsyebeUNvDR.a57uWFr3dUy} + #{bsyebeUNvDR.MJAGUpeHkpn} + #{Dw7FUtnE0SQ.a57uWFr3dUy} + #{Dw7FUtnE0SQ.MJAGUpeHkpn} + #{JIK6cm7XHZu.a57uWFr3dUy} + #{JIK6cm7XHZu.MJAGUpeHkpn}),1
MOH-729B Total No. Hepatitis B Patients who are HIV-ve,eVpM9hZHsPA,MOH-729B Total No. HepB Pt HIV-ve,(#{VINh7l122hh} + #{S81s5gZcFXA}),1
MOH-729B Total Number Adult PEP,DsFmAa7Ib4D,MOH-729B Total Number Adult PEP,(#{eq4rc07ARwD} + #{AYNAyx4h883} + #{Neqx6RwDm6r}),1
MOH-729B Total Patient NO. on Adult ART 1st Line regimens,elTsv32rHfB,Total Patient NO. on Adult ART 1st Line regimens,(#{kNokscGppSN.a57uWFr3dUy} + #{kNokscGppSN.MJAGUpeHkpn} + #{nvlg1R2lfk7.a57uWFr3dUy} + #{nvlg1R2lfk7.MJAGUpeHkpn} + #{IZzywU15TMV.a57uWFr3dUy} + #{IZzywU15TMV.MJAGUpeHkpn} + #{pVmj4ahWYTE.a57uWFr3dUy} + #{pVmj4ahWYTE.MJAGUpeHkpn} + #{FpMYq4HjT2F.a57uWFr3dUy} + #{FpMYq4HjT2F.MJAGUpeHkpn} + #{dADZ0Nr32OO.a57uWFr3dUy} + #{dADZ0Nr32OO.MJAGUpeHkpn} + #{T5g3NtacUoS.a57uWFr3dUy} + #{T5g3NtacUoS.MJAGUpeHkpn} + #{zm7tSuCWrGj.a57uWFr3dUy} + #{zm7tSuCWrGj.MJAGUpeHkpn} + #{OqRySKfNRgA.a57uWFr3dUy} + #{OqRySKfNRgA.MJAGUpeHkpn} + #{DUvf4JL8jlb.a57uWFr3dUy} + #{DUvf4JL8jlb.MJAGUpeHkpn} + #{pppWCUkRmL3.a57uWFr3dUy} + #{pppWCUkRmL3.MJAGUpeHkpn} + #{lU1W5CAlfl1.a57uWFr3dUy} + #{lU1W5CAlfl1.MJAGUpeHkpn} + #{xQ4pyncPVNv.a57uWFr3dUy} + #{xQ4pyncPVNv.MJAGUpeHkpn} + #{Vk1YlE5Bw80.a57uWFr3dUy} + #{Vk1YlE5Bw80.MJAGUpeHkpn}),1
MOH-729B Total Patient NO. on Adult ART 2nd Line regimens,sOsEUePRlT6,Total Patient No on Adult ART 2nd Line regimens,(#{CZtw0MYeSOM.a57uWFr3dUy} + #{CZtw0MYeSOM.MJAGUpeHkpn} + #{GVb6Ug32hAy.a57uWFr3dUy} + #{GVb6Ug32hAy.MJAGUpeHkpn} + #{M7v8ia6E6Ow.a57uWFr3dUy} + #{M7v8ia6E6Ow.MJAGUpeHkpn} + #{XjiT3TayEmE.a57uWFr3dUy} + #{XjiT3TayEmE.MJAGUpeHkpn} + #{HzO5TxcmtLa.a57uWFr3dUy} + #{HzO5TxcmtLa.MJAGUpeHkpn} + #{XebXlcydH1n.a57uWFr3dUy} + #{XebXlcydH1n.MJAGUpeHkpn} + #{idY7qwCwToV.a57uWFr3dUy} + #{idY7qwCwToV.MJAGUpeHkpn} + #{dFtW19VciD3.a57uWFr3dUy} + #{dFtW19VciD3.MJAGUpeHkpn} + #{V0wBx93ZzWO.a57uWFr3dUy} + #{V0wBx93ZzWO.MJAGUpeHkpn} + #{DTmAM1Xpk8p.a57uWFr3dUy} + #{DTmAM1Xpk8p.MJAGUpeHkpn}),1
MOH-729B Total no. PEP for Adults,z4MupX22XHC,MOH-729B Total no. PEP for Adults,(#{Iqy2oxk9Nzg} + #{R4o8kf2YWjI} + #{Agy3s1vQRgL} + #{nndocQeaNdK}),1
MOH-729B Total no.PEP for Children,QvYG6dy2QvN,MOH-729B Total no.PEP for Children,(#{Ae6Mr5bHV4i} + #{xh9CsCTyiBE} + #{kSdEcRgHmAT}),1
MOH733B Nutrition Diagnosis Total HIV Negative MAM,pUzRUnYnKjw,MOH733B Nutrition Diagnosis Total HIV Negative MAM,#{n94oRd5fbjR.UpLAmG5b9J5} + #{dfbF6bR9IIz.UpLAmG5b9J5} + #{q55MGZQLMBj.UpLAmG5b9J5} + #{V3ULwnX5N4u.UpLAmG5b9J5},1
MOH733B Nutrition Diagnosis Total HIV Negative SAM,RFPl0Gx5A0G,MOH733B Nutrition Diagnosis Total HIV Negative SAM,#{n94oRd5fbjR.Oz4jK0cumb4} + #{dfbF6bR9IIz.Oz4jK0cumb4} + #{q55MGZQLMBj.Oz4jK0cumb4} + #{V3ULwnX5N4u.Oz4jK0cumb4},1
MOH733B Nutrition Diagnosis Total HIV Positive MAM,VgHHSA85Cp3,MOH733B Nutrition Diagnosis Total HIV Positive MAM,#{n94oRd5fbjR.a6fhsBFtV1z} + #{dfbF6bR9IIz.a6fhsBFtV1z} + #{V3ULwnX5N4u.a6fhsBFtV1z} + #{q55MGZQLMBj.a6fhsBFtV1z},1
MOH733B Nutrition Diagnosis Total HIV Positive SAM,q47Uw97KN9Y,MOH733B Nutrition Diagnosis Total HIV Positive SAM,#{n94oRd5fbjR.eEGOD8fIUdA} + #{dfbF6bR9IIz.eEGOD8fIUdA} + #{V3ULwnX5N4u.eEGOD8fIUdA} + #{q55MGZQLMBj.eEGOD8fIUdA},1
MOH733B Nutrition Diagnosis Total MAM,JRKVXs9gp0Z,MOH733B Nutrition Diagnosis Total MAM,#{n94oRd5fbjR.qUe0T7evwKz} + #{dfbF6bR9IIz.qUe0T7evwKz} + #{q55MGZQLMBj.UpLAmG5b9J5} + #{V3ULwnX5N4u.qUe0T7evwKz},1
MOH733B Nutrition Diagnosis Total SAM,UupeALUaCLL,MOH733B Nutrition Diagnosis Total SAM,#{n94oRd5fbjR.mTPUdHyZKse} + #{dfbF6bR9IIz.Oz4jK0cumb4} + #{q55MGZQLMBj.Oz4jK0cumb4} + #{V3ULwnX5N4u.Oz4jK0cumb4},1
MOH733B Rev.2019 ART and co existing infections New Diarrhoea,JKiVnD6wcij,MOH733B Rev.2019 ART and Diarrhoea,#{WzTdoYn3uLK} + #{CU2Tinx3k74} + #{GjXRIgL7zDi.zdzMNcrqCJy} + #{lrlh76SBavS.zdzMNcrqCJy} + #{o6cxRvb7g2O.zdzMNcrqCJy},1
MOH733B Rev.2019 ART and co existing infections New Other OI's	,XvqvFuiN6D4,MOH733B Rev.2019 ART New Other OI's	,#{LTtVluZIkI1} + #{zXVWqaKgmw8} + #{GjXRIgL7zDi.QxNHwgDpSi9} + #{lrlh76SBavS.QxNHwgDpSi9} + #{o6cxRvb7g2O.B2EkWft5kgV},1
MOH733B Rev.2019 ART and co existing infections Revisting ART Initiated	,svgikgUHqdC,MOH733B Rev.2019 ART  Revisting ART Initiated	,#{z7OtSG8bpHG} + #{NgOAo7guGHb} + #{GjXRIgL7zDi.rPQOcPc3iih} + #{lrlh76SBavS.rPQOcPc3iih} + #{o6cxRvb7g2O.rPQOcPc3iih},1
MOH733B Rev.2019 ART and co existing infections Revisting Diarrhoea,cVvHm7umkYB,MOH733B Rev.2019 ARTRevisting Diarrhoea,#{QwFZIBiLfLm} + #{cumZ2DUQHCN} + #{GjXRIgL7zDi.zdzMNcrqCJy} + #{lrlh76SBavS.d4u05Iq9LDo} + #{o6cxRvb7g2O.d4u05Iq9LDo},1
MOH733B Rev.2019 ART and co existing infections Revisting TB+,m1Rptp8Buy6,MOH733B Rev.2019 ART Revisting TB+,#{EV6wQvh0ble} + #{H50HwCw2uyV} + #{GjXRIgL7zDi.u68zm5UO0zh} + #{lrlh76SBavS.u68zm5UO0zh} + #{o6cxRvb7g2O.u68zm5UO0zh},1
MOH733B Rev.2019 ART and existing infections New TB+,OalAhYcjREu,MOH733B Rev.2019 ART and existing inf,#{iMgT8U0qVby} + #{xGgSD7wSF2q} + #{GjXRIgL7zDi.uoZuNbNXbW4} + #{lrlh76SBavS.uoZuNbNXbW4} + #{o6cxRvb7g2O.uoZuNbNXbW4},1
MOH747A_QR_ IUCD Non-Hormonal,W2IVug1x1fl,MOH747A_QR_ IUCD Non-Hormonal,(4 * #{tfPZ6sGgh4q.to0Pssxkq4S} - #{tfPZ6sGgh4q.i9dqmLZr7fd}),1
MOH747A_QR_COC,Wc146fPsfHB,MOH747A_QR_COC,(4 * #{hH9gmEmEhH4.to0Pssxkq4S} - #{hH9gmEmEhH4.i9dqmLZr7fd}),1
MOH747A_QR_DMPA IM,tcFQY9kA3cq,MOH747A_QR_DMPA IM,(4 * #{J6qnTev1LXw.to0Pssxkq4S} - #{J6qnTev1LXw.i9dqmLZr7fd}),1
MOH747A_QR_DMPA SC,Z8mpSzyvlKx,MOH747A_QR_DMPA SC,(4 * #{hXa1xyUMfTa.to0Pssxkq4S} - #{hXa1xyUMfTa.i9dqmLZr7fd}),1
MOH747A_QR_EPILL,wD7452c2FKz,MOH747A_QR_EPILL,(4 * #{qaBPR9wbWku.to0Pssxkq4S} -#{qaBPR9wbWku.i9dqmLZr7fd}),1
MOH747A_QR_Female Condoms,qkFmydCcdMx,MOH747A_QR_Female Condoms,(4 * #{AR7RhdC90IV.to0Pssxkq4S} - #{AR7RhdC90IV.i9dqmLZr7fd}),1
MOH747A_QR_Implant 2-Rod (5 years),TUinMUQ00s7,MOH747A_QR_Implant 2-Rod (5 years),(4*#{MsS41X1GEFr.to0Pssxkq4S}) - (#{MsS41X1GEFr.i9dqmLZr7fd}),1
MOH747A_QR_Implants 1Rod,ekAS55VDG0f,MOH747A_QR_Implants 1Rod,(4*#{XgJfT71Unkn.to0Pssxkq4S}) - (#{XgJfT71Unkn.i9dqmLZr7fd}),1
MOH747A_QR_POP,lsdgKFNx88C,MOH747A_QR_POP,(4*#{dl4JcBnxu0X.to0Pssxkq4S} - #{dl4JcBnxu0X.i9dqmLZr7fd}),1
MOHApplicator sticks MOS,L3KgsHFKshz,MOHApplicator sticks MOS,#{MAJFIOUSZQC.B1sPPfIobef}/#{MAJFIOUSZQC.OV0KZq0N7Pf},1
MOH_364_Rev 2023 Grand Total number of GBV Clients Female,exvrSL6KVtL,MOH_364_Rev 2023Total number of GBV Clients Female,"(#{ls9e3jKJcBJ.nJGOv6yFskK}
 + #{iWSCBUquuLE.nJGOv6yFskK} + #{bpyn4hSTIN4.nJGOv6yFskK} )+ (#{bpyn4hSTIN4.Tf8zVyOvc1j} + #{ls9e3jKJcBJ.Tf8zVyOvc1j} + #{sbq23bJOu5s.Tf8zVyOvc1j} +#{iWSCBUquuLE.Tf8zVyOvc1j}) + (#{ls9e3jKJcBJ.fDce9OVthqj} + #{bpyn4hSTIN4.fDce9OVthqj} + #{sbq23bJOu5s.fDce9OVthqj})  + (#{ls9e3jKJcBJ.hXtjmuYPdCx} + #{bpyn4hSTIN4.hXtjmuYPdCx} + #{sbq23bJOu5s.hXtjmuYPdCx})",1
MOH_364_Rev 2023 Grand Total number of GBV Clients male,NtD8IMQkb9Z,Grand Total number of GBV Clients male,((#{ls9e3jKJcBJ.gLTZoiFaj1E} ) + (#{ls9e3jKJcBJ.TcLzBcFPBnl} + #{sbq23bJOu5s.TcLzBcFPBnl}) + (#{bpyn4hSTIN4.viFzvkU3gqq} + #{sbq23bJOu5s.viFzvkU3gqq}) + (#{sbq23bJOu5s.cbN3KDb839s} + #{ls9e3jKJcBJ.cbN3KDb839s})),1
MOH_364_Rev 2023 Grand Total number of GBV Clients male + Female,GZmE7mtv6xk,Grand Total number of GBV Clients male + Female,"(#{ls9e3jKJcBJ.nJGOv6yFskK}
 + #{iWSCBUquuLE.nJGOv6yFskK} + #{bpyn4hSTIN4.nJGOv6yFskK} )+ (#{bpyn4hSTIN4.Tf8zVyOvc1j} + #{ls9e3jKJcBJ.Tf8zVyOvc1j} + #{sbq23bJOu5s.Tf8zVyOvc1j} +#{iWSCBUquuLE.Tf8zVyOvc1j}) + (#{ls9e3jKJcBJ.fDce9OVthqj} + #{bpyn4hSTIN4.fDce9OVthqj} + #{sbq23bJOu5s.fDce9OVthqj})  + (#{ls9e3jKJcBJ.hXtjmuYPdCx} + #{bpyn4hSTIN4.hXtjmuYPdCx} + #{sbq23bJOu5s.hXtjmuYPdCx}) + ((#{ls9e3jKJcBJ.gLTZoiFaj1E} ) + (#{ls9e3jKJcBJ.TcLzBcFPBnl} + #{sbq23bJOu5s.TcLzBcFPBnl}) + (#{bpyn4hSTIN4.viFzvkU3gqq} + #{sbq23bJOu5s.viFzvkU3gqq}) + (#{sbq23bJOu5s.cbN3KDb839s} + #{ls9e3jKJcBJ.cbN3KDb839s}))",1
MOH_364_Rev 2023 GrandTotal No of survivors testing negative for pregnancy-1st visit,wm3ENKv5h8I,Total No of survivors testing neg preg1st visit,(#{yqpYfBK3NVX.nJGOv6yFskK} + #{yqpYfBK3NVX.Tf8zVyOvc1j} + #{yqpYfBK3NVX.fDce9OVthqj} + #{yqpYfBK3NVX.hXtjmuYPdCx}),1
MOH_364_Rev 2023 Total No of survivors testing negative for pregnancy-1st visit,mOvcdH55C5l,Total No of survivors testing neg preg1st visit,(#{yqpYfBK3NVX.nJGOv6yFskK} + #{yqpYfBK3NVX.Tf8zVyOvc1j} + #{yqpYfBK3NVX.fDce9OVthqj} + #{yqpYfBK3NVX.hXtjmuYPdCx}),1
MOH_364_Rev 2023GrandTotal No. of survivors eligible for Emergency Contraception,kQNF0IZQPgg,Total No. of survivors eligible for EC,(#{wfun9TOq4XI.nJGOv6yFskK} + #{wfun9TOq4XI.Tf8zVyOvc1j} + #{wfun9TOq4XI.fDce9OVthqj} + #{wfun9TOq4XI.hXtjmuYPdCx}),1
MOH_364_Rev 2023GrandTotal Number given Emergency Contraception,fA4kjwtKHJL,Total Number given Emergency Contraception,(#{QY9uJbpHICm.nJGOv6yFskK} + #{QY9uJbpHICm.Tf8zVyOvc1j} + #{QY9uJbpHICm.fDce9OVthqj} + #{QY9uJbpHICm.hXtjmuYPdCx}),1
MOH_364_Rev 2023GrandTotal Number given HPV vaccine Female,EfCfsZdXks5,Total Number given HPV vaccine Female,#{BBdDXswAmG6.Tf8zVyOvc1j},1
MOH_364_Rev 2023GrandTotal Number of FGM  survivors seen,GrEbbHdczlf,Total Number of FGM  survivors seen,(#{bpyn4hSTIN4.nJGOv6yFskK} + #{bpyn4hSTIN4.Tf8zVyOvc1j} + #{bpyn4hSTIN4.fDce9OVthqj} + #{bpyn4hSTIN4.hXtjmuYPdCx}),1
MOH_364_Rev 2023GrandTotal Number of FGM performed at the community ,gvRFqYxZOmX,Total Number of FGM performed at the community ,(#{uSdQP1zEJxj.nJGOv6yFskK} + #{uSdQP1zEJxj.Tf8zVyOvc1j} +  + #{uSdQP1zEJxj.hXtjmuYPdCx}),1
MOH_364_Rev 2023GrandTotal Number of FGM performed by medical professional,xTzsvo44X3m,Total Number of FGM perf by medical professional,(#{h2XpN5sPLeR.nJGOv6yFskK} + #{h2XpN5sPLeR.Tf8zVyOvc1j} + #{h2XpN5sPLeR.fDce9OVthqj} + #{h2XpN5sPLeR.hXtjmuYPdCx}),1
MOH_364_Rev 2023GrandTotal Number of FGM performed in the health facility,oldC04pHhi0,Total Number of FGM perf in the health facility,(#{azY7XuqaFPV.nJGOv6yFskK} + #{azY7XuqaFPV.Tf8zVyOvc1j} + #{azY7XuqaFPV.fDce9OVthqj} + #{azY7XuqaFPV.hXtjmuYPdCx}),1
MOH_364_Rev 2023GrandTotal Number of child marriage survivors seen,Vocen4QhiC7,Total Number of child marriage survivors seen,(#{iWSCBUquuLE.nJGOv6yFskK} + #{iWSCBUquuLE.Tf8zVyOvc1j} + #{iWSCBUquuLE.fDce9OVthqj} + #{iWSCBUquuLE.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total  GBV survivors with disability Female,YHFYBJV4liN,Total  GBV survivors with disability Female,(#{xSVgXBknHLh.nJGOv6yFskK} + #{xSVgXBknHLh.Tf8zVyOvc1j} + #{xSVgXBknHLh.fDce9OVthqj} + #{xSVgXBknHLh.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total  GBV survivors with disability male,NGLSTkbPQZz,Total  GBV survivors with disability male,(#{xSVgXBknHLh.gLTZoiFaj1E} + #{xSVgXBknHLh.TcLzBcFPBnl} + #{xSVgXBknHLh.viFzvkU3gqq} + #{xSVgXBknHLh.cbN3KDb839s}),1
MOH_364_Rev 2023Total  GBV survivors with disability male + Female,W4rI4jK4IDX,Total  GBV survivors with disability male + Female,(#{xSVgXBknHLh.nJGOv6yFskK} + #{xSVgXBknHLh.Tf8zVyOvc1j} + #{xSVgXBknHLh.fDce9OVthqj} + #{xSVgXBknHLh.hXtjmuYPdCx}) + (#{xSVgXBknHLh.gLTZoiFaj1E} + #{xSVgXBknHLh.TcLzBcFPBnl} + #{xSVgXBknHLh.viFzvkU3gqq} + #{xSVgXBknHLh.cbN3KDb839s}),1
MOH_364_Rev 2023Total No. of survivors eligible for Emergency Contraception,jt33gcd8aVQ,Total No. of survivors eligible for EC,(#{wfun9TOq4XI.nJGOv6yFskK} + #{wfun9TOq4XI.Tf8zVyOvc1j} + #{wfun9TOq4XI.fDce9OVthqj} + #{wfun9TOq4XI.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number given Emergency Contraception,SB4g1WU3IIT,Total Number given Emergency Contraception,(#{QY9uJbpHICm.nJGOv6yFskK} + #{QY9uJbpHICm.Tf8zVyOvc1j} + #{QY9uJbpHICm.fDce9OVthqj} + #{QY9uJbpHICm.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number given HPV vaccine Female,f08LyKIFEzB,Total Number given HPV vaccine Female,#{BBdDXswAmG6.Tf8zVyOvc1j},1
MOH_364_Rev 2023Total Number given Hep B vaccine Female,jn2S4dGXsuo,Total Number given Hep B vaccine Female,(#{wZOiiPADPod.nJGOv6yFskK} + #{wZOiiPADPod.Tf8zVyOvc1j} + #{wZOiiPADPod.fDce9OVthqj} + #{wZOiiPADPod.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number given Hep B vaccine male,elSHhesqJxp,Total Number given Hep B vaccine male,(#{wZOiiPADPod.gLTZoiFaj1E} + #{wZOiiPADPod.TcLzBcFPBnl} + #{wZOiiPADPod.viFzvkU3gqq} + #{wZOiiPADPod.cbN3KDb839s}),1
MOH_364_Rev 2023Total Number given Hep B vaccine male + Female,YjjqhqB7FPW,Total Number given Hep B vaccine male + Female,(#{wZOiiPADPod.gLTZoiFaj1E} + #{wZOiiPADPod.TcLzBcFPBnl} + #{wZOiiPADPod.viFzvkU3gqq} + #{wZOiiPADPod.cbN3KDb839s} + #{wZOiiPADPod.nJGOv6yFskK} + #{wZOiiPADPod.Tf8zVyOvc1j} + #{wZOiiPADPod.fDce9OVthqj} + #{wZOiiPADPod.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number given STI prophylaxis /treatment Female,hI09JoXEvz5,Total No. given STI prophylaxis /treatment Female,(#{r9LdD39PEUO.nJGOv6yFskK} + #{r9LdD39PEUO.Tf8zVyOvc1j} + #{r9LdD39PEUO.fDce9OVthqj} + #{r9LdD39PEUO.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number given STI prophylaxis /treatment male,xYwqya9MtDB,Total Number given STI prophylaxis /treatment male,(#{r9LdD39PEUO.gLTZoiFaj1E} + #{r9LdD39PEUO.TcLzBcFPBnl} + #{r9LdD39PEUO.viFzvkU3gqq} + #{r9LdD39PEUO.cbN3KDb839s}),1
MOH_364_Rev 2023Total Number given STI prophylaxis /treatment male + Female,r834t728Z4n,Total No given STI prophylaxis male + Female,(#{r9LdD39PEUO.gLTZoiFaj1E} + #{r9LdD39PEUO.TcLzBcFPBnl} + #{r9LdD39PEUO.viFzvkU3gqq} + #{r9LdD39PEUO.cbN3KDb839s} + #{r9LdD39PEUO.nJGOv6yFskK} + #{r9LdD39PEUO.Tf8zVyOvc1j} + #{r9LdD39PEUO.fDce9OVthqj} + #{r9LdD39PEUO.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number given Tetanus diphtheria (Td) Female,ZlO66qVAekc,Total Number given Tetanus diphtheria (Td) Female,(#{htacdr9tGyh.nJGOv6yFskK} + #{htacdr9tGyh.Tf8zVyOvc1j} + #{htacdr9tGyh.fDce9OVthqj} + #{htacdr9tGyh.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number given Tetanus diphtheria (Td) male,zhyKPoHF7sD,Total Number given Tetanus diphtheria (Td) male,(#{htacdr9tGyh.gLTZoiFaj1E} + #{htacdr9tGyh.TcLzBcFPBnl} + #{htacdr9tGyh.viFzvkU3gqq} + #{htacdr9tGyh.cbN3KDb839s}),1
MOH_364_Rev 2023Total Number given Tetanus diphtheria (Td) male + Female,NUVlQM8nRl0,Total  given Tetanus diphtheria (Td) male + Female,(#{htacdr9tGyh.gLTZoiFaj1E} + #{htacdr9tGyh.TcLzBcFPBnl} + #{htacdr9tGyh.viFzvkU3gqq} + #{htacdr9tGyh.cbN3KDb839s} + #{htacdr9tGyh.nJGOv6yFskK} + #{htacdr9tGyh.Tf8zVyOvc1j} + #{htacdr9tGyh.fDce9OVthqj} + #{htacdr9tGyh.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number of  Intimate Partner Violence survivors seen Female,LeRBveodcc0,Total  Intimate Partner Violence seen Female,(#{sbq23bJOu5s.fDce9OVthqj} + #{sbq23bJOu5s.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number of  Intimate Partner Violence survivors seen male + Female,oLqCGcsE8rq,Total NoInt Partner Violence seen male + Female,(#{sbq23bJOu5s.viFzvkU3gqq} + #{sbq23bJOu5s.cbN3KDb839s} + #{sbq23bJOu5s.fDce9OVthqj} + #{sbq23bJOu5s.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number of  SGBV survivors Female,n2O61ks8sjR,Total Number of  SGBV survivors Female,(#{ls9e3jKJcBJ.nJGOv6yFskK} + #{ls9e3jKJcBJ.Tf8zVyOvc1j} + #{ls9e3jKJcBJ.fDce9OVthqj} + #{ls9e3jKJcBJ.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number of  SGBV survivors male,SCl7uZJk8QT,Total Number of  SGBV survivors male,(#{ls9e3jKJcBJ.gLTZoiFaj1E} + #{ls9e3jKJcBJ.TcLzBcFPBnl} + #{ls9e3jKJcBJ.viFzvkU3gqq} + #{ls9e3jKJcBJ.cbN3KDb839s}),1
MOH_364_Rev 2023Total Number of  SGBV survivors male + Female,EWb3ID2fqPN,Total No of  SGBV survivors male + Female,(#{ls9e3jKJcBJ.gLTZoiFaj1E} + #{ls9e3jKJcBJ.TcLzBcFPBnl} + #{ls9e3jKJcBJ.viFzvkU3gqq} + #{ls9e3jKJcBJ.cbN3KDb839s} + #{ls9e3jKJcBJ.nJGOv6yFskK} + #{ls9e3jKJcBJ.Tf8zVyOvc1j} + #{ls9e3jKJcBJ.fDce9OVthqj} + #{ls9e3jKJcBJ.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number of  survivors HIV negative at 1st visit Female,Zb8A4tWmuXN,Total  survivors HIV negative at 1st visit Female,(#{mLhtPiSiBH4.nJGOv6yFskK} + #{mLhtPiSiBH4.Tf8zVyOvc1j} + #{mLhtPiSiBH4.fDce9OVthqj} + #{mLhtPiSiBH4.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number of  survivors HIV negative at 1st visit male,OLCEccYtWgK,Total survivors HIV negative at 1st visit male,(#{mLhtPiSiBH4.gLTZoiFaj1E} + #{mLhtPiSiBH4.TcLzBcFPBnl} + #{mLhtPiSiBH4.viFzvkU3gqq} + #{mLhtPiSiBH4.cbN3KDb839s}),1
MOH_364_Rev 2023Total Number of  survivors HIV negative at 1st visit male + Female,W9jmgSIlZCe,Total survivors HIV neg at 1st visit male + Female,(#{mLhtPiSiBH4.gLTZoiFaj1E} + #{mLhtPiSiBH4.TcLzBcFPBnl} + #{mLhtPiSiBH4.viFzvkU3gqq} + #{mLhtPiSiBH4.cbN3KDb839s} + #{mLhtPiSiBH4.nJGOv6yFskK} + #{mLhtPiSiBH4.Tf8zVyOvc1j} + #{mLhtPiSiBH4.fDce9OVthqj} + #{mLhtPiSiBH4.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number of  survivors initiated on PEP Female,cZEBAd4ETqf,Total Number of  survivors initiated on PEP Female,(#{LPeR2Fvlyyv.nJGOv6yFskK} + #{LPeR2Fvlyyv.Tf8zVyOvc1j} + #{LPeR2Fvlyyv.fDce9OVthqj} + #{LPeR2Fvlyyv.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number of  survivors initiated on PEP male,xFaoLrXrwcL,Total Number of  survivors initiated on PEP male,(#{LPeR2Fvlyyv.gLTZoiFaj1E} + #{LPeR2Fvlyyv.TcLzBcFPBnl} + #{LPeR2Fvlyyv.viFzvkU3gqq} + #{LPeR2Fvlyyv.cbN3KDb839s}),1
MOH_364_Rev 2023Total Number of  survivors initiated on PEP male + Female,ymxNlduawmp,Total of  survivors initiated on PEP male + Female,(#{LPeR2Fvlyyv.gLTZoiFaj1E} + #{LPeR2Fvlyyv.TcLzBcFPBnl} + #{LPeR2Fvlyyv.viFzvkU3gqq} + #{LPeR2Fvlyyv.cbN3KDb839s} + #{LPeR2Fvlyyv.nJGOv6yFskK} + #{LPeR2Fvlyyv.Tf8zVyOvc1j} + #{LPeR2Fvlyyv.fDce9OVthqj} + #{LPeR2Fvlyyv.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number of  survivors presenting within 72 hours Female,mFccNWSpxgR,Total survivors presenting within 72 hours Female,(#{tyDpvDzvqkQ.nJGOv6yFskK} + #{tyDpvDzvqkQ.Tf8zVyOvc1j} + #{tyDpvDzvqkQ.fDce9OVthqj} + #{tyDpvDzvqkQ.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number of  survivors presenting within 72 hours Male + Female,hkQhgt0Ay3U,Total survivors pre within 72 hrs Female+ male,(#{tyDpvDzvqkQ.gLTZoiFaj1E} + #{tyDpvDzvqkQ.TcLzBcFPBnl} + #{tyDpvDzvqkQ.viFzvkU3gqq} + #{tyDpvDzvqkQ.cbN3KDb839s} + #{tyDpvDzvqkQ.nJGOv6yFskK} + #{tyDpvDzvqkQ.Tf8zVyOvc1j} + #{tyDpvDzvqkQ.fDce9OVthqj} + #{tyDpvDzvqkQ.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number of  survivors presenting within 72 hours male,XwJy7kfEJHt,Total  survivors presenting within 72 hours male,(#{tyDpvDzvqkQ.gLTZoiFaj1E} + #{tyDpvDzvqkQ.TcLzBcFPBnl} + #{tyDpvDzvqkQ.viFzvkU3gqq} + #{tyDpvDzvqkQ.cbN3KDb839s}),1
MOH_364_Rev 2023Total Number of FGM  survivors seen,rhsC3YlufJA,Total Number of FGM  survivors seen,(#{bpyn4hSTIN4.nJGOv6yFskK} + #{bpyn4hSTIN4.Tf8zVyOvc1j} + #{bpyn4hSTIN4.fDce9OVthqj} + #{bpyn4hSTIN4.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number of FGM performed at the community ,YNkMIgmJmOm,Total Number of FGM performed at the community ,(#{uSdQP1zEJxj.nJGOv6yFskK} + #{uSdQP1zEJxj.Tf8zVyOvc1j} +  + #{uSdQP1zEJxj.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number of FGM performed by medical professional,mAFarG9aI8M,Total Number of FGM perf by medical professional,(#{h2XpN5sPLeR.nJGOv6yFskK} + #{h2XpN5sPLeR.Tf8zVyOvc1j} + #{h2XpN5sPLeR.fDce9OVthqj} + #{h2XpN5sPLeR.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number of FGM performed in the health facility,nuFrKQgIEwE,Total Number of FGM perf in the health facility,(#{azY7XuqaFPV.nJGOv6yFskK} + #{azY7XuqaFPV.Tf8zVyOvc1j} + #{azY7XuqaFPV.fDce9OVthqj} + #{azY7XuqaFPV.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number of Intimate Partner Violence survivors seen male,OybRrpcgYTs,Total No. of Intimate Part Violence surv male, (#{sbq23bJOu5s.viFzvkU3gqq} + #{sbq23bJOu5s.cbN3KDb839s}),1
MOH_364_Rev 2023Total Number of child marriage survivors seen,ze0Kc2v7usr,Total Number of child marriage survivors seen,(#{iWSCBUquuLE.nJGOv6yFskK} + #{iWSCBUquuLE.Tf8zVyOvc1j} + #{iWSCBUquuLE.fDce9OVthqj} + #{iWSCBUquuLE.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number of survivors offered trauma counselling and psychological support Female,zhMP5GGemD2,Total counselling and psychological support Female,(#{jqMXLUVGtPE.nJGOv6yFskK} + #{jqMXLUVGtPE.Tf8zVyOvc1j} +  #{jqMXLUVGtPE.fDce9OVthqj} + #{jqMXLUVGtPE.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number of survivors offered trauma counselling and psychological support male,Nz6V9MA4fZh,Total survivors  and psychological support male,(#{jqMXLUVGtPE.gLTZoiFaj1E} + #{jqMXLUVGtPE.TcLzBcFPBnl} + #{jqMXLUVGtPE.viFzvkU3gqq} + #{jqMXLUVGtPE.cbN3KDb839s}),1
MOH_364_Rev 2023Total Number of survivors offered trauma counselling and psychological support male +Female,EPm7WoUgMik,Tot counselling and psychological sup male +Female,(#{jqMXLUVGtPE.gLTZoiFaj1E} + #{jqMXLUVGtPE.TcLzBcFPBnl} + #{jqMXLUVGtPE.viFzvkU3gqq} + #{jqMXLUVGtPE.cbN3KDb839s} + #{jqMXLUVGtPE.nJGOv6yFskK} + #{jqMXLUVGtPE.Tf8zVyOvc1j} + #{jqMXLUVGtPE.fDce9OVthqj} + #{jqMXLUVGtPE.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number of survivors tested for HIV Female,ZSpkgO1wPzD,Total Number of survivors tested for HIV Female,(#{PiCeypB3PKH.nJGOv6yFskK} + #{PiCeypB3PKH.Tf8zVyOvc1j} + #{PiCeypB3PKH.fDce9OVthqj} + #{PiCeypB3PKH.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total Number of survivors tested for HIV male,zU93o9rFvQr,Total Number of survivors tested for HIV male,(#{PiCeypB3PKH.gLTZoiFaj1E} + #{PiCeypB3PKH.TcLzBcFPBnl} + #{PiCeypB3PKH.viFzvkU3gqq} + #{PiCeypB3PKH.cbN3KDb839s}),1
MOH_364_Rev 2023Total Number of survivors tested for HIV male + Female,b0JAPdzpw5C,Total No of survivors tested for HIV male + Female,(#{PiCeypB3PKH.gLTZoiFaj1E} + #{PiCeypB3PKH.TcLzBcFPBnl} + #{PiCeypB3PKH.viFzvkU3gqq} + #{PiCeypB3PKH.cbN3KDb839s} + #{PiCeypB3PKH.nJGOv6yFskK} + #{PiCeypB3PKH.Tf8zVyOvc1j} + #{PiCeypB3PKH.fDce9OVthqj} + #{PiCeypB3PKH.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total number of GBV Clients male,k4ZhCWrPrAY,MOH_364_Rev 2023Total number of GBV Clients male,(#{ls9e3jKJcBJ.gLTZoiFaj1E} ) + (#{ls9e3jKJcBJ.TcLzBcFPBnl} + #{sbq23bJOu5s.TcLzBcFPBnl}) + (#{bpyn4hSTIN4.viFzvkU3gqq} + #{sbq23bJOu5s.viFzvkU3gqq}) + (#{sbq23bJOu5s.cbN3KDb839s} + #{ls9e3jKJcBJ.cbN3KDb839s}),1
MOH_364_Rev 2023Total number of GBV Clients male +Female,aJdMpJYPzoq,Total number of GBV Clients male +Female,"(#{ls9e3jKJcBJ.nJGOv6yFskK}
 + #{iWSCBUquuLE.nJGOv6yFskK} + #{bpyn4hSTIN4.nJGOv6yFskK} )+ (#{bpyn4hSTIN4.Tf8zVyOvc1j} + #{ls9e3jKJcBJ.Tf8zVyOvc1j} + #{sbq23bJOu5s.Tf8zVyOvc1j} +#{iWSCBUquuLE.Tf8zVyOvc1j}) + (#{ls9e3jKJcBJ.fDce9OVthqj} + #{bpyn4hSTIN4.fDce9OVthqj} + #{sbq23bJOu5s.fDce9OVthqj})  + (#{ls9e3jKJcBJ.hXtjmuYPdCx} + #{bpyn4hSTIN4.hXtjmuYPdCx} + #{sbq23bJOu5s.hXtjmuYPdCx}) + (#{ls9e3jKJcBJ.gLTZoiFaj1E} ) + (#{ls9e3jKJcBJ.TcLzBcFPBnl} + #{sbq23bJOu5s.TcLzBcFPBnl}) + (#{bpyn4hSTIN4.viFzvkU3gqq} + #{sbq23bJOu5s.viFzvkU3gqq}) + (#{sbq23bJOu5s.cbN3KDb839s} + #{ls9e3jKJcBJ.cbN3KDb839s})",1
MOH_364_Rev 2023Total number of GBV Clients seen0_9Female,u6FkVcz01ZX,Total number of GBV Clients seen0_9Female,"(#{ls9e3jKJcBJ.nJGOv6yFskK}
 + #{iWSCBUquuLE.nJGOv6yFskK} + #{bpyn4hSTIN4.nJGOv6yFskK} )",1
MOH_364_Rev 2023Total number of GBV Clients seen0_9Male,bHI3OnEgUqF,Total number of GBV Clients seen0_9Male,(#{ls9e3jKJcBJ.gLTZoiFaj1E} ),1
MOH_364_Rev 2023Total number of GBV Clients seen10_17Female,EBq08Cescm8,Total number of GBV Clients seen10_17Female,(#{bpyn4hSTIN4.Tf8zVyOvc1j} + #{ls9e3jKJcBJ.Tf8zVyOvc1j} + #{sbq23bJOu5s.Tf8zVyOvc1j} +#{iWSCBUquuLE.Tf8zVyOvc1j}),1
MOH_364_Rev 2023Total number of GBV Clients seen10_17Male,abHTHXh4cTS,Total number of GBV Clients seen10_17Male,(#{ls9e3jKJcBJ.TcLzBcFPBnl} + #{sbq23bJOu5s.TcLzBcFPBnl}),1
MOH_364_Rev 2023Total number of GBV Clients seen18_49Female,lsOfcV2agJs,Total number of GBV Clients seen18_49Female,(#{ls9e3jKJcBJ.fDce9OVthqj} + #{bpyn4hSTIN4.fDce9OVthqj} + #{sbq23bJOu5s.fDce9OVthqj}),1
MOH_364_Rev 2023Total number of GBV Clients seen18_49Male,iKvRlFhYXFb,2023Total number of GBV Clients seen18_49Male,(#{bpyn4hSTIN4.viFzvkU3gqq} + #{sbq23bJOu5s.viFzvkU3gqq}),1
MOH_364_Rev 2023Total number of GBV Clients seen50+Female,L9btZTrqVmO,Total number of GBV Clients seen50+Female,(#{ls9e3jKJcBJ.hXtjmuYPdCx} + #{bpyn4hSTIN4.hXtjmuYPdCx} + #{sbq23bJOu5s.hXtjmuYPdCx}),1
MOH_364_Rev 2023Total number of GBV Clients seen50+Male,bqd72X1j4rD,Total number of GBV Clients seen50+Male,(#{sbq23bJOu5s.cbN3KDb839s} + #{ls9e3jKJcBJ.cbN3KDb839s}),1
MOS-MoH 730A Revision 2017  TB/ HIV DRUGS Ethambutol 400mg Tab (for Pack of 28 tabs) 28s,jxT03ZBSzC6,MOS-MoH 730A  Ethambutol 400mg Tab ,(#{HNNxzJkRT3X.GvjV9gy3OOc} + #{XYarFhtrZnM.GvjV9gy3OOc}),#{XYarFhtrZnM.yP6vevc91WZ}
MOS-MoH 730A Revision 2017  TB/ HIV DRUGS Isoniazid (H) 100mg Tablets 100s,gUfpDBZn1Qr,MOS-MoH 730A Isoniazid (H) 100mg Tablets 100s,(#{U7MJuTQe0jD.GvjV9gy3OOc} + #{ow27FKynLOP.GvjV9gy3OOc}),#{ow27FKynLOP.yP6vevc91WZ}
MOS-MoH 730A Revision 2017  TB/ HIV DRUGS Isoniazid (H) 10mg/ml (120ml Bottles) 120ml Bottle,T0ZKrZrJIY9,MOS-MoH 730A  Isoniazid  10mg/ml (120ml Bottles) ,(#{T8LUxKSdxVM.GvjV9gy3OOc} + #{hI5dsFlNwro.GvjV9gy3OOc}),#{hI5dsFlNwro.yP6vevc91WZ}
MOS-MoH 730A Revision 2017  TB/ HIV DRUGS Isoniazid (H) 300mg Tabs (for Pack of 100 tabs) 100s,H6TtxBohWoV,MOS-MoH 730A  Isoniazid (H) 300mg Tabs 100s,(#{MVzZPF9Yldh.GvjV9gy3OOc} + #{bjqajaEgKDD.GvjV9gy3OOc}),#{bjqajaEgKDD.yP6vevc91WZ}
MOS-MoH 730A Revision 2017  TB/ HIV DRUGS Isoniazid (H) 300mg Tabs (for Pack of 672 tabs) 672s,OajAL1jLUNT,MOS-MoH 730A  Isoniazid (H) 300mg Tabs 672s,(#{MVzZPF9Yldh.GvjV9gy3OOc} + #{bjqajaEgKDD.GvjV9gy3OOc}),#{bjqajaEgKDD.yP6vevc91WZ}
MOS-MoH 730A Revision 2017  TB/ HIV DRUGS Pyrazinamide 500mg Tab (for Pack of 28 tabs) 28s,rnpThAOUYXG,MOS-MoH 730A Pyrazinamide 500mg Tab 28s,(#{KYj7Frl3A6j.GvjV9gy3OOc} + #{rgrECRA0XVz.GvjV9gy3OOc}),#{rgrECRA0XVz.yP6vevc91WZ}
MOS-MoH 730A Revision 2017  TB/ HIV DRUGS Pyridoxine 25mg Tabs 100s,Hi6KrQ3Mqcc,MOS-MoH 730A  Pyridoxine 25mg Tabs 100s,(#{EaT2A78t25J.GvjV9gy3OOc} + #{noIMGcbffat.GvjV9gy3OOc}),#{EaT2A78t25J.yP6vevc91WZ}
MOS-MoH 730A Revision 2017  TB/ HIV DRUGS Pyridoxine 50mg Tablets 100s,rAvGmlRa5jf,MOS-MoH 730A Pyridoxine 50mg Tablets 100s,(#{r6Vjttmixln.GvjV9gy3OOc} + #{nReJj3EEIHt.GvjV9gy3OOc}),#{r6Vjttmixln.yP6vevc91WZ}
MOS-MoH 730A Revision 2017  TB/ HIV DRUGS Rifabutin 150mg Tab 30s,MCNq70D2atQ,MOS-MoH 730A  Rifabutin 150mg Tab 30s,(#{p5KQL5gDzTs.GvjV9gy3OOc} + #{gjOJC5nWO9W.GvjV9gy3OOc}),#{gjOJC5nWO9W.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Adult preparations  Dolutegravir(DTG) 50mg tabs 30s,kcnlgM9IzYr,MOS-MoH 730A Dolutegravir(DTG) 50mg tabs 30s,(#{L806dq5McGs.GvjV9gy3OOc} + #{Qr8Hx7Nl02R.GvjV9gy3OOc}),#{Qr8Hx7Nl02R.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Adult preparations  Nevirapine (NVP) 200mg Tablets 60s,CPqnXChcGO0,MOS-MoH 730A Nevirapine (NVP) 200mg Tablets 60s,(#{pphp4jO2Zmu.GvjV9gy3OOc} + #{Fo2gnhRx1eB.GvjV9gy3OOc}),#{Fo2gnhRx1eB.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Adult preparations  Tenofovir (TDF) 300mg Tablets 30s,xEzzZ8YatZE,MOS-MoH 730ATenofovir (TDF) 300mg Tablets 30s,(#{Hw9BdL5sFjT.GvjV9gy3OOc} + #{lMHWiV1wfzU.GvjV9gy3OOc}),#{lMHWiV1wfzU.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Adult preparations  Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/400mg) FDC Tablets 30s,I1fJHCza52U,MOS-MoH 730A enofovir/Lamivudine/Efavirenz 30s,(#{rn8h3fzdCxJ.GvjV9gy3OOc} + #{wJTbaU9jnf2.GvjV9gy3OOc}),#{wJTbaU9jnf2.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Adult preparations  Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/600mg) FDC Tablets 30s,DydLV6bysfB,MOS-MoH 730A Tenofovir/Lamivudine/Efavirenz  30s,(#{w1rvXikvYgb.GvjV9gy3OOc} + #{YpjdjMD6yeC.GvjV9gy3OOc}),#{YpjdjMD6yeC.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Adult preparations Abacavir/Lamivudine (ABC/3TC) 120mg/60mg FDC Tablets 30s,DSBPCgmxfE8,MOS-MoH 730A Revision 2017 Abacavir Tablets 30s,(#{SKLDREldu2P.GvjV9gy3OOc} + #{KnOB8nSo99l.GvjV9gy3OOc}),#{KnOB8nSo99l.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Adult preparations Abacavir/Lamivudine (ABC/3TC) 600mg/300mg FDCTablets 60s,Krt3fEBu5Mc,MOS-MoH 730A ABC/3TC) 600mg/300mg FDCTablets 60s,(#{z56Zx3oNT6k.GvjV9gy3OOc} + #{WeA3sq0ELOE.GvjV9gy3OOc}),#{WeA3sq0ELOE.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Adult preparations Efavirenz (EFV) 600mg Tablets 30s,tXJAIwNWegF,MOS-MoH 730A Efavirenz (EFV) 600mg Tablets 30s,(#{BtchKQKI9Zp.GvjV9gy3OOc} + #{JfkxhCPe29t.GvjV9gy3OOc}),#{JfkxhCPe29t.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Adult preparations Lamivudine (3TC) 150mg Tablets 60s,REd30wkVzQZ,MOS-MoH 730A Lamivudine (3TC) 150mg Tablets 60s,(#{NxM8T8jjy8q.GvjV9gy3OOc} + #{jC1clm8DHjU.GvjV9gy3OOc}),#{jC1clm8DHjU.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Adult preparations Lopinavir/ritonavir (LPV/r) 200/50mg Tablets 120s,rSftAKsjE0u,MOS-MoH 730A(LPV/r) 200/50mg Tablets 120s,(#{bzf61UaI7tn.GvjV9gy3OOc} + #{GjYg7sEHVAx.GvjV9gy3OOc}),#{GjYg7sEHVAx.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Adult preparations Raltegravir (RAL) 400mg Tablets 60s,FhGlZCAdIG6,MOS-MoH 730A Raltegravir (RAL) 400mg Tablets 60s,(#{IMDLTkQZgAG.GvjV9gy3OOc} + #{dsZqocFWAqm.GvjV9gy3OOc}),#{IMDLTkQZgAG.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Adult preparations Tenofovir/Emtricitabine (TDF/FTC) FDC (300/200mg) Tablets 30s,Zpb0qxOO15p,MOS-MoH 730A Tenofovir/Emtricitabine 30s,(#{KT42Hlo0nav.GvjV9gy3OOc} + #{Ovk1BBcACSN.GvjV9gy3OOc}),#{Ovk1BBcACSN.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Adult preparations Tenofovir/Lamivudine (TDF/3TC) FDC (300/300mg) Tablets 30s,wvmWnbWQzfF,MOS-MoH 730A  Tenofovir/Lamivudine 30s,(#{w1rvXikvYgb.GvjV9gy3OOc} + #{YpjdjMD6yeC.GvjV9gy3OOc}),#{YpjdjMD6yeC.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Adult preparations Zidovudine (AZT) 300mg Tablets 60s,kDsj6lbaoHA,MOS-MoH 730A Zidovudine (AZT) 300mg Tablets 60s,(#{P0TtNqNdPge.GvjV9gy3OOc} + #{L9VlZFQZGbv.GvjV9gy3OOc}),#{P0TtNqNdPge.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Adult preparations Zidovudine/Lamivudine (AZT/3TC) FDC (300/150mg) Tablets 60s,DaLTpKDI5Fz,MOS-MoH 730A  Zidovudine/Lamivudine 60s, (#{j9ycZIqOK9r.GvjV9gy3OOc} + #{YUbsR6vuIVF.GvjV9gy3OOc}),#{YUbsR6vuIVF.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Adult preparations Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (300/150/200mg) Tablets 60s,CYO8fONCytp,MOS-MoH 730A Zidovudine/Lamivudine/Nevirapine 60s,(#{sI4hUKLxgF3.GvjV9gy3OOc} + #{ZPdNDKh0jtf.GvjV9gy3OOc}),(#{sI4hUKLxgF3.GvjV9gy3OOc} + #{ZPdNDKh0jtf.GvjV9gy3OOc})
MOS-MoH 730A Revision 2017 Medicines for OIs Acyclovir 400mg Tablets 30s,hUbZgC10oos,MoH 730A Revision 2017 ,(#{G79eRBegBQC.GvjV9gy3OOc} + #{ZYYcDSXFHcq.GvjV9gy3OOc}),#{ZYYcDSXFHcq.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Medicines for OIs Cotrimoxazole 960mg Tablets 100s,NmRpzyQB9LW,MOS-MoH 730A Revision 2017 ,(#{Br5f2GZsVcv.GvjV9gy3OOc} + #{uYwZjUIeoY2.GvjV9gy3OOc}),#{uYwZjUIeoY2.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Medicines for OIs Cotrimoxazole suspension 240mg/5ml 100ml bottle,JTvDOJP9dzH,MOS-MoH 730A Revision 2017 ,(#{DfeThidLCMV.GvjV9gy3OOc} + #{rS62iKZ6Idq.GvjV9gy3OOc}),#{rS62iKZ6Idq.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Medicines for OIs Fluconazole 200mg Tablets 100s,jZ033eXYehG,MOS-MoH 730A Revision 2017,(#{wXxwZvfPYpY.GvjV9gy3OOc} + #{BHlhxD6Wjct.GvjV9gy3OOc}),#{BHlhxD6Wjct.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Medicines for Ols Amphotericin B 50mg IV Injection 1vial,aEmbZO2b35O,MOS-MoH 730A Revision 2017 Medicines ,(#{L50s6D0CmoI.GvjV9gy3OOc} + #{Ywi6QrCf4wp.GvjV9gy3OOc}),#{Ywi6QrCf4wp.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Paediatric preparations  Darunavir (DRV) susp 100mg/ml (200ml Bottles),LhNrmzZejzl,MOS-MoH 730A Revision 2017 (200ml Bottles),(#{OIp2FO4CouI.GvjV9gy3OOc} + #{Zp4GO6RalC3.GvjV9gy3OOc}),#{Zp4GO6RalC3.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Paediatric preparations  Efavirenz (EFV) 200mg Tablets 90s,WODGbmIfjwo,MOS-MoH 730A Revision 2017 Tablets 90s,(#{H5eOAm3h1dr.GvjV9gy3OOc} + #{FWfv9nwqQNj.GvjV9gy3OOc}),#{FWfv9nwqQNj.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Paediatric preparations Abacavir/Lamivudine (ABC/3TC) 120mg/60mg FDC Tablets 30s,xqvHU7AU8hR,MoH 730A Revision 2017  Abacavir Tablets 30s,(#{SKLDREldu2P.GvjV9gy3OOc} + #{KnOB8nSo99l.GvjV9gy3OOc}),#{KnOB8nSo99l.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Paediatric preparations Darunavir (DRV) 150mg Tablets 240s,lLbZTxSuLDF,MOS-MoH 730A Revision 2017Tablets 240s,(#{mekSQpOF9HK.GvjV9gy3OOc} + #{Fmu24faR6RP.GvjV9gy3OOc}),#{Fmu24faR6RP.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Paediatric preparations Darunavir (DRV) 75mg Tablets 480s,WamBR7eFcDd,MOS-MoH 730A Revision 2017  Tablets 480s,(#{cruasBPAIjm.GvjV9gy3OOc} + #{YvUG4Tj5pBB.GvjV9gy3OOc}),#{YvUG4Tj5pBB.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Paediatric preparations Etravirine (ETV) 100mg Tablets 60s,BWP7C3Ljrxb,MOS-MoH 730A Revision 2017  Etravirine  60s,(#{Ot6dTlnWqsm.GvjV9gy3OOc} + #{CUkg2rMIBqV.GvjV9gy3OOc}),#{CUkg2rMIBqV.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Paediatric preparations Lamivudine (3TC) liquid 10mg/ml (240ml Bottles),N4kydOGMylG,MOS-MoH 730A 2017 Paediatric  240ml Bottles,(#{ktBUXRrp3tm.GvjV9gy3OOc} + #{k820rGmrG7y.GvjV9gy3OOc}),#{k820rGmrG7y.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Paediatric preparations Lopinavir/ritonavir (LPV/r) 100/25mg Tabs 60s,dzAGvx3DlxI,MOS-MoH 730A Revision 2017 Paediatric 60s,(#{P26n530GcCS.GvjV9gy3OOc} + #{bNwb0BQTiXu.GvjV9gy3OOc}),#{bNwb0BQTiXu.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Paediatric preparations Lopinavir/ritonavir (LPV/r) liquid 80/20mg/ml (60ml Bottles),IxNSMMKlso0,MOS-MoH 730A Revision 2017 (60ml Bottles),(#{J6AWEBA2aJM.GvjV9gy3OOc} + #{GTqdnEoYWpl.GvjV9gy3OOc}),#{GTqdnEoYWpl.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Paediatric preparations Nevirapine (NVP) Susp 10mg/ml (100 ml Bottles),FL7eBMeY8RH,MOS-MoH 730A Revision 2017 Paediatric Nevirapine ,(#{KM2CZvHdtHs.GvjV9gy3OOc} + #{w96pwQ6povd.GvjV9gy3OOc}),#{KM2CZvHdtHs.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Paediatric preparations Ritonavir liquid 80mg/ml (90ml Bottles),Yv6NHrW99Zp,MOS-MoH 730A Revision 2017 Paediatric ,(#{tHmpXCXAhOe.GvjV9gy3OOc} + #{LdqZPGOt7px.GvjV9gy3OOc}),#{LdqZPGOt7px.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Paediatric preparations Zidovudine (AZT) liquid 10mg/ml (240ml Bottles),GQ6aAgf7wqO,MOS-MoH 730A Revision 2017 Paediatric ,(#{wmZ3TqEjUMW.GvjV9gy3OOc} + #{U3h59Gd6zNP.GvjV9gy3OOc}),#{U3h59Gd6zNP.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Paediatric preparations Zidovudine/Lamivudine (AZT/3TC) FDC (60/30mg) Tablets 60s,NBUplmiMrZG,MOS-MoH 730A Revision 2017 Paediatric ,(#{BrUQAzkTHfa.GvjV9gy3OOc} + #{cgSXbyWnsji.GvjV9gy3OOc}),#{cgSXbyWnsji.yP6vevc91WZ}
MOS-MoH 730A Revision 2017 Paediatric preparations Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (60/30/50mg) Tablets 60s,SK9avkpJ4Fo,MOS-MoH 730A Revision 2017 Paediatric ,(#{GIlEEebWrJ3.GvjV9gy3OOc} + #{CV5vmItEeGO.GvjV9gy3OOc}),#{CV5vmItEeGO.yP6vevc91WZ}
MOS-MoH 730A Revision 2019Abacavir/Lamivudine/Dolutegravir (ABC/3TC/DTG) 60mg/30mg/5mg FDC Tablets 60s,btAIi5PUAPd,MOS-MoH 730A Revision 2019Abacavir Tablets 60s,(#{AihGJD0XytK.GvjV9gy3OOc} + #{y849186w1rj.GvjV9gy3OOc}),#{y849186w1rj.yP6vevc91WZ}
MOS-MoH 730A Revision 2019Abacavir/Lamivudine/Lopinavir/ritonavir (ABC/3TC/LPV/r) 60mg/30mg/5mg FDC Tablets 120s,rv65TQxPGdN,MOS-MoH 730A Revision 2019AbacavirTablets 120s,(#{NxkvMYCLnMY.GvjV9gy3OOc} + #{orN14YLwwZM.GvjV9gy3OOc}),#{orN14YLwwZM.yP6vevc91WZ}
MOS-MoH 730A Revision 2019Dolutegravir (DTG) 10mg Dispersible Scored 30s,HUem1aC3fbc,MOS-MoH 730A Revision 2019 Scored 30s,(#{nMt5hTeJQg4.GvjV9gy3OOc} + #{ms3ICb7Ic6Z.GvjV9gy3OOc}),#{ms3ICb7Ic6Z.yP6vevc91WZ}
MOS-MoH 730A Revision 2019Lopinavir/ritonavir (LPV/r) 40/10mg Caps(Pellets) 120s,diaJG44kUBH,MOS-MoH 730A Revision 2019 120s,(#{QQbIGK5mcw0.GvjV9gy3OOc} + #{qvS7TkgQO1f.GvjV9gy3OOc}),#{QQbIGK5mcw0.yP6vevc91WZ}
MOS-MoH 730A Revision 2019Nevirapine (NVP) Susp 10mg/ml (240 ml Bottles),IjpyihpgqJf,MOS-MoH 730A Revision 2019Nevirapine ,(#{oBuilc3mqu6.GvjV9gy3OOc} + #{SeDTXsB8p8g.GvjV9gy3OOc}),#{SeDTXsB8p8g.yP6vevc91WZ}
MOS-MoH 730A Revision 2019Raltegravir (RAL) 100mg Chewable Tablets 60s,lhnBgkWsLlC,MOS-MoH 730A Revision 2019 60s,(#{sfd7avOtG03.GvjV9gy3OOc} + #{aGYM59Vptun.GvjV9gy3OOc}),#{aGYM59Vptun.yP6vevc91WZ}
MOS-MoH 730A Revision 2019Raltegravir (RAL) 25mg Chewable Tablets 60s,qyQU7A2zmF8,MOS-MoH 730A Revision 2019 60s,(#{CUbiGWRdsVM.GvjV9gy3OOc} + #{q7xXQuGgvgB.GvjV9gy3OOc}),#{aGYM59Vptun.yP6vevc91WZ}
MOS-MoH 730A Revision 2019Rifapentine (P) 150mg tab 24s ,DxowK5zccoY,MOS-MoH 730A Rifapentine (P) 150mg tab 24s ,(#{ILCAt8e9uu4.GvjV9gy3OOc} + #{POCEHFzbrPN.GvjV9gy3OOc}),#{ILCAt8e9uu4.yP6vevc91WZ}
MOS-MoH 730A Revision 2019Tenofovir/Lamivudine/Dolutegravir (TDF/3TC/DTG) FDC (300/300/50mg) FDC Tablets 90s,ojiCox9SOh9,MOS-MoH 730A Tenofovir/Lamivudine/Dolutegravir 90s,(#{Rq1rNR8Sari.GvjV9gy3OOc} + #{EqZyS1EUSQc.GvjV9gy3OOc}),#{EqZyS1EUSQc.yP6vevc91WZ}
MOS-MoH 730A Revision 2019Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/400mg) FDC Tablets 90s,UuLG4lktx7X,MOS-MoH 730A Tenofovir/Lamivudine/Efavirenz  ,(#{UNv9tNoU0jr.GvjV9gy3OOc} + #{H6HgMLW2tWl.GvjV9gy3OOc}),#{H6HgMLW2tWl.yP6vevc91WZ}
MOS-MoH 730A Revision 2019Zidovudine (AZT) liquid 10mg/ml (100ml Bottles),hVKPHsLDvOL,MOS-MoH 730A Revision 2019,(#{WHKZw6fXcuj.GvjV9gy3OOc} + #{KRY9yB58imr.GvjV9gy3OOc}),#{KRY9yB58imr.yP6vevc91WZ}
MOS-MoH 730B Revision 2019 Dolutegravir(DTG) 10mg Dispersible Scored 30S,LquRPTZWCLo,MOS-MoH 730B Revision 2019 Dolutegravir Scored 30S,(#{ms3ICb7Ic6Z.GvjV9gy3OOc} + #{nMt5hTeJQg4.GvjV9gy3OOc}),#{ms3ICb7Ic6Z.yP6vevc91WZ}
MOS-MoH 730B Revision 2019Abacavir/Lamivudine/Dolutegravir (ABC/3TC/DTG) 60mg/30mg /5mg FDC TabletsTablets 60S,hJ3cS9V2gyZ,MOS-MoH 730A AbacavirTablets 60s,(#{y849186w1rj.GvjV9gy3OOc} + #{AihGJD0XytK.GvjV9gy3OOc}),#{y849186w1rj.yP6vevc91WZ}
MOS-MoH 730B Revision 2019Abacavir/Lamivudine/Lopinavir/ritonavir (ABC/3TC/LPV/r) 60mg/30mg /5mg FDC Tablets 120s,KL2aIrZ5kdb,MOS-MoH 730B Revision 2019Abacavir Tablets 120s,(#{NxkvMYCLnMY.GvjV9gy3OOc} + #{orN14YLwwZM.GvjV9gy3OOc}),#{orN14YLwwZM.GvjV9gy3OOc}
"Magnesium Sulphate Injection, 500mg/mL (50%), 10mL (Ampoule, 10ml) MoS",P9PNWcxgAHG,"Magnesium Sulphate Injection, 500mg/mL 10mL",#{WbDKZsPHAOK.n8XlCFUpWOG},#{VuGtfH5eHug.QvctQfKAQn3}
Malaria BS Positive Results,Y073EcVeHBR,Malaria BS Positive Results,#{pacXvg8XEYT.nwpzSJ8o7hD} + #{qi4TilPOx6o.nwpzSJ8o7hD},1
Malaria Blood Examination Rate,TSpLeTr16ov,Malaria Blood Examination Rate,#{E64sUrp6DrX.hH6R0ZkxiK0} + #{TSgMfWzStx6.hH6R0ZkxiK0} + #{pacXvg8XEYT.TZ7UnG134RW} + #{qi4TilPOx6o.TZ7UnG134RW} + #{CVHsV294PjK} + #{NeUMw0K561Q} + #{TZHFXJrxbUU} + #{EA3C82Tnftk} + #{vmQj5H8ImG4} + #{nqa34Xgoq3T},#{Mpv8crmnOzy} + #{w5ltvnNihEZ}
Malaria Blood Slide Positivity Rate,ubWDgTG5LlL,Malaria Blood Slide Positivity Rate,#{pacXvg8XEYT.nwpzSJ8o7hD} + #{qi4TilPOx6o.nwpzSJ8o7hD},#{pacXvg8XEYT.TZ7UnG134RW} + #{qi4TilPOx6o.TZ7UnG134RW}
Malaria Blood Slide Positivity Rate (Under 5yrs),bhweC4QMIf0,Malaria Blood Slide Positivity Rate (Under5yrs), #{qi4TilPOx6o.nwpzSJ8o7hD},#{qi4TilPOx6o.TZ7UnG134RW}
Malaria Commodities Results Negative Total,Q2CcJq3aVcR,Malaria Commodities Results Negative Total,#{TSgMfWzStx6.QKy6jjocOLj}+#{TSgMfWzStx6.hH6R0ZkxiK0},1
Malaria Commodities Results Positive Total,JHFzhO8BEtQ,Malaria Commodities Results Positive Total,#{E64sUrp6DrX.QKy6jjocOLj}+#{E64sUrp6DrX.hH6R0ZkxiK0},1
Malaria Commodities Results Total Tests,qLKvTLcJqN8,Malaria Commodities Results Total Tests,#{TSgMfWzStx6.QKy6jjocOLj}+#{TSgMfWzStx6.hH6R0ZkxiK0}+#{E64sUrp6DrX.QKy6jjocOLj}+#{E64sUrp6DrX.hH6R0ZkxiK0},1
Malaria Commodities Results Total Tests(Microscopy),Xg5YxRL6qui,Malaria Commodities Results Total Tests(Microscopy,#{E64sUrp6DrX.QKy6jjocOLj}+#{TSgMfWzStx6.QKy6jjocOLj},1
Malaria Commodities Results Total Tests(RDT),kTybIsWJabF,Malaria Commodities Results Total Tests(RDT),#{E64sUrp6DrX.hH6R0ZkxiK0}+#{TSgMfWzStx6.hH6R0ZkxiK0}+#{FJV0d0Ie4Z1.hH6R0ZkxiK0},1
Malaria I-4 Malaria test positivity rate,Sz15XnWXPoq,Malaria I-4 Malaria test positivity rate,#{E64sUrp6DrX.hH6R0ZkxiK0} + #{pacXvg8XEYT.nwpzSJ8o7hD} + #{qi4TilPOx6o.nwpzSJ8o7hD},#{E64sUrp6DrX.hH6R0ZkxiK0} +  #{TSgMfWzStx6.hH6R0ZkxiK0} + #{pacXvg8XEYT.TZ7UnG134RW} + #{qi4TilPOx6o.TZ7UnG134RW}
Malaria Incidence Rate (per 1000 population)-IDSR,FjdLmmKHVLC,Malaria Incidence Rate (per 1000 population)-IDSR,#{IYnqoV2vlRq.FIYMDBzdabP} + #{IYnqoV2vlRq.ROXPeIvP89X},( #{w5ltvnNihEZ} + #{Mpv8crmnOzy})
Malaria Percentage Negative Rate,Oy1mT81Ajo8,Malaria Percentage Negative Rate,((#{TSgMfWzStx6.QKy6jjocOLj}+#{TSgMfWzStx6.hH6R0ZkxiK0})/(#{TSgMfWzStx6.QKy6jjocOLj}+#{TSgMfWzStx6.hH6R0ZkxiK0}+#{E64sUrp6DrX.QKy6jjocOLj}+#{E64sUrp6DrX.hH6R0ZkxiK0}))*100,1
Malaria Percentage Positive Rate,m4PhAD1W6P7,Malaria Percentage Positive Rate,((#{E64sUrp6DrX.QKy6jjocOLj}+#{E64sUrp6DrX.hH6R0ZkxiK0})/(#{E64sUrp6DrX.hH6R0ZkxiK0}+#{E64sUrp6DrX.QKy6jjocOLj}+#{TSgMfWzStx6.QKy6jjocOLj}+#{TSgMfWzStx6.hH6R0ZkxiK0}))*100,1
Malaria Prevalence Rate (MEW),Cts4ZtaQhfA,Malaria Prevalence Rate (MEW),#{MC1YVLVKkjd.NhSoXUMPK2K},#{NLKRV7bYbVy.NhSoXUMPK2K}
Malaria RDT Postivity Rate - Health Facility,jmRFWENO0fQ,Malaria RDT Postivity Rate,#{E64sUrp6DrX.hH6R0ZkxiK0},#{E64sUrp6DrX.hH6R0ZkxiK0} + #{TSgMfWzStx6.hH6R0ZkxiK0}
Malaria Test Positivity Rate (by RDT),IauqBotHI86,Malaria positivity - RDT,#{vORT3FUaS6P.nwpzSJ8o7hD} +   #{E64sUrp6DrX.hH6R0ZkxiK0},#{vORT3FUaS6P.TZ7UnG134RW} + #{E64sUrp6DrX.hH6R0ZkxiK0} +  #{TSgMfWzStx6.hH6R0ZkxiK0} +  #{FJV0d0Ie4Z1.hH6R0ZkxiK0}
Malaria Test Positivity Rate (by microscopy),lFKCkMJpepP,positivity microscopy,#{pacXvg8XEYT.nwpzSJ8o7hD} + #{qi4TilPOx6o.nwpzSJ8o7hD} +  #{E64sUrp6DrX.QKy6jjocOLj},#{qi4TilPOx6o.TZ7UnG134RW} + #{pacXvg8XEYT.TZ7UnG134RW} + #{E64sUrp6DrX.QKy6jjocOLj} +  #{TSgMfWzStx6.QKy6jjocOLj} + #{FJV0d0Ie4Z1.QKy6jjocOLj}
Malaria Test Positivity Rate - Overall,dPIz1OUvz54,Malaria positivity,#{pacXvg8XEYT.nwpzSJ8o7hD} + #{qi4TilPOx6o.nwpzSJ8o7hD} +  #{E64sUrp6DrX.hH6R0ZkxiK0},#{qi4TilPOx6o.TZ7UnG134RW} + #{pacXvg8XEYT.TZ7UnG134RW} +  #{E64sUrp6DrX.hH6R0ZkxiK0} + #{TSgMfWzStx6.hH6R0ZkxiK0}
Malaria _Vaccine  Proportion of Under 1 Receiving Malaria vaccine Dose 1,VbrBNdhtTRy, Prop of Under 1 Receiving Malaria vaccine Dose 1,#{U46JIUFqgvj},#{pMbuvKvH4rg}
Malaria _Vaccine  dropout rate in children under 1- year-old in the eight malaria lake endemic counties in Kenya,mjtJnVEPGUv,Malaria _Vaccine  dropout rate,#{YXYc1y0jq0f} - #{iWydZEcRX0d},#{YXYc1y0jq0f}
Malaria _Vaccine Proportion of 24-59 months Receiving Malaria vaccine Dose 4	,lKWeajHAkYv,Prop of 24-59 months Rec Malaria vaccine Dose 4	,#{pznTlBTeIb7},#{KNrK5VWTZkx}*0.6
Malaria _Vaccine Proportion of Under 1 Receiving Malaria vaccine Dose 2	,URrssjq15zX,Prop of Under 1 Receiving Malaria vaccine Dose 2	,#{Rhkz9D6hdZV},#{pMbuvKvH4rg}
Malaria _Vaccine Proportion of Under 1 Receiving Malaria vaccine Dose 3	,nMQyDmye7Wm,Prop of Under 1 Receiving Malaria vaccine Dose 3	,#{znLJPgpYjpF},#{pMbuvKvH4rg}
"Malaria cases per 1,000 population",P9ZWsVtFqvQ,Mlr/popn,#{BBZVk4BJ62Y.VOGsN2CJ4V9} + #{BBZVk4BJ62Y.AElGEFxvUmt},#{Mpv8crmnOzy.NhSoXUMPK2K} + #{w5ltvnNihEZ.NhSoXUMPK2K}
Malaria clinical incidence rate,x5wULTwWiJo,Malaria cl. inc rate,#{Lt0FqtnHraW.lHl2rmXpHse}+#{Lt0FqtnHraW.SeDaCnHi3m5} + #{OoakJhWiyZp.lHl2rmXpHse} + #{OoakJhWiyZp.SeDaCnHi3m5},#{NLKRV7bYbVy.NhSoXUMPK2K}
Malaria confirmed cases ratio,Rf4OHVigdrQ,Malaria conf. ratio,#{OoakJhWiyZp.lHl2rmXpHse}+#{OoakJhWiyZp.SeDaCnHi3m5},#{qi4TilPOx6o.TZ7UnG134RW} + #{pacXvg8XEYT.TZ7UnG134RW} + #{vORT3FUaS6P.TZ7UnG134RW}+ #{cPlWFYbBacW.w77uMi1KzOH} + #{Lt0FqtnHraW.lHl2rmXpHse}  + #{Lt0FqtnHraW.SeDaCnHi3m5}
Malaria in pregnancy rate (per 1k),g5YpuF4iYrR,Malaria in pregnancy rate (per 1k),#{gvZmXInRLuD},#{IDeJME1RKqM.NhSoXUMPK2K}
Malaria positivity rate (MEW),P7gMlKmSrDZ,Malaria positivity rate (MEW),#{MC1YVLVKkjd.NhSoXUMPK2K},#{NPuZ6AxuFWw.NhSoXUMPK2K}
Malaria test uptake,GO1jT7G7tx3,Malaria test uptake,#{qi4TilPOx6o.TZ7UnG134RW} + #{pacXvg8XEYT.TZ7UnG134RW} + #{vORT3FUaS6P.TZ7UnG134RW}+ #{cPlWFYbBacW.w77uMi1KzOH},#{qi4TilPOx6o.TZ7UnG134RW} + #{pacXvg8XEYT.TZ7UnG134RW} + #{vORT3FUaS6P.TZ7UnG134RW}+ #{cPlWFYbBacW.w77uMi1KzOH} + #{Lt0FqtnHraW.lHl2rmXpHse}  + #{Lt0FqtnHraW.SeDaCnHi3m5}
Male 0-4 yrs tested for HIV (EPTB),btg2ro6Ic1y,% of Male 0-4yrs tested,#{tZYhz9UkfxJ.k6pLc73EqHg},#{jJSUs0JbSra.k6pLc73EqHg}
Male 0-4yrs tested HIV+ (Tested for HIV) (EPTB),UdHYOnKfNJD,% Male 0-4 yrs tested HIV,#{F7BQXT7ExEh.k6pLc73EqHg},#{tZYhz9UkfxJ.k6pLc73EqHg}
Male 0-4yrs tested HIV+ (Tested for HIV) (PTB+),DhqEGSvTfvK,% Male 0-4yrs tested HIV+,#{m9rOYAy4LZT.k6pLc73EqHg},#{NNkcO5xJ4D8.k6pLc73EqHg}
Male 0-4yrs tested HIV+ (Tested for HIV) (PTB-),u1ooaWHYHyd,%Male 0-4yrs tested HIV,#{pRlwE15DsEF.k6pLc73EqHg},#{DGOE9qBg0S9.k6pLc73EqHg}
Male 0-4yrs tested for HIV (PTB+),pCXasenVfBW,% Male 0-4yrs tested HIV,#{NNkcO5xJ4D8.k6pLc73EqHg},#{mYcTFL89KEW.k6pLc73EqHg}
Male 0-4yrs tested for HIV (PTB-),Jpvhi6w7u3A,% Male 0-4yrs tested ,#{DGOE9qBg0S9.k6pLc73EqHg},#{u8dU1LPUUWD.k6pLc73EqHg}
Male 10-14 yrs tested HIV+ (Tested for HIV) (EPTB),AMct3V7VVvh,% of Male 10-14 yrs te,#{F7BQXT7ExEh.sp5O3uieiaL},#{tZYhz9UkfxJ.sp5O3uieiaL}
Male 10-14 yrs tested HIV+ (Tested for HIV) (PTB+),Rim2vixphBT,% of Male 10-14 yrs t,#{m9rOYAy4LZT.sp5O3uieiaL},#{NNkcO5xJ4D8.sp5O3uieiaL}
Male 10-14 yrs tested HIV+ (Tested for HIV) (PTB-),zkPscznffX4,% of Male 10-14 yrs ,#{pRlwE15DsEF.sp5O3uieiaL},#{DGOE9qBg0S9.sp5O3uieiaL}
Male 10-14 yrs tested for HIV (EPTB),Oi2rSSv9u6G,% of Male 10-14 yrs teste,#{tZYhz9UkfxJ.sp5O3uieiaL},#{jJSUs0JbSra.sp5O3uieiaL}
Male 10-14 yrs tested for HIV (PTB+),B3jFeMkluj4,% of Male 10-14 yrs test,#{NNkcO5xJ4D8.sp5O3uieiaL},#{mYcTFL89KEW.sp5O3uieiaL}
Male 10-14 yrs tested for HIV (PTB-),QqIAcoi9VVY,% of Male 10-14 yrs tes,#{DGOE9qBg0S9.sp5O3uieiaL},#{u8dU1LPUUWD.sp5O3uieiaL}
Male 15-24 yrs tested HIV+ (Tested for HIV) (EPTB),jVsTuQgKZea,% of Male 15-24 yrs te,#{F7BQXT7ExEh.bvvGm4SkxGX},#{tZYhz9UkfxJ.bvvGm4SkxGX}
Male 15-24 yrs tested HIV+ (Tested for HIV) (PTB+),jAh9Q99rCF9,% of Male 15-24 yrs t,#{m9rOYAy4LZT.bvvGm4SkxGX},#{NNkcO5xJ4D8.bvvGm4SkxGX}
Male 15-24 yrs tested HIV+ (Tested for HIV) (PTB-),kWP7eGpk8Uo,% of Male 15-24 yrs ,#{pRlwE15DsEF.bvvGm4SkxGX},#{DGOE9qBg0S9.bvvGm4SkxGX}
Male 15-24 yrs tested for HIV (EPTB),x4fgOIZBs7a,% of Male 15-24 yrs teste,#{tZYhz9UkfxJ.bvvGm4SkxGX},#{jJSUs0JbSra.bvvGm4SkxGX}
Male 15-24 yrs tested for HIV (PTB+),ImtNRgbrlKl,% of Male 15-24 yrs test,#{NNkcO5xJ4D8.bvvGm4SkxGX},#{mYcTFL89KEW.bvvGm4SkxGX}
Male 15-24 yrs tested for HIV (PTB-),IPm0zLrFaLu,% of Male 15-24 yrs tes,#{DGOE9qBg0S9.bvvGm4SkxGX},#{u8dU1LPUUWD.bvvGm4SkxGX}
Male 25-34 yrs tested HIV+ (Tested for HIV) (EPTB),mRFSEIBepTM,% of Male 25-34 yrs te,#{F7BQXT7ExEh.ZlAlLmbVO9k},#{tZYhz9UkfxJ.ZlAlLmbVO9k}
Male 25-34 yrs tested HIV+ (Tested for HIV) (PTB+),toFquL7OvYz,% of Male 25-34 yrs t,#{m9rOYAy4LZT.ZlAlLmbVO9k},#{NNkcO5xJ4D8.ZlAlLmbVO9k}
Male 25-34 yrs tested HIV+ (Tested for HIV) (PTB-),gsgNrbzJeGB,% of Male 25-34 yrs ,#{pRlwE15DsEF.ZlAlLmbVO9k},#{DGOE9qBg0S9.ZlAlLmbVO9k}
Male 25-34 yrs tested for HIV (EPTB),c0rWFWHWibr,% of Male 25-34 yrs teste,#{tZYhz9UkfxJ.ZlAlLmbVO9k},#{jJSUs0JbSra.ZlAlLmbVO9k}
Male 25-34 yrs tested for HIV (PTB+),EyPGSEWfKV6,% of Male 25-34 yrs test,#{NNkcO5xJ4D8.ZlAlLmbVO9k},#{mYcTFL89KEW.ZlAlLmbVO9k}
Male 25-34 yrs tested for HIV (PTB-),cbQyDHWd8Gt,% of Male 25-34 yrs tes,#{DGOE9qBg0S9.ZlAlLmbVO9k},#{u8dU1LPUUWD.ZlAlLmbVO9k}
Male 35-44 yrs tested HIV+ (Tested for HIV) (EPTB),BVK7F9fw1zF,% of Male 35-44 yrs te,#{F7BQXT7ExEh.r5VV8KQkAUG},#{tZYhz9UkfxJ.r5VV8KQkAUG}
Male 35-44 yrs tested HIV+ (Tested for HIV) (PTB+),p3u3Gg5ADXO,% of Male 35-44 yrs t,#{m9rOYAy4LZT.ZlAlLmbVO9k},#{NNkcO5xJ4D8.ZlAlLmbVO9k}
Male 35-44 yrs tested HIV+ (Tested for HIV) (PTB-),XLzo2jKmjNy,% of Male 35-44 yrs ,#{pRlwE15DsEF.r5VV8KQkAUG},#{DGOE9qBg0S9.r5VV8KQkAUG}
Male 35-44 yrs tested for HIV (EPTB),gUROBVvmz08,% of Male 35-44 yrs teste,#{tZYhz9UkfxJ.r5VV8KQkAUG},#{jJSUs0JbSra.r5VV8KQkAUG}
Male 35-44 yrs tested for HIV (PTB+),foIpMlB71NV,% of Male 35-44 yrs test,#{NNkcO5xJ4D8.r5VV8KQkAUG},#{mYcTFL89KEW.r5VV8KQkAUG}
Male 35-44 yrs tested for HIV (PTB-),jDqQxVmFOAV,% of Male 35-44 yrs tes,#{DGOE9qBg0S9.r5VV8KQkAUG},#{u8dU1LPUUWD.r5VV8KQkAUG}
Male 45-54 yrs tested HIV+ (Tested for HIV) (EPTB),zPiKGZJgBQn,% of Male 45-54 yrs te,#{F7BQXT7ExEh.Bhcon9Mwf1x},#{tZYhz9UkfxJ.Bhcon9Mwf1x}
Male 45-54 yrs tested HIV+ (Tested for HIV) (PTB+),SlcZgXPWjb1,% of Male 45-54 yrs t,#{m9rOYAy4LZT.Bhcon9Mwf1x},#{NNkcO5xJ4D8.Bhcon9Mwf1x}
Male 45-54 yrs tested HIV+ (Tested for HIV) (PTB-),RwS0r4j2RML,% of Male 45-54 yrs ,#{pRlwE15DsEF.Bhcon9Mwf1x},#{DGOE9qBg0S9.Bhcon9Mwf1x}
Male 45-54 yrs tested for HIV (EPTB),FPfYe7ZvgJ6,% of Male 45-54 yrs teste,#{tZYhz9UkfxJ.Bhcon9Mwf1x},#{jJSUs0JbSra.Bhcon9Mwf1x}
Male 45-54 yrs tested for HIV (PTB+),DcUb0xBLLGb,% of Male 45-54 yrs test,#{NNkcO5xJ4D8.Bhcon9Mwf1x},#{mYcTFL89KEW.Bhcon9Mwf1x}
Male 45-54 yrs tested for HIV (PTB-),GaQ007Lo2Ov,% of Male 45-54 yrs tes,#{DGOE9qBg0S9.Bhcon9Mwf1x},#{u8dU1LPUUWD.Bhcon9Mwf1x}
Male 5-9 yrs tested HIV+ (Tested for HIV) (EPTB),RJWQxatYK3L,% of Male 5-9 yrs test,#{F7BQXT7ExEh.ZBKfkjMF8TE},#{tZYhz9UkfxJ.ZBKfkjMF8TE}
Male 5-9 yrs tested HIV+ (Tested for HIV) (PTB+),QjeuVndpMU8,% of Male 5-9 yrs tes,#{m9rOYAy4LZT.ZBKfkjMF8TE},#{NNkcO5xJ4D8.ZBKfkjMF8TE}
Male 5-9 yrs tested HIV+ (Tested for HIV) (PTB-),HBblp9NqJRw,% of Male 5-9 yrs te,#{pRlwE15DsEF.ZBKfkjMF8TE},#{DGOE9qBg0S9.ZBKfkjMF8TE}
Male 5-9 yrs tested for HIV (EPTB),O2SKRKFZE0J,% of Male 5-9 yrs tested ,#{tZYhz9UkfxJ.ZBKfkjMF8TE},#{jJSUs0JbSra.ZBKfkjMF8TE}
Male 5-9 yrs tested for HIV (PTB+),hxGWyKUPno7,% of Male 5-9 yrs tested,#{NNkcO5xJ4D8.ZBKfkjMF8TE},#{mYcTFL89KEW.ZBKfkjMF8TE}
Male 5-9 yrs tested for HIV (PTB-),j3AhrVRVqBa,% of Male 5-9 yrs teste,#{DGOE9qBg0S9.ZBKfkjMF8TE},#{u8dU1LPUUWD.ZBKfkjMF8TE}
Male 55-64 yrs tested HIV+ (Tested for HIV) (EPTB),NnBakzRtBgZ,% of Male 55-64 yrs te,#{F7BQXT7ExEh.RYmHjCLU2CB},#{tZYhz9UkfxJ.RYmHjCLU2CB}
Male 55-64 yrs tested HIV+ (Tested for HIV) (PTB+),dnc2mC5HjY7,% of Male 55-64 yrs t,#{m9rOYAy4LZT.RYmHjCLU2CB},#{NNkcO5xJ4D8.RYmHjCLU2CB}
Male 55-64 yrs tested HIV+ (Tested for HIV) (PTB-),zxnyQfklI7i,% of Male 55-64 yrs ,#{pRlwE15DsEF.RYmHjCLU2CB},#{DGOE9qBg0S9.RYmHjCLU2CB}
Male 55-64 yrs tested for HIV (EPTB),zARsGqJLfjL,% of Male 55-64 yrs teste,#{tZYhz9UkfxJ.RYmHjCLU2CB},#{jJSUs0JbSra.RYmHjCLU2CB}
Male 55-64 yrs tested for HIV (PTB+),j9atiCxwRfx,% of Male 55-64 yrs test,#{NNkcO5xJ4D8.RYmHjCLU2CB},#{mYcTFL89KEW.RYmHjCLU2CB}
Male 55-64 yrs tested for HIV (PTB-),MPIMVgf10jD,% of Male 55-64 yrs tes,#{DGOE9qBg0S9.RYmHjCLU2CB},#{u8dU1LPUUWD.RYmHjCLU2CB}
Male 65+ yrs tested HIV+ (Tested for HIV) (EPTB),rebtsPYJ1LH,% of Male 65+ yrs test,#{F7BQXT7ExEh.DqxmUcaZ8FL},#{tZYhz9UkfxJ.DqxmUcaZ8FL}
Male 65+ yrs tested HIV+ (Tested for HIV) (PTB+),VYJ6A8AGILK,% of Male 65+ yrs tes,#{m9rOYAy4LZT.DqxmUcaZ8FL},#{NNkcO5xJ4D8.DqxmUcaZ8FL}
Male 65+ yrs tested HIV+ (Tested for HIV) (PTB-),Q0jZPupst3w,% of Male 65+ yrs te,#{pRlwE15DsEF.DqxmUcaZ8FL},#{DGOE9qBg0S9.DqxmUcaZ8FL}
Male 65+ yrs tested for HIV (EPTB),PsjbSjCrsio,% of Male 65+ yrs tested ,#{tZYhz9UkfxJ.DqxmUcaZ8FL},#{jJSUs0JbSra.DqxmUcaZ8FL}
Male 65+ yrs tested for HIV (PTB+),UkmtiZs7AQC,% of Male 65+ yrs tested,#{NNkcO5xJ4D8.DqxmUcaZ8FL},#{mYcTFL89KEW.DqxmUcaZ8FL}
Male 65+ yrs tested for HIV (PTB-),t3ILEQgnaHT,% of Male 65+ yrs teste,#{DGOE9qBg0S9.DqxmUcaZ8FL},#{u8dU1LPUUWD.DqxmUcaZ8FL}
Male Condom Dispensed,qJFiaE3DdKs,Male Condom Dispensed,#{HLg3sz4j82I.LkO5M9beZqG},1
Male Condom Ending Balance,OOdh18PjbSx,Male Condom EB,#{HLg3sz4j82I.NvpLpQxmzkZ},1
Male Infants below 6 months on exclusive breastfeeding,UlUoAiVbs51,Male <6month Exclusive Breastfed,#{QUueF25THDC.MJAGUpeHkpn},#{twpy25QKLk9.MJAGUpeHkpn}+#{lvyOQjZaXZ3.MJAGUpeHkpn}+#{ENjll6PbaI8.MJAGUpeHkpn}+#{AIduSzrilaz.MJAGUpeHkpn}+#{QCNHvzgxurQ.MJAGUpeHkpn}
Male partners tested,XFsTUNmoSZp,Male partners tested,#{BnPSZj7YWX4.NhSoXUMPK2K},1
Males_Vaccinated,Jne7PRCsW6Y,Males_Vaccinated,#{myQD3R0GBUq.OfZG3d4UTEe} + #{myQD3R0GBUq.x4bdfcs1Eyf} + #{myQD3R0GBUq.wM9T6slu124} + #{myQD3R0GBUq.KMGJlmXh7fa} + #{myQD3R0GBUq.hsgnO0aLtTH} + #{ZWMO83OyDwx.OfZG3d4UTEe} + #{ZWMO83OyDwx.x4bdfcs1Eyf}  + #{ZWMO83OyDwx.wM9T6slu124} + #{ZWMO83OyDwx.KMGJlmXh7fa} + #{ZWMO83OyDwx.hsgnO0aLtTH} + #{qRQ3LIl7SmG.OfZG3d4UTEe} + #{qRQ3LIl7SmG.x4bdfcs1Eyf} + #{qRQ3LIl7SmG.wM9T6slu124} + #{qRQ3LIl7SmG.KMGJlmXh7fa} + #{qRQ3LIl7SmG.hsgnO0aLtTH} + #{LTJsHtrbyML.OfZG3d4UTEe} + #{LTJsHtrbyML.x4bdfcs1Eyf} + #{LTJsHtrbyML.wM9T6slu124} + #{LTJsHtrbyML.KMGJlmXh7fa} + #{LTJsHtrbyML.hsgnO0aLtTH} + #{UoaXvx7kTB7.OfZG3d4UTEe} + #{UoaXvx7kTB7.x4bdfcs1Eyf} + #{UoaXvx7kTB7.wM9T6slu124} + #{UoaXvx7kTB7.KMGJlmXh7fa} + #{UoaXvx7kTB7.hsgnO0aLtTH} + #{gOksPnou3je.OfZG3d4UTEe} + #{gOksPnou3je.wM9T6slu124} + #{gOksPnou3je.KMGJlmXh7fa} + #{gOksPnou3je.hsgnO0aLtTH} + #{NHd2e6QGCkk.OfZG3d4UTEe} + #{NHd2e6QGCkk.x4bdfcs1Eyf} + #{NHd2e6QGCkk.wM9T6slu124} + #{NHd2e6QGCkk.KMGJlmXh7fa} + #{NHd2e6QGCkk.hsgnO0aLtTH} + #{pkrY92yugfK.x4bdfcs1Eyf} + #{pkrY92yugfK.wM9T6slu124} + #{pkrY92yugfK.KMGJlmXh7fa} + #{pkrY92yugfK.hsgnO0aLtTH} + #{jm6G9QtE6Th.OfZG3d4UTEe} + #{jm6G9QtE6Th.x4bdfcs1Eyf} + #{jm6G9QtE6Th.wM9T6slu124} + #{jm6G9QtE6Th.KMGJlmXh7fa} + #{jm6G9QtE6Th.hsgnO0aLtTH} + #{pkrY92yugfK.OfZG3d4UTEe},1
Maternal HAART Missed Opportunities,kU5ew70I7kj,Maternal HAART Missed Opportunities,(#{nwXS5vxrrr7} + #{hn3aChn4sVx} + #{AfHArvGun12}+#{hHLR1HP8xzI} + #{qSgLzXh46n9}) - (#{lJpaBye9B0H} + #{UMyB7dSIdz1} + #{vkOYqEesPAi} + #{ckPCoAwmWmT} + #{WNFWVHMqPv9}),1
"Maternal Mortality ratio per 100,000",GSUURTiqBkr,"Maternal Mortality ratio per 100,000",#{eBHhfupqMHz.NhSoXUMPK2K} + #{CoAXLBxR0Ik} + #{KDFtI6rqYwI} + #{BYMSIbnUzXQ} + #{AC1Iorxdijc} + #{dPRCstLVkZu},(#{jaPrPmor6WV} + #{rAZBTMa7Jy3} + #{sMqM8DwiAaj} + #{Kx64gGqaFVq})
Maternal deaths audited Performance,udtFToZmLsn,Maternal death Perf,#{kAp7ViUXEKh.NhSoXUMPK2K},#{eiH39gH5CS6.ea7VHlwMkhH}
Measles Wastage Rate,gbepA6x4WV0,Measles Wastage Rate,#{AMVejJGpKI9.NhSoXUMPK2K}+#{smag5V5gz0s.NhSoXUMPK2K}-#{Gk6WlfVitbC.NhSoXUMPK2K}-#{sRbqc5gBQhI.bCfwecaPx2W}+#{sRbqc5gBQhI.ieuodyY5ybC},#{AMVejJGpKI9.NhSoXUMPK2K}+#{smag5V5gz0s.NhSoXUMPK2K}
Measles-Rubella 1 Scorecard,ntk5N5SsHyQ,Measles-Rubella 1 Scorecard,#{sRbqc5gBQhI.ieuodyY5ybC},#{pMbuvKvH4rg.NhSoXUMPK2K}
Measles-rubella dropout rate,BIUZ2pdLqbL,Measles-rubella dropout,#{OyddF1qflzP}-#{sRbqc5gBQhI},#{OyddF1qflzP.ieuodyY5ybC}
Mental_Alcohol use Disorders_New,oBwwCutSIKo,Mental_Alcohol use Disorders_New,#{ftzM2BUTEac.fOfxucEDolz} + #{ftzM2BUTEac.CuMG5YBsnQq} + #{ftzM2BUTEac.pV8UrTqSP0J} + #{ftzM2BUTEac.ByrQMv6BSzA} + #{ftzM2BUTEac.Kg2tjGzgDj4} + #{ftzM2BUTEac.c0ketZ2YS2X} + #{ftzM2BUTEac.FE99ZPWJGCn} + #{ftzM2BUTEac.FdRbTtJCPNZ} + #{ftzM2BUTEac.vdnV0CRugTx} + #{ftzM2BUTEac.q04AhBOLQ7V} + #{ftzM2BUTEac.C6mJaoRjHrP},1
Mental_Alcohol use Disorders_Revisit,qrms0q8GUFd,Alcohol use Disorders,#{ftzM2BUTEac.joYkZip1BOt} + #{ftzM2BUTEac.holZk3EaqIx} + #{ftzM2BUTEac.LM9Kc8XNRkl} + #{ftzM2BUTEac.sKnR5sXLZGJ} + #{ftzM2BUTEac.vL1LaGwzDif} + #{ftzM2BUTEac.cCvVMr685Lg} + #{ftzM2BUTEac.Mg5QcS6W9uQ} + #{ftzM2BUTEac.nfFrx9kddQW} + #{ftzM2BUTEac.iZX4ZP7FCot} + #{ftzM2BUTEac.n7XRPIGbHp7} + #{ftzM2BUTEac.fH2LDYKXQLn} + #{ftzM2BUTEac.JLKljXW2FtJ},1
Mental_Anxiety disorders_New ,mTZWkZdF6C3,Mental_Anxiety disorders_New ,#{YTsnQpgHBYW.fOfxucEDolz} + #{YTsnQpgHBYW.CuMG5YBsnQq} + #{YTsnQpgHBYW.pV8UrTqSP0J} + #{YTsnQpgHBYW.ByrQMv6BSzA} + #{YTsnQpgHBYW.Kg2tjGzgDj4} + #{YTsnQpgHBYW.c0ketZ2YS2X} + #{YTsnQpgHBYW.FE99ZPWJGCn} + #{YTsnQpgHBYW.FdRbTtJCPNZ} + #{YTsnQpgHBYW.vdnV0CRugTx} + #{YTsnQpgHBYW.q04AhBOLQ7V} + #{YTsnQpgHBYW.C6mJaoRjHrP} + #{YTsnQpgHBYW.exYUulGr9S8},1
Mental_Anxiety disorders_New Visit_Male,K88hOdUz03e,Mental_Anxiety disorders_New Visit_Male,#{YTsnQpgHBYW.fOfxucEDolz} + #{YTsnQpgHBYW.pV8UrTqSP0J} + #{YTsnQpgHBYW.Kg2tjGzgDj4} + #{YTsnQpgHBYW.FE99ZPWJGCn} + #{YTsnQpgHBYW.vdnV0CRugTx} + #{YTsnQpgHBYW.C6mJaoRjHrP},1
Mental_Anxiety disorders_Revisit,a1isBAowUQE,Anxiety disorders,#{YTsnQpgHBYW.joYkZip1BOt} + #{YTsnQpgHBYW.holZk3EaqIx} + #{YTsnQpgHBYW.LM9Kc8XNRkl} + #{YTsnQpgHBYW.sKnR5sXLZGJ} + #{YTsnQpgHBYW.vL1LaGwzDif} + #{YTsnQpgHBYW.cCvVMr685Lg} + #{YTsnQpgHBYW.Mg5QcS6W9uQ} + #{YTsnQpgHBYW.nfFrx9kddQW} + #{YTsnQpgHBYW.iZX4ZP7FCot} + #{YTsnQpgHBYW.n7XRPIGbHp7} + #{YTsnQpgHBYW.fH2LDYKXQLn} + #{YTsnQpgHBYW.JLKljXW2FtJ},1
Mental_Anxiety disorders_Revisit,orMME1r1l5h,Mental_Anxiety disorders_Revisit,#{YTsnQpgHBYW.joYkZip1BOt} + #{YTsnQpgHBYW.LM9Kc8XNRkl} + #{YTsnQpgHBYW.vL1LaGwzDif} + #{YTsnQpgHBYW.Mg5QcS6W9uQ} + #{YTsnQpgHBYW.iZX4ZP7FCot} + #{YTsnQpgHBYW.fH2LDYKXQLn},1
Mental_Bipolar disorders_New,hu6ChrILPpk,Mental_Bipolar disorders_New,#{sMMdZwX4D0t.fOfxucEDolz} + #{sMMdZwX4D0t.CuMG5YBsnQq} + #{sMMdZwX4D0t.pV8UrTqSP0J} + #{sMMdZwX4D0t.ByrQMv6BSzA} + #{sMMdZwX4D0t.Kg2tjGzgDj4} + #{sMMdZwX4D0t.FE99ZPWJGCn} + #{sMMdZwX4D0t.FdRbTtJCPNZ} + #{sMMdZwX4D0t.vdnV0CRugTx} + #{sMMdZwX4D0t.q04AhBOLQ7V} + #{sMMdZwX4D0t.C6mJaoRjHrP} + #{sMMdZwX4D0t.JLKljXW2FtJ} + #{sMMdZwX4D0t.c0ketZ2YS2X},1
Mental_Bipolar disorders_New Visit,Juog3LkUPhC,Mental_Bipolar disorders_New Visit,#{sMMdZwX4D0t.CuMG5YBsnQq} + #{sMMdZwX4D0t.pV8UrTqSP0J} + #{sMMdZwX4D0t.Kg2tjGzgDj4} + #{sMMdZwX4D0t.FE99ZPWJGCn} + #{sMMdZwX4D0t.vdnV0CRugTx} + #{sMMdZwX4D0t.C6mJaoRjHrP},1
Mental_Bipolar disorders_Revisit,JtCcy7ne1aa,Mental_Bipolar disorders_Revisit,#{sMMdZwX4D0t.joYkZip1BOt} + #{sMMdZwX4D0t.LM9Kc8XNRkl} + #{sMMdZwX4D0t.vL1LaGwzDif} + #{sMMdZwX4D0t.Mg5QcS6W9uQ} + #{sMMdZwX4D0t.iZX4ZP7FCot} + #{sMMdZwX4D0t.fH2LDYKXQLn},1
Mental_Bipolar disorders_Revisit,Y6tI1cHkjfe,Bipolar disorders,#{sMMdZwX4D0t.joYkZip1BOt} + #{sMMdZwX4D0t.holZk3EaqIx} + #{sMMdZwX4D0t.LM9Kc8XNRkl} + #{sMMdZwX4D0t.sKnR5sXLZGJ} + #{sMMdZwX4D0t.vL1LaGwzDif} + #{sMMdZwX4D0t.cCvVMr685Lg} + #{sMMdZwX4D0t.Mg5QcS6W9uQ} + #{sMMdZwX4D0t.nfFrx9kddQW} + #{sMMdZwX4D0t.iZX4ZP7FCot} + #{sMMdZwX4D0t.n7XRPIGbHp7} + #{sMMdZwX4D0t.fH2LDYKXQLn} + #{sMMdZwX4D0t.JLKljXW2FtJ},1
Mental_Depressive disorders_New,xQRh7gDeApo,Mental_Depressive disorders_New,#{MGz2u65FXIx.CuMG5YBsnQq} + #{MGz2u65FXIx.pV8UrTqSP0J} + #{MGz2u65FXIx.ByrQMv6BSzA} + #{MGz2u65FXIx.Kg2tjGzgDj4} + #{MGz2u65FXIx.c0ketZ2YS2X} + #{MGz2u65FXIx.FE99ZPWJGCn}  + #{MGz2u65FXIx.FdRbTtJCPNZ} + #{MGz2u65FXIx.vdnV0CRugTx} + #{MGz2u65FXIx.q04AhBOLQ7V} + #{MGz2u65FXIx.C6mJaoRjHrP} + #{MGz2u65FXIx.exYUulGr9S8} + #{MGz2u65FXIx.fOfxucEDolz},1
Mental_Depressive disorders_New Visits,NOOepHfzFX1,Mental_Depressive disorders_New Visits,#{MGz2u65FXIx.fOfxucEDolz} + #{MGz2u65FXIx.pV8UrTqSP0J} + #{MGz2u65FXIx.Kg2tjGzgDj4} + #{MGz2u65FXIx.FE99ZPWJGCn} + #{MGz2u65FXIx.vdnV0CRugTx} + #{MGz2u65FXIx.C6mJaoRjHrP},1
Mental_Depressive disorders_Revisit,w8pH8kq3iXR,Depressive disorders,#{MGz2u65FXIx.joYkZip1BOt} + #{MGz2u65FXIx.holZk3EaqIx} + #{MGz2u65FXIx.LM9Kc8XNRkl} + #{MGz2u65FXIx.sKnR5sXLZGJ} + #{MGz2u65FXIx.vL1LaGwzDif} + #{MGz2u65FXIx.cCvVMr685Lg} + #{MGz2u65FXIx.Mg5QcS6W9uQ} + #{MGz2u65FXIx.nfFrx9kddQW} + #{MGz2u65FXIx.iZX4ZP7FCot} + #{MGz2u65FXIx.n7XRPIGbHp7} + #{MGz2u65FXIx.fH2LDYKXQLn} + #{MGz2u65FXIx.JLKljXW2FtJ},1
Mental_Depressive disorders_Revisit,zrycpF4w1Di,Mental_Depressive disorders_Revisit,#{MGz2u65FXIx.joYkZip1BOt} + #{MGz2u65FXIx.LM9Kc8XNRkl} + #{MGz2u65FXIx.vL1LaGwzDif} + #{MGz2u65FXIx.Mg5QcS6W9uQ} + #{MGz2u65FXIx.iZX4ZP7FCot} + #{MGz2u65FXIx.fH2LDYKXQLn},1
Mental_Disruptive impulse control & conduct disorder_New,JZlSxWVTTTU,Disruptive impulse control & conduct disorder,#{JXKly1atg0L.fOfxucEDolz} + #{JXKly1atg0L.CuMG5YBsnQq} + #{JXKly1atg0L.pV8UrTqSP0J} + #{JXKly1atg0L.ByrQMv6BSzA} + #{JXKly1atg0L.Kg2tjGzgDj4} + #{JXKly1atg0L.c0ketZ2YS2X} + #{JXKly1atg0L.FE99ZPWJGCn} + #{JXKly1atg0L.FdRbTtJCPNZ} + #{JXKly1atg0L.vdnV0CRugTx} + #{JXKly1atg0L.q04AhBOLQ7V} + #{JXKly1atg0L.C6mJaoRjHrP} + #{JXKly1atg0L.exYUulGr9S8},1
Mental_Disruptive impulse control & conduct disorder_Revisit,r4MRc9MRZCp,Disruptive impulse control & conduct disorder,#{JXKly1atg0L.joYkZip1BOt} + #{JXKly1atg0L.holZk3EaqIx} + #{JXKly1atg0L.LM9Kc8XNRkl} + #{JXKly1atg0L.sKnR5sXLZGJ} + #{JXKly1atg0L.vL1LaGwzDif} + #{JXKly1atg0L.cCvVMr685Lg} + #{JXKly1atg0L.Mg5QcS6W9uQ} + #{JXKly1atg0L.nfFrx9kddQW} + #{JXKly1atg0L.iZX4ZP7FCot} + #{JXKly1atg0L.n7XRPIGbHp7} + #{JXKly1atg0L.fH2LDYKXQLn} + #{JXKly1atg0L.JLKljXW2FtJ},1
Mental_Eating disorders_New,ooyUFeYHQqS,Eating disorders,#{BDXeokZy7ON.fOfxucEDolz} + #{BDXeokZy7ON.CuMG5YBsnQq} + #{BDXeokZy7ON.pV8UrTqSP0J} + #{BDXeokZy7ON.ByrQMv6BSzA} + #{BDXeokZy7ON.Kg2tjGzgDj4} + #{BDXeokZy7ON.c0ketZ2YS2X} + #{BDXeokZy7ON.FE99ZPWJGCn} + #{BDXeokZy7ON.FdRbTtJCPNZ} + #{BDXeokZy7ON.vdnV0CRugTx} + #{BDXeokZy7ON.q04AhBOLQ7V} + #{BDXeokZy7ON.C6mJaoRjHrP} + #{BDXeokZy7ON.exYUulGr9S8},1
Mental_Eating disorders_Revisit,wOKN7kxz0gt,Eating disorders,#{BDXeokZy7ON.joYkZip1BOt} + #{BDXeokZy7ON.holZk3EaqIx} + #{BDXeokZy7ON.LM9Kc8XNRkl} + #{BDXeokZy7ON.sKnR5sXLZGJ} + #{BDXeokZy7ON.vL1LaGwzDif} + #{BDXeokZy7ON.cCvVMr685Lg} + #{BDXeokZy7ON.Mg5QcS6W9uQ} + #{BDXeokZy7ON.nfFrx9kddQW} + #{BDXeokZy7ON.iZX4ZP7FCot} + #{BDXeokZy7ON.n7XRPIGbHp7} + #{BDXeokZy7ON.fH2LDYKXQLn} + #{BDXeokZy7ON.JLKljXW2FtJ},1
Mental_Neurocognitive disorders_New,V955fX4LrUE,Mental_Neurocognitive disorders_New,#{wK5xigkyqb7.fOfxucEDolz} + #{wK5xigkyqb7.CuMG5YBsnQq} + #{wK5xigkyqb7.pV8UrTqSP0J} + #{wK5xigkyqb7.ByrQMv6BSzA} + #{wK5xigkyqb7.Kg2tjGzgDj4} + #{wK5xigkyqb7.c0ketZ2YS2X} + #{wK5xigkyqb7.FE99ZPWJGCn} + #{wK5xigkyqb7.FdRbTtJCPNZ} + #{wK5xigkyqb7.vdnV0CRugTx} + #{wK5xigkyqb7.q04AhBOLQ7V} + #{wK5xigkyqb7.C6mJaoRjHrP} + #{wK5xigkyqb7.exYUulGr9S8},1
Mental_Neurocognitive disorders_Revisit,MN2ZvewLnX6,Neurocognitive disorders,#{wK5xigkyqb7.joYkZip1BOt} + #{wK5xigkyqb7.holZk3EaqIx} + #{wK5xigkyqb7.LM9Kc8XNRkl} + #{wK5xigkyqb7.sKnR5sXLZGJ} + #{wK5xigkyqb7.vL1LaGwzDif} + #{wK5xigkyqb7.cCvVMr685Lg} + #{wK5xigkyqb7.Mg5QcS6W9uQ} + #{wK5xigkyqb7.nfFrx9kddQW} + #{wK5xigkyqb7.iZX4ZP7FCot} + #{wK5xigkyqb7.n7XRPIGbHp7} + #{wK5xigkyqb7.fH2LDYKXQLn} + #{wK5xigkyqb7.JLKljXW2FtJ},1
Mental_Neurodevelopmental disorders_New,mrpCCxubAqI,Mental_Neurodevelopmental disorders_New,#{yeDqLDZS5rn.fOfxucEDolz} + #{yeDqLDZS5rn.CuMG5YBsnQq} + #{yeDqLDZS5rn.pV8UrTqSP0J} + #{yeDqLDZS5rn.ByrQMv6BSzA} + #{yeDqLDZS5rn.Kg2tjGzgDj4} + #{yeDqLDZS5rn.c0ketZ2YS2X} + #{yeDqLDZS5rn.FE99ZPWJGCn} + #{yeDqLDZS5rn.FdRbTtJCPNZ} + #{yeDqLDZS5rn.vdnV0CRugTx} + #{yeDqLDZS5rn.q04AhBOLQ7V} + #{yeDqLDZS5rn.C6mJaoRjHrP} + #{yeDqLDZS5rn.exYUulGr9S8},1
Mental_Neurodevelopmental disorders_New Visit,wwYjJ90zN5M,Mental_Neurodevelopmental disorders_New Visit,#{yeDqLDZS5rn.joYkZip1BOt} + #{yeDqLDZS5rn.pV8UrTqSP0J} + #{yeDqLDZS5rn.Kg2tjGzgDj4} + #{yeDqLDZS5rn.FE99ZPWJGCn} + #{yeDqLDZS5rn.vdnV0CRugTx} + #{yeDqLDZS5rn.C6mJaoRjHrP},1
Mental_Neurodevelopmental disorders_Revisit,wn59RU025oX,Neurodevelopmental disorders, #{yeDqLDZS5rn.joYkZip1BOt} + #{yeDqLDZS5rn.holZk3EaqIx} + #{yeDqLDZS5rn.LM9Kc8XNRkl} + #{yeDqLDZS5rn.sKnR5sXLZGJ} + #{yeDqLDZS5rn.vL1LaGwzDif} + #{yeDqLDZS5rn.cCvVMr685Lg} + #{yeDqLDZS5rn.Mg5QcS6W9uQ} + #{yeDqLDZS5rn.nfFrx9kddQW} + #{yeDqLDZS5rn.iZX4ZP7FCot} + #{yeDqLDZS5rn.n7XRPIGbHp7} + #{yeDqLDZS5rn.fH2LDYKXQLn} + #{yeDqLDZS5rn.JLKljXW2FtJ},1
Mental_Obsessive-compulsive & related disorders_New,YCxAuBkUz7n,Obsessive-compulsive & related disorders,#{F255f6YXS4N.fOfxucEDolz} + #{F255f6YXS4N.CuMG5YBsnQq} + #{F255f6YXS4N.pV8UrTqSP0J} + #{F255f6YXS4N.ByrQMv6BSzA} + #{F255f6YXS4N.Kg2tjGzgDj4} + #{F255f6YXS4N.c0ketZ2YS2X} + #{F255f6YXS4N.FE99ZPWJGCn} + #{F255f6YXS4N.FdRbTtJCPNZ} + #{F255f6YXS4N.vdnV0CRugTx} + #{F255f6YXS4N.q04AhBOLQ7V} + #{F255f6YXS4N.C6mJaoRjHrP} + #{F255f6YXS4N.exYUulGr9S8},1
Mental_Obsessive-compulsive & related disorders_Revisit,HSCjJ4VyJoX,Obsessive-compulsive & related disorders,#{F255f6YXS4N.joYkZip1BOt} + #{F255f6YXS4N.holZk3EaqIx} + #{F255f6YXS4N.LM9Kc8XNRkl} + #{F255f6YXS4N.sKnR5sXLZGJ} + #{F255f6YXS4N.vL1LaGwzDif} + #{F255f6YXS4N.cCvVMr685Lg} + #{F255f6YXS4N.Mg5QcS6W9uQ} + #{F255f6YXS4N.nfFrx9kddQW} + #{F255f6YXS4N.iZX4ZP7FCot} + #{F255f6YXS4N.n7XRPIGbHp7} + #{F255f6YXS4N.fH2LDYKXQLn} + #{F255f6YXS4N.JLKljXW2FtJ},1
Mental_Other Behavioral adictions_New,JJ6hYFAzWxC,Mental_Other Behavioral adictions_New,#{Knjut7Bo7y6.fOfxucEDolz} + #{Knjut7Bo7y6.CuMG5YBsnQq} + #{Knjut7Bo7y6.pV8UrTqSP0J} + #{Knjut7Bo7y6.ByrQMv6BSzA} + #{Knjut7Bo7y6.Kg2tjGzgDj4} + #{Knjut7Bo7y6.c0ketZ2YS2X} + #{Knjut7Bo7y6.FE99ZPWJGCn} + #{Knjut7Bo7y6.FdRbTtJCPNZ} + #{Knjut7Bo7y6.vdnV0CRugTx} + #{Knjut7Bo7y6.q04AhBOLQ7V} + #{Knjut7Bo7y6.C6mJaoRjHrP} + #{Knjut7Bo7y6.exYUulGr9S8},1
Mental_Other Behavioral adictions_Revisit,j7fjTNTwQ0u,Other Behavioral adictions,#{Knjut7Bo7y6.joYkZip1BOt} + #{Knjut7Bo7y6.holZk3EaqIx} + #{Knjut7Bo7y6.LM9Kc8XNRkl} + #{Knjut7Bo7y6.sKnR5sXLZGJ} + #{Knjut7Bo7y6.vL1LaGwzDif} + #{Knjut7Bo7y6.cCvVMr685Lg} + #{Knjut7Bo7y6.Mg5QcS6W9uQ} + #{Knjut7Bo7y6.nfFrx9kddQW} + #{Knjut7Bo7y6.iZX4ZP7FCot} + #{Knjut7Bo7y6.n7XRPIGbHp7} + #{Knjut7Bo7y6.fH2LDYKXQLn} + #{Knjut7Bo7y6.JLKljXW2FtJ},1
Mental_Other Disorders due to substance use_New,KcGOrgehhl0,Mental_Other Disorders due to substance use_New,#{krqxYoEUtti.fOfxucEDolz} + #{krqxYoEUtti.CuMG5YBsnQq} + #{krqxYoEUtti.pV8UrTqSP0J} + #{krqxYoEUtti.ByrQMv6BSzA} + #{krqxYoEUtti.Kg2tjGzgDj4} + #{krqxYoEUtti.c0ketZ2YS2X} + #{krqxYoEUtti.FE99ZPWJGCn} + #{krqxYoEUtti.FdRbTtJCPNZ} + #{krqxYoEUtti.vdnV0CRugTx} + #{krqxYoEUtti.q04AhBOLQ7V} + #{krqxYoEUtti.C6mJaoRjHrP} + #{krqxYoEUtti.exYUulGr9S8},1
Mental_Other Disorders due to substance use_Revisit,C7u4clL6ZNe,Other Disorders due to substance use,#{krqxYoEUtti.joYkZip1BOt} + #{krqxYoEUtti.holZk3EaqIx} + #{krqxYoEUtti.LM9Kc8XNRkl} + #{krqxYoEUtti.sKnR5sXLZGJ} + #{krqxYoEUtti.vL1LaGwzDif} + #{krqxYoEUtti.cCvVMr685Lg} + #{krqxYoEUtti.Mg5QcS6W9uQ} + #{krqxYoEUtti.nfFrx9kddQW} + #{krqxYoEUtti.iZX4ZP7FCot} + #{krqxYoEUtti.n7XRPIGbHp7} + #{krqxYoEUtti.fH2LDYKXQLn} + #{krqxYoEUtti.JLKljXW2FtJ},1
Mental_Other Psychotic disorders_New,X58pcPkdjRY,Mental_Other Psychotic disorders_New,#{JML3BARhFcV.fOfxucEDolz} + #{JML3BARhFcV.CuMG5YBsnQq} + #{JML3BARhFcV.pV8UrTqSP0J} + #{JML3BARhFcV.ByrQMv6BSzA} + #{JML3BARhFcV.Kg2tjGzgDj4} + #{JML3BARhFcV.c0ketZ2YS2X} + #{JML3BARhFcV.FE99ZPWJGCn} + #{JML3BARhFcV.FdRbTtJCPNZ} + #{JML3BARhFcV.vdnV0CRugTx} + #{JML3BARhFcV.q04AhBOLQ7V} + #{JML3BARhFcV.C6mJaoRjHrP} + #{JML3BARhFcV.exYUulGr9S8},1
Mental_Other Psychotic disorders_New Visit,tXXqfwLwU6D,Mental_Other Psychotic disorders_New Visit,#{JML3BARhFcV.fOfxucEDolz} + #{JML3BARhFcV.pV8UrTqSP0J} + #{JML3BARhFcV.Kg2tjGzgDj4} + #{JML3BARhFcV.FE99ZPWJGCn} + #{JML3BARhFcV.vdnV0CRugTx} + #{JML3BARhFcV.C6mJaoRjHrP},1
Mental_Other Psychotic disorders_Revisit,zRO8LJIk5Fv,Other Psychotic disorders,#{JML3BARhFcV.joYkZip1BOt} + #{JML3BARhFcV.holZk3EaqIx} + #{JML3BARhFcV.LM9Kc8XNRkl} + #{JML3BARhFcV.sKnR5sXLZGJ} + #{JML3BARhFcV.vL1LaGwzDif} + #{JML3BARhFcV.cCvVMr685Lg} + #{JML3BARhFcV.Mg5QcS6W9uQ} + #{JML3BARhFcV.nfFrx9kddQW} + #{JML3BARhFcV.iZX4ZP7FCot} + #{JML3BARhFcV.n7XRPIGbHp7} + #{JML3BARhFcV.fH2LDYKXQLn} + #{JML3BARhFcV.JLKljXW2FtJ},1
Mental_Perinatal Mental Disorders_New,RCHr4v3WPq3,Mental_Perinatal Mental Disorders_New,#{PhPqJ4vnXWA.fOfxucEDolz} + #{PhPqJ4vnXWA.CuMG5YBsnQq} + #{PhPqJ4vnXWA.pV8UrTqSP0J} + #{PhPqJ4vnXWA.ByrQMv6BSzA} + #{PhPqJ4vnXWA.Kg2tjGzgDj4} + #{PhPqJ4vnXWA.c0ketZ2YS2X} + #{PhPqJ4vnXWA.FE99ZPWJGCn} + #{PhPqJ4vnXWA.FdRbTtJCPNZ} + #{PhPqJ4vnXWA.vdnV0CRugTx} + #{PhPqJ4vnXWA.q04AhBOLQ7V} + #{PhPqJ4vnXWA.C6mJaoRjHrP} + #{PhPqJ4vnXWA.exYUulGr9S8},1
Mental_Perinatal Mental Disorders_Revisit,uLd7LGixg0S,Perinatal Mental Disorders,#{PhPqJ4vnXWA.joYkZip1BOt} + #{PhPqJ4vnXWA.holZk3EaqIx} + #{PhPqJ4vnXWA.LM9Kc8XNRkl} + #{PhPqJ4vnXWA.sKnR5sXLZGJ} + #{PhPqJ4vnXWA.vL1LaGwzDif} + #{PhPqJ4vnXWA.cCvVMr685Lg} + #{PhPqJ4vnXWA.Mg5QcS6W9uQ} + #{PhPqJ4vnXWA.nfFrx9kddQW} + #{PhPqJ4vnXWA.iZX4ZP7FCot} + #{PhPqJ4vnXWA.n7XRPIGbHp7} + #{PhPqJ4vnXWA.fH2LDYKXQLn} + #{PhPqJ4vnXWA.JLKljXW2FtJ},1
Mental_Personality disorders_New,ryTpfA261lK,Personality disorders,#{hFWBTqyCyR8.fOfxucEDolz} + #{hFWBTqyCyR8.CuMG5YBsnQq} + #{hFWBTqyCyR8.pV8UrTqSP0J} + #{hFWBTqyCyR8.ByrQMv6BSzA} + #{hFWBTqyCyR8.Kg2tjGzgDj4} + #{hFWBTqyCyR8.c0ketZ2YS2X} + #{hFWBTqyCyR8.FE99ZPWJGCn} + #{hFWBTqyCyR8.FdRbTtJCPNZ} + #{hFWBTqyCyR8.vdnV0CRugTx} + #{hFWBTqyCyR8.q04AhBOLQ7V} + #{hFWBTqyCyR8.C6mJaoRjHrP} + #{hFWBTqyCyR8.exYUulGr9S8},1
Mental_Personality disorders_Revisit,S4VUcinC6CE,Personality disorders,#{hFWBTqyCyR8.joYkZip1BOt} + #{hFWBTqyCyR8.holZk3EaqIx} + #{hFWBTqyCyR8.LM9Kc8XNRkl} + #{hFWBTqyCyR8.sKnR5sXLZGJ} + #{hFWBTqyCyR8.vL1LaGwzDif} + #{hFWBTqyCyR8.cCvVMr685Lg} + #{hFWBTqyCyR8.Mg5QcS6W9uQ} + #{hFWBTqyCyR8.nfFrx9kddQW} + #{hFWBTqyCyR8.iZX4ZP7FCot} + #{hFWBTqyCyR8.n7XRPIGbHp7} + #{hFWBTqyCyR8.fH2LDYKXQLn} + #{hFWBTqyCyR8.JLKljXW2FtJ},1
Mental_Schizophrenia spectrum disorders_New,zvwP4Q9Mswe,Mental_Schizophrenia spectrum disorders_New,#{pXA8IfrQsgz.fOfxucEDolz} + #{pXA8IfrQsgz.CuMG5YBsnQq} + #{pXA8IfrQsgz.pV8UrTqSP0J} + #{pXA8IfrQsgz.ByrQMv6BSzA} + #{pXA8IfrQsgz.Kg2tjGzgDj4} + #{pXA8IfrQsgz.c0ketZ2YS2X} + #{pXA8IfrQsgz.FE99ZPWJGCn} + #{pXA8IfrQsgz.FdRbTtJCPNZ} + #{pXA8IfrQsgz.vdnV0CRugTx} + #{pXA8IfrQsgz.q04AhBOLQ7V} + #{pXA8IfrQsgz.C6mJaoRjHrP} + #{pXA8IfrQsgz.exYUulGr9S8},1
Mental_Schizophrenia spectrum disorders_New Visits,WnokiqfgHfb,Mental_Schizophrenia spectrum disorders_New Visits,#{pXA8IfrQsgz.fOfxucEDolz} + #{pXA8IfrQsgz.pV8UrTqSP0J} + #{pXA8IfrQsgz.Kg2tjGzgDj4} + #{pXA8IfrQsgz.FE99ZPWJGCn} + #{pXA8IfrQsgz.vdnV0CRugTx} + #{pXA8IfrQsgz.C6mJaoRjHrP},1
Mental_Schizophrenia spectrum disorders_Revisit,qXb4EWMuwU6,Mental_Schizophrenia spectrum disorders_Revisit,#{pXA8IfrQsgz.joYkZip1BOt} + #{pXA8IfrQsgz.LM9Kc8XNRkl} + #{pXA8IfrQsgz.vL1LaGwzDif} + #{pXA8IfrQsgz.Mg5QcS6W9uQ} + #{pXA8IfrQsgz.iZX4ZP7FCot} + #{pXA8IfrQsgz.fH2LDYKXQLn},1
Mental_Schizophrenia spectrum disorders_Revisit,reHwPzrQPUw,Schizophrenia spectrum disorders,#{pXA8IfrQsgz.joYkZip1BOt} + #{pXA8IfrQsgz.holZk3EaqIx} + #{pXA8IfrQsgz.LM9Kc8XNRkl} + #{pXA8IfrQsgz.sKnR5sXLZGJ} + #{pXA8IfrQsgz.vL1LaGwzDif} + #{pXA8IfrQsgz.cCvVMr685Lg} + #{pXA8IfrQsgz.Mg5QcS6W9uQ} + #{pXA8IfrQsgz.nfFrx9kddQW} + #{pXA8IfrQsgz.iZX4ZP7FCot} + #{pXA8IfrQsgz.n7XRPIGbHp7} + #{pXA8IfrQsgz.fH2LDYKXQLn} + #{pXA8IfrQsgz.JLKljXW2FtJ},1
Mental_Sexual dysfunctional disorders_New,rR5whO3r0gI,Sexual dysfunctional disorders,#{wTCQQUip9Lg.fOfxucEDolz} + #{wTCQQUip9Lg.CuMG5YBsnQq} + #{wTCQQUip9Lg.pV8UrTqSP0J} + #{wTCQQUip9Lg.ByrQMv6BSzA} + #{wTCQQUip9Lg.Kg2tjGzgDj4} + #{wTCQQUip9Lg.c0ketZ2YS2X} + #{wTCQQUip9Lg.FE99ZPWJGCn} + #{wTCQQUip9Lg.FdRbTtJCPNZ} + #{wTCQQUip9Lg.vdnV0CRugTx} + #{wTCQQUip9Lg.q04AhBOLQ7V} + #{wTCQQUip9Lg.C6mJaoRjHrP} + #{wTCQQUip9Lg.exYUulGr9S8},1
Mental_Sexual dysfunctional disorders_Revisit,pbl1EXDeoiU,Sexual dysfunctional disorders,#{wTCQQUip9Lg.joYkZip1BOt} + #{wTCQQUip9Lg.holZk3EaqIx} + #{wTCQQUip9Lg.LM9Kc8XNRkl} + #{wTCQQUip9Lg.sKnR5sXLZGJ} + #{wTCQQUip9Lg.vL1LaGwzDif} + #{wTCQQUip9Lg.cCvVMr685Lg} + #{wTCQQUip9Lg.Mg5QcS6W9uQ} + #{wTCQQUip9Lg.nfFrx9kddQW} + #{wTCQQUip9Lg.iZX4ZP7FCot} + #{wTCQQUip9Lg.n7XRPIGbHp7} + #{wTCQQUip9Lg.fH2LDYKXQLn} + #{wTCQQUip9Lg.JLKljXW2FtJ},1
Mental_Sleep-wake disorders_New,zuHHNsmzLBA,Mental_Sleep-wake disorders_New,#{DbNsPT5it0j.fOfxucEDolz} + #{DbNsPT5it0j.CuMG5YBsnQq} + #{DbNsPT5it0j.pV8UrTqSP0J} + #{DbNsPT5it0j.ByrQMv6BSzA} + #{DbNsPT5it0j.Kg2tjGzgDj4} + #{DbNsPT5it0j.c0ketZ2YS2X} + #{DbNsPT5it0j.FE99ZPWJGCn} + #{DbNsPT5it0j.FdRbTtJCPNZ} + #{DbNsPT5it0j.vdnV0CRugTx} + #{DbNsPT5it0j.q04AhBOLQ7V} + #{DbNsPT5it0j.C6mJaoRjHrP} + #{DbNsPT5it0j.exYUulGr9S8},1
Mental_Sleep-wake disorders_Revisit,GNydfT9tq1Y,Sleep-wake disorders,#{DbNsPT5it0j.joYkZip1BOt} + #{DbNsPT5it0j.holZk3EaqIx} + #{DbNsPT5it0j.LM9Kc8XNRkl} + #{DbNsPT5it0j.sKnR5sXLZGJ} + #{DbNsPT5it0j.vL1LaGwzDif} + #{DbNsPT5it0j.cCvVMr685Lg} + #{DbNsPT5it0j.Mg5QcS6W9uQ} + #{DbNsPT5it0j.nfFrx9kddQW} + #{DbNsPT5it0j.iZX4ZP7FCot} + #{DbNsPT5it0j.n7XRPIGbHp7} + #{DbNsPT5it0j.fH2LDYKXQLn} + #{DbNsPT5it0j.JLKljXW2FtJ},1
Mental_Somatoform disorders_New,MDuMrzRIFPz,Mental_Somatoform disorders_New,#{OsphZs193ut.fOfxucEDolz} + #{OsphZs193ut.CuMG5YBsnQq} + #{OsphZs193ut.pV8UrTqSP0J} + #{OsphZs193ut.ByrQMv6BSzA} + #{OsphZs193ut.Kg2tjGzgDj4} + #{OsphZs193ut.c0ketZ2YS2X} + #{OsphZs193ut.FE99ZPWJGCn} + #{OsphZs193ut.FdRbTtJCPNZ} + #{OsphZs193ut.vdnV0CRugTx} + #{OsphZs193ut.q04AhBOLQ7V} + #{OsphZs193ut.C6mJaoRjHrP} + #{OsphZs193ut.exYUulGr9S8},1
Mental_Somatoform disorders_Revisit,jWd0mLkUZYN,Somatoform disorders,#{OsphZs193ut.joYkZip1BOt} + #{OsphZs193ut.holZk3EaqIx} + #{OsphZs193ut.LM9Kc8XNRkl} + #{OsphZs193ut.sKnR5sXLZGJ} + #{OsphZs193ut.vL1LaGwzDif} + #{OsphZs193ut.cCvVMr685Lg} + #{OsphZs193ut.Mg5QcS6W9uQ} + #{OsphZs193ut.nfFrx9kddQW} + #{OsphZs193ut.iZX4ZP7FCot} + #{OsphZs193ut.n7XRPIGbHp7} + #{OsphZs193ut.fH2LDYKXQLn} + #{OsphZs193ut.JLKljXW2FtJ},1
Mental_Stress-trauma related disorders_New,mHxelkok6li,Mental_Stress-trauma related disorders_New,#{In83rF9l92o.fOfxucEDolz} + #{In83rF9l92o.CuMG5YBsnQq} + #{In83rF9l92o.pV8UrTqSP0J} + #{In83rF9l92o.ByrQMv6BSzA} + #{In83rF9l92o.Kg2tjGzgDj4} + #{In83rF9l92o.c0ketZ2YS2X} + #{In83rF9l92o.FE99ZPWJGCn} + #{In83rF9l92o.FdRbTtJCPNZ} + #{In83rF9l92o.vdnV0CRugTx} + #{In83rF9l92o.q04AhBOLQ7V} + #{In83rF9l92o.C6mJaoRjHrP} + #{In83rF9l92o.exYUulGr9S8},1
Mental_Stress-trauma related disorders_Revisit,xAk6Nb1AJY5,Stress-trauma related disorders,#{In83rF9l92o.joYkZip1BOt} + #{In83rF9l92o.holZk3EaqIx} + #{In83rF9l92o.LM9Kc8XNRkl} + #{In83rF9l92o.sKnR5sXLZGJ} + #{In83rF9l92o.vL1LaGwzDif} + #{In83rF9l92o.cCvVMr685Lg} + #{In83rF9l92o.Mg5QcS6W9uQ} + #{In83rF9l92o.nfFrx9kddQW} + #{In83rF9l92o.iZX4ZP7FCot} + #{In83rF9l92o.n7XRPIGbHp7} + #{In83rF9l92o.fH2LDYKXQLn} + #{In83rF9l92o.JLKljXW2FtJ} + #{In83rF9l92o.JLKljXW2FtJ},1
Mental_Suicidal Behaviour_New,qcJWGTrb5F2,Mental_Suicidal Behaviour_New,#{fYntxxpoi0p.fOfxucEDolz} + #{fYntxxpoi0p.CuMG5YBsnQq} + #{fYntxxpoi0p.pV8UrTqSP0J} + #{fYntxxpoi0p.ByrQMv6BSzA} + #{fYntxxpoi0p.Kg2tjGzgDj4} + #{fYntxxpoi0p.c0ketZ2YS2X} + #{fYntxxpoi0p.FE99ZPWJGCn} + #{fYntxxpoi0p.FdRbTtJCPNZ} + #{fYntxxpoi0p.vdnV0CRugTx} + #{fYntxxpoi0p.q04AhBOLQ7V} + #{fYntxxpoi0p.C6mJaoRjHrP} + #{fYntxxpoi0p.exYUulGr9S8},1
Mental_Suicidal Behaviour_Revisit,vynpbz0WO93,Suicidal Behaviour,#{fYntxxpoi0p.joYkZip1BOt} + #{fYntxxpoi0p.holZk3EaqIx} + #{fYntxxpoi0p.LM9Kc8XNRkl} + #{fYntxxpoi0p.sKnR5sXLZGJ} + #{fYntxxpoi0p.vL1LaGwzDif} + #{fYntxxpoi0p.cCvVMr685Lg} + #{fYntxxpoi0p.Mg5QcS6W9uQ} + #{fYntxxpoi0p.nfFrx9kddQW} + #{fYntxxpoi0p.iZX4ZP7FCot} + #{fYntxxpoi0p.n7XRPIGbHp7} + #{fYntxxpoi0p.fH2LDYKXQLn} + #{fYntxxpoi0p.JLKljXW2FtJ},1
"Metronidazole Tablet, 400mg (Tablet) MoS",QkKle90Kwfs,"Metronidazole Tablet, 400mg (Tablet)",#{mvrXlqZoM0a.n8XlCFUpWOG},#{VJRNI5qVkN1.QvctQfKAQn3}
"Midazolam Injection 5mg/ml, 3ml (Ampoule) MoS",IjHwXyp22GE,"Midazolam Injection 5mg/ml, 3ml (Ampoule)",#{v4Ql5RkIJ7M.n8XlCFUpWOG},#{GmDKO6zO1u9.QvctQfKAQn3}
Mild number of AEFI per 100000 doses Administered,tf0RclfHqSh,Mild number of AEFI per 100000 doses Administered,#{BAqNYvjMM06.zQoY624Edct} + #{Ojoh1BOou9Y.zQoY624Edct} + #{cll5lwGYIwo.zQoY624Edct} + #{oI9F4BBqNqM.zQoY624Edct} + #{dJruyJIjeV1.zQoY624Edct},#{myQD3R0GBUq} + #{qRQ3LIl7SmG} + #{LTJsHtrbyML} + #{UoaXvx7kTB7} + #{gOksPnou3je} + #{ZWMO83OyDwx} + #{jm6G9QtE6Th} + #{pkrY92yugfK} + #{NHd2e6QGCkk}
MoH 711 Total number of Women of Reproductive Age 25-49Years screened for cervical cancer,q1EoqjQfCKq,WRA 25-49yrs screened for cervical cancer,#{ommbnTANmGo.FqagtL5h8ni}+#{kl4RvWOGb7x.FqagtL5h8ni}+#{G9COyloYLYa.FqagtL5h8ni},1
MoH 730A rev2017 Aggregated Dispensed Adult preparations Abacavir (ABC) 300mg Tablets 60s,wk5E3yFpj57,Moh730Arev2017aggdispensed22,#{Bv08ScvBzZy.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Adult preparations Abacavir/Lamivudine (ABC/3TC) 600mg/300mg FDC Tablets 60s,P1UeoTiQGGe,Moh730Arev2017aggdispensed42,#{WeA3sq0ELOE.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Adult preparations Atazanavir/Ritonavir (ATV/r) 300/100mg Tablets 30s,CF7cJyC0OPY,Moh730Arev2017aggdispensed54,#{hnMei2LGuhw.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Adult preparations Darunavir (DRV) 600mg Tablets 60s,TkyDQJmd1q0,Moh730Arev2017aggdispensed12,#{Lo1lUEHEXap.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Adult preparations Dolutegravir(DTG) 50mg tabs 30s,iM9mvxIgwq2,Moh730Arev2017aggdispensed35,#{Qr8Hx7Nl02R.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Adult preparations Efavirenz (EFV) 400mg Tablets 30s,uFtc6PWmOCm,Moh730Arev2017aggdispensed14,#{eeQ9f2aQHE2.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Adult preparations Efavirenz (EFV) 600mg Tablets 30s,UrILALLm4xU,Moh730Arev2017aggdispensed29,#{JfkxhCPe29t.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Adult preparations Etravirine (ETV) 200mg Tablets 60s,Mxdxlm94M6M,Moh730Arev2017aggdispensed4,#{NRXgJMykiJq.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Adult preparations Lamivudine (3TC) 150mg Tablets 60s,iGcUSp9mWiF,Moh730Arev2017aggdispensed48,#{jC1clm8DHjU.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Adult preparations Lopinavir/ritonavir (LPV/r) 200/50mg Tablets 120s,ahMEvllHolz,Moh730Arev2017aggdispensed36,#{GjYg7sEHVAx.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Adult preparations Nevirapine (NVP) 200mg Tablets 60s,CxIpMg70w9Y,Moh730Arev2017aggdispensed28,#{Fo2gnhRx1eB.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Adult preparations Raltegravir (RAL) 400mg Tablets 60s,qO0HtouGYIj,Moh730Arev2017aggdispensed8,#{dsZqocFWAqm.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Adult preparations Ritonavir (RTV) 100mg Tablets 60s,E3qIcQf57tK,Moh730Arev2017aggdispensed9,#{FE6o5uZ6Ey3.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Adult preparations Tenofovir (TDF) 300mg Tablets 30s,s01zx7aqT2V,Moh730Arev2017aggdispensed57,#{lMHWiV1wfzU.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Adult preparations Tenofovir/Emtricitabine (TDF/FTC) FDC (300/200mg) Tablets 30s,zXuH3gqTub6,Moh730Arev2017aggdispensed1,#{Ovk1BBcACSN.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Adult preparations Tenofovir/Lamivudine (TDF/3TC) FDC (300/300mg) Tablets 30s,a3V32qFZV39,Moh730Arev2017aggdispensed23,#{VJMNX2JtVAL.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Adult preparations Tenofovir/Lamivudine/Dolutegravir (TDF/3TC/DTG) FDC (300/300/50mg) FDC Tablets 30s,xnD3uuxiFgv,Moh730Arev2017aggdispensed26,#{YpjdjMD6yeC.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Adult preparations Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/400mg) FDC Tablets 30s,Cx0Wv5r1CDW,Moh730Arev2017aggdispensed33,#{wJTbaU9jnf2.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Adult preparations Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/600mg) FDC Tablets 30s,GpMuoZT0Ne0,Moh730Arev2017aggdispensed19,#{MtiBOPPd7Ke.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Adult preparations Zidovudine (AZT) 300mg Tablets 60s,xU9w8sJll64,Moh730Arev2017aggdispensed45,#{L9VlZFQZGbv.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Adult preparations Zidovudine/Lamivudine (AZT/3TC) FDC (300/150mg) Tablets 30s,vbcAVfgCgVk,Moh730Arev2017aggdispensed31,#{YUbsR6vuIVF.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Adult preparations Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (300/150/200mg) Tablets 60s,RsczbYbRtjz,Moh730Arev2017aggdispensed17,#{ZPdNDKh0jtf.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Medicines for OIs Acyclovir 400mg Tablets 30s,wQg9OKTisFT,Moh730Arev2017aggdispensed3,#{ZYYcDSXFHcq.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Medicines for OIs Amphotericin B 50mg IV Injection 1 vial,Is2gKrIftoS,Moh730Arev2017aggdispensed55,#{Ywi6QrCf4wp.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Medicines for OIs Cotrimoxazole 960mg Tablets 100s,bit7ioR9F9e,Moh730Arev2017aggdispensed46,#{uYwZjUIeoY2.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Medicines for OIs Cotrimoxazole suspension 240mg/5ml 100ml bottle,nVSFfY1wIjm,Moh730Arev2017aggdispensed27,#{rS62iKZ6Idq.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Medicines for OIs Dapsone 100mg Tablets 100s,sNbL7zX41es,Moh730Arev2017aggdispensed25,#{bW4ekQmQCeb.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Medicines for OIs Fluconazole 200mg Tablets 100s,u1JPAA58x4m,Moh730Arev2017aggdispensed24,#{BHlhxD6Wjct.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Medicines for OIs Fluconazole 50mg Tablets 100s,as0frBGEWwr,Moh730Arev2017aggdispensed49,#{T0j4amtuSwQ.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Paediatric preparations Abacavir/Lamivudine (ABC/3TC) 120mg/60mg FDC Tablets 30s,vsTrOT03eyX,Moh730Arev2017aggdispensed39,#{KnOB8nSo99l.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Paediatric preparations Abacavir/Lamivudine (ABC/3TC) 60mg/30mg FDC Tablets 60s,J8bL9YFBTmH,Moh730Arev2017aggdispensed5,#{HTN8wtCULbh.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Paediatric preparations Atazanavir (ATV) 100mg Caps 60s,VLPhiwxhku4,Moh730Arev2017aggdispensed56,#{r3zeScG21hV.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Paediatric preparations Darunavir (DRV) 150mg Tablets 240s,nT3PMXHy9sv,Moh730Arev2017aggdispensed30,#{Fmu24faR6RP.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Paediatric preparations Darunavir (DRV) 75mg Tablets 480s,ERhmT45HtpS,Moh730Arev2017aggdispensed21,#{YvUG4Tj5pBB.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Paediatric preparations Darunavir (DRV) susp 100mg/ml (200ml Bottles) 200ml bottle,EsrD0EJPbav,Moh730Arev2017aggdispensed38,#{Zp4GO6RalC3.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Paediatric preparations Efavirenz (EFV) 200mg Tablets 90s,Ml26X55M6nt,Moh730Arev2017aggdispensed43,#{FWfv9nwqQNj.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Paediatric preparations Etravirine (ETV) 100mg Tablets 60s,Ma1jRHt8bUq,Moh730Arev2017aggdispensed20,#{CUkg2rMIBqV.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Paediatric preparations Etravirine (ETV) 25mg Tablets 60s,Y3XB3LPz6px,Moh730Arev2017aggdispensed52,#{rj7yWKzevzK.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Paediatric preparations Lamivudine (3TC) liquid 10mg/ml (240ml Bottles) 240ml bottle,VTCOIp2BFTQ,Moh730Arev2017aggdispensed58,#{k820rGmrG7y.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Paediatric preparations Lopinavir/ritonavir (LPV/r) 100/25mg Tabs 60s,JFLKAp9nyGF,Moh730Arev2017aggdispensed11,#{bNwb0BQTiXu.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Paediatric preparations Lopinavir/ritonavir (LPV/r) 40/10mg Caps 120s,N6VPNcGypxm,Moh730Arev2017aggdispensed47,#{KPNtoZA2hVb.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Paediatric preparations Lopinavir/ritonavir (LPV/r) liquid 80/20mg/ml (60ml Bottles) 60ml bottle,sj1ERyi8uVW,Moh730Arev2017aggdispensed2,#{GTqdnEoYWpl.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Paediatric preparations Nevirapine (NVP) Susp 10mg/ml (100 ml Bottles) 100ml bottle,LqXaopI7pci,Moh730Arev2017aggdispensed40,#{w96pwQ6povd.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Paediatric preparations Raltegravir (RAL) 100mg Tablets 60s,qYSa8UA7XGZ,Moh730Arev2017aggdispensed6,#{rMpIsXAIBcN.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Paediatric preparations Raltegravir (RAL) 25mg Tablets 60s,dgFMJ0FKOFl,Moh730Arev2017aggdispensed16,#{ynIttHBVTyK.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Paediatric preparations Ritonavir liquid 80mg/ml (90ml Bottles) 90ml bottle,IHdkm33fLOJ,Moh730Arev2017aggdispensed50,#{LdqZPGOt7px.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Paediatric preparations Zidovudine (AZT) liquid 10mg/ml (240ml Bottles) 240ml bottle,JUJr40AvUmf,Moh730Arev2017aggdispensed7,#{U3h59Gd6zNP.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Paediatric preparations Zidovudine/Lamivudine (AZT/3TC) FDC (60/30mg) Tablets 60s,PiZpXNqL2kh,Moh730Arev2017aggdispensed44,#{cgSXbyWnsji.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed Paediatric preparations Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (60/30/50mg) Tablets 60s,WzXBP4ZBqqL,Moh730Arev2017aggdispensed34,#{CV5vmItEeGO.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed TB/ HIV DRUGS Ethambutol 400mg Tab (for Pack of 28 tabs) 28s,elpKQqljGQj,Moh730Arev2017aggdispensed18,#{XYarFhtrZnM.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed TB/ HIV DRUGS Isoniazid (H) 100mg Tablets 100s,vWhR6840YNf,Moh730Arev2017aggdispensed41,#{ow27FKynLOP.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed TB/ HIV DRUGS Isoniazid (H) 10mg/ml (120ml Bottles) 120ml bottle,vi2G6Py6BAL,Moh730Arev2017aggdispensed53,#{hI5dsFlNwro.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed TB/ HIV DRUGS Isoniazid (H) 300mg Tabs (for Pack of 100 tabs) 100s,VQ9mqOVsiaX,Moh730Arev2017aggdispensed13,#{bjqajaEgKDD.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed TB/ HIV DRUGS Isoniazid (H) 300mg Tabs (for Pack of 672 tabs) 672s,r1jlHclSEkb,Moh730Arev2017aggdispensed37,#{ScMZvEURp0k.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed TB/ HIV DRUGS Pyrazinamide 500mg Tab (for Pack of 28 tabs) 28s,WEGszEIKBh9,Moh730Arev2017aggdispensed10,#{rgrECRA0XVz.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed TB/ HIV DRUGS Pyridoxine 25mg Tabs 100s,hx4KhBWRzlH,Moh730Arev2017aggdispensed51,#{noIMGcbffat.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed TB/ HIV DRUGS Pyridoxine 50mg Tablets 100s,o4aCTXMjPqb,Moh730Arev2017aggdispensed32,#{nReJj3EEIHt.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Dispensed TB/ HIV DRUGS Rifabutin 150mg Tab 30s,l7KxD0koBzW,Moh730Arev2017aggdispensed15,#{gjOJC5nWO9W.yP6vevc91WZ},1
MoH 730A rev2017 Aggregated Physical Stock Adult preparations Abacavir (ABC) 300mg Tablets 60s,Csj0LLriBus,Moh730Arev2017aggstock22,#{Bv08ScvBzZy.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Adult preparations Abacavir/Lamivudine (ABC/3TC) 600mg/300mg FDC Tablets 60s,UStdc2tJN9Q,Moh730Arev2017aggstock42,#{WeA3sq0ELOE.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Adult preparations Atazanavir/Ritonavir (ATV/r) 300/100mg Tablets 30s,gu7EhEzuRu0,Moh730Arev2017aggstock54,#{hnMei2LGuhw.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Adult preparations Darunavir (DRV) 600mg Tablets 60s,Q6riiH7vG3N,Moh730Arev2017aggstock12,#{Lo1lUEHEXap.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Adult preparations Dolutegravir(DTG) 50mg tabs 30s,KROLEZuM5O1,Moh730Arev2017aggstock35,#{Qr8Hx7Nl02R.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Adult preparations Efavirenz (EFV) 400mg Tablets 30s,vfM5gLzJjTd,Moh730Arev2017aggstock14,#{eeQ9f2aQHE2.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Adult preparations Efavirenz (EFV) 600mg Tablets 30s,YBpnsVBYBYz,Moh730Arev2017aggstock29,#{JfkxhCPe29t.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Adult preparations Etravirine (ETV) 200mg Tablets 60s,LWDlaCJfLBR,Moh730Arev2017aggstock4,#{NRXgJMykiJq.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Adult preparations Lamivudine (3TC) 150mg Tablets 60s,oPWGHZyWaVZ,Moh730Arev2017aggstock48,#{jC1clm8DHjU.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Adult preparations Lopinavir/ritonavir (LPV/r) 200/50mg Tablets 120s,xa3K14qshYi,Moh730Arev2017aggstock36,#{GjYg7sEHVAx.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Adult preparations Nevirapine (NVP) 200mg Tablets 60s,B5sapQbRTME,Moh730Arev2017aggstock28,#{Fo2gnhRx1eB.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Adult preparations Raltegravir (RAL) 400mg Tablets 60s,LhYZMSCiaVb,Moh730Arev2017aggstock8,#{dsZqocFWAqm.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Adult preparations Ritonavir (RTV) 100mg Tablets 60s,eWtRyBPUPjA,Moh730Arev2017aggstock9,#{FE6o5uZ6Ey3.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Adult preparations Tenofovir (TDF) 300mg Tablets 30s,FL2be75wh2h,Moh730Arev2017aggstock57,#{lMHWiV1wfzU.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Adult preparations Tenofovir/Emtricitabine (TDF/FTC) FDC (300/200mg) Tablets 30s,nvJJmiLgGIb,Moh730Arev2017aggstock1,#{Ovk1BBcACSN.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Adult preparations Tenofovir/Lamivudine (TDF/3TC) FDC (300/300mg) Tablets 30s,ctivi0Qr4Kr,Moh730Arev2017aggstock23,#{VJMNX2JtVAL.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Adult preparations Tenofovir/Lamivudine/Dolutegravir (TDF/3TC/DTG) FDC (300/300/50mg) FDC Tablets 30s,WVfMU1HGMhJ,Moh730Arev2017aggstock26,#{YpjdjMD6yeC.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Adult preparations Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/400mg) FDC Tablets 30s,jxSo3f8mKYC,Moh730Arev2017aggstock33,#{wJTbaU9jnf2.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Adult preparations Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/600mg) FDC Tablets 30s,JNl70r5vPMS,Moh730Arev2017aggstock19,#{MtiBOPPd7Ke.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Adult preparations Zidovudine (AZT) 300mg Tablets 60s,uWzrrcTItXn,Moh730Arev2017aggstock45,#{L9VlZFQZGbv.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Adult preparations Zidovudine/Lamivudine (AZT/3TC) FDC (300/150mg) Tablets 30s,qdROwgA4be5,Moh730Arev2017aggstock31,#{YUbsR6vuIVF.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Adult preparations Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (300/150/200mg) Tablets 60s,mOstmn0Is0W,Moh730Arev2017aggstock17,#{ZPdNDKh0jtf.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Medicines for OIs Acyclovir 400mg Tablets 30s,Aovc93Hh5iT,Moh730Arev2017aggstock3,#{ZYYcDSXFHcq.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Medicines for OIs Amphotericin B 50mg IV Injection 1 vial,SC6PlI5C3bK,Moh730Arev2017aggstock55,#{Ywi6QrCf4wp.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Medicines for OIs Cotrimoxazole 960mg Tablets 100s,iJyC1bbvCb5,Moh730Arev2017aggstock46,#{uYwZjUIeoY2.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Medicines for OIs Cotrimoxazole suspension 240mg/5ml 100ml bottle,dgoNCSuJsFg,Moh730Arev2017aggstock27,#{rS62iKZ6Idq.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Medicines for OIs Dapsone 100mg Tablets 100s,H21B1AkiP0V,Moh730Arev2017aggstock25,#{bW4ekQmQCeb.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Medicines for OIs Fluconazole 200mg Tablets 100s,tvzM41TqNmh,Moh730Arev2017aggstock24,#{BHlhxD6Wjct.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Medicines for OIs Fluconazole 50mg Tablets 100s,w68X7tUSDD0,Moh730Arev2017aggstock49,#{T0j4amtuSwQ.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Paediatric preparations Abacavir/Lamivudine (ABC/3TC) 120mg/60mg FDC Tablets 30s,nyH2fWs3uwj,Moh730Arev2017aggstock39,#{KnOB8nSo99l.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Paediatric preparations Abacavir/Lamivudine (ABC/3TC) 60mg/30mg FDC Tablets 60s,Z19Ts0LnGYq,Moh730Arev2017aggstock5,#{HTN8wtCULbh.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Paediatric preparations Atazanavir (ATV) 100mg Caps 60s,QMfSXb8wUyx,Moh730Arev2017aggstock56,#{r3zeScG21hV.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Paediatric preparations Darunavir (DRV) 150mg Tablets 240s,EoDDEQLPtkf,Moh730Arev2017aggstock30,#{Fmu24faR6RP.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Paediatric preparations Darunavir (DRV) 75mg Tablets 480s,QHl5EeVJrYE,Moh730Arev2017aggstock21,#{YvUG4Tj5pBB.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Paediatric preparations Darunavir (DRV) susp 100mg/ml (200ml Bottles) 200ml bottle,D0zFRcR10N1,Moh730Arev2017aggstock38,#{Zp4GO6RalC3.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Paediatric preparations Efavirenz (EFV) 200mg Tablets 90s,z1YXDnEXiq0,Moh730Arev2017aggstock43,#{FWfv9nwqQNj.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Paediatric preparations Etravirine (ETV) 100mg Tablets 60s,IFzYdTXhohB,Moh730Arev2017aggstock20,#{CUkg2rMIBqV.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Paediatric preparations Etravirine (ETV) 25mg Tablets 60s,HjHW4sJn9kf,Moh730Arev2017aggstock52,#{rj7yWKzevzK.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Paediatric preparations Lamivudine (3TC) liquid 10mg/ml (240ml Bottles) 240ml bottle,OyK2vs7Gl1c,Moh730Arev2017aggstock58,#{k820rGmrG7y.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Paediatric preparations Lopinavir/ritonavir (LPV/r) 100/25mg Tabs 60s,rZdpsXvn1ea,Moh730Arev2017aggstock11,#{bNwb0BQTiXu.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Paediatric preparations Lopinavir/ritonavir (LPV/r) 40/10mg Caps 120s,RfSUYk9892o,Moh730Arev2017aggstock47,#{KPNtoZA2hVb.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Paediatric preparations Lopinavir/ritonavir (LPV/r) liquid 80/20mg/ml (60ml Bottles) 60ml bottle,qkqlieVWnaK,Moh730Arev2017aggstock2,#{GTqdnEoYWpl.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Paediatric preparations Nevirapine (NVP) Susp 10mg/ml (100 ml Bottles) 100ml bottle,irazXMxE5Gt,Moh730Arev2017aggstock40,#{w96pwQ6povd.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Paediatric preparations Raltegravir (RAL) 100mg Tablets 60s,vX7YtloXdmm,Moh730Arev2017aggstock6,#{rMpIsXAIBcN.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Paediatric preparations Raltegravir (RAL) 25mg Tablets 60s,uhcbRwA9BjT,Moh730Arev2017aggstock16,#{ynIttHBVTyK.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Paediatric preparations Ritonavir liquid 80mg/ml (90ml Bottles) 90ml bottle,N2f10P3wDSn,Moh730Arev2017aggstock50,#{LdqZPGOt7px.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Paediatric preparations Zidovudine (AZT) liquid 10mg/ml (240ml Bottles) 240ml bottle,KZ7PloIYRK9,Moh730Arev2017aggstock7,#{U3h59Gd6zNP.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Paediatric preparations Zidovudine/Lamivudine (AZT/3TC) FDC (60/30mg) Tablets 60s,VeZqYMchqdh,Moh730Arev2017aggstock44,#{cgSXbyWnsji.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock Paediatric preparations Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (60/30/50mg) Tablets 60s,kBXBCLfycF6,Moh730Arev2017aggstock34,#{CV5vmItEeGO.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock TB/ HIV DRUGS Ethambutol 400mg Tab (for Pack of 28 tabs) 28s,a588JwUG3CF,Moh730Arev2017aggstock18,#{XYarFhtrZnM.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock TB/ HIV DRUGS Isoniazid (H) 100mg Tablets 100s,YMnTS5RN1Ls,Moh730Arev2017aggstock41,#{ow27FKynLOP.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock TB/ HIV DRUGS Isoniazid (H) 10mg/ml (120ml Bottles) 120ml bottle,iBR3SmVs6Ug,Moh730Arev2017aggstock53,#{hI5dsFlNwro.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock TB/ HIV DRUGS Isoniazid (H) 300mg Tabs (for Pack of 100 tabs) 100s,bg2RNBbCS6D,Moh730Arev2017aggstock13,#{bjqajaEgKDD.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock TB/ HIV DRUGS Isoniazid (H) 300mg Tabs (for Pack of 672 tabs) 672s,t6s0onF9E62,Moh730Arev2017aggstock37,#{ScMZvEURp0k.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock TB/ HIV DRUGS Pyrazinamide 500mg Tab (for Pack of 28 tabs) 28s,azbF7mQQ6zL,Moh730Arev2017aggstock10,#{rgrECRA0XVz.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock TB/ HIV DRUGS Pyridoxine 25mg Tabs 100s,D4V0x1RImG6,Moh730Arev2017aggstock51,#{noIMGcbffat.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock TB/ HIV DRUGS Pyridoxine 50mg Tablets 100s,tqwBkZmnEDW,Moh730Arev2017aggstock32,#{nReJj3EEIHt.GvjV9gy3OOc},1
MoH 730A rev2017 Aggregated Physical Stock TB/ HIV DRUGS Rifabutin 150mg Tab 30s,ZZVs35bJ48y,Moh730Arev2017aggstock15,#{gjOJC5nWO9W.GvjV9gy3OOc},1
MoH 730B Revision 2017 Adult preparations Abacavir (ABC) 300mg Tablets 60s-QR,fSu0dkTMXIc,MoH 730B Revision 2017Abacavir (ABC) 300mg 60s-QR,(#{Bv08ScvBzZy.b11dZBeBzRE} * 3) - #{Bv08ScvBzZy.GvjV9gy3OOc},1
MoH 730B Revision 2017 Adult preparations Abacavir/Lamivudine (ABC/3TC) 600mg/300mg FDC Tablets 60s-QR,XwISYuRyrcc,MoH730B Rev2017Adult(ABC/3TC)600mg/300mgFD 60s-QR,(#{WeA3sq0ELOE.b11dZBeBzRE} * 3) - #{WeA3sq0ELOE.GvjV9gy3OOc},1
MoH 730B Revision 2017 Adult preparations Atazanavir/Ritonavir (ATV/r) 300/100mg Tablets 30s-QR,s4d36VxRwQI,MoH730BRevisio2017Adultprep(ATV/r)300/100mg 30s-QR,(#{hnMei2LGuhw.yP6vevc91WZ} * 3) - #{hnMei2LGuhw.GvjV9gy3OOc},1
MoH 730B Revision 2017 Adult preparations Darunavir (DRV) 600mg Tablets 60s-QR,wwOG968csXH,MoH730BRevision2017Adult prep(DRV)600mg Tab 60s-QR,(#{Lo1lUEHEXap.yP6vevc91WZ} * 3) - #{Lo1lUEHEXap.GvjV9gy3OOc},1
MoH 730B Revision 2017 Adult preparations Efavirenz (EFV) 400mg Tablets 30s-QR,gWv9jBIDILV,MoH730BRevision2017Adultprep(EFV)400mgTabs30s-QR,(#{eeQ9f2aQHE2.yP6vevc91WZ} * 3) - #{eeQ9f2aQHE2.GvjV9gy3OOc},1
MoH 730B Revision 2017 Adult preparations Efavirenz (EFV) 600mg Tablets 30s-QR,tZaQAS6Urdk,MoH730BRevision2017Adultprep(EFV)600mgTabs30s-QR,(#{JfkxhCPe29t.b11dZBeBzRE} * 3) - #{JfkxhCPe29t.GvjV9gy3OOc},1
MoH 730B Revision 2017 Adult preparations Etravirine (ETV) 200mg Tablets 60s-QR,VpkZytoRpyk,MoH730BRevision2017Adultprep(ETV)200mgTabs 60s-QR,(#{NRXgJMykiJq.b11dZBeBzRE}  * 3) - #{NRXgJMykiJq.GvjV9gy3OOc},1
MoH 730B Revision 2017 Adult preparations Lamivudine (3TC) 150mg Tablets 60s-QR,pBimTHSq7TB,MoH730BRevision2017Adultprep(3TC)150mgTabs60s-QR,(#{jC1clm8DHjU.yP6vevc91WZ} * 3) - #{jC1clm8DHjU.GvjV9gy3OOc},1
MoH 731-3 Retention,u76A7XDayWu,MoH 731-3 Retention,#{RwTKRWWKGhn}+#{p1wJaxpErlY}+#{MY5Cq1UcLbk} + #{pHCaA5yineM},1
MoH 745 Total number of Women of Reproductive Age 25-49Years screened for cervical cancer,UseUoDXQI4o,WRA 25-49yrs screened for cervical cancer,#{rFtB3keaVWm.fxXNsn1ppIe} + #{rFtB3keaVWm.gLkLCkCx1Ad} + #{rFtB3keaVWm.SMt1XYz1xId} + #{gQro1y7Rsbq.fxXNsn1ppIe} + #{gQro1y7Rsbq.gLkLCkCx1Ad} + #{gQro1y7Rsbq.SMt1XYz1xId} + #{VR7vdS7P0Gb.fxXNsn1ppIe} + #{VR7vdS7P0Gb.gLkLCkCx1Ad} + #{VR7vdS7P0Gb.SMt1XYz1xId},1
MoH731B Total Active Key Population,EPSgzoCHtw9,Total Active Key Population,#{O15YgUn4XIF.P5m2QwNQGg2} + #{O15YgUn4XIF.YmBEiArx8Pv} + #{O15YgUn4XIF.wi8hQpWLRAp} + #{O15YgUn4XIF.EZGVAq3B7kL} + #{O15YgUn4XIF.eyWZhsRz9oa} + #{O15YgUn4XIF.hVZNjSQBAsk} + #{UHB0NBnFCV2.P5m2QwNQGg2} + #{UHB0NBnFCV2.YmBEiArx8Pv} + #{UHB0NBnFCV2.wi8hQpWLRAp} + #{UHB0NBnFCV2.EZGVAq3B7kL} + #{UHB0NBnFCV2.eyWZhsRz9oa} + #{UHB0NBnFCV2.hVZNjSQBAsk} + #{HPEjrnNhklk.P5m2QwNQGg2} + #{HPEjrnNhklk.YmBEiArx8Pv} + #{HPEjrnNhklk.wi8hQpWLRAp} + #{HPEjrnNhklk.EZGVAq3B7kL} + #{HPEjrnNhklk.eyWZhsRz9oa} + #{HPEjrnNhklk.hVZNjSQBAsk} + #{MQb54FdPpQm.P5m2QwNQGg2} + #{MQb54FdPpQm.YmBEiArx8Pv} + #{MQb54FdPpQm.wi8hQpWLRAp} + #{MQb54FdPpQm.EZGVAq3B7kL} + #{MQb54FdPpQm.eyWZhsRz9oa} + #{MQb54FdPpQm.hVZNjSQBAsk},1
MoH747A_QR_Male Condom,Hrfscxx1V08,MoH747A_QR_Male Condom,4* #{AVDzuypqGt9.wkXcJRRTRxA}-#{AVDzuypqGt9.i9dqmLZr7fd},1
MoH_735_2023 Cataract surgical rate (CSR),frR6srVFJ3w,Cataract surgical rate (CSR),"#{uIMaPBbyoZO} + #{uIMaPBbyoZO.n4G0FsuKm4G} +
 #{uIMaPBbyoZO.wwfNWKTEigw} + #{uIMaPBbyoZO.I3kbMu6YUMm} + #{uIMaPBbyoZO.v5TzHzAjuZe} + #{uIMaPBbyoZO.N7pZ3wnscGw} + #{uIMaPBbyoZO.V3A5eOcjjgY} + #{uIMaPBbyoZO.px8KCmwoOoT} + #{uIMaPBbyoZO.Tr98w2CG8DV} + #{uIMaPBbyoZO.V4scNeLvCJG} + #{uIMaPBbyoZO.HBo8vAmzv5P} + #{uIMaPBbyoZO.lkgQ38O2V4D} 
+ #{tnqjyKzgNqZ} + #{tnqjyKzgNqZ.n4G0FsuKm4G} +
 #{tnqjyKzgNqZ.I3kbMu6YUMm} + #{tnqjyKzgNqZ.v5TzHzAjuZe} + #{tnqjyKzgNqZ.N7pZ3wnscGw} + #{tnqjyKzgNqZ.V3A5eOcjjgY} + #{tnqjyKzgNqZ.px8KCmwoOoT} + #{tnqjyKzgNqZ.Tr98w2CG8DV} + #{tnqjyKzgNqZ.V4scNeLvCJG} + #{tnqjyKzgNqZ.HBo8vAmzv5P} + #{tnqjyKzgNqZ.QWshKHY1vc9} + #{tnqjyKzgNqZ.lkgQ38O2V4D}",#{NLKRV7bYbVy}
MoH_735_2023 Ophthalmic service Utilization rate,qZxnAv4anK7,Ophthalmic service Utilization rate,#{DQsRyjmTOS7.piLmuyAjjI3} + #{DQsRyjmTOS7.DHZ42ax0oPV} + #{DQsRyjmTOS7.pfRg16V6bme} + #{DQsRyjmTOS7.y0a9RYDpr2X} + #{w5UInTjvl72.piLmuyAjjI3} + #{w5UInTjvl72.DHZ42ax0oPV} + #{w5UInTjvl72.pfRg16V6bme} + #{w5UInTjvl72.y0a9RYDpr2X} + #{z4PgokaW1S0.piLmuyAjjI3} + #{z4PgokaW1S0.DHZ42ax0oPV} + #{z4PgokaW1S0.pfRg16V6bme} + #{z4PgokaW1S0.y0a9RYDpr2X},#{NLKRV7bYbVy}
MoH_735_2023 Percentage of Clients  who received cataract surgery,EKkkQRGXTXE,% of Clients  who recieved cataract surgery,#{uIMaPBbyoZO.n4G0FsuKm4G} + #{uIMaPBbyoZO.wwfNWKTEigw} + #{uIMaPBbyoZO.I3kbMu6YUMm} + #{uIMaPBbyoZO.v5TzHzAjuZe} + #{uIMaPBbyoZO.N7pZ3wnscGw} + #{uIMaPBbyoZO.V3A5eOcjjgY} + #{uIMaPBbyoZO.px8KCmwoOoT} + #{uIMaPBbyoZO.Tr98w2CG8DV} + #{uIMaPBbyoZO.V4scNeLvCJG} + #{uIMaPBbyoZO.HBo8vAmzv5P} + #{uIMaPBbyoZO.QWshKHY1vc9} + #{uIMaPBbyoZO.lkgQ38O2V4D} + #{tnqjyKzgNqZ.n4G0FsuKm4G} + #{tnqjyKzgNqZ.wwfNWKTEigw} + #{tnqjyKzgNqZ.I3kbMu6YUMm} + #{tnqjyKzgNqZ.v5TzHzAjuZe} + #{tnqjyKzgNqZ.N7pZ3wnscGw} + #{tnqjyKzgNqZ.V3A5eOcjjgY} + #{tnqjyKzgNqZ.px8KCmwoOoT} + #{tnqjyKzgNqZ.Tr98w2CG8DV} + #{tnqjyKzgNqZ.V4scNeLvCJG} + #{tnqjyKzgNqZ.HBo8vAmzv5P} + #{tnqjyKzgNqZ.QWshKHY1vc9} + #{tnqjyKzgNqZ.lkgQ38O2V4D},#{Pc27brtaf42.jhYvM0Yqigf} + #{Pc27brtaf42.ByMfU2PdEoj} + #{Pc27brtaf42.F8VZ4hjeSWC} + #{Pc27brtaf42.a1ZjiEQnO6m} + #{Pc27brtaf42.eR53SBXqXgk} + #{Pc27brtaf42.MGrPmTraxSm} + #{Pc27brtaf42.YRznowneRgB} + #{Pc27brtaf42.xSRxxmyzmzf} + #{Pc27brtaf42.Af3KwhB787f} + #{Pc27brtaf42.YlUuxXLfNJl} + #{Pc27brtaf42.o7G4JOIHdSt} + #{Pc27brtaf42.osKbW4Kxdy7} + #{Pc27brtaf42.EUgu49YLiYV} + #{Pc27brtaf42.kb0U8v2DzhH} + #{Pc27brtaf42.uHzP0OaOZ3k} + #{Pc27brtaf42.r0X54dyKXrd} + #{Pc27brtaf42.To0xL5qViVb} + #{Pc27brtaf42.VE95Fu3Ruxn}
MoH_735_2023 Percentage of clients who received glaucoma surgery,FvVOFPIsOZN,% of clients who received glaucoma surgery,#{ClD6Xg5cohu.n4G0FsuKm4G} + #{ClD6Xg5cohu.wwfNWKTEigw} + #{ClD6Xg5cohu.I3kbMu6YUMm} + #{ClD6Xg5cohu.v5TzHzAjuZe} + #{ClD6Xg5cohu.N7pZ3wnscGw} + #{ClD6Xg5cohu.V3A5eOcjjgY} + #{ClD6Xg5cohu.px8KCmwoOoT} + #{ClD6Xg5cohu.Tr98w2CG8DV} + #{ClD6Xg5cohu.V4scNeLvCJG} + #{ClD6Xg5cohu.HBo8vAmzv5P} + #{ClD6Xg5cohu.QWshKHY1vc9} + #{ClD6Xg5cohu.lkgQ38O2V4D},#{O1fFuiTXVNu.jhYvM0Yqigf} + #{O1fFuiTXVNu.ByMfU2PdEoj} + #{O1fFuiTXVNu.F8VZ4hjeSWC} + #{O1fFuiTXVNu.a1ZjiEQnO6m} + #{O1fFuiTXVNu.eR53SBXqXgk} + #{O1fFuiTXVNu.MGrPmTraxSm} + #{O1fFuiTXVNu.YRznowneRgB} + #{O1fFuiTXVNu.xSRxxmyzmzf} + #{O1fFuiTXVNu.Af3KwhB787f} + #{O1fFuiTXVNu.YlUuxXLfNJl} + #{O1fFuiTXVNu.o7G4JOIHdSt} + #{O1fFuiTXVNu.osKbW4Kxdy7} + #{O1fFuiTXVNu.EUgu49YLiYV} + #{O1fFuiTXVNu.kb0U8v2DzhH} + #{O1fFuiTXVNu.uHzP0OaOZ3k} + #{O1fFuiTXVNu.r0X54dyKXrd} + #{O1fFuiTXVNu.To0xL5qViVb} + #{O1fFuiTXVNu.VE95Fu3Ruxn}
MoH_735_2023 Percentage of clients with refractive error who received spectacles,nDDpzchWs82,%Refractive error who received spectacles,#{uPzbweDWsj8} ,#{w5ixh3ii8ZW.jhYvM0Yqigf} + #{w5ixh3ii8ZW.ByMfU2PdEoj} + #{w5ixh3ii8ZW.F8VZ4hjeSWC} + #{w5ixh3ii8ZW.a1ZjiEQnO6m} + #{w5ixh3ii8ZW.eR53SBXqXgk} + #{w5ixh3ii8ZW.MGrPmTraxSm} + #{w5ixh3ii8ZW.YRznowneRgB} + #{w5ixh3ii8ZW.xSRxxmyzmzf} + #{w5ixh3ii8ZW.Af3KwhB787f} + #{w5ixh3ii8ZW.YlUuxXLfNJl} + #{w5ixh3ii8ZW.o7G4JOIHdSt} + #{w5ixh3ii8ZW.osKbW4Kxdy7}
MoH_735_2023 Percentage of live births administered Tetracycline Eye Ointment (TEO) at Community,wJ0jA1vwq7C,Tetracycline Eye Ointment (TEO) at birth,#{X69Jzbvj6BR},#{X9d8oaBHDqx}
MoH_735_2023 Percentage of live births administered Tetracycline Eye Ointment (TEO) at Facility,nqrL3uvaYHj,Tetracycline Eye Ointment (TEO) at birth,#{xCFQ0pftS2u},#{UqKC1DJnymn}
MoH_735_2023 Percentage of persons with disability attending eye clinic,OLFLiuvXVuI,%of persons with disability attending eye clinic,#{SpwB7lu0NG6.S7qkG7CkY2O} + #{SpwB7lu0NG6.fRG8Kq8DKNg} + #{SpwB7lu0NG6.BQ1k07JGAHZ} + #{SpwB7lu0NG6.bDpNdi5FT9T} + #{SpwB7lu0NG6.tWQ6YWQxeN3} + #{SpwB7lu0NG6.EANS7wHyZqj} + #{eYPnjBFhQup.S7qkG7CkY2O} + #{eYPnjBFhQup.fRG8Kq8DKNg} + #{eYPnjBFhQup.BQ1k07JGAHZ} + #{eYPnjBFhQup.bDpNdi5FT9T} + #{eYPnjBFhQup.tWQ6YWQxeN3} + #{eYPnjBFhQup.EANS7wHyZqj} + #{qG6c5KLGao0.S7qkG7CkY2O} + #{qG6c5KLGao0.fRG8Kq8DKNg} + #{qG6c5KLGao0.BQ1k07JGAHZ} + #{qG6c5KLGao0.bDpNdi5FT9T} + #{qG6c5KLGao0.tWQ6YWQxeN3} + #{qG6c5KLGao0.EANS7wHyZqj} + #{WSOZ9FWoVb1.S7qkG7CkY2O} + #{WSOZ9FWoVb1.fRG8Kq8DKNg} +   #{WSOZ9FWoVb1.BQ1k07JGAHZ} + #{WSOZ9FWoVb1.bDpNdi5FT9T} + #{WSOZ9FWoVb1.tWQ6YWQxeN3} + #{WSOZ9FWoVb1.EANS7wHyZqj} + #{cV6QxdL7bju.S7qkG7CkY2O} + #{cV6QxdL7bju.fRG8Kq8DKNg} + #{cV6QxdL7bju.BQ1k07JGAHZ} + #{cV6QxdL7bju.bDpNdi5FT9T} + #{cV6QxdL7bju.tWQ6YWQxeN3} + #{cV6QxdL7bju.EANS7wHyZqj}   + #{RdY1QdI7vAX.S7qkG7CkY2O} + #{RdY1QdI7vAX.fRG8Kq8DKNg} + #{RdY1QdI7vAX.BQ1k07JGAHZ}+ #{RdY1QdI7vAX.bDpNdi5FT9T} + #{RdY1QdI7vAX.tWQ6YWQxeN3} + #{RdY1QdI7vAX.EANS7wHyZqj},#{DQsRyjmTOS7.piLmuyAjjI3} + #{DQsRyjmTOS7.DHZ42ax0oPV} + #{DQsRyjmTOS7.pfRg16V6bme} + #{DQsRyjmTOS7.y0a9RYDpr2X} + #{w5UInTjvl72.piLmuyAjjI3} + #{w5UInTjvl72.DHZ42ax0oPV} + #{w5UInTjvl72.pfRg16V6bme} + #{w5UInTjvl72.y0a9RYDpr2X} + #{z4PgokaW1S0.piLmuyAjjI3} + #{z4PgokaW1S0.DHZ42ax0oPV} + #{z4PgokaW1S0.pfRg16V6bme} + #{z4PgokaW1S0.y0a9RYDpr2X} 
MoH_735_2023 Total children identified with squint at MCH,ZJN2vNOHLGd,Total children identified with squint at MCH,#{zxBXktocimn},1
MoH_755_2023 Acetazolamide Tablet 250mg Dispensed this Month,Ofxy5OwHsPM,Acetazolamide Tablet 250mg Dispensed this Month,#{AO3dAMOhueQ.qUUwvc197T4},1
MoH_755_2023 Acetazolamide Tablet 250mg Percentage of Losses,Gn6FgjKKxcI,Acetazolamide Tablet 250mg Percentage of Losses,#{AO3dAMOhueQ.nMLalvbzwXM},#{AO3dAMOhueQ.Xrqplg36b9m}
MoH_755_2023 Acyclovir 3% eye Ointment Dispensed this Month,iRwjOjR2aJt, Acyclovir 3% eye Ointment Dispensed this Month,#{uWpqltXVeSj.qUUwvc197T4},1
MoH_755_2023 Acyclovir 3% eye Ointment Percentage of Losses,hlJoTdx2Yn5,Acyclovir 3% eye Ointment Percentage of Losses,#{uWpqltXVeSj.nMLalvbzwXM},#{uWpqltXVeSj.Xrqplg36b9m}
MoH_755_2023 Aflibercept 2mg/0.05ml Dispensed this Month,Ei1c6nquWEo,Aflibercept 2mg/0.05ml Dispensed this Month,#{QZfwSzFj4PV.qUUwvc197T4},1
MoH_755_2023 Aflibercept 2mg/0.05ml Percentage of Losses,kb5yZhgAqSf,Aflibercept 2mg/0.05ml Percentage of Losses,#{QZfwSzFj4PV.nMLalvbzwXM},#{QZfwSzFj4PV.Xrqplg36b9m}
MoH_755_2023 Anterior Chamber intra Ocular lens (+18D) Dispensed this Month,IVSmVUvEo9m,Anter Chr intra Ocular lens (+18D) Disp this Mth,#{e1TCDm0EmXc.qUUwvc197T4},1
MoH_755_2023 Anterior Chamber intra Ocular lens (+18D) Percentage of Losses,GdiNHSvHq6E,Anterior Chamber intra Ocular lens (+18D) ,#{e1TCDm0EmXc.nMLalvbzwXM},#{e1TCDm0EmXc.Xrqplg36b9m}
MoH_755_2023 Anterior Chamber intra Ocular lens (+19D) Dispensed this Month,wQ0Maweoadv,Anter Chr intra Ocular lens (+19D) Disp this Mth,#{VsNKyfJ8oWg.qUUwvc197T4},1
MoH_755_2023 Anterior Chamber intra Ocular lens (+19D) Percentage of Losses,iPaNBvZEbYn,Anterior Chamber intra Ocular lens (+19D) ,#{VsNKyfJ8oWg.nMLalvbzwXM},#{VsNKyfJ8oWg.Xrqplg36b9m}
MoH_755_2023 Atropine 0.1% eye drops (as sulfate) Dispensed this Month,sxroDtcONmo,Atropine 0.1% eye drops (as sulfate) Dispensed,#{o2BzBNEgFjw.qUUwvc197T4},1
MoH_755_2023 Atropine 0.1% eye drops (as sulfate) Percentage of Losses,uVJnrlH65HB,Atropine 0.1% eye drops (as sulfate) % of Losses,#{o2BzBNEgFjw.nMLalvbzwXM},#{o2BzBNEgFjw.Xrqplg36b9m}
MoH_755_2023 Azelastine 0.05% eye drops Dispensed this Month,cn7pqIOn7Ak,Azelastine 0.05% eye drops Dispensed this Month,#{LvJ6BQaU14A.qUUwvc197T4},1
MoH_755_2023 Azelastine 0.05% eye drops Percentage of Losses,dYEswC5LwDI,Azelastine 0.05% eye drops Percentage of Losses,#{LvJ6BQaU14A.nMLalvbzwXM},#{LvJ6BQaU14A.Xrqplg36b9m}
MoH_755_2023 Bevacizumab 100mg/4ml Injection Dispensed this Month,ekfJuOSmWHG,Bevacizumab 100mg/4ml Injection Dispensed ,#{xbdA1XNK3jb.qUUwvc197T4},1
MoH_755_2023 Bevacizumab 100mg/4ml Injection Percentage of Losses,Lqo8t7A8QoU,Bevacizumab 100mg/4ml Injection ,#{xbdA1XNK3jb.nMLalvbzwXM},#{xbdA1XNK3jb.Xrqplg36b9m}
MoH_755_2023 Bimatoprost 0.03 mg/ml /Timolol 5mg/ml Dispensed this Month,G2DBvSsxHl8,Bimatoprost 0.03 mg/ml /Timolol 5mg/ml ,#{wg8IDAVPhbp.FKZIGWFJxiV},1
MoH_755_2023 Bimatoprost 0.03 mg/ml /Timolol 5mg/ml Percentage of Losses,wxRkPU069CK,Bimatoprost 0.03 mg/ml /Timolol 5mg/ml % of Losses,#{wg8IDAVPhbp.nMLalvbzwXM},#{wg8IDAVPhbp.Xrqplg36b9m}
MoH_755_2023 Brimonidine 0.2%/Timolol 0.5% Combination eye drops Dispensed this Month,asEvpdqazzQ,Brimonidine 0.2%/Timol 0.5% Combination eye drops,#{Ts4xDEoiDCZ.qUUwvc197T4},1
MoH_755_2023 Brimonidine 0.2%/Timolol 0.5% Combination eye drops Percentage of Losses,wFmJiLgznPs,Brimonide 0.2%/Timolol 0.5% eye drops % of Losses,#{Ts4xDEoiDCZ.nMLalvbzwXM},#{Ts4xDEoiDCZ.Xrqplg36b9m}
MoH_755_2023 Carbomer eye gel 10 gm Dispensed this Month,aaYoUEzc7Aj,Carbomer eye gel 10 gm Dispensed this Month,#{oX5ol0oS5K5.qUUwvc197T4},1
MoH_755_2023 Carbomer eye gel 10 gm Percentage of Losses ,VZBcr2XtY6A,Carbomer eye gel 10 gm Percentage of Losses,#{oX5ol0oS5K5.nMLalvbzwXM},#{oX5ol0oS5K5.Xrqplg36b9m}
MoH_755_2023 Cataract kit for 10 patients Dispensed this Month,CdXt9mM8akb,Cataract kit for 10 patients Dispensed this Month,#{sDMBcMoIdHn.qUUwvc197T4},1
MoH_755_2023 Cataract kit for 10 patients Percentage of Losses,MMfrbpAy9fn,Cataract kit for 10 patients Percentage of Losses,#{sDMBcMoIdHn.nMLalvbzwXM},#{sDMBcMoIdHn.Xrqplg36b9m}
MoH_755_2023 Cyclopentolate 0.5% - 2% eye drops Dispensed this Month,ZdxOTX3bXB4,Cyclopentolate 0.5% - 2% eye drops Dispensed ,#{hJ6FHDrkdFq.qUUwvc197T4},1
MoH_755_2023 Cyclopentolate 0.5% - 2% eye drops Percentage of Losses,KImF1hZAXvs,Cyclopentolate 0.5% - 2% eye drops % of Losses,#{hJ6FHDrkdFq.nMLalvbzwXM},#{hJ6FHDrkdFq.Xrqplg36b9m}
MoH_755_2023 Dexamethasone 0.1% eye drops Dispensed this Month,OqFLNgQwjWZ,Dexamethasone 0.1% eye drops Dispensed this Month,#{trPs0qlSulX.qUUwvc197T4},1
MoH_755_2023 Dexamethasone 0.1% eye drops Percentage of Losses,WVz72AQFwvb,Dexamethasone 0.1% eye drops Percentage of Losses,#{trPs0qlSulX.nMLalvbzwXM},#{trPs0qlSulX.Xrqplg36b9m}
MoH_755_2023 Dexamethasone 1mg/Polymyxin-B sulfate 6000 IU/Neomycin sulfate Ointment 3500IU Dispensed this Month for the past three months,VG6FHCB70WJ,Dex 1mg/Poly-B sul 6000 IU/Neo sulfate Oin 3500IU ,#{MselfDiW2MM.qUUwvc197T4},1
MoH_755_2023 Dexamethasone 1mg/Polymyxin-B sulfate 6000 IU/Neomycin sulfate Ointment 3500IU Percentage of Losses,JtTjFLdKGLU, Dex 1mg/Poly-B sul 6000 IU/Neo sul Oin 3500IU % ,#{MselfDiW2MM.nMLalvbzwXM},#{MselfDiW2MM.Xrqplg36b9m}
MoH_755_2023 Dorzolamide 2% eye drops Dispensed this Month,d8T2DFOfHNL,Dorzolamide 2% eye drops Dispensed this Month,#{uIgOXAJ6IZ9.qUUwvc197T4},1
MoH_755_2023 Dorzolamide 2% eye drops Percentage of Losses,p7RZfzy0V8y,Dorzolamide 2% eye drops Percentage of Losses,#{uIgOXAJ6IZ9.nMLalvbzwXM},#{uIgOXAJ6IZ9.Xrqplg36b9m}
MoH_755_2023 Fluorescein Test strip 0.6mg Dispensed this Month,IBIBqhxw9Ld,Fluorescein Test strip 0.6mg Dispensed this Month,#{Q4jSxabw8yu.qUUwvc197T4},1
MoH_755_2023 Fluorescein Test strip 0.6mg Percentage of Losses,cpeZXz4Trvb,Fluorescein Test strip 0.6mg ,#{Q4jSxabw8yu.nMLalvbzwXM},#{Q4jSxabw8yu.Xrqplg36b9m}
MoH_755_2023 Fluorometholone eye drops 0.1% Dispensed this Month,D7EH8hc9bS7,Fluorometholone eye drops 0.1% Dispensed,#{zASysb1RJ1I.qUUwvc197T4},1
MoH_755_2023 Fluorometholone eye drops 0.1% Percentage of Losses,itKrOAOi52g,Fluorometholone eye drops 0.1%  of Losses,#{zASysb1RJ1I.nMLalvbzwXM},#{zASysb1RJ1I.Xrqplg36b9m}
MoH_755_2023 Gentamicin 0.3% + Dexamethasone 0.1% eye drops Dispensed this Month,PnQB9IDvs3H,Gentamicin 0.3% + Dexa 0.1% eye drops Dispensed ,#{irhrk76osdO.qUUwvc197T4},1
MoH_755_2023 Gentamicin 0.3% + Dexamethasone 0.1% eye drops Percentage of Losses,A9g1e4IyGkj,Gent 0.3% + Dex 0.1% eye drops Per of Losses,#{irhrk76osdO.nMLalvbzwXM},#{irhrk76osdO.Xrqplg36b9m}
MoH_755_2023 Gentamicin 0.3% eye drops Dispensed this Month,c5yyY1ELEqo,Gentamicin 0.3% eye drops Dispensed this Month,#{FpgL813u0Rx.qUUwvc197T4},1
MoH_755_2023 Gentamicin 0.3% eye drops Percentage of Losses,yoLy35ACZ40,Gentamicin 0.3% eye drops Percentage of Losses,#{FpgL813u0Rx.nMLalvbzwXM},#{FpgL813u0Rx.Xrqplg36b9m}
MoH_755_2023 Hypertonic saline 3% eye drops Dispensed this Month,dGZtybecurS,Hypertonic saline 3% eye drops Dispensed,#{LIp7RWWl4Rq.qUUwvc197T4},1
MoH_755_2023 Hypertonic saline 3% eye drops Percentage of Losses,zaqbIKJCrpP,Hypertonic saline 3% eye drops ,#{LIp7RWWl4Rq.nMLalvbzwXM},#{LIp7RWWl4Rq.Xrqplg36b9m}
MoH_755_2023 Ketorolac trometamol 0.5% eye drops Dispensed this Month,wowkwS9G3J0,Ketorolac trometamol 0.5% eye drops,#{HjybSmemj5A.FKZIGWFJxiV},1
MoH_755_2023 Ketorolac trometamol 0.5% eye drops Percentage of Losses,eQbyrY2rw3Z, Ketorolac trometamol 0.5% eye drops % of Losses,#{HjybSmemj5A.nMLalvbzwXM},#{HjybSmemj5A.Xrqplg36b9m}
MoH_755_2023 Latanoprost 0.005% eye drops Dispensed this Month,OmbaZ0bsVcT,Latanoprost 0.005% eye drops Dispensed this Month,#{whlomBAuXLu.qUUwvc197T4},1
MoH_755_2023 Latanoprost 0.005% eye drops Percentage of Losses,Z37Z6JUNNKt,Latanoprost 0.005% eye drops Percentage of Losses,#{whlomBAuXLu.nMLalvbzwXM},#{whlomBAuXLu.Xrqplg36b9m}
MoH_755_2023 Methylcellulose 0.3% - 1% eye drops Dispensed this Month,wugqmNVzE1X,Methylcellulose 0.3% - 1% eye drops Dispensed,#{ZFUUEYcBeEo.qUUwvc197T4},1
MoH_755_2023 Methylcellulose 0.3% - 1% eye drops Percentage of Losses,BEtK7nNh3fT,Methylcellulose 0.3% - 1% eye drops ,#{ZFUUEYcBeEo.nMLalvbzwXM},#{ZFUUEYcBeEo.Xrqplg36b9m}
MoH_755_2023 Methylprednisolone PFI 1gm (as sodium succinate) Dispensed this Month,TgV4w0R23Ae,Methylprednisolone PFI 1gm Dispensed,#{mWixZ34z7dh.qUUwvc197T4},1
MoH_755_2023 Methylprednisolone PFI 1gm (as sodium succinate) Percentage of Losses,cXXFcYLDgMr,Methylprednisolone PFI 1gm  Percentage of Losses,#{mWixZ34z7dh.nMLalvbzwXM},#{mWixZ34z7dh.Xrqplg36b9m}
MoH_755_2023 Moxifloxacin eye drops 0.5% Dispensed this Month,PttGcBqBcB9,Moxifloxacin eye drops 0.5% Dispensed this Month,#{oMxIpPZd1BV.qUUwvc197T4},1
MoH_755_2023 Moxifloxacin eye drops 0.5% Percentage of Losses,ciIxccYGbAU,Moxifloxacin eye drops 0.5% Percentage of Losses,#{oMxIpPZd1BV.nMLalvbzwXM},#{oMxIpPZd1BV.Xrqplg36b9m}
MoH_755_2023 Natamycin 5% eye drops Dispensed this Month,YVhXm1eIl8D,Natamycin 5% eye drops Dispensed this Month,#{XFLxv9HYwVv.qUUwvc197T4},1
MoH_755_2023 Natamycin 5% eye drops Percentage of Losses,JVakUab6AeJ,Natamycin 5% eye drops Percentage of Losses,#{XFLxv9HYwVv.nMLalvbzwXM},#{XFLxv9HYwVv.Xrqplg36b9m}
MoH_755_2023 Ofloxacin eye drops 0.3% (as sulfate) Dispensed this Month,A3qJfuOcJhA,Ofloxacin eye drops 0.3% (as sulfate) Dispensed,#{fmGVY1xocas.FKZIGWFJxiV},1
MoH_755_2023 Ofloxacin eye drops 0.3% (as sulfate) Percentage of Losses,qdekvJrcHWM,Oflox eye drops 0.3% (as sulfate) % of Losses,#{fmGVY1xocas.nMLalvbzwXM},#{fmGVY1xocas.Xrqplg36b9m}
"MoH_755_2023 Olopatadine 0.1%, 0.2% eye drops (HCl) Dispensed this Month",Dtgt6fz3NEL,"Olop 0.1%, 0.2% eye drops (HCl) Disp this Mth",#{eNomhAGQ8N3.qUUwvc197T4},1
"MoH_755_2023 Olopatadine 0.1%, 0.2% eye drops (HCl) Percentage of Losses",JOwB60XFmhH,"Olopatadine 0.1%, 0.2% eye drops (HCl) ",#{eNomhAGQ8N3.nMLalvbzwXM},#{eNomhAGQ8N3.Xrqplg36b9m}
MoH_755_2023 Pilocarpine 4% eye drops Dispensed this Month,VzuZwGeR7Q3,Pilocarpine 4% eye drops Dispensed this Month,#{L89spFJW3X2.qUUwvc197T4},1
MoH_755_2023 Pilocarpine 4% eye drops Percentage of Losses,Z6pdrmy2uLu,Pilocarpine 4% eye drops Percentage of Losses,#{L89spFJW3X2.nMLalvbzwXM},#{L89spFJW3X2.Xrqplg36b9m}
MoH_755_2023 Posterior Chamber Intra Ocular Lens (+16D) Dispensed this Month,eqnadUe82ZD,Posterr Chr Intra Ocular Lens (+16D) Disp this Mth,#{oe9qBVZ5FLK.qUUwvc197T4},1
MoH_755_2023 Posterior Chamber Intra Ocular Lens (+16D) Percentage of Losses,p1YqxtVg6jN,Posterior Chamber Intra Ocular Lens (+16D),#{oe9qBVZ5FLK.nMLalvbzwXM},#{oe9qBVZ5FLK.Xrqplg36b9m}
MoH_755_2023 Posterior Chamber Intra Ocular Lens (+18D) Dispensed this Month,avHPaB3aN7U,Posterior Chamber Intra Ocular Lens (+18D),#{BrtlXR2qYMP.qUUwvc197T4},1
MoH_755_2023 Posterior Chamber Intra Ocular Lens (+18D) Percentage of Losses,MslYNLaFs0F,Posterior Chamber Intra Ocular Lens (+18D),#{BrtlXR2qYMP.nMLalvbzwXM},#{BrtlXR2qYMP.Xrqplg36b9m}
MoH_755_2023 Posterior Chamber Intra Ocular Lens (+19D) Dispensed this Month,FJqOZnyJC6M,Posterior Chamber Intra Ocular Lens (+19D) ,#{gOyGbzCbDlo.qUUwvc197T4},1
MoH_755_2023 Posterior Chamber Intra Ocular Lens (+19D) Percentage of Losses,HukSbO1Zymc,Posterior Chamber Intra Ocular Lens (+19D),#{gOyGbzCbDlo.nMLalvbzwXM},#{gOyGbzCbDlo.Xrqplg36b9m}
MoH_755_2023 Posterior Chamber Intra Ocular Lens (+20D) Dispensed this Month,ntHqpEQ9zLQ, Posterior Chamber Intra Ocular Lens (+20D) ,#{dvtNZUGiw2U.qUUwvc197T4},1
MoH_755_2023 Posterior Chamber Intra Ocular Lens (+20D) Percentage of Losses,j95TIk5IVRX,Posterior Chamber Intra Ocular Lens (+20D),#{dvtNZUGiw2U.nMLalvbzwXM},#{dvtNZUGiw2U.Xrqplg36b9m}
MoH_755_2023 Posterior Chamber Intra Ocular Lens (+21D) Dispensed this Month,Oj1O9Zcx6uE,Posterior Chamber Intra Ocular Lens (+21D),#{CilVzclVWe2.qUUwvc197T4},1
MoH_755_2023 Posterior Chamber Intra Ocular Lens (+21D) Percentage of Losses,PgLz6zLcXxv,Posterior Chamber Intra Ocular Lens (+21D),#{CilVzclVWe2.nMLalvbzwXM},#{CilVzclVWe2.Xrqplg36b9m}
MoH_755_2023 Posterior Chamber Intra Ocular Lens (+22D) Dispensed this Month,e5ykKMpWcY5,Posterior Chamber Intra Ocular Lens (+22D),#{g6MhwA8Z7IA.qUUwvc197T4},1
MoH_755_2023 Posterior Chamber Intra Ocular Lens (+22D) Percentage of Losses,uMhr4yJ5Djl,Posterior Chamber Intra Ocular Lens (+22D),#{g6MhwA8Z7IA.nMLalvbzwXM},#{g6MhwA8Z7IA.Xrqplg36b9m}
MoH_755_2023 Posterior Chamber Intra Ocular Lens (+23D) Dispensed this Month,EzPOB8ZkwFl,Posterior Chamber Intra Ocular Lens (+23D) ,#{GkXA5GB0Hf3.qUUwvc197T4},1
MoH_755_2023 Posterior Chamber Intra Ocular Lens (+23D) Percentage of Losses,u5FCoIhz8NI,Posterior Chamber Intra Ocular Lens (+23D),#{GkXA5GB0Hf3.nMLalvbzwXM},#{GkXA5GB0Hf3.Xrqplg36b9m}
MoH_755_2023 Posterior Chamber Intra Ocular Lens (+24D) Dispensed this Month,En7kPlhRFMP,Posterior Chamber Intra Ocular Lens (+24D),#{RLz23TnKuUI.qUUwvc197T4},1
MoH_755_2023 Posterior Chamber Intra Ocular Lens (+24D) Percentage of Losses,jYR5nFmXN7d,Posterior Chamber Intra Ocular Lens (+24D),#{RLz23TnKuUI.nMLalvbzwXM},#{RLz23TnKuUI.Xrqplg36b9m}
MoH_755_2023 Prednisolone eye drops 1% (as acetate) (5mL) Dispensed this Month,yHVrsw9K7bQ,Prednisolone eye drops 1% (as acetate) (5mL) ,#{VWRS2kSETv0.qUUwvc197T4},1
MoH_755_2023 Prednisolone eye drops 1% (as acetate) (5mL) Percentage of Losses,L4dsZVb3XJU,Prednisolone eye drops 1% Percentage of Losses,#{VWRS2kSETv0.nMLalvbzwXM},#{VWRS2kSETv0.Xrqplg36b9m}
MoH_755_2023 Riboflavin Dispensed this Month,UvHGfRszu0J,MoH_755_2023 Riboflavin Dispensed this Month,#{wJ8nYFPUjaV.qUUwvc197T4},1
MoH_755_2023 Riboflavin Percentage of Losses,E31hchTSrgA,MoH_755_2023 Riboflavin Percentage of Losses,#{wJ8nYFPUjaV.nMLalvbzwXM},#{wJ8nYFPUjaV.Xrqplg36b9m}
MoH_755_2023 Sodium Hyaluronate 1% Eye drops (preservative free) Dispensed this Month,Oc5pkf1dtkp,Sodium Hyaluronate 1% Eye drops ,#{Xo1gS2MiprS.qUUwvc197T4},1
MoH_755_2023 Sodium Hyaluronate 1% Eye drops (preservative free) Percentage of Losses,mcN4XAD7g0t,Sodium Hyaluronate 1% Eye drops (preservative free,#{Xo1gS2MiprS.nMLalvbzwXM},#{Xo1gS2MiprS.Xrqplg36b9m}
MoH_755_2023 Sodium cromoglycate 2% eye drops Dispensed this Month,BMcDE5E6CeI,Sodium cglycate 2% eye drops Dispensed this Month,#{kM18pVTX8cl.qUUwvc197T4},1
MoH_755_2023 Sodium cromoglycate 2% eye drops Percentage of Losses,jyJ6uBTYwsw,MoH_755_2023 Sodium cromoglycate 2% eye drops ,#{kM18pVTX8cl.nMLalvbzwXM},#{kM18pVTX8cl.Xrqplg36b9m}
MoH_755_2023 Tetracaine eye drops 0.5% (as HCl) Dispensed this Month,O3KEAXJBRNO,Tetracaine eye drops 0.5% (as HCl) Dispensed,#{FL6La4dLNNh.qUUwvc197T4},1
MoH_755_2023 Tetracaine eye drops 0.5% (as HCl) Percentage of Losses,F5w6KkC5uQ2,Tetracaine eye drops 0.5% Percentage of Losses,#{FL6La4dLNNh.nMLalvbzwXM},#{FL6La4dLNNh.Xrqplg36b9m}
MoH_755_2023 Tetracycline 1% eye ointment Dispensed this Month,jf3yhlnKtl7,Tetracycline 1% eye ointment Dispensed this Month,#{YmqBWf3eIqj.qUUwvc197T4},1
MoH_755_2023 Tetracycline 1% eye ointment Percentage of Losses,fBw693QJHeG,Tetracycline 1% eye ointment % of Losses,#{YmqBWf3eIqj.nMLalvbzwXM},#{YmqBWf3eIqj.Xrqplg36b9m}
MoH_755_2023 Timolol 0.5% eye drops (as hyd. maleate) Dispensed this Month,pkEV3bk4Kyg,Timolol 0.5% eye drops (as hyd. maleate) Dispensed,#{VKBKnwSrD4V.qUUwvc197T4},1
MoH_755_2023 Timolol 0.5% eye drops (as hyd. maleate) Percentage of Losses,aM9K659U6MI,Timolol 0.5% eye drops (as hyd. malea) % of Losses,#{wg8IDAVPhbp.nMLalvbzwXM},#{VKBKnwSrD4V.Xrqplg36b9m}
MoH_755_2023 Tobramycin 0.3% + Dexamethasone 1% eye drops Dispensed this Month,Oi9KbjHF3ld,Tobramycin 0.3% + Dexa 1% eye drops Dispensed ,#{YjYAp6TuEKi.qUUwvc197T4},1
MoH_755_2023 Tobramycin 0.3% + Dexamethasone 1% eye drops Percentage of Losses,YktN2OzrUwr,Tobramycin 0.3% + Dex  1% eye drop % of Losses,#{YjYAp6TuEKi.nMLalvbzwXM},#{YjYAp6TuEKi.Xrqplg36b9m}
MoH_755_2023 Tobramycin 0.3% eye drops Dispensed this Month,GiYEgC9Nj2X,Tobramycin 0.3% eye drops Dispensed this Month,#{Tv7DZYRKqPo.qUUwvc197T4},1
MoH_755_2023 Tobramycin 0.3% eye drops Percentage of Losses,wwFNOKkY3pR,Tobramycin 0.3% eye drops Percentage of Losses,#{Tv7DZYRKqPo.nMLalvbzwXM},#{Tv7DZYRKqPo.Xrqplg36b9m}
MoH_755_2023 Triamcinolone acetonide inj 40 mg/ml Dispensed this Month,Wp0nKOKKnuA,Triamcinolone acetonide inj 40 mg/ml Dispensed,#{aLsQOiEm6cm.qUUwvc197T4},1
MoH_755_2023 Triamcinolone acetonide inj 40 mg/ml Percentage of Losses,XxZKQaxT94S,Triamcinolone acetonide inj 40 mg/ml %  of Losses,#{aLsQOiEm6cm.nMLalvbzwXM},#{aLsQOiEm6cm.Xrqplg36b9m}
MoH_755_2023 Tropicamide 0.8% /phenylephrine 5% Dispensed this Month,uJGmFzVKNGn,Tropicamide 0.8% /phenylephrine 5% Dispensed,#{WGRA5kucGJb.qUUwvc197T4},1
MoH_755_2023 Tropicamide 0.8% /phenylephrine 5% Percentage of Losses,wFEkZokgFpD,Tropicamide 0.8% /phenylephrine 5% % of Losses,#{WGRA5kucGJb.nMLalvbzwXM},#{WGRA5kucGJb.Xrqplg36b9m}
MoH_755_2023 Voriconazole 1% eye drops Dispensed this Month,bL7GiZqmuRA,Voriconazole 1% eye drops Dispensed this Month,#{iuwlBEuYgQo.qUUwvc197T4},1
MoH_755_2023 Voriconazole 1% eye drops Percentage of Losses,eKVBVFOJzHB,Voriconazole 1% eye drops Percentage of Losses,#{iuwlBEuYgQo.nMLalvbzwXM},#{iuwlBEuYgQo.Xrqplg36b9m}
Moderna_Vaccine_Type,uQLTS0pTwkY,Moderna_Vaccine_Type,#{LTJsHtrbyML} + #{jm6G9QtE6Th},1
Moh_735_2023  Proportion of Ophthalmia Neonatorum to live births,LjFb5xmMMp4,Proportion of Ophthalmia Neonatorum to live births,#{DQHpRnXqxPU.jhYvM0Yqigf} + #{DQHpRnXqxPU.ByMfU2PdEoj}+ #{DQHpRnXqxPU.EUgu49YLiYV} + #{DQHpRnXqxPU.kb0U8v2DzhH} + #{DQHpRnXqxPU.YRznowneRgB} + #{DQHpRnXqxPU.xSRxxmyzmzf},#{UqKC1DJnymn}
Moh_735_2023 Percentage of clients with Diabetes Retinopathy receiving intravitreal injection treatment,hP4hS4cKRyh,%of clients with DR receiving intravitreal Inj.,#{hlnNWUwzMIN.n4G0FsuKm4G} + #{hlnNWUwzMIN.wwfNWKTEigw} + #{hlnNWUwzMIN.I3kbMu6YUMm} + #{hlnNWUwzMIN.v5TzHzAjuZe} + #{hlnNWUwzMIN.N7pZ3wnscGw} + #{hlnNWUwzMIN.V3A5eOcjjgY} + #{hlnNWUwzMIN.px8KCmwoOoT} + #{hlnNWUwzMIN.Tr98w2CG8DV} + #{hlnNWUwzMIN.V4scNeLvCJG} + #{hlnNWUwzMIN.HBo8vAmzv5P} + #{hlnNWUwzMIN.QWshKHY1vc9} + #{hlnNWUwzMIN.lkgQ38O2V4D} ,#{y5Y7KBOFjhy.jhYvM0Yqigf} + #{y5Y7KBOFjhy.ByMfU2PdEoj} + #{y5Y7KBOFjhy.F8VZ4hjeSWC} + #{y5Y7KBOFjhy.a1ZjiEQnO6m} + #{y5Y7KBOFjhy.eR53SBXqXgk} + #{y5Y7KBOFjhy.MGrPmTraxSm} + #{y5Y7KBOFjhy.YRznowneRgB} + #{y5Y7KBOFjhy.xSRxxmyzmzf} + #{y5Y7KBOFjhy.Af3KwhB787f} + #{y5Y7KBOFjhy.YlUuxXLfNJl} + #{y5Y7KBOFjhy.o7G4JOIHdSt} + #{y5Y7KBOFjhy.osKbW4Kxdy7} + #{y5Y7KBOFjhy.EUgu49YLiYV} + #{y5Y7KBOFjhy.kb0U8v2DzhH} + #{y5Y7KBOFjhy.uHzP0OaOZ3k} + #{y5Y7KBOFjhy.r0X54dyKXrd} + #{y5Y7KBOFjhy.To0xL5qViVb} + #{y5Y7KBOFjhy.VE95Fu3Ruxn}
Moh_735_2023 Percentage of clients with Diabetes Retinopathy receiving retinal laser treatment,ws2TPGflZgm,% of clients with DR receiving laser treatment,#{rVcY7gDKDCd.n4G0FsuKm4G} + #{rVcY7gDKDCd.wwfNWKTEigw} + #{rVcY7gDKDCd.I3kbMu6YUMm} + #{rVcY7gDKDCd.v5TzHzAjuZe} + #{rVcY7gDKDCd.N7pZ3wnscGw} + #{rVcY7gDKDCd.V3A5eOcjjgY} + #{rVcY7gDKDCd.px8KCmwoOoT} + #{rVcY7gDKDCd.Tr98w2CG8DV} + #{rVcY7gDKDCd.V4scNeLvCJG} + #{rVcY7gDKDCd.HBo8vAmzv5P}  + #{rVcY7gDKDCd.QWshKHY1vc9} + #{rVcY7gDKDCd.lkgQ38O2V4D},#{y5Y7KBOFjhy.jhYvM0Yqigf} + #{y5Y7KBOFjhy.ByMfU2PdEoj} + #{y5Y7KBOFjhy.F8VZ4hjeSWC} + #{y5Y7KBOFjhy.a1ZjiEQnO6m} + #{y5Y7KBOFjhy.eR53SBXqXgk} + #{y5Y7KBOFjhy.MGrPmTraxSm} + #{y5Y7KBOFjhy.YRznowneRgB} + #{y5Y7KBOFjhy.xSRxxmyzmzf} + #{y5Y7KBOFjhy.Af3KwhB787f} + #{y5Y7KBOFjhy.YlUuxXLfNJl} + #{y5Y7KBOFjhy.o7G4JOIHdSt} + #{y5Y7KBOFjhy.osKbW4Kxdy7} + #{y5Y7KBOFjhy.EUgu49YLiYV} + #{y5Y7KBOFjhy.kb0U8v2DzhH} + #{y5Y7KBOFjhy.uHzP0OaOZ3k} + #{y5Y7KBOFjhy.r0X54dyKXrd} + #{y5Y7KBOFjhy.To0xL5qViVb} + #{y5Y7KBOFjhy.VE95Fu3Ruxn}
Moh_735_2023 Percentage of clients with refractive error,J3LNkzK5AkT,Percentage of clients with refractive error,#{w5ixh3ii8ZW.jhYvM0Yqigf} + #{w5ixh3ii8ZW.ByMfU2PdEoj} + #{w5ixh3ii8ZW.F8VZ4hjeSWC} + #{w5ixh3ii8ZW.a1ZjiEQnO6m} + #{w5ixh3ii8ZW.eR53SBXqXgk} + #{w5ixh3ii8ZW.MGrPmTraxSm} + #{w5ixh3ii8ZW.YRznowneRgB} + #{w5ixh3ii8ZW.xSRxxmyzmzf} + #{w5ixh3ii8ZW.Af3KwhB787f} + #{w5ixh3ii8ZW.YlUuxXLfNJl} + #{w5ixh3ii8ZW.o7G4JOIHdSt} + #{w5ixh3ii8ZW.osKbW4Kxdy7},#{DQsRyjmTOS7.piLmuyAjjI3} + #{DQsRyjmTOS7.DHZ42ax0oPV}  + #{DQsRyjmTOS7.pfRg16V6bme} + #{DQsRyjmTOS7.y0a9RYDpr2X} + #{w5UInTjvl72.piLmuyAjjI3} + #{w5UInTjvl72.DHZ42ax0oPV} + #{w5UInTjvl72.pfRg16V6bme} + #{w5UInTjvl72.y0a9RYDpr2X} +#{z4PgokaW1S0.piLmuyAjjI3} + #{z4PgokaW1S0.DHZ42ax0oPV} + #{z4PgokaW1S0.pfRg16V6bme} + #{z4PgokaW1S0.y0a9RYDpr2X} 
Moh_735_2023 Percentage of diabetic patients with Diabetes Retinopathy,qrR32zZ4Lc3,%Diabetic patients with Diabetes Retinopathy,#{y5Y7KBOFjhy.jhYvM0Yqigf} + #{y5Y7KBOFjhy.ByMfU2PdEoj} + #{y5Y7KBOFjhy.F8VZ4hjeSWC} + #{y5Y7KBOFjhy.a1ZjiEQnO6m} + #{y5Y7KBOFjhy.eR53SBXqXgk} + #{y5Y7KBOFjhy.MGrPmTraxSm} + #{y5Y7KBOFjhy.YRznowneRgB} + #{y5Y7KBOFjhy.xSRxxmyzmzf} + #{y5Y7KBOFjhy.Af3KwhB787f} + #{y5Y7KBOFjhy.YlUuxXLfNJl} + #{y5Y7KBOFjhy.o7G4JOIHdSt} + #{y5Y7KBOFjhy.osKbW4Kxdy7} + #{y5Y7KBOFjhy.EUgu49YLiYV} + #{y5Y7KBOFjhy.kb0U8v2DzhH} + #{y5Y7KBOFjhy.uHzP0OaOZ3k} + #{y5Y7KBOFjhy.r0X54dyKXrd} + #{y5Y7KBOFjhy.To0xL5qViVb} + #{y5Y7KBOFjhy.VE95Fu3Ruxn},#{YNfr17yqhll.EynBGhY9Yg4} + #{YNfr17yqhll.QOIpb8LBRtm}
Moh_735_2023 Percentage of under 5 years with Strabismus,ZQXhPjvNCry,Percentage of under 5 with Strabismus,#{scD61cczLoR.jhYvM0Yqigf} + #{scD61cczLoR.ByMfU2PdEoj} + #{scD61cczLoR.YRznowneRgB} + #{scD61cczLoR.xSRxxmyzmzf} + #{scD61cczLoR.EUgu49YLiYV} + #{scD61cczLoR.kb0U8v2DzhH},#{w5UInTjvl72.piLmuyAjjI3} + #{w5UInTjvl72.DHZ42ax0oPV} + #{w5UInTjvl72.pfRg16V6bme} + #{w5UInTjvl72.y0a9RYDpr2X}
NCD_Total cumulative diabetes in care,Com9tsaEySk,Total cumulative diabetes in care,#{YNfr17yqhll} + #{tVa6KHmClU8},1
NCD_Total cumulative hypertension in care,zyLea94vBID,Total hypertension in Care,#{zjfkSMegwML} + #{tVa6KHmClU8},1
NEMIS_ Number of children dewormed PZQ,vw44eiApkOr,NEMIS_ Number of children dewormed PZQ,#{J2z72L4pvqe.PH8wNjPxzwN} + #{J2z72L4pvqe.RqJHVRrwyJQ} + #{gsNmGNuIAI3.mJ5a7SVykcr} + #{gsNmGNuIAI3.Q0KgItGnPbj} + #{gsNmGNuIAI3.jaEc6yalIld} + #{gsNmGNuIAI3.ivYSQl3ta8J} + #{djFfvCouwsu.HuPe2PZJlbu} + #{djFfvCouwsu.rlRvlZr4Bjp} + #{djFfvCouwsu.YldriK0J6kX} + #{djFfvCouwsu.mJvL38FRIZi} + #{djFfvCouwsu.toyS3GvBwUz} + #{djFfvCouwsu.JBggQ4AQC4d},1
NEMIS_ children dewormed by age group PZQ,Cn4cIxvHi4e,NEMIS_ children dewormed by age group PZQ,#{J2z72L4pvqe.PH8wNjPxzwN} + #{J2z72L4pvqe.RqJHVRrwyJQ} + #{djFfvCouwsu.HuPe2PZJlbu} + #{djFfvCouwsu.rlRvlZr4Bjp} + #{gsNmGNuIAI3.mJ5a7SVykcr} + #{gsNmGNuIAI3.Q0KgItGnPbj} + #{gsNmGNuIAI3.jaEc6yalIld} + #{gsNmGNuIAI3.ivYSQl3ta8J} + #{djFfvCouwsu.YldriK0J6kX} + #{djFfvCouwsu.mJvL38FRIZi} + #{djFfvCouwsu.toyS3GvBwUz} + #{djFfvCouwsu.JBggQ4AQC4d},1
NEMIS_ children dewormed by enrollment status PZQ,aVZogKJzHcM,NEMIS_ children dewormed by enrollment status PZQ,#{J2z72L4pvqe.PH8wNjPxzwN} + #{J2z72L4pvqe.RqJHVRrwyJQ} + #{gsNmGNuIAI3.mJ5a7SVykcr} + #{gsNmGNuIAI3.Q0KgItGnPbj} + #{gsNmGNuIAI3.jaEc6yalIld} + #{gsNmGNuIAI3.ivYSQl3ta8J} + #{djFfvCouwsu.HuPe2PZJlbu} + #{djFfvCouwsu.rlRvlZr4Bjp} + #{djFfvCouwsu.YldriK0J6kX} + #{djFfvCouwsu.mJvL38FRIZi} + #{djFfvCouwsu.toyS3GvBwUz} + #{djFfvCouwsu.JBggQ4AQC4d},1
NEMIS_Children dewormed by enrollment status_PZQ,Kbpr6dGGrTY,NEMIS_Children dewormed by enrollment status_PZQ,#{J2z72L4pvqe.SB5hMRUl4wa} + #{J2z72L4pvqe.zmGBJZqAmgT} + #{gsNmGNuIAI3.mJ5a7SVykcr} + #{gsNmGNuIAI3.Q0KgItGnPbj} + #{gsNmGNuIAI3.jaEc6yalIld} + #{gsNmGNuIAI3.ivYSQl3ta8J} + #{djFfvCouwsu.HuPe2PZJlbu} + #{djFfvCouwsu.rlRvlZr4Bjp} + #{djFfvCouwsu.YldriK0J6kX} + #{djFfvCouwsu.mJvL38FRIZi} + #{djFfvCouwsu.toyS3GvBwUz} + #{djFfvCouwsu.JBggQ4AQC4d},1
NEMIS_Children in register enrolment numbers_PZQ,L4Imscq5csH,NEMIS_Children in register enrolment numbers_PZQ,#{J2z72L4pvqe.SB5hMRUl4wa} + #{J2z72L4pvqe.zmGBJZqAmgT} + #{gsNmGNuIAI3.XCTkPGLioWe} + #{gsNmGNuIAI3.JiubJz5NvW6},1
NEMIS_Children in register/ enrolment numbers,BFrZWTCjyGX,NEMIS_Children in register/ enrolment numbers,#{J2z72L4pvqe.SB5hMRUl4wa} + #{J2z72L4pvqe.zmGBJZqAmgT} + #{gsNmGNuIAI3.XCTkPGLioWe} + #{gsNmGNuIAI3.JiubJz5NvW6},1
NEMIS_Children in register_ABZ,FXPNGM4Ug38,NEMIS_Children in register_ABZ,#{Ip9XHUQoFcA.SB5hMRUl4wa} + #{Ip9XHUQoFcA.zmGBJZqAmgT},1
NEMIS_Enrolled No. of children 6-14 dewormed_ABZ,LMcgMRW7eMS,NEMIS_Enrolled No of children 6-14 dewormed_ABZ,#{Te02k92LpYV.mJ5a7SVykcr} + #{Te02k92LpYV.Q0KgItGnPbj} + #{twTnvbLsDHs.YldriK0J6kX} + #{twTnvbLsDHs.mJvL38FRIZi},1
NEMIS_Enrolled No. of children dewormed_ABZ,GR7u0h8qqbL,NEMIS_Enrolled No of children dewormed_ABZ,#{Ip9XHUQoFcA.PH8wNjPxzwN} + #{Ip9XHUQoFcA.RqJHVRrwyJQ} + #{Te02k92LpYV.mJ5a7SVykcr} + #{Te02k92LpYV.Q0KgItGnPbj} + #{Te02k92LpYV.jaEc6yalIld} + #{Te02k92LpYV.ivYSQl3ta8J},1
NEMIS_No of adult treated_ABZ,fG7fb5Ne5sH,NEMIS_No of adult treated_ABZ,#{Q7Q7hUV8DjO},1
NEMIS_No of children dewormed_ABZ,IrdAj2zteQT,NEMIS_No of children dewormed__ABZ,#{Ip9XHUQoFcA.PH8wNjPxzwN} + #{Ip9XHUQoFcA.RqJHVRrwyJQ}  + #{Te02k92LpYV.mJ5a7SVykcr} + #{Te02k92LpYV.Q0KgItGnPbj} + #{Te02k92LpYV.jaEc6yalIld} + #{Te02k92LpYV.ivYSQl3ta8J} + #{twTnvbLsDHs.HuPe2PZJlbu} + #{twTnvbLsDHs.rlRvlZr4Bjp} + #{twTnvbLsDHs.YldriK0J6kX} + #{twTnvbLsDHs.mJvL38FRIZi} + #{twTnvbLsDHs.toyS3GvBwUz} + #{twTnvbLsDHs.JBggQ4AQC4d},1
NEMIS_No of female dewormed_ABZ,VPvwabbRnnO,NEMIS_No of female dewormed_ABZ,#{Ip9XHUQoFcA.RqJHVRrwyJQ} + #{Te02k92LpYV.Q0KgItGnPbj} + #{Te02k92LpYV.ivYSQl3ta8J} + #{twTnvbLsDHs.rlRvlZr4Bjp} + #{twTnvbLsDHs.mJvL38FRIZi} + #{twTnvbLsDHs.JBggQ4AQC4d},1
NEMIS_No of male dewormed_ABZ,Q8CsdeuJYrk,NEMIS_No of male dewormed_ABZ,#{twTnvbLsDHs.toyS3GvBwUz} + #{twTnvbLsDHs.YldriK0J6kX} + #{twTnvbLsDHs.HuPe2PZJlbu}  + #{Te02k92LpYV.jaEc6yalIld} + #{Te02k92LpYV.mJ5a7SVykcr} + #{Ip9XHUQoFcA.PH8wNjPxzwN},1
NEMIS_No of school treated_ABZ,Uw3ymLtiDVx,NEMIS_No of school treated_ABZ,#{OCbcF5FGO9R},1
NEMIS_No of tablets received by school_ABZ,IqT17gDH4LL,NEMIS_No of tablet received by school_ABZ,#{ez3jV2uWISB},1
NEMIS_Number of adults treated PZQ,kfSc4PD0v5B,NEMIS_Number of adults treated PZQ,#{BSMyviqszMn},1
NEMIS_Number of schools treated PZQ,xSyEwtlod5q,NEMIS_Number of schools treated PZQ,#{DoytyQe2yjQ} ,1
NEMIS_Number of tablets given _PZQ,LIlXvyxubI0,NEMIS_Number of tablets given _PZQ,#{Yg8YyjaYvCf},1
NEMIS_Out of School No. of children dewormed_ABZ,BnRdvHWzRBX,NEMIS_Out of School No of children dewormed_ABZ,#{twTnvbLsDHs.HuPe2PZJlbu} + #{twTnvbLsDHs.rlRvlZr4Bjp} + #{twTnvbLsDHs.YldriK0J6kX} + #{twTnvbLsDHs.mJvL38FRIZi} + #{twTnvbLsDHs.toyS3GvBwUz} + #{twTnvbLsDHs.JBggQ4AQC4d},1
NEMIS_PSAC No of children dewormed_ABZ,qpifMHzEHnU,NEMIS_PSAC No of children dewormed_ABZ,#{Ip9XHUQoFcA.PH8wNjPxzwN} + #{Ip9XHUQoFcA.RqJHVRrwyJQ} + #{twTnvbLsDHs.HuPe2PZJlbu} + #{twTnvbLsDHs.rlRvlZr4Bjp},1
NEMIS_Preprimary Children in register_ABZ,lcqP2nNMl9n,NEMIS_Children in register_ABZ,#{Ip9XHUQoFcA.SB5hMRUl4wa} + #{Ip9XHUQoFcA.zmGBJZqAmgT},1
NEMIS_Primary Children in register_ABZ,HHSNcxVPm14,NEMIS_Primary Children in register_ABZ,#{Te02k92LpYV.XCTkPGLioWe} + #{Te02k92LpYV.JiubJz5NvW6},1
NEMIS_SAC No of children dewormed_ABZ,frESLWCM9lf,NEMIS_SAC No of children dewormed_ABZ,#{Te02k92LpYV.jaEc6yalIld} + #{Te02k92LpYV.mJ5a7SVykcr} + #{Te02k92LpYV.Q0KgItGnPbj} + #{Te02k92LpYV.ivYSQl3ta8J} + #{twTnvbLsDHs.YldriK0J6kX} + #{twTnvbLsDHs.mJvL38FRIZi} + #{twTnvbLsDHs.toyS3GvBwUz} + #{twTnvbLsDHs.JBggQ4AQC4d},1
NEMIS_Total number of children Male 6-14,W9q2EBzdECk,NEMIS_Total number of children Male 6-14,#{gsNmGNuIAI3.mJ5a7SVykcr} + #{gsNmGNuIAI3.jaEc6yalIld},1
NEMIS_Total number of children Male _PZQ,RyHSxl80vEt,NEMIS_Total number of children Male _PZQ,#{gsNmGNuIAI3.mJ5a7SVykcr} + #{gsNmGNuIAI3.jaEc6yalIld} + #{djFfvCouwsu.YldriK0J6kX} + #{djFfvCouwsu.toyS3GvBwUz},1
NEMIS_Total number of children female_PZQ,QT3YQifYwoI,NEMIS_Total number of children female _PZQ,#{gsNmGNuIAI3.Q0KgItGnPbj} + #{gsNmGNuIAI3.ivYSQl3ta8J} + #{djFfvCouwsu.mJvL38FRIZi} +#{djFfvCouwsu.JBggQ4AQC4d},1
NEMIS_children dewormed,OCIOZ2cw23N,NEMIS_children dewormed,#{FaSVvT4ZQxl.mJ5a7SVykcr} + #{FaSVvT4ZQxl.Q0KgItGnPbj} + #{FaSVvT4ZQxl.jaEc6yalIld} + #{FaSVvT4ZQxl.ivYSQl3ta8J} + #{djFfvCouwsu.HuPe2PZJlbu} + #{djFfvCouwsu.rlRvlZr4Bjp} + #{djFfvCouwsu.YldriK0J6kX} + #{djFfvCouwsu.mJvL38FRIZi} + #{djFfvCouwsu.toyS3GvBwUz} + #{djFfvCouwsu.JBggQ4AQC4d},1
NEMIS_children dewormed by gender PZQ,nc3v9AcrGSL,NEMIS_children dewormed by gender PZQ,#{J2z72L4pvqe.SB5hMRUl4wa} +  #{gsNmGNuIAI3.mJ5a7SVykcr} + #{gsNmGNuIAI3.jaEc6yalIld} + #{djFfvCouwsu.HuPe2PZJlbu} + #{djFfvCouwsu.YldriK0J6kX} + #{djFfvCouwsu.toyS3GvBwUz} +  #{J2z72L4pvqe.RqJHVRrwyJQ} + #{gsNmGNuIAI3.Q0KgItGnPbj} + #{gsNmGNuIAI3.ivYSQl3ta8J} + #{djFfvCouwsu.rlRvlZr4Bjp} + #{djFfvCouwsu.mJvL38FRIZi} + #{djFfvCouwsu.JBggQ4AQC4d},1
NEMIS_proportion of tablets spoiled_ABZ,MW7WOoszQ1J,NEMIS_proportion of tablets spoiled_ABZ,#{Pjn855QS4YS},#{ez3jV2uWISB} + #{pavw50gfFJa} - (#{Pjn855QS4YS} + #{fzKCGkCgwwa})
Need for PMTCT,ZH8BGmU9SHJ,Need for PMTCT,#{rSfCham9BzD},1
Need for PMTCT (KP at 1st ANC + Newly Positive at ANC),XBaEY6d5bzt,Need for PMTCT,#{qSgLzXh46n9} + #{nwXS5vxrrr7},1
Neonates 0-28 days of the total Population,su3n8FKtw11,% Neonates 0-28 days,#{rHHcj6tWlU1.NhSoXUMPK2K},#{NLKRV7bYbVy.NhSoXUMPK2K}
Net Cash/Bank available,voXZRWtd0U7,Net Cash/Bank available,((#{QokZ5jjGLRz.NhSoXUMPK2K}+#{H5NKPaRikyM.NhSoXUMPK2K}+#{cKGenTODtq8.NhSoXUMPK2K}+#{nspiDhcn12j.NhSoXUMPK2K}+#{zo5v2sL2Pcz.NhSoXUMPK2K}+#{YkVzbDfJKMy.NhSoXUMPK2K}+#{FLT5619aj9V.NhSoXUMPK2K})-(#{jY3JFizFzQN.NhSoXUMPK2K}+#{usMDjlboKn4.NhSoXUMPK2K}+#{WuEJXcFURTY.NhSoXUMPK2K}+#{t75eApxzxfv.NhSoXUMPK2K}+#{q04fFLke4PE.NhSoXUMPK2K}+#{IxfhqZSgGy9.NhSoXUMPK2K}+#{QrHdlGiLTpv.NhSoXUMPK2K}+#{nGagRoo4BzA.NhSoXUMPK2K}+#{RijWww0GNyd.NhSoXUMPK2K}+#{sDEtpJj8IeQ.NhSoXUMPK2K}+#{VV8rxMutqgB.NhSoXUMPK2K}+#{W6kjK1t3oha.NhSoXUMPK2K}+#{DOPHF9sDlCE.NhSoXUMPK2K}+#{uHj0fEYrjTx.NhSoXUMPK2K}+#{Q3Dtz4uTL0J.NhSoXUMPK2K}+#{RIdOyfRqT15.NhSoXUMPK2K}+#{KAVPEvsu7GB.NhSoXUMPK2K}+#{sW1FEKkUlno.NhSoXUMPK2K}+#{JgjYnWEbbXI.NhSoXUMPK2K}+#{GeLsHQnBJSl.NhSoXUMPK2K}+#{Anntg74AWAc.NhSoXUMPK2K}+#{NAWDpCTju9c.NhSoXUMPK2K}+#{uIKFwsGjL8l.NhSoXUMPK2K}+#{zfE43ojuX27.NhSoXUMPK2K}+#{Jm0j7eIJw22.NhSoXUMPK2K}+#{Kvrh6Edh4ux.NhSoXUMPK2K}+#{kZVa4Dfz3oW.NhSoXUMPK2K}+#{ozuOGiiROjR.NhSoXUMPK2K}+#{zq5cC1mHOjZ.NhSoXUMPK2K}+#{kkKxlgb0SIK.NhSoXUMPK2K}+#{eWJI88NUHju.NhSoXUMPK2K}+#{ZL5umjFvNZT.NhSoXUMPK2K}+#{kMyKJqs4tP6.NhSoXUMPK2K}+#{JfMlkDb7sfP.NhSoXUMPK2K}+#{ERUP9jd5kr8.NhSoXUMPK2K}+#{VE7bP4Hd0Y8.NhSoXUMPK2K}+#{G10FiANc4uK.NhSoXUMPK2K}+#{jER1yfrClYQ.NhSoXUMPK2K}+#{zmTKl26bqXb.NhSoXUMPK2K}+#{JqVPN31hItf.NhSoXUMPK2K}+#{FNaQfndi92d.NhSoXUMPK2K}+#{pwYhMY7SObK.NhSoXUMPK2K}+#{T6Zosl4H5TG.NhSoXUMPK2K}+#{W53qF6leiPm.NhSoXUMPK2K}+#{MxceLE1Wgwj.NhSoXUMPK2K}+#{HGfobnG3qSX.NhSoXUMPK2K}+#{WypNzlF1rxb.NhSoXUMPK2K}+#{kltZozM5rkg.NhSoXUMPK2K}+#{SWHhf1eE89t.NhSoXUMPK2K}+#{qLWHhVTIp0l.NhSoXUMPK2K}+#{s2Ha3e0xwwp.NhSoXUMPK2K}+#{RMsgMQj2SBM.NhSoXUMPK2K}+#{X3nuiSHRJJP.NhSoXUMPK2K}+#{bDSQEZM3rtd.NhSoXUMPK2K}+#{dvo26Xu2g3G.NhSoXUMPK2K}+#{ksAM140tLvc.NhSoXUMPK2K}+#{mYIZtgEPa5S.NhSoXUMPK2K}+#{RWwJcCEIcZw.NhSoXUMPK2K}+#{u9TiVtfs3or.NhSoXUMPK2K}+#{BsyP5AnR1pE.NhSoXUMPK2K}+#{p4Vk0aCXUKj.NhSoXUMPK2K}+#{ZysDicYyDxN.NhSoXUMPK2K}+#{aLt2Db8y8VE.NhSoXUMPK2K}+#{Mnz4Ts6dMVo.NhSoXUMPK2K}+#{Mnz4Ts6dMVo.NhSoXUMPK2K}+#{Tpp5Fh9rV07.NhSoXUMPK2K}+#{sDEtpJj8IeQ.NhSoXUMPK2K}+#{DOPHF9sDlCE.NhSoXUMPK2K}+#{uHj0fEYrjTx.NhSoXUMPK2K}))+(#{fKvHjy58Hoe.NhSoXUMPK2K}+#{OheXXPgAdBi.NhSoXUMPK2K}+#{EWCqmXmU1Aj.NhSoXUMPK2K}),1
Net Cohort 12 Months ,leXxhRus5st,Net Cohort 12 Months ,#{MciNE2W7sor} + #{cbrwRebovN1},1
New PTB- <15 yrs HIV+ out of Tested New PTB- <15 yrs,tV8RJtDqTa0,PTB- <15 yrs HIV+,#{Vri74blSuoL.cWPCEmypCYS},#{CQVzChlE9qw.cWPCEmypCYS}
New PTB- <15 yrs out of total TB cases,H7BzEkNaQrc,New PTB- <15 yrs ,#{MmsSJfunbRu.cWPCEmypCYS},#{MmsSJfunbRu}
New PTB- <15 yrs tested for HIV out of the registered New PTB- <15 yrs,urUKxP7Adj6,New PTB- <15 yrs,#{CQVzChlE9qw.cWPCEmypCYS},#{MmsSJfunbRu.cWPCEmypCYS}
New PTB- >15 yrs HIV+ out of Tested New PTB- >15 yrs,VQjPihnWufT,New PTB- >15 yrs  HIV+,#{Vri74blSuoL.TgiG5Y15JDI},#{CQVzChlE9qw.TgiG5Y15JDI}
New PTB- >15 yrs out of total TB cases,XtBAVKkKOsL,PTB- >15 yrs ,#{MmsSJfunbRu.TgiG5Y15JDI},#{MmsSJfunbRu}
New borns receiving BCG Performance,hTD3KMCJ6Ap,New born BCG Perf,#{O3qECFGrzeF.bCfwecaPx2W},#{JHT37THOQjN.ea7VHlwMkhH}
New outpatient (curative) visits Total,h2Q3WHNUlAW,New OP curative visits,#{rIkD2jIDqPh.wBWcFk7k1qY}+#{zXzBILTVJzD.wBWcFk7k1qY}+#{F6AwnxbwiK2.wBWcFk7k1qY}+#{Ha96SBKI06u.wBWcFk7k1qY}+#{x13zGZKuxzs.wBWcFk7k1qY},1
New patients enrolled in HIV care,l2qzh3lEWgp,Patients on HIV care,#{I6U6idiMIOC}+#{PZb5Bk5JKSw}+#{j4bfChlEqWb}+#{k8Y2rcga2FJ}+#{C8ZgpIWef1p}+#{dnNfHX89udH},1
"Newly diagnosed diabetes patients per 100,000 population",JJlLwfvGL5h,"Newly diagnoDM patients per 100,000 population",(#{X1nfVRZfgoj.EynBGhY9Yg4} + #{X1nfVRZfgoj.QOIpb8LBRtm}),#{NLKRV7bYbVy}
"Newly diagnosed hypertension patients per 100,000 population",qGLryjfzcVW,"Newly diagnosed hypertension PTs/100,000",#{s7cDALEmOP0},#{NLKRV7bYbVy}
Number MDR-TB tested HIV+,ASY0sm054rW,Number MDR-TB tested HIV+,#{PZxFOwfXC1u.OkitnJWqNwK}+#{PZxFOwfXC1u.ZKt9O4laTpl}+#{PZxFOwfXC1u.Muh7KDYkzTH}+#{PZxFOwfXC1u.lLgSvDGjkQq},1
Number MDR-TB tested for HIV,Qahv6yeZ0nO,Number MDR-TB tested for ,#{qgh5VZTdydJ.OkitnJWqNwK}+#{qgh5VZTdydJ.ZKt9O4laTpl}+#{qgh5VZTdydJ.Muh7KDYkzTH}+#{qgh5VZTdydJ.lLgSvDGjkQq},1
Number of Clients  Diagnosed with cataract,T9GYDj1x7lC,Number of Clients  Diagnosed with cataract,#{Pc27brtaf42.jhYvM0Yqigf} + #{Pc27brtaf42.ByMfU2PdEoj} + #{Pc27brtaf42.F8VZ4hjeSWC} + #{Pc27brtaf42.a1ZjiEQnO6m} + #{Pc27brtaf42.eR53SBXqXgk} + #{Pc27brtaf42.MGrPmTraxSm} + #{Pc27brtaf42.YRznowneRgB} + #{Pc27brtaf42.xSRxxmyzmzf} + #{Pc27brtaf42.Af3KwhB787f} + #{Pc27brtaf42.YlUuxXLfNJl} + #{Pc27brtaf42.o7G4JOIHdSt} + #{Pc27brtaf42.osKbW4Kxdy7} + #{Pc27brtaf42.EUgu49YLiYV} + #{Pc27brtaf42.kb0U8v2DzhH} + #{Pc27brtaf42.uHzP0OaOZ3k} + #{Pc27brtaf42.r0X54dyKXrd} + #{Pc27brtaf42.To0xL5qViVb} + #{Pc27brtaf42.VE95Fu3Ruxn},1
Number of Clients tested for HIV,YNxQ8nmvbeH,Number of Clients tested for HIV,#{nki1OZT0f4X.NhSoXUMPK2K},1
Number of HIV positive clients  assessed for nutrition status ,rZSyrqQojsY,No.of HIV+ clients assessed for nutrition status ,#{EqhcLCyzn6b} + #{ONFHSFsYoPS},1
Number of Maternal Deaths audited in health facilities_Rev2020,sEmbbCR882p,# of Maternal Deaths audited in facilities_Rev2020,#{dPRCstLVkZu} + #{AC1Iorxdijc} + #{BYMSIbnUzXQ} + #{KDFtI6rqYwI} + #{eBHhfupqMHz} + #{CoAXLBxR0Ik},1
Number of Maternal Deaths reported in health facilities (Old and New tool),RIvynmrUFRZ,# Maternal Deaths reported in health facilities,#{eBHhfupqMHz.NhSoXUMPK2K} + #{CoAXLBxR0Ik} + #{KDFtI6rqYwI} + #{BYMSIbnUzXQ} + #{AC1Iorxdijc} + #{dPRCstLVkZu},1
Number of Maternal Deaths reported in health facilities_Rev2020,ZhjVo2jcO2v,# Maternal Deaths reported in health facilities,#{dPRCstLVkZu} + #{AC1Iorxdijc} + #{BYMSIbnUzXQ} + #{KDFtI6rqYwI} ,1
Number of Neonatal deaths reported in health facilities,BRhvDxKn5p2,# Neonatal deaths reported in health facilities,#{GAr6xu6f1n7},1
Number of New Consultations (all cause)_PMI,CN7wJQKUQJT,Number of New Consultations (all cause)_PMI, #{Dx3XYket0sf.wBWcFk7k1qY} + #{uTQOSp7rx5h.wBWcFk7k1qY} + #{EsfvxFcltV0.wBWcFk7k1qY} + #{aq64ukEqs2N.wBWcFk7k1qY} + #{JQkE0bN9OTB.wBWcFk7k1qY} + #{d3jNYZueSmn.wBWcFk7k1qY} + #{paDQStynGGD.wBWcFk7k1qY} + #{hAH08l33p9B.wBWcFk7k1qY} + #{JGbmLfjZPEf.wBWcFk7k1qY} + #{SyUQl638r5P.wBWcFk7k1qY} + #{nqysBKopEhA.wBWcFk7k1qY} + #{OYSFd2DqOPN.wBWcFk7k1qY} + #{zXzBILTVJzD.wBWcFk7k1qY} + #{Ha96SBKI06u.wBWcFk7k1qY} + #{rIkD2jIDqPh.wBWcFk7k1qY} + #{F6AwnxbwiK2.wBWcFk7k1qY} + #{x13zGZKuxzs.wBWcFk7k1qY} + #{aMKXyBh2GcE.wBWcFk7k1qY} + #{oZWvITIip2r.wBWcFk7k1qY} + #{QStt76mU06X.wBWcFk7k1qY} + #{Izvuj3rkju4.wBWcFk7k1qY} + #{WEW9Bjga52F.wBWcFk7k1qY} + #{GAeKNgKXNDm.wBWcFk7k1qY}  + #{T22hPVk4yGZ.wBWcFk7k1qY}  + #{oZWvITIip2r.wBWcFk7k1qY} + #{YyKbS5UrJlQ.wBWcFk7k1qY},1
Number of PLHIV that were nutritionally assessed and found to be clinically malnourished.,z7vQU9IHz3s,No. PLHIV found to be clinicall malnourished,#{j0x31E1xybY} + #{FuDzKYjF69C},1
Number of Persons living with HIV enrolled in HIV care and receiving  Cotrimoxazole prophylaxis,jnTjTTvdWvQ, No_receiving  Cotrimoxazole prophylaxis,(#{cHsaND37lsM} + #{bApoj9WVrgW} + #{SJ0wy4wfe8A} + #{DgIkkP1XAYG} + #{DH7miEgpVP2} + #{sNPnPD56nzD}),1
"Number of Persons referred to facility, from Community Units",PoVOh5QhcIp,Referral from community to facility,#{LVDvk3wjZbE.NhSoXUMPK2K},1
Number of Pregnant Women receiving TT2 Plus immunization,lnGYVuOg4E5,Pregnant women receiving TT2 plus,#{au9lav766rM.B4gIWbNNUFc}+#{au9lav766rM.Qzjct1emaaj}+#{au9lav766rM.kHFI1LYOvZF}+#{au9lav766rM.WmSjcUiJumX},1
Number of Pregnant women given Tetanus Toxoid (1st dose),R6S3RnOqeCv,Pregnant women given 1st Tetanus Toxoid,#{au9lav766rM.nYnnLevxuXP},1
Number of Pregnant women given Tetanus Toxoid (2nd dose),hyAUI51okTI,Pregnant women 2nd dose Tetanus Toxoid ,#{au9lav766rM.B4gIWbNNUFc},1
Number of Pregnant women given Tetanus Toxoid (3+ dose),HGdOVcbbH3U,Pregnant women given 3+ dose TT,#{au9lav766rM.Qzjct1emaaj}+#{au9lav766rM.kHFI1LYOvZF}+#{au9lav766rM.WmSjcUiJumX},1
Number of Women of reproductive age (WRA) receiving family planning (FP) commodities,xD7BTgHre20,WRA FP Total,#{BQmcVE8fex4}+#{uHM6lzLXDBd}+#{yQFyyQBhXQf}+#{DuBH6qPPdaO}+#{otgQMOXuyIn}+#{PggNwT09D3U}+#{cV4qoKSYiBs}+#{OiuBpHJw4kf}+#{Fxb4iVJdw2g}+#{paDQStynGGD} + #{PgQIx7Hq1kp} + #{NMCIxSeGpS3}  + #{Wv02gixbRpT} + #{hRktPfPEegP} + #{CJdFYcZ1zOq} + #{TUHzoPGLM3t},1
Number of above 5YRs admission,Bs4CNSuOBYB,Number of above 5YRs admission,#{r7LJ3kCX8EZ.Lj5arkL7GL8}+#{r7LJ3kCX8EZ.bPNw3Km3Ug7}+#{r7LJ3kCX8EZ.JUI7tesx6as},1
Number of above 5YRs admission 1,kmrcyjaZ11z,Number of above 5YRs admission,#{r7LJ3kCX8EZ.Lj5arkL7GL8}+#{r7LJ3kCX8EZ.bPNw3Km3Ug7}+#{r7LJ3kCX8EZ.JUI7tesx6as},1
Number of clinically undernourished PLHIV that received therapeutic or supplementary food,LcyNRauDTIn,No. of undernourished recvng thera/supp food,#{rwTvrrkKot4} + #{PXMPO6t3FIh},1
Number of days with stock-out  of ACT,LtM0ZwsOIrk,Number of days with stock-out  of ACT,#{c0MB4RmVjxk.DV8l1KuASLR} + #{gVp1KSFI69G.DV8l1KuASLR} + #{qnZmg5tNSMy.DV8l1KuASLR} + #{BnGDrFwyQp9.DV8l1KuASLR},1
Number of drop out Pent1-3,SL1yviuFNjM,drop out pent1-3,#{ku80YRejJPg.ieuodyY5ybC}-#{OyddF1qflzP.ieuodyY5ybC},1
Number of eligible HIV clients on ARVs,BCya2dpFlNh,Total on ARVs,#{qa1IrxISrSJ}+#{qMybCnYBkNY},1
Number of inpatient (admissions) Over 5,Ts7O6RF1oyX,Number of above 5YRs admission,#{r7LJ3kCX8EZ},1
Number of inpatients (admissions) Under 5,tFohXG8vTo0,Number of under 5Yrs Admission,#{cvJuw6Fbuiw},1
Number of new Outpatients (female),dxzfnBDB03h,new Outpatients (female),#{zXzBILTVJzD.wBWcFk7k1qY}+#{Ha96SBKI06u.wBWcFk7k1qY},1
Number of new Outpatients (male),lZkBndO7e3P,new Outpatients (male),#{rIkD2jIDqPh.wBWcFk7k1qY}+#{F6AwnxbwiK2.wBWcFk7k1qY},1
Number of  Maternal deaths audited,rESXChngDxA,Number of  Maternal deaths audited,#{kAp7ViUXEKh.NhSoXUMPK2K},1
Number on Maternal HAART,Hp2jBjAsu8U,Number on Maternal HAART,#{WNFWVHMqPv9} + #{ckPCoAwmWmT} + #{UMyB7dSIdz1} + #{vkOYqEesPAi} + #{lJpaBye9B0H},1
"Number tested for HIV (ANC,Maternity, DTC,PITC,VCT)",Tv7Dxp2LT9q,Number tested for HIV,#{tZYhz9UkfxJ}+#{F7BQXT7ExEh}+#{qgh5VZTdydJ}+#{PZb5Bk5JKSw}+#{NeH2XNZ4B78}+#{OPII6vOKimx.NhSoXUMPK2K}+#{tZYhz9UkfxJ}+#{F7BQXT7ExEh.k6pLc73EqHg},1
Number tested for HIV at ANC,vlme3PThHl1,Number tested for HIV at ANC,#{qSgLzXh46n9} + #{ETX9cUWF43c},1
Number tested for HIV at ANC Missed Opportunity,AlWRnztxhOU,Number tested for HIV at ANC Missed Opportunity,#{uSxBUWnagGg} - (#{ETX9cUWF43c}  + #{qSgLzXh46n9}),1
Nurse-Patient Ratio Scorecard,uqryq81uCXy,Nurse-Patient Ratio Scorecard,#{EsfvxFcltV0}+#{uTQOSp7rx5h}+#{QStt76mU06X}+#{SyUQl638r5P}+#{rIkD2jIDqPh}+#{zXzBILTVJzD}+#{F6AwnxbwiK2}+#{Ha96SBKI06u}+#{x13zGZKuxzs},#{bilUTys6MtB.xXgE2m6clMx}+#{Q4UX8cZyqSZ.xXgE2m6clMx}+#{e6j7Suomzvt.xXgE2m6clMx}
Nystatin oral suspension 100IU/ml (24ml Bottle)MoS,zdEZm4Z5KML,Nystatin oral suspension 100IU/ml (24ml Bottle),#{v424EPiNCAt.n8XlCFUpWOG},#{f1SlNJAAxMr.QvctQfKAQn3}
OPD Total Attendances (New +Revisit),p6QtFjN5M1R,OPD Total Attendances (New +Revisit),#{zXzBILTVJzD.wBWcFk7k1qY} + #{zXzBILTVJzD.K4WLOEhtcvC} + #{Ha96SBKI06u.wBWcFk7k1qY} + #{Ha96SBKI06u.K4WLOEhtcvC} + #{rIkD2jIDqPh.wBWcFk7k1qY} + #{rIkD2jIDqPh.K4WLOEhtcvC} + #{F6AwnxbwiK2.wBWcFk7k1qY} + #{F6AwnxbwiK2.K4WLOEhtcvC} + #{x13zGZKuxzs.wBWcFk7k1qY} +  #{x13zGZKuxzs.K4WLOEhtcvC} + #{hAH08l33p9B.wBWcFk7k1qY} + #{hAH08l33p9B.K4WLOEhtcvC} + #{JGbmLfjZPEf.wBWcFk7k1qY} + #{WEW9Bjga52F.wBWcFk7k1qY} + #{WEW9Bjga52F.K4WLOEhtcvC} + #{GAeKNgKXNDm.wBWcFk7k1qY} + #{GAeKNgKXNDm.K4WLOEhtcvC} + #{DpR59HXC0jW.wBWcFk7k1qY} + #{DpR59HXC0jW.K4WLOEhtcvC} + #{T22hPVk4yGZ.wBWcFk7k1qY} + #{T22hPVk4yGZ.K4WLOEhtcvC} + #{Dx3XYket0sf.wBWcFk7k1qY} + #{Dx3XYket0sf.K4WLOEhtcvC} + #{EsfvxFcltV0.wBWcFk7k1qY} + #{EsfvxFcltV0.K4WLOEhtcvC} + #{uTQOSp7rx5h.wBWcFk7k1qY} + #{uTQOSp7rx5h.K4WLOEhtcvC} + #{QStt76mU06X.wBWcFk7k1qY} + #{QStt76mU06X.K4WLOEhtcvC} + #{QStt76mU06X.K4WLOEhtcvC} + #{SyUQl638r5P.wBWcFk7k1qY} + #{SyUQl638r5P.K4WLOEhtcvC} + #{aq64ukEqs2N.wBWcFk7k1qY} + #{aq64ukEqs2N.K4WLOEhtcvC} + #{d3jNYZueSmn.wBWcFk7k1qY} + #{d3jNYZueSmn.K4WLOEhtcvC} + #{JQkE0bN9OTB.wBWcFk7k1qY} + #{JQkE0bN9OTB.K4WLOEhtcvC} +#{JGbmLfjZPEf.K4WLOEhtcvC},1
OPD attendance - total female (717),xNZOF242UaV,OPD attend. female (717),#{Ha96SBKI06u}+#{zXzBILTVJzD},1
OPD attendance - total male (717),pFHAXocl50Q,OPD attend. male (717),#{F6AwnxbwiK2}+#{rIkD2jIDqPh},1
OPD utilisation rate (705),eDbgfcoV8zr,OPD util. rate (705),#{IxhbkNwhcvE}+#{BwROYFIiXKG},#{NLKRV7bYbVy.NhSoXUMPK2K}
OPD utilisation rate (717),dKKPLNX47li,OPD util. rate (717),#{Ha96SBKI06u}+#{F6AwnxbwiK2}+#{zXzBILTVJzD}+#{rIkD2jIDqPh},#{w5ltvnNihEZ.NhSoXUMPK2K}+#{Mpv8crmnOzy.NhSoXUMPK2K}
OPD utilisation rate <5y (705A),OqqdG6xcS1F,OPD util. rate <5y (705),#{IxhbkNwhcvE.lHl2rmXpHse}+#{BwROYFIiXKG.lHl2rmXpHse},#{KNrK5VWTZkx.NhSoXUMPK2K}
OPD utilisation rate <5y (717),xfOHs4sKUkk,OPD util. rate <5y (717),#{Ha96SBKI06u}+#{F6AwnxbwiK2},#{KNrK5VWTZkx.NhSoXUMPK2K}
OPD utilisation rate female (717),h6RUF0o11XT,OPD util. rate fem. (717),#{Ha96SBKI06u.wBWcFk7k1qY}+#{Ha96SBKI06u.K4WLOEhtcvC}+#{zXzBILTVJzD.wBWcFk7k1qY}+#{zXzBILTVJzD.K4WLOEhtcvC},#{w5ltvnNihEZ.NhSoXUMPK2K}
OPD utilisation rate male (717),dQqzw1c9TkW,OPD util. rate male (717),#{F6AwnxbwiK2}+#{rIkD2jIDqPh},#{Mpv8crmnOzy.NhSoXUMPK2K}
OPD: Total New attendance of Outpatient Services,Yi25YF8AkzD,New OPD,#{zXzBILTVJzD.wBWcFk7k1qY}+#{rIkD2jIDqPh.wBWcFk7k1qY}+#{Ha96SBKI06u.wBWcFk7k1qY}+#{F6AwnxbwiK2.wBWcFk7k1qY}+#{x13zGZKuxzs.wBWcFk7k1qY}+#{hAH08l33p9B.wBWcFk7k1qY}+#{JGbmLfjZPEf.wBWcFk7k1qY}+#{WEW9Bjga52F.wBWcFk7k1qY}+#{GAeKNgKXNDm.wBWcFk7k1qY}+#{DpR59HXC0jW.wBWcFk7k1qY}+#{T22hPVk4yGZ.wBWcFk7k1qY}+#{Dx3XYket0sf.wBWcFk7k1qY}+#{EsfvxFcltV0.wBWcFk7k1qY}+#{uTQOSp7rx5h.wBWcFk7k1qY}+#{QStt76mU06X.wBWcFk7k1qY}+#{SyUQl638r5P.wBWcFk7k1qY}+#{aq64ukEqs2N.wBWcFk7k1qY}+#{d3jNYZueSmn.wBWcFk7k1qY}+#{JQkE0bN9OTB.wBWcFk7k1qY},1
OPV SIA Percentage Vaccinated Children (0-11months),hVaIkMgaTx5,OPV SIA % Vaccinated Children (0-11months),#{qNnxpuVlFUV.jJunUl8bg6i} + #{qNnxpuVlFUV.VXA6MsmIx6b} + #{NjNPOHuemgm.jJunUl8bg6i} + #{NjNPOHuemgm.VXA6MsmIx6b} + #{fiehe67U9O1.jJunUl8bg6i} + #{fiehe67U9O1.VXA6MsmIx6b} + #{IFJfF7NLgu0.jJunUl8bg6i} + #{IFJfF7NLgu0.VXA6MsmIx6b} + #{ttipyjqR9mH.jJunUl8bg6i} + #{ttipyjqR9mH.VXA6MsmIx6b} + #{xpZcEqvnYoc.bUz00a8pctE} + #{xpZcEqvnYoc.oip6bIFCwOB} + #{xpZcEqvnYoc.roRnszpDJQQ} + #{xpZcEqvnYoc.C4f3Y9LnsRf} + #{xpZcEqvnYoc.OcSeYPLi5Q2} + #{xpZcEqvnYoc.oCgj86VulzL} + #{xpZcEqvnYoc.MCmG5Kn2Nyi} + #{xpZcEqvnYoc.ps9tZ8BH5hf} + #{xpZcEqvnYoc.Awmk7Vfo6x5} + #{xpZcEqvnYoc.qySDh7KOMOo} + #{xpZcEqvnYoc.LAHQdNG9a9s} + #{xpZcEqvnYoc.MkzcdA1CYzy} + #{JveFJDlz6oV.MCmG5Kn2Nyi} + #{JveFJDlz6oV.ps9tZ8BH5hf} + #{JveFJDlz6oV.Awmk7Vfo6x5} + #{JveFJDlz6oV.qySDh7KOMOo} + #{JveFJDlz6oV.LAHQdNG9a9s} + #{JveFJDlz6oV.MkzcdA1CYzy} + #{JveFJDlz6oV.bUz00a8pctE} + #{JveFJDlz6oV.oip6bIFCwOB} + #{JveFJDlz6oV.roRnszpDJQQ} + #{JveFJDlz6oV.C4f3Y9LnsRf} + #{JveFJDlz6oV.OcSeYPLi5Q2} + #{JveFJDlz6oV.oCgj86VulzL} + #{ocZqT75qL0Q.bUz00a8pctE} + #{ocZqT75qL0Q.oip6bIFCwOB} + #{ocZqT75qL0Q.roRnszpDJQQ} + #{ocZqT75qL0Q.C4f3Y9LnsRf} + #{ocZqT75qL0Q.OcSeYPLi5Q2} + #{ocZqT75qL0Q.oCgj86VulzL} + #{ocZqT75qL0Q.MCmG5Kn2Nyi} + #{ocZqT75qL0Q.ps9tZ8BH5hf} + #{ocZqT75qL0Q.Awmk7Vfo6x5} + #{ocZqT75qL0Q.qySDh7KOMOo} + #{ocZqT75qL0Q.LAHQdNG9a9s} + #{ocZqT75qL0Q.MkzcdA1CYzy} +#{sgEpaCzTzvY.bUz00a8pctE} + #{sgEpaCzTzvY.oip6bIFCwOB} + #{sgEpaCzTzvY.roRnszpDJQQ} + #{sgEpaCzTzvY.C4f3Y9LnsRf} + #{sgEpaCzTzvY.OcSeYPLi5Q2} + #{sgEpaCzTzvY.oCgj86VulzL} + #{sgEpaCzTzvY.MCmG5Kn2Nyi} + #{sgEpaCzTzvY.ps9tZ8BH5hf} + #{sgEpaCzTzvY.Awmk7Vfo6x5} + #{sgEpaCzTzvY.qySDh7KOMOo} + #{sgEpaCzTzvY.LAHQdNG9a9s} + #{sgEpaCzTzvY.MkzcdA1CYzy}  + #{OoQXhDZC2rl.bUz00a8pctE} + #{OoQXhDZC2rl.oip6bIFCwOB} + #{OoQXhDZC2rl.roRnszpDJQQ} + #{OoQXhDZC2rl.C4f3Y9LnsRf} + #{OoQXhDZC2rl.OcSeYPLi5Q2} + #{OoQXhDZC2rl.oCgj86VulzL} + #{OoQXhDZC2rl.MCmG5Kn2Nyi} + #{OoQXhDZC2rl.ps9tZ8BH5hf} + #{OoQXhDZC2rl.Awmk7Vfo6x5} + #{OoQXhDZC2rl.qySDh7KOMOo} + #{OoQXhDZC2rl.LAHQdNG9a9s} + #{OoQXhDZC2rl.MkzcdA1CYzy} + #{vaejdFkKmbO.jJunUl8bg6i} + #{vaejdFkKmbO.VXA6MsmIx6b},#{qNnxpuVlFUV} + #{NjNPOHuemgm} + #{fiehe67U9O1} + #{IFJfF7NLgu0} + #{ttipyjqR9mH} + #{vaejdFkKmbO} + #{xpZcEqvnYoc} + #{JveFJDlz6oV} + #{sgEpaCzTzvY} + #{OoQXhDZC2rl} + #{ocZqT75qL0Q}
OPV SIA Percentage Vaccinated Children (12-59months),PolAXlRSb4H,OPV % Vaccinated Children (12-59months),(#{qNnxpuVlFUV} + #{NjNPOHuemgm} + #{fiehe67U9O1} + #{IFJfF7NLgu0} + #{ttipyjqR9mH} + #{vaejdFkKmbO} + #{xpZcEqvnYoc} + #{JveFJDlz6oV} + #{sgEpaCzTzvY} + #{OoQXhDZC2rl} + #{ocZqT75qL0Q})-(#{qNnxpuVlFUV.jJunUl8bg6i} + #{qNnxpuVlFUV.VXA6MsmIx6b} + #{NjNPOHuemgm.jJunUl8bg6i} + #{NjNPOHuemgm.VXA6MsmIx6b} + #{fiehe67U9O1.jJunUl8bg6i} + #{fiehe67U9O1.VXA6MsmIx6b} + #{IFJfF7NLgu0.jJunUl8bg6i} + #{IFJfF7NLgu0.VXA6MsmIx6b} + #{ttipyjqR9mH.jJunUl8bg6i} + #{ttipyjqR9mH.VXA6MsmIx6b} + #{xpZcEqvnYoc.bUz00a8pctE} + #{xpZcEqvnYoc.oip6bIFCwOB} + #{xpZcEqvnYoc.roRnszpDJQQ} + #{xpZcEqvnYoc.C4f3Y9LnsRf} + #{xpZcEqvnYoc.OcSeYPLi5Q2} + #{xpZcEqvnYoc.oCgj86VulzL} + #{xpZcEqvnYoc.MCmG5Kn2Nyi} + #{xpZcEqvnYoc.ps9tZ8BH5hf} + #{xpZcEqvnYoc.Awmk7Vfo6x5} + #{xpZcEqvnYoc.qySDh7KOMOo} + #{xpZcEqvnYoc.LAHQdNG9a9s} + #{xpZcEqvnYoc.MkzcdA1CYzy} + #{JveFJDlz6oV.MCmG5Kn2Nyi} + #{JveFJDlz6oV.ps9tZ8BH5hf} + #{JveFJDlz6oV.Awmk7Vfo6x5} + #{JveFJDlz6oV.qySDh7KOMOo} + #{JveFJDlz6oV.LAHQdNG9a9s} + #{JveFJDlz6oV.MkzcdA1CYzy} + #{JveFJDlz6oV.bUz00a8pctE} + #{JveFJDlz6oV.oip6bIFCwOB} + #{JveFJDlz6oV.roRnszpDJQQ} + #{JveFJDlz6oV.C4f3Y9LnsRf} + #{JveFJDlz6oV.OcSeYPLi5Q2} + #{JveFJDlz6oV.oCgj86VulzL} + #{ocZqT75qL0Q.bUz00a8pctE} + #{ocZqT75qL0Q.oip6bIFCwOB} + #{ocZqT75qL0Q.roRnszpDJQQ} + #{ocZqT75qL0Q.C4f3Y9LnsRf} + #{ocZqT75qL0Q.OcSeYPLi5Q2} + #{ocZqT75qL0Q.oCgj86VulzL} + #{ocZqT75qL0Q.MCmG5Kn2Nyi} + #{ocZqT75qL0Q.ps9tZ8BH5hf} + #{ocZqT75qL0Q.Awmk7Vfo6x5} + #{ocZqT75qL0Q.qySDh7KOMOo} + #{ocZqT75qL0Q.LAHQdNG9a9s} + #{ocZqT75qL0Q.MkzcdA1CYzy} +#{sgEpaCzTzvY.bUz00a8pctE} + #{sgEpaCzTzvY.oip6bIFCwOB} + #{sgEpaCzTzvY.roRnszpDJQQ} + #{sgEpaCzTzvY.C4f3Y9LnsRf} + #{sgEpaCzTzvY.OcSeYPLi5Q2} + #{sgEpaCzTzvY.oCgj86VulzL} + #{sgEpaCzTzvY.MCmG5Kn2Nyi} + #{sgEpaCzTzvY.ps9tZ8BH5hf} + #{sgEpaCzTzvY.Awmk7Vfo6x5} + #{sgEpaCzTzvY.qySDh7KOMOo} + #{sgEpaCzTzvY.LAHQdNG9a9s} + #{sgEpaCzTzvY.MkzcdA1CYzy}  + #{OoQXhDZC2rl.bUz00a8pctE} + #{OoQXhDZC2rl.oip6bIFCwOB} + #{OoQXhDZC2rl.roRnszpDJQQ} + #{OoQXhDZC2rl.C4f3Y9LnsRf} + #{OoQXhDZC2rl.OcSeYPLi5Q2} + #{OoQXhDZC2rl.oCgj86VulzL} + #{OoQXhDZC2rl.MCmG5Kn2Nyi} + #{OoQXhDZC2rl.ps9tZ8BH5hf} + #{OoQXhDZC2rl.Awmk7Vfo6x5} + #{OoQXhDZC2rl.qySDh7KOMOo} + #{OoQXhDZC2rl.LAHQdNG9a9s} + #{OoQXhDZC2rl.MkzcdA1CYzy} + #{vaejdFkKmbO.jJunUl8bg6i} + #{vaejdFkKmbO.VXA6MsmIx6b} ),#{qNnxpuVlFUV} + #{NjNPOHuemgm} + #{fiehe67U9O1} + #{IFJfF7NLgu0} + #{ttipyjqR9mH} + #{vaejdFkKmbO} + #{xpZcEqvnYoc} + #{JveFJDlz6oV} + #{sgEpaCzTzvY} + #{OoQXhDZC2rl} + #{ocZqT75qL0Q}
OPV SIA Percentage Vaccinated(Ordinary Population),r9lEi4a7lsv,OPV SIA % Vaccinated(Ordinary Population),(#{qNnxpuVlFUV} + #{NjNPOHuemgm} + #{fiehe67U9O1} + #{IFJfF7NLgu0} + #{ttipyjqR9mH} + #{vaejdFkKmbO} ),#{qNnxpuVlFUV} + #{NjNPOHuemgm} + #{fiehe67U9O1} + #{IFJfF7NLgu0} + #{ttipyjqR9mH} + #{vaejdFkKmbO} + #{xpZcEqvnYoc} + #{JveFJDlz6oV} + #{sgEpaCzTzvY} + #{OoQXhDZC2rl} + #{ocZqT75qL0Q}
OPV SIA Percentage Vaccinated(Special Population),fA4U9oLvMVX,OPV SIA % Vaccinated(Special Population),(#{xpZcEqvnYoc} + #{JveFJDlz6oV} + #{sgEpaCzTzvY} + #{OoQXhDZC2rl} + #{ocZqT75qL0Q}),#{qNnxpuVlFUV} + #{NjNPOHuemgm} + #{fiehe67U9O1} + #{IFJfF7NLgu0} + #{ttipyjqR9mH} + #{vaejdFkKmbO} + #{xpZcEqvnYoc} + #{JveFJDlz6oV} + #{sgEpaCzTzvY} + #{OoQXhDZC2rl} + #{ocZqT75qL0Q}
OPV SIA Percentage of children vaccinated,X9MhvdTX3gN,OPV Percentage of children vaccinated,#{qNnxpuVlFUV} + #{NjNPOHuemgm} + #{fiehe67U9O1} + #{IFJfF7NLgu0} + #{ttipyjqR9mH} + #{vaejdFkKmbO} + #{xpZcEqvnYoc} + #{JveFJDlz6oV} + #{sgEpaCzTzvY} + #{OoQXhDZC2rl} + #{ocZqT75qL0Q},#{cgdsjNMhLeQ} 
OPV SIA Percentage of children vaccinated(Not Zero Doses),sJTtCxbp3Lz,OPV SIA % of children vaccinated(Not Zero Doses),"((#{qNnxpuVlFUV} + #{NjNPOHuemgm} + #{fiehe67U9O1} + #{IFJfF7NLgu0} + #{ttipyjqR9mH} + #{vaejdFkKmbO} + #{xpZcEqvnYoc} + #{JveFJDlz6oV} + #{sgEpaCzTzvY} + #{OoQXhDZC2rl} + #{ocZqT75qL0Q}
)-
(#{qNnxpuVlFUV.jJunUl8bg6i} + #{qNnxpuVlFUV.hJN7RTX0qPC} + #{vaejdFkKmbO.jJunUl8bg6i} + #{vaejdFkKmbO.hJN7RTX0qPC} + #{ttipyjqR9mH.jJunUl8bg6i} + #{ttipyjqR9mH.hJN7RTX0qPC} + #{ocZqT75qL0Q.bUz00a8pctE} + #{ocZqT75qL0Q.Lvd1oGx0HHb} + #{xpZcEqvnYoc.MCmG5Kn2Nyi} + #{xpZcEqvnYoc.aKLMNGAKq01} + #{xpZcEqvnYoc.Awmk7Vfo6x5} + #{xpZcEqvnYoc.HYrPyQ7Ymab} + #{xpZcEqvnYoc.LAHQdNG9a9s} + #{xpZcEqvnYoc.uvY3DYOSEcH} + #{OoQXhDZC2rl.bUz00a8pctE} + #{OoQXhDZC2rl.Lvd1oGx0HHb} + #{OoQXhDZC2rl.roRnszpDJQQ} + #{OoQXhDZC2rl.ApyTrxh6Biw} + #{OoQXhDZC2rl.OcSeYPLi5Q2} + #{OoQXhDZC2rl.i10mq40hICw} + #{OoQXhDZC2rl.MCmG5Kn2Nyi} + #{OoQXhDZC2rl.aKLMNGAKq01} + #{OoQXhDZC2rl.Awmk7Vfo6x5} + #{OoQXhDZC2rl.HYrPyQ7Ymab} + #{OoQXhDZC2rl.LAHQdNG9a9s} + #{OoQXhDZC2rl.uvY3DYOSEcH} + #{JveFJDlz6oV.Lvd1oGx0HHb} + #{JveFJDlz6oV.roRnszpDJQQ} + #{JveFJDlz6oV.ApyTrxh6Biw} + #{JveFJDlz6oV.OcSeYPLi5Q2} + #{JveFJDlz6oV.i10mq40hICw} + #{JveFJDlz6oV.MCmG5Kn2Nyi} + #{JveFJDlz6oV.aKLMNGAKq01} + #{JveFJDlz6oV.Awmk7Vfo6x5} + #{JveFJDlz6oV.HYrPyQ7Ymab} + #{JveFJDlz6oV.LAHQdNG9a9s} + #{JveFJDlz6oV.uvY3DYOSEcH} + #{IFJfF7NLgu0.jJunUl8bg6i} + #{IFJfF7NLgu0.hJN7RTX0qPC}  + #{NjNPOHuemgm.jJunUl8bg6i} + #{NjNPOHuemgm.hJN7RTX0qPC} + #{fiehe67U9O1.jJunUl8bg6i} + #{fiehe67U9O1.hJN7RTX0qPC} + #{sgEpaCzTzvY.bUz00a8pctE} + #{sgEpaCzTzvY.Lvd1oGx0HHb} + #{sgEpaCzTzvY.roRnszpDJQQ} + #{sgEpaCzTzvY.ApyTrxh6Biw} + #{sgEpaCzTzvY.OcSeYPLi5Q2} + #{sgEpaCzTzvY.i10mq40hICw} + #{sgEpaCzTzvY.MCmG5Kn2Nyi} + #{sgEpaCzTzvY.aKLMNGAKq01} + #{sgEpaCzTzvY.Awmk7Vfo6x5} + #{sgEpaCzTzvY.HYrPyQ7Ymab} + #{sgEpaCzTzvY.LAHQdNG9a9s} + #{sgEpaCzTzvY.uvY3DYOSEcH} + #{JveFJDlz6oV.bUz00a8pctE} + #{xpZcEqvnYoc.bUz00a8pctE} + #{xpZcEqvnYoc.Lvd1oGx0HHb} + #{xpZcEqvnYoc.roRnszpDJQQ} + #{xpZcEqvnYoc.ApyTrxh6Biw} + #{xpZcEqvnYoc.OcSeYPLi5Q2} + #{xpZcEqvnYoc.i10mq40hICw} + #{ocZqT75qL0Q.roRnszpDJQQ} + #{ocZqT75qL0Q.ApyTrxh6Biw} + #{ocZqT75qL0Q.OcSeYPLi5Q2} + #{ocZqT75qL0Q.i10mq40hICw} + #{ocZqT75qL0Q.MCmG5Kn2Nyi} + #{ocZqT75qL0Q.aKLMNGAKq01} + #{ocZqT75qL0Q.Awmk7Vfo6x5} + #{ocZqT75qL0Q.HYrPyQ7Ymab} + #{ocZqT75qL0Q.LAHQdNG9a9s} + #{ocZqT75qL0Q.uvY3DYOSEcH}))","#{qNnxpuVlFUV} + #{NjNPOHuemgm} + #{fiehe67U9O1} + #{IFJfF7NLgu0} + #{ttipyjqR9mH} + #{vaejdFkKmbO} + #{xpZcEqvnYoc} + #{JveFJDlz6oV} + #{sgEpaCzTzvY} + #{OoQXhDZC2rl} + #{ocZqT75qL0Q}



"
OPV SIA Percentage of children vaccinated(Zero Doses),DvNK1NaRdyz,OPV SIA % of children vaccinated(Zero Doses),#{qNnxpuVlFUV.jJunUl8bg6i} + #{qNnxpuVlFUV.hJN7RTX0qPC} + #{vaejdFkKmbO.jJunUl8bg6i} + #{vaejdFkKmbO.hJN7RTX0qPC} + #{ttipyjqR9mH.jJunUl8bg6i} + #{ttipyjqR9mH.hJN7RTX0qPC} + #{ocZqT75qL0Q.bUz00a8pctE} + #{ocZqT75qL0Q.Lvd1oGx0HHb} + #{xpZcEqvnYoc.MCmG5Kn2Nyi} + #{xpZcEqvnYoc.aKLMNGAKq01} + #{xpZcEqvnYoc.Awmk7Vfo6x5} + #{xpZcEqvnYoc.HYrPyQ7Ymab} + #{xpZcEqvnYoc.LAHQdNG9a9s} + #{xpZcEqvnYoc.uvY3DYOSEcH} + #{OoQXhDZC2rl.bUz00a8pctE} + #{OoQXhDZC2rl.Lvd1oGx0HHb} + #{OoQXhDZC2rl.roRnszpDJQQ} + #{OoQXhDZC2rl.ApyTrxh6Biw} + #{OoQXhDZC2rl.OcSeYPLi5Q2} + #{OoQXhDZC2rl.i10mq40hICw} + #{OoQXhDZC2rl.MCmG5Kn2Nyi} + #{OoQXhDZC2rl.aKLMNGAKq01} + #{OoQXhDZC2rl.Awmk7Vfo6x5} + #{OoQXhDZC2rl.HYrPyQ7Ymab} + #{OoQXhDZC2rl.LAHQdNG9a9s} + #{OoQXhDZC2rl.uvY3DYOSEcH} + #{JveFJDlz6oV.Lvd1oGx0HHb} + #{JveFJDlz6oV.roRnszpDJQQ} + #{JveFJDlz6oV.ApyTrxh6Biw} + #{JveFJDlz6oV.OcSeYPLi5Q2} + #{JveFJDlz6oV.i10mq40hICw} + #{JveFJDlz6oV.MCmG5Kn2Nyi} + #{JveFJDlz6oV.aKLMNGAKq01} + #{JveFJDlz6oV.Awmk7Vfo6x5} + #{JveFJDlz6oV.HYrPyQ7Ymab} + #{JveFJDlz6oV.LAHQdNG9a9s} + #{JveFJDlz6oV.uvY3DYOSEcH} + #{IFJfF7NLgu0.jJunUl8bg6i} + #{IFJfF7NLgu0.hJN7RTX0qPC}  + #{NjNPOHuemgm.jJunUl8bg6i} + #{NjNPOHuemgm.hJN7RTX0qPC} + #{fiehe67U9O1.jJunUl8bg6i} + #{fiehe67U9O1.hJN7RTX0qPC} + #{sgEpaCzTzvY.bUz00a8pctE} + #{sgEpaCzTzvY.Lvd1oGx0HHb} + #{sgEpaCzTzvY.roRnszpDJQQ} + #{sgEpaCzTzvY.ApyTrxh6Biw} + #{sgEpaCzTzvY.OcSeYPLi5Q2} + #{sgEpaCzTzvY.i10mq40hICw} + #{sgEpaCzTzvY.MCmG5Kn2Nyi} + #{sgEpaCzTzvY.aKLMNGAKq01} + #{sgEpaCzTzvY.Awmk7Vfo6x5} + #{sgEpaCzTzvY.HYrPyQ7Ymab} + #{sgEpaCzTzvY.LAHQdNG9a9s} + #{sgEpaCzTzvY.uvY3DYOSEcH} + #{JveFJDlz6oV.bUz00a8pctE} + #{xpZcEqvnYoc.bUz00a8pctE} + #{xpZcEqvnYoc.Lvd1oGx0HHb} + #{xpZcEqvnYoc.roRnszpDJQQ} + #{xpZcEqvnYoc.ApyTrxh6Biw} + #{xpZcEqvnYoc.OcSeYPLi5Q2} + #{xpZcEqvnYoc.i10mq40hICw} + #{ocZqT75qL0Q.roRnszpDJQQ} + #{ocZqT75qL0Q.ApyTrxh6Biw} + #{ocZqT75qL0Q.OcSeYPLi5Q2} + #{ocZqT75qL0Q.i10mq40hICw} + #{ocZqT75qL0Q.MCmG5Kn2Nyi} + #{ocZqT75qL0Q.aKLMNGAKq01} + #{ocZqT75qL0Q.Awmk7Vfo6x5} + #{ocZqT75qL0Q.HYrPyQ7Ymab} + #{ocZqT75qL0Q.LAHQdNG9a9s} + #{ocZqT75qL0Q.uvY3DYOSEcH},"#{qNnxpuVlFUV} + #{NjNPOHuemgm} + #{fiehe67U9O1} + #{IFJfF7NLgu0} + #{ttipyjqR9mH} + #{vaejdFkKmbO} + #{xpZcEqvnYoc} + #{JveFJDlz6oV} + #{sgEpaCzTzvY} + #{OoQXhDZC2rl} + #{ocZqT75qL0Q}



"
OPV SIA Total Vaccinated Children (0-11months),Z99r1denYMM,OPV SIA Total Vaccinated Children (0-11months),#{qNnxpuVlFUV.jJunUl8bg6i} + #{qNnxpuVlFUV.VXA6MsmIx6b} + #{NjNPOHuemgm.jJunUl8bg6i} + #{NjNPOHuemgm.VXA6MsmIx6b} + #{fiehe67U9O1.jJunUl8bg6i} + #{fiehe67U9O1.VXA6MsmIx6b} + #{IFJfF7NLgu0.jJunUl8bg6i} + #{IFJfF7NLgu0.VXA6MsmIx6b} + #{ttipyjqR9mH.jJunUl8bg6i} + #{ttipyjqR9mH.VXA6MsmIx6b} + #{xpZcEqvnYoc.bUz00a8pctE} + #{xpZcEqvnYoc.oip6bIFCwOB} + #{xpZcEqvnYoc.roRnszpDJQQ} + #{xpZcEqvnYoc.C4f3Y9LnsRf} + #{xpZcEqvnYoc.OcSeYPLi5Q2} + #{xpZcEqvnYoc.oCgj86VulzL} + #{xpZcEqvnYoc.MCmG5Kn2Nyi} + #{xpZcEqvnYoc.ps9tZ8BH5hf} + #{xpZcEqvnYoc.Awmk7Vfo6x5} + #{xpZcEqvnYoc.qySDh7KOMOo} + #{xpZcEqvnYoc.LAHQdNG9a9s} + #{xpZcEqvnYoc.MkzcdA1CYzy} + #{JveFJDlz6oV.MCmG5Kn2Nyi} + #{JveFJDlz6oV.ps9tZ8BH5hf} + #{JveFJDlz6oV.Awmk7Vfo6x5} + #{JveFJDlz6oV.qySDh7KOMOo} + #{JveFJDlz6oV.LAHQdNG9a9s} + #{JveFJDlz6oV.MkzcdA1CYzy} + #{JveFJDlz6oV.bUz00a8pctE} + #{JveFJDlz6oV.oip6bIFCwOB} + #{JveFJDlz6oV.roRnszpDJQQ} + #{JveFJDlz6oV.C4f3Y9LnsRf} + #{JveFJDlz6oV.OcSeYPLi5Q2} + #{JveFJDlz6oV.oCgj86VulzL} + #{ocZqT75qL0Q.bUz00a8pctE} + #{ocZqT75qL0Q.oip6bIFCwOB} + #{ocZqT75qL0Q.roRnszpDJQQ} + #{ocZqT75qL0Q.C4f3Y9LnsRf} + #{ocZqT75qL0Q.OcSeYPLi5Q2} + #{ocZqT75qL0Q.oCgj86VulzL} + #{ocZqT75qL0Q.MCmG5Kn2Nyi} + #{ocZqT75qL0Q.ps9tZ8BH5hf} + #{ocZqT75qL0Q.Awmk7Vfo6x5} + #{ocZqT75qL0Q.qySDh7KOMOo} + #{ocZqT75qL0Q.LAHQdNG9a9s} + #{ocZqT75qL0Q.MkzcdA1CYzy} +#{sgEpaCzTzvY.bUz00a8pctE} + #{sgEpaCzTzvY.oip6bIFCwOB} + #{sgEpaCzTzvY.roRnszpDJQQ} + #{sgEpaCzTzvY.C4f3Y9LnsRf} + #{sgEpaCzTzvY.OcSeYPLi5Q2} + #{sgEpaCzTzvY.oCgj86VulzL} + #{sgEpaCzTzvY.MCmG5Kn2Nyi} + #{sgEpaCzTzvY.ps9tZ8BH5hf} + #{sgEpaCzTzvY.Awmk7Vfo6x5} + #{sgEpaCzTzvY.qySDh7KOMOo} + #{sgEpaCzTzvY.LAHQdNG9a9s} + #{sgEpaCzTzvY.MkzcdA1CYzy}  + #{OoQXhDZC2rl.bUz00a8pctE} + #{OoQXhDZC2rl.oip6bIFCwOB} + #{OoQXhDZC2rl.roRnszpDJQQ} + #{OoQXhDZC2rl.C4f3Y9LnsRf} + #{OoQXhDZC2rl.OcSeYPLi5Q2} + #{OoQXhDZC2rl.oCgj86VulzL} + #{OoQXhDZC2rl.MCmG5Kn2Nyi} + #{OoQXhDZC2rl.ps9tZ8BH5hf} + #{OoQXhDZC2rl.Awmk7Vfo6x5} + #{OoQXhDZC2rl.qySDh7KOMOo} + #{OoQXhDZC2rl.LAHQdNG9a9s} + #{OoQXhDZC2rl.MkzcdA1CYzy} + #{vaejdFkKmbO.jJunUl8bg6i} + #{vaejdFkKmbO.VXA6MsmIx6b},1
OPV SIA Total Vaccinated Children (12-59months),TMSPc7wyS6H,OPV Total Vaccinated Children (12-59months),(#{qNnxpuVlFUV} + #{NjNPOHuemgm} + #{fiehe67U9O1} + #{IFJfF7NLgu0} + #{ttipyjqR9mH} + #{vaejdFkKmbO} + #{xpZcEqvnYoc} + #{JveFJDlz6oV} + #{sgEpaCzTzvY} + #{OoQXhDZC2rl} + #{ocZqT75qL0Q})-(#{qNnxpuVlFUV.jJunUl8bg6i} + #{qNnxpuVlFUV.VXA6MsmIx6b} + #{NjNPOHuemgm.jJunUl8bg6i} + #{NjNPOHuemgm.VXA6MsmIx6b} + #{fiehe67U9O1.jJunUl8bg6i} + #{fiehe67U9O1.VXA6MsmIx6b} + #{IFJfF7NLgu0.jJunUl8bg6i} + #{IFJfF7NLgu0.VXA6MsmIx6b} + #{ttipyjqR9mH.jJunUl8bg6i} + #{ttipyjqR9mH.VXA6MsmIx6b} + #{xpZcEqvnYoc.bUz00a8pctE} + #{xpZcEqvnYoc.oip6bIFCwOB} + #{xpZcEqvnYoc.roRnszpDJQQ} + #{xpZcEqvnYoc.C4f3Y9LnsRf} + #{xpZcEqvnYoc.OcSeYPLi5Q2} + #{xpZcEqvnYoc.oCgj86VulzL} + #{xpZcEqvnYoc.MCmG5Kn2Nyi} + #{xpZcEqvnYoc.ps9tZ8BH5hf} + #{xpZcEqvnYoc.Awmk7Vfo6x5} + #{xpZcEqvnYoc.qySDh7KOMOo} + #{xpZcEqvnYoc.LAHQdNG9a9s} + #{xpZcEqvnYoc.MkzcdA1CYzy} + #{JveFJDlz6oV.MCmG5Kn2Nyi} + #{JveFJDlz6oV.ps9tZ8BH5hf} + #{JveFJDlz6oV.Awmk7Vfo6x5} + #{JveFJDlz6oV.qySDh7KOMOo} + #{JveFJDlz6oV.LAHQdNG9a9s} + #{JveFJDlz6oV.MkzcdA1CYzy} + #{JveFJDlz6oV.bUz00a8pctE} + #{JveFJDlz6oV.oip6bIFCwOB} + #{JveFJDlz6oV.roRnszpDJQQ} + #{JveFJDlz6oV.C4f3Y9LnsRf} + #{JveFJDlz6oV.OcSeYPLi5Q2} + #{JveFJDlz6oV.oCgj86VulzL} + #{ocZqT75qL0Q.bUz00a8pctE} + #{ocZqT75qL0Q.oip6bIFCwOB} + #{ocZqT75qL0Q.roRnszpDJQQ} + #{ocZqT75qL0Q.C4f3Y9LnsRf} + #{ocZqT75qL0Q.OcSeYPLi5Q2} + #{ocZqT75qL0Q.oCgj86VulzL} + #{ocZqT75qL0Q.MCmG5Kn2Nyi} + #{ocZqT75qL0Q.ps9tZ8BH5hf} + #{ocZqT75qL0Q.Awmk7Vfo6x5} + #{ocZqT75qL0Q.qySDh7KOMOo} + #{ocZqT75qL0Q.LAHQdNG9a9s} + #{ocZqT75qL0Q.MkzcdA1CYzy} +#{sgEpaCzTzvY.bUz00a8pctE} + #{sgEpaCzTzvY.oip6bIFCwOB} + #{sgEpaCzTzvY.roRnszpDJQQ} + #{sgEpaCzTzvY.C4f3Y9LnsRf} + #{sgEpaCzTzvY.OcSeYPLi5Q2} + #{sgEpaCzTzvY.oCgj86VulzL} + #{sgEpaCzTzvY.MCmG5Kn2Nyi} + #{sgEpaCzTzvY.ps9tZ8BH5hf} + #{sgEpaCzTzvY.Awmk7Vfo6x5} + #{sgEpaCzTzvY.qySDh7KOMOo} + #{sgEpaCzTzvY.LAHQdNG9a9s} + #{sgEpaCzTzvY.MkzcdA1CYzy}  + #{OoQXhDZC2rl.bUz00a8pctE} + #{OoQXhDZC2rl.oip6bIFCwOB} + #{OoQXhDZC2rl.roRnszpDJQQ} + #{OoQXhDZC2rl.C4f3Y9LnsRf} + #{OoQXhDZC2rl.OcSeYPLi5Q2} + #{OoQXhDZC2rl.oCgj86VulzL} + #{OoQXhDZC2rl.MCmG5Kn2Nyi} + #{OoQXhDZC2rl.ps9tZ8BH5hf} + #{OoQXhDZC2rl.Awmk7Vfo6x5} + #{OoQXhDZC2rl.qySDh7KOMOo} + #{OoQXhDZC2rl.LAHQdNG9a9s} + #{OoQXhDZC2rl.MkzcdA1CYzy} + #{vaejdFkKmbO.jJunUl8bg6i} + #{vaejdFkKmbO.VXA6MsmIx6b} ),1
OPV SIA Total Vaccinated Children(Not Zero Dose),neovMqikD6E,OPV SIA Total Vaccinated Children(Not Zero Dose),"((#{qNnxpuVlFUV} + #{NjNPOHuemgm} + #{fiehe67U9O1} + #{IFJfF7NLgu0} + #{ttipyjqR9mH} + #{vaejdFkKmbO} + #{xpZcEqvnYoc} + #{JveFJDlz6oV} + #{sgEpaCzTzvY} + #{OoQXhDZC2rl} + #{ocZqT75qL0Q})- 
(#{qNnxpuVlFUV.jJunUl8bg6i} + #{qNnxpuVlFUV.hJN7RTX0qPC} + #{vaejdFkKmbO.jJunUl8bg6i} + #{vaejdFkKmbO.hJN7RTX0qPC} + #{ttipyjqR9mH.jJunUl8bg6i} + #{ttipyjqR9mH.hJN7RTX0qPC} + #{ocZqT75qL0Q.bUz00a8pctE} + #{ocZqT75qL0Q.Lvd1oGx0HHb} + #{xpZcEqvnYoc.MCmG5Kn2Nyi} + #{xpZcEqvnYoc.aKLMNGAKq01} + #{xpZcEqvnYoc.Awmk7Vfo6x5} + #{xpZcEqvnYoc.HYrPyQ7Ymab} + #{xpZcEqvnYoc.LAHQdNG9a9s} + #{xpZcEqvnYoc.uvY3DYOSEcH} + #{OoQXhDZC2rl.bUz00a8pctE} + #{OoQXhDZC2rl.Lvd1oGx0HHb} + #{OoQXhDZC2rl.roRnszpDJQQ} + #{OoQXhDZC2rl.ApyTrxh6Biw} + #{OoQXhDZC2rl.OcSeYPLi5Q2} + #{OoQXhDZC2rl.i10mq40hICw} + #{OoQXhDZC2rl.MCmG5Kn2Nyi} + #{OoQXhDZC2rl.aKLMNGAKq01} + #{OoQXhDZC2rl.Awmk7Vfo6x5} + #{OoQXhDZC2rl.HYrPyQ7Ymab} + #{OoQXhDZC2rl.LAHQdNG9a9s} + #{OoQXhDZC2rl.uvY3DYOSEcH} + #{JveFJDlz6oV.Lvd1oGx0HHb} + #{JveFJDlz6oV.roRnszpDJQQ} + #{JveFJDlz6oV.ApyTrxh6Biw} + #{JveFJDlz6oV.OcSeYPLi5Q2} + #{JveFJDlz6oV.i10mq40hICw} + #{JveFJDlz6oV.MCmG5Kn2Nyi} + #{JveFJDlz6oV.aKLMNGAKq01} + #{JveFJDlz6oV.Awmk7Vfo6x5} + #{JveFJDlz6oV.HYrPyQ7Ymab} + #{JveFJDlz6oV.LAHQdNG9a9s} + #{JveFJDlz6oV.uvY3DYOSEcH} + #{IFJfF7NLgu0.jJunUl8bg6i} + #{IFJfF7NLgu0.hJN7RTX0qPC}  + #{NjNPOHuemgm.jJunUl8bg6i} + #{NjNPOHuemgm.hJN7RTX0qPC} + #{fiehe67U9O1.jJunUl8bg6i} + #{fiehe67U9O1.hJN7RTX0qPC} + #{sgEpaCzTzvY.bUz00a8pctE} + #{sgEpaCzTzvY.Lvd1oGx0HHb} + #{sgEpaCzTzvY.roRnszpDJQQ} + #{sgEpaCzTzvY.ApyTrxh6Biw} + #{sgEpaCzTzvY.OcSeYPLi5Q2} + #{sgEpaCzTzvY.i10mq40hICw} + #{sgEpaCzTzvY.MCmG5Kn2Nyi} + #{sgEpaCzTzvY.aKLMNGAKq01} + #{sgEpaCzTzvY.Awmk7Vfo6x5} + #{sgEpaCzTzvY.HYrPyQ7Ymab} + #{sgEpaCzTzvY.LAHQdNG9a9s} + #{sgEpaCzTzvY.uvY3DYOSEcH} + #{JveFJDlz6oV.bUz00a8pctE} + #{xpZcEqvnYoc.bUz00a8pctE} + #{xpZcEqvnYoc.Lvd1oGx0HHb} + #{xpZcEqvnYoc.roRnszpDJQQ} + #{xpZcEqvnYoc.ApyTrxh6Biw} + #{xpZcEqvnYoc.OcSeYPLi5Q2} + #{xpZcEqvnYoc.i10mq40hICw} + #{ocZqT75qL0Q.roRnszpDJQQ} + #{ocZqT75qL0Q.ApyTrxh6Biw} + #{ocZqT75qL0Q.OcSeYPLi5Q2} + #{ocZqT75qL0Q.i10mq40hICw} + #{ocZqT75qL0Q.MCmG5Kn2Nyi} + #{ocZqT75qL0Q.aKLMNGAKq01} + #{ocZqT75qL0Q.Awmk7Vfo6x5} + #{ocZqT75qL0Q.HYrPyQ7Ymab} + #{ocZqT75qL0Q.LAHQdNG9a9s} + #{ocZqT75qL0Q.uvY3DYOSEcH}))",1
OPV SIA Total Vaccinated Children(Zero Dose),dlH4y1A3sm0,OPV SIA Total Vaccinated Children(Zero Dose),"


#{qNnxpuVlFUV.jJunUl8bg6i} + #{qNnxpuVlFUV.hJN7RTX0qPC} + #{vaejdFkKmbO.jJunUl8bg6i} + #{vaejdFkKmbO.hJN7RTX0qPC} + #{ttipyjqR9mH.jJunUl8bg6i} + #{ttipyjqR9mH.hJN7RTX0qPC} + #{ocZqT75qL0Q.bUz00a8pctE} + #{ocZqT75qL0Q.Lvd1oGx0HHb} + #{xpZcEqvnYoc.MCmG5Kn2Nyi} + #{xpZcEqvnYoc.aKLMNGAKq01} + #{xpZcEqvnYoc.Awmk7Vfo6x5} + #{xpZcEqvnYoc.HYrPyQ7Ymab} + #{xpZcEqvnYoc.LAHQdNG9a9s} + #{xpZcEqvnYoc.uvY3DYOSEcH} + #{OoQXhDZC2rl.bUz00a8pctE} + #{OoQXhDZC2rl.Lvd1oGx0HHb} + #{OoQXhDZC2rl.roRnszpDJQQ} + #{OoQXhDZC2rl.ApyTrxh6Biw} + #{OoQXhDZC2rl.OcSeYPLi5Q2} + #{OoQXhDZC2rl.i10mq40hICw} + #{OoQXhDZC2rl.MCmG5Kn2Nyi} + #{OoQXhDZC2rl.aKLMNGAKq01} + #{OoQXhDZC2rl.Awmk7Vfo6x5} + #{OoQXhDZC2rl.HYrPyQ7Ymab} + #{OoQXhDZC2rl.LAHQdNG9a9s} + #{OoQXhDZC2rl.uvY3DYOSEcH} + #{JveFJDlz6oV.Lvd1oGx0HHb} + #{JveFJDlz6oV.roRnszpDJQQ} + #{JveFJDlz6oV.ApyTrxh6Biw} + #{JveFJDlz6oV.OcSeYPLi5Q2} + #{JveFJDlz6oV.i10mq40hICw} + #{JveFJDlz6oV.MCmG5Kn2Nyi} + #{JveFJDlz6oV.aKLMNGAKq01} + #{JveFJDlz6oV.Awmk7Vfo6x5} + #{JveFJDlz6oV.HYrPyQ7Ymab} + #{JveFJDlz6oV.LAHQdNG9a9s} + #{JveFJDlz6oV.uvY3DYOSEcH} + #{IFJfF7NLgu0.jJunUl8bg6i} + #{IFJfF7NLgu0.hJN7RTX0qPC}  + #{NjNPOHuemgm.jJunUl8bg6i} + #{NjNPOHuemgm.hJN7RTX0qPC} + #{fiehe67U9O1.jJunUl8bg6i} + #{fiehe67U9O1.hJN7RTX0qPC} + #{sgEpaCzTzvY.bUz00a8pctE} + #{sgEpaCzTzvY.Lvd1oGx0HHb} + #{sgEpaCzTzvY.roRnszpDJQQ} + #{sgEpaCzTzvY.ApyTrxh6Biw} + #{sgEpaCzTzvY.OcSeYPLi5Q2} + #{sgEpaCzTzvY.i10mq40hICw} + #{sgEpaCzTzvY.MCmG5Kn2Nyi} + #{sgEpaCzTzvY.aKLMNGAKq01} + #{sgEpaCzTzvY.Awmk7Vfo6x5} + #{sgEpaCzTzvY.HYrPyQ7Ymab} + #{sgEpaCzTzvY.LAHQdNG9a9s} + #{sgEpaCzTzvY.uvY3DYOSEcH} + #{JveFJDlz6oV.bUz00a8pctE} + #{xpZcEqvnYoc.bUz00a8pctE} + #{xpZcEqvnYoc.Lvd1oGx0HHb} + #{xpZcEqvnYoc.roRnszpDJQQ} + #{xpZcEqvnYoc.ApyTrxh6Biw} + #{xpZcEqvnYoc.OcSeYPLi5Q2} + #{xpZcEqvnYoc.i10mq40hICw} + #{ocZqT75qL0Q.roRnszpDJQQ} + #{ocZqT75qL0Q.ApyTrxh6Biw} + #{ocZqT75qL0Q.OcSeYPLi5Q2} + #{ocZqT75qL0Q.i10mq40hICw} + #{ocZqT75qL0Q.MCmG5Kn2Nyi} + #{ocZqT75qL0Q.aKLMNGAKq01} + #{ocZqT75qL0Q.Awmk7Vfo6x5} + #{ocZqT75qL0Q.HYrPyQ7Ymab} + #{ocZqT75qL0Q.LAHQdNG9a9s} + #{ocZqT75qL0Q.uvY3DYOSEcH}",1
OPV SIA Total Vaccinated(Ordinary Population),FjAXpqNdajd,OPV SIA Total Vaccinated(Ordinary Population),(#{qNnxpuVlFUV} + #{NjNPOHuemgm} + #{fiehe67U9O1} + #{IFJfF7NLgu0} + #{ttipyjqR9mH} + #{vaejdFkKmbO} ),1
OPV SIA Total Vaccinated(Special Population),Nh1anljoZS9,OPV SIA Total Vaccinated(Special Population),(#{xpZcEqvnYoc} + #{JveFJDlz6oV} + #{sgEpaCzTzvY} + #{OoQXhDZC2rl} + #{ocZqT75qL0Q}),1
OPV SIA Wastage Rate,MSQ95Z1iIFj,OPV SIA Wastage Rate,"(((#{lW5IiQIcOfZ} - (#{QX1YQitZw3F}))*20)

-
(
#{qNnxpuVlFUV} + #{NjNPOHuemgm} + #{fiehe67U9O1} + #{IFJfF7NLgu0} + #{ttipyjqR9mH} + #{vaejdFkKmbO} ))",((#{lW5IiQIcOfZ} - (#{QX1YQitZw3F}))*20)
OPV Wastage Rate,ETtGrPkdhR5,OPV Wastage Rate,#{kuxcnLoB85c.NhSoXUMPK2K}+#{g2ZhqF3DKMx.NhSoXUMPK2K}-#{iX5pEjcJowF.bCfwecaPx2W}+#{iX5pEjcJowF.ieuodyY5ybC}+#{t3QKFZbCf2B.bCfwecaPx2W}+#{t3QKFZbCf2B.ieuodyY5ybC}+#{OLlWZUfLtsR.bCfwecaPx2W}+#{OLlWZUfLtsR.ieuodyY5ybC}+#{c2Gm5hW3I4i.bCfwecaPx2W}+#{c2Gm5hW3I4i.ieuodyY5ybC}-#{g2ZhqF3DKMx.NhSoXUMPK2K},#{kuxcnLoB85c.NhSoXUMPK2K}+#{g2ZhqF3DKMx.NhSoXUMPK2K}
OPV Wastage Rate (WR),fb9rmo2aCHG,OPV Wastage Rate (WR),((#{kuxcnLoB85c.NhSoXUMPK2K}+#{BhPzqSAoc9Y.NhSoXUMPK2K})-#{g2ZhqF3DKMx.NhSoXUMPK2K})-(#{iX5pEjcJowF}+#{t3QKFZbCf2B}+#{OLlWZUfLtsR}+#{c2Gm5hW3I4i}),(#{kuxcnLoB85c.NhSoXUMPK2K}+#{BhPzqSAoc9Y.NhSoXUMPK2K})-#{g2ZhqF3DKMx.NhSoXUMPK2K}
ORS Co-Pack (4 sachets of low osmolarity ORS (500ml formulation) + 10 tablets of dispersible zinc sulphate tablets 20mg) (Pack)MoS,JTrO9OYowPR,ORS Co-Pack  + 10 tablets,#{IXOZKkAxEFu.n8XlCFUpWOG},#{vu1eIRte2X7.QvctQfKAQn3}
OTP total admissions,KRHm7Sanfxt,OTP total admissions,#{LjsOqUgyXHh} + #{bd8U9fw9YjP} + #{ue73Z4usGVw} + #{O8o1g2j4zTD},1
On ART_12 months,veRXrcZe8eF,On ART_12 months,#{S1z1doLHQg1},1
Oral self-test Kit MoS,K8hSSQSwnny,Oral self-test Kit MoS,#{nkbtH1u9zfA.CGnwPpnZ7n7},#{uSncmqR1fxb.QvctQfKAQn3}
Other GOK funds Accounting Rate,FWbfaE4Solq,Other GOKAccounting Rate,#{oMWJpAyAIUh.wpNbJwjNUZy},#{uq2Izs9ZGT7.wpNbJwjNUZy}
Other GOK funds utilization Rate,cmmTutH98Ig,Other GOK utilization Rat,#{uq2Izs9ZGT7.wpNbJwjNUZy},#{QLC6ejj76za.wpNbJwjNUZy}
Oxytocin Injection 10 I.U. (Ampoule) MoS,ffP7j9XBixo,Oxytocin Injection 10 I.U. (Ampoule),#{rEQd6IDeXWT.n8XlCFUpWOG},#{PQks88LiY83.QvctQfKAQn3}
PCR (3 to 8 months) Confirmed Infant Test Results Positive,hu6pGi3Otf4,PCR (3-8m) Positive,#{DmzoPpXMH6H.NhSoXUMPK2K},1
PCR (3 to 8 months) Infant Testing,iScDHVk20nQ,PCR (3-8m) Testing,#{dU4uzYQRht0.NhSoXUMPK2K},1
PCR (9 to 12 months) Confirmed Infant Test Results Positive,OZoYCP5tYZh,PCR (9-12m) Positive,#{XDBAu5ZHxVM.NhSoXUMPK2K},1
PCR (9 to 12 months) Infant Testing,HbQ7bU8Rna7,PCR (9-12m) Testing,#{zuxd3VsX5Tg.NhSoXUMPK2K},1
PCR (by 2 months) Confirmed Infant Test Results Positive,f60Ttg8uio3,PCR (2m) Positive,#{WvDEUeGbKND.NhSoXUMPK2K},1
PCR (by 2 months) Infant Testing,TW7F64i4hdY,PCR (2m) Testing,#{xHzNEXBp4Hd.NhSoXUMPK2K},1
PEP Occupational,yHJ4IPKFSzg,PEP Occupational,#{mVqxeaMf4eM.NhSoXUMPK2K}+#{a7bKRU1Cyy9.NhSoXUMPK2K},1
PEP Other Reasons,sehSFqYaLJq,PEP Other Reasons,#{eEQVqOeYn7t.NhSoXUMPK2K}+#{mL7cDqmhW9T.NhSoXUMPK2K},1
PEP Sexual Assault,Ixd2WB2yscQ,PEP Sexual Assault,#{e86oTpPw0Us.NhSoXUMPK2K}+#{zSWnmIya1jy.NhSoXUMPK2K},1
PEP_Proportion of Clients who Received PEP,kRyEpiV3Wwl,PEP_Prop of Clients who Received PEP,(#{SMUVPzuyFAB} + #{KrDWcJMS9Vi}),(#{v3dZh9KqTv0} + #{BHbWgZR2CAQ})
PMI Total ALs Dispensed,E1J6vMP5hFO,PMI Total ALs Dispensed,(#{BnGDrFwyQp9.w77uMi1KzOH}*6)+(#{c0MB4RmVjxk.w77uMi1KzOH}*12)+(#{qnZmg5tNSMy.w77uMi1KzOH}*18)+(#{gVp1KSFI69G.w77uMi1KzOH}*24),1
PMI Total ALs dispensed by WT band,Gwr4lywXLiM,PMI Total ALs dispensed by WT band,(#{zB1NW37bi46.LGF6iqCIERd}*6) + (#{zB1NW37bi46.Y91nbvpppbG}*12)+(#{zB1NW37bi46.lBMSm0aBgXs}*18) + (#{zB1NW37bi46.abmGKYBTUWU}*24),1
PMI_ACT MOS,lHPLS1G5CUc,PMI_ACT MOS,(#{BnGDrFwyQp9.rPAsF4cpNxm}*6) + (#{c0MB4RmVjxk.rPAsF4cpNxm}*12)  + (#{qnZmg5tNSMy.rPAsF4cpNxm}*18) + (#{gVp1KSFI69G.rPAsF4cpNxm}*24) ,(#{jfUzb86mBSP.miM6uIJ2cWx}*6) + (#{HwvUHnslwbh.miM6uIJ2cWx}*12) + (#{OLYLVMDHEj8.miM6uIJ2cWx}*18) + (#{UJeKVZzAnfS.miM6uIJ2cWx}*24)
PMI_AL12 MOS Stock,VJjIApOdBDM,PMI_AL12 MOS Stock,#{iZe9QHpC31Y.HMTuusGLTUj},#{HwvUHnslwbh.miM6uIJ2cWx}
PMI_AL12 Pending MOS,LzIEVzUpWIG,PMI_AL12 Pending MOS,#{iZe9QHpC31Y.sEiFVVjqcfg},#{HwvUHnslwbh.miM6uIJ2cWx}
PMI_AL12 RoQ,gcVpQzvCAvD,PMI_AL12 RoQ,(#{HwvUHnslwbh.miM6uIJ2cWx} * 6) - #{c0MB4RmVjxk.rPAsF4cpNxm},1
PMI_AL18 MoS Stock,xifzJdZepGL,AL18 MoS Stock,#{Kkh8ZtRWFmX.HMTuusGLTUj},#{OLYLVMDHEj8.miM6uIJ2cWx}
PMI_AL18 Pending MOS,UW54RautAEK,PMI_AL18 Pending MOS,#{Kkh8ZtRWFmX.sEiFVVjqcfg},#{OLYLVMDHEj8.miM6uIJ2cWx}
PMI_AL18 RoQ,XaKPjqodefi,PMI_AL18 RoQ,(#{OLYLVMDHEj8.miM6uIJ2cWx} * 6) - #{qnZmg5tNSMy.rPAsF4cpNxm},1
PMI_AL24 MoS Stock,m5JchlPXYGh,AL24 MoS Stock,#{E7M967QxxFc.HMTuusGLTUj},#{UJeKVZzAnfS.miM6uIJ2cWx}
PMI_AL24 Pending MOS,V00M1X2mgCp,PMI_AL24 Pending MOS,#{E7M967QxxFc.sEiFVVjqcfg},#{UJeKVZzAnfS.miM6uIJ2cWx}
PMI_AL24 RoQ,dFUJ2s5wqU9,PMI_AL24 RoQ,(#{UJeKVZzAnfS.miM6uIJ2cWx} * 6) - #{gVp1KSFI69G.rPAsF4cpNxm} ,1
PMI_AL6 MoS Stock,A3hCPRmBEc1,AL6 MoS Stock,#{Aui7lNDOsSF.HMTuusGLTUj},#{jfUzb86mBSP.miM6uIJ2cWx}
PMI_AL6 Pending MOS,E8WZg2xUe6D,PMI_AL6 Pending MOS,#{Aui7lNDOsSF.sEiFVVjqcfg},#{jfUzb86mBSP.miM6uIJ2cWx}
PMI_AL6 RoQ,M9GteSIZ0XN,PMI_AL6 RoQ,(#{jfUzb86mBSP.miM6uIJ2cWx} * 6) - #{BnGDrFwyQp9.rPAsF4cpNxm},1
PMI_ASinj MOS,SSARcWY2Ge1, PMI_ASinj MOS,#{iOARK31NdLp.rPAsF4cpNxm},#{naztfZrbMtd.miM6uIJ2cWx}
PMI_ASinj need pq ,U2KpOVZOegw,PMI_ASinj need pq ,#{naztfZrbMtd.miM6uIJ2cWx} * 6,1
PMI_All AL Adjusted consumption,fiVSJyM5cDs,PMI_All AL Adjusted consumption,(#{jfUzb86mBSP.miM6uIJ2cWx}*6) + (#{HwvUHnslwbh.miM6uIJ2cWx}*12) + (#{OLYLVMDHEj8.miM6uIJ2cWx}*18) + (#{UJeKVZzAnfS.miM6uIJ2cWx}*24),1
PMI_All ALs physical count,Mmy9MoUdbhZ,PMI_All ALs physical count,(#{BnGDrFwyQp9.rPAsF4cpNxm}*6) + (#{c0MB4RmVjxk.rPAsF4cpNxm}*12)  + (#{qnZmg5tNSMy.rPAsF4cpNxm}*18) + (#{gVp1KSFI69G.rPAsF4cpNxm}*24) ,1
PMI_ArtInj MoS Stock,AcHIhCDHQ5q,ArtInj MoS Stock,#{Wupc6TOJhcK.HMTuusGLTUj},#{naztfZrbMtd.miM6uIJ2cWx}
PMI_Artemether-Lumefantrine 20/120 Tabs 12s MOS,nK8sqMAeQHY,Artemether-Lumefantrine 20/120 Tabs 12s MOS,#{c0MB4RmVjxk.rPAsF4cpNxm},#{HwvUHnslwbh.miM6uIJ2cWx}
PMI_Artemether-Lumefantrine 20/120 Tabs 18s MOS,ZcngDQJKiEg,Artemether-Lumefantrine 20/120 Tabs 18s MOS,#{qnZmg5tNSMy.rPAsF4cpNxm},#{OLYLVMDHEj8.miM6uIJ2cWx}
PMI_Artemether-Lumefantrine 20/120 Tabs 24s MOS,wOKbEd8Dbi3,Artemether-Lumefantrine 20/120 Tabs 24s MOS,#{gVp1KSFI69G.rPAsF4cpNxm},#{UJeKVZzAnfS.miM6uIJ2cWx}
PMI_Artemether-Lumefantrine 20/120 Tabs 6s MOS,HfGVoCZAwtd,Artemether-Lumefantrine 20/120 Tabs 6s,#{BnGDrFwyQp9.rPAsF4cpNxm},#{jfUzb86mBSP.miM6uIJ2cWx}
PMI_Consistency_AL12,qpx0fqeDegY,PMI_Consistency_AL12,((#{c0MB4RmVjxk.HWtHCLAwprR} + #{c0MB4RmVjxk.CckV73xy6HB} + #{c0MB4RmVjxk.yuvCdaFqdCW}) - ( #{c0MB4RmVjxk.w77uMi1KzOH} + #{c0MB4RmVjxk.unVIt2C0cdW})),1
PMI_Consistency_AL18,SCr494TlOHl,PMI_Consistency_AL18,((#{qnZmg5tNSMy.HWtHCLAwprR} + #{qnZmg5tNSMy.yuvCdaFqdCW} + #{qnZmg5tNSMy.CckV73xy6HB}) - (#{qnZmg5tNSMy.w77uMi1KzOH} + #{qnZmg5tNSMy.unVIt2C0cdW})),1
PMI_Consistency_AL24,XRT0idLdlWN,PMI_Consistency_AL24,((#{gVp1KSFI69G.HWtHCLAwprR} + #{gVp1KSFI69G.CckV73xy6HB} + #{gVp1KSFI69G.yuvCdaFqdCW}) - (#{gVp1KSFI69G.w77uMi1KzOH} + #{gVp1KSFI69G.unVIt2C0cdW})),1
PMI_Consistency_AL6,z9SY9cLvpHd,PMI_Consistency_AL6,((#{BnGDrFwyQp9.HWtHCLAwprR} + #{BnGDrFwyQp9.CckV73xy6HB} + #{BnGDrFwyQp9.yuvCdaFqdCW}) - (#{BnGDrFwyQp9.w77uMi1KzOH} + #{BnGDrFwyQp9.unVIt2C0cdW})),1
PMI_Consistency_ASInj,kZvehAC6BM6,PMI_Consistency_ASInj,((#{iOARK31NdLp.HWtHCLAwprR} + #{iOARK31NdLp.CckV73xy6HB} + #{iOARK31NdLp.yuvCdaFqdCW}) - (#{iOARK31NdLp.unVIt2C0cdW} + #{iOARK31NdLp.w77uMi1KzOH})),1
PMI_Consistency_RDT,PFkHE2JAtQr,PMI_Consistency_RDT,((#{cPlWFYbBacW.HWtHCLAwprR} + #{cPlWFYbBacW.yuvCdaFqdCW} + #{cPlWFYbBacW.CckV73xy6HB}) - (#{cPlWFYbBacW.unVIt2C0cdW} + #{cPlWFYbBacW.w77uMi1KzOH})),1
PMI_Consistency_SP,oU6RZ8HgzYE,PMI_Consistency_SP,((#{imheYfA1Kiw.HWtHCLAwprR} + #{imheYfA1Kiw.CckV73xy6HB} + #{imheYfA1Kiw.yuvCdaFqdCW}) - (#{imheYfA1Kiw.unVIt2C0cdW} + #{imheYfA1Kiw.w77uMi1KzOH})),1
PMI_LLIN MOS,gEDxkvJmRAm,PMI_LLIN MOS,#{f0AIAR5pJ2F.rPAsF4cpNxm},#{xZs759QOGvh.miM6uIJ2cWx}
PMI_LLIN MOS Stock,TaF3YvKkHvw,PMI_LLIN MOS Stock,#{ZiLVFNkjwdB.HMTuusGLTUj},#{xZs759QOGvh.miM6uIJ2cWx}
PMI_LLIN need pq,nNlAdtxPHRL,PMI_LLIN need pq,#{xZs759QOGvh.miM6uIJ2cWx}  * 6,1
PMI_LLIN pending MOS,GIT0eNn3vbW,PMI_LLIN pending MOS,#{ZiLVFNkjwdB.sEiFVVjqcfg},#{xZs759QOGvh.miM6uIJ2cWx}
PMI_RDT MOS,UUNwkYQhYgX,PMI_RDT MOS,#{cPlWFYbBacW.rPAsF4cpNxm},#{Umi8ZsiqBHw.miM6uIJ2cWx}
PMI_RDT MOS Stock,MqaP08m7qpB,PMI_RDT MOS Stock,#{ALnonKSyDct.HMTuusGLTUj},#{Umi8ZsiqBHw.miM6uIJ2cWx}
PMI_RDT RoQ,SQ6fJu6iUGz,PMI_RDT RoQ,(#{Umi8ZsiqBHw.miM6uIJ2cWx} * 6) - #{eFqDcjgvt39.ZxUQw1ay1cw},1
PMI_RDT need pq ,AecI5IRlRSR,PMI_RDT need pq ,#{Umi8ZsiqBHw.miM6uIJ2cWx} * 6,1
PMI_RDT pending MOS,W1VReF5uwnI,PMI_RDT pending MOS,#{ALnonKSyDct.sEiFVVjqcfg},#{Umi8ZsiqBHw.miM6uIJ2cWx}
PMI_SP MOS,AX1co0SXobM,PMI_SP MOS,#{imheYfA1Kiw.rPAsF4cpNxm},#{EtG9ozt2joA.miM6uIJ2cWx}
PMI_SP MoS Stock,ImjyH2PKcrb,SP MoS Stock,#{lZCba7Ijb7x.HMTuusGLTUj},#{EtG9ozt2joA.miM6uIJ2cWx}
PMI_SP RoQ,p6CAZPb0mId,PMI_SP RoQ,(#{EtG9ozt2joA.miM6uIJ2cWx} * 6) - #{imheYfA1Kiw.rPAsF4cpNxm},1
PMI_SP need pq,TNWcde51FIt,PMI_SP need pq,#{EtG9ozt2joA.miM6uIJ2cWx}  * 6,1
PMI_SP pending MOS,ELorMg0kQhA,PMI_SP pending MOS,#{lZCba7Ijb7x.sEiFVVjqcfg},#{EtG9ozt2joA.miM6uIJ2cWx}
PMI_artinj Pending MOS,Rf9K17Q8KA5,PMI_artinj Pending MOS,#{Wupc6TOJhcK.sEiFVVjqcfg},#{naztfZrbMtd.miM6uIJ2cWx}
PMI_artinj RoQ,GjTDTx3NYPn,PMI_artinj RoQ,(#{naztfZrbMtd.miM6uIJ2cWx} * 6) - #{iOARK31NdLp.rPAsF4cpNxm},1
PMTCT (EBF + ERF) Rate,uwOktfOYc7t,PMTCT (EBF + ERF) Rate,#{Gz58GjVpyHH.NhSoXUMPK2K}+#{Q1PZPHZGp8B.NhSoXUMPK2K},#{TanTUukvqDX.NhSoXUMPK2K}
PMTCT ARV Prophylaxis Rate (Infant),r5gZDfgogp0,ARV Prophylaxis Rate-Infa,#{uay9KC6l64J.NhSoXUMPK2K},#{aU3yS6kF44S.NhSoXUMPK2K}
PMTCT ARV Prophylaxis Rate (Mother),BYkpezlbl5y,ARV Prophylaxis Rate,#{g62PclQcVba.NhSoXUMPK2K},#{A00MjWUoJu7.NhSoXUMPK2K}
PMTCT Infant Prophylaxis,KMy83Jn1QgO,PMTCT Infant Prophylaxis,#{HAumxpKBaoK} + #{Jn6ATTfXp02} + #{RY1js5pK2Ep},1
PMTCT MF Rate,cjMPhs0yyoR,PMTCT MF Rate,#{gm5CUNLylIt.NhSoXUMPK2K},#{TanTUukvqDX.NhSoXUMPK2K}
PMTCT Positive,OOxIjUgF4A7,PMTCT Positive,#{nwXS5vxrrr7} + #{hn3aChn4sVx} + #{AfHArvGun12} + #{hHLR1HP8xzI},1
PMTCT Positivity Infants,qJxnnnqkeVi,PMTCT Positivity Infants,#{PrJOGNh7o2I.NhSoXUMPK2K},#{o9XSl5xVCez.NhSoXUMPK2K}
PMTCT Positivity at ANC,wwGiaOYituR,PMTCT Positivity at ANC,#{TJMdle70A7X.NhSoXUMPK2K}+#{GCAkHwMAWM6.NhSoXUMPK2K},#{f9vesk5d4IY.NhSoXUMPK2K}
PMTCT Prophylaxis Ratio - (AZT+SdNVP),ef6iSFXY2Zw,Prophylaxis  (AZT+SdNVP),#{dba7gHtgiLi.NhSoXUMPK2K},#{dba7gHtgiLi.NhSoXUMPK2K}+#{ZXz75qizYqq.NhSoXUMPK2K}+#{BZ9EGLQPnvl.NhSoXUMPK2K}+#{gZJBc0JpNXy.NhSoXUMPK2K}
PMTCT Prophylaxis Ratio - Interrupted HAART,tGHzBr24oEl,Prophylaxis - Interrupted,#{ZXz75qizYqq.NhSoXUMPK2K},#{dba7gHtgiLi.NhSoXUMPK2K}+#{ZXz75qizYqq.NhSoXUMPK2K}+#{BZ9EGLQPnvl.NhSoXUMPK2K}+#{gZJBc0JpNXy.NhSoXUMPK2K}
PMTCT Prophylaxis Ratio - NVP Only,GWV3Aa6HLf1,Prophylaxis - NVP Only,#{BZ9EGLQPnvl.NhSoXUMPK2K},#{dba7gHtgiLi.NhSoXUMPK2K}+#{ZXz75qizYqq.NhSoXUMPK2K}+#{BZ9EGLQPnvl.NhSoXUMPK2K}+#{gZJBc0JpNXy.NhSoXUMPK2K}
PMTCT Prophylaxis Ratio - Treatment HAART (ART),iRZlRBXV7eS,Prophylaxis - HAART (ART),#{gZJBc0JpNXy.NhSoXUMPK2K},#{dba7gHtgiLi.NhSoXUMPK2K}+#{ZXz75qizYqq.NhSoXUMPK2K}+#{BZ9EGLQPnvl.NhSoXUMPK2K}+#{gZJBc0JpNXy.NhSoXUMPK2K}
PMTCT Total Positive,VsRrzNMda22,PMTCT Total Positive,#{nwXS5vxrrr7} + #{hn3aChn4sVx} + #{AfHArvGun12}+#{hHLR1HP8xzI} + #{qSgLzXh46n9},1
PMTCT Unreached Mothers,cmeMfuPL3VL,PMTCT Unreached Mothers,#{rSfCham9BzD} - (#{nwXS5vxrrr7} + #{hn3aChn4sVx} + #{AfHArvGun12}+#{hHLR1HP8xzI} + #{qSgLzXh46n9}),1
PMTCT updake among ANC clients,gdOTEyXdIhq,PMTCT ANC test rate,#{nspwXhqQaAz.NhSoXUMPK2K},#{f9vesk5d4IY.NhSoXUMPK2K}
PMTCT_Maternal HAART,ArG6zbCMBr2,Total Maternal HAART,#{lJpaBye9B0H} + #{UMyB7dSIdz1} + #{vkOYqEesPAi} + #{ckPCoAwmWmT} + #{WNFWVHMqPv9},1
"PMTCT_Number of HIV Positive  women at (ANC,L&D and PNC) ",FDFbFf4wBn9,"PMTCT (ANC,L&D and PNC) ",#{nwXS5vxrrr7} + #{hn3aChn4sVx} + #{AfHArvGun12}+#{hHLR1HP8xzI} + #{qSgLzXh46n9},1
PMTCT_Proportion of HEI who had an initial PCR test within 12 months.,mVxlI0MBFg4,PMTCT_Prop of HEI had  initial PCR test  12 mths.,(#{UIok7l6W4nh} + #{KQDcvUpq0rx}),(#{C8xdcRWT9d2} + #{AfHArvGun12})
PMTCT_Proportion of HIV positive women receiving Maternal HAART,oiM2CeBHx22,PMTCT_PrOP of HIV positive women receiving HAART,(#{lJpaBye9B0H} + #{WNFWVHMqPv9} + #{ckPCoAwmWmT} + #{vkOYqEesPAi} + #{UMyB7dSIdz1} ),(#{nwXS5vxrrr7} + #{hn3aChn4sVx} + #{AfHArvGun12} + #{hHLR1HP8xzI} + #{qSgLzXh46n9})
PMTCT_Proportion of HIV postive preganant women issued with Infant prophylaxis,beRpKBartBo,PMTCT_ProP HIV+preG women iss Infant prophylaxis,(#{HAumxpKBaoK} + #{Jn6ATTfXp02} + #{RY1js5pK2Ep}),(#{oZc8MNc0nLZ} + #{nwXS5vxrrr7} + #{hn3aChn4sVx} + #{AfHArvGun12})
"PMTCT_Proportion of HIV pregnant and breastfeeding women identified in ANC, L&D and PNC(coverage)",LlB3NWi7JZs,propof HIV preg and brstfng womn identified,(#{nwXS5vxrrr7} + #{hn3aChn4sVx} + #{AfHArvGun12} + #{hHLR1HP8xzI} + #{qSgLzXh46n9}),63045
PMTCT_Proportion of Pregnant women who know their HIV status,mYm3hGNDKr8,PMTCT-Prop of Pg women who know their HIV status,(#{qSgLzXh46n9} + #{ETX9cUWF43c} + #{mQz4DhBSv9V} + #{LQpQQP3KnU1}) + #{UMyB7dSIdz1},#{pct05jgGcLt}
PMTCT_Proportion of pregnant women attending ANC screened for syphilis,hKKyQC5IHar,PMTCT_Prop of  ANC women screened for syphilis,#{i5jVVTm1vI8},#{uSxBUWnagGg}
PMTCT_Total tested,JHbRQiLrFyc,PMTCT_tsted,(#{PXUzSsmeY0P} + #{mQz4DhBSv9V} + #{ETX9cUWF43c} + #{LQpQQP3KnU1}),1
PNC Attendance (2-3days) Coverage,LAiLxs7oCAg,PNC Attendance (2-3days) Cov,#{wAeGJlvuydG},#{tmlMpIqHimf.NhSoXUMPK2K}
PNC Attendance (3days-6weeks) Coverage,h1zRbfKuY3l,PNC Attendance (3days-6weeks) Coverage,#{Lp9qb2iKLMJ},#{tmlMpIqHimf}
PNC Attendance (within 48 hours) Coverage,xgMf5X8cE7D,PNC Attendance (within 48 hours) Coverage,#{qahRo2120r8},#{QStt76mU06X}
PNC Attendance 1st Visit,Jo8mm5EII0i,PNC Attendance 1st Visit,#{QStt76mU06X.wBWcFk7k1qY},#{JOnT3OiMd5o}
PNC within 48hours (Infants),IhseOshzo8K,PNC within 48hours (Infants),#{wxg6cuH9cXF},#{UqKC1DJnymn}
PNC within 48hours (Mother),KXOpQO6bxoU,PNC within 48hours (Mother),#{qahRo2120r8},#{jaPrPmor6WV} + #{rAZBTMa7Jy3} + #{sMqM8DwiAaj} + #{Kx64gGqaFVq}
PSI: Total incident Category (Patient),HtRAthSF4Al,PSI-Total,#{JisUZvtOpbc} + #{ASXjpUvLetG} + #{j0n5Zvis3gl} + #{HkRiwqnnyKn} + #{PvRaMA7c9cI},1
PTB+ HIV+ out of Tested PTB+,m3OHf1uL88H,% PTB+ HIV+,#{Vri74blSuoL.PIRmDAU7eSv},#{CQVzChlE9qw.PIRmDAU7eSv}
PTB+ out of total TB cases,CZFIlU5nkLr,PTB+ out of total TB ,#{MmsSJfunbRu.PIRmDAU7eSv},#{MmsSJfunbRu}
PTB+ tested for HIV out of  the registered PTB+,XSVvJ2lYhua,% PTB+ tested,#{CQVzChlE9qw.PIRmDAU7eSv},#{MmsSJfunbRu.PIRmDAU7eSv}
PTB- >15 yrs tested for HIV out of the registered PTB- >15 yrs,NANEwxoBHMl,% PTB- >15 yrs tested,#{CQVzChlE9qw.TgiG5Y15JDI},#{MmsSJfunbRu.TgiG5Y15JDI}
"PTB<15 yrs, smear not done and are HIV+ out of Tested PTB<15 yrs, smear not done",IWYcl38p1e4,"% PTB<15 yrs, smear not d",#{Vri74blSuoL.JblIQh4f0Oc},#{CQVzChlE9qw.JblIQh4f0Oc}
"PTB<15 yrs, smear not done out of total TB cases",W0s4lhlNkc5,"% PTB<15 yrs,  not done",#{MmsSJfunbRu.cWPCEmypCYS},#{MmsSJfunbRu}
"PTB>15 yrs, smear not done and are HIV+ out of Tested PTB>15 yrs, smear not done",ezyvhgfuklu,"% PTB>15 yrs, smear not d",#{Vri74blSuoL.dNZZydqWJFy},#{CQVzChlE9qw.dNZZydqWJFy}
"PTB>15 yrs, smear not done out of total TB cases",jYt6HbKsLkK,"% PTB>15 yrs, not done",#{MmsSJfunbRu.dNZZydqWJFy},#{MmsSJfunbRu}
"Paracetamol Syrup/Suspension, 120mg/5ml (60ml Bottle) MoS",tAcjBkf9vqR,"Paracetamol Syrup/Suspension, 120mg/5ml ",#{DclammcSWra.n8XlCFUpWOG},#{fssTWMkgFm3.QvctQfKAQn3}
"Paracetamol Tablets, 500mg (Tablet) MoS",MVFnuEjVRIH,"Paracetamol Tablets, 500mg (Tablet)",#{l5mDKpIdb3U.n8XlCFUpWOG},#{NKHbkWxRihZ.QvctQfKAQn3}
Patients currently on prophylaxis,IbK2qJEk17b,Patients Prophylaxis,#{KzIawX7xMAv.j03wX0lCHZc}+#{KzIawX7xMAv.vVketPHJwSY}+#{KzIawX7xMAv.omEDL5LVgDJ}+#{KzIawX7xMAv.g6112VF7T29}+#{eM7FcVVzvz1.j03wX0lCHZc}+#{eM7FcVVzvz1.vVketPHJwSY}+#{eM7FcVVzvz1.omEDL5LVgDJ}+#{eM7FcVVzvz1.g6112VF7T29},1
Patients started on ARVs,ISQsztUZJnX,Patients start ARV,#{cTY2tTKwUqd.j03wX0lCHZc}+#{cTY2tTKwUqd.vVketPHJwSY}+#{cTY2tTKwUqd.omEDL5LVgDJ}+#{cTY2tTKwUqd.g6112VF7T29}+#{eNcsljfoUKW.j03wX0lCHZc}+#{eNcsljfoUKW.vVketPHJwSY}+#{eNcsljfoUKW.omEDL5LVgDJ}+#{eNcsljfoUKW.g6112VF7T29}+#{jFrSw8UkNQ4.j03wX0lCHZc}+#{jFrSw8UkNQ4.vVketPHJwSY}+#{jFrSw8UkNQ4.omEDL5LVgDJ}+#{jFrSw8UkNQ4.g6112VF7T29}+#{GlGolXdf6gr.j03wX0lCHZc}+#{GlGolXdf6gr.vVketPHJwSY}+#{GlGolXdf6gr.omEDL5LVgDJ}+#{GlGolXdf6gr.g6112VF7T29},1
Payments ( Uses of Funds),qIAhTQZIAaj,Payments ( Uses of Funds),#{jY3JFizFzQN.NhSoXUMPK2K}+#{usMDjlboKn4.NhSoXUMPK2K}+#{WuEJXcFURTY.NhSoXUMPK2K}+#{t75eApxzxfv.NhSoXUMPK2K}+#{q04fFLke4PE.NhSoXUMPK2K}+#{IxfhqZSgGy9.NhSoXUMPK2K}+#{QrHdlGiLTpv.NhSoXUMPK2K}+#{nGagRoo4BzA.NhSoXUMPK2K}+#{RijWww0GNyd.NhSoXUMPK2K}+#{sDEtpJj8IeQ.NhSoXUMPK2K}+#{VV8rxMutqgB.NhSoXUMPK2K}+#{W6kjK1t3oha.NhSoXUMPK2K}+#{KAVPEvsu7GB.NhSoXUMPK2K}+#{sW1FEKkUlno.NhSoXUMPK2K}+#{JgjYnWEbbXI.NhSoXUMPK2K}+#{GeLsHQnBJSl.NhSoXUMPK2K}+#{Anntg74AWAc.NhSoXUMPK2K}+#{NAWDpCTju9c.NhSoXUMPK2K}+#{uIKFwsGjL8l.NhSoXUMPK2K}+#{zfE43ojuX27.NhSoXUMPK2K}+#{Jm0j7eIJw22.NhSoXUMPK2K}+#{Kvrh6Edh4ux.NhSoXUMPK2K}+#{kZVa4Dfz3oW.NhSoXUMPK2K}+#{ozuOGiiROjR.NhSoXUMPK2K}+#{zq5cC1mHOjZ.NhSoXUMPK2K}+#{kkKxlgb0SIK.NhSoXUMPK2K}+#{eWJI88NUHju.NhSoXUMPK2K}+#{ZL5umjFvNZT.NhSoXUMPK2K}+#{kMyKJqs4tP6.NhSoXUMPK2K}+#{JfMlkDb7sfP.NhSoXUMPK2K}+#{ERUP9jd5kr8.NhSoXUMPK2K}+#{VE7bP4Hd0Y8.NhSoXUMPK2K}+#{G10FiANc4uK.NhSoXUMPK2K}+#{jER1yfrClYQ.NhSoXUMPK2K}+#{zmTKl26bqXb.NhSoXUMPK2K}+#{JqVPN31hItf.NhSoXUMPK2K}+#{FNaQfndi92d.NhSoXUMPK2K}+#{pwYhMY7SObK.NhSoXUMPK2K}+#{T6Zosl4H5TG.NhSoXUMPK2K}+#{W53qF6leiPm.NhSoXUMPK2K}+#{MxceLE1Wgwj.NhSoXUMPK2K}+#{HGfobnG3qSX.NhSoXUMPK2K}+#{WypNzlF1rxb.NhSoXUMPK2K}+#{kltZozM5rkg.NhSoXUMPK2K}+#{SWHhf1eE89t.NhSoXUMPK2K}+#{qLWHhVTIp0l.NhSoXUMPK2K}+#{s2Ha3e0xwwp.NhSoXUMPK2K}+#{RMsgMQj2SBM.NhSoXUMPK2K}+#{X3nuiSHRJJP.NhSoXUMPK2K}+#{bDSQEZM3rtd.NhSoXUMPK2K}+#{dvo26Xu2g3G.NhSoXUMPK2K}+#{ksAM140tLvc.NhSoXUMPK2K}+#{mYIZtgEPa5S.NhSoXUMPK2K}+#{RWwJcCEIcZw.NhSoXUMPK2K}+#{u9TiVtfs3or.NhSoXUMPK2K}+#{BsyP5AnR1pE.NhSoXUMPK2K}+#{p4Vk0aCXUKj.NhSoXUMPK2K}+#{ZysDicYyDxN.NhSoXUMPK2K}+#{aLt2Db8y8VE.NhSoXUMPK2K}+#{Mnz4Ts6dMVo.NhSoXUMPK2K}+#{Mnz4Ts6dMVo.NhSoXUMPK2K}+#{Tpp5Fh9rV07.NhSoXUMPK2K}+#{sDEtpJj8IeQ.NhSoXUMPK2K}+#{uHj0fEYrjTx.NhSoXUMPK2K}+#{uHj0fEYrjTx.NhSoXUMPK2K}+#{Q3Dtz4uTL0J.NhSoXUMPK2K}+#{RIdOyfRqT15.NhSoXUMPK2K}+#{DOPHF9sDlCE.NhSoXUMPK2K},1
"Percentage  of Closed Reductions (Fractures, Dislocation) done to patients",WWLnrWCTmMn,Percentage  of Closed Reductions done to patients,#{uOC56DfVqib},#{hrizXiyGvom} + #{uOC56DfVqib} + #{IEfyuOqoU2d} + #{LXTbgcVjV8p}  + #{uybnpBUS3np} + #{Kg9hiOXlIKg} + #{TMZfrOY1OJG} + #{Gjn4bEoaFZK}
Percentage Bed Occupancy,b8xcB7llyND,Percentage Bed Occupancy,#{S9BU0xS5QRf.CFyfkW0xUuP}+#{OdXZaAsAGRU.CFyfkW0xUuP}+#{C3srxhSBods.CFyfkW0xUuP}+#{KcmpbSvRETO.CFyfkW0xUuP}+#{IgnbdUEWMd4.CFyfkW0xUuP}+#{VuMnNeKMui9.CFyfkW0xUuP}+#{knorevTYX7E.CFyfkW0xUuP}+#{rAvVxANpmvq.CFyfkW0xUuP}+#{slxcaBIJQFz.CFyfkW0xUuP}+#{zqqP41WTYNk.CFyfkW0xUuP}+#{Y1sxN73phAf.CFyfkW0xUuP}+#{ndneSgDusqj.CFyfkW0xUuP}+#{BcVftn5I5NL.CFyfkW0xUuP}+#{zTIGTbphtuA.CFyfkW0xUuP}+#{bRP7RnMWTK8.CFyfkW0xUuP},#{OdXZaAsAGRU.fgY5yxfRFHN}+#{OdXZaAsAGRU.ERX6phnRjMW}+#{S9BU0xS5QRf.fgY5yxfRFHN}+#{S9BU0xS5QRf.ERX6phnRjMW}+#{C3srxhSBods.fgY5yxfRFHN}+#{C3srxhSBods.ERX6phnRjMW}+#{KcmpbSvRETO.fgY5yxfRFHN}+#{KcmpbSvRETO.ERX6phnRjMW}+#{IgnbdUEWMd4.fgY5yxfRFHN}+#{IgnbdUEWMd4.ERX6phnRjMW}+#{VuMnNeKMui9.fgY5yxfRFHN}+#{VuMnNeKMui9.ERX6phnRjMW}+#{knorevTYX7E.fgY5yxfRFHN}+#{knorevTYX7E.ERX6phnRjMW}+#{rAvVxANpmvq.fgY5yxfRFHN}+#{rAvVxANpmvq.ERX6phnRjMW}+#{slxcaBIJQFz.fgY5yxfRFHN}+#{slxcaBIJQFz.ERX6phnRjMW}+#{zqqP41WTYNk.fgY5yxfRFHN}+#{zqqP41WTYNk.ERX6phnRjMW}+#{Y1sxN73phAf.fgY5yxfRFHN}+#{Y1sxN73phAf.ERX6phnRjMW}+#{ndneSgDusqj.fgY5yxfRFHN}+#{ndneSgDusqj.ERX6phnRjMW}+#{BcVftn5I5NL.fgY5yxfRFHN}+#{BcVftn5I5NL.ERX6phnRjMW}+#{zTIGTbphtuA.fgY5yxfRFHN}+#{zTIGTbphtuA.ERX6phnRjMW}+#{bRP7RnMWTK8.fgY5yxfRFHN}+#{bRP7RnMWTK8.ERX6phnRjMW}
Percentage of  HIV-positive  women enrolled antenatally delivering at a health facility,s1xrVlqaJiE,% HIV-positive  women enrolled,#{sb8Oey1dcej.NhSoXUMPK2K},#{ttD9HMfe88t.NhSoXUMPK2K}
Percentage of Children under 5 years treated for malaria,MjeQRaczstj,Child <5 yr malaria (%),#{Lt0FqtnHraW.lHl2rmXpHse} + #{OoakJhWiyZp.lHl2rmXpHse},#{KNrK5VWTZkx.NhSoXUMPK2K}
Percentage of Children under 5 years treated for malaria against target (Performance),bZebO2ERWIK,Malaria treat <5yrs Performance (%),#{Lt0FqtnHraW.lHl2rmXpHse}+#{OoakJhWiyZp.lHl2rmXpHse},#{dAoidsSLKsU.ea7VHlwMkhH}
Percentage of HIV Positive pregnant women on ARVs scorecard,gfsigBBkr5K,No. of HIV Positive pregnant women on ARVs,#{g62PclQcVba.NhSoXUMPK2K},#{A00MjWUoJu7.NhSoXUMPK2K}
Percentage of HIV-exposed infants exclusively breastfeed for the first 6 months,Kfekr5atCaa,% HIV-exposed infants exclusively breast,#{TZnTfeEM2HV.NhSoXUMPK2K},#{B8igC69Eq7w.NhSoXUMPK2K}
Percentage of HIV-exposed infants who receive a PCR at 6 -8 weeks,IwgzS3p8i44,% HIV-exposed infants who receive a PCR ,#{x554GYJkgNJ.NhSoXUMPK2K},#{n8GTfzjoCU8.NhSoXUMPK2K}
Percentage of HIV-positive clients who have disclosed their HIV status to their sexual partner,jZfBLmjj0AB,% of HIV-positive  clients disclosed,#{TOuoyeCi6HX.NhSoXUMPK2K},#{bNx0UJApWHC.NhSoXUMPK2K}
Percentage of HIV-positive pregnant women enrolled in KMMP services,KCYRKP7cIIw,%  HIV-positive pregnant women enrolled,#{H1iLlx9wVMk.NhSoXUMPK2K},#{rTPA9UHdT59.NhSoXUMPK2K}
Percentage of HIV-positive women who finished four antenatal visits,Kpj7LYn1mfI,% HIV-positive women who finished,#{asnfu8cylln.NhSoXUMPK2K},#{ttD9HMfe88t.NhSoXUMPK2K}
Percentage of Maternal Deaths Audited Scorecard,o1fmyeWkz1M,Percentage of Maternal Deaths Audited Scorecard,#{kAp7ViUXEKh.NhSoXUMPK2K},#{dPRCstLVkZu} + #{AC1Iorxdijc} + #{BYMSIbnUzXQ} + #{KDFtI6rqYwI} + #{eBHhfupqMHz} + #{CoAXLBxR0Ik}
Percentage of Pregnant Women Receiving folate,sNuvwnqB72j,Percentage of Pregnant Women Receiving folate,#{JbcvbCEBnu6.NhSoXUMPK2K},#{f9vesk5d4IY.NhSoXUMPK2K}+#{hxXwYIgT8rI.NhSoXUMPK2K}
Percentage of Pregnant women given Tetanus Toxoid 3+,Nn1n1AmZbVG,TT plus coverage,#{au9lav766rM.Qzjct1emaaj}+#{au9lav766rM.kHFI1LYOvZF}+#{au9lav766rM.WmSjcUiJumX},#{JOnT3OiMd5o}
Percentage of TB Cases offered DOTs by CHVs,b2zkxO5l3lm,Percentage of TB Cases offered DOTs by CHVs,#{LjlyHsz5eSK.NhSoXUMPK2K},#{xhQlihiebMH.WwOVo8ccFpn}
Percentage of TB cases tested for HIV with known results,e66WIC5ApJf,% TB cases tested for HIV with known results,#{uFJqFxWUnQi.SW68XRmPP8J} + #{uFJqFxWUnQi.M5gPRkmYrbr},#{xhQlihiebMH.WwOVo8ccFpn}
Percentage of TB/HIV Co-infected cases initiated on ART,K65W7SDrMyZ,%TB/HIV Co-infected cases initiated on ART,#{kRUTjkncfLE.NhSoXUMPK2K},#{uFJqFxWUnQi.SW68XRmPP8J}
Percentage of Women of Reproductive Age 25-49Years screened for cervical cancer,irhPm0DFjV5,%Cervical Cancer screening,#{ommbnTANmGo.qWama2bwQZR}+#{ommbnTANmGo.FqagtL5h8ni}+#{kl4RvWOGb7x.qWama2bwQZR}+#{kl4RvWOGb7x.FqagtL5h8ni}+#{G9COyloYLYa.qWama2bwQZR}+#{G9COyloYLYa.FqagtL5h8ni},#{F1Z1dnzuD3D}
Percentage of Women of Reproductive Age screened for cervical cancer in the facility Scorecard,A6F6kUm24r7,Percentage of Women of Reproductive Age screened,#{G9COyloYLYa.qWama2bwQZR}+#{G9COyloYLYa.FqagtL5h8ni}+#{kl4RvWOGb7x.qWama2bwQZR}+#{kl4RvWOGb7x.FqagtL5h8ni},#{bPQDV3mud0v.NhSoXUMPK2K}
Percentage of children <5years who are underweight,AaulbTKIvL4,Child <5yrs underweight,#{ENjll6PbaI8.a57uWFr3dUy} + #{ENjll6PbaI8.MJAGUpeHkpn} + #{HlZXTFN2B61.a57uWFr3dUy} + #{HlZXTFN2B61.MJAGUpeHkpn} + #{Ype6qUApdlR.a57uWFr3dUy} + #{Ype6qUApdlR.MJAGUpeHkpn} + #{AIduSzrilaz.a57uWFr3dUy} + #{AIduSzrilaz.MJAGUpeHkpn} + #{AYT1IPxFRZx.a57uWFr3dUy} + #{AYT1IPxFRZx.MJAGUpeHkpn} + #{uYBa6RU8wUZ.a57uWFr3dUy} + #{uYBa6RU8wUZ.MJAGUpeHkpn},(#{ENjll6PbaI8.a57uWFr3dUy} + #{ENjll6PbaI8.MJAGUpeHkpn} + #{HlZXTFN2B61.a57uWFr3dUy} + #{HlZXTFN2B61.MJAGUpeHkpn} + #{Ype6qUApdlR.a57uWFr3dUy} + #{Ype6qUApdlR.MJAGUpeHkpn} + #{AIduSzrilaz.a57uWFr3dUy} + #{AIduSzrilaz.MJAGUpeHkpn} + #{AYT1IPxFRZx.a57uWFr3dUy} + #{AYT1IPxFRZx.MJAGUpeHkpn} + #{uYBa6RU8wUZ.a57uWFr3dUy} + #{uYBa6RU8wUZ.MJAGUpeHkpn})  + (#{twpy25QKLk9.a57uWFr3dUy} + #{twpy25QKLk9.MJAGUpeHkpn} + #{qoEPwxCNrll.a57uWFr3dUy} + #{qoEPwxCNrll.MJAGUpeHkpn} + #{ikI4r8YuZZ0.a57uWFr3dUy} + #{ikI4r8YuZZ0.MJAGUpeHkpn}) + (#{QCNHvzgxurQ.a57uWFr3dUy} + #{QCNHvzgxurQ.MJAGUpeHkpn} + #{mv0ICssqScK.a57uWFr3dUy} + #{mv0ICssqScK.MJAGUpeHkpn} + #{k3xX4NKJaaY.a57uWFr3dUy} + #{k3xX4NKJaaY.MJAGUpeHkpn}) + (#{lvyOQjZaXZ3.a57uWFr3dUy} + #{lvyOQjZaXZ3.MJAGUpeHkpn} + #{zels3jARvGQ.a57uWFr3dUy} + #{zels3jARvGQ.MJAGUpeHkpn} + #{PW4W1Fa7b5b.a57uWFr3dUy} + #{PW4W1Fa7b5b.MJAGUpeHkpn})
Percentage of deliveries conducted by skilled health attendant in the facility Scorecard,x9qIyvMz2Su,Percentage of deliveries conducted by skilled heal,#{jaPrPmor6WV.NhSoXUMPK2K}+#{rAZBTMa7Jy3.NhSoXUMPK2K}+#{sMqM8DwiAaj.NhSoXUMPK2K}+#{Kx64gGqaFVq.NhSoXUMPK2K},#{tmlMpIqHimf}
Percentage of facility based Fresh still births Scorecard,PSnwU6uwaRj,Percentage of facility based Fresh still births,#{rYn8RCcHJg1.NhSoXUMPK2K},#{jaPrPmor6WV.NhSoXUMPK2K}+#{rAZBTMa7Jy3.NhSoXUMPK2K}+#{sMqM8DwiAaj.NhSoXUMPK2K}+#{Kx64gGqaFVq.NhSoXUMPK2K}
Percentage of health facilities that offer STI services,INQLYaXoU8p,Percentage of health facilities ,#{asVEogwOWZT},12729
Percentage of newborns visited at home within 48 hours of Birth,fhCOLjKxZ3G,% of newborns visited at home within 48 hours,#{NjcDm9nopWu},#{JvjczkbdPTy}
Percentage of patients fixed with Casts ,UyXOGW6NArr,Percentage of patients fixed with Casts ,#{hrizXiyGvom},#{hrizXiyGvom} + #{uOC56DfVqib} + #{IEfyuOqoU2d} + #{LXTbgcVjV8p}  + #{uybnpBUS3np} + #{Kg9hiOXlIKg} + #{TMZfrOY1OJG} + #{Gjn4bEoaFZK}
Percentage of pregnant women attending at least 4 ANC visits,ZIPx4sHoGCN,Percentage of pregnant women attending at least 4,#{Fz0LzxMT1vV.NhSoXUMPK2K},#{f9vesk5d4IY.NhSoXUMPK2K}
Percentage of pregnant women whose male partners were tested for HIV in the facility Scorecard,GYGlWaG8tHo,Percentage of pregnant women whose male partners,#{BnPSZj7YWX4.NhSoXUMPK2K},#{Du49LE8Qndk.NhSoXUMPK2K}
Percentage of women who deliver in a facility and initiate or leave with a modern contraceptive method prior to discharge (Post partum family planning),Pm5jdnWLIug,Post partum family planning,#{NQu4LwpsBIL} + #{yCxL5hNHViI},#{jaPrPmor6WV} + #{rAZBTMa7Jy3} + #{sMqM8DwiAaj} + #{Kx64gGqaFVq}
Pfizer_vaccine_type,bRpBGzP4UQX,Pfizer_vaccine_type,#{UoaXvx7kTB7} + #{pkrY92yugfK},1
Phsio-Total number of treatments given,AyJT4IKuhpo,Total number of treatments given,#{wa8UoC55KZ0} + #{GKZDeb3jDdn} + #{bb293YKfnO2},1
Physio-Number of disability Mainstreaming audits carried out,YdqTzF9Sguk,Number of disability Mainstreaming audits carried,#{zdpb53eoL1o},1
Physio-Percentage  of physiotherapy attendees   with sports injuries.,y0rhfWrdLW2,Percentage  of attendees with sports injuries.,#{HS1SKBafxjA},#{mLfcvv7AedN}
Physio-Percentage  of physiotherapy attendees  receiving physiotherapy wellness services through physical activity,EvvjUjuEOGQ,Percentage  of physiotherapy attendees,#{gvn9F0VyNXr},#{mLfcvv7AedN}
Physio-Percentage of  CHPs trained on CBR concept,WOlnLQS6qML,Physio-Percentage of  CHPs trained on CBR concept,#{quVRcI9fwQe},1
Physio-Percentage of  physiotherapy  attendees with low back pain.,gj8mbHg59b5,Percentage of  physiotherapy  attendees,#{eMur6NpE1Y1},#{mLfcvv7AedN}
Physio-Percentage of  physiotherapy attendees  with Cerebrovascular accident-CVA (Stroke).,lZnM4aCRh3R,Percentage of  physiotherapy attendees,#{awhncmChQms},#{mLfcvv7AedN}
Physio-Percentage of  physiotherapy attendees  with mental health conditions.,rU0AwmFd2wt,Percentage of  physiotherapy attendees,#{szsb5B99z2B},#{mLfcvv7AedN}
"Physio-Percentage of Clients assessed ,prescribed, fitted and trained on assistive products.",P1xtYgFZFOG,% of Clients fitted and trained on assistive.,#{grqHZLJmA4c},#{KYGw6QSQy5b}
Physio-Percentage of Geriatrics receiving physiotherapy services,EZWM0qJgE5y,Percentage of Geriatrics receiving physiotherapy,#{z0OT8X14QNl},#{mLfcvv7AedN}
Physio-Percentage of health workers sensitized on disability mainstreaming.,qmIY4rt9IOp,% of HW sensitized on disability mainstreaming,#{SHoXOiHR3sx},1
Physio-Percentage of health workers trained on Community Based Rehabilitation (CBR) concept.,Qp4BgGXif5Z,% of health workers trained on  (CBR) concept.,#{AkTFP3tgr6Y},1
Physio-Percentage of physiotherapy clients receiving Digital /Tele Rehabilitation services,yqIkyL9h2Cr,% of physiotherapy clients receiving Digital /Tele,#{Z5GW5IA1Pga},#{hxx5FLJPbwy} + #{Ab8KSSUuwhu} + #{tdnjd7uTJEy} + #{BTiEUgZSGxj}+#{Vq4LIb7N5dN}
"Physio-Percentage of women of reproductive age with gynaecological, pelvic, and other reproductive health conditions receiving  Physiotherapy services ",n0E8B7AjmFu,Percentage of women of reproductive age,#{V5AAcImua7f} + #{CiXoiiQUEG3},1
Physio-Proportion of Persons with Disabilities assessed and categorized.,bZp60NPw5kb,Proportion of Persons assessed categorized.,#{KYGw6QSQy5b},0.1 * #{NLKRV7bYbVy}
Physio-Proportion of clients screened for disability in Community Based Rehabilitation (CBR) programs,XIXYzQ4m9cX,Proportion of clients screened for disability,#{U0YBskEVYKA},10 / 100 * #{NLKRV7bYbVy}
Physio-Proportion of women of reproductive age with disability identified and receiving physiotherapy services,QxjDHUjhr7G,Proportion of women of reproductive age,#{YCfcNRMsH3P},10 / 100 * #{bPQDV3mud0v}
Physio-Total attendance of patients,wKpTafixZgA,Total attendance of patients,#{mLfcvv7AedN},1
Physio-Total number of persons with disabilites identified and receiving physiotherapy services,ATCva29KkP3,Total number of persons with disabilites,#{tdnjd7uTJEy} + #{Ab8KSSUuwhu} + #{hxx5FLJPbwy},1
Pills Couple Year protection,WtRUiKMMeyZ,Pills CYP,#{BQmcVE8fex4} + #{uHM6lzLXDBd},15
Pneumococal Wastage Rate (WR),VS4DgOhLSxW,Pneumococal Wastage,((#{BQeaCpVaUYB.NhSoXUMPK2K}+#{XkemTADiLv4.NhSoXUMPK2K})-#{VRD05emEwOF.NhSoXUMPK2K})-(#{L2dPeH9VkBc}+#{xiaJWeXNYif}+#{h1GlCYbIQvU}),(#{BQeaCpVaUYB.NhSoXUMPK2K}+#{XkemTADiLv4.NhSoXUMPK2K})-#{VRD05emEwOF.NhSoXUMPK2K}
Pneumococal2 coverage,pjEAskZmwVs,Pneumococal2 coverage,#{xiaJWeXNYif.ieuodyY5ybC},#{pMbuvKvH4rg.NhSoXUMPK2K}
Pneumonia incidence rate under 5 years ,rDt2WCGOaNS,Pneumonia incidence <5y,#{PHXPCqYlS5v.lHl2rmXpHse},#{KNrK5VWTZkx.NhSoXUMPK2K}
Population  5 -15 years ,teqmL38ntWd,Population  5 -15 years ,#{iYiM4K22JwD.NhSoXUMPK2K}-#{KNrK5VWTZkx.NhSoXUMPK2K},1
Population  6-23 Months (30 % of < 5yrs),IN2v5E9RtUD,6-23 Months (30 % of < 5y,#{KNrK5VWTZkx.NhSoXUMPK2K}*(30/100),1
Population 12-59 Months (80% of < 5yrs),mzHTre1yUfv,Population 12-59 Months ,#{KNrK5VWTZkx.NhSoXUMPK2K}*80/100,1
Population 15-24 years of the total Population,B0y58DpGWdW,%Population 15-24 years,#{EaR7DO0Fz9g.NhSoXUMPK2K},#{NLKRV7bYbVy.NhSoXUMPK2K}
Population 25-59 years to the total Population,PRmlwO3ht2T,% 25-59 years of popn,#{G5AHuOAotQq.NhSoXUMPK2K},#{NLKRV7bYbVy.NhSoXUMPK2K}
Population 6-11 Months (50% of <1yrs),KKAQM3KkDtD,Population 6-11 Months,#{pMbuvKvH4rg.NhSoXUMPK2K}*50/100,1
Population 6-59 Months (90% of < 5yrs),HNt8E6osxJg,Population 6-59 Months,#{KNrK5VWTZkx.NhSoXUMPK2K}*90/100,1
Population 60+ years of  the total Population,dH7s8QGAcfX,% Population 60+ year,#{X488n9G9I4x.NhSoXUMPK2K},#{NLKRV7bYbVy.NhSoXUMPK2K}
Population Male of  the total Population,mi8PCw0akC3,% Population Male of Popn,#{Mpv8crmnOzy.NhSoXUMPK2K},#{NLKRV7bYbVy.NhSoXUMPK2K}
Population female of  the total Population,lt3ceZWgUhD,% Population female Popn,#{w5ltvnNihEZ.NhSoXUMPK2K},#{NLKRV7bYbVy.NhSoXUMPK2K}
Postnatal Coverage(New and Revisits) Revised,iRahFc4dXnr,Postnatal Coverage(New and Revisits) Revised,#{Gw8C0uUQade} + #{pp5FTNgUXmf},#{JOnT3OiMd5o} + #{rYn8RCcHJg1} + #{wZtDYVBa41h}
PrEP New,yWqmHkilEDc,PrEP New,#{TtvO6ol7Kq7} + #{tvkamFcbjEa} + #{m5tdPqpqQKa} + #{cucGQCux2ld} + #{IibqwYumcez},1
PrEP_Proportion Discordant Couple Testing HIV+ While on PrEP ,dBMQky5hHNP,PrEP_Prop Disc Couple HIV+ PrEP ,(#{GbvylxKPrHp.ZKbW6MLnAcC} + #{GbvylxKPrHp.sraE4rIg9VH} + #{GbvylxKPrHp.aqj7xj4GnPM} + #{GbvylxKPrHp.zE8Bz9GRDDG} + #{GbvylxKPrHp.wd81pJR3DHd} + #{GbvylxKPrHp.ymUuvLjWL5k} + #{GbvylxKPrHp.YiMsc4BPg3g} + #{GbvylxKPrHp.Ht2wNXVwbLA}),(#{Tikx6x3xghp.ZKbW6MLnAcC} + #{Tikx6x3xghp.sraE4rIg9VH} + #{Tikx6x3xghp.aqj7xj4GnPM} + #{Tikx6x3xghp.zE8Bz9GRDDG} + #{Tikx6x3xghp.wd81pJR3DHd} + #{Tikx6x3xghp.ymUuvLjWL5k} + #{Tikx6x3xghp.YiMsc4BPg3g} + #{Tikx6x3xghp.Ht2wNXVwbLA} + #{DWOXcLFInzC.ZKbW6MLnAcC} + #{DWOXcLFInzC.sraE4rIg9VH} + #{DWOXcLFInzC.aqj7xj4GnPM} + #{DWOXcLFInzC.zE8Bz9GRDDG} + #{DWOXcLFInzC.wd81pJR3DHd} + #{DWOXcLFInzC.ymUuvLjWL5k} + #{DWOXcLFInzC.YiMsc4BPg3g} + #{DWOXcLFInzC.Ht2wNXVwbLA} + #{SvUs6rPKruy.ZKbW6MLnAcC} + #{SvUs6rPKruy.sraE4rIg9VH} + #{SvUs6rPKruy.aqj7xj4GnPM} + #{SvUs6rPKruy.zE8Bz9GRDDG} + #{SvUs6rPKruy.wd81pJR3DHd} + #{SvUs6rPKruy.ymUuvLjWL5k} + #{SvUs6rPKruy.YiMsc4BPg3g} + #{SvUs6rPKruy.Ht2wNXVwbLA} + #{eUXDNCzAWO7.ZKbW6MLnAcC} + #{eUXDNCzAWO7.sraE4rIg9VH} + #{eUXDNCzAWO7.aqj7xj4GnPM} + #{eUXDNCzAWO7.zE8Bz9GRDDG} + #{eUXDNCzAWO7.wd81pJR3DHd} + #{eUXDNCzAWO7.ymUuvLjWL5k} + #{eUXDNCzAWO7.YiMsc4BPg3g} + #{eUXDNCzAWO7.Ht2wNXVwbLA} + #{uJGBLoQwCb4.ZKbW6MLnAcC} + #{uJGBLoQwCb4.sraE4rIg9VH} + #{uJGBLoQwCb4.aqj7xj4GnPM} + #{uJGBLoQwCb4.zE8Bz9GRDDG} + #{uJGBLoQwCb4.wd81pJR3DHd} + #{uJGBLoQwCb4.ymUuvLjWL5k} + #{uJGBLoQwCb4.YiMsc4BPg3g} + #{uJGBLoQwCb4.Ht2wNXVwbLA})
PrEP_Proportion FSW Testing HIV+ While on PrEP,zkHnBDrPvN8,PrEP_Prop FSW Testing HIV+ While on PrEP,(#{ppfuNWKmJpU.ZKbW6MLnAcC} + #{ppfuNWKmJpU.sraE4rIg9VH} + #{ppfuNWKmJpU.aqj7xj4GnPM} + #{ppfuNWKmJpU.zE8Bz9GRDDG} + #{ppfuNWKmJpU.wd81pJR3DHd} + #{ppfuNWKmJpU.ymUuvLjWL5k} + #{ppfuNWKmJpU.YiMsc4BPg3g} + #{ppfuNWKmJpU.Ht2wNXVwbLA}),(#{Tikx6x3xghp.ZKbW6MLnAcC} + #{Tikx6x3xghp.sraE4rIg9VH} + #{Tikx6x3xghp.aqj7xj4GnPM} + #{Tikx6x3xghp.zE8Bz9GRDDG} + #{Tikx6x3xghp.wd81pJR3DHd} + #{Tikx6x3xghp.ymUuvLjWL5k} + #{Tikx6x3xghp.YiMsc4BPg3g} + #{Tikx6x3xghp.Ht2wNXVwbLA} + #{DWOXcLFInzC.ZKbW6MLnAcC} + #{DWOXcLFInzC.sraE4rIg9VH} + #{DWOXcLFInzC.aqj7xj4GnPM} + #{DWOXcLFInzC.zE8Bz9GRDDG} + #{DWOXcLFInzC.wd81pJR3DHd} + #{DWOXcLFInzC.ymUuvLjWL5k} + #{DWOXcLFInzC.YiMsc4BPg3g} + #{DWOXcLFInzC.Ht2wNXVwbLA} + #{SvUs6rPKruy.ZKbW6MLnAcC} + #{SvUs6rPKruy.sraE4rIg9VH} + #{SvUs6rPKruy.aqj7xj4GnPM} + #{SvUs6rPKruy.zE8Bz9GRDDG} + #{SvUs6rPKruy.wd81pJR3DHd} + #{SvUs6rPKruy.ymUuvLjWL5k} + #{SvUs6rPKruy.YiMsc4BPg3g} + #{SvUs6rPKruy.Ht2wNXVwbLA} + #{eUXDNCzAWO7.ZKbW6MLnAcC} + #{eUXDNCzAWO7.sraE4rIg9VH} + #{eUXDNCzAWO7.aqj7xj4GnPM} + #{eUXDNCzAWO7.zE8Bz9GRDDG} + #{eUXDNCzAWO7.wd81pJR3DHd} + #{eUXDNCzAWO7.ymUuvLjWL5k} + #{eUXDNCzAWO7.YiMsc4BPg3g} + #{eUXDNCzAWO7.Ht2wNXVwbLA} + #{uJGBLoQwCb4.ZKbW6MLnAcC} + #{uJGBLoQwCb4.sraE4rIg9VH} + #{uJGBLoQwCb4.aqj7xj4GnPM} + #{uJGBLoQwCb4.zE8Bz9GRDDG} + #{uJGBLoQwCb4.wd81pJR3DHd} + #{uJGBLoQwCb4.ymUuvLjWL5k} + #{uJGBLoQwCb4.YiMsc4BPg3g} + #{uJGBLoQwCb4.Ht2wNXVwbLA})
PrEP_Proportion General Population Testing HIV+ While on PrEP,Z8qffDXF7cU,PrEP_Prop Gen Pop Testing HIV+ PrEP,(#{AysMjoh9ISq.ZKbW6MLnAcC} + #{AysMjoh9ISq.sraE4rIg9VH} + #{AysMjoh9ISq.aqj7xj4GnPM} + #{AysMjoh9ISq.zE8Bz9GRDDG} + #{AysMjoh9ISq.wd81pJR3DHd} + #{AysMjoh9ISq.ymUuvLjWL5k} + #{AysMjoh9ISq.YiMsc4BPg3g} + #{AysMjoh9ISq.Ht2wNXVwbLA}),(#{Tikx6x3xghp.ZKbW6MLnAcC} + #{Tikx6x3xghp.sraE4rIg9VH} + #{Tikx6x3xghp.aqj7xj4GnPM} + #{Tikx6x3xghp.zE8Bz9GRDDG} + #{Tikx6x3xghp.wd81pJR3DHd} + #{Tikx6x3xghp.ymUuvLjWL5k} + #{Tikx6x3xghp.YiMsc4BPg3g} + #{Tikx6x3xghp.Ht2wNXVwbLA} + #{DWOXcLFInzC.ZKbW6MLnAcC} + #{DWOXcLFInzC.sraE4rIg9VH} + #{DWOXcLFInzC.aqj7xj4GnPM} + #{DWOXcLFInzC.zE8Bz9GRDDG} + #{DWOXcLFInzC.wd81pJR3DHd} + #{DWOXcLFInzC.ymUuvLjWL5k} + #{DWOXcLFInzC.YiMsc4BPg3g} + #{DWOXcLFInzC.Ht2wNXVwbLA} + #{SvUs6rPKruy.ZKbW6MLnAcC} + #{SvUs6rPKruy.sraE4rIg9VH} + #{SvUs6rPKruy.aqj7xj4GnPM} + #{SvUs6rPKruy.zE8Bz9GRDDG} + #{SvUs6rPKruy.wd81pJR3DHd} + #{SvUs6rPKruy.ymUuvLjWL5k} + #{SvUs6rPKruy.YiMsc4BPg3g} + #{SvUs6rPKruy.Ht2wNXVwbLA} + #{eUXDNCzAWO7.ZKbW6MLnAcC} + #{eUXDNCzAWO7.sraE4rIg9VH} + #{eUXDNCzAWO7.aqj7xj4GnPM} + #{eUXDNCzAWO7.zE8Bz9GRDDG} + #{eUXDNCzAWO7.wd81pJR3DHd} + #{eUXDNCzAWO7.ymUuvLjWL5k} + #{eUXDNCzAWO7.YiMsc4BPg3g} + #{eUXDNCzAWO7.Ht2wNXVwbLA} + #{uJGBLoQwCb4.ZKbW6MLnAcC} + #{uJGBLoQwCb4.sraE4rIg9VH} + #{uJGBLoQwCb4.aqj7xj4GnPM} + #{uJGBLoQwCb4.zE8Bz9GRDDG} + #{uJGBLoQwCb4.wd81pJR3DHd} + #{uJGBLoQwCb4.ymUuvLjWL5k} + #{uJGBLoQwCb4.YiMsc4BPg3g} + #{uJGBLoQwCb4.Ht2wNXVwbLA})
PrEP_Proportion MSMTesting HIV+ While on PrEP,eoSgHk3cDMm,PrEP_Prop MSM HIV+ on PrEP,(#{uHuVudVThh8.ZKbW6MLnAcC} + #{uHuVudVThh8.sraE4rIg9VH} + #{uHuVudVThh8.aqj7xj4GnPM} + #{uHuVudVThh8.zE8Bz9GRDDG} + #{uHuVudVThh8.wd81pJR3DHd} + #{uHuVudVThh8.ymUuvLjWL5k} + #{uHuVudVThh8.YiMsc4BPg3g} + #{uHuVudVThh8.Ht2wNXVwbLA}),(#{Tikx6x3xghp.ZKbW6MLnAcC} + #{Tikx6x3xghp.sraE4rIg9VH} + #{Tikx6x3xghp.aqj7xj4GnPM} + #{Tikx6x3xghp.zE8Bz9GRDDG} + #{Tikx6x3xghp.wd81pJR3DHd} + #{Tikx6x3xghp.ymUuvLjWL5k} + #{Tikx6x3xghp.YiMsc4BPg3g} + #{Tikx6x3xghp.Ht2wNXVwbLA} + #{DWOXcLFInzC.ZKbW6MLnAcC} + #{DWOXcLFInzC.sraE4rIg9VH} + #{DWOXcLFInzC.aqj7xj4GnPM} + #{DWOXcLFInzC.zE8Bz9GRDDG} + #{DWOXcLFInzC.wd81pJR3DHd} + #{DWOXcLFInzC.ymUuvLjWL5k} + #{DWOXcLFInzC.YiMsc4BPg3g} + #{DWOXcLFInzC.Ht2wNXVwbLA} + #{SvUs6rPKruy.ZKbW6MLnAcC} + #{SvUs6rPKruy.sraE4rIg9VH} + #{SvUs6rPKruy.aqj7xj4GnPM} + #{SvUs6rPKruy.zE8Bz9GRDDG} + #{SvUs6rPKruy.wd81pJR3DHd} + #{SvUs6rPKruy.ymUuvLjWL5k} + #{SvUs6rPKruy.YiMsc4BPg3g} + #{SvUs6rPKruy.Ht2wNXVwbLA} + #{eUXDNCzAWO7.ZKbW6MLnAcC} + #{eUXDNCzAWO7.sraE4rIg9VH} + #{eUXDNCzAWO7.aqj7xj4GnPM} + #{eUXDNCzAWO7.zE8Bz9GRDDG} + #{eUXDNCzAWO7.wd81pJR3DHd} + #{eUXDNCzAWO7.ymUuvLjWL5k} + #{eUXDNCzAWO7.YiMsc4BPg3g} + #{eUXDNCzAWO7.Ht2wNXVwbLA} + #{uJGBLoQwCb4.ZKbW6MLnAcC} + #{uJGBLoQwCb4.sraE4rIg9VH} + #{uJGBLoQwCb4.aqj7xj4GnPM} + #{uJGBLoQwCb4.zE8Bz9GRDDG} + #{uJGBLoQwCb4.wd81pJR3DHd} + #{uJGBLoQwCb4.ymUuvLjWL5k} + #{uJGBLoQwCb4.YiMsc4BPg3g} + #{uJGBLoQwCb4.Ht2wNXVwbLA})
PrEP_Proportion PWID Testing HIV+ While on PrEP,y6iQQxcZDeG,PrEP_Prop PWID HIV+ PrEP,(#{I7UYjUus5l3.ZKbW6MLnAcC} + #{I7UYjUus5l3.sraE4rIg9VH} + #{I7UYjUus5l3.aqj7xj4GnPM} + #{I7UYjUus5l3.zE8Bz9GRDDG} + #{I7UYjUus5l3.wd81pJR3DHd} + #{I7UYjUus5l3.ymUuvLjWL5k} + #{I7UYjUus5l3.YiMsc4BPg3g} + #{I7UYjUus5l3.Ht2wNXVwbLA}),(#{Tikx6x3xghp.ZKbW6MLnAcC} + #{Tikx6x3xghp.sraE4rIg9VH} + #{Tikx6x3xghp.aqj7xj4GnPM} + #{Tikx6x3xghp.zE8Bz9GRDDG} + #{Tikx6x3xghp.wd81pJR3DHd} + #{Tikx6x3xghp.ymUuvLjWL5k} + #{Tikx6x3xghp.YiMsc4BPg3g} + #{Tikx6x3xghp.Ht2wNXVwbLA} + #{DWOXcLFInzC.ZKbW6MLnAcC} + #{DWOXcLFInzC.sraE4rIg9VH} + #{DWOXcLFInzC.aqj7xj4GnPM} + #{DWOXcLFInzC.zE8Bz9GRDDG} + #{DWOXcLFInzC.wd81pJR3DHd} + #{DWOXcLFInzC.ymUuvLjWL5k} + #{DWOXcLFInzC.YiMsc4BPg3g} + #{DWOXcLFInzC.Ht2wNXVwbLA} + #{SvUs6rPKruy.ZKbW6MLnAcC} + #{SvUs6rPKruy.sraE4rIg9VH} + #{SvUs6rPKruy.aqj7xj4GnPM} + #{SvUs6rPKruy.zE8Bz9GRDDG} + #{SvUs6rPKruy.wd81pJR3DHd} + #{SvUs6rPKruy.ymUuvLjWL5k} + #{SvUs6rPKruy.YiMsc4BPg3g} + #{SvUs6rPKruy.Ht2wNXVwbLA} + #{eUXDNCzAWO7.ZKbW6MLnAcC} + #{eUXDNCzAWO7.sraE4rIg9VH} + #{eUXDNCzAWO7.aqj7xj4GnPM} + #{eUXDNCzAWO7.zE8Bz9GRDDG} + #{eUXDNCzAWO7.wd81pJR3DHd} + #{eUXDNCzAWO7.ymUuvLjWL5k} + #{eUXDNCzAWO7.YiMsc4BPg3g} + #{eUXDNCzAWO7.Ht2wNXVwbLA} + #{uJGBLoQwCb4.ZKbW6MLnAcC} + #{uJGBLoQwCb4.sraE4rIg9VH} + #{uJGBLoQwCb4.aqj7xj4GnPM} + #{uJGBLoQwCb4.zE8Bz9GRDDG} + #{uJGBLoQwCb4.wd81pJR3DHd} + #{uJGBLoQwCb4.ymUuvLjWL5k} + #{uJGBLoQwCb4.YiMsc4BPg3g} + #{uJGBLoQwCb4.Ht2wNXVwbLA})
PrEP_Proportion Testing HIV+ While on PrEP,K82gGprccyI,PrEP_Proportion Testing HIV+ While on PrEP,(#{GbvylxKPrHp.ZKbW6MLnAcC} + #{GbvylxKPrHp.sraE4rIg9VH} + #{GbvylxKPrHp.aqj7xj4GnPM} + #{GbvylxKPrHp.zE8Bz9GRDDG} + #{GbvylxKPrHp.wd81pJR3DHd} + #{GbvylxKPrHp.ymUuvLjWL5k} + #{GbvylxKPrHp.YiMsc4BPg3g} + #{GbvylxKPrHp.Ht2wNXVwbLA} + #{ppfuNWKmJpU.ZKbW6MLnAcC} + #{ppfuNWKmJpU.sraE4rIg9VH} + #{ppfuNWKmJpU.aqj7xj4GnPM} + #{ppfuNWKmJpU.zE8Bz9GRDDG} + #{ppfuNWKmJpU.wd81pJR3DHd} + #{ppfuNWKmJpU.ymUuvLjWL5k} + #{ppfuNWKmJpU.YiMsc4BPg3g} + #{ppfuNWKmJpU.Ht2wNXVwbLA} + #{AysMjoh9ISq.ZKbW6MLnAcC} + #{AysMjoh9ISq.sraE4rIg9VH} + #{AysMjoh9ISq.aqj7xj4GnPM} + #{AysMjoh9ISq.zE8Bz9GRDDG} + #{AysMjoh9ISq.wd81pJR3DHd} + #{AysMjoh9ISq.ymUuvLjWL5k} + #{AysMjoh9ISq.YiMsc4BPg3g} + #{AysMjoh9ISq.Ht2wNXVwbLA} + #{uHuVudVThh8.ZKbW6MLnAcC} + #{uHuVudVThh8.sraE4rIg9VH} + #{uHuVudVThh8.aqj7xj4GnPM} + #{uHuVudVThh8.zE8Bz9GRDDG} + #{uHuVudVThh8.wd81pJR3DHd} + #{uHuVudVThh8.ymUuvLjWL5k} + #{uHuVudVThh8.YiMsc4BPg3g} + #{uHuVudVThh8.Ht2wNXVwbLA} + #{I7UYjUus5l3.ZKbW6MLnAcC} + #{I7UYjUus5l3.sraE4rIg9VH} + #{I7UYjUus5l3.aqj7xj4GnPM} + #{I7UYjUus5l3.zE8Bz9GRDDG} + #{I7UYjUus5l3.wd81pJR3DHd} + #{I7UYjUus5l3.ymUuvLjWL5k} + #{I7UYjUus5l3.YiMsc4BPg3g} + #{I7UYjUus5l3.Ht2wNXVwbLA}),(#{Tikx6x3xghp.ZKbW6MLnAcC} + #{Tikx6x3xghp.sraE4rIg9VH} + #{Tikx6x3xghp.aqj7xj4GnPM} + #{Tikx6x3xghp.zE8Bz9GRDDG} + #{Tikx6x3xghp.wd81pJR3DHd} + #{Tikx6x3xghp.ymUuvLjWL5k} + #{Tikx6x3xghp.YiMsc4BPg3g} + #{Tikx6x3xghp.Ht2wNXVwbLA} + #{DWOXcLFInzC.ZKbW6MLnAcC} + #{DWOXcLFInzC.sraE4rIg9VH} + #{DWOXcLFInzC.aqj7xj4GnPM} + #{DWOXcLFInzC.zE8Bz9GRDDG} + #{DWOXcLFInzC.wd81pJR3DHd} + #{DWOXcLFInzC.ymUuvLjWL5k} + #{DWOXcLFInzC.YiMsc4BPg3g} + #{DWOXcLFInzC.Ht2wNXVwbLA} + #{SvUs6rPKruy.ZKbW6MLnAcC} + #{SvUs6rPKruy.sraE4rIg9VH} + #{SvUs6rPKruy.aqj7xj4GnPM} + #{SvUs6rPKruy.zE8Bz9GRDDG} + #{SvUs6rPKruy.wd81pJR3DHd} + #{SvUs6rPKruy.ymUuvLjWL5k} + #{SvUs6rPKruy.YiMsc4BPg3g} + #{SvUs6rPKruy.Ht2wNXVwbLA} + #{eUXDNCzAWO7.ZKbW6MLnAcC} + #{eUXDNCzAWO7.sraE4rIg9VH} + #{eUXDNCzAWO7.aqj7xj4GnPM} + #{eUXDNCzAWO7.zE8Bz9GRDDG} + #{eUXDNCzAWO7.wd81pJR3DHd} + #{eUXDNCzAWO7.ymUuvLjWL5k} + #{eUXDNCzAWO7.YiMsc4BPg3g} + #{eUXDNCzAWO7.Ht2wNXVwbLA} + #{uJGBLoQwCb4.ZKbW6MLnAcC} + #{uJGBLoQwCb4.sraE4rIg9VH} + #{uJGBLoQwCb4.aqj7xj4GnPM} + #{uJGBLoQwCb4.zE8Bz9GRDDG} + #{uJGBLoQwCb4.wd81pJR3DHd} + #{uJGBLoQwCb4.ymUuvLjWL5k} + #{uJGBLoQwCb4.YiMsc4BPg3g} + #{uJGBLoQwCb4.Ht2wNXVwbLA})
PrEP_Proportion of Discordant Couple Currently on PrEP,ZNZa9lx8xM8,PrEP_Prop Disc Couple Currently on PrEP,(#{Tikx6x3xghp.ZKbW6MLnAcC} + #{Tikx6x3xghp.sraE4rIg9VH} + #{Tikx6x3xghp.aqj7xj4GnPM} + #{Tikx6x3xghp.zE8Bz9GRDDG} + #{Tikx6x3xghp.wd81pJR3DHd} + #{Tikx6x3xghp.ymUuvLjWL5k} + #{Tikx6x3xghp.YiMsc4BPg3g} + #{Tikx6x3xghp.Ht2wNXVwbLA}),(#{Tikx6x3xghp.ZKbW6MLnAcC} + #{Tikx6x3xghp.sraE4rIg9VH} + #{Tikx6x3xghp.aqj7xj4GnPM} + #{Tikx6x3xghp.zE8Bz9GRDDG} + #{Tikx6x3xghp.wd81pJR3DHd} + #{Tikx6x3xghp.ymUuvLjWL5k} + #{Tikx6x3xghp.YiMsc4BPg3g} + #{Tikx6x3xghp.Ht2wNXVwbLA} + #{DWOXcLFInzC.ZKbW6MLnAcC} + #{DWOXcLFInzC.sraE4rIg9VH} + #{DWOXcLFInzC.aqj7xj4GnPM} + #{DWOXcLFInzC.zE8Bz9GRDDG} + #{DWOXcLFInzC.wd81pJR3DHd} + #{DWOXcLFInzC.ymUuvLjWL5k} + #{DWOXcLFInzC.YiMsc4BPg3g} + #{DWOXcLFInzC.Ht2wNXVwbLA} + #{SvUs6rPKruy.ZKbW6MLnAcC} + #{SvUs6rPKruy.sraE4rIg9VH} + #{SvUs6rPKruy.aqj7xj4GnPM} + #{SvUs6rPKruy.zE8Bz9GRDDG} + #{SvUs6rPKruy.wd81pJR3DHd} + #{SvUs6rPKruy.ymUuvLjWL5k} + #{SvUs6rPKruy.YiMsc4BPg3g} + #{SvUs6rPKruy.Ht2wNXVwbLA} + #{eUXDNCzAWO7.ZKbW6MLnAcC} + #{eUXDNCzAWO7.sraE4rIg9VH} + #{eUXDNCzAWO7.aqj7xj4GnPM} + #{eUXDNCzAWO7.zE8Bz9GRDDG} + #{eUXDNCzAWO7.wd81pJR3DHd} + #{eUXDNCzAWO7.ymUuvLjWL5k} + #{eUXDNCzAWO7.YiMsc4BPg3g} + #{eUXDNCzAWO7.Ht2wNXVwbLA} + #{uJGBLoQwCb4.ZKbW6MLnAcC} + #{uJGBLoQwCb4.sraE4rIg9VH} + #{uJGBLoQwCb4.aqj7xj4GnPM} + #{uJGBLoQwCb4.zE8Bz9GRDDG} + #{uJGBLoQwCb4.wd81pJR3DHd} + #{uJGBLoQwCb4.ymUuvLjWL5k} + #{uJGBLoQwCb4.YiMsc4BPg3g} + #{uJGBLoQwCb4.Ht2wNXVwbLA})
PrEP_Proportion of Eligible Discordant Couple Clients Started on PrEP,nHatpZYGuuE,PrEP_Prop Eligible Disc Cple Clients Start PrEP,(#{TtvO6ol7Kq7.sraE4rIg9VH} + #{TtvO6ol7Kq7.aqj7xj4GnPM} + #{TtvO6ol7Kq7.zE8Bz9GRDDG} + #{TtvO6ol7Kq7.wd81pJR3DHd} + #{TtvO6ol7Kq7.ymUuvLjWL5k} + #{TtvO6ol7Kq7.YiMsc4BPg3g} + #{TtvO6ol7Kq7.Ht2wNXVwbLA}),(#{d5oDbyxUZNw.ZKbW6MLnAcC} + #{d5oDbyxUZNw.sraE4rIg9VH} + #{d5oDbyxUZNw.aqj7xj4GnPM} + #{d5oDbyxUZNw.zE8Bz9GRDDG} + #{d5oDbyxUZNw.wd81pJR3DHd} + #{d5oDbyxUZNw.ymUuvLjWL5k} + #{d5oDbyxUZNw.YiMsc4BPg3g} + #{d5oDbyxUZNw.Ht2wNXVwbLA})
PrEP_Proportion of Eligible FSW  Clients Started on PrEP,MMN2o2jaoRA,PrEP_Proportion of Eligible FSW Started on PrEP,(#{tvkamFcbjEa.ZKbW6MLnAcC} + #{tvkamFcbjEa.sraE4rIg9VH} + #{tvkamFcbjEa.aqj7xj4GnPM} + #{tvkamFcbjEa.zE8Bz9GRDDG} + #{tvkamFcbjEa.wd81pJR3DHd} + #{tvkamFcbjEa.ymUuvLjWL5k} + #{tvkamFcbjEa.YiMsc4BPg3g} + #{tvkamFcbjEa.Ht2wNXVwbLA}),(#{GK5eHJVjf45.ZKbW6MLnAcC} + #{GK5eHJVjf45.sraE4rIg9VH} + #{GK5eHJVjf45.aqj7xj4GnPM} + #{GK5eHJVjf45.zE8Bz9GRDDG} + #{GK5eHJVjf45.wd81pJR3DHd} + #{GK5eHJVjf45.ymUuvLjWL5k} + #{GK5eHJVjf45.YiMsc4BPg3g} + #{GK5eHJVjf45.Ht2wNXVwbLA})
PrEP_Proportion of Eligible General Population  Clients Started on PrEP,XUCq9AT1b8T,PrEP_Prop of Gen Popln Eligible Started on PrEP,(#{m5tdPqpqQKa.ZKbW6MLnAcC} + #{m5tdPqpqQKa.sraE4rIg9VH} + #{m5tdPqpqQKa.aqj7xj4GnPM} + #{m5tdPqpqQKa.zE8Bz9GRDDG}),(#{TmJeb0ttJXO.ZKbW6MLnAcC} + #{TmJeb0ttJXO.sraE4rIg9VH} + #{TmJeb0ttJXO.aqj7xj4GnPM} + #{TmJeb0ttJXO.zE8Bz9GRDDG} + #{TmJeb0ttJXO.wd81pJR3DHd} + #{TmJeb0ttJXO.ymUuvLjWL5k} + #{TmJeb0ttJXO.YiMsc4BPg3g} + #{TmJeb0ttJXO.Ht2wNXVwbLA})
PrEP_Proportion of Eligible MSM  Clients Started on PrEP,tqV5yHePx1H, PrEP_Prop Eligible MSM  Clients Started on PrEP,( + #{cucGQCux2ld.ZKbW6MLnAcC} + #{cucGQCux2ld.sraE4rIg9VH} + #{cucGQCux2ld.aqj7xj4GnPM} + #{cucGQCux2ld.zE8Bz9GRDDG} + #{cucGQCux2ld.wd81pJR3DHd} + #{cucGQCux2ld.ymUuvLjWL5k} + #{cucGQCux2ld.YiMsc4BPg3g} + #{cucGQCux2ld.Ht2wNXVwbLA}),(#{RAxC6dok0ZU.ZKbW6MLnAcC} + #{RAxC6dok0ZU.sraE4rIg9VH} + #{RAxC6dok0ZU.aqj7xj4GnPM} + #{RAxC6dok0ZU.zE8Bz9GRDDG} + #{RAxC6dok0ZU.wd81pJR3DHd} + #{RAxC6dok0ZU.ymUuvLjWL5k} + #{RAxC6dok0ZU.YiMsc4BPg3g} + #{RAxC6dok0ZU.Ht2wNXVwbLA})
PrEP_Proportion of Eligible PWID  Clients Started on PrEP,DJEnXUR31yp,PrEP_Prop Eligible PWID Started on PrEP,(#{IibqwYumcez.ZKbW6MLnAcC} + #{IibqwYumcez.sraE4rIg9VH} + #{IibqwYumcez.aqj7xj4GnPM} + #{IibqwYumcez.zE8Bz9GRDDG} + #{IibqwYumcez.wd81pJR3DHd} + #{IibqwYumcez.ymUuvLjWL5k} + #{IibqwYumcez.YiMsc4BPg3g} + #{IibqwYumcez.Ht2wNXVwbLA}),(#{N9v5DeqnxRo.ZKbW6MLnAcC} + #{N9v5DeqnxRo.sraE4rIg9VH} + #{N9v5DeqnxRo.aqj7xj4GnPM} + #{N9v5DeqnxRo.zE8Bz9GRDDG} + #{N9v5DeqnxRo.wd81pJR3DHd} + #{N9v5DeqnxRo.ymUuvLjWL5k} + #{N9v5DeqnxRo.YiMsc4BPg3g} + #{N9v5DeqnxRo.Ht2wNXVwbLA})
PrEP_Proportion of FSW Currently on PrEP,MYiGj6NbO3r,PrEP_Proportion of FSW Currently on PrEP,(#{Mc8JPUVVMfD.ZKbW6MLnAcC} + #{Mc8JPUVVMfD.sraE4rIg9VH} + #{Mc8JPUVVMfD.aqj7xj4GnPM} + #{Mc8JPUVVMfD.zE8Bz9GRDDG} + #{Mc8JPUVVMfD.wd81pJR3DHd} + #{Mc8JPUVVMfD.ymUuvLjWL5k} + #{Mc8JPUVVMfD.YiMsc4BPg3g} + #{Mc8JPUVVMfD.Ht2wNXVwbLA}),(#{Tikx6x3xghp.ZKbW6MLnAcC} + #{Tikx6x3xghp.sraE4rIg9VH} + #{Tikx6x3xghp.aqj7xj4GnPM} + #{Tikx6x3xghp.zE8Bz9GRDDG} + #{Tikx6x3xghp.wd81pJR3DHd} + #{Tikx6x3xghp.ymUuvLjWL5k} + #{Tikx6x3xghp.YiMsc4BPg3g} + #{Tikx6x3xghp.Ht2wNXVwbLA} + #{DWOXcLFInzC.ZKbW6MLnAcC} + #{DWOXcLFInzC.sraE4rIg9VH} + #{DWOXcLFInzC.aqj7xj4GnPM} + #{DWOXcLFInzC.zE8Bz9GRDDG} + #{DWOXcLFInzC.wd81pJR3DHd} + #{DWOXcLFInzC.ymUuvLjWL5k} + #{DWOXcLFInzC.YiMsc4BPg3g} + #{DWOXcLFInzC.Ht2wNXVwbLA} + #{SvUs6rPKruy.ZKbW6MLnAcC} + #{SvUs6rPKruy.sraE4rIg9VH} + #{SvUs6rPKruy.aqj7xj4GnPM} + #{SvUs6rPKruy.zE8Bz9GRDDG} + #{SvUs6rPKruy.wd81pJR3DHd} + #{SvUs6rPKruy.ymUuvLjWL5k} + #{SvUs6rPKruy.YiMsc4BPg3g} + #{SvUs6rPKruy.Ht2wNXVwbLA} + #{eUXDNCzAWO7.ZKbW6MLnAcC} + #{eUXDNCzAWO7.sraE4rIg9VH} + #{eUXDNCzAWO7.aqj7xj4GnPM} + #{eUXDNCzAWO7.zE8Bz9GRDDG} + #{eUXDNCzAWO7.wd81pJR3DHd} + #{eUXDNCzAWO7.ymUuvLjWL5k} + #{eUXDNCzAWO7.YiMsc4BPg3g} + #{eUXDNCzAWO7.Ht2wNXVwbLA} + #{uJGBLoQwCb4.ZKbW6MLnAcC} + #{uJGBLoQwCb4.sraE4rIg9VH} + #{uJGBLoQwCb4.aqj7xj4GnPM} + #{uJGBLoQwCb4.zE8Bz9GRDDG} + #{uJGBLoQwCb4.wd81pJR3DHd} + #{uJGBLoQwCb4.ymUuvLjWL5k} + #{uJGBLoQwCb4.YiMsc4BPg3g} + #{uJGBLoQwCb4.Ht2wNXVwbLA})
PrEP_Proportion of MSM Currently on PrEP,nE94gYXfhsa,PrEP_Proportion of MSM Currently on PrEP,(#{eUXDNCzAWO7.ZKbW6MLnAcC} + #{eUXDNCzAWO7.sraE4rIg9VH} + #{eUXDNCzAWO7.aqj7xj4GnPM} + #{eUXDNCzAWO7.zE8Bz9GRDDG} + #{eUXDNCzAWO7.wd81pJR3DHd} + #{eUXDNCzAWO7.ymUuvLjWL5k} + #{eUXDNCzAWO7.YiMsc4BPg3g} + #{eUXDNCzAWO7.Ht2wNXVwbLA}),(#{Tikx6x3xghp.ZKbW6MLnAcC} + #{Tikx6x3xghp.sraE4rIg9VH} + #{Tikx6x3xghp.aqj7xj4GnPM} + #{Tikx6x3xghp.zE8Bz9GRDDG} + #{Tikx6x3xghp.wd81pJR3DHd} + #{Tikx6x3xghp.ymUuvLjWL5k} + #{Tikx6x3xghp.YiMsc4BPg3g} + #{Tikx6x3xghp.Ht2wNXVwbLA} + #{DWOXcLFInzC.ZKbW6MLnAcC} + #{DWOXcLFInzC.sraE4rIg9VH} + #{DWOXcLFInzC.aqj7xj4GnPM} + #{DWOXcLFInzC.zE8Bz9GRDDG} + #{DWOXcLFInzC.wd81pJR3DHd} + #{DWOXcLFInzC.ymUuvLjWL5k} + #{DWOXcLFInzC.YiMsc4BPg3g} + #{DWOXcLFInzC.Ht2wNXVwbLA} + #{SvUs6rPKruy.ZKbW6MLnAcC} + #{SvUs6rPKruy.sraE4rIg9VH} + #{SvUs6rPKruy.aqj7xj4GnPM} + #{SvUs6rPKruy.zE8Bz9GRDDG} + #{SvUs6rPKruy.wd81pJR3DHd} + #{SvUs6rPKruy.ymUuvLjWL5k} + #{SvUs6rPKruy.YiMsc4BPg3g} + #{SvUs6rPKruy.Ht2wNXVwbLA} + #{eUXDNCzAWO7.ZKbW6MLnAcC} + #{eUXDNCzAWO7.sraE4rIg9VH} + #{eUXDNCzAWO7.aqj7xj4GnPM} + #{eUXDNCzAWO7.zE8Bz9GRDDG} + #{eUXDNCzAWO7.wd81pJR3DHd} + #{eUXDNCzAWO7.ymUuvLjWL5k} + #{eUXDNCzAWO7.YiMsc4BPg3g} + #{eUXDNCzAWO7.Ht2wNXVwbLA} + #{uJGBLoQwCb4.ZKbW6MLnAcC} + #{uJGBLoQwCb4.sraE4rIg9VH} + #{uJGBLoQwCb4.aqj7xj4GnPM} + #{uJGBLoQwCb4.zE8Bz9GRDDG} + #{uJGBLoQwCb4.wd81pJR3DHd} + #{uJGBLoQwCb4.ymUuvLjWL5k} + #{uJGBLoQwCb4.YiMsc4BPg3g} + #{uJGBLoQwCb4.Ht2wNXVwbLA})
PrEP_Proportion of PWID Currently on PrEP,GdYh0ZFjOYG,PrEP_Proportion of PWID Currently on PrEP,(#{uJGBLoQwCb4.ZKbW6MLnAcC} + #{uJGBLoQwCb4.sraE4rIg9VH} + #{uJGBLoQwCb4.aqj7xj4GnPM} + #{uJGBLoQwCb4.zE8Bz9GRDDG} + #{uJGBLoQwCb4.wd81pJR3DHd} + #{uJGBLoQwCb4.ymUuvLjWL5k} + #{uJGBLoQwCb4.YiMsc4BPg3g} + #{uJGBLoQwCb4.Ht2wNXVwbLA}),(#{Tikx6x3xghp.ZKbW6MLnAcC} + #{Tikx6x3xghp.sraE4rIg9VH} + #{Tikx6x3xghp.aqj7xj4GnPM} + #{Tikx6x3xghp.zE8Bz9GRDDG} + #{Tikx6x3xghp.wd81pJR3DHd} + #{Tikx6x3xghp.ymUuvLjWL5k} + #{Tikx6x3xghp.YiMsc4BPg3g} + #{Tikx6x3xghp.Ht2wNXVwbLA} + #{DWOXcLFInzC.ZKbW6MLnAcC} + #{DWOXcLFInzC.sraE4rIg9VH} + #{DWOXcLFInzC.aqj7xj4GnPM} + #{DWOXcLFInzC.zE8Bz9GRDDG} + #{DWOXcLFInzC.wd81pJR3DHd} + #{DWOXcLFInzC.ymUuvLjWL5k} + #{DWOXcLFInzC.YiMsc4BPg3g} + #{DWOXcLFInzC.Ht2wNXVwbLA} + #{SvUs6rPKruy.ZKbW6MLnAcC} + #{SvUs6rPKruy.sraE4rIg9VH} + #{SvUs6rPKruy.aqj7xj4GnPM} + #{SvUs6rPKruy.zE8Bz9GRDDG} + #{SvUs6rPKruy.wd81pJR3DHd} + #{SvUs6rPKruy.ymUuvLjWL5k} + #{SvUs6rPKruy.YiMsc4BPg3g} + #{SvUs6rPKruy.Ht2wNXVwbLA} + #{eUXDNCzAWO7.ZKbW6MLnAcC} + #{eUXDNCzAWO7.sraE4rIg9VH} + #{eUXDNCzAWO7.aqj7xj4GnPM} + #{eUXDNCzAWO7.zE8Bz9GRDDG} + #{eUXDNCzAWO7.wd81pJR3DHd} + #{eUXDNCzAWO7.ymUuvLjWL5k} + #{eUXDNCzAWO7.YiMsc4BPg3g} + #{eUXDNCzAWO7.Ht2wNXVwbLA} + #{uJGBLoQwCb4.ZKbW6MLnAcC} + #{uJGBLoQwCb4.sraE4rIg9VH} + #{uJGBLoQwCb4.aqj7xj4GnPM} + #{uJGBLoQwCb4.zE8Bz9GRDDG} + #{uJGBLoQwCb4.wd81pJR3DHd} + #{uJGBLoQwCb4.ymUuvLjWL5k} + #{uJGBLoQwCb4.YiMsc4BPg3g} + #{uJGBLoQwCb4.Ht2wNXVwbLA})
PrEP_Proportion of Total Eligible Clients Started on PrEP,xNesNntwcTe,PrEP_Proportion of Eligible Clients Start on PrEP,(#{TtvO6ol7Kq7.ZKbW6MLnAcC} + #{TtvO6ol7Kq7.sraE4rIg9VH} + #{TtvO6ol7Kq7.aqj7xj4GnPM} + #{TtvO6ol7Kq7.zE8Bz9GRDDG} + #{TtvO6ol7Kq7.wd81pJR3DHd} + #{TtvO6ol7Kq7.ymUuvLjWL5k} + #{TtvO6ol7Kq7.YiMsc4BPg3g} + #{TtvO6ol7Kq7.Ht2wNXVwbLA} + #{tvkamFcbjEa.ZKbW6MLnAcC} + #{tvkamFcbjEa.sraE4rIg9VH} + #{tvkamFcbjEa.aqj7xj4GnPM} + #{tvkamFcbjEa.zE8Bz9GRDDG} + #{tvkamFcbjEa.wd81pJR3DHd} + #{tvkamFcbjEa.ymUuvLjWL5k} + #{tvkamFcbjEa.YiMsc4BPg3g} + #{tvkamFcbjEa.Ht2wNXVwbLA} + #{m5tdPqpqQKa.ZKbW6MLnAcC} + #{m5tdPqpqQKa.sraE4rIg9VH} + #{m5tdPqpqQKa.aqj7xj4GnPM} + #{m5tdPqpqQKa.zE8Bz9GRDDG} + #{m5tdPqpqQKa.wd81pJR3DHd} + #{m5tdPqpqQKa.ymUuvLjWL5k} + #{m5tdPqpqQKa.YiMsc4BPg3g} + #{m5tdPqpqQKa.Ht2wNXVwbLA} + #{cucGQCux2ld.ZKbW6MLnAcC} + #{cucGQCux2ld.sraE4rIg9VH} + #{cucGQCux2ld.aqj7xj4GnPM} + #{cucGQCux2ld.zE8Bz9GRDDG} + #{cucGQCux2ld.wd81pJR3DHd} + #{cucGQCux2ld.ymUuvLjWL5k} + #{cucGQCux2ld.YiMsc4BPg3g} + #{cucGQCux2ld.Ht2wNXVwbLA} + #{IibqwYumcez.ZKbW6MLnAcC} + #{IibqwYumcez.sraE4rIg9VH} + #{IibqwYumcez.aqj7xj4GnPM} + #{IibqwYumcez.zE8Bz9GRDDG} + #{IibqwYumcez.wd81pJR3DHd} + #{IibqwYumcez.ymUuvLjWL5k} + #{IibqwYumcez.YiMsc4BPg3g}),(#{TmJeb0ttJXO.ZKbW6MLnAcC} + #{TmJeb0ttJXO.sraE4rIg9VH} + #{TmJeb0ttJXO.aqj7xj4GnPM} + #{TmJeb0ttJXO.zE8Bz9GRDDG} + #{TmJeb0ttJXO.wd81pJR3DHd} + #{TmJeb0ttJXO.ymUuvLjWL5k} + #{TmJeb0ttJXO.YiMsc4BPg3g} + #{TmJeb0ttJXO.Ht2wNXVwbLA} + #{GK5eHJVjf45.ZKbW6MLnAcC} + #{GK5eHJVjf45.sraE4rIg9VH} + #{GK5eHJVjf45.aqj7xj4GnPM} + #{GK5eHJVjf45.zE8Bz9GRDDG} + #{GK5eHJVjf45.wd81pJR3DHd} + #{GK5eHJVjf45.ymUuvLjWL5k} + #{GK5eHJVjf45.YiMsc4BPg3g} + #{GK5eHJVjf45.Ht2wNXVwbLA} + #{N9v5DeqnxRo.ZKbW6MLnAcC} + #{N9v5DeqnxRo.sraE4rIg9VH} + #{N9v5DeqnxRo.aqj7xj4GnPM} + #{N9v5DeqnxRo.zE8Bz9GRDDG} + #{N9v5DeqnxRo.wd81pJR3DHd} + #{N9v5DeqnxRo.ymUuvLjWL5k} + #{N9v5DeqnxRo.YiMsc4BPg3g} + #{N9v5DeqnxRo.Ht2wNXVwbLA} + #{d5oDbyxUZNw.ZKbW6MLnAcC} + #{d5oDbyxUZNw.sraE4rIg9VH} + #{d5oDbyxUZNw.aqj7xj4GnPM} + #{d5oDbyxUZNw.zE8Bz9GRDDG} + #{d5oDbyxUZNw.wd81pJR3DHd} + #{d5oDbyxUZNw.ymUuvLjWL5k} + #{d5oDbyxUZNw.YiMsc4BPg3g} + #{d5oDbyxUZNw.Ht2wNXVwbLA} + #{RAxC6dok0ZU.ZKbW6MLnAcC} + #{RAxC6dok0ZU.sraE4rIg9VH} + #{RAxC6dok0ZU.aqj7xj4GnPM} + #{RAxC6dok0ZU.zE8Bz9GRDDG} + #{RAxC6dok0ZU.wd81pJR3DHd} + #{RAxC6dok0ZU.ymUuvLjWL5k} + #{RAxC6dok0ZU.YiMsc4BPg3g} + #{RAxC6dok0ZU.Ht2wNXVwbLA})
Pregnant women completing 4 ANC visits missed opportunities,qp8WQXmWtnr,4 ANC visits missed opportunities,#{uSxBUWnagGg} - #{Fz0LzxMT1vV},1
Pregnant women receiving iron supplement Performance,jJqVRc25AzM,Preg women iron supp Perf,#{QgjmGMoIcGu.NhSoXUMPK2K},#{S6ieq0XsOvT.ea7VHlwMkhH}
Pregnant women receiving two doses of IPT Performance,Yf8cWsXPKQO,Preg rec IPT2 Perf,#{EHGBrVPiG3N.NhSoXUMPK2K},#{x9AyqsnY1js.ea7VHlwMkhH}
Pregnant women starting on ART,gV0r6reEKKn,Preg women start ART,#{y6Vi9uqabo4.NhSoXUMPK2K},1
Previous HSSF Accounting rate,lcgAnzgYDzt,Previous HSSF Accounting ,#{oMWJpAyAIUh},#{uq2Izs9ZGT7}
Previous HSSF Utilization rate,foRxsoNwNDW,HSSF Utilization rate,#{LwS5qdivh4n},#{QLC6ejj76za}
Progestin only Pills Dispensed,HBLgR9KYOt7,Progestin only Pills Disp,#{vUp79dLJ4Ee.LkO5M9beZqG},1
Progestin only Pills Ending Balance,rUGZUiy3R2C,Progestin only Pills EB,#{vUp79dLJ4Ee.NvpLpQxmzkZ},1
Proportion  of  GBV survivors who expereinced SGBV ,GdI3HP60pPV,Proportion  of  GBV survivors who expGBV ,(#{ls9e3jKJcBJ.gLTZoiFaj1E} + #{ls9e3jKJcBJ.TcLzBcFPBnl} + #{ls9e3jKJcBJ.viFzvkU3gqq} + #{ls9e3jKJcBJ.cbN3KDb839s} + #{ls9e3jKJcBJ.nJGOv6yFskK} + #{ls9e3jKJcBJ.Tf8zVyOvc1j} + #{ls9e3jKJcBJ.fDce9OVthqj} + #{ls9e3jKJcBJ.hXtjmuYPdCx}),(#{ls9e3jKJcBJ.nJGOv6yFskK} + #{bpyn4hSTIN4.nJGOv6yFskK}) +(#{bpyn4hSTIN4.gLTZoiFaj1E} + #{sbq23bJOu5s.gLTZoiFaj1E} + #{bpyn4hSTIN4.gLTZoiFaj1E})  + (#{bpyn4hSTIN4.Tf8zVyOvc1j} + #{ls9e3jKJcBJ.Tf8zVyOvc1j} + #{sbq23bJOu5s.Tf8zVyOvc1j}) + (#{ls9e3jKJcBJ.TcLzBcFPBnl} + #{sbq23bJOu5s.TcLzBcFPBnl}) + (#{ls9e3jKJcBJ.fDce9OVthqj} + #{bpyn4hSTIN4.fDce9OVthqj} + #{sbq23bJOu5s.fDce9OVthqj}) + (#{sbq23bJOu5s.cbN3KDb839s} + #{ls9e3jKJcBJ.cbN3KDb839s}) + (#{bpyn4hSTIN4.viFzvkU3gqq} + #{sbq23bJOu5s.viFzvkU3gqq}) + (#{ls9e3jKJcBJ.hXtjmuYPdCx} + #{bpyn4hSTIN4.hXtjmuYPdCx} + #{sbq23bJOu5s.hXtjmuYPdCx})
Proportion  of infants less than 6 months old on Exclusive Breastfeeding,vFLtqe1SuXK,Infants <6 months on EBF,#{QUueF25THDC.a57uWFr3dUy} + #{QUueF25THDC.MJAGUpeHkpn},#{twpy25QKLk9}+#{ENjll6PbaI8}+#{AIduSzrilaz}+#{lvyOQjZaXZ3} +#{QCNHvzgxurQ}
Proportion HIV + client  screened for TB,OpAc5cvXkn0,Proportion HIV + client  screened for TB,#{KgiStXnhQBo},(#{PUrg2dmCjGI} + #{W3vq00wM6BL})
Proportion given EC,edzamQDjujF,Proportion given EC,#{ASOks4GRuS6},#{uidGoWq3fyM}
Proportion of  HIV+ TB cases on ART,orujHBXIA1a,Proportion of  HIV+ TB cases on ART,#{sqTqnSR7PGk},#{rXpPsImxbBx}
Proportion of 10-14yr old girls given HPV 1,g0NiKcqj8mQ,Proportion of 10-14yr old girls given HPV 1,#{xmwpcsYb2vk},#{dRhugDCanvB}
Proportion of 10-14yr old girls given HPV2,Q4BBr05HGIK,Proportion of 10-14yr old girls given HPV2,#{NPZXXjBOSil},#{dRhugDCanvB}
Proportion of 8th contact Antenatal Care (ANC) Coverage (%),Xs9vHvZIcGp,8th ANC Coverage (%),#{cKr5133RFuN},#{pct05jgGcLt}
Proportion of ALHIV on ART -Adolescent 10-19 years,auXcl0mdREa,Prop of ALHIV on ART -Adolescent 10-19 years,(#{Jbu4if6gtDp} + #{GSEmLUnrvzj} + #{oOOnacUi9Jm} + #{AQsTt7jtKbt}),91634
Proportion of ANC clients tested Syphilis positive ,ZQi5XbmgPVc,ANC Syphilis tested positive,#{zIiDTYhg8K5.NhSoXUMPK2K},#{uvBuzBj0AbL.NhSoXUMPK2K}
Proportion of ANC clients with Hb <11g/dl,wjnQtqXm6Ix,Proportion of ANC clients with Hb <11g/dl,#{T59McmnP4FJ},#{f9vesk5d4IY}
Proportion of ANC facilities currently offering PMTCT services (ARVs) among those targeted to provide PMTCT,bV1NmEibf5I,offering PMTCT ,#{XgLRwITuVZH},12729
Proportion of CHV's Reporting ,pyc7A6Z9LQf,Proportion of CHV's Reporting ,#{b0lgFG5TTTW.NhSoXUMPK2K},#{e4hqycGYRtb.NhSoXUMPK2K}
Proportion of CLHIV on ART -Children 0-14 years,C7shZkdE1SL,Prop of CLHIV on ART -Children 0-14 years,(#{SJL4k6Gl53C} + #{wbJOu4h2SSz} + #{Jbu4if6gtDp} + #{GSEmLUnrvzj}),106807
Proportion of Children  aged 6 - 59 Months  supplemented with Vitamin A ,phRT4Dwlpr5,Children 6-59 months Vit A,#{MAGmTkOIZus} + #{UTXjB4dxdrp} + #{KXifjlklHaU} + #{jDxknS7Eu0Q} + #{cPeaV6caNqJ} + #{QvQzYi8ik43} + #{VVMKbm0VD3E.bCfwecaPx2W} + #{MAGmTkOIZus.ieuodyY5ybC},#{pkgghI15gSL} * 2
Proportion of Children 2- 59 months with diarrhoea treated with ORS Zinc Copack (Community),zh8ZJj3Mb9a,Children treated with ORS Zinc Copack (Community),#{AR3WCfcKDwX},#{V00z4bQRaqe}
Proportion of Children aged 6-59 months  with moderate Acute Malnutrition(MAM) who are defaulted  while on treatment in the SFP  program (SFP Defaulter Rate-  Nutrition),LUyp3dvEoPz,SFP Default Rate- Nutrition 6-59months,#{sLFHgquSRGx.g3NguFeSV2h} + #{sLFHgquSRGx.J4oQVAR80oo},#{myEpgfhSPLZ.g3NguFeSV2h} + #{myEpgfhSPLZ.J4oQVAR80oo} + #{SX03cV81yb0.g3NguFeSV2h} + #{SX03cV81yb0.J4oQVAR80oo} + #{sLFHgquSRGx.g3NguFeSV2h} + #{sLFHgquSRGx.J4oQVAR80oo} + #{WGdahj4S1QU.g3NguFeSV2h} + #{WGdahj4S1QU.J4oQVAR80oo}
Proportion of Children under 5 years attending Child Welfare Clinics for growth monitoring for the first time in the calendar year,lpGBKAhA11C,% <5 years growth monitoring,(#{YvAmz4L0a1d.a57uWFr3dUy} + #{YvAmz4L0a1d.MJAGUpeHkpn}),#{KNrK5VWTZkx}
Proportion of Children under five attending CWC who under weight,j8Jp1FtkX9M,Underweight <5yrs ,#{AIduSzrilaz.a57uWFr3dUy} + #{AIduSzrilaz.MJAGUpeHkpn} + #{uYBa6RU8wUZ.a57uWFr3dUy} + #{uYBa6RU8wUZ.MJAGUpeHkpn} + #{AYT1IPxFRZx.a57uWFr3dUy} + #{AYT1IPxFRZx.MJAGUpeHkpn},#{ENjll6PbaI8.a57uWFr3dUy} + #{ENjll6PbaI8.MJAGUpeHkpn} + #{HlZXTFN2B61.a57uWFr3dUy} + #{HlZXTFN2B61.MJAGUpeHkpn} + #{Ype6qUApdlR.a57uWFr3dUy} + #{Ype6qUApdlR.MJAGUpeHkpn}  + #{AIduSzrilaz.a57uWFr3dUy} + #{AIduSzrilaz.MJAGUpeHkpn} + #{uYBa6RU8wUZ.a57uWFr3dUy} + #{uYBa6RU8wUZ.MJAGUpeHkpn} + #{AYT1IPxFRZx.a57uWFr3dUy} + #{AYT1IPxFRZx.MJAGUpeHkpn} + #{QCNHvzgxurQ.a57uWFr3dUy} + #{QCNHvzgxurQ.MJAGUpeHkpn} + #{k3xX4NKJaaY.a57uWFr3dUy} + #{k3xX4NKJaaY.MJAGUpeHkpn} + #{mv0ICssqScK.a57uWFr3dUy} + #{mv0ICssqScK.MJAGUpeHkpn} + #{lvyOQjZaXZ3.a57uWFr3dUy} + #{lvyOQjZaXZ3.MJAGUpeHkpn} + #{PW4W1Fa7b5b.a57uWFr3dUy} + #{PW4W1Fa7b5b.MJAGUpeHkpn} + #{zels3jARvGQ.a57uWFr3dUy} + #{zels3jARvGQ.MJAGUpeHkpn} + #{twpy25QKLk9.a57uWFr3dUy} + #{twpy25QKLk9.MJAGUpeHkpn} + #{ikI4r8YuZZ0.a57uWFr3dUy} + #{ikI4r8YuZZ0.MJAGUpeHkpn} + #{qoEPwxCNrll.a57uWFr3dUy} + #{qoEPwxCNrll.MJAGUpeHkpn}
Proportion of Clients with club foot seen /corrected (Ponseti method),VjEdMXpcl4i,Clients with club foot seen /corrected,#{zWN7AH9guom} ,#{hrizXiyGvom} + #{uOC56DfVqib} + #{IEfyuOqoU2d} + #{LXTbgcVjV8p}  + #{uybnpBUS3np} + #{Kg9hiOXlIKg} + #{TMZfrOY1OJG} + #{Gjn4bEoaFZK}
Proportion of Confirmed MDR-TB cases detected among TB patients,Q4kTwQ4ZMLU,% of Confirmed MDR-TB cases among TB patients,#{LasXpeDhjiX.rsTqC3xCHGR} + #{L26dYFXoKeX.ooooM6y7XbZ} + #{LasXpeDhjiX.Q9jJBl8pOy4} + #{L26dYFXoKeX.xCpDoojxqH1},#{xhQlihiebMH.Fmwb7qAGS9L} + #{xhQlihiebMH.ugrZILDyXFQ} + #{xhQlihiebMH.v00k2Vla7gU} + #{xhQlihiebMH.G7luR3OjbVK}
Proportion of Diabetic Clients  diagnosed with Diabetes Retinopathy,xjAVb68J8Fg,%Diabetic Clients with Diabetes Retinopathy,#{HYdMSUkzDdF},#{HYdMSUkzDdF}+#{qzLSvOgBb2S}+#{e4TLO34L0eJ}
Proportion of GBV survivors completing 5th visit,Gpu4fgsxR22,Proportion of GBV survivors completing 5th visit,#{nd3f3LqZ8lV},#{XxnWU21pRrS}
Proportion of GBV survivors who expereinced Intimate Partner Violence ,FSYlSFZ78EE,Prop of GBV survivors who partner Violence ,(#{sbq23bJOu5s.TcLzBcFPBnl} + #{sbq23bJOu5s.viFzvkU3gqq} + #{sbq23bJOu5s.cbN3KDb839s} + #{sbq23bJOu5s.nJGOv6yFskK} + #{sbq23bJOu5s.Tf8zVyOvc1j} + #{sbq23bJOu5s.fDce9OVthqj} + #{sbq23bJOu5s.hXtjmuYPdCx}),(#{ls9e3jKJcBJ.nJGOv6yFskK} + #{bpyn4hSTIN4.nJGOv6yFskK}) +(#{bpyn4hSTIN4.gLTZoiFaj1E} + #{sbq23bJOu5s.gLTZoiFaj1E} + #{bpyn4hSTIN4.gLTZoiFaj1E})  + (#{bpyn4hSTIN4.Tf8zVyOvc1j} + #{ls9e3jKJcBJ.Tf8zVyOvc1j} + #{sbq23bJOu5s.Tf8zVyOvc1j}) + (#{ls9e3jKJcBJ.TcLzBcFPBnl} + #{sbq23bJOu5s.TcLzBcFPBnl}) + (#{ls9e3jKJcBJ.fDce9OVthqj} + #{bpyn4hSTIN4.fDce9OVthqj} + #{sbq23bJOu5s.fDce9OVthqj}) + (#{sbq23bJOu5s.cbN3KDb839s} + #{ls9e3jKJcBJ.cbN3KDb839s}) + (#{bpyn4hSTIN4.viFzvkU3gqq} + #{sbq23bJOu5s.viFzvkU3gqq}) + (#{ls9e3jKJcBJ.hXtjmuYPdCx} + #{bpyn4hSTIN4.hXtjmuYPdCx} + #{sbq23bJOu5s.hXtjmuYPdCx})
Proportion of GBV survivors whoexperienced FGM,c3Hxv9pGvr8,Proportion of GBV s FGM,(#{bpyn4hSTIN4.nJGOv6yFskK} + #{bpyn4hSTIN4.Tf8zVyOvc1j} + #{bpyn4hSTIN4.fDce9OVthqj} + #{bpyn4hSTIN4.hXtjmuYPdCx}),(#{ls9e3jKJcBJ.nJGOv6yFskK} + #{bpyn4hSTIN4.nJGOv6yFskK}) +(#{bpyn4hSTIN4.gLTZoiFaj1E} + #{sbq23bJOu5s.gLTZoiFaj1E} + #{bpyn4hSTIN4.gLTZoiFaj1E})  + (#{bpyn4hSTIN4.Tf8zVyOvc1j} + #{ls9e3jKJcBJ.Tf8zVyOvc1j} + #{sbq23bJOu5s.Tf8zVyOvc1j}) + (#{ls9e3jKJcBJ.TcLzBcFPBnl} + #{sbq23bJOu5s.TcLzBcFPBnl}) + (#{ls9e3jKJcBJ.fDce9OVthqj} + #{bpyn4hSTIN4.fDce9OVthqj} + #{sbq23bJOu5s.fDce9OVthqj}) + (#{sbq23bJOu5s.cbN3KDb839s} + #{ls9e3jKJcBJ.cbN3KDb839s}) + (#{bpyn4hSTIN4.viFzvkU3gqq} + #{sbq23bJOu5s.viFzvkU3gqq}) + (#{ls9e3jKJcBJ.hXtjmuYPdCx} + #{bpyn4hSTIN4.hXtjmuYPdCx} + #{sbq23bJOu5s.hXtjmuYPdCx})
Proportion of HEI who had a PCR within 12 months,ylm6B9PE6G7,% of HEI who had a PCR within 12 months,#{R0CoqawtNCc},#{KYpWTsp2yHv}
Proportion of HEI who had a PCR within 2 months ,qARIGYYFrUH,%of HEI who had a PCR within 2 months ,#{UIok7l6W4nh},#{R0CoqawtNCc}
Proportion of HEI who turned HIV positive at 24 months,gB5WZ6BMOT9,% of HEI who turned HIV positive at 24 months,#{DMr8fYCKJzF},#{xHufJhG2OJx}
Proportion of HIV + patients on ART 12 months after initiation,pjK33PmjUVv,%of HIV + patients on ART 12mths aft initiation,#{S1z1doLHQg1},#{cbrwRebovN1}
Proportion of HIV patients screened for TB,GaGrhxO0HTT,Prop of HIV patients scrned for TB,(#{UIIkCIajLVh} + #{TxR1FNVfzMH} + #{YQGzbNSKQV5} + #{piVmBFjFkfM} + #{cbaDJgQ2X4k} + #{LyNflllos12}),(#{KknDtmFfDBM} + #{Vhx18QRosUs} + #{SJL4k6Gl53C} + #{wbJOu4h2SSz} + #{Jbu4if6gtDp} + #{GSEmLUnrvzj} + #{oOOnacUi9Jm} + #{AQsTt7jtKbt} + #{e93GKJTHKAX} + #{EhZQp3PTA3C} + #{pR7VzBydoj3} + #{yNCUlEYkmyA})
Proportion of HIV positive clients assessed for nutrition status,ua13s73VsQH,Propo of HIV+ clnts assessed for nutrition status,#{EqhcLCyzn6b} + #{ONFHSFsYoPS},(#{Vhx18QRosUs} + #{KknDtmFfDBM} + #{SJL4k6Gl53C} + #{wbJOu4h2SSz} + #{Jbu4if6gtDp} + #{GSEmLUnrvzj} + #{oOOnacUi9Jm} + #{AQsTt7jtKbt} + #{e93GKJTHKAX} + #{EhZQp3PTA3C} + #{pR7VzBydoj3} + #{yNCUlEYkmyA})
Proportion of HIV positive mothers issued with  Infant prophylaxis ,NnXtP5pOcxn,% HIV positive mothers issued Infant prophylaxis ,#{PgYIC96gz70},#{KYpWTsp2yHv}
Proportion of HIV positive mothers on  HAART.,sFUlouKopaL,Proportion of HIV positive mothers on  HAART.,#{PyDKoTxqKB9},#{KYpWTsp2yHv}
"Proportion of HIV pregnant and breastfeeding women identified in ANC, L&D and PNC(Uptake)",MeWh3J83UbG,prop of hiv preg and brstfing womn identified,(#{qSgLzXh46n9} + #{nwXS5vxrrr7} + #{hn3aChn4sVx} + #{AfHArvGun12} + #{hHLR1HP8xzI}),(#{PXUzSsmeY0P} + #{LQpQQP3KnU1} + #{mQz4DhBSv9V} + #{ETX9cUWF43c})
Proportion of HIV+new and relapse TB patients on (ART),KZBD5Bky2jL,%HIV+ new and relapse TB patients on (ART),#{kRUTjkncfLE},#{uFJqFxWUnQi.SW68XRmPP8J}
Proportion of Health Facilities with a Stockout of AL12,K2inrHi77FB,Stockout of AL12 %,#{iO6RFel3foT.SB8kRIf8SHF},R{RRnz4uPHXdl.ACTUAL_REPORTS}
Proportion of Health Facilities with a Stockout of AL18,IyaHlLl0rdV,Stockout of AL18 %,#{NA9yT71lc5t.SB8kRIf8SHF},R{RRnz4uPHXdl.ACTUAL_REPORTS}
Proportion of Health Facilities with a Stockout of AL24,k2BlNuoqBT0,Stockout of AL24 %,#{RXCZKKTO2mB.SB8kRIf8SHF},R{RRnz4uPHXdl.ACTUAL_REPORTS}
Proportion of Health Facilities with a Stockout of AL6,x73gxJeUEGh,Stockout of AL6 %,#{XCDwfwjoCC7.SB8kRIf8SHF},R{RRnz4uPHXdl.ACTUAL_REPORTS}
Proportion of Health Facilities with a Stockout of Artesunate Injection,CxDv5oUEiEB,Stockout of ASInj %,#{wG1xfru0oBN.SB8kRIf8SHF},R{RRnz4uPHXdl.ACTUAL_REPORTS}
Proportion of Health Facilities with a Stockout of LLIN,OGLbGcGO5tp,Stockout of LLIN %,#{sFQGz5syuXW.SB8kRIf8SHF},R{RRnz4uPHXdl.ACTUAL_REPORTS}
Proportion of Health Facilities with a Stockout of RDT,xCFHN4qDPFn,Stockout of RDT %,#{W4Xy7ozkSNp.SB8kRIf8SHF},R{RRnz4uPHXdl.ACTUAL_REPORTS}
Proportion of Health Facilities with a Stockout of SP,XCYLXLs15me,Stockout of SP %,#{ZBhl3V2wIYe.SB8kRIf8SHF},R{RRnz4uPHXdl.ACTUAL_REPORTS}
Proportion of Households Visited ,mnBNSsWaVVj,Proportion of households visited ,#{LGsW5FyZFwZ} ,#{rdcZ1ni3jrD}
Proportion of Households with Hand washing facilities,BKeJ24s3jKr,Hand washing facilities,#{zhwGF3FDj8B},#{LGsW5FyZFwZ}
Proportion of Households with Refuse disposal Facility,iD9QzyDiOKA,Proportion with Refuse disposal Facility,#{lhkXObzaWr3},#{LGsW5FyZFwZ}
Proportion of IPTp missed opportunities referred to the Health Facility,dKAiyz1D9fJ,IPTp Missed Opprotunities,#{VrpxWLhfIr6},#{NvUUbEhFVcO}
Proportion of Maternal death audited,ykg2HCzqNLt,% of Maternal death audited,#{kAp7ViUXEKh.NhSoXUMPK2K},#{dPRCstLVkZu} + #{AC1Iorxdijc} + #{BYMSIbnUzXQ} + #{KDFtI6rqYwI}
Proportion of Neonatal Deaths Audited,rm9AVzYcCQM,% of Perinatal Deaths Audited,#{tHRlLvvCObn},#{GAr6xu6f1n7}
Proportion of Neonatal deaths due to pre-maturity ,eC92tlqA9B7,% Neonatal deaths due to prematurity ,#{bS5lymcUHZ9},#{GAr6xu6f1n7}
Proportion of Newborn initiated on breast milk within the first one hour after delivery,Y3hOy8JaAUp,Newborn breastfed within one hour,#{UiGlnkNmCut},#{UqKC1DJnymn}
Proportion of PLHIV on ART -Adults>15 years,IfpJQfkAyBK,Prop of PLHIV on ART -Adlts>15 years,(#{AQsTt7jtKbt} + #{oOOnacUi9Jm} + #{e93GKJTHKAX} + #{EhZQp3PTA3C} + #{pR7VzBydoj3} + #{yNCUlEYkmyA}),1401598
Proportion of PLHIV on ART -Overall,P425HLObAsX,prop of PLHIV on ART,(#{SJL4k6Gl53C} + #{wbJOu4h2SSz} + #{Jbu4if6gtDp} + #{GSEmLUnrvzj} + #{oOOnacUi9Jm} + #{AQsTt7jtKbt} + #{e93GKJTHKAX} + #{EhZQp3PTA3C} + #{pR7VzBydoj3} + #{yNCUlEYkmyA}),1508405
Proportion of PLHIV that are known to be alive and on ART treatment at 12 months on initiation ART,CZHDzi4wwqE,Prop of PLHIV alve & on ART trtmnt at 12 mnths,#{S1z1doLHQg1},#{cbrwRebovN1}
Proportion of PWDs identified and receiving physiotherapy from IPD under 5 years,I6xhc9QO1G9,PWDs identified/receiving physiotherapy from IPD,#{lKqnqzu10e1.SBZ670uVABW} + #{y75by9tXSJQ.Iqc3hqMwVqK},#{cvJuw6Fbuiw}
Proportion of PWDs identified and receiving physiotherapy from OPD under 5 years,du1rxIcsO2e,PWDs identified/receiving physiotherapy from OPD ,#{BzMxvzMNkCR.SBZ670uVABW} + #{y75by9tXSJQ.M6GEc2cZ3ES},#{Ha96SBKI06u} + #{F6AwnxbwiK2}
Proportion of Persons living with HIV receiving Cotrimoxazole Prophylaxis ,jitS2HRtipl,Prop living with HIV receiving Ctrimle Proxis ,(#{cHsaND37lsM} + #{bApoj9WVrgW} + #{SJ0wy4wfe8A} + #{DgIkkP1XAYG} + #{DH7miEgpVP2} + #{sNPnPD56nzD}),(#{Nj4fdwBMPSv} + #{Qx6MQyeLsbW} + #{voKyCW93y78} + #{fEreYoprpD1} + #{k3XKbFkk2ZR} + #{tCuuWVCan0K} + #{IEPIbqqB7FP} + #{nNE84uVg0xN} + #{LGMBmncr1Qw} + #{FsnRF3p3qVc})
Proportion of Pregnant & Lactating Mothers  with moderate Acute Malnutrition(MAM) who were discharged   non recovered  while in the SFP  program (SFP  Non Recovery  Rate- Nutrition PLW),NiiGfjlfl9e,SFP Non Recovered Rate PLW,#{WGdahj4S1QU.RxueJ9pzyTM},#{myEpgfhSPLZ.RxueJ9pzyTM} + #{SX03cV81yb0.RxueJ9pzyTM} + #{sLFHgquSRGx.RxueJ9pzyTM} + #{WGdahj4S1QU.RxueJ9pzyTM}
Proportion of Pregnant & Lactating Mothers with moderate Acute Malnutrition(MAM) who are defaulted  while on treatment in the SFP  program (SFP Defaulter Rate-  Pregnant and lactating mothers),YpwYSDMpKnn,SFP Default Rate Nutrition PLW,#{sLFHgquSRGx.RxueJ9pzyTM},#{myEpgfhSPLZ.RxueJ9pzyTM} + #{SX03cV81yb0.RxueJ9pzyTM} + #{sLFHgquSRGx.RxueJ9pzyTM} + #{WGdahj4S1QU.RxueJ9pzyTM}
Proportion of Pregnant &Lactating mothers  with moderate Acute Malnutrition(MAM) who were discharged cured  while in the SFP  program (SFP Recovery  Rate- Nutrition PLW),nA591nBWeaM,SFP Cure Rate Nutrition PLW,#{myEpgfhSPLZ.RxueJ9pzyTM},#{myEpgfhSPLZ.RxueJ9pzyTM} + #{SX03cV81yb0.RxueJ9pzyTM} + #{sLFHgquSRGx.RxueJ9pzyTM} + #{WGdahj4S1QU.RxueJ9pzyTM}
Proportion of Pregnant Women Receiving folate,NraxJdcSd3Y,Proportion of Pregnant Women Receiving folate,#{JbcvbCEBnu6.NhSoXUMPK2K},#{JOnT3OiMd5o.NhSoXUMPK2K}
Proportion of Pregnant Women receiving Toxoid 2+ ,GDT9fBjuKNC,TT2+ preg. cov,#{au9lav766rM.B4gIWbNNUFc} + #{au9lav766rM.Qzjct1emaaj} + #{au9lav766rM.kHFI1LYOvZF} + #{au9lav766rM.WmSjcUiJumX},#{tmlMpIqHimf.NhSoXUMPK2K}
Proportion of Pregnant women receiving 2nd Tetanus Toxoid ,en5AHE6mNvD,TT 2 coverage,#{au9lav766rM.B4gIWbNNUFc},#{JOnT3OiMd5o.NhSoXUMPK2K}
Proportion of SGBV clients seen within 72 hours,pDW5tLxO2DI,Proportion of SGBV clients seen within 72 hours,(#{tyDpvDzvqkQ.gLTZoiFaj1E} + #{tyDpvDzvqkQ.TcLzBcFPBnl} + #{tyDpvDzvqkQ.viFzvkU3gqq} + #{tyDpvDzvqkQ.cbN3KDb839s} + #{tyDpvDzvqkQ.nJGOv6yFskK} + #{tyDpvDzvqkQ.Tf8zVyOvc1j} + #{tyDpvDzvqkQ.fDce9OVthqj} + #{tyDpvDzvqkQ.hXtjmuYPdCx}),(#{ls9e3jKJcBJ.gLTZoiFaj1E} + #{ls9e3jKJcBJ.TcLzBcFPBnl} + #{ls9e3jKJcBJ.viFzvkU3gqq} + #{ls9e3jKJcBJ.cbN3KDb839s} + #{ls9e3jKJcBJ.nJGOv6yFskK} + #{ls9e3jKJcBJ.Tf8zVyOvc1j} + #{ls9e3jKJcBJ.fDce9OVthqj} + #{ls9e3jKJcBJ.hXtjmuYPdCx})
Proportion of SGBV survivors given STI prophylaxis/Treatment,bHh3jUk4Kog,Proportion of SGBV survivors given STI prophylaxis,#{KMQTp1xss9Y},#{HiQyqX0jk64}
Proportion of Still births that are Fresh still births,nJDOZR5XAzy,Proportion of Still births that are Fresh ,#{rYn8RCcHJg1},(#{rYn8RCcHJg1} + #{wZtDYVBa41h})
Proportion of TB HIV positive patients started on (CPT),fooITfigznV,% TB HIV positive patients started on (CPT),#{HHdKUcFctz9},#{uFJqFxWUnQi.SW68XRmPP8J}
Proportion of TB cases lost to follow up,Tq4cmgp5qzC,TB_CT Proportion of TB cases lost to follow up,#{YpM2CXCPZbf.CelxNNpkrdt} + #{H61J8pIAjLQ.BzwDCspO4yg} + #{yEyrFyJryXL.ULjhM25nAxq} + #{m7BMQu4HYRT.KAuNTGdpL0G} + #{Z9AVW5bKTaG.ZdpyYvlURuy},#{YpM2CXCPZbf.oTxLi0v4fb1} + #{m7BMQu4HYRT.W1sDC9IzJ1d} + #{yEyrFyJryXL.ufORzeLtcEl} + #{H61J8pIAjLQ.Z5hHUGiaOh4} + #{Z9AVW5bKTaG.wiD5SVABQHR}
Proportion of TB cases not evaluated,VNlYwsMTfGl,TB_CT Proportion of TB cases not evaluated,#{YpM2CXCPZbf.FRUKNHjACuF} + #{m7BMQu4HYRT.IZNl83g9nbb} + #{yEyrFyJryXL.tKUYehXSgUR} + #{H61J8pIAjLQ.GekWn3oiKAr} + #{Z9AVW5bKTaG.nGdatAwURrL},"#{YpM2CXCPZbf.oTxLi0v4fb1} + #{m7BMQu4HYRT.W1sDC9IzJ1d} + #{yEyrFyJryXL.ufORzeLtcEl} + #{H61J8pIAjLQ.Z5hHUGiaOh4} + #{Z9AVW5bKTaG.wiD5SVABQHR}
"
Proportion of TB cases referred by CHVs,iZjCyoChIYU,Proportion of TB cases referred by CHVs,#{V1Ido6I9xkA.NhSoXUMPK2K},#{xhQlihiebMH.WwOVo8ccFpn}
Proportion of TB cases that failed treatment,Z9tOn0yTx77,TB_CT Proportion of TB cases that failed treatment,"",""
Proportion of TB patient HIV+ who are on CPT,X3nfx1M1oQy,TB patients on CPT,#{Mn3FQ9r5Wtp.vVketPHJwSY}+#{Mn3FQ9r5Wtp.g6112VF7T29}+#{Mn3FQ9r5Wtp.omEDL5LVgDJ}+#{Mn3FQ9r5Wtp.j03wX0lCHZc},#{bhFvc6EeCTC.vVketPHJwSY}+#{bhFvc6EeCTC.g6112VF7T29}+#{bhFvc6EeCTC.omEDL5LVgDJ}+#{bhFvc6EeCTC.j03wX0lCHZc}
Proportion of Under 5yrs attending CWC who are obese,lfHxMnPeqiJ,Prop of Under 5yrs attending CWC who are obese,(#{lvyOQjZaXZ3} + #{zels3jARvGQ} + #{PW4W1Fa7b5b}),#{EsfvxFcltV0}
Proportion of Under 5yrs attending CWC who are stunted,r5YMQX0SlFI,Under 5yrs stunted,#{IHlMRYVhmOX}+#{madOGCuPg8q}+#{f0SJMmqh8un},#{EsfvxFcltV0.K4WLOEhtcvC} + #{EsfvxFcltV0.wBWcFk7k1qY}
Proportion of Under Five Treated for Diarrhoea (Facility),Gqb5eXLsFe6,% of Under Five Treated for Diarrhoea (Facility),#{JcgMuSM3NnI.lHl2rmXpHse} + #{hGhUdN3KgrK.lHl2rmXpHse} + #{ZI3qZ2mfBER.lHl2rmXpHse} + #{tovFNTW5b9K.lHl2rmXpHse},#{IxhbkNwhcvE.lHl2rmXpHse}+#{BwROYFIiXKG.lHl2rmXpHse}
Proportion of babies initiated on Kangaroo Mother Care,g9mphD2WGEq,Proportion of babies initiated on KMC,#{AxqwEdpy6AH},#{Hh4daYAcb49} + #{syjjPqXbjTm}
Proportion of children  aged  12--59 months  supplemented with Vitamin A,KwN3jWkmjgu,Vit A cov child12-59 mths,((#{UTXjB4dxdrp.NhSoXUMPK2K})+(#{cPeaV6caNqJ.NhSoXUMPK2K})+(#{Oaysbgtl1gF.NhSoXUMPK2K}) + #{lxEQY7XM7Oy}) ,(#{KNrK5VWTZkx.NhSoXUMPK2K}-#{pMbuvKvH4rg.NhSoXUMPK2K})*2
Proportion of children 0-59 months with Severe Acute Malnutrition(SAM) who defaulted  while on treatment in the stabilisation / inpatient  program (Stabilization Centre Defaulter rate -Nutrition),rYL4D3reFrV,IP Default Rate-Nutrition,#{iyeYZ4QGzBW.KfdnIJGDpJ4} + #{iyeYZ4QGzBW.g3NguFeSV2h} + #{iyeYZ4QGzBW.J4oQVAR80oo},#{kXsIskFokOj.KfdnIJGDpJ4} + #{kXsIskFokOj.g3NguFeSV2h} + #{kXsIskFokOj.J4oQVAR80oo} + #{iVmGsHq3nQi.KfdnIJGDpJ4} + #{iVmGsHq3nQi.g3NguFeSV2h} + #{iVmGsHq3nQi.J4oQVAR80oo} + #{iyeYZ4QGzBW.KfdnIJGDpJ4} + #{iyeYZ4QGzBW.g3NguFeSV2h} + #{iyeYZ4QGzBW.J4oQVAR80oo} + #{eXCVrSR9IqM.KfdnIJGDpJ4} + #{eXCVrSR9IqM.g3NguFeSV2h} + #{eXCVrSR9IqM.J4oQVAR80oo}
Proportion of children 0-59 months with Severe Acute Malnutrition(SAM) who died while on treatment in the stabilisation / inpatient  program (Stabilization Centre Death rate -Nutrition),mWQlRjjbNId,Inpatient Death Rate- Nut,#{iVmGsHq3nQi.KfdnIJGDpJ4} + #{iVmGsHq3nQi.g3NguFeSV2h} + #{iVmGsHq3nQi.J4oQVAR80oo},#{kXsIskFokOj.KfdnIJGDpJ4} + #{kXsIskFokOj.g3NguFeSV2h} + #{kXsIskFokOj.J4oQVAR80oo} + #{iVmGsHq3nQi.KfdnIJGDpJ4} + #{iVmGsHq3nQi.g3NguFeSV2h} + #{iVmGsHq3nQi.J4oQVAR80oo} + #{iyeYZ4QGzBW.KfdnIJGDpJ4} + #{iyeYZ4QGzBW.g3NguFeSV2h} + #{iyeYZ4QGzBW.J4oQVAR80oo} + #{eXCVrSR9IqM.KfdnIJGDpJ4} + #{eXCVrSR9IqM.g3NguFeSV2h} + #{eXCVrSR9IqM.J4oQVAR80oo}
Proportion of children 0-59 months with Severe Acute Malnutrition(SAM) who recovered/cured from treatment(Stabilization Centre Recovery rate -Nutrition),BntEIzeMXBZ,Stabilization Centre Recovery rate ,#{kXsIskFokOj.KfdnIJGDpJ4} + #{kXsIskFokOj.g3NguFeSV2h} + #{kXsIskFokOj.J4oQVAR80oo},#{kXsIskFokOj.KfdnIJGDpJ4} + #{kXsIskFokOj.g3NguFeSV2h} + #{kXsIskFokOj.J4oQVAR80oo} + #{iVmGsHq3nQi.KfdnIJGDpJ4} + #{iVmGsHq3nQi.g3NguFeSV2h} + #{iVmGsHq3nQi.J4oQVAR80oo} + #{iyeYZ4QGzBW.KfdnIJGDpJ4} + #{iyeYZ4QGzBW.g3NguFeSV2h} + #{iyeYZ4QGzBW.J4oQVAR80oo} + #{eXCVrSR9IqM.KfdnIJGDpJ4} + #{eXCVrSR9IqM.g3NguFeSV2h} + #{eXCVrSR9IqM.J4oQVAR80oo}
Proportion of children 2-59 months with diarrhoea treated with ORS zinc (copack) - Community,uPIaX43yZ2e,Children <5yr treated with zinc & ORS ( Community),#{mVUOXNSh8Rc} +#{AR3WCfcKDwX},#{L9tTxknCnKq} + #{V00z4bQRaqe}
Proportion of children 6-59 months with Severe Acute Malnutrition(SAM) who defaulted while on treatment in the OTP  program (OTP Default rate - Nutrition),mTSjurfb86p,OTP Default rate - Nutrition, #{mpoyMvkgwKA.g3NguFeSV2h} + #{mpoyMvkgwKA.J4oQVAR80oo}, #{d0mQHTddjre.g3NguFeSV2h} + #{d0mQHTddjre.J4oQVAR80oo} + #{D0QBMSslDpI.g3NguFeSV2h} + #{D0QBMSslDpI.J4oQVAR80oo} + #{mpoyMvkgwKA.g3NguFeSV2h} + #{mpoyMvkgwKA.J4oQVAR80oo} + #{dGcVurKfrSB.g3NguFeSV2h} + #{dGcVurKfrSB.J4oQVAR80oo}
Proportion of children 6-59 months with Severe Acute Malnutrition(SAM) who died while on treatment in the OTP  program (OTP Death rate - Nutrition),zKwDAdYbspR,OTP Death Rate- Nutrition,#{D0QBMSslDpI.g3NguFeSV2h} + #{D0QBMSslDpI.J4oQVAR80oo},#{d0mQHTddjre.g3NguFeSV2h} + #{d0mQHTddjre.J4oQVAR80oo} + #{D0QBMSslDpI.g3NguFeSV2h} + #{D0QBMSslDpI.J4oQVAR80oo} + #{mpoyMvkgwKA.g3NguFeSV2h} + #{mpoyMvkgwKA.J4oQVAR80oo} + #{dGcVurKfrSB.g3NguFeSV2h} + #{dGcVurKfrSB.J4oQVAR80oo}
Proportion of children 6-59 months with Severe Acute Malnutrition(SAM) who recovered while on treatment in the OTP  program (OTP Recovery rate - Nutrition),OQiEEUfQic1,OTP Recovery Rate- Nutrition, #{d0mQHTddjre.g3NguFeSV2h} + #{d0mQHTddjre.J4oQVAR80oo}, #{d0mQHTddjre.g3NguFeSV2h} + #{d0mQHTddjre.J4oQVAR80oo} + #{D0QBMSslDpI.g3NguFeSV2h} + #{D0QBMSslDpI.J4oQVAR80oo} + #{mpoyMvkgwKA.g3NguFeSV2h} + #{mpoyMvkgwKA.J4oQVAR80oo} + #{dGcVurKfrSB.g3NguFeSV2h} + #{dGcVurKfrSB.J4oQVAR80oo}
Proportion of children 6-59 months with moderate Acute Malnutrition(MAM) who are non recovered while on treatment in the SFP  program (SFP Non Recovery  Rate- Nutrition 6-59 months),Bj4LBQtpnjl,SFP Non Recovery - Nutrition 6-59months,#{WGdahj4S1QU.g3NguFeSV2h} + #{WGdahj4S1QU.J4oQVAR80oo},#{myEpgfhSPLZ.g3NguFeSV2h} + #{myEpgfhSPLZ.J4oQVAR80oo} + #{SX03cV81yb0.g3NguFeSV2h} + #{SX03cV81yb0.J4oQVAR80oo} + #{sLFHgquSRGx.g3NguFeSV2h} + #{sLFHgquSRGx.J4oQVAR80oo} + #{WGdahj4S1QU.g3NguFeSV2h} + #{WGdahj4S1QU.J4oQVAR80oo}
Proportion of children 6-59 months with moderate Acute Malnutrition(MAM) who died while on treatment in the SFP  program (SFP Death Rate- Nutrition 6-59 months),YhxzfzCplq5,SFP Death Rate- Nutrition  6-59 months,#{SX03cV81yb0.g3NguFeSV2h} + #{SX03cV81yb0.J4oQVAR80oo},#{myEpgfhSPLZ.g3NguFeSV2h} + #{myEpgfhSPLZ.J4oQVAR80oo} + #{SX03cV81yb0.g3NguFeSV2h} + #{SX03cV81yb0.J4oQVAR80oo} + #{sLFHgquSRGx.g3NguFeSV2h} + #{sLFHgquSRGx.J4oQVAR80oo} + #{WGdahj4S1QU.g3NguFeSV2h} + #{WGdahj4S1QU.J4oQVAR80oo}
Proportion of children 6-59 months with moderate Acute Malnutrition(MAM) who were discharged cured  while in the SFP  program (SFP Cure  Rate- Nutrition 6-59),SCBopSEHImJ,Proportion of children 6-59 months with (MAM) ,(#{myEpgfhSPLZ.g3NguFeSV2h} + #{myEpgfhSPLZ.J4oQVAR80oo}),(#{myEpgfhSPLZ.g3NguFeSV2h} + #{myEpgfhSPLZ.J4oQVAR80oo} + #{SX03cV81yb0.g3NguFeSV2h} + #{SX03cV81yb0.J4oQVAR80oo} + #{sLFHgquSRGx.g3NguFeSV2h} + #{sLFHgquSRGx.J4oQVAR80oo} + #{WGdahj4S1QU.g3NguFeSV2h} + #{WGdahj4S1QU.J4oQVAR80oo})
Proportion of children aged 12-59 months dewormed ,XaEj5cOCSe9,Proportion of 12-59months children dewormed,#{NXl959cFhDr.a57uWFr3dUy} + #{NXl959cFhDr.MJAGUpeHkpn},(#{KNrK5VWTZkx.NhSoXUMPK2K})-(#{pMbuvKvH4rg.NhSoXUMPK2K})
Proportion of children aged 2-59 months with pneumonia treated with Amoxycillin DT,kCCE9FT8YYF,% pneumonia  2-59 months Amoxycillin DT,#{wMQolZyIR5P},#{WBTvg49kJHr}
Proportion of children aged 6-59 months  who have not recovered in the In patient/ Stabilization center Therapeutic Program( 1P/stabilazioncentre),yMxs7VCuPKN,Stabilization Centre Non Recovery Rate,#{eXCVrSR9IqM.KfdnIJGDpJ4} + #{eXCVrSR9IqM.g3NguFeSV2h} + #{eXCVrSR9IqM.J4oQVAR80oo},#{kXsIskFokOj.KfdnIJGDpJ4} + #{kXsIskFokOj.g3NguFeSV2h} + #{kXsIskFokOj.J4oQVAR80oo} + #{iVmGsHq3nQi.KfdnIJGDpJ4} + #{iVmGsHq3nQi.g3NguFeSV2h} + #{iVmGsHq3nQi.J4oQVAR80oo} + #{iyeYZ4QGzBW.KfdnIJGDpJ4} + #{iyeYZ4QGzBW.g3NguFeSV2h} + #{iyeYZ4QGzBW.J4oQVAR80oo} + #{eXCVrSR9IqM.KfdnIJGDpJ4} + #{eXCVrSR9IqM.g3NguFeSV2h} + #{eXCVrSR9IqM.J4oQVAR80oo}
Proportion of children aged 6-59 months  who have not recovered in the Out patient Theraupetic Program( OTP),g7fCkPWq7fD,OTP Non Recovered - Nutrition, #{dGcVurKfrSB.g3NguFeSV2h} + #{dGcVurKfrSB.J4oQVAR80oo}, #{d0mQHTddjre.g3NguFeSV2h} + #{d0mQHTddjre.J4oQVAR80oo} + #{D0QBMSslDpI.g3NguFeSV2h} + #{D0QBMSslDpI.J4oQVAR80oo} + #{mpoyMvkgwKA.g3NguFeSV2h} + #{mpoyMvkgwKA.J4oQVAR80oo} + #{dGcVurKfrSB.g3NguFeSV2h} + #{dGcVurKfrSB.J4oQVAR80oo}
Proportion of children under five treated for pneumonia ,YeWecx3vYZk,children under five treated for pneumonia,#{QgiADNKtauy.lHl2rmXpHse} + #{EEVfLW0M8vU.lHl2rmXpHse},#{BwROYFIiXKG.lHl2rmXpHse} + #{IxhbkNwhcvE.lHl2rmXpHse}
Proportion of children under five with delayed developmental milestones,qqxvWrOzJ6N,% <5yrs with delayed developmental milestones,#{PfepqFEnOTP.MJAGUpeHkpn} + #{PfepqFEnOTP.a57uWFr3dUy},#{YvAmz4L0a1d.MJAGUpeHkpn} + #{YvAmz4L0a1d.a57uWFr3dUy} + #{EsfvxFcltV0.K4WLOEhtcvC}
Proportion of children under five with diarrhoea treated with ORS Zinc Copack (Facility),N9Xzq84PhNY,Children with diarrheoa treated ORS Zinc Copack,#{Z1seH9SG7wY},#{JcgMuSM3NnI.lHl2rmXpHse} + #{hGhUdN3KgrK.lHl2rmXpHse} + #{ZI3qZ2mfBER.lHl2rmXpHse}
Proportion of children under five with hypoxaemia(spo2<90%),AHdR0tcKgQT, % <5 with hypoxaemia(spo2<90%),#{XktzVlcfJnf.lHl2rmXpHse},#{F6AwnxbwiK2} + #{Ha96SBKI06u} + #{BwROYFIiXKG.lHl2rmXpHse}
Proportion of children under five years with pneumonia treated with Amoxicillin DT,wy7YzxnzDuW,% of <5yrs with pneumonia Rx with Amoxicillin DT,#{WnldbKXWWe7},#{QgiADNKtauy.lHl2rmXpHse} + #{EEVfLW0M8vU.lHl2rmXpHse}
Proportion of children under one year vaccinated with IPV,yRSlrkpbK3Q,IPV Coverage,#{gw4Zog5qvBy.ieuodyY5ybC},#{JOnT3OiMd5o.NhSoXUMPK2K}
Proportion of children under one year who are fully immunized,p4JRNrjpkLr,FIC Coverage,#{tBPGQFhWB7M.ieuodyY5ybC},#{pMbuvKvH4rg.NhSoXUMPK2K}
Proportion of children who recived penta-3,wOunS7EeDkH,Proportion of children who recived penta-3,#{OyddF1qflzP.ieuodyY5ybC},#{pMbuvKvH4rg.NhSoXUMPK2K}
Proportion of clients starting ART,ncdSV5Bn17m,Proportion of clients starting ART,#{cTY2tTKwUqd}+#{eNcsljfoUKW}+#{jFrSw8UkNQ4}+#{GlGolXdf6gr},#{qa1IrxISrSJ}+#{qMybCnYBkNY}+#{cTY2tTKwUqd}+#{eNcsljfoUKW}+#{jFrSw8UkNQ4}+#{GlGolXdf6gr}
Proportion of clients tested for HIV who were HIV positive,nSTCKnX3bK9,% of clients tested for HIV who were HIV positive,#{dlldM4hP2Wk},#{NOga2tabGrd}
Proportion of clients with 1st ANC contact at 12 or less weeks,cX3zGVccwjR,Proportion 1st ANC contact at 12 or less weeks,#{etbuJ3chcZL},#{pct05jgGcLt}
Proportion of clients with a reported self test in the last 12 months,zIsxiuQwTEy,%of clients self test in the last 12 months,#{q50r2FWg6de},#{NOga2tabGrd}
Proportion of clients with refractive error,u5oB1H2BQZN,% of clients with refractive error,#{txuFX4UOFHg.G6wouBqxaa6} + #{txuFX4UOFHg.F67kLNn1eqH} + #{txuFX4UOFHg.bTmCEG1Fy4Z} + #{txuFX4UOFHg.yvSOIkq4CQb} + #{txuFX4UOFHg.eRbamIQg7qs} + #{txuFX4UOFHg.f9uvBDukdWQ} + #{txuFX4UOFHg.kRQHtVzyeep} + #{txuFX4UOFHg.SJ0IxuymxMs} + #{txuFX4UOFHg.RWiHakY4JPb} + #{txuFX4UOFHg.QYR3239aB7m} + #{txuFX4UOFHg.tUFEWAovcCf} + #{txuFX4UOFHg.b3Kk4PqZbSW} + #{txuFX4UOFHg.OdPRuXx7Vyj} + #{txuFX4UOFHg.iDRNZ2mnaIF} + #{txuFX4UOFHg.rf4rzMwjMWT} + #{txuFX4UOFHg.FFbIRKLaebq} + #{txuFX4UOFHg.jvRuY1CUNpS} + #{txuFX4UOFHg.b2vTzTLN8au},1
Proportion of confirmed malaria cases treated using ACT,LuWZz9r17FQ,Confirmed malaria cases treated using ACT,#{oVxxa344TPs}+#{V9SqzZHKoP7},#{CVHsV294PjK}
Proportion of deliveries among HIV positive mothers  ,M6UCtehnjv7,% of deliveries among HIV positive mothers  ,#{C8xdcRWT9d2},#{KYpWTsp2yHv}
Proportion of diabetes patients tested for HBA1c,BNGlVIdWWCc,Proportion of diabetes patients tested for HBA1c,(#{SNIA8DX7tap.EynBGhY9Yg4} + #{SNIA8DX7tap.QOIpb8LBRtm}),(#{YNfr17yqhll.EynBGhY9Yg4} + #{YNfr17yqhll.QOIpb8LBRtm})
Proportion of diabetes patients tested for HBA1c on target (<7%),fyGcvYFGFuv,Prop of dm pt tested for HBA1c on target (<7%),(#{VoFeZvr48Lh.EynBGhY9Yg4} + #{VoFeZvr48Lh.QOIpb8LBRtm}),(#{SNIA8DX7tap.EynBGhY9Yg4} + #{SNIA8DX7tap.QOIpb8LBRtm})*2
Proportion of eligible HIV positive clients receiving Therapeutic or Supplementary Food ,jxJcA7n8KYp,Prop of HIV+ clnts receiving Thtic/Suptary Food ,#{rwTvrrkKot4} + #{PXMPO6t3FIh},#{FuDzKYjF69C} + #{j0x31E1xybY}
Proportion of eligible clients started on ART,LGTj6juiAFC,eligible started on ART,#{AtMqM0wLKHm},#{kMe8cor2UxQ}
Proportion of eligible persons started on ART-MOH 711 (NASCOP),nHsRCRmdgRf,ART Initiation uptake,#{cTY2tTKwUqd}+#{eNcsljfoUKW}+#{jFrSw8UkNQ4}+#{GlGolXdf6gr},#{cTY2tTKwUqd}+#{eNcsljfoUKW}+#{jFrSw8UkNQ4}+#{GlGolXdf6gr}+#{kMe8cor2UxQ}
Proportion of eligible survivors initiated on PEP,qFwv6T4k94w,Proportion of eligible survivors initiated on PEP,#{A39ImTKQBMr},#{c7kRskMlv4w}
Proportion of expectant women at ANC with known HIV status (includes KP),ssWHlQdaL2m,%of expectant women at ANC with known HIV status,#{ssqPT53vnZf},#{uSxBUWnagGg}
Proportion of funds received(GOK funds) scorecard,zWTej5vPabl,Proportion of funds allocated to the facility,(#{QLC6ejj76za.PbvwbLA3fbd}+#{QLC6ejj76za.wpNbJwjNUZy}+#{QLC6ejj76za.HOgzR50Zd4h}+#{QLC6ejj76za.VCWJK5P18lI}+#{QLC6ejj76za.VNcrvgnT5bL}+#{QLC6ejj76za.ho19GFuJL4X}+#{QLC6ejj76za.ZV3ZXLCvILg}),(#{LwS5qdivh4n.PbvwbLA3fbd}+#{LwS5qdivh4n.wpNbJwjNUZy}+#{LwS5qdivh4n.HOgzR50Zd4h}+#{LwS5qdivh4n.VCWJK5P18lI}+#{LwS5qdivh4n.VNcrvgnT5bL}+#{LwS5qdivh4n.ho19GFuJL4X}+#{LwS5qdivh4n.ZV3ZXLCvILg})
Proportion of health facilities currently offering virological testing (onsite or through DBS) among those targeted to provide virological testing (onsite or DBS),np9GvezrmUr, (onsite or through DBS),#{eUmbggQGgzS},12729
Proportion of health facilities providing ART initiation services,ni7NBJLFVeI,Proportion of health facilities,#{NhdWK1O9QK3},12729
Proportion of home deliveries Referred for post natal care (PNC) services,ny8xmo3td3C,Home deliveries referred for PNC (Community),#{JrdSl1ADdBC},#{X9d8oaBHDqx}
Proportion of households using treated water (perfomance),mc1ODtQR72i,Proportion of households using treated water,#{OXgWwVp4SLi},#{LGsW5FyZFwZ}
Proportion of households with fucntional latrines (perfomance),qhOGMZLJfAg,Proportion of households with fucntional latrines,#{b16FHzbfVUe.NhSoXUMPK2K},#{LGsW5FyZFwZ}
Proportion of households with upto date health insurance (New Visits),HGNEOgIubBL,Proportion of households  with H insurance,#{z9qwgod3UiG},#{LGsW5FyZFwZ}
Proportion of hypertension clients not meeting blood pressure target (>140/90mmHg),J9KIEQ6lgdR,% hypertension not meeting BP target (>140/90mmHg),#{CJB9gTlPyD5},#{gVW4hI8pdDb}
Proportion of malnourished clients provided with Food by prescription,HKjcXBNoemO,% of malnourished provided with FBP,#{wIUVuHpWTkW},#{oUsZ0Zo2YhG}
Proportion of maternal deaths audited,l1KEm2mpsDU,Maternal death audit,#{kAp7ViUXEKh.NhSoXUMPK2K},#{dPRCstLVkZu} + #{AC1Iorxdijc} + #{BYMSIbnUzXQ} + #{KDFtI6rqYwI}
Proportion of neonatal deaths audited within 7 days,d8zsNQ0g7KO,Proportion of neonatal deaths audited,#{tHRlLvvCObn},#{GAr6xu6f1n7}
Proportion of neonatal deaths due to birth asphyxia,HmwSSt98WoS,% of neonatal deaths due to birth asphyxia,#{dncP9CPM8QS},#{GAr6xu6f1n7}
Proportion of neonatal deaths due to sepsis,JVLBWqNijAe,Proportion of neonatal deaths due to sepsis,#{Q5XrSjTMXRi},#{GAr6xu6f1n7}
Proportion of neonatal deaths reported,EzkxYFVJTVl,Proportion of neonatal deaths reported,#{BA4dSFQINJq},#{HNl64GqRCd5}
Proportion of new ANC clients who are anaemic,tZCSLYPzSRp,Proportion of new ANC clients who are anaemic,#{T59McmnP4FJ},#{f9vesk5d4IY}
"Proportion of new HIV positive mothers out of total HIV positive in PMTCT ( ANC, MAT & PNC)  ",CBKaFVcGtH3,% of new HIV positive mothers Total ,#{nwXS5vxrrr7} + #{hn3aChn4sVx} + #{AfHArvGun12},#{KYpWTsp2yHv}
Proportion of new TB cases who know their HIV status,OsnclYGvDRw,%of new TB cases who know their HIV status,#{I6cSo3w0TkN},#{Vb9I1VRoaZt}
Proportion of new borns who received chlorhexidine digluconate 7.1% for umbilical cord care at birth,XqOUNSDBVyT,new borns applied chlorhexidine cord care,#{bPpRMDzpXXN},#{UqKC1DJnymn}
Proportion of new borns with low birth weight  (<2500g),HxWKVdBCNUe,Proportion of new borns with LBW  (<2500g),#{syjjPqXbjTm.NhSoXUMPK2K},#{UqKC1DJnymn.NhSoXUMPK2K}
Proportion of newborns who received vitamin K at birth,lt1oKCJQWWP,% newborns who received vitamin K at birth,#{HccwgsIZjnN},#{UqKC1DJnymn}
Proportion of newly diagnosed HIV clients linked to HIV care within 3 months of diagnosis,LQNEtOETxna,%of newly  HIV+ linked to HIV care within 3 month,#{NYkr7LlxmUg},#{l2OiHQroa5M}
Proportion of notified TB cases (all forms) contributed by non-national TB program providers – community referrals,e3M1IQqTTx0,Referral by CHV,#{V1Ido6I9xkA},#{xhQlihiebMH.WwOVo8ccFpn}
Proportion of patients  removed Casts,I1gKGzM3Rfw,Proportion of patients  removed Casts,#{Kg9hiOXlIKg},#{hrizXiyGvom} + #{uOC56DfVqib} + #{IEfyuOqoU2d} + #{LXTbgcVjV8p}  + #{uybnpBUS3np} + #{Kg9hiOXlIKg} + #{TMZfrOY1OJG} + #{Gjn4bEoaFZK}
Proportion of patients  removed; Casts,vA7xDAYJp6o,Proportion of patients  removed; Casts,#{Kg9hiOXlIKg},1
"Proportion of patients currently on ART ,who are virally suppressed",E7Jf3NBcYjG,"% patients currently on ART ,who are virally suppr",#{RNfqUayuZP2},#{MR5lxj7v7Lt}
Proportion of people age 45-75 years screened for colorectal cancer with a positive screening result,ppsJKbFYxMr,Prop 45-75  screened  colorectal cancer + result,(#{qojd0pB1cqG.xuvR3V5eYVW} + #{qojd0pB1cqG.ZiuHZWl2NPe} + #{qojd0pB1cqG.RSmIZI1R62V} + #{lqoWj3bLJtY.xuvR3V5eYVW} + #{lqoWj3bLJtY.ZiuHZWl2NPe} + #{lqoWj3bLJtY.RSmIZI1R62V} + #{DtbPQS4KWbo.xuvR3V5eYVW} + #{DtbPQS4KWbo.ZiuHZWl2NPe} + #{DtbPQS4KWbo.RSmIZI1R62V}),(#{qojd0pB1cqG.xuvR3V5eYVW} + #{qojd0pB1cqG.ZiuHZWl2NPe} + #{qojd0pB1cqG.RSmIZI1R62V} + #{lqoWj3bLJtY.xuvR3V5eYVW} + #{lqoWj3bLJtY.ZiuHZWl2NPe} + #{lqoWj3bLJtY.RSmIZI1R62V} + #{DtbPQS4KWbo.xuvR3V5eYVW} + #{DtbPQS4KWbo.ZiuHZWl2NPe} + #{DtbPQS4KWbo.RSmIZI1R62V} + #{w46XSyvQyYb.xuvR3V5eYVW} + #{w46XSyvQyYb.ZiuHZWl2NPe} + #{w46XSyvQyYb.RSmIZI1R62V} + #{tp8HEHpqx3T.xuvR3V5eYVW} + #{tp8HEHpqx3T.RSmIZI1R62V} + #{tp8HEHpqx3T.ZiuHZWl2NPe} + #{zt7cJpfaFSx.xuvR3V5eYVW} + #{zt7cJpfaFSx.ZiuHZWl2NPe} + #{zt7cJpfaFSx.RSmIZI1R62V})
Proportion of pregnant women attending 1st ANC,cNdSyYa0Q0H,Proportion of pregnant women attending 1st ANC,#{f9vesk5d4IY},#{tmlMpIqHimf}
Proportion of pregnant women attending ANC  provided with LLITNs,PfCFfxgVJNb,Proportion ANC  provided with LLITNS,#{eIvn8VgI5Zx},#{f9vesk5d4IY}
Proportion of pregnant women attending ANC who received combined  iron and folate supplements,uez88dD7zrL,% ANC Issued with combined Iron&Folate,#{NTLdyLadTk1.NhSoXUMPK2K},#{f9vesk5d4IY.NhSoXUMPK2K}+#{hxXwYIgT8rI.NhSoXUMPK2K}
Proportion of pregnant women receiving IPT3,mH7RgXUPbP7,IPT 3 Coverage,#{N931F2wuVVO},#{pct05jgGcLt}
Proportion of pregnant women referred for ANC (community),DAcYYjnywnT, pregnant women referred for ANC (community),#{VrpxWLhfIr6},#{NvUUbEhFVcO}
Proportion of pregnant women screened for syphilis at 1st ANC visit,aQjqu1MnqED,% of pregnant women screened for syphilis,#{i5jVVTm1vI8},#{uSxBUWnagGg}
Proportion of pregnant women who attended at least one ANC visit during pregnancy,Vxbu62QgqNB,ANC 1 Coverage,#{f9vesk5d4IY.NhSoXUMPK2K},#{pct05jgGcLt}
Proportion of registered new and relapse TB cases with documented HIV status,BgB8CvDhNUr,% registered  TB cases with HIV status,#{uFJqFxWUnQi.SW68XRmPP8J} + #{uFJqFxWUnQi.M5gPRkmYrbr},#{uFJqFxWUnQi.jrdAh5KQPkH}
Proportion of registered new and relapse TB patients with documented HIV+ status,ilwvSV9ScDf,% of registered TB patients with HIV+ status,#{uFJqFxWUnQi.SW68XRmPP8J},#{uFJqFxWUnQi.jrdAh5KQPkH}
Proportion of regnant &Lactating mothers with moderate Acute Malnutrition(MAM) who died while on treatment in the SFP  program (SFP PLW Death Rate- Nutrition 6-59 months),P30RTr730Og,SFP Death Rate - Nutrition PLW,#{SX03cV81yb0.RxueJ9pzyTM},#{myEpgfhSPLZ.RxueJ9pzyTM} + #{SX03cV81yb0.RxueJ9pzyTM} + #{sLFHgquSRGx.RxueJ9pzyTM} + #{WGdahj4S1QU.RxueJ9pzyTM}
Proportion of school age children dewormed (6-14yrs),X4Toj8kLsX3,Proportion of school age children dewormed 6-14yrs,#{i4yzzAyCrDk.NhSoXUMPK2K},(#{iYiM4K22JwD.NhSoXUMPK2K})-(#{KNrK5VWTZkx.NhSoXUMPK2K})
Proportion of secondary level facilities offering CEmONC services,gnM5ZkCaIeG,Proportion of secondary level facilities,#{e838Zwu48il},36
Proportion of survivors completing trauma counselling sessions,i9QVgAHH10j,Proportion completing trauma counselling sessions,#{mJFygTkNAiS},#{XxnWU21pRrS}
Proportion of survivors presenting within 72 hours,hdMBr5ZXoQL,Proportion of survivors presenting within 72 hours,#{c7kRskMlv4w},#{MhFarbZB9Fx}
Proportion of survivors seroconverting 3 months after exposure,kwANcrcYHrP,% of survivors seroconverting 3 months a,#{EvGD68D5qPZ},#{AC54kgHb6gP}
Proportion of survivors testing positive after PEP initiation,KvAMssrWCKn,Proportion testing positive after PEP initiation,#{xlOXUJvZlmT},#{XxnWU21pRrS}
Proportion of suspected malaria cases tested,v0QPfTutA0C,Proportion of suspected malaria cases tested,#{siOyOiOJpI8.lHl2rmXpHse}+#{siOyOiOJpI8.SeDaCnHi3m5},#{Lt0FqtnHraW.lHl2rmXpHse}+#{Lt0FqtnHraW.SeDaCnHi3m5}
Proportion of suspected malaria cases tested (Under 5yrs),D34Sf0xSLHo,Proportion suspected cases tested (Under5yrs),#{siOyOiOJpI8.lHl2rmXpHse},#{Lt0FqtnHraW.lHl2rmXpHse}
Proportion of suspected malaria cases that receive a parasitological test in the community,vqKKCwwQeTB, suspected malaria cases test, #{CVHsV294PjK} + #{NeUMw0K561Q} + #{TZHFXJrxbUU} + #{EA3C82Tnftk} + #{vmQj5H8ImG4} + #{nqa34Xgoq3T},#{M48SVvFpwHM} + #{UB5wMmYe9kL} + #{l2S58qxe2bt}
Proportion of targeted pregnant women provided with LLITNs,V4JsXZnGxak,LLITN Coverage in ANC,#{eIvn8VgI5Zx.NhSoXUMPK2K},#{pct05jgGcLt}
Proportion of tested for HIV TB patient,xogRbyE0Bh9,TB Testing,#{oq4vCrIRVxb.vVketPHJwSY}+#{oq4vCrIRVxb.g6112VF7T29}+#{oq4vCrIRVxb.omEDL5LVgDJ}+#{oq4vCrIRVxb.j03wX0lCHZc},#{BRzqHfgsmn9.vVketPHJwSY}+#{BRzqHfgsmn9.g6112VF7T29}+#{BRzqHfgsmn9.omEDL5LVgDJ}+#{BRzqHfgsmn9.j03wX0lCHZc}
Proportion of under 1 receiving Pneumococal3 ,qQwWfp8DJVp,Pneumococal3 coverage,#{h1GlCYbIQvU.ieuodyY5ybC},#{pMbuvKvH4rg.NhSoXUMPK2K}
Proportion of under 1 year receiving  receiving Rota 1,uCbcnmRz2FZ,Proportion of <1 yrs given Rota 1,#{KLmFbdqADgn.ieuodyY5ybC},#{pMbuvKvH4rg}
Proportion of under 1 year receiving BCG ,c0HtZ4wP9nS,BCG Coverage,#{O3qECFGrzeF.ieuodyY5ybC},#{pMbuvKvH4rg}
Proportion of under 1 year receiving DPT/Hep+HiB1 ,BnRDeg1IHov,DPT/Hep+HiB1 Coverage,#{ku80YRejJPg.ieuodyY5ybC},#{pMbuvKvH4rg.NhSoXUMPK2K}
Proportion of under 1 year receiving DPT/Hep+HiB3,o3YWDmrL9pq,DPT 3 Coverage,#{OyddF1qflzP.ieuodyY5ybC},#{pMbuvKvH4rg}
Proportion of under 1 year receiving OPV 2,KH4eOYS7USz,OPV 2 Coverage,#{OLlWZUfLtsR.ieuodyY5ybC},#{pMbuvKvH4rg.NhSoXUMPK2K}
Proportion of under 1 year receiving OPV birth dose ,QYUkPEhnhBX,OPV birth dose coverage,#{iX5pEjcJowF.ieuodyY5ybC},#{pMbuvKvH4rg.NhSoXUMPK2K}
Proportion of under 1 year receiving Pneumococal1 ,UU3Ngfx8Wep,Pneumococal1 coverage,#{L2dPeH9VkBc.ieuodyY5ybC},#{pMbuvKvH4rg}
Proportion of under 1 year receiving Rota 2,U0faEd0ybJL,Proportion of <1yrs given Rota 2,#{ZbGbUEnRxs1.ieuodyY5ybC},#{pMbuvKvH4rg}
Proportion of under 1 year receiving Rota 3,ZYKMn8f1btQ,Proportion of <1yrs given Rota 3,#{EsbbHHhwz5r.ieuodyY5ybC},#{pMbuvKvH4rg}
Proportion of under 1 year receiving Yellow Fever,pLSCG0MabCk,Yellow Fever Coverage,#{PJCUSyQ6Ahv.ieuodyY5ybC},#{pMbuvKvH4rg}
Proportion of under 1 year receiving receiving IPV,vwT4sgPezoL,Proportion of <1years receiving IPV,#{gw4Zog5qvBy.ieuodyY5ybC},#{pMbuvKvH4rg}
Proportion of under 1 year receiving vaccine against Measles and Rubella 1,biBPl5GYQNH,Measles & Rubella 1 coverage,#{sRbqc5gBQhI.ieuodyY5ybC},#{pMbuvKvH4rg}
Proportion of under two years receiving  vaccine against Measles and Rubella 2,OLNeFVlozVb,Proportion of <1yrs given MR2,#{Jw3alL29ZEi} ,#{pMbuvKvH4rg}
Proportion of women 25-49 years of age with a positive cervical cancer screening test who received treatment for pre-cancerous lesions,NYKM1wOqwW5,Prop 25-49 ypositive cervical canceions,(#{Yv6LiN65lCJ.fxXNsn1ppIe} + #{Yv6LiN65lCJ.gLkLCkCx1Ad} + #{Yv6LiN65lCJ.SMt1XYz1xId} + #{MIQ3HgFlHnS.fxXNsn1ppIe} + #{MIQ3HgFlHnS.gLkLCkCx1Ad} + #{MIQ3HgFlHnS.SMt1XYz1xId} + #{uXi8AjF8YR0.fxXNsn1ppIe} + #{uXi8AjF8YR0.gLkLCkCx1Ad} + #{uXi8AjF8YR0.SMt1XYz1xId} + #{lx4fx2bluTm.fxXNsn1ppIe} + #{lx4fx2bluTm.gLkLCkCx1Ad} + #{lx4fx2bluTm.SMt1XYz1xId}),(#{xBjAMa2KFwD.fxXNsn1ppIe} + #{xBjAMa2KFwD.gLkLCkCx1Ad} + #{xBjAMa2KFwD.SMt1XYz1xId} + #{wYHt86csbhn.fxXNsn1ppIe} + #{wYHt86csbhn.gLkLCkCx1Ad} + #{wYHt86csbhn.SMt1XYz1xId} + #{KLQZDP0ycOY.fxXNsn1ppIe} + #{KLQZDP0ycOY.gLkLCkCx1Ad} + #{KLQZDP0ycOY.SMt1XYz1xId})
Proportion of women 25-49 years of age with screened for cervical cancer with a positive result ,LvfWRKydeiH,Propwomen 25-49 yrs with cacxcer with a pos ,(#{xBjAMa2KFwD.fxXNsn1ppIe} + #{xBjAMa2KFwD.gLkLCkCx1Ad} + #{xBjAMa2KFwD.SMt1XYz1xId} + #{wYHt86csbhn.fxXNsn1ppIe} + #{wYHt86csbhn.gLkLCkCx1Ad} + #{wYHt86csbhn.SMt1XYz1xId} + #{KLQZDP0ycOY.fxXNsn1ppIe} + #{KLQZDP0ycOY.gLkLCkCx1Ad} + #{KLQZDP0ycOY.SMt1XYz1xId}),(#{rFtB3keaVWm.fxXNsn1ppIe} + #{rFtB3keaVWm.gLkLCkCx1Ad} + #{rFtB3keaVWm.SMt1XYz1xId} + #{gQro1y7Rsbq.fxXNsn1ppIe} + #{gQro1y7Rsbq.gLkLCkCx1Ad} + #{gQro1y7Rsbq.SMt1XYz1xId} + #{VR7vdS7P0Gb.fxXNsn1ppIe} + #{VR7vdS7P0Gb.gLkLCkCx1Ad} + #{VR7vdS7P0Gb.SMt1XYz1xId})
Proportion of women 40-74 years screened for breast cancer with abnormal screening results,FTwZW8DZe0L,Prop women 40-74 breast abnormal results,(#{XEX93uLsAm2.BOlkmyThYPV} + #{XEX93uLsAm2.MCjWEzxjm9Z} + #{cLlPY6DlvW7.BOlkmyThYPV} + #{cLlPY6DlvW7.MCjWEzxjm9Z} + #{NPiyy6QSi7I.BOlkmyThYPV} + #{NPiyy6QSi7I.MCjWEzxjm9Z} + #{mJrNfjiiNDE.BOlkmyThYPV} + #{mJrNfjiiNDE.MCjWEzxjm9Z} + #{Sorvgq7NDug.BOlkmyThYPV} + #{Sorvgq7NDug.MCjWEzxjm9Z} + #{bi1ipJR6zNJ.BOlkmyThYPV} + #{bi1ipJR6zNJ.MCjWEzxjm9Z} + #{APhWHU4KLWF.BOlkmyThYPV} + #{APhWHU4KLWF.MCjWEzxjm9Z}),(#{cXe64Yk0QMY.BOlkmyThYPV} + #{cXe64Yk0QMY.MCjWEzxjm9Z} + #{XEX93uLsAm2.BOlkmyThYPV} + #{XEX93uLsAm2.MCjWEzxjm9Z} + #{MmffJIuHxFm.BOlkmyThYPV} + #{MmffJIuHxFm.MCjWEzxjm9Z} + #{cLlPY6DlvW7.BOlkmyThYPV} + #{cLlPY6DlvW7.MCjWEzxjm9Z} + #{NPiyy6QSi7I.BOlkmyThYPV} + #{NPiyy6QSi7I.MCjWEzxjm9Z} + #{mJrNfjiiNDE.BOlkmyThYPV} + #{mJrNfjiiNDE.MCjWEzxjm9Z} + #{T3crNg5D3Xa.BOlkmyThYPV} + #{T3crNg5D3Xa.MCjWEzxjm9Z} + #{Sorvgq7NDug.BOlkmyThYPV} + #{Sorvgq7NDug.MCjWEzxjm9Z} + #{bi1ipJR6zNJ.BOlkmyThYPV} + #{bi1ipJR6zNJ.MCjWEzxjm9Z} + #{APhWHU4KLWF.BOlkmyThYPV} + #{APhWHU4KLWF.MCjWEzxjm9Z})
Proportion of women Enrolled in HIV Care screened for Cervical Cancer,UmkI9cASZDY,prop. wmn Enrd HIV Care screened  Cervical Cancer,#{kLOV2cSRS3i},#{OL1vSu52qrw}
Proportion of women provided with IPT1 during the ANC visits,cGnlqeEOkQV,IPT 1 Coverage,#{gAKCshSgSH3.NhSoXUMPK2K},#{tmlMpIqHimf.NhSoXUMPK2K}
Proportion of women provided with IPT2 during the ANC visits,nIZFHwh1vy0,IPT 2 Coverage,#{EHGBrVPiG3N.NhSoXUMPK2K},#{tmlMpIqHimf.NhSoXUMPK2K}
Proportion of women screened at 1st ANC who test positive for syphilis ,tIhCLmmdB2h,% of 1st ANC who test positive for syphilis ,#{hZrdUVigO54},#{i5jVVTm1vI8}
Proportion of women who have postpartum cantact with a health provider within 2 day of delivery,duXznbyEgAU,Mothers receiving Postpartum Care within 48 hours,#{qahRo2120r8},#{jaPrPmor6WV} +#{rAZBTMa7Jy3} + #{sMqM8DwiAaj} + #{Kx64gGqaFVq}
Quarterly Community dialogue days held,bCrn6mOyjBF,Quarterly Community dialogue days held,#{iiJhU1VFgoO.NhSoXUMPK2K},1
Quinine (200mg) Tabs Quantity for resupply,zDx46dxDLQ5,Quinine (200mg) Tabs Quantity for resupply,((#{TH5xz4WcRI7.w77uMi1KzOH}*[days]/[days]-#{TH5xz4WcRI7.DV8l1KuASLR})*3)-#{TH5xz4WcRI7.rPAsF4cpNxm},1
Quinine (300mg) Tabs Quantity for Resupply,pDZ2fmwwVpS,Quinine (300mg) Tabs Quantity for Resupply,((#{EjdfgUUAfJO.w77uMi1KzOH}*[days]/[days]-#{EjdfgUUAfJO.DV8l1KuASLR})*3)-#{EjdfgUUAfJO.rPAsF4cpNxm},1
Quinine Injection MOS,F34j1JsLgHy,Quinine Injection MOS,#{TH5xz4WcRI7.rPAsF4cpNxm},#{TH5xz4WcRI7.w77uMi1KzOH}
Quinine Injections (600mg/2ml) Adjusted Consumption,FKbKw7VfpB6,Quinine Inject 600mg/2ml,#{qeK4CnBmpBQ.w77uMi1KzOH}*31,31-#{qeK4CnBmpBQ.DV8l1KuASLR}
Quinine Tabs (200mg) Adjusted Consumption,Xn9Jasvh7fJ,Quinine Tabs 200mg,#{TH5xz4WcRI7.w77uMi1KzOH}*31,31-#{TH5xz4WcRI7.DV8l1KuASLR}
Quinine Tabs (300mg) Adjusted Consumption,azKQf8wCkgL,Quinine Tabs 300mg,#{EjdfgUUAfJO.w77uMi1KzOH}*31,31-#{EjdfgUUAfJO.DV8l1KuASLR}
Quinine inj(600mg/2ml) Amps Quantity for resupply,z4EWxX4A0BD,Quinine inj(600mg/2ml) Amps Quantity for resupply,((#{qeK4CnBmpBQ.w77uMi1KzOH}*[days]/[days]-#{qeK4CnBmpBQ.DV8l1KuASLR})*3)-#{qeK4CnBmpBQ.rPAsF4cpNxm},1
RTK Confirmatory MOS,mba4XxmJ29j,RTK Confirmatory MOS,#{fgGcpHh5Bl6.ZxUQw1ay1cw},#{fgGcpHh5Bl6.HMJ9YZLMqo3}
RTK Tiebreaker MOS,ztYVjYFjPAL,RTK Tiebreaker MOS,#{H3PiVz5cdlS.ZxUQw1ay1cw},#{H3PiVz5cdlS.HMJ9YZLMqo3}
RTKScreening Consumption,KyL9kaPVxCN,RTKScreening Consumption,#{nNhisoZuTzR.HMJ9YZLMqo3},1
RTKScreening MOS,QAPKwjDVLqd,RTKScreening MOS,#{nNhisoZuTzR.ZxUQw1ay1cw},#{nNhisoZuTzR.HMJ9YZLMqo3}
Rapid Diagnostic Tests Adjusted Consumption,jA6S2paYxln,Rapid Diagnostic Tests,#{cPlWFYbBacW.w77uMi1KzOH}*31,31-#{cPlWFYbBacW.DV8l1KuASLR}
Rapid Diagnostic Tests Quantity for Resupply,jh3T4zwLxbU,Rapid Diagnostic Tests Quantity for Resupply,((#{cPlWFYbBacW.w77uMi1KzOH}*[days]/[days]-#{cPlWFYbBacW.DV8l1KuASLR})*3)-#{cPlWFYbBacW.rPAsF4cpNxm},1
RapidMOS,HweghoiGWkb,RapidMOS,#{nNhisoZuTzR.ZxUQw1ay1cw},#{nNhisoZuTzR.HMJ9YZLMqo3}
Ratio of facility based  Maternal deaths Scorecard,Ox2MfO5BCll,Ratio of facility based  Maternal deaths,#{eBHhfupqMHz.NhSoXUMPK2K},#{UqKC1DJnymn.NhSoXUMPK2K}
Receipts (Sources of Funds),EI4th2ByQnI,Receipts (Sources of Funds),#{QokZ5jjGLRz.NhSoXUMPK2K}+#{H5NKPaRikyM.NhSoXUMPK2K}+#{cKGenTODtq8.NhSoXUMPK2K}+#{nspiDhcn12j.NhSoXUMPK2K}+#{zo5v2sL2Pcz.NhSoXUMPK2K}+#{YkVzbDfJKMy.NhSoXUMPK2K}+#{FLT5619aj9V.NhSoXUMPK2K},1
Receipts over Expenditure,dYmzM6qIVbU,Receipts over Expenditure,(#{QokZ5jjGLRz.NhSoXUMPK2K}+#{H5NKPaRikyM.NhSoXUMPK2K}+#{cKGenTODtq8.NhSoXUMPK2K}+#{nspiDhcn12j.NhSoXUMPK2K}+#{zo5v2sL2Pcz.NhSoXUMPK2K}+#{YkVzbDfJKMy.NhSoXUMPK2K}+#{FLT5619aj9V.NhSoXUMPK2K})-(#{jY3JFizFzQN.NhSoXUMPK2K}+#{usMDjlboKn4.NhSoXUMPK2K}+#{WuEJXcFURTY.NhSoXUMPK2K}+#{t75eApxzxfv.NhSoXUMPK2K}+#{q04fFLke4PE.NhSoXUMPK2K}+#{IxfhqZSgGy9.NhSoXUMPK2K}+#{QrHdlGiLTpv.NhSoXUMPK2K}+#{nGagRoo4BzA.NhSoXUMPK2K}+#{RijWww0GNyd.NhSoXUMPK2K}+#{sDEtpJj8IeQ.NhSoXUMPK2K}+#{VV8rxMutqgB.NhSoXUMPK2K}+#{W6kjK1t3oha.NhSoXUMPK2K}+#{DOPHF9sDlCE.NhSoXUMPK2K}+#{uHj0fEYrjTx.NhSoXUMPK2K}+#{Q3Dtz4uTL0J.NhSoXUMPK2K}+#{RIdOyfRqT15.NhSoXUMPK2K}+#{KAVPEvsu7GB.NhSoXUMPK2K}+#{sW1FEKkUlno.NhSoXUMPK2K}+#{JgjYnWEbbXI.NhSoXUMPK2K}+#{GeLsHQnBJSl.NhSoXUMPK2K}+#{Anntg74AWAc.NhSoXUMPK2K}+#{NAWDpCTju9c.NhSoXUMPK2K}+#{uIKFwsGjL8l.NhSoXUMPK2K}+#{zfE43ojuX27.NhSoXUMPK2K}+#{Jm0j7eIJw22.NhSoXUMPK2K}+#{Kvrh6Edh4ux.NhSoXUMPK2K}+#{kZVa4Dfz3oW.NhSoXUMPK2K}+#{ozuOGiiROjR.NhSoXUMPK2K}+#{zq5cC1mHOjZ.NhSoXUMPK2K}+#{kkKxlgb0SIK.NhSoXUMPK2K}+#{eWJI88NUHju.NhSoXUMPK2K}+#{ZL5umjFvNZT.NhSoXUMPK2K}+#{kMyKJqs4tP6.NhSoXUMPK2K}+#{JfMlkDb7sfP.NhSoXUMPK2K}+#{ERUP9jd5kr8.NhSoXUMPK2K}+#{VE7bP4Hd0Y8.NhSoXUMPK2K}+#{G10FiANc4uK.NhSoXUMPK2K}+#{jER1yfrClYQ.NhSoXUMPK2K}+#{zmTKl26bqXb.NhSoXUMPK2K}+#{JqVPN31hItf.NhSoXUMPK2K}+#{FNaQfndi92d.NhSoXUMPK2K}+#{pwYhMY7SObK.NhSoXUMPK2K}+#{T6Zosl4H5TG.NhSoXUMPK2K}+#{W53qF6leiPm.NhSoXUMPK2K}+#{MxceLE1Wgwj.NhSoXUMPK2K}+#{HGfobnG3qSX.NhSoXUMPK2K}+#{WypNzlF1rxb.NhSoXUMPK2K}+#{kltZozM5rkg.NhSoXUMPK2K}+#{SWHhf1eE89t.NhSoXUMPK2K}+#{qLWHhVTIp0l.NhSoXUMPK2K}+#{s2Ha3e0xwwp.NhSoXUMPK2K}+#{RMsgMQj2SBM.NhSoXUMPK2K}+#{X3nuiSHRJJP.NhSoXUMPK2K}+#{bDSQEZM3rtd.NhSoXUMPK2K}+#{dvo26Xu2g3G.NhSoXUMPK2K}+#{ksAM140tLvc.NhSoXUMPK2K}+#{mYIZtgEPa5S.NhSoXUMPK2K}+#{RWwJcCEIcZw.NhSoXUMPK2K}+#{u9TiVtfs3or.NhSoXUMPK2K}+#{BsyP5AnR1pE.NhSoXUMPK2K}+#{p4Vk0aCXUKj.NhSoXUMPK2K}+#{ZysDicYyDxN.NhSoXUMPK2K}+#{aLt2Db8y8VE.NhSoXUMPK2K}+#{Mnz4Ts6dMVo.NhSoXUMPK2K}+#{Mnz4Ts6dMVo.NhSoXUMPK2K}+#{Tpp5Fh9rV07.NhSoXUMPK2K}+#{sDEtpJj8IeQ.NhSoXUMPK2K}+#{DOPHF9sDlCE.NhSoXUMPK2K}+#{uHj0fEYrjTx.NhSoXUMPK2K}),1
Relapse PTB+ and are HIV+ out of Tested Relapse PTB+,E5Y4QzCLAr1,% Relapse PTB+ HIV+,#{Vri74blSuoL.oAk5orcJaEF},#{CQVzChlE9qw.oAk5orcJaEF}
Relapse PTB+ out of total TB cases,kjw3pczHfNI,% Relapse PTB+  Total TB,#{MmsSJfunbRu.oAk5orcJaEF},#{MmsSJfunbRu}
Relapse PTB+ tested for HIV of the registered Relapse PTB+,gqBuntm5nyf,% Relapse PTB+ tested HIV,#{CQVzChlE9qw.oAk5orcJaEF},#{MmsSJfunbRu.oAk5orcJaEF}
Relapse PTB-/EPTB  tested HIV+ out of tested Relapse PTB-/EPTB,VTO5UfUV7ES,Relapse PTB-/EPTB HIV+,#{Vri74blSuoL.wMCUnTibIsX},#{CQVzChlE9qw.wMCUnTibIsX}
Relapse PTB-/EPTB tested for HIV   out of registered Relapse PTB-/EPTB,GHjsbOjiE0a,% Relapse PTB-/EPTB,#{CQVzChlE9qw.wMCUnTibIsX},#{MmsSJfunbRu.wMCUnTibIsX}
Relapse PTB-/EPTB+ out of total TB cases,eV0I6ptDxR9,%Relapse PTB-/EPTB,#{MmsSJfunbRu.wMCUnTibIsX},#{MmsSJfunbRu}
Repeat Testers Proportion,xo0jvSL3uz0,Repeat  Testers,#{jbzrwpsfYMN.NhSoXUMPK2K},#{jbzrwpsfYMN.NhSoXUMPK2K}+#{Aioi6LxPb3N.NhSoXUMPK2K}
Reporting Rate (MOH 711),uUp0Wl8wOo1,Reporting Rate (MOH 711),R{UpS2bTVcClZ.ACTUAL_REPORTS},R{UpS2bTVcClZ.EXPECTED_REPORTS}
Reporting Rate within Community Unit,u2vcvolt090,CU Reporting rate,#{mGfDUtnX1uH.NhSoXUMPK2K},#{h8hqsoPBwFq.NhSoXUMPK2K}
Return after Default  HIV+ out of Tested Return after Default,lTWQYgoj7lz,% Return after Default  H,#{Vri74blSuoL.tHclu1dgnFD},#{CQVzChlE9qw.tHclu1dgnFD}
Return after Default and are HIV+ out of Tested Return after Default,fqESKnsF268,% Return Default HIV+,#{Vri74blSuoL.tHclu1dgnFD},#{CQVzChlE9qw.tHclu1dgnFD}
Return after Default out of total TB cases,BczA6ulNEIg,% Return after Default,#{MmsSJfunbRu.tHclu1dgnFD},#{MmsSJfunbRu}
Return after Default tested for HIV of the registered Returnr Default,CixOPuuGyGE,% Returnr Default HIV,#{CQVzChlE9qw.tHclu1dgnFD},#{MmsSJfunbRu.tHclu1dgnFD}
Road traffic injuries (facility) per 1000 OPD visits,cbliztiDulq,RTA injuries (facility) per 1000 opd visits,#{I5611kWZgh8},(#{IxhbkNwhcvE.lHl2rmXpHse} + #{IxhbkNwhcvE.SeDaCnHi3m5} + #{BwROYFIiXKG.lHl2rmXpHse} + #{BwROYFIiXKG.SeDaCnHi3m5})
SFP Recovery Rate- Nutrition 6-59 months,sTB6ocEUVpQ,SFP Recovery Rate- Nutrition 6-59 months,#{myEpgfhSPLZ.g3NguFeSV2h} + #{myEpgfhSPLZ.J4oQVAR80oo},#{myEpgfhSPLZ.g3NguFeSV2h} + #{myEpgfhSPLZ.J4oQVAR80oo} +#{SX03cV81yb0.g3NguFeSV2h} + #{SX03cV81yb0.J4oQVAR80oo} + #{sLFHgquSRGx.g3NguFeSV2h} + #{sLFHgquSRGx.J4oQVAR80oo} + #{WGdahj4S1QU.g3NguFeSV2h} + #{WGdahj4S1QU.J4oQVAR80oo}
SFP total admissions,y2kZ1qQGhsR,SFP total admissions,#{cs3igWdcTtr} + #{IJnsnK5HtAt} + #{B7xc7C2bwmI}  + #{sgvaNvr1bSv},1
SGBV_Proportion of sexual violence survivors who received comprehensive care,mh3d6mtP2MF,SGBV_survivors who received comprehensive care,#{WXQP6ourCcG},#{v4xg5WthUSY}
SGBV_Total SGBV cases,fXRK6N7zP2N,Total SGBV cases,#{v4xg5WthUSY.NhSoXUMPK2K} + #{E4p5o4PgvMc.NhSoXUMPK2K},1
SGBV_Total SGBV cases (<18 yrs),iX9u55ukPtr,SGBV_Total SGBV cases (<18 yrs),#{SdPjpBJwrGq} + #{p75N1HqTcDm},1
SGBV_proportion of sexual violence survivors completed on PEP for HIV,plrjNGIsLci,survivors completed on PEP for HIV,#{E4p5o4PgvMc.NhSoXUMPK2K},#{v4xg5WthUSY.NhSoXUMPK2K}
SSI2022_Total number of Ceaserian sections,pCEWFSsQInH,Total number of Ceaserian sections,#{zCRJ4ewe4zj.gCzcvmYlYd5} + #{oqw6eWy5Zvw.gCzcvmYlYd5},1
SSI_2022_Incidence of surgical site infections(SSI) post caesarean section,CNhiaUPyUd3,Incidence of (SSI) post caesarean section,#{ibkTjUtwb2v.cei2o8zhP8b} + #{Gpndi3wlefY.cei2o8zhP8b} + #{dsBHTvn6sYV.cei2o8zhP8b},#{LVT4UNJmcqh}
Screening test (Determine) MoS,Evw5X3BVjyX,Screening test (Determine) MoS,#{z03HNuc5LEN.CGnwPpnZ7n7},#{BwCUxZno6JV.QvctQfKAQn3}
Severe Malnutrition Coverage,HRVuTimdokZ,Severe Malnutrition Cov,#{K4hrSqX6zW7},#{KNrK5VWTZkx.NhSoXUMPK2K}
Severe Malnutrition Performance,YHL46V3Xtkw,Severe Malnutrition Perf,#{K4hrSqX6zW7},#{Z1KYWodTTTf.ea7VHlwMkhH}
Sinopharm_vaccine_type,ZaxUESUt1Ur,Sinopharm_vaccine_type,#{gOksPnou3je} + #{NHd2e6QGCkk},1
Skilled Deliveries Missed Opportunities,MHmKiukySbZ,Skilled Deliveries Missed Opportunities,#{pct05jgGcLt} - (#{jaPrPmor6WV} + #{rAZBTMa7Jy3} + #{sMqM8DwiAaj} + #{Kx64gGqaFVq}),1
Smear Negative Pulmonary TB,kHwPzZc7uBp,Smear Negative,#{hNsd8cQIYun.vVketPHJwSY}+#{hNsd8cQIYun.g6112VF7T29}+#{hNsd8cQIYun.omEDL5LVgDJ}+#{hNsd8cQIYun.j03wX0lCHZc},#{BRzqHfgsmn9.vVketPHJwSY}+#{BRzqHfgsmn9.g6112VF7T29}+#{BRzqHfgsmn9.omEDL5LVgDJ}+#{BRzqHfgsmn9.j03wX0lCHZc}
Smear Positive Pulmonary TB,GenEEw5KWtJ,Smear Positive,"#{VihTrdMMli8.vVketPHJwSY}+#{VihTrdMMli8.g6112VF7T29}+
#{VihTrdMMli8.omEDL5LVgDJ}+#{VihTrdMMli8.j03wX0lCHZc}",#{BRzqHfgsmn9.vVketPHJwSY}+#{BRzqHfgsmn9.g6112VF7T29}+#{BRzqHfgsmn9.omEDL5LVgDJ}+#{BRzqHfgsmn9.j03wX0lCHZc}
Smear negative TB Total,byFQe3vxS4a,Smear negative TB Total,#{hNsd8cQIYun},1
Smear positive TB Total,wJbXrg7ZpR9,Smear positive TB Total,#{VihTrdMMli8},1
"Sodium chloride, 0.9% (isotonic), (500mL bottle) (Bottle) MoS",qOKc8iEdsZ8,"Sodium chloride, 0.9% (isotonic), (500mL bottle) ",#{jiOLjNl8eXE.n8XlCFUpWOG},#{ZkMqBIlB6h4.QvctQfKAQn3}
Sodium hypochlorite solution 4-6% (5Lt Jar) MoS,mLJhBXN6d3m,Sodium hypochlorite solution 4-6% (5Lt Jar),#{VwIbS3g8kPG.n8XlCFUpWOG},#{JGcQHMwZP0b.QvctQfKAQn3}
Stabilisation Centre total admissions,jRrjjBG0cov,SC total admissions,#{Bd0iiac6bo5.KfdnIJGDpJ4} + #{Bd0iiac6bo5.g3NguFeSV2h} + #{Bd0iiac6bo5.J4oQVAR80oo} + #{uiZFrHhwcMJ.KfdnIJGDpJ4} + #{uiZFrHhwcMJ.g3NguFeSV2h} + #{uiZFrHhwcMJ.J4oQVAR80oo} + #{vGdvTPt1JQV.KfdnIJGDpJ4} + #{vGdvTPt1JQV.g3NguFeSV2h} + #{vGdvTPt1JQV.J4oQVAR80oo} + #{NMTIio5bwmM.KfdnIJGDpJ4} + #{NMTIio5bwmM.g3NguFeSV2h} + #{NMTIio5bwmM.J4oQVAR80oo},1
Started ART,nVYOxM6Qevp,Number Started on ART (Sum all age groups),#{jthpt5cVV9c} + #{LC2OqnUC5Sn} + #{DaNcGZnkclz} + #{yWkSi8L3qGm} + #{Hbc2qRi0U5x} + #{mACm1JUzeLT} + #{zNCSlBKbS6d} + #{K59f8nZ5vhy} + #{Nv4OkbdDvmm} + #{SCMKsiNj6c5},1
"Started on Infant Prophylaxis in ANC, L&D and PNC",LhVCexhVr4n,"Started on Infant Prophylaxis in ANC, L&D and PNC",#{RY1js5pK2Ep} + #{HAumxpKBaoK} + #{Jn6ATTfXp02},1
Still birth rate,lQcIWTAxqMa,Still birth rate,(#{rYn8RCcHJg1.NhSoXUMPK2K})+(#{wZtDYVBa41h.NhSoXUMPK2K}),(#{rYn8RCcHJg1.NhSoXUMPK2K}+#{wZtDYVBa41h.NhSoXUMPK2K})+#{UqKC1DJnymn.NhSoXUMPK2K}
Stunting Rate,cuujj7SE9fZ,Stunting Rate,#{fGAuIUP6lHC}+#{mnsOAdOfXSi}+#{YloG1P6jXSR},#{KNrK5VWTZkx}
Sub-county TB_2017 Rifapentine + Isoniazid 300/300mg,aya5qGHWYv1,Rifapentine + Isoniazid 300/300mg,(#{Ak39JAb6v08.e2os98CantY} * 2) - #{APyPtjgxmmm.i65ATXAav6k},1
Sub-county TB_2017 Rifapentine 150mg,ZY3YFqiW86m,Sub-county TB_2017 Rifapentine 150mg,(#{BfXSH6Bcgd8.e2os98CantY} * 2) - #{aLIbEUxsRpC.i65ATXAav6k},1
Subcount TB_2017 Amoxiclavulin 1gm,Krprg54ehAF,Amoxiclavulin 1gm,(#{mHP7rUjFTTY.e2os98CantY} * 3) - (#{mHP7rUjFTTY.TRw8Amoledr} + #{u33m3ptjO4F.TRw8Amoledr}),1
Subcount TB_2017 Azithromycin 500mg,PBejqxhvG7V,Azithromycin 500mg,(#{WFCn1iUUcIC.voMGxzxapMN} * 3) - (#{WFCn1iUUcIC.TRw8Amoledr} + #{V7YK0NMirAW.TRw8Amoledr}),1
Subcount TB_2017 Beclomethasone inhaler,NtZrZKSOa2J,Beclomethasone inhaler,(#{Y7gPHtYCDr3.e2os98CantY} * 3) - (#{Y7gPHtYCDr3.TRw8Amoledr} + #{yUUYYPvGa9f.TRw8Amoledr}),1
Subcount TB_2017 Carbamezebine 200mg,HDNdHgS1Aez,Subcount TB_2017 Carbamezebine 200mg,(#{nADIXnQjn5X.e2os98CantY} * 3) - (#{jhvmdN8Wzbz.i65ATXAav6k} + #{nADIXnQjn5X.TRw8Amoledr}),1
Subcount TB_2017 Dexamethazone 6mg  ,eh6DM4aJgfk,Dexamethazone 6mg  ,(#{LsESMSgHcBJ.e2os98CantY} * 3) - (#{LsESMSgHcBJ.TRw8Amoledr} + #{jTFhfOAMAZJ.TRw8Amoledr}),1
Subcount TB_2017 Formoterol fumarate tubohaler,JEXggH2pBzP,Formoterol fumarate tubohaler,(#{jlOADslbCdY.e2os98CantY} * 3) - (#{jlOADslbCdY.TRw8Amoledr}  + #{N1LncVEUWND.TRw8Amoledr}),1
Subcount TB_2017 Gloves,PPJgUBGzav5,Gloves,(#{XDfVSKTx8fb.e2os98CantY} * 3) - (#{XDfVSKTx8fb.TRw8Amoledr} + #{YJ0WA2Eu6EW.TRw8Amoledr}),1
Subcount TB_2017 Hydrocortisone 20mg,FSH43IusbkY,Hydrocortisone 20mg,(#{t5DU9lxKgcW.e2os98CantY} * 3) - (#{t5DU9lxKgcW.TRw8Amoledr} + #{ECzsR9MiH1l.TRw8Amoledr}),1
Subcount TB_2017 Hydroxyquinolone (HCQ) 600mg,D2bq4gNMXUo,Hydroxyquinolone (HCQ) 600mg,(#{TKDMm5FgSRr.e2os98CantY} * 3) - (#{TKDMm5FgSRr.TRw8Amoledr} + #{eHEYO2RHOEM.TRw8Amoledr}),1
Subcount TB_2017 Inhalers,PzjT2M7xywP,Inhalers,(#{tqvroR4eECO.e2os98CantY}  * 3) - (#{tqvroR4eECO.TRw8Amoledr} + #{tjuzwl6mABi.TRw8Amoledr}),1
Subcount TB_2017 Ipratropium bromide inhaler,mXpoG8s3jQr,Ipratropium bromide inhaler,(#{Zvq6hyfQSzm.e2os98CantY} * 3) - (#{Zvq6hyfQSzm.TRw8Amoledr} + #{BPR8n4apoMY.TRw8Amoledr}),1
Subcount TB_2017 Masks KN95,rEkCUpJ33YI,Masks KN95,(#{gAq62iuXlyH.e2os98CantY} * 3) - (#{gAq62iuXlyH.TRw8Amoledr} + #{OBAk9BarSfF.TRw8Amoledr}),1
Subcount TB_2017 Masks N95,j4nJ1OPInVI,Masks N95,(#{ycKXmDGOcVQ.e2os98CantY} * 3 ) - (#{ycKXmDGOcVQ.TRw8Amoledr} + #{gZY2vrPDYW5.TRw8Amoledr}),1
Subcount TB_2017 Masks surgical,aGkdmvnplCk,Masks surgical,(#{tCc5Bh2goul.e2os98CantY} * 3) - (#{tCc5Bh2goul.TRw8Amoledr} + #{u1eTCLgI4DU.TRw8Amoledr}),1
Subcount TB_2017 Methyl -prednisolone 5mg,C2bLzkYXkVx,Methyl -prednisolone 5mg,(#{Rp647ZSkkff.e2os98CantY} * 3) - (#{Rp647ZSkkff.TRw8Amoledr} + #{bVh0GNRSLaH.TRw8Amoledr}),1
Subcount TB_2017 Montelukast 5mg,DBjoTUIT0YZ,Montelukast 5mg,(#{wzdknuko9QA.e2os98CantY} * 3) - (#{wzdknuko9QA.TRw8Amoledr} + #{ZHfmMBeYMmr.TRw8Amoledr}),1
Subcount TB_2017 Nebulizers,E9FFHv8pQAM,Nebulizers,(#{L4jPNf5l1tv.e2os98CantY} * 3) - (#{L4jPNf5l1tv.TRw8Amoledr} + #{zqjrtIAagiu.TRw8Amoledr}),1
Subcount TB_2017 Nirmatrevir/ritonavir 150mg/100mg,mCWGDS9roCB,Nirmatrevir/ritonavir 150mg/100mg,(#{M9ExhULkaGz.ShAXH8W58Ju} * 3) - (#{M9ExhULkaGz.dRvK7VxuTSd} + #{wkWZQLyu8X4.i65ATXAav6k}),1
Subcount TB_2017 Omeprazole 20mg,WlU3YVjrxtG,Subcount TB_2017 Omeprazole 20mg,(#{XWIm2t6lglg.e2os98CantY} * 3) - (#{XWIm2t6lglg.TRw8Amoledr} + #{Vt0EQwXVIGf.i65ATXAav6k}),1
Subcount TB_2017 Peakfow meters,UkhnuVNhJJf,Peakfow meters,(#{IBcqtCtwUCZ.e2os98CantY} * 3) - (#{IBcqtCtwUCZ.TRw8Amoledr} + #{joruBJwXdsc.TRw8Amoledr}),1
Subcount TB_2017 Redemsavir 100mg,V9sfeEV1gBd,Redemsavir 100mg,(#{hGzJIJhxjZy.e2os98CantY} * 3) - (#{hGzJIJhxjZy.TRw8Amoledr} + #{j1L9wWEI9Zb.TRw8Amoledr}),1
Subcount TB_2017 Salbutamol inhaler,PdZ7AX2hbn3,Salbutamol inhaler,(#{uJxT82ybnOf.e2os98CantY} * 3) - (#{uJxT82ybnOf.TRw8Amoledr} + #{hu4HZoRlAVW.TRw8Amoledr}),1
Subcount TB_2017 Sanitizers 0.5 Ltr,S8CpW9WbeUR,Sanitizers 0.5 Ltr,(#{iPgIJNN8V5F.e2os98CantY} * 3) - (#{iPgIJNN8V5F.TRw8Amoledr} + #{nRxiJzyGQ1x.TRw8Amoledr}),1
Subcount TB_2017 Spacers,MNOr2NeORnd,Spacers,(#{eDaqTtzslrs.e2os98CantY} * 3) - (#{eDaqTtzslrs.TRw8Amoledr} + #{dEJ57nyjmFt.TRw8Amoledr}),1
Subcount TB_2017 Spirometer,Wc5n7kdSSex,Spirometer,(#{TFoxzxJVEun.e2os98CantY} * 3) - (#{TFoxzxJVEun.TRw8Amoledr} + #{NFALvjf6rBM.TRw8Amoledr}),1
Subcounty TB_2017 Capreomycin 1gm vial,TFWJsHJKflI,Subcounty TB_2017 Capreomycin 1gm vial,(#{XUq7mFujyzS.e2os98CantY} * 3) - ( #{H31HfJJVUG2.i65ATXAav6k} + #{XUq7mFujyzS.TRw8Amoledr}),1
Subcounty TB_2017 Clofazimine 100mg,mpaZgbkoiGq,Subcounty TB_2017 Clofazimine 100mg,(#{yv1hvHcKgrH.e2os98CantY} * 3) - ( #{mVtZxMVagWR.i65ATXAav6k} + #{yv1hvHcKgrH.TRw8Amoledr}),1
Subcounty TB_2017 Cycloserine 250mg,cCGWTjrEln1,Subcounty TB_2017 Cycloserine 250mg,(#{wMqBG6RUQlh.e2os98CantY} * 3) - ( #{Q8ZSMH0grxI.i65ATXAav6k} + #{wMqBG6RUQlh.TRw8Amoledr}),1
Subcounty TB_2017 Ethambutol 100 mg,b4GD7NurXjq,Subcounty TB_2017 Ethambutol 100 mg,(#{leD1F35SGYm.e2os98CantY} * 3) - ( #{RvnjC94Bl9D.i65ATXAav6k} + #{leD1F35SGYm.TRw8Amoledr}),1
Subcounty TB_2017 Ethambutol 400 mg,yXCbmzIe9p7,Subcounty TB_2017 Ethambutol 400 mg,(#{EG8iaqKX2eq.e2os98CantY} * 3) - (#{bUMuNcexNcG.i65ATXAav6k} + #{EG8iaqKX2eq.TRw8Amoledr}),1
Subcounty TB_2017 FBF(Fortified Blended Foods),HNsCkXgfWHg,Subcounty TB_2017 FBF(Fortified Blended Foods),(#{k1mVrXUuOnL.e2os98CantY} * 3 ) - ( #{jn4KpOfsr2y.i65ATXAav6k} + #{k1mVrXUuOnL.TRw8Amoledr}),1
Subcounty TB_2017 Fluoxetine 20mg,yCTG7GTZscH,Subcounty TB_2017 Fluoxetine 20mg,(#{rEATKgNCxVW.e2os98CantY} * 3) - ( #{j214PKxhpnQ.i65ATXAav6k} + #{rEATKgNCxVW.TRw8Amoledr}),1
Subcounty TB_2017 Haloperidol 5mg,dnDFewVxOkh,Subcounty TB_2017 Haloperidol 5mg,(#{RsgBr5i55fn.e2os98CantY} * 3) - ( #{IvPdCJrfxOh.i65ATXAav6k} + #{RsgBr5i55fn.TRw8Amoledr}),1
Subcounty TB_2017 Isoniazid 100 mg,TTk4J4SNX4k,Subcounty TB_2017 Isoniazid 100 mg,(#{SDdm1ePFws5.e2os98CantY} * 3) - (#{rvV97qWtmCZ.i65ATXAav6k} + #{SDdm1ePFws5.TRw8Amoledr}),1
Subcounty TB_2017 Isoniazid 100mg/5ml,N1ENNws6c60,Subcounty TB_2017 Isoniazid 100mg/5ml,(#{FdzG6oQZ2yh.e2os98CantY} * 3) - ( #{ET8mLYk0EJG.i65ATXAav6k} + #{FdzG6oQZ2yh.TRw8Amoledr}),1
Subcounty TB_2017 Isoniazid 300 mg,EmS95PSzKIy,Subcounty TB_2017 Isoniazid 300 mg,(#{foBquRqvLR5.e2os98CantY} * 3) - ( #{QzBgQbm5V9U.i65ATXAav6k} + #{foBquRqvLR5.TRw8Amoledr}),1
Subcounty TB_2017 Isoniazid syrup 50mg/5ml,IM50w3kMaiG,Subcounty TB_2017 Isoniazid syrup 50mg/5ml,(#{OhBNKe1NTeq.e2os98CantY} * 3) - ( #{qELcEb0XdNK.i65ATXAav6k}),1
Subcounty TB_2017 Kanamycin 1gm vial,d2V5SeZyQDJ,Subcounty TB_2017 Kanamycin 1gm vial,(#{ATZnUs2RmVd.e2os98CantY} * 3) - (#{ATZnUs2RmVd.TRw8Amoledr} + #{ZlXSszbz6NM.i65ATXAav6k}),1
Subcounty TB_2017 Levofloxacin 250mg,AKjs3sWBj2Q,Subcounty TB_2017 Levofloxacin 250mg,(#{FoWAp7gEibO.e2os98CantY} * 3) - (#{FoWAp7gEibO.TRw8Amoledr} + #{JCtV0FIevI1.i65ATXAav6k}),1
Subcounty TB_2017 Levofloxacin 500mg,EocZoO8mhho,Subcounty TB_2017 Levofloxacin 500mg,( #{zm2U9nJQ2x2.e2os98CantY} * 3) - ( #{IifGE2301IM.i65ATXAav6k} + #{zm2U9nJQ2x2.TRw8Amoledr}),1
Subcounty TB_2017 Linezolid 600mg,fnn9ix6Hb3p,Subcounty TB_2017 Linezolid 600mg,(#{L1My0KTxKBk.e2os98CantY} * 3) - (#{L1My0KTxKBk.TRw8Amoledr} + #{rpQdLJV53J5.i65ATXAav6k}),1
Subcounty TB_2017 MB Adult Blister,HzHeTukeBJc,Subcounty TB_2017 MB Adult Blister,(#{MgQ2Bq8EEAq.e2os98CantY} * 3) - ( #{IDQjJmKI4WZ.i65ATXAav6k} + #{MgQ2Bq8EEAq.TRw8Amoledr}),1
Subcounty TB_2017 MB Child Blister Packs,WTgFAndamtS,Subcounty TB_2017 MB Child Blister Packs,(#{i8PkCUh5Fik.e2os98CantY} * 3) - ( #{XxKcHjNibdm.i65ATXAav6k} + #{i8PkCUh5Fik.TRw8Amoledr}),1
Subcounty TB_2017 Moxifloxacin 400mg,sRfoGRYouPb,Subcounty TB_2017 Moxifloxacin 400mg,(#{ZIDG9tCleKX.e2os98CantY} * 3) - ( #{exphlTc9hoi.i65ATXAav6k} + #{ZIDG9tCleKX.TRw8Amoledr}),1
Subcounty TB_2017 PB Adult Blister Packs,EtKc8ulYuRp,Subcounty TB_2017 PB Adult Blister Packs,(#{NuM1I0MnmoP.e2os98CantY} * 3) - ( #{GkYu7zXzyuQ.i65ATXAav6k} + #{NuM1I0MnmoP.TRw8Amoledr}),1
Subcounty TB_2017 PB Child Blister Packs,MEkVuE7QP4F,Subcounty TB_2017 PB Child Blister Packs,(#{zstDvWVPooz.e2os98CantY} * 3) - ( #{zb9qCh1SLra.i65ATXAav6k} + #{zstDvWVPooz.TRw8Amoledr}),1
Subcounty TB_2017 Para-aminosalicylic acid 4mg,fn5F4jkrgjY,Subcounty TB_2017 Para-aminosalicylic acid 4mg,(#{JjRwLmhZHbH.e2os98CantY} * 3) - ( #{y7zdwOhvhO1.i65ATXAav6k} + #{JjRwLmhZHbH.TRw8Amoledr}),1
Subcounty TB_2017 Prednisolone 5mg,B8oGK0hkhP7,Subcounty TB_2017 Prednisolone 5mg,(#{wXP4iP9414P.e2os98CantY} * 3) - ( #{ABdjOqMr8J2.i65ATXAav6k} + #{wXP4iP9414P.TRw8Amoledr}),1
Subcounty TB_2017 Prothionamide 250mg,TOlyJxSuf9a,Subcounty TB_2017 Prothionamide 250mg,(#{qqTaOHPl8MN.e2os98CantY} * 3) - ( #{tn6jf6sdcCz.i65ATXAav6k} + #{qqTaOHPl8MN.TRw8Amoledr}),1
Subcounty TB_2017 Pyrazinamide 500mg,ni4AUrsXH1c,Subcounty TB_2017 Pyrazinamide 500mg,(#{j6EB9U0HB4P.e2os98CantY} * 3) - ( #{j6EB9U0HB4P.TRw8Amoledr} + #{c2Lyi4jCth4.i65ATXAav6k}),1
Subcounty TB_2017 Pyridoxine 25mg,Kf8enFkXa6N,Subcounty TB_2017 Pyridoxine 25mg,(#{bpUp4QMn3Iu.e2os98CantY} * 3) - ( #{bpUp4QMn3Iu.TRw8Amoledr} + #{DVBHr5B4Bl9.i65ATXAav6k}),1
Subcounty TB_2017 Pyridoxine 50mg,ndINa0ipA7S,Subcounty TB_2017 Pyridoxine 50mg,(#{iI3oxVgjWGS.e2os98CantY} * 3) - ( #{iI3oxVgjWGS.TRw8Amoledr} + #{hxjMP3iAMk8.i65ATXAav6k}),1
Subcounty TB_2017 R/H 75/50 mg,pXqaSAeqhqi,Subcounty TB_2017 R/H 75/50 mg,"(#{VfvEWB7ukWJ.e2os98CantY} * 3) - ( #{xKmeXi1F4ZS.i65ATXAav6k}
 + #{VfvEWB7ukWJ.TRw8Amoledr})",1
Subcounty TB_2017 R/H/Z 75/50/150 mg,upFpQfkuErh,Subcounty TB_2017 R/H/Z 75/50/150 mg,(#{Xwat5Cw8bo0.e2os98CantY} * 3) - (#{Xwat5Cw8bo0.TRw8Amoledr} + #{ijrp7veGlbW.i65ATXAav6k}),1
Subcounty TB_2017 R/H/Z/E 150/75/400/275 mg,ifTqrpNG4Dv,Subcounty TB_2017 R/H/Z/E 150/75/400/275 mg,(#{WoHyCSyeiPI.e2os98CantY} * 3) - ( #{Yut9Dn6gydL.i65ATXAav6k}  + #{WoHyCSyeiPI.TRw8Amoledr}),1
Subcounty TB_2017 RUTF(Ready to Use Therapeutic Feed),KffIno4JoYv,Subcounty TB_2017 RUTF,"(#{txAzEoC1TDB.e2os98CantY} * 3) - ( #{FBQ1roZ6kWw.i65ATXAav6k}
 + #{txAzEoC1TDB.TRw8Amoledr})",1
Subcounty TB_2017 Rifampicin 150mg,ftlugwvExIo,Subcounty TB_2017 Rifampicin 150mg,(#{DNnJnuCr44Y.e2os98CantY} * 3) - ( #{GKQsROQyPvC.i65ATXAav6k} + #{DNnJnuCr44Y.TRw8Amoledr}),1
Subcounty TB_2017 Rifampicin 300mg,ZGHi27m9Y5L,Subcounty TB_2017 Rifampicin 300mg,(#{VOOsfe4pPxC.e2os98CantY} * 3) - ( #{qUKbOJARPe8.dRvK7VxuTSd} + #{tOaEe73M6Sc.i65ATXAav6k}),1
Subcounty TB_2017 TB Patient Packs,gIr66gGo5gp,Subcounty TB_2017 TB Patient Packs,(#{kiSFcMKPA8R.e2os98CantY} * 3) - ( #{a24buAoLzmk.i65ATXAav6k} +#{kiSFcMKPA8R.TRw8Amoledr}),1
Subcounty TB_2017 Valproic Acid 200mg,PZ139iV08rI,Subcounty TB_2017 Valproic Acid 200mg,(#{gyDc2CtG70j.e2os98CantY} * 3) - ( #{ceDZiufxGvw.i65ATXAav6k} + #{gyDc2CtG70j.TRw8Amoledr}),1
Subcounty TB_2017Delaminid 50mg,zI5eVotCedO, Subcounty TB_2017Delaminid 50mg,(#{wcJ0H0yL0Rr.e2os98CantY} * 3 ) - ( #{LXtSlgJ4VBE.i65ATXAav6k} + #{wcJ0H0yL0Rr.TRw8Amoledr}),1
Subcounty TB_2017MB Adult Blister,mxxWCrOtMGp,Subcounty TB_2017MB Adult Blister,(#{MgQ2Bq8EEAq.e2os98CantY} * 3) - ( #{IDQjJmKI4WZ.i65ATXAav6k}),1
Sucounty TB_2017 Bedaquiline 100mg,YxHZrmNeaGa,Sucounty TB_2017 Bedaquiline 100mg,(#{S64D56OjB9w.e2os98CantY} * 3) - (#{S64D56OjB9w.TRw8Amoledr} + #{Jbmws6l9cl7.i65ATXAav6k}),1
Sulphadoxine MOS,Yc1JyfHJhTM,Sulphadoxine MOS,#{imheYfA1Kiw.rPAsF4cpNxm},#{imheYfA1Kiw.w77uMi1KzOH}
Sulphadoxine Pyrimethamine	Tabs Quantity for Resupply,bfZ3EIDw3a1,Sulphadoxine Pyrimethamine	Tabs,((#{imheYfA1Kiw.w77uMi1KzOH}*[days]/[days]-#{imheYfA1Kiw.DV8l1KuASLR})*3)-#{imheYfA1Kiw.rPAsF4cpNxm},1
Sulphadoxine Pyrimethamine Adjusted Consumption,k3WM4g9QHyB,Sulphadoxine Pyrimetham,#{imheYfA1Kiw.w77uMi1KzOH}*31,31-#{imheYfA1Kiw.DV8l1KuASLR}
Sum of ANC & CWC clients,VlJEww8KcUD,LLIN Risk 3,#{f9vesk5d4IY} + #{ku80YRejJPg},1
Surplus/(Deficit) (Kshs),OiGkWVXoMcf,Surplus/(Deficit) (Kshs),(#{RvNJvXCx4El.NhSoXUMPK2K}+#{zo5v2sL2Pcz.NhSoXUMPK2K}+#{QokZ5jjGLRz.NhSoXUMPK2K}+#{YkVzbDfJKMy.NhSoXUMPK2K}+#{H5NKPaRikyM.NhSoXUMPK2K}+#{FLT5619aj9V.NhSoXUMPK2K}+#{cKGenTODtq8.NhSoXUMPK2K}+#{nspiDhcn12j.NhSoXUMPK2K})-(#{kQ4NVgc2MYs.NhSoXUMPK2K}+#{jY3JFizFzQN.NhSoXUMPK2K}+#{usMDjlboKn4.NhSoXUMPK2K}+#{WuEJXcFURTY.NhSoXUMPK2K}+#{KAVPEvsu7GB.NhSoXUMPK2K}+#{sW1FEKkUlno.NhSoXUMPK2K}+#{JgjYnWEbbXI.NhSoXUMPK2K}+#{GeLsHQnBJSl.NhSoXUMPK2K}+#{Anntg74AWAc.NhSoXUMPK2K}+#{NAWDpCTju9c.NhSoXUMPK2K}+#{uIKFwsGjL8l.NhSoXUMPK2K}+#{zfE43ojuX27.NhSoXUMPK2K}+#{Jm0j7eIJw22.NhSoXUMPK2K}+#{Kvrh6Edh4ux.NhSoXUMPK2K}+#{kZVa4Dfz3oW.NhSoXUMPK2K}+#{ozuOGiiROjR.NhSoXUMPK2K}+#{zq5cC1mHOjZ.NhSoXUMPK2K}+#{kkKxlgb0SIK.NhSoXUMPK2K}+#{ChuFUyaFoat.NhSoXUMPK2K}+#{Ta4fC50ws12.NhSoXUMPK2K}+#{pMp1v17OVlZ.NhSoXUMPK2K}+#{ktAiKqEgewS.NhSoXUMPK2K}+#{eWJI88NUHju.NhSoXUMPK2K}+#{ZL5umjFvNZT.NhSoXUMPK2K}+#{kMyKJqs4tP6.NhSoXUMPK2K}+#{JfMlkDb7sfP.NhSoXUMPK2K}+#{ERUP9jd5kr8.NhSoXUMPK2K}+#{VE7bP4Hd0Y8.NhSoXUMPK2K}+#{G10FiANc4uK.NhSoXUMPK2K}+#{jER1yfrClYQ.NhSoXUMPK2K}+#{zmTKl26bqXb.NhSoXUMPK2K}+#{JqVPN31hItf.NhSoXUMPK2K}+#{FNaQfndi92d.NhSoXUMPK2K}+#{pwYhMY7SObK.NhSoXUMPK2K}+#{T6Zosl4H5TG.NhSoXUMPK2K}+#{W53qF6leiPm.NhSoXUMPK2K}+#{MxceLE1Wgwj.NhSoXUMPK2K}+#{HGfobnG3qSX.NhSoXUMPK2K}+#{WypNzlF1rxb.NhSoXUMPK2K}+#{kltZozM5rkg.NhSoXUMPK2K}+#{SWHhf1eE89t.NhSoXUMPK2K}+#{qLWHhVTIp0l.NhSoXUMPK2K}+#{s2Ha3e0xwwp.NhSoXUMPK2K}+#{RMsgMQj2SBM.NhSoXUMPK2K}+#{X3nuiSHRJJP.NhSoXUMPK2K}+#{bDSQEZM3rtd.NhSoXUMPK2K}+#{dvo26Xu2g3G.NhSoXUMPK2K}+#{dvo26Xu2g3G.NhSoXUMPK2K}+#{ksAM140tLvc.NhSoXUMPK2K}+#{mYIZtgEPa5S.NhSoXUMPK2K}+#{RWwJcCEIcZw.NhSoXUMPK2K}+#{u9TiVtfs3or.NhSoXUMPK2K}+#{BsyP5AnR1pE.NhSoXUMPK2K}+#{p4Vk0aCXUKj.NhSoXUMPK2K}+#{ZysDicYyDxN.NhSoXUMPK2K}+#{Mnz4Ts6dMVo.NhSoXUMPK2K}),1
TB Case Notification Rate ,nuvGI8ifjux,TB Case Notification Rate,#{BRzqHfgsmn9},#{BRzqHfgsmn9}
"TB Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases",jYZwAb1yegu,TB CNR  -new and relapse,#{CQNuu86XczN.Fmwb7qAGS9L} + #{CQNuu86XczN.ugrZILDyXFQ} + #{z8QuJHnjbnq.Fmwb7qAGS9L} + #{z8QuJHnjbnq.ugrZILDyXFQ} + #{DBa1E1JSJ5K.Fmwb7qAGS9L} + #{DBa1E1JSJ5K.ugrZILDyXFQ},#{NLKRV7bYbVy}
"TB Case notification rate per 100,000",ae30uCeFdl0,"TB Case notification rate per 100,000",#{xhQlihiebMH.Fmwb7qAGS9L} + #{xhQlihiebMH.ugrZILDyXFQ} + #{xhQlihiebMH.v00k2Vla7gU} + #{xhQlihiebMH.G7luR3OjbVK} + #{LasXpeDhjiX.sMK6ULXT6vQ} + #{L26dYFXoKeX.kOjLlBDf1sg},#{NLKRV7bYbVy}
"TB I-1 TB mortality rate per 100,000 population",Bh6CWULUCLc,Death due to TB per 100000,#{Z9AVW5bKTaG.rH2x9vLTldI} + #{mb7gNISsJ8b.bfnePhN6SH6} + #{qF3ilXwp479.wyLTTL3nGWQ} + #{YpM2CXCPZbf.Xc27LcZstD5} + #{yEyrFyJryXL.OMQWRyqq6aA} + #{m7BMQu4HYRT.rf6Umm9tJJo} + #{t730XRFI4WL.roiBu39Ry1Y} + #{H61J8pIAjLQ.Lf8OCNIaUZ2},#{NLKRV7bYbVy}
TB Patient Pack Adjusted Consumption - HF,eNbj0KcGGJ4,TB Patient Pack Adjusted Consumption - HF,(#{i0HKwGrB5sQ.wGSba4uJwJ8}+#{ExSwHJiPywn.dRvK7VxuTSd})/#{ExSwHJiPywn.ShAXH8W58Ju},1
TB Patient Packs - Opening SOH + Pos Adj - Neg Adj,tB8kNL6ow9D,Opening SOH + Pos Adj - Neg Adj,(#{kiSFcMKPA8R.Y2NaSMdjxsC} + #{kiSFcMKPA8R.Vx8fG1bRxJp}) - #{kiSFcMKPA8R.voMGxzxapMN},1
TB Re-treatment rate,St3mbpuJbDF,TB Re-treatment rate,#{YDZlFPpGO2W.vVketPHJwSY}+#{YDZlFPpGO2W.g6112VF7T29}+#{YDZlFPpGO2W.omEDL5LVgDJ}+#{YDZlFPpGO2W.j03wX0lCHZc},#{VihTrdMMli8.vVketPHJwSY}+#{VihTrdMMli8.g6112VF7T29}+#{VihTrdMMli8.omEDL5LVgDJ}+#{VihTrdMMli8.j03wX0lCHZc}
TB cases detected Female <14years,efj19N55H76,No of TB Case detected- M,#{VihTrdMMli8.omEDL5LVgDJ}+#{hNsd8cQIYun.omEDL5LVgDJ}+#{BgFeMs6gQ7E.omEDL5LVgDJ}+#{YDZlFPpGO2W.omEDL5LVgDJ},1
TB cases detected Female >14years,e1V31FgtGuA,TB cases detected Female ,#{VihTrdMMli8.j03wX0lCHZc}+#{hNsd8cQIYun.j03wX0lCHZc}+#{BgFeMs6gQ7E.j03wX0lCHZc}+#{YDZlFPpGO2W.j03wX0lCHZc},1
TB cases detected Male <14years,zBZ7GJgnRkQ,TB cases detected M <14yr,#{VihTrdMMli8.g6112VF7T29}+#{hNsd8cQIYun.g6112VF7T29}+#{BgFeMs6gQ7E.g6112VF7T29}+#{YDZlFPpGO2W.g6112VF7T29},1
TB cases detected Male >14years,EqxNd2GKGwo,TB cases detected M >14yr,#{VihTrdMMli8.vVketPHJwSY}+#{hNsd8cQIYun.vVketPHJwSY}+#{BgFeMs6gQ7E.vVketPHJwSY}+#{YDZlFPpGO2W.vVketPHJwSY},1
TB cases detected Total,H2UOLdEdBiA,TB cases detected Total,#{BRzqHfgsmn9},1
TB curative Rate,eSpVDWd4prW,TB curative Rate,#{DctS9Z2a1bz.NhSoXUMPK2K},#{VihTrdMMli8.vVketPHJwSY}+#{VihTrdMMli8.g6112VF7T29}+#{VihTrdMMli8.omEDL5LVgDJ}+#{VihTrdMMli8.j03wX0lCHZc}
TB patients tested for HIV among TB cases detected Coverage,RKMZchcCX8Y,TB patients test HIV Cov,#{jnRAS7B3piw},#{BRzqHfgsmn9}
TB patients who have completed treatment Total,PLwO3KMPUV5,TB patients completed,#{oiZ7R6su8ZX},1
TB-Bedaquiline 100mg SoH,ila7bTFlJlj,TB-Bedaquiline 100mg SoH,#{DZWHKi63Zhz.wGSba4uJwJ8}+#{Sqdwoopw1nD.dRvK7VxuTSd},1
TB-Benzhexol 5mg SoH,f7GfMyWiiIi,TB-Benzhexol 5mg SoH,#{pTd0bdG8MLl.wGSba4uJwJ8}+#{m5aO5WzuOPX.dRvK7VxuTSd},1
TB-Capreomycin 1gm vial  SoH,B1iyrLw1AB8,TB-Capreomycin 1gm vial  SoH,#{iH0rC4i8K6c.wGSba4uJwJ8}+#{LzsYXJhjPUp.dRvK7VxuTSd},1
TB-Carbamazepine 200mg SoH,hOt5EUptGbr,TB-Carbamazepine 200mg SoH,#{jTbFesGG8A1.wGSba4uJwJ8}+#{ggIlzCf3jlk.dRvK7VxuTSd},1
TB-Clofazimine 100mg SoH,e85JyhYtaab,TB-Clofazimine 100mg SoH,#{YOB7gdu9kE1.wGSba4uJwJ8}+#{ZrXmJW51TgK.dRvK7VxuTSd},1
TB-Cycloserine 250mg Tablets SoH,q0LRk0LJl9y,TB-Cycloserine 250mg Tablets SoH,#{wEGZb0FsWSx.wGSba4uJwJ8}+#{gY6wnANUQL9.dRvK7VxuTSd},1
TB-Delaminid 50mg SoH,oH2pgPoiDNB,TB-Delaminid 50mg SoH,#{lvn2UYyzeMP.wGSba4uJwJ8}+#{xAdz2MrUUsc.dRvK7VxuTSd},1
TB-Ethambutol 100 mg  SoH,GSaZC0SX2ca,TB-Ethambutol 100 mg  SoH,#{qJH6detUa4O.dRvK7VxuTSd}+#{w1XL8QcYeED.wGSba4uJwJ8},1
TB-Ethambutol 400 mg SoH,HZX8NZy8C4o,TB-Ethambutol 400 mg SoH,#{iNJizHAnZLc.wGSba4uJwJ8}+#{ZRBJ3WVYEsQ.dRvK7VxuTSd},1
TB-Fluoxetine 20mg SoH,gJBxLRqbw8w,TB-Fluoxetine 20mg SoH,#{tlAdLRE8i6O.wGSba4uJwJ8}+#{cXFzTLs8yTH.dRvK7VxuTSd},1
TB-Haloperidol 5mg SoH,CcfUuVazrgK,TB-Haloperidol 5mg SoH,#{mC3ernb4Bif.wGSba4uJwJ8}+#{he3yHUQndmR.dRvK7VxuTSd},1
TB-Kanamycin 1gm vial SoH,sLNhdZ6Sg6I,TB-Kanamycin 1gm vial SoH,#{ciuJuhCFd1M.wGSba4uJwJ8}+#{gyUSyHt1z0q.dRvK7VxuTSd},1
TB-Levofloxacin 250mg Tablets SoH,S4Zo2ZPYdsx,TB-Levofloxacin 250mg Tablets SoH,#{WewsaQYzYHL.wGSba4uJwJ8}+#{BH5HUOfZs4M.dRvK7VxuTSd},1
TB-Levofloxacin 500mg Tablets SoH,O9QuE98mWPA,TB-Levofloxacin 500mg Tablets SoH,#{qGIJQ7cfzch.wGSba4uJwJ8}+#{CNdY2UgHIET.dRvK7VxuTSd},1
TB-Linezolid 600mg SoH,VLrfV3b9qZP,TB-Linezolid 600mg SoH,#{xqQsLyybIw5.wGSba4uJwJ8}+#{z9QMZREIpkY.dRvK7VxuTSd},1
TB-Magnesium Tricilicate 500mg SoH,KRiSKvcnAbq,TB-Magnesium Tricilicate 500mg SoH,#{QFDI7royKcj.wGSba4uJwJ8}+#{gnEaXO3qhCE.dRvK7VxuTSd},1
TB-Omeprazole 20mg SoH,y4sZWs693uY,TB-Omeprazole 20mg SoH,(#{oYnSlmnHu81.dRvK7VxuTSd})+(#{AZ7GyS8dvip.wGSba4uJwJ8}),1
TB-Para-aminosalicylic acid 4mg SoH,vkfk8Dwxfsv,TB-Para-aminosalicylic acid 4mg SoH,#{GRycZaWtmu3.dRvK7VxuTSd}+#{zth75ip3MUd.wGSba4uJwJ8},1
TB-Patient Packs SoH,zgpZuCMGsZF,TB-Patient Packs SoH,#{i0HKwGrB5sQ.wGSba4uJwJ8}+#{ExSwHJiPywn.dRvK7VxuTSd},1
TB-Prothionamide 250mg SoH,YqdSV0ZsyZw,TB-Prothionamide 250mg SoH,#{IoUEO6cfUFM.dRvK7VxuTSd}+#{KeVDWqho9hw.wGSba4uJwJ8},1
TB-Pyrazinamide 500mg SoH,QuUlAY4vFgG,TB-Pyrazinamide 500mg SoH,#{knfInTNYGJ4.wGSba4uJwJ8}+#{x9Vob0qwPaE.dRvK7VxuTSd},1
TB-R/H 60/60 mg  SoH,ylpWMPAmzuN,TB-R/H 60/60 mg  SoH,#{G2yIfsUWhyM.dRvK7VxuTSd}+#{mGmxyB2ynjC.wGSba4uJwJ8},1
TB-R/H 75/50 mg SoH,aHmjGAVOh02,TB-R/H 75/50 mg SoH,#{D25RrfG5JlP.wGSba4uJwJ8}+#{L9uipIDbAd1.dRvK7VxuTSd},1
TB-R/H/Z 75/50/150 mg SoH,cA4o0UcRUlt,TB-R/H/Z 75/50/150 mg SoH,#{FFklDDzQwaA.wGSba4uJwJ8}+#{MfT3krz1tyl.dRvK7VxuTSd},1
TB-Rifampicin 300mg  SoH,CkaJPvcFzsw,TB-Rifampicin 300mg  SoH,#{i7EE0lkzaAo.wGSba4uJwJ8}+#{qUKbOJARPe8.dRvK7VxuTSd},1
TB-Valproic acid  (Sodium valproate) 200mg SoH,edKko54eNdp,TB-Valproic acid  (Sodium valproate) 200mg SoH,#{lDWk0wX87gt.wGSba4uJwJ8}+#{Ag7xA8qpU36.dRvK7VxuTSd},1
TB/HIV Co-infection rate,O5GobpI9MaS,TB/HIV Co-infection rate,#{uFJqFxWUnQi.SW68XRmPP8J},#{uFJqFxWUnQi.SW68XRmPP8J} + #{uFJqFxWUnQi.M5gPRkmYrbr}
TBS_CDRR Revision 2017 Bedaquiline 100mg Tablets Physical Stock,oC7YxvY0Ukn,Bedaquiline 100mg Tablets Physical Stock,#{Jbmws6l9cl7.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 Capreomycin 1gm vial Vial Physical Stock,ZQ3GdUw8nmZ,Capreomycin 1gm vial Vial Physical Stock,#{H31HfJJVUG2.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 Carbamezebine 200mg Tablets Physical Stock,C9fLceXBQfn,Carbamezebine 200mg Tablets Physical Stock,#{jhvmdN8Wzbz.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 Clofazimine 100mg Capsules Physical Stock,sY64a0Qozl8,Clofazimine 100mg Capsules Physical Stock,#{mVtZxMVagWR.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 Cycloserine 250mg Tablets Physical Stock,ngEDkNu41Q1,Cycloserine 250mg Tablets Physical Stock,#{Q8ZSMH0grxI.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 Delaminid 50mg Tablets Physical Stock,KReuhUz8vQP,Delaminid 50mg Tablets Physical Stock,#{LXtSlgJ4VBE.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 FBF(Fortified Blended Foods) Satchets Physical Stock,wrR5rjor5cf,FBF(Fortified Blended Foods) Physical Stock,#{jn4KpOfsr2y.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 Fluoxetine 20mg Capsule Physical Stock,MQBT9EJrkOX,Fluoxetine 20mg Capsule Physical Stock,#{j214PKxhpnQ.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 Haloperidol Tablets Physical Stock,IY8RVJy9Yd3,Haloperidol Tablets Physical Stock,#{IvPdCJrfxOh.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 Isoniazid 100 mg Tablets Physical Stock,p8sJ4sxm20X, Isoniazid 100 mgPhysical Stock,#{rvV97qWtmCZ.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 Isoniazid 100mg/5ml Bottle Physical Stock,nlf2eXjfOfl, Isoniazid 100mg/5ml Bottle Physical Stock,#{ET8mLYk0EJG.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 Isoniazid 300 mg Tablets Physical Stock,RQZ3iBPwi9C, Isoniazid 300 mg Tablets Physical Stock,#{QzBgQbm5V9U.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 Isoniazid syrup 50mg/5ml Bottle Physical Stock,DLUyLdxhODP,TBS_CDRRIsoniazid syrup 50mg/5ml Physical Stock,#{qELcEb0XdNK.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 Kanamycin 1gm vial Vial Physical Stock,Pgs8yRY2Cee, Kanamycin 1gm vial Vial Physical Stock,#{ZlXSszbz6NM.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 Levofloxacin 250mg Tablets Physical Stock,oEYmO9Z3aDF,Levofloxacin 250mg Tablets Physical Stock,#{JCtV0FIevI1.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 Levofloxacin 500mg Tablets Physical Stock,LyDXP2Aku3N, Levofloxacin 500mg Tablets Physical Stock,#{IifGE2301IM.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 Linezolid 600mg Tablets Physical Stoc,sQ9wYXc5kaP,Linezolid 600mg Tablets Physical Stock,#{rpQdLJV53J5.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 MB Adult Blister Packs Physical Stock,dPqKvfbFxNV,MB Adult Blister Packs Physical Stock,#{IDQjJmKI4WZ.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 MB Child Blister Packs Packs Physical Stock,hE9OaJUYdNY,MB Child Blister Packs Packs Physical Stock,#{XxKcHjNibdm.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 Moxifloxacin 400mg Tablets Physical Stock,SrpFUueWWAo,Moxifloxacin 400mg Tablets Physical Stock,#{exphlTc9hoi.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 Omeprazole 20mg Tablets Physical Stock,vx5nViVa7y1,Omeprazole 20mg Tablets Physical Stock,#{Vt0EQwXVIGf.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 PB Adult Blister Packs Packs Physical Stock,It6HYy36EGH,Adult Blister Packs Packs Physical Stock,#{GkYu7zXzyuQ.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 PB Child Blister Packs Packs Physical Stock,yPTeeTZSYU2,PB Child Blister Packs Packs Physical Stock,#{zb9qCh1SLra.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 Para-aminosalicylic acid 4mg Sachets Physical Stock,pfcmwQMd7Hb,Para-aminosalicylic acid 4mgPhysical Stock,#{y7zdwOhvhO1.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 Prednisolone 5mg Tablets Physical Stock,efjzY4LuCeS,Prednisolone 5mg Tablets Physical Stock,#{ABdjOqMr8J2.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 Prothionamide 250mg Tablets Physical Stock,KI0RjRZPEOM,Prothionamide 250mg Tablets Physical Stock,#{tn6jf6sdcCz.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 Pyridoxine 25mg Tablets Physical Stock,LplsQ31dPNw, Pyridoxine 25mg Tablets Physical Stock,#{DVBHr5B4Bl9.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 Pyridoxine 50mg Tablets Physical Stock,ahnjUU61VUU,Pyridoxine 50mg Tablets Physical Stock,#{hxjMP3iAMk8.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 RUTF(Ready to Use Therapeutic Feed) Satchets Physical count,zGHaUxxvBcO,RUTF(Ready to Use Therapeutic Feed) Physical count,#{FBQ1roZ6kWw.PTYglXUo8ZN},1
TBS_CDRR Revision 2017 Rifapentine + Isoniazid 300/300mg,ehSlGXFZrQ7,TBS_CDRR Revision 2017 Rifapentine + Isoniazid,(#{APyPtjgxmmm.faKK7JDcme7} *2 ) - #{APyPtjgxmmm.i65ATXAav6k},1
TBS_CDRR Revision 2017 Rifapentine 150mg tabs,pALDeN4ugET,TBS_CDRR Revision 2017 Rifapentine 150mg tabs,(#{aLIbEUxsRpC.faKK7JDcme7} * 2) - #{aLIbEUxsRpC.i65ATXAav6k},1
TBS_CDRR Revision 2017 Valproic Acid Tablets Physical Stock,UzTGWl3b6FO,Valproic Acid Tablets Physical Stock,#{ceDZiufxGvw.PTYglXUo8ZN},1
TBS_CDRR rev2017 Aggregated Dispensed Bedaquiline 100mg Tablets,bnBa8MFJixM,TBS_CDRRrev2017aggbal24,#{S64D56OjB9w.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Capreomycin 1gm vial Vial,zWWA9bfs89v,TBS_CDRRrev2017aggbal31,#{XUq7mFujyzS.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Carbamezebine 200mg Tablets,obD9LbD7aWx,TBS_CDRRrev2017aggbal33,#{nADIXnQjn5X.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Clofazemine 100mg Capsules,H6wSc1CfXRx,TBS_CDRRrev2017aggbal5,#{AWKfdnXz4LC.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Clofazimine 100mg Capsules,ZYztSILvFsj,TBS_CDRRrev2017aggbal19,#{yv1hvHcKgrH.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Cycloserine 250mg Tablets,t210FEt9m4o,TBS_CDRRrev2017aggbal38,#{wMqBG6RUQlh.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Delaminid 50mg Tablets,ixYiSgIacwx,TBS_CDRRrev2017aggbal14,#{wcJ0H0yL0Rr.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Ethambutol 100 mg Tablets,j7c6RLTVLme,TBS_CDRRrev2017aggbal4,#{leD1F35SGYm.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Ethambutol 400 mg Tablets,Wz35gLOs7uD,TBS_CDRRrev2017aggbal27,#{EG8iaqKX2eq.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed FBF(Fortified Blended Foods) Satchets,CBIjzReGYFZ,TBS_CDRRrev2017aggbal28,#{k1mVrXUuOnL.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Fluoxetine 20mg Capsule,nFtVHISjhXM,TBS_CDRRrev2017aggbal17,#{rEATKgNCxVW.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Haloperidol Tablets,dgtPCG3CoT7,TBS_CDRRrev2017aggbal22,#{RsgBr5i55fn.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Isoniazid 100 mg Tablets,wtrTqjhg6sv,TBS_CDRRrev2017aggbal18,#{SDdm1ePFws5.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Isoniazid 100mg/5ml Bottle,CHzxmZxR5SL,TBS_CDRRrev2017aggbal9,#{FdzG6oQZ2yh.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Isoniazid 300 mg Tablets,ZBxTHRtPPhs,TBS_CDRRrev2017aggbal1,#{foBquRqvLR5.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Isoniazid syrup 50mg/5ml Bottle,EaUI0Nq7Pz0,TBS_CDRRrev2017aggbal8,#{OhBNKe1NTeq.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Kanamycin 1gm vial Vial,W1C2BVOAInE,TBS_CDRRrev2017aggbal23,#{ATZnUs2RmVd.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Levofloxacin 250mg Tablets,FWebTusKE4L,TBS_CDRRrev2017aggbal13,#{FoWAp7gEibO.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Levofloxacin 500mg Tablets,z3URXwFitIt,TBS_CDRRrev2017aggbal29,#{zm2U9nJQ2x2.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Linezolid 600mg Tablets,c3RrfwXK4ts,TBS_CDRRrev2017aggbal3,#{L1My0KTxKBk.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed MB Adult Blister Packs,SjOR5bbnIMk,TBS_CDRRrev2017aggbal15,#{MgQ2Bq8EEAq.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed MB Child Blister Packs Packs,lbcXyBR9kAV,TBS_CDRRrev2017aggbal39,#{i8PkCUh5Fik.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Moxifloxacin 400mg Tablets,KTALt615qaU,TBS_CDRRrev2017aggbal7,#{ZIDG9tCleKX.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Omeprazole 20mg Tablets,tIf3imCqHa5,TBS_CDRRrev2017aggbal21,#{XWIm2t6lglg.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed PB Adult Blister Packs Packs,ZjQ0Az1lJ1C,TBS_CDRRrev2017aggbal34,#{NuM1I0MnmoP.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed PB Child Blister Packs Packs,uwJjaSy6CMA,TBS_CDRRrev2017aggbal12,#{zstDvWVPooz.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Para-aminosalicylic acid 4mg Sachets,UHS9nfRHRu6,TBS_CDRRrev2017aggbal16,#{JjRwLmhZHbH.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Prednisolone 5mg Tablets,O3p1urVhqLQ,TBS_CDRRrev2017aggbal35,#{wXP4iP9414P.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Prothionamide 250mg Tablets,L1oySDYbDOv,TBS_CDRRrev2017aggbal10,#{qqTaOHPl8MN.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Pyrazinamide 500mg Tablets,P5Uf34HVbuf,TBS_CDRRrev2017aggbal20,#{j6EB9U0HB4P.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Pyridoxine 25mg Tablets,jyHoh4PWf6F,TBS_CDRRrev2017aggbal36,#{bpUp4QMn3Iu.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Pyridoxine 50mg Tablets,V1hgdxIlhsr,TBS_CDRRrev2017aggbal40,#{iI3oxVgjWGS.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed R/H 75/50 mg Tablets,pSGYvHklrtS,TBS_CDRRrev2017aggbal6,#{VfvEWB7ukWJ.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed R/H/Z 75/50/150 mg Tablets,rID2yMuw7ob,TBS_CDRRrev2017aggbal11,#{Xwat5Cw8bo0.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed R/H/Z/E 150/75/400/275 mg Tablets,a3S0L5T9S6h,TBS_CDRRrev2017aggbal32,#{WoHyCSyeiPI.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed RUTF(Ready to Use Therapeutic Feed) Satchets,xqyKO2PhEyr,TBS_CDRRrev2017aggbal30,#{txAzEoC1TDB.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Rifampicin 150mg Tablets,O3Cq1jWnMBf,TBS_CDRRrev2017aggbal37,#{DNnJnuCr44Y.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Rifampicin 300mg Tablets,jdfXE3fyuHg,TBS_CDRRrev2017aggbal26,#{VOOsfe4pPxC.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Rifapentine + Isoniazid 300/300mg,bdEDvdguc58,Aggr Dispensed Rifapentine + Isoniazid 300/300mg,#{Ak39JAb6v08.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Rifapentine 150mg tabs,WVowcXcqek0, Aggr Dispensed Rifapentine 150mg tabs,#{BfXSH6Bcgd8.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed TB Patient Packs Packs,CMLhjyJPRGW,TBS_CDRRrev2017aggbal2,#{kiSFcMKPA8R.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Dispensed Valproic Acid Tablets,CXmjrD1sFlu,TBS_CDRRrev2017aggbal25,#{gyDc2CtG70j.e2os98CantY},1
TBS_CDRR rev2017 Aggregated Ending Balance Bedaquiline 100mg Tablets,ryN5xWHfewC,TBS_CDRRrev2017aggendbal24,#{S64D56OjB9w.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Capreomycin 1gm vial Vial,Ksx8fFhAOGY,TBS_CDRRrev2017aggendbal31,#{XUq7mFujyzS.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Carbamezebine 200mg Tablets,pz8gUVxCLIS,TBS_CDRRrev2017aggendbal33,#{nADIXnQjn5X.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Clofazemine 100mg Capsules,Jd3CvK6P3Bx,TBS_CDRRrev2017aggendbal5,#{AWKfdnXz4LC.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Clofazimine 100mg Capsules,ItJWPV8Vr99,TBS_CDRRrev2017aggendbal19,#{yv1hvHcKgrH.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Cycloserine 250mg Tablets,Rk0CYS9l2zV,TBS_CDRRrev2017aggendbal38,#{wMqBG6RUQlh.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Delaminid 50mg Tablets,zpHfouUyLYh,TBS_CDRRrev2017aggendbal14,#{wcJ0H0yL0Rr.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Ethambutol 100 mg Tablets,oYTHOBnyxSS,TBS_CDRRrev2017aggendbal4,#{leD1F35SGYm.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Ethambutol 400 mg Tablets,uUcAhnDK7uX,TBS_CDRRrev2017aggendbal27,#{EG8iaqKX2eq.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance FBF(Fortified Blended Foods) Satchets,zfj4DRM51Ii,TBS_CDRRrev2017aggendbal28,#{k1mVrXUuOnL.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Fluoxetine 20mg Capsule,d8ZIYEX9reT,TBS_CDRRrev2017aggendbal17,#{rEATKgNCxVW.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Haloperidol Tablets,VmBRT7L4FWk,TBS_CDRRrev2017aggendbal22,#{RsgBr5i55fn.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Isoniazid 100 mg Tablets,X62MGjn97EA,TBS_CDRRrev2017aggendbal18,#{SDdm1ePFws5.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Isoniazid 100mg/5ml Bottle,YtmGlnxZW3t,TBS_CDRRrev2017aggendbal9,#{FdzG6oQZ2yh.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Isoniazid 300 mg Tablets,MqZhOVnu1Kj,TBS_CDRRrev2017aggendbal1,#{foBquRqvLR5.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Isoniazid syrup 50mg/5ml Bottle,se9X9HBpuW9,TBS_CDRRrev2017aggendbal8,#{OhBNKe1NTeq.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Kanamycin 1gm vial Vial,ngGf6rTUNMy,TBS_CDRRrev2017aggendbal23,#{ATZnUs2RmVd.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Levofloxacin 250mg Tablets,JXAicsNqvSw,TBS_CDRRrev2017aggendbal13,#{FoWAp7gEibO.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Levofloxacin 500mg Tablets,tQSohZpz3rx,TBS_CDRRrev2017aggendbal29,#{zm2U9nJQ2x2.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Linezolid 600mg Tablets,oV4DtaqqZPb,TBS_CDRRrev2017aggendbal3,#{L1My0KTxKBk.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance MB Adult Blister Packs,Ba2rt3Fylnm,TBS_CDRRrev2017aggendbal15,#{MgQ2Bq8EEAq.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance MB Child Blister Packs Packs,DeQjxK8A1lF,TBS_CDRRrev2017aggendbal39,#{i8PkCUh5Fik.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Moxifloxacin 400mg Tablets,qGATxuJlxaC,TBS_CDRRrev2017aggendbal7,#{ZIDG9tCleKX.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Omeprazole 20mg Tablets,hK5m5irwxMv,TBS_CDRRrev2017aggendbal21,#{XWIm2t6lglg.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance PB Adult Blister Packs Packs,iwjrGVFREdN,TBS_CDRRrev2017aggendbal34,#{NuM1I0MnmoP.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance PB Child Blister Packs Packs,S9DVnF7lXXc,TBS_CDRRrev2017aggendbal12,#{zstDvWVPooz.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Para-aminosalicylic acid 4mg Sachets,w7fOprfwsnr,TBS_CDRRrev2017aggendbal16,#{JjRwLmhZHbH.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Prednisolone 5mg Tablets,o861gG5ASMs,TBS_CDRRrev2017aggendbal35,#{wXP4iP9414P.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Prothionamide 250mg Tablets,IcU7IPa63Gw,TBS_CDRRrev2017aggendbal10,#{qqTaOHPl8MN.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Pyrazinamide 500mg Tablets,kn8ppGcYHFa,TBS_CDRRrev2017aggendbal20,#{j6EB9U0HB4P.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Pyridoxine 25mg Tablets,SdF2DlnbnEl,TBS_CDRRrev2017aggendbal36,#{bpUp4QMn3Iu.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Pyridoxine 50mg Tablets,GZRKalPK8DE,TBS_CDRRrev2017aggendbal40,#{iI3oxVgjWGS.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance R/H 75/50 mg Tablets,yP6P96Rt9Cy,TBS_CDRRrev2017aggendbal6,#{VfvEWB7ukWJ.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance R/H/Z 75/50/150 mg Tablets,htQC8yjJXb5,TBS_CDRRrev2017aggendbal11,#{Xwat5Cw8bo0.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance R/H/Z/E 150/75/400/275 mg Tablets,nyNjfOX1GCk,TBS_CDRRrev2017aggendbal32,#{WoHyCSyeiPI.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance RUTF(Ready to Use Therapeutic Feed) Satchets,YIhzqiqEm1j,TBS_CDRRrev2017aggendbal30,#{txAzEoC1TDB.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Rifampicin 150mg Tablets,mdHPOzR1RLP,TBS_CDRRrev2017aggendbal37,#{DNnJnuCr44Y.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Rifampicin 300mg Tablets,ZDck7VPh5ah,TBS_CDRRrev2017aggendbal26,#{VOOsfe4pPxC.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance TB Patient Packs Packs,dO4yo8BcLqW,TBS_CDRRrev2017aggendbal2,#{kiSFcMKPA8R.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Ending Balance Valproic Acid Tablets,YzvXou9i4eq,TBS_CDRRrev2017aggendbal25,#{gyDc2CtG70j.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Physical Stock Tablets Rifapentine + Isoniazid 300/300mg,mw8ktipbB0j,Agg Phy Stock Rifapentine + Isoniazid 300/300mg,#{Ak39JAb6v08.TRw8Amoledr},1
TBS_CDRR rev2017 Aggregated Physical StockTablets Rifapentine 150mg tabs,kgzfzzCGqNv,Aggr Physical StockTablets Rifapentine 150mg tabs,#{BfXSH6Bcgd8.TRw8Amoledr},1
TB_Amiloride 5mg MoS,waTfHA0riUL,TB_Amiloride 5mg MoS,(#{JF53ZPceeLh.wGSba4uJwJ8}+#{knvYrfjYSgF.dRvK7VxuTSd})/#{knvYrfjYSgF.ShAXH8W58Ju},1
TB_Amiloride 5mg SoH,HI4ksyoi1rn,TB_Amiloride 5mg SoH,#{JF53ZPceeLh.wGSba4uJwJ8}+#{knvYrfjYSgF.dRvK7VxuTSd},1
TB_Bedaquiline 100mg MoS,uQXGtlqvIrM,TB_Bedaquiline 100mg MoS,(#{DZWHKi63Zhz.wGSba4uJwJ8}+#{Sqdwoopw1nD.dRvK7VxuTSd})/#{Sqdwoopw1nD.ShAXH8W58Ju},1
TB_Benzhexol 5mg MoS,Urc5Z8SHkoC,TB_Benzhexol 5mg MoS,(#{pTd0bdG8MLl.wGSba4uJwJ8}+#{m5aO5WzuOPX.dRvK7VxuTSd})/#{m5aO5WzuOPX.ShAXH8W58Ju},1
TB_Capreomycin 1gm vial MoS,ChnYmzcN7Fj,TB_Capreomycin 1gm vial MoS,(#{iH0rC4i8K6c.wGSba4uJwJ8}+#{LzsYXJhjPUp.dRvK7VxuTSd})/#{LzsYXJhjPUp.ShAXH8W58Ju},1
TB_Carbamazepine 200mg MoS,VxpflyRvSKC,TB_Carbamazepine 200mg MoS,(#{jTbFesGG8A1.wGSba4uJwJ8}+#{ggIlzCf3jlk.dRvK7VxuTSd})/#{ggIlzCf3jlk.ShAXH8W58Ju},1
TB_Clofazimine 100mg MoS,ZiCsBh0wxmD,TB_Clofazimine 100mg MoS,(#{YOB7gdu9kE1.wGSba4uJwJ8}+#{ZrXmJW51TgK.dRvK7VxuTSd})/#{ZrXmJW51TgK.ShAXH8W58Ju},1
TB_Cycloserine 250mg Tablets MoS,NxO5K5uU1k6,TB_Cycloserine 250mg Tablets MoS,(#{wEGZb0FsWSx.wGSba4uJwJ8}+#{gY6wnANUQL9.dRvK7VxuTSd})/#{gY6wnANUQL9.ShAXH8W58Ju},1
TB_Delaminid 50mg MoS,oZSFJrF0wpa,TB_Delaminid 50mg MoS,(#{lvn2UYyzeMP.wGSba4uJwJ8}+#{xAdz2MrUUsc.dRvK7VxuTSd})/#{xAdz2MrUUsc.ShAXH8W58Ju},1
TB_Ethambutol 100 mg MoS,uv1uXXCFSyo,TB_Ethambutol 100 mg MoS,(#{w1XL8QcYeED.wGSba4uJwJ8}+#{qJH6detUa4O.dRvK7VxuTSd})/#{qJH6detUa4O.ShAXH8W58Ju},1
TB_Ethambutol 400 mg MoS,prjZMrR8UPX,TB_Ethambutol 400 mg MoS,(#{iNJizHAnZLc.wGSba4uJwJ8}+#{ZRBJ3WVYEsQ.dRvK7VxuTSd})/#{ZRBJ3WVYEsQ.ShAXH8W58Ju},1
TB_FCDRR Supply Box-Ending Bal_EH (400/150mg),wy2YhAdlVel,TB_FCDRR Supply Box-Ending Bal_EH (400/150mg),(#{mqeqzoaHvAs.dBSwZCGnO3g}+#{mqeqzoaHvAs.FQwXWgdKypA})-(#{mqeqzoaHvAs.eyY5dkpL6hQ}+#{mqeqzoaHvAs.pegHgDLPVTA}),1
TB_FCDRR Supply Box-Ending Bal_RH(150/75 mg),fGwpnjYGSle,TB_FCDRR Supply Box-Ending Bal_RH(150/75 mg),(#{Ffw6dHDZDBx.dBSwZCGnO3g}+#{Ffw6dHDZDBx.FQwXWgdKypA})-(#{Ffw6dHDZDBx.eyY5dkpL6hQ}+#{Ffw6dHDZDBx.pegHgDLPVTA}),1
TB_FCDRR Supply Box-Ending Bal_RHZE (150/75/400/275 mg),mElLUtnyg3u,TB_FCDRR Supply Box-Ending Bal_RHZE (150/75/400/27,(#{RAzGnSGDJC5.dBSwZCGnO3g}+#{RAzGnSGDJC5.FQwXWgdKypA})-(#{RAzGnSGDJC5.eyY5dkpL6hQ}+#{RAzGnSGDJC5.pegHgDLPVTA}),1
TB_FCDRR-Ending Bal_Amiloride 5mg,hx9ng2r3VLO,TB_FCDRR-Ending Bal_Amiloride 5mg,(#{knvYrfjYSgF.FD55KIV91Hi}+#{knvYrfjYSgF.aszbsgufcrc}+#{knvYrfjYSgF.yivS0PoGxNe})-(#{knvYrfjYSgF.ShAXH8W58Ju}+#{knvYrfjYSgF.xRcQyWQdwx1}+#{knvYrfjYSgF.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Bedaquiline 100mg,WnBAG3vwFnD,TB_FCDRR-Ending Bal_Bedaquiline 100mg,(#{Sqdwoopw1nD.FD55KIV91Hi}+#{Sqdwoopw1nD.aszbsgufcrc}+#{Sqdwoopw1nD.yivS0PoGxNe})-(#{Sqdwoopw1nD.ShAXH8W58Ju}+#{Sqdwoopw1nD.xRcQyWQdwx1}+#{Sqdwoopw1nD.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Benzhexol 5mg,HzyYfBvUZIT,TB_FCDRR-Ending Bal_Benzhexol 5mg,(#{m5aO5WzuOPX.FD55KIV91Hi}+#{m5aO5WzuOPX.aszbsgufcrc}+#{m5aO5WzuOPX.yivS0PoGxNe})-(#{m5aO5WzuOPX.ShAXH8W58Ju}+#{m5aO5WzuOPX.xRcQyWQdwx1}+#{m5aO5WzuOPX.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Capreomycin 1gm vial,sqLeFaM5yrC,TB_FCDRR-Ending Bal_Capreomycin 1gm vial,(#{LzsYXJhjPUp.FD55KIV91Hi}+#{LzsYXJhjPUp.aszbsgufcrc}+#{LzsYXJhjPUp.yivS0PoGxNe})-(#{LzsYXJhjPUp.ShAXH8W58Ju}+#{LzsYXJhjPUp.xRcQyWQdwx1}+#{LzsYXJhjPUp.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Carbamazepine 200mg,MR96ntK9O9P,TB_FCDRR-Ending Bal_Carbamazepine 200mg,(#{ggIlzCf3jlk.FD55KIV91Hi}+#{ggIlzCf3jlk.aszbsgufcrc}+#{ggIlzCf3jlk.yivS0PoGxNe})-(#{ggIlzCf3jlk.ShAXH8W58Ju}+#{ggIlzCf3jlk.xRcQyWQdwx1}+#{ggIlzCf3jlk.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Clofazimine 100mg,sMU0MG4qfGy,TB_FCDRR-Ending Bal_Clofazimine 100mg,(#{ZrXmJW51TgK.FD55KIV91Hi}+#{ZrXmJW51TgK.aszbsgufcrc}+#{ZrXmJW51TgK.yivS0PoGxNe})-(#{ZrXmJW51TgK.ShAXH8W58Ju}+#{ZrXmJW51TgK.xRcQyWQdwx1}+#{ZrXmJW51TgK.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Cycloserine 250mg Tablets,NxxeKeIVUpi,TB_FCDRR-Ending Bal_Cycloserine 250mg Tablets,(#{gY6wnANUQL9.FD55KIV91Hi}+#{gY6wnANUQL9.aszbsgufcrc}+#{gY6wnANUQL9.yivS0PoGxNe})-(#{gY6wnANUQL9.ShAXH8W58Ju}+#{gY6wnANUQL9.xRcQyWQdwx1}+#{gY6wnANUQL9.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Delaminid 50mg,t44Nr1QrAV5,TB_FCDRR-Ending Bal_Delaminid 50mg,(#{xAdz2MrUUsc.FD55KIV91Hi}+#{xAdz2MrUUsc.aszbsgufcrc}+#{xAdz2MrUUsc.yivS0PoGxNe})-(#{xAdz2MrUUsc.ShAXH8W58Ju}+#{xAdz2MrUUsc.xRcQyWQdwx1}+#{xAdz2MrUUsc.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Fluoxetine 20mg,dGueM06XgKj,TB_FCDRR-Ending Bal_Fluoxetine 20mg,(#{cXFzTLs8yTH.FD55KIV91Hi}+#{cXFzTLs8yTH.aszbsgufcrc}+#{cXFzTLs8yTH.yivS0PoGxNe})-(#{cXFzTLs8yTH.ShAXH8W58Ju}+#{cXFzTLs8yTH.xRcQyWQdwx1}+#{cXFzTLs8yTH.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Granisentron 3mg,v0PtjzlYa0W,TB_FCDRR-Ending Bal_Granisentron 3mg,(#{Tki8cbMlLrY.FD55KIV91Hi}+#{Tki8cbMlLrY.aszbsgufcrc}+#{Tki8cbMlLrY.yivS0PoGxNe})-(#{Tki8cbMlLrY.ShAXH8W58Ju}+#{Tki8cbMlLrY.xRcQyWQdwx1}+#{Tki8cbMlLrY.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Granisentron 3mg inj,FZjrRVb2KYS,TB_FCDRR-Ending Bal_Granisentron 3mg inj,(#{huBFtRYod0h.FD55KIV91Hi}+#{huBFtRYod0h.aszbsgufcrc}+#{huBFtRYod0h.yivS0PoGxNe})-(#{huBFtRYod0h.ShAXH8W58Ju}+#{huBFtRYod0h.xRcQyWQdwx1}+#{huBFtRYod0h.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Haloperidol 5mg,C4gHyOPnXMq,TB_FCDRR-Ending Bal_Haloperidol 5mg,(#{he3yHUQndmR.FD55KIV91Hi}+#{he3yHUQndmR.aszbsgufcrc}+#{he3yHUQndmR.yivS0PoGxNe})-(#{he3yHUQndmR.ShAXH8W58Ju}+#{he3yHUQndmR.xRcQyWQdwx1}+#{he3yHUQndmR.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Isoniazid 100mg,UelxHLB1Xx2,TB_FCDRR-Ending Bal_Isoniazid 100mg,(#{caL56WGvOFP.FD55KIV91Hi}+#{caL56WGvOFP.aszbsgufcrc}+#{caL56WGvOFP.yivS0PoGxNe})-(#{caL56WGvOFP.ShAXH8W58Ju}+#{caL56WGvOFP.xRcQyWQdwx1}+#{caL56WGvOFP.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Isoniazid 300mg,Qf2qmvIRRsb,TB_FCDRR-Ending Bal_Isoniazid 300mg,(#{sjnsBPf10NR.FD55KIV91Hi}+#{sjnsBPf10NR.aszbsgufcrc}+#{sjnsBPf10NR.yivS0PoGxNe})-(#{sjnsBPf10NR.ShAXH8W58Ju}+#{sjnsBPf10NR.xRcQyWQdwx1}+#{sjnsBPf10NR.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Isoniazid Syrup 100mg /5ml and pyridoxine 5mg/5ml,TmJDTg5yLyP,TB_FCDRR-Ending Bal_Isoniazid Syrup 100mg /5ml and,(#{u5LaSQLJbEw.FD55KIV91Hi}+#{u5LaSQLJbEw.aszbsgufcrc}+#{u5LaSQLJbEw.yivS0PoGxNe})-(#{u5LaSQLJbEw.ShAXH8W58Ju}-#{u5LaSQLJbEw.xRcQyWQdwx1}+#{u5LaSQLJbEw.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Isoniazid Syrup 50mg/5ml,uLzxi6uniLL,TB_FCDRR-Ending Bal_Isoniazid Syrup 50mg/5ml,(#{HtYrJ9WPcas.FD55KIV91Hi}+#{HtYrJ9WPcas.aszbsgufcrc}+#{HtYrJ9WPcas.yivS0PoGxNe})-(#{HtYrJ9WPcas.ShAXH8W58Ju}+#{HtYrJ9WPcas.xRcQyWQdwx1}+#{HtYrJ9WPcas.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Kanamycin 1gm vial,KfIOVESpao0,TB_FCDRR-Ending Bal_Kanamycin 1gm vial,(#{gyUSyHt1z0q.FD55KIV91Hi}+#{gyUSyHt1z0q.aszbsgufcrc}+#{gyUSyHt1z0q.yivS0PoGxNe})-(#{gyUSyHt1z0q.ShAXH8W58Ju}+#{gyUSyHt1z0q.xRcQyWQdwx1}+#{gyUSyHt1z0q.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Levofloxacin 250mg Tablets,mOW1yAKOjwG,TB_FCDRR-Ending Bal_Levofloxacin 250mg Tablets,(#{BH5HUOfZs4M.FD55KIV91Hi}+#{BH5HUOfZs4M.aszbsgufcrc}+#{BH5HUOfZs4M.yivS0PoGxNe})-(#{BH5HUOfZs4M.ShAXH8W58Ju}+#{BH5HUOfZs4M.xRcQyWQdwx1}+#{BH5HUOfZs4M.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Levofloxacin 500mg Tablets,NM0bNtuWFfa,TB_FCDRR-Ending Bal_Levofloxacin 500mg Tablets,(#{CNdY2UgHIET.FD55KIV91Hi}+#{CNdY2UgHIET.aszbsgufcrc}+#{CNdY2UgHIET.yivS0PoGxNe})-(#{CNdY2UgHIET.ShAXH8W58Ju}+#{CNdY2UgHIET.xRcQyWQdwx1}+#{CNdY2UgHIET.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Linezolid 600mg,zADchukTD87,TB_FCDRR-Ending Bal_Linezolid 600mg,(#{z9QMZREIpkY.FD55KIV91Hi}+#{z9QMZREIpkY.aszbsgufcrc}+#{z9QMZREIpkY.yivS0PoGxNe})-(#{z9QMZREIpkY.ShAXH8W58Ju}+#{z9QMZREIpkY.xRcQyWQdwx1}+#{z9QMZREIpkY.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_MB Adult Blister,eN41RjVQzUV,TB_FCDRR-Ending Bal_MB Adult Blister,(#{tQJxBYjCikx.FD55KIV91Hi}+#{tQJxBYjCikx.aszbsgufcrc}+#{tQJxBYjCikx.yivS0PoGxNe})-(#{tQJxBYjCikx.ShAXH8W58Ju}+#{tQJxBYjCikx.xRcQyWQdwx1}+#{tQJxBYjCikx.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_MB Child Blister Packs,VOwhfgwHef5,TB_FCDRR-Ending Bal_MB Child Blister Packs,(#{hpGvkfaRHNR.FD55KIV91Hi}+#{hpGvkfaRHNR.aszbsgufcrc}+#{hpGvkfaRHNR.yivS0PoGxNe})-(#{hpGvkfaRHNR.ShAXH8W58Ju}+#{hpGvkfaRHNR.xRcQyWQdwx1}+#{hpGvkfaRHNR.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Magnesium Tricilicate 500mg,nZS1PzvbmfF,TB_FCDRR-Ending Bal_Magnesium Tricilicate 500mg,(#{gnEaXO3qhCE.FD55KIV91Hi}+#{gnEaXO3qhCE.aszbsgufcrc}+#{gnEaXO3qhCE.yivS0PoGxNe})-(#{gnEaXO3qhCE.ShAXH8W58Ju}+#{gnEaXO3qhCE.xRcQyWQdwx1}+#{gnEaXO3qhCE.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Omeprazole 20mg,CDdsTd9uUt2,TB_FCDRR-Ending Bal_Omeprazole 20mg,(#{oYnSlmnHu81.FD55KIV91Hi}+#{oYnSlmnHu81.aszbsgufcrc}+#{oYnSlmnHu81.yivS0PoGxNe})-(#{oYnSlmnHu81.ShAXH8W58Ju}+#{oYnSlmnHu81.xRcQyWQdwx1}+#{oYnSlmnHu81.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_PB Adult Blister Packs,iX6wRL5mZWB,TB_FCDRR-Ending Bal_PB Adult Blister Packs,(#{oQS3dHVO1r8.FD55KIV91Hi}+#{oQS3dHVO1r8.aszbsgufcrc}+#{oQS3dHVO1r8.yivS0PoGxNe})-(#{oQS3dHVO1r8.ShAXH8W58Ju}+#{oQS3dHVO1r8.xRcQyWQdwx1}+#{oQS3dHVO1r8.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_PB Child Blister Packs,pSaWiv0YRH8,TB_FCDRR-Ending Bal_PB Child Blister Packs,(#{Jt8yDvqxMyO.FD55KIV91Hi}+#{Jt8yDvqxMyO.aszbsgufcrc}+#{Jt8yDvqxMyO.yivS0PoGxNe})-(#{Jt8yDvqxMyO.ShAXH8W58Ju}+#{Jt8yDvqxMyO.xRcQyWQdwx1}+#{Jt8yDvqxMyO.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Para-aminosalicylic acid 4mg,CatHP8aFs5j,TB_FCDRR-Ending Bal_Para-aminosalicylic acid 4mg,(#{GRycZaWtmu3.FD55KIV91Hi}+#{GRycZaWtmu3.aszbsgufcrc}+#{GRycZaWtmu3.yivS0PoGxNe})-(#{GRycZaWtmu3.ShAXH8W58Ju}+#{GRycZaWtmu3.xRcQyWQdwx1}+#{GRycZaWtmu3.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Potassium Chloride 470mg/285mg chloride SR,QN5CEdZ6ksV,TB_FCDRR-Ending Bal_Potassium Chloride 470mg/285mg,(#{IXJu8pnpklX.FD55KIV91Hi}+#{IXJu8pnpklX.aszbsgufcrc}+#{IXJu8pnpklX.yivS0PoGxNe})-(#{IXJu8pnpklX.ShAXH8W58Ju}+#{IXJu8pnpklX.xRcQyWQdwx1}+#{IXJu8pnpklX.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Prednisolone 5mg,HjkfcwkImLg,TB_FCDRR-Ending Bal_Prednisolone 5mg,(#{lY3T8d8tdFZ.FD55KIV91Hi}+#{lY3T8d8tdFZ.aszbsgufcrc}+#{lY3T8d8tdFZ.yivS0PoGxNe})-(#{lY3T8d8tdFZ.ShAXH8W58Ju}+#{lY3T8d8tdFZ.xRcQyWQdwx1}+#{lY3T8d8tdFZ.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Prothionamide 250mg,ws9JxU942QD,TB_FCDRR-Ending Bal_Prothionamide 250mg,(#{IoUEO6cfUFM.FD55KIV91Hi}+#{IoUEO6cfUFM.aszbsgufcrc}+#{IoUEO6cfUFM.yivS0PoGxNe})-(#{IoUEO6cfUFM.ShAXH8W58Ju}+#{IoUEO6cfUFM.xRcQyWQdwx1}+#{IoUEO6cfUFM.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Pyridoxine 25mg,IJgHge1eAYQ,TB_FCDRR-Ending Bal_Pyridoxine 25mg,(#{e3Cuw6ziKyG.FD55KIV91Hi}+#{e3Cuw6ziKyG.aszbsgufcrc}+#{e3Cuw6ziKyG.yivS0PoGxNe})-(#{e3Cuw6ziKyG.ShAXH8W58Ju}+#{e3Cuw6ziKyG.xRcQyWQdwx1}+#{e3Cuw6ziKyG.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Pyridoxine 50mg,AkmZJWXHmqw,TB_FCDRR-Ending Bal_Pyridoxine 50mg,(#{WgmhbXVnUdP.FD55KIV91Hi}+#{WgmhbXVnUdP.aszbsgufcrc}+#{WgmhbXVnUdP.yivS0PoGxNe})-(#{WgmhbXVnUdP.ShAXH8W58Ju}+#{WgmhbXVnUdP.xRcQyWQdwx1}+#{WgmhbXVnUdP.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Spironolactone 25mg,vx4vQav337L,TB_FCDRR-Ending Bal_Spironolactone 25mg,(#{jNoTODy1y13.FD55KIV91Hi}+#{jNoTODy1y13.aszbsgufcrc}+#{jNoTODy1y13.yivS0PoGxNe})-(#{jNoTODy1y13.ShAXH8W58Ju}+#{jNoTODy1y13.xRcQyWQdwx1}+#{jNoTODy1y13.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Spironolactone 50mg,VHxRBvnQvSF,TB_FCDRR-Ending Bal_Spironolactone 50mg,(#{iql2FvQxQn8.FD55KIV91Hi}+#{iql2FvQxQn8.aszbsgufcrc}+#{iql2FvQxQn8.yivS0PoGxNe})-(#{iql2FvQxQn8.ShAXH8W58Ju}+#{iql2FvQxQn8.xRcQyWQdwx1}+#{iql2FvQxQn8.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_TB Patient Packs,r80xKBRrotT,TB_FCDRR-Ending Bal_TB Patient Packs,(#{ExSwHJiPywn.FD55KIV91Hi}+#{ExSwHJiPywn.aszbsgufcrc}+#{ExSwHJiPywn.yivS0PoGxNe})-(#{ExSwHJiPywn.ShAXH8W58Ju}+#{ExSwHJiPywn.xRcQyWQdwx1}+#{ExSwHJiPywn.H5rSTGwNFsK}),1
TB_FCDRR-Ending Bal_Valproic acid (Sodium valproate) 200mg,dvfaJqJZpXX,TB_FCDRR-Ending Bal_Valproic acid (Sodium valproat,(#{Ag7xA8qpU36.FD55KIV91Hi}+#{Ag7xA8qpU36.aszbsgufcrc}+#{Ag7xA8qpU36.yivS0PoGxNe})-(#{Ag7xA8qpU36.ShAXH8W58Ju}+#{Ag7xA8qpU36.xRcQyWQdwx1}+#{Ag7xA8qpU36.H5rSTGwNFsK}),1
TB_FCDRR-Qty for resupply_Amiloride 5mg,JUGIaSjSuk7,TB_FCDRR-Qty for resupply_Amiloride 5mg,(#{knvYrfjYSgF.ShAXH8W58Ju}*2)-#{knvYrfjYSgF.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Bedaquiline 100mg,YsMVCx5Whko,TB_FCDRR-Qty for resupply_Bedaquiline 100mg,(#{Sqdwoopw1nD.ShAXH8W58Ju}*2)-#{Sqdwoopw1nD.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Benzhexol 5mg,WFp83UhtCvq,TB_FCDRR-Qty for resupply_Benzhexol 5mg,(#{m5aO5WzuOPX.ShAXH8W58Ju}*2)-#{m5aO5WzuOPX.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Capreomycin 1gm vial,PQ6hfo1AYTc,TB_FCDRR-Qty for resupply_Capreomycin 1gm vial,(#{LzsYXJhjPUp.ShAXH8W58Ju}*2)-#{LzsYXJhjPUp.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Carbamazepine 200mg,QFHmqQBu600,TB_FCDRR-Qty for resupply_Carbamazepine 200mg,(#{ggIlzCf3jlk.ShAXH8W58Ju}*2)-#{ggIlzCf3jlk.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Clofazimine 100mg,SzyeHcwihnZ,TB_FCDRR-Qty for resupply_Clofazimine 100mg,(#{ZrXmJW51TgK.ShAXH8W58Ju}*2)-#{ZrXmJW51TgK.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Cycloserine 250mg Tablets,KpzZlmXSBql,TB_FCDRR-Qty for resupply_Cycloserine 250mg Tablet,(#{gY6wnANUQL9.ShAXH8W58Ju}*2)-#{gY6wnANUQL9.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Delaminid 50mg,SLslaGZuNqQ,TB_FCDRR-Qty for resupply_Delaminid 50mg,(#{xAdz2MrUUsc.ShAXH8W58Ju}*2)-#{xAdz2MrUUsc.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Ethambutol 100 mg,IsDSuYEkEN2,TB_FCDRR-Qty for resupply_Ethambutol 100 mg,(#{qJH6detUa4O.ShAXH8W58Ju}*2)-#{qJH6detUa4O.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Ethambutol 400 mg,gvXCYXIrdT0,TB_FCDRR-Qty for resupply_Ethambutol 400 mg,(#{ZRBJ3WVYEsQ.ShAXH8W58Ju}*2)-#{ZRBJ3WVYEsQ.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Fluoxetine 20mg,BBXosyBw8WK,TB_FCDRR-Qty for resupply_Fluoxetine 20mg,(#{cXFzTLs8yTH.ShAXH8W58Ju}*2)-#{cXFzTLs8yTH.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Granisentron 3mg,yjvylpbx7QT,TB_FCDRR-Qty for resupply_Granisentron 3mg,(#{Tki8cbMlLrY.ShAXH8W58Ju}*2)-#{Tki8cbMlLrY.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Granisentron 3mg inj,EAxn2c7983P,TB_FCDRR-Qty for resupply_Granisentron 3mg inj,(#{huBFtRYod0h.ShAXH8W58Ju}*2)-#{huBFtRYod0h.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Haloperidol 5mg,zfFriOSpZIV,TB_FCDRR-Qty for resupply_Haloperidol 5mg,(#{he3yHUQndmR.ShAXH8W58Ju}*2)-#{he3yHUQndmR.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Isoniazid 100mg,qwZxdufg9y7,TB_FCDRR-Qty for resupply_Isoniazid 100mg,(#{caL56WGvOFP.ShAXH8W58Ju}*2)-#{caL56WGvOFP.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Isoniazid 300mg,PWkmRoPksfl,TB_FCDRR-Qty for resupply_Isoniazid 300mg,(#{sjnsBPf10NR.ShAXH8W58Ju}*2)-#{sjnsBPf10NR.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Isoniazid Syrup 100mg /5ml and pyridoxine 5mg/5ml,d9D4IZqIaFc,TB_FCDRR-Qty for resupply_Isoniazid Syrup 100mg /5,(#{u5LaSQLJbEw.ShAXH8W58Ju}*2)-#{u5LaSQLJbEw.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Isoniazid Syrup 50mg /5ml,BHQ2E6yeef5,TB_FCDRR-Qty for resupply_Isoniazid Syrup 50mg /5m,(#{HtYrJ9WPcas.ShAXH8W58Ju}*2)-#{HtYrJ9WPcas.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Kanamycin 1gm vial,LaUIadOWpPx,TB_FCDRR-Qty for resupply_Kanamycin 1gm vial,(#{gyUSyHt1z0q.ShAXH8W58Ju}*2)-#{gyUSyHt1z0q.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Levofloxacin 250mg Tablets,Vmnq9Zvhfkl,TB_FCDRR-Qty for resupply_Levofloxacin 250mg Table,(#{BH5HUOfZs4M.ShAXH8W58Ju}*2)-#{BH5HUOfZs4M.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Levofloxacin 500mg Tablets,Iyn7dI7uuKS,TB_FCDRR-Qty for resupply_Levofloxacin 500mg Table,(#{CNdY2UgHIET.ShAXH8W58Ju}*2)-#{CNdY2UgHIET.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Linezolid 600mg,vwUxNnruN33,TB_FCDRR-Qty for resupply_Linezolid 600mg,(#{z9QMZREIpkY.ShAXH8W58Ju}*2)-#{z9QMZREIpkY.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_MB Adult Blister,rWwfALzzLvv,TB_FCDRR-Qty for resupply_MB Adult Blister,(#{tQJxBYjCikx.ShAXH8W58Ju}*2)-#{tQJxBYjCikx.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_MB Child Blister Packs,m5En0WgV83w,TB_FCDRR-Qty for resupply_MB Child Blister Packs,(#{hpGvkfaRHNR.ShAXH8W58Ju}*2)-#{hpGvkfaRHNR.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Magnesium Tricilicate 500mg,qbXtQeUhkvl,TB_FCDRR-Qty for resupply_Magnesium Tricilicate 50,(#{gnEaXO3qhCE.ShAXH8W58Ju}*2)-#{gnEaXO3qhCE.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Omeprazole 20mg,m3hieQ4dE5C,TB_FCDRR-Qty for resupply_Omeprazole 20mg,(#{oYnSlmnHu81.ShAXH8W58Ju}*2)-#{oYnSlmnHu81.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_PB Adult Blister Packs,zQcsFgJHTbC,TB_FCDRR-Qty for resupply_PB Adult Blister Packs,(#{oQS3dHVO1r8.ShAXH8W58Ju}*2)-#{oQS3dHVO1r8.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_PB Child Blister Packs,SY2HhbJZCM5,TB_FCDRR-Qty for resupply_PB Child Blister Packs,(#{Jt8yDvqxMyO.ShAXH8W58Ju}*2)-#{Jt8yDvqxMyO.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Para-aminosalicylic acid 4mg,ixhpAcw31hO,TB_FCDRR-Qty for resupply_Para-aminosalicylic acid,(#{GRycZaWtmu3.ShAXH8W58Ju}*2)-#{GRycZaWtmu3.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Potassium Chloride 470mg/285mg chloride SR,gi4VCBybqzS,TB_FCDRR-Qty for resupply_Potassium Chloride 470mg,(#{IXJu8pnpklX.ShAXH8W58Ju}*2)-#{IXJu8pnpklX.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Prednisolone 5mg,FIdIbtpjk0L,TB_FCDRR-Qty for resupply_Prednisolone 5mg,(#{lY3T8d8tdFZ.ShAXH8W58Ju}*2)-#{lY3T8d8tdFZ.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Prothionamide 250mg,j1AWlkxXJii,TB_FCDRR-Qty for resupply_Prothionamide 250mg,(#{IoUEO6cfUFM.ShAXH8W58Ju}*2)-#{IoUEO6cfUFM.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Pyrazinamide 500mg,UZSjBabTCLR,TB_FCDRR-Qty for resupply_Pyrazinamide 500mg,(#{x9Vob0qwPaE.ShAXH8W58Ju}*2)-#{x9Vob0qwPaE.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Pyridoxine 25mg,KhNiftsqrLD,TB_FCDRR-Qty for resupply_Pyridoxine 25mg,(#{e3Cuw6ziKyG.ShAXH8W58Ju}*2)-#{e3Cuw6ziKyG.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Pyridoxine 50mg,pDTf6Me8Qpt,TB_FCDRR-Qty for resupply_Pyridoxine 50mg,(#{WgmhbXVnUdP.ShAXH8W58Ju}*2)-#{WgmhbXVnUdP.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_R/H 150/75 mg,DYUHz29iCQo,TB_FCDRR-Qty for resupply_R/H 150/75 mg,(#{h8dH734G8iX.ShAXH8W58Ju}*2)-#{h8dH734G8iX.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_R/H 60/30 mg,xvYxioXYJTc,TB_FCDRR-Qty for resupply_R/H 60/30 mg,(#{MDMlHMkkEOG.ShAXH8W58Ju}*2)-#{MDMlHMkkEOG.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_R/H 60/60 mg,nHpWCwhkqJJ,TB_FCDRR-Qty for resupply_R/H 60/60 mg,(#{G2yIfsUWhyM.ShAXH8W58Ju}*2)-#{G2yIfsUWhyM.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_R/H 75/50 mg,fonw9k0Dtn8,TB_FCDRR-Qty for resupply_R/H 75/50 mg,(#{L9uipIDbAd1.ShAXH8W58Ju}*2)-#{L9uipIDbAd1.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_R/H/E 150/75/275 mg,N6TfnU55NxZ,TB_FCDRR-Qty for resupply_R/H/E 150/75/275 mg,(#{cBFzgnMFJjR.ShAXH8W58Ju}*2)-#{cBFzgnMFJjR.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_R/H/Z 60/30/150 mg,sW6xH1Kr3oA,TB_FCDRR-Qty for resupply_R/H/Z 60/30/150 mg,(#{xPQ7dKSqfSz.ShAXH8W58Ju}*2)-#{xPQ7dKSqfSz.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_R/H/Z 75/50/150 mg,pYF9ClMEiXV,TB_FCDRR-Qty for resupply_R/H/Z 75/50/150 mg,(#{MfT3krz1tyl.ShAXH8W58Ju}*2)-#{MfT3krz1tyl.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_R/H/Z/E 150/75/400/275 mg,nRVb7WSZeFb,TB_FCDRR-Qty for resupply_R/H/Z/E 150/75/400/275 m,(#{yrbLuCsTfPQ.ShAXH8W58Ju}*2)-#{yrbLuCsTfPQ.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Rifampicin 300mg,zhkDMTJ0TWF,TB_FCDRR-Qty for resupply_Rifampicin 300mg,(#{qUKbOJARPe8.ShAXH8W58Ju}*2)-#{qUKbOJARPe8.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Spironolactone 25mg,DcBmrOZHjoi,TB_FCDRR-Qty for resupply_Spironolactone 25mg,(#{jNoTODy1y13.ShAXH8W58Ju}*2)-#{jNoTODy1y13.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Spironolactone 50mg,Ugel2DlDv5v,TB_FCDRR-Qty for resupply_Spironolactone 50mg,(#{iql2FvQxQn8.ShAXH8W58Ju}*2)-#{iql2FvQxQn8.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_TB Patient Packs,PsSxC7ouZBc,TB_FCDRR-Qty for resupply_TB Patient Packs,(#{ExSwHJiPywn.ShAXH8W58Ju}*2)-#{ExSwHJiPywn.dRvK7VxuTSd},1
TB_FCDRR-Qty for resupply_Valproic acid  (Sodium valproate) 200mg,xeSX65Kfupq,TB_FCDRR-Qty for resupply_Valproic acid  (Sodium v,(#{Ag7xA8qpU36.ShAXH8W58Ju}*2)-#{Ag7xA8qpU36.dRvK7VxuTSd},1
TB_FCDRR_ Ending Bal _R/H 150/75 mg,vPAJ9izBl31,TB_FCDRR_ Ending Bal _R/H 150/75 mg,(#{h8dH734G8iX.FD55KIV91Hi}+#{h8dH734G8iX.aszbsgufcrc}+#{h8dH734G8iX.yivS0PoGxNe})-(#{h8dH734G8iX.ShAXH8W58Ju}+#{h8dH734G8iX.xRcQyWQdwx1}+#{h8dH734G8iX.H5rSTGwNFsK}),1
TB_FCDRR_ Ending Bal _R/H/E 150/75/275 mg,h7tJKPhUY5f,TB_FCDRR_ Ending Bal _R/H/E 150/75/275 mg,"(#{cBFzgnMFJjR.FD55KIV91Hi}+#{cBFzgnMFJjR.aszbsgufcrc}+#{cBFzgnMFJjR.yivS0PoGxNe})-(#{cBFzgnMFJjR.ShAXH8W58Ju}+
#{cBFzgnMFJjR.xRcQyWQdwx1}+#{cBFzgnMFJjR.H5rSTGwNFsK})",1
TB_FCDRR_ Ending Bal _R/H/Z/E 150/75/400/275 mg,eTDNOVpqHGg,R/H/Z/E 150/75/400/275 mg,(#{yrbLuCsTfPQ.FD55KIV91Hi}+#{yrbLuCsTfPQ.aszbsgufcrc}+#{yrbLuCsTfPQ.yivS0PoGxNe})-(#{yrbLuCsTfPQ.ShAXH8W58Ju}+#{yrbLuCsTfPQ.xRcQyWQdwx1}+#{yrbLuCsTfPQ.H5rSTGwNFsK}),1
TB_FCDRR_Ending Bal _Ethambutol 100 mg,eTgG4JMT7LQ,TB_FCDRR_Ending Bal _Ethambutol 100 mg,(#{qJH6detUa4O.FD55KIV91Hi}+#{qJH6detUa4O.aszbsgufcrc}+#{qJH6detUa4O.yivS0PoGxNe})-(#{qJH6detUa4O.ShAXH8W58Ju}+#{qJH6detUa4O.xRcQyWQdwx1}+#{qJH6detUa4O.H5rSTGwNFsK}),1
TB_FCDRR_Ending Bal _Ethambutol 400 mg,K9VKykUWKBV,TB_FCDRR_Ending Bal _Ethambutol 400 mg,(#{ZRBJ3WVYEsQ.FD55KIV91Hi}+#{ZRBJ3WVYEsQ.aszbsgufcrc}+#{ZRBJ3WVYEsQ.yivS0PoGxNe})-(#{ZRBJ3WVYEsQ.ShAXH8W58Ju}+#{ZRBJ3WVYEsQ.xRcQyWQdwx1}+#{ZRBJ3WVYEsQ.H5rSTGwNFsK}),1
TB_FCDRR_Ending Bal _Pyrazinamide 500mg,dZ4jE2Ofmiw,TB_FCDRR_Ending Bal _Pyrazinamide 500mg,(#{x9Vob0qwPaE.FD55KIV91Hi}+#{x9Vob0qwPaE.aszbsgufcrc}+#{x9Vob0qwPaE.yivS0PoGxNe})-(#{x9Vob0qwPaE.ShAXH8W58Ju}+#{x9Vob0qwPaE.xRcQyWQdwx1}+#{x9Vob0qwPaE.H5rSTGwNFsK}),1
TB_FCDRR_Ending Bal _R/H 60/30 mg,zKdryLtkSUg,TB_FCDRR_Ending Bal _R/H 60/30 mg,(#{MDMlHMkkEOG.FD55KIV91Hi}+#{MDMlHMkkEOG.aszbsgufcrc}+#{MDMlHMkkEOG.yivS0PoGxNe})-(#{MDMlHMkkEOG.ShAXH8W58Ju}+#{MDMlHMkkEOG.xRcQyWQdwx1}+#{MDMlHMkkEOG.H5rSTGwNFsK}),1
TB_FCDRR_Ending Bal _R/H 60/60 mg,Q7qzAnbLdyh,TB_FCDRR_Ending Bal _R/H 60/60 mg,(#{G2yIfsUWhyM.FD55KIV91Hi}+#{G2yIfsUWhyM.aszbsgufcrc}+#{G2yIfsUWhyM.yivS0PoGxNe})-(#{G2yIfsUWhyM.ShAXH8W58Ju}+#{G2yIfsUWhyM.xRcQyWQdwx1}+#{G2yIfsUWhyM.H5rSTGwNFsK}),1
TB_FCDRR_Ending Bal _R/H 75/50 mg,eq4xXpo2MH7,TB_FCDRR_Ending Bal _R/H 75/50 mg,(#{L9uipIDbAd1.FD55KIV91Hi}+#{L9uipIDbAd1.aszbsgufcrc}+#{L9uipIDbAd1.yivS0PoGxNe})-(#{L9uipIDbAd1.ShAXH8W58Ju}+#{L9uipIDbAd1.xRcQyWQdwx1}+#{L9uipIDbAd1.H5rSTGwNFsK}),1
TB_FCDRR_Ending Bal _R/H/Z 60/30/150 mg,VCFXyjtHqUX,TB_FCDRR_Ending Bal _R/H/Z 60/30/150 mg,(#{xPQ7dKSqfSz.FD55KIV91Hi}+#{xPQ7dKSqfSz.aszbsgufcrc}+#{xPQ7dKSqfSz.yivS0PoGxNe})-(#{xPQ7dKSqfSz.ShAXH8W58Ju}+#{xPQ7dKSqfSz.xRcQyWQdwx1}+#{xPQ7dKSqfSz.H5rSTGwNFsK}),1
TB_FCDRR_Ending Bal _R/H/Z 75/50/150 mg,S6vWb32dk3Y,TB_FCDRR_Ending Bal _R/H/Z 75/50/150 mg,(#{MfT3krz1tyl.FD55KIV91Hi}+#{MfT3krz1tyl.aszbsgufcrc}+#{MfT3krz1tyl.yivS0PoGxNe})-(#{MfT3krz1tyl.ShAXH8W58Ju}+#{MfT3krz1tyl.xRcQyWQdwx1}+#{MfT3krz1tyl.H5rSTGwNFsK}),1
TB_FCDRR_Ending Bal _Rifampicin 300mg,nSW9pV7OhH9,TB_FCDRR_Ending Bal _Rifampicin 300mg,(#{qUKbOJARPe8.FD55KIV91Hi}+#{qUKbOJARPe8.aszbsgufcrc}+#{qUKbOJARPe8.yivS0PoGxNe})-(#{qUKbOJARPe8.ShAXH8W58Ju}+#{qUKbOJARPe8.xRcQyWQdwx1}+#{qUKbOJARPe8.H5rSTGwNFsK}),1
TB_Fluoxetine 20mg MoS,quCO2qps0Vc,TB_Fluoxetine 20mg MoS,(#{tlAdLRE8i6O.wGSba4uJwJ8}+#{cXFzTLs8yTH.dRvK7VxuTSd})/#{cXFzTLs8yTH.ShAXH8W58Ju},1
TB_Granisentron 3mg MoS,otXeK20pfJL,TB_Granisentron 3mg MoS,(#{FhFswrKjn5b.wGSba4uJwJ8}+#{Tki8cbMlLrY.dRvK7VxuTSd})/#{Tki8cbMlLrY.ShAXH8W58Ju},1
TB_Granisentron 3mg SoH,qT3QLf0eFyu,TB_Granisentron 3mg SoH,#{FhFswrKjn5b.wGSba4uJwJ8}+#{Tki8cbMlLrY.dRvK7VxuTSd},1
TB_Granisentron 3mg inj MoS,pSyRRwfHEAj,TB_Granisentron 3mg inj MoS,(#{zimxbmoOchd.wGSba4uJwJ8}+#{huBFtRYod0h.dRvK7VxuTSd})/#{huBFtRYod0h.ShAXH8W58Ju},1
TB_Granisentron 3mg inj SoH,SDu10wpH7NJ,TB_Granisentron 3mg inj SoH,#{zimxbmoOchd.wGSba4uJwJ8}+#{huBFtRYod0h.dRvK7VxuTSd},1
TB_Haloperidol 5mg MoS,zoPmxsuffdi,TB_Haloperidol 5mg MoS,(#{mC3ernb4Bif.wGSba4uJwJ8}+#{he3yHUQndmR.dRvK7VxuTSd})/#{he3yHUQndmR.ShAXH8W58Ju},1
TB_Isoniazid 100mg MoS,g5CXB9RZVun,TB_Isoniazid 100mg MoS,(#{GxA30wdyeGY.wGSba4uJwJ8}+#{caL56WGvOFP.dRvK7VxuTSd})/#{caL56WGvOFP.ShAXH8W58Ju},1
TB_Isoniazid 100mg SoH,Rq87fx5oMzq,TB_Isoniazid 100mg SoH,#{GxA30wdyeGY.wGSba4uJwJ8}+#{caL56WGvOFP.dRvK7VxuTSd},1
TB_Isoniazid 300mg MoS,UTjskn4Sohv,TB_Isoniazid 300mg MoS,(#{Kkg7QvFUhzq.wGSba4uJwJ8}+#{sjnsBPf10NR.dRvK7VxuTSd})/#{sjnsBPf10NR.ShAXH8W58Ju},1
TB_Isoniazid 300mg SoH,EPWrjJgiG8j,TB_Isoniazid 300mg SoH,#{Kkg7QvFUhzq.wGSba4uJwJ8}+#{sjnsBPf10NR.dRvK7VxuTSd},1
TB_Isoniazid Syrup 100mg /5ml and pyridoxine 5mg/5m SoH,rY8MTqNVO0x,TB_Isoniazid Syrup 100mg /5ml and pyridoxine,#{u5LaSQLJbEw.dRvK7VxuTSd}+#{gxcMGiLILNi.wGSba4uJwJ8},1
TB_Isoniazid Syrup 100mg /5ml and pyridoxine 5mg/5ml MoS,I8JG5YXT085,TB_Isoniazid Syrup 100mg /5ml and pyridoxine 5mg/5,(#{gxcMGiLILNi.wGSba4uJwJ8}+#{u5LaSQLJbEw.dRvK7VxuTSd})/#{u5LaSQLJbEw.ShAXH8W58Ju},1
TB_Isoniazid Syrup 50mg /5ml MoS,TtYf0KMAJWB,TB_Isoniazid Syrup 50mg /5ml MoS,(#{PVy2CcHmOHS.wGSba4uJwJ8}+#{HtYrJ9WPcas.dRvK7VxuTSd})/#{HtYrJ9WPcas.ShAXH8W58Ju},1
TB_Isoniazid Syrup 50mg /5ml SoH,JbbqqVrSnAj,TB_Isoniazid Syrup 50mg /5ml SoH,#{PVy2CcHmOHS.wGSba4uJwJ8}+#{HtYrJ9WPcas.dRvK7VxuTSd},1
TB_Kanamycin 1gm vial MoS,RM4IgpyE6a4,TB_Kanamycin 1gm vial MoS,(#{ciuJuhCFd1M.wGSba4uJwJ8}+#{gyUSyHt1z0q.dRvK7VxuTSd})/#{gyUSyHt1z0q.ShAXH8W58Ju},1
TB_Levofloxacin 250mg Tablets MoS,rVhGmC6CwlE,TB_Levofloxacin 250mg Tablets MoS,(#{WewsaQYzYHL.wGSba4uJwJ8}+#{BH5HUOfZs4M.dRvK7VxuTSd})/#{BH5HUOfZs4M.ShAXH8W58Ju},1
TB_Levofloxacin 500mg Tablets MoS,DUnoBr3C992,TB_Levofloxacin 500mg Tablets MoS,(#{qGIJQ7cfzch.wGSba4uJwJ8}+#{CNdY2UgHIET.dRvK7VxuTSd})/#{CNdY2UgHIET.ShAXH8W58Ju},1
TB_Linezolid 600mg MoS,hEhC2ytSkmv,TB_Linezolid 600mg MoS,(#{xqQsLyybIw5.wGSba4uJwJ8}+#{z9QMZREIpkY.dRvK7VxuTSd})/#{z9QMZREIpkY.ShAXH8W58Ju},1
TB_MB Adult Blister MoS,ALSgCnaX3bf,TB_MB Adult Blister MoS,(#{RHyi89GzBr0.wGSba4uJwJ8}+#{tQJxBYjCikx.dRvK7VxuTSd})/#{tQJxBYjCikx.ShAXH8W58Ju},1
TB_MB Adult Blister SoH,JRFs3ylU0y2,TB_MB Adult Blister SoH,#{RHyi89GzBr0.wGSba4uJwJ8}+#{tQJxBYjCikx.dRvK7VxuTSd},1
TB_MB Child Blister Packs MoS,CLtpK8FOiXz,TB_MB Child Blister Packs MoS,(#{mYOrZTeH8jh.wGSba4uJwJ8}+#{hpGvkfaRHNR.dRvK7VxuTSd})/#{hpGvkfaRHNR.ShAXH8W58Ju},1
TB_MB Child Blister Packs SoH,O00GkgMzw0u,TB_MB Child Blister Packs SoH,#{mYOrZTeH8jh.wGSba4uJwJ8}+#{hpGvkfaRHNR.dRvK7VxuTSd},1
TB_Magnesium Tricilicate 500mg MoS,fFius32CuXX,TB_Magnesium Tricilicate 500mg MoS,(#{QFDI7royKcj.wGSba4uJwJ8}+#{gnEaXO3qhCE.dRvK7VxuTSd})/#{gnEaXO3qhCE.ShAXH8W58Ju},1
TB_Omeprazole 20mg MoS,EGXbWMW7JFl,TB_Omeprazole 20mg MoS,(#{oYnSlmnHu81.dRvK7VxuTSd})+(#{AZ7GyS8dvip.wGSba4uJwJ8})/ #{oYnSlmnHu81.ShAXH8W58Ju},1
TB_PB Adult Blister Packs MoS,iyUrimmdVd6,TB_PB Adult Blister Packs MoS,(#{wmWwsojQzKE.wGSba4uJwJ8}+#{oQS3dHVO1r8.dRvK7VxuTSd})/#{oQS3dHVO1r8.ShAXH8W58Ju},1
TB_PB Adult Blister Packs SoH,cjs3TWOW7CS,TB_PB Adult Blister Packs SoH,#{wmWwsojQzKE.wGSba4uJwJ8}+#{oQS3dHVO1r8.dRvK7VxuTSd},1
TB_PB Child Blister Packs MoS,OEFQlixa2Ub,TB_PB Child Blister Packs MoS,(#{FF0L8oflr91.wGSba4uJwJ8}+#{Jt8yDvqxMyO.dRvK7VxuTSd})/#{Jt8yDvqxMyO.ShAXH8W58Ju},1
TB_PB Child Blister Packs SoH,JivDd1RgxlL,TB_PB Child Blister Packs SoH,#{FF0L8oflr91.wGSba4uJwJ8}+#{Jt8yDvqxMyO.dRvK7VxuTSd},1
TB_Para-aminosalicylic acid 4mg MoS,BKcN5VjdoM9,TB_Para-aminosalicylic acid 4mg MoS,(#{zth75ip3MUd.wGSba4uJwJ8}+#{GRycZaWtmu3.dRvK7VxuTSd})/#{GRycZaWtmu3.ShAXH8W58Ju},1
TB_Potassium Chloride 470mg/285mg chloride  SR MoS,bdpbb950RbE,TB_Potassium Chloride 470mg/285mg chloride  SR MoS,(#{u02pNUNt9Qx.wGSba4uJwJ8}+#{IXJu8pnpklX.dRvK7VxuTSd})/#{IXJu8pnpklX.ShAXH8W58Ju},1
TB_Potassium Chloride 470mg/285mg chloride  SR SoH,CLEG0csIlIW,TB_Potassium Chloride 470mg/285mg chloride  SR SoH,#{u02pNUNt9Qx.wGSba4uJwJ8}+#{IXJu8pnpklX.dRvK7VxuTSd},1
TB_Prednisolone 5mg MoS,d39waQZWThm,TB_Prednisolone 5mg MoS,(#{u2kwqlDvbiN.wGSba4uJwJ8}+#{lY3T8d8tdFZ.dRvK7VxuTSd})/#{lY3T8d8tdFZ.ShAXH8W58Ju},1
TB_Prednisolone 5mg SoH,Qeg8n82FA06,TB_Prednisolone 5mg SoH,#{u2kwqlDvbiN.wGSba4uJwJ8}+#{lY3T8d8tdFZ.dRvK7VxuTSd},1
TB_Prothionamide 250mg MoS,RfWBZY3dNEP,TB_Prothionamide 250mg MoS,(#{KeVDWqho9hw.wGSba4uJwJ8}+#{IoUEO6cfUFM.dRvK7VxuTSd})/#{IoUEO6cfUFM.ShAXH8W58Ju},1
TB_Pyrazinamide 500mg MoS,lRp0pgNZc5g,TB_Pyrazinamide 500mg MoS,(#{knfInTNYGJ4.wGSba4uJwJ8}+#{x9Vob0qwPaE.dRvK7VxuTSd})/#{x9Vob0qwPaE.ShAXH8W58Ju},1
TB_Pyridoxine 25mg MoS,xN6hJn1LopC,TB_Pyridoxine 25mg MoS,(#{i47XvoEEK8p.wGSba4uJwJ8}+#{e3Cuw6ziKyG.dRvK7VxuTSd})/#{e3Cuw6ziKyG.ShAXH8W58Ju},1
TB_Pyridoxine 25mg SoH,tqimG1wJNDT,TB_Pyridoxine 25mg SoH,#{i47XvoEEK8p.wGSba4uJwJ8}+#{e3Cuw6ziKyG.dRvK7VxuTSd},1
TB_Pyridoxine 50mg MoS,PHCNXMbCEqs,TB_Pyridoxine 50mg MoS,(#{DSiqSvwjfWl.wGSba4uJwJ8}+#{WgmhbXVnUdP.dRvK7VxuTSd})/#{WgmhbXVnUdP.ShAXH8W58Ju},1
TB_Pyridoxine 50mg SoH,g6uqnO0KDPz,TB_Pyridoxine 50mg SoH,#{WgmhbXVnUdP.dRvK7VxuTSd}+#{DSiqSvwjfWl.wGSba4uJwJ8},1
TB_R/H 150/75 mg  SoH,Ldb7AYlw5ds,TB_R/H 150/75 mg  SoH,#{SReftoGTyK1.wGSba4uJwJ8}+#{h8dH734G8iX.dRvK7VxuTSd},1
TB_R/H 150/75 mg MoS,zGcXtNee0sB,TB_R/H 150/75 mg MoS,(#{SReftoGTyK1.wGSba4uJwJ8}+#{h8dH734G8iX.dRvK7VxuTSd})/#{h8dH734G8iX.ShAXH8W58Ju},1
TB_R/H 60/30 mg MoS,y491EdWHxbn,TB_R/H 60/30 mg MoS,(#{sGgT9iawrWp.wGSba4uJwJ8}+#{MDMlHMkkEOG.dRvK7VxuTSd})/#{MDMlHMkkEOG.ShAXH8W58Ju},1
TB_R/H 60/30 mg SOH,W1WigXM3pPA,TB_R/H 60/30 mg SOH,#{MDMlHMkkEOG.dRvK7VxuTSd}+#{sGgT9iawrWp.wGSba4uJwJ8},1
TB_R/H 60/60 mg MoS,ZWaDArQU0Mr,TB_R/H 60/60 mg MoS,(#{mGmxyB2ynjC.wGSba4uJwJ8}+#{G2yIfsUWhyM.dRvK7VxuTSd})/#{G2yIfsUWhyM.ShAXH8W58Ju},1
TB_R/H 75/50 mg MoS,HLPVHGxQu5V,TB_R/H 75/50 mg MoS,(#{D25RrfG5JlP.wGSba4uJwJ8}+#{L9uipIDbAd1.dRvK7VxuTSd})/#{L9uipIDbAd1.ShAXH8W58Ju},1
TB_R/H/E 150/75/275 mg MoS,bKKKgskAcUp,TB_R/H/E 150/75/275 mg MoS,(#{ae6EBrnahyr.wGSba4uJwJ8}+#{cBFzgnMFJjR.dRvK7VxuTSd})/#{cBFzgnMFJjR.ShAXH8W58Ju},1
TB_R/H/E 150/75/275 mg SoH,rKsD1BT32hI,TB_R/H/E 150/75/275 mg SoH,#{cBFzgnMFJjR.dRvK7VxuTSd}+#{ae6EBrnahyr.wGSba4uJwJ8},1
TB_R/H/Z 60/30/150 mg MoS,PU1CE97feZK,TB_R/H/Z 60/30/150 mg MoS,(#{gsSWDJ81fuH.wGSba4uJwJ8}+#{xPQ7dKSqfSz.dRvK7VxuTSd})/#{xPQ7dKSqfSz.ShAXH8W58Ju},1
TB_R/H/Z 75/50/150 mg MoS,TDrhDiBEib0,TB_R/H/Z 75/50/150 mg MoS,(#{FFklDDzQwaA.wGSba4uJwJ8}+#{MfT3krz1tyl.dRvK7VxuTSd})/#{MfT3krz1tyl.ShAXH8W58Ju},1
TB_R/H/Z/E 150/75/400/275 mg  SoH,tKLAFk6puPD,TB_R/H/Z/E 150/75/400/275 mg  SoH,#{yrbLuCsTfPQ.dRvK7VxuTSd}+#{Vp6ycWrIssj.wGSba4uJwJ8},1
TB_R/H/Z/E 150/75/400/275 mg MoS,hxC5v0OZrZ2,TB_R/H/Z/E 150/75/400/275 mg MoS,(#{Vp6ycWrIssj.wGSba4uJwJ8}+#{yrbLuCsTfPQ.dRvK7VxuTSd})/#{yrbLuCsTfPQ.ShAXH8W58Ju},1
TB_Rifampicin 300mg MoS,Ip95646x3vj,TB_Rifampicin 300mg MoS,(#{i7EE0lkzaAo.wGSba4uJwJ8}+#{qUKbOJARPe8.dRvK7VxuTSd})/#{qUKbOJARPe8.ShAXH8W58Ju},1
TB_SCDRR Amiloride 5mg,uYDjzGiOjQj,TB_SCDRR Amiloride 5mg,(#{JF53ZPceeLh.cK2SyNZElX3}+#{JF53ZPceeLh.bmfVdmRmt2K}+#{JF53ZPceeLh.cNxMJ2HZVro})-(#{JF53ZPceeLh.j247mdtxxTx}+#{JF53ZPceeLh.D0TfJD4FuKO}+#{JF53ZPceeLh.LaQhI0l2hg8}),1
TB_SCDRR Benzhexol 5mg,RuhjGw4YrYO,TB_SCDRR Benzhexol 5mg,(#{pTd0bdG8MLl.cK2SyNZElX3}+#{pTd0bdG8MLl.bmfVdmRmt2K}+#{pTd0bdG8MLl.cNxMJ2HZVro})-(#{pTd0bdG8MLl.j247mdtxxTx}+#{pTd0bdG8MLl.D0TfJD4FuKO}+#{pTd0bdG8MLl.LaQhI0l2hg8}),1
TB_SCDRR Carbamazepine 200mg,dfXem9fiC3n,TB_SCDRR Carbamazepine 200mg,(#{jTbFesGG8A1.cK2SyNZElX3}+#{jTbFesGG8A1.bmfVdmRmt2K}+#{jTbFesGG8A1.cNxMJ2HZVro})-(#{jTbFesGG8A1.j247mdtxxTx}+#{jTbFesGG8A1.D0TfJD4FuKO}+#{jTbFesGG8A1.LaQhI0l2hg8}),1
TB_SCDRR Fluoxetine 20mg,P8sJhw5kxO9,TB_SCDRR Fluoxetine 20mg,(#{tlAdLRE8i6O.cK2SyNZElX3}+#{tlAdLRE8i6O.bmfVdmRmt2K}+#{tlAdLRE8i6O.cNxMJ2HZVro})-(#{tlAdLRE8i6O.j247mdtxxTx}+#{tlAdLRE8i6O.D0TfJD4FuKO}+#{tlAdLRE8i6O.LaQhI0l2hg8}),1
TB_SCDRR Granisentron 3mg,WMDt0yc0f9W,TB_SCDRR Granisentron 3mg,(#{FhFswrKjn5b.cK2SyNZElX3}+#{FhFswrKjn5b.bmfVdmRmt2K}+#{FhFswrKjn5b.cNxMJ2HZVro})-(#{FhFswrKjn5b.j247mdtxxTx}+#{FhFswrKjn5b.D0TfJD4FuKO}+#{FhFswrKjn5b.LaQhI0l2hg8}),1
TB_SCDRR Granisentron 3mg inj,t4VeQ70CvUa,TB_SCDRR Granisentron 3mg inj,(#{zimxbmoOchd.cK2SyNZElX3}+#{zimxbmoOchd.bmfVdmRmt2K}+#{zimxbmoOchd.cNxMJ2HZVro})-(#{zimxbmoOchd.j247mdtxxTx}+#{zimxbmoOchd.D0TfJD4FuKO}+#{zimxbmoOchd.LaQhI0l2hg8}),1
TB_SCDRR Haloperidol 5mg,yunVJjhowSZ,TB_SCDRR Haloperidol 5mg,(#{mC3ernb4Bif.cK2SyNZElX3}+#{mC3ernb4Bif.bmfVdmRmt2K}+#{mC3ernb4Bif.cNxMJ2HZVro})-(#{mC3ernb4Bif.j247mdtxxTx}+#{mC3ernb4Bif.D0TfJD4FuKO}+#{mC3ernb4Bif.LaQhI0l2hg8}),1
TB_SCDRR Magnesium Tricilicate 500mg,LZ42ft1dp2Q,TB_SCDRR Magnesium Tricilicate 500mg,(#{QFDI7royKcj.cK2SyNZElX3}+#{QFDI7royKcj.bmfVdmRmt2K}+#{QFDI7royKcj.cNxMJ2HZVro})-(#{QFDI7royKcj.j247mdtxxTx}+#{QFDI7royKcj.D0TfJD4FuKO}+#{QFDI7royKcj.LaQhI0l2hg8}),1
TB_SCDRR Omeprazole 20mg,xDa389Afg34,TB_SCDRR Omeprazole 20mg,(#{AZ7GyS8dvip.cK2SyNZElX3}+#{AZ7GyS8dvip.bmfVdmRmt2K}+#{AZ7GyS8dvip.cNxMJ2HZVro})-(#{AZ7GyS8dvip.j247mdtxxTx}+#{AZ7GyS8dvip.D0TfJD4FuKO}+#{AZ7GyS8dvip.LaQhI0l2hg8}),1
TB_SCDRR Potassium Chloride 470mg/285mg chloride  SR,bTwcaGchO0q,TB_SCDRR  Potassium Chloride 470mg/285mg chloride,(#{u02pNUNt9Qx.cK2SyNZElX3}+#{u02pNUNt9Qx.bmfVdmRmt2K}+#{u02pNUNt9Qx.cNxMJ2HZVro})-(#{u02pNUNt9Qx.j247mdtxxTx}+#{u02pNUNt9Qx.D0TfJD4FuKO}+#{u02pNUNt9Qx.LaQhI0l2hg8}),1
TB_SCDRR Prednisolone 5mg,m1B9DPBdrXH,TB_SCDRR Prednisolone 5mg,(#{u2kwqlDvbiN.cK2SyNZElX3}+#{u2kwqlDvbiN.bmfVdmRmt2K}+#{u2kwqlDvbiN.cNxMJ2HZVro})-(#{u2kwqlDvbiN.j247mdtxxTx}+#{u2kwqlDvbiN.D0TfJD4FuKO}+#{u2kwqlDvbiN.LaQhI0l2hg8}),1
TB_SCDRR Spironolactone 25mg,OCrMPCoHbjp,TB_SCDRR Spironolactone 25mg,(#{mUJAzE9NO9x.cK2SyNZElX3}+#{mUJAzE9NO9x.bmfVdmRmt2K}+#{mUJAzE9NO9x.cNxMJ2HZVro})-(#{mUJAzE9NO9x.j247mdtxxTx}+#{mUJAzE9NO9x.D0TfJD4FuKO}+#{mUJAzE9NO9x.LaQhI0l2hg8}),1
TB_SCDRR Spironolactone 50mg,qIsYyfV8FiQ,TB_SCDRR Spironolactone 50mg,(#{BNGUyEulUtw.cK2SyNZElX3}+#{BNGUyEulUtw.bmfVdmRmt2K}+#{BNGUyEulUtw.cNxMJ2HZVro})-(#{BNGUyEulUtw.j247mdtxxTx}+#{BNGUyEulUtw.D0TfJD4FuKO}+#{BNGUyEulUtw.LaQhI0l2hg8}),1
TB_SCDRR Valproic acid  (Sodium valproate) 200mg,itSk8TvLZxQ,TB_SCDRR Valproic acid  (Sodium valproate) 200mg,(#{lDWk0wX87gt.cK2SyNZElX3}+#{lDWk0wX87gt.bmfVdmRmt2K}+#{lDWk0wX87gt.cNxMJ2HZVro})-(#{lDWk0wX87gt.j247mdtxxTx}+#{lDWk0wX87gt.D0TfJD4FuKO}+#{lDWk0wX87gt.LaQhI0l2hg8}),1
TB_SCDRR-Ending Bal_Ethambutol 100 mg,R3e2h2XChwz,TB_SCDRR-Ending Bal_Ethambutol 100 mg,(#{w1XL8QcYeED.cK2SyNZElX3}+#{w1XL8QcYeED.bmfVdmRmt2K}+#{w1XL8QcYeED.cNxMJ2HZVro})-(#{w1XL8QcYeED.j247mdtxxTx}+#{w1XL8QcYeED.D0TfJD4FuKO} +#{w1XL8QcYeED.LaQhI0l2hg8}),1
TB_SCDRR-Ending Bal_Ethambutol 400 mg,lLe0ZQ7tRcM,TB_SCDRR-Ending Bal_Ethambutol 400 mg,(#{iNJizHAnZLc.cK2SyNZElX3}+#{iNJizHAnZLc.bmfVdmRmt2K}+#{iNJizHAnZLc.cNxMJ2HZVro})-(#{iNJizHAnZLc.j247mdtxxTx}+#{iNJizHAnZLc.D0TfJD4FuKO}+#{iNJizHAnZLc.LaQhI0l2hg8}),1
TB_SCDRR-Ending Bal_Isoniazid 100mg,Om8vJtmksBx,TB_SCDRR-Ending Bal_Isoniazid 100mg,(#{GxA30wdyeGY.cK2SyNZElX3}+#{GxA30wdyeGY.bmfVdmRmt2K}+#{GxA30wdyeGY.cNxMJ2HZVro})-(#{GxA30wdyeGY.j247mdtxxTx}+#{GxA30wdyeGY.D0TfJD4FuKO}+#{GxA30wdyeGY.LaQhI0l2hg8}),1
TB_SCDRR-Ending Bal_Isoniazid 300mg,WyYsbwvMb81,TB_SCDRR-Ending Bal_Isoniazid 300mg,(#{Kkg7QvFUhzq.cK2SyNZElX3}+#{Kkg7QvFUhzq.bmfVdmRmt2K}+#{Kkg7QvFUhzq.cNxMJ2HZVro})-(#{Kkg7QvFUhzq.j247mdtxxTx}+#{Kkg7QvFUhzq.D0TfJD4FuKO}),1
TB_SCDRR-Ending Bal_Isoniazid Syrup 50mg /5ml,pYreYqtRI44,TB_SCDRR-Ending Bal_Isoniazid Syrup 50mg /5ml,(#{PVy2CcHmOHS.cK2SyNZElX3}+#{PVy2CcHmOHS.bmfVdmRmt2K}+#{PVy2CcHmOHS.cNxMJ2HZVro})-(#{PVy2CcHmOHS.j247mdtxxTx}+#{PVy2CcHmOHS.D0TfJD4FuKO}+#{PVy2CcHmOHS.LaQhI0l2hg8}),1
TB_SCDRR-Ending Bal_Pyrazinamide 500mg,Ws6HlTCb2n5,TB_SCDRR-Ending Bal_Pyrazinamide 500mg,(#{knfInTNYGJ4.cK2SyNZElX3}+#{knfInTNYGJ4.bmfVdmRmt2K}+#{knfInTNYGJ4.cNxMJ2HZVro})-(#{knfInTNYGJ4.j247mdtxxTx}+#{knfInTNYGJ4.D0TfJD4FuKO}+#{x9Vob0qwPaE.H5rSTGwNFsK}),1
TB_SCDRR-Ending Bal_R/H 150/75 mg,VEjlsvFFDFh,TB_SCDRR-Ending Bal_R/H 150/75 mg,(#{SReftoGTyK1.cK2SyNZElX3}+#{SReftoGTyK1.bmfVdmRmt2K}+#{SReftoGTyK1.cNxMJ2HZVro})-(#{SReftoGTyK1.j247mdtxxTx}+#{SReftoGTyK1.D0TfJD4FuKO}+#{SReftoGTyK1.LaQhI0l2hg8}),1
TB_SCDRR-Ending Bal_R/H 60/30 mg,azeV3XYnAFU,TB_SCDRR-Ending Bal_R/H 60/30 mg,(#{sGgT9iawrWp.cK2SyNZElX3}+#{sGgT9iawrWp.bmfVdmRmt2K}+#{sGgT9iawrWp.cNxMJ2HZVro})-(#{sGgT9iawrWp.j247mdtxxTx}+#{sGgT9iawrWp.D0TfJD4FuKO}+#{sGgT9iawrWp.LaQhI0l2hg8}),1
TB_SCDRR-Ending Bal_R/H 60/60 mg,NWrvmxHEeUF,TB_SCDRR-Ending Bal_R/H 60/60 mg,(#{mGmxyB2ynjC.cK2SyNZElX3}+#{mGmxyB2ynjC.bmfVdmRmt2K}+#{mGmxyB2ynjC.cNxMJ2HZVro})-(#{mGmxyB2ynjC.j247mdtxxTx}+#{mGmxyB2ynjC.D0TfJD4FuKO}+#{mGmxyB2ynjC.LaQhI0l2hg8}),1
TB_SCDRR-Ending Bal_R/H 75/50 mg,B16zXrE2FKJ,TB_SCDRR-Ending Bal_R/H 75/50 mg,(#{D25RrfG5JlP.cK2SyNZElX3}+#{D25RrfG5JlP.bmfVdmRmt2K}+#{D25RrfG5JlP.cNxMJ2HZVro})-(#{D25RrfG5JlP.j247mdtxxTx}+#{D25RrfG5JlP.D0TfJD4FuKO}+#{D25RrfG5JlP.LaQhI0l2hg8}),1
TB_SCDRR-Ending Bal_R/H/E 150/75/275 mg,h5tjGLAAp2h,TB_SCDRR-Ending Bal_R/H/E 150/75/275 mg,(#{ae6EBrnahyr.cK2SyNZElX3}+#{ae6EBrnahyr.bmfVdmRmt2K}+#{ae6EBrnahyr.cNxMJ2HZVro})-(#{ae6EBrnahyr.j247mdtxxTx}+#{ae6EBrnahyr.D0TfJD4FuKO}+#{ae6EBrnahyr.LaQhI0l2hg8}),1
TB_SCDRR-Ending Bal_R/H/Z 60/30/150 mg,St6ziyf0INd,TB_SCDRR-Ending Bal_R/H/Z 60/30/150 mg,(#{gsSWDJ81fuH.cK2SyNZElX3}+#{gsSWDJ81fuH.bmfVdmRmt2K}+#{gsSWDJ81fuH.cNxMJ2HZVro})-(#{gsSWDJ81fuH.j247mdtxxTx}+#{gsSWDJ81fuH.D0TfJD4FuKO}+#{gsSWDJ81fuH.LaQhI0l2hg8}),1
TB_SCDRR-Ending Bal_R/H/Z 75/50/150 mg,Fo3fCekTb99,TB_SCDRR-Ending Bal_R/H/Z 75/50/150 mg,(#{FFklDDzQwaA.cK2SyNZElX3}+#{FFklDDzQwaA.bmfVdmRmt2K}+#{FFklDDzQwaA.cNxMJ2HZVro})-(#{FFklDDzQwaA.j247mdtxxTx}+#{FFklDDzQwaA.D0TfJD4FuKO}+#{FFklDDzQwaA.LaQhI0l2hg8}),1
TB_SCDRR-Ending Bal_R/H/Z/E 150/75/400/275 mg,wbiA93NOSac,TB_SCDRR-Ending Bal_R/H/Z/E 150/75/400/275 mg,(#{Vp6ycWrIssj.cK2SyNZElX3}+#{Vp6ycWrIssj.bmfVdmRmt2K}+#{Vp6ycWrIssj.cNxMJ2HZVro})-(#{Vp6ycWrIssj.j247mdtxxTx}+#{Vp6ycWrIssj.D0TfJD4FuKO}+#{Vp6ycWrIssj.LaQhI0l2hg8}),1
TB_SCDRR-Ending Bal_Rifampicin 300mg,bn5mlhBBYHI,TB_SCDRR-Ending Bal_Rifampicin 300mg,(#{i7EE0lkzaAo.cK2SyNZElX3}+#{i7EE0lkzaAo.bmfVdmRmt2K}+#{i7EE0lkzaAo.cNxMJ2HZVro})-(#{i7EE0lkzaAo.j247mdtxxTx}+#{i7EE0lkzaAo.D0TfJD4FuKO}+#{i7EE0lkzaAo.LaQhI0l2hg8}),1
TB_SCDRR-Ending Bal_TB Patient Packs,MXsV7joUmNq,TB_SCDRR-Ending Bal_TB Patient Packs,(#{i0HKwGrB5sQ.cK2SyNZElX3}+#{i0HKwGrB5sQ.bmfVdmRmt2K}+#{i0HKwGrB5sQ.cNxMJ2HZVro})-(#{i0HKwGrB5sQ.j247mdtxxTx}+#{i0HKwGrB5sQ.D0TfJD4FuKO}+#{i0HKwGrB5sQ.LaQhI0l2hg8}),1
TB_SCDRR-Ending Balance Capreomycin 1gm vial,XilsF9yX4eW,TB_SCDRR-Capreomycin 1gm vial,(#{iH0rC4i8K6c.cK2SyNZElX3} + #{iH0rC4i8K6c.bmfVdmRmt2K} + #{iH0rC4i8K6c.cNxMJ2HZVro}) - (#{iH0rC4i8K6c.LaQhI0l2hg8} + #{iH0rC4i8K6c.D0TfJD4FuKO} + #{iH0rC4i8K6c.j247mdtxxTx}),1
TB_SCDRR-Ending Balance Cycloserine 250mg Tablets,eJExee5WOvd,TB_SCDRR-Cycloserine 250mg Tablets,(#{wEGZb0FsWSx.cK2SyNZElX3} + #{wEGZb0FsWSx.bmfVdmRmt2K} + #{wEGZb0FsWSx.cNxMJ2HZVro}) - (#{wEGZb0FsWSx.LaQhI0l2hg8} + #{wEGZb0FsWSx.D0TfJD4FuKO} + #{wEGZb0FsWSx.j247mdtxxTx}),1
TB_SCDRR-Kanamycin 1gm vial,uWQ6vsDByQm,TB_SCDRR-Kanamycin 1gm vial,(#{ciuJuhCFd1M.cK2SyNZElX3}+#{ciuJuhCFd1M.bmfVdmRmt2K}+#{ciuJuhCFd1M.cNxMJ2HZVro})-(#{ciuJuhCFd1M.LaQhI0l2hg8}+#{ciuJuhCFd1M.D0TfJD4FuKO}+#{ciuJuhCFd1M.j247mdtxxTx}),1
TB_SCDRR-Levofloxacin 250mg Tablets,GoxAYXx27kB,TB_SCDRR-Levofloxacin 250mg Tablets,(#{WewsaQYzYHL.cK2SyNZElX3}+#{WewsaQYzYHL.cNxMJ2HZVro}+#{WewsaQYzYHL.bmfVdmRmt2K})-(#{WewsaQYzYHL.LaQhI0l2hg8}+#{WewsaQYzYHL.D0TfJD4FuKO}+#{WewsaQYzYHL.j247mdtxxTx}),1
TB_SCDRR-Levofloxacin 500mg Tablets,DTc7uqbDQZn,TB_SCDRR-Levofloxacin 500mg Tablets,(#{qGIJQ7cfzch.cK2SyNZElX3}+#{qGIJQ7cfzch.cNxMJ2HZVro}+#{qGIJQ7cfzch.bmfVdmRmt2K})-(#{qGIJQ7cfzch.j247mdtxxTx}+#{qGIJQ7cfzch.D0TfJD4FuKO}+#{qGIJQ7cfzch.LaQhI0l2hg8}),1
TB_SCDRR-Qty for resupply_Amiloride 5mg,hSAVkUGUZXb,TB_SCDRR-Qty for resupply_Amiloride 5mg,(#{knvYrfjYSgF.ShAXH8W58Ju}*3)-(#{knvYrfjYSgF.dRvK7VxuTSd}+#{JF53ZPceeLh.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Bedaquiline 100mg,MfvqM6SDXbB,TB_SCDRR-Qty for resupply_Bedaquiline 100mg,(#{Sqdwoopw1nD.ShAXH8W58Ju}*3)-(#{Sqdwoopw1nD.dRvK7VxuTSd}+#{DZWHKi63Zhz.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Benzhexol 5mg,JxLtIDgW608,TB_SCDRR-Qty for resupply_Benzhexol 5mg,(#{m5aO5WzuOPX.ShAXH8W58Ju}*3)-(#{m5aO5WzuOPX.dRvK7VxuTSd}+#{pTd0bdG8MLl.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Capreomycin 1gm vial,LfEXTjggZ6i,TB_SCDRR-Qty for resupply_Capreomycin 1gm vial,(#{LzsYXJhjPUp.ShAXH8W58Ju}*3)-(#{LzsYXJhjPUp.dRvK7VxuTSd}+#{iH0rC4i8K6c.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Carbamazepine 200mg,pQXr3r6xovn,TB_SCDRR-Qty for resupply_Carbamazepine 200mg,(#{ggIlzCf3jlk.ShAXH8W58Ju}*3)-(#{ggIlzCf3jlk.dRvK7VxuTSd}+#{jTbFesGG8A1.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Clofazimine 100mg,yjS2Cgg6krw,TB_SCDRR-Qty for resupply_Clofazimine 100mg,(#{ZrXmJW51TgK.ShAXH8W58Ju}*3)-(#{ZrXmJW51TgK.dRvK7VxuTSd}+#{YOB7gdu9kE1.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Cycloserine 250mg Tablets,jrmQ91VkIGs,TB_SCDRR-Qty for resupply_Cycloserine 250mg Tablet,(#{gY6wnANUQL9.ShAXH8W58Ju}*3)-(#{gY6wnANUQL9.dRvK7VxuTSd}+#{wEGZb0FsWSx.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Delaminid 50mg,TWn2XGWpI5s,TB_SCDRR-Qty for resupply_Delaminid 50mg,(#{xAdz2MrUUsc.ShAXH8W58Ju}*3)-(#{xAdz2MrUUsc.dRvK7VxuTSd}+#{lvn2UYyzeMP.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Ethambutol 100 mg,KYU5ZxrKa3f,TB_SCDRR-Qty for resupply_Ethambutol 100 mg,(#{qJH6detUa4O.ShAXH8W58Ju}*3)-(#{qJH6detUa4O.dRvK7VxuTSd}+#{w1XL8QcYeED.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Ethambutol 400 mg,EhRNA44ir26,TB_SCDRR-Qty for resupply_Ethambutol 400 mg,(#{ZRBJ3WVYEsQ.ShAXH8W58Ju}*3)-(#{ZRBJ3WVYEsQ.dRvK7VxuTSd}+#{iNJizHAnZLc.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Fluoxetine 20mg,Jak6o1MAdsW,TB_SCDRR-Qty for resupply_Fluoxetine 20mg,(#{cXFzTLs8yTH.ShAXH8W58Ju}*3)-(#{cXFzTLs8yTH.dRvK7VxuTSd}+#{tlAdLRE8i6O.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Granisentron 3mg,vJeM8QpNFXs,TB_SCDRR-Qty for resupply_Granisentron 3mg,(#{Tki8cbMlLrY.ShAXH8W58Ju}*3)-(#{Tki8cbMlLrY.dRvK7VxuTSd}+#{zimxbmoOchd.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Granisentron 3mg inj,q31605fpSXd,TB_SCDRR-Qty for resupply_Granisentron 3mg inj,(#{huBFtRYod0h.ShAXH8W58Ju}*3)-(#{huBFtRYod0h.dRvK7VxuTSd}+#{zimxbmoOchd.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Haloperidol 5mg,WOyXKRMUQw5,TB_SCDRR-Qty for resupply_Haloperidol 5mg,(#{he3yHUQndmR.ShAXH8W58Ju}*3)-(#{he3yHUQndmR.dRvK7VxuTSd}+#{mC3ernb4Bif.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Isoniazid 100mg,GWnL1tdu7QT,TB_SCDRR-Qty for resupply_Isoniazid 100mg,(#{caL56WGvOFP.ShAXH8W58Ju}*3)-(#{caL56WGvOFP.dRvK7VxuTSd}+#{GxA30wdyeGY.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Isoniazid 300mg,dScxKQ4aOLF,TB_SCDRR-Qty for resupply_Isoniazid 300mg,(#{sjnsBPf10NR.ShAXH8W58Ju}*3)-(#{sjnsBPf10NR.dRvK7VxuTSd}+#{Kkg7QvFUhzq.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Isoniazid Syrup 100mg /5ml and pyridoxine 5mg/5ml,NHMWLh9ssFo,TB_SCDRR-Qty for resupply_Isoniazid Syrup 100mg /5,(#{u5LaSQLJbEw.ShAXH8W58Ju}*3)-(#{u5LaSQLJbEw.dRvK7VxuTSd}+#{gxcMGiLILNi.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Isoniazid Syrup 50mg /5ml,O97Dzt1lHzo,TB_SCDRR-Qty for resupply_Isoniazid Syrup 50mg /5m,(#{HtYrJ9WPcas.ShAXH8W58Ju}*3)-(#{HtYrJ9WPcas.dRvK7VxuTSd}+#{PVy2CcHmOHS.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Kanamycin 1gm vial,X5L6HHZLTTn,TB_SCDRR-Qty for resupply_Kanamycin 1gm vial,(#{gyUSyHt1z0q.ShAXH8W58Ju}*3)-(#{gyUSyHt1z0q.dRvK7VxuTSd}+#{ciuJuhCFd1M.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Levofloxacin 250mg Tablets,tuJpTn3xZZQ,TB_SCDRR-Qty for resupply_Levofloxacin 250mg Table,(#{BH5HUOfZs4M.ShAXH8W58Ju}*3)-(#{BH5HUOfZs4M.dRvK7VxuTSd}+#{WewsaQYzYHL.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Levofloxacin 500mg Tablets,V9FD5a9cWsd,TB_SCDRR-Qty for resupply_Levofloxacin 500mg Table,(#{CNdY2UgHIET.ShAXH8W58Ju}*3)-(#{CNdY2UgHIET.dRvK7VxuTSd}+#{qGIJQ7cfzch.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Linezolid 600mg,pGpao2RpVYH,TB_SCDRR-Qty for resupply_Linezolid 600mg,(#{z9QMZREIpkY.ShAXH8W58Ju}*3)-(#{z9QMZREIpkY.dRvK7VxuTSd}+#{xqQsLyybIw5.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_MB Adult Blister,jCDBfnq3sba,TB_SCDRR-Qty for resupply_MB Adult Blister,(#{tQJxBYjCikx.ShAXH8W58Ju}*3)-(#{tQJxBYjCikx.dRvK7VxuTSd}+#{RHyi89GzBr0.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_MB Child Blister Packs,LAjdK7V8czl,TB_SCDRR-Qty for resupply_MB Child Blister Packs,(#{hpGvkfaRHNR.ShAXH8W58Ju}*3)-(#{hpGvkfaRHNR.dRvK7VxuTSd}+#{mYOrZTeH8jh.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Magnesium Tricilicate 500mg,vfejWkDuJIO,TB_SCDRR-Qty for resupply_Magnesium Tricilicate 50,(#{gnEaXO3qhCE.ShAXH8W58Ju}*3)-(#{gnEaXO3qhCE.dRvK7VxuTSd}+#{QFDI7royKcj.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Omeprazole 20mg,tJgxPNf36ME,TB_SCDRR-Qty for resupply_Omeprazole 20mg,(#{oYnSlmnHu81.ShAXH8W58Ju}*3)-(#{oYnSlmnHu81.dRvK7VxuTSd}+#{AZ7GyS8dvip.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_PB Adult Blister Packs,ozxxAefF7HQ,TB_SCDRR-Qty for resupply_PB Adult Blister Packs,(#{oQS3dHVO1r8.ShAXH8W58Ju}*3)-(#{oQS3dHVO1r8.dRvK7VxuTSd}+#{wmWwsojQzKE.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_PB Child Blister Packs,v3Eo7BSmORW,TB_SCDRR-Qty for resupply_PB Child Blister Packs,(#{Jt8yDvqxMyO.ShAXH8W58Ju}*3)-(#{Jt8yDvqxMyO.dRvK7VxuTSd}+#{FF0L8oflr91.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Para-aminosalicylic acid 4mg,Ib9G3S92LZS,TB_SCDRR-Qty for resupply_Para-aminosalicylic acid,(#{GRycZaWtmu3.ShAXH8W58Ju}*3)-(#{GRycZaWtmu3.dRvK7VxuTSd}+#{zth75ip3MUd.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Potassium Chloride 470mg/285mg chloride SR,RI12fhdPATu,TB_SCDRR-Qty for resupply_Potassium Chloride 470mg,(#{IXJu8pnpklX.ShAXH8W58Ju}*3)-(#{IXJu8pnpklX.dRvK7VxuTSd}+#{u02pNUNt9Qx.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Prednisolone 5mg,B9kVqEfrPEA,TB_SCDRR-Qty for resupply_Prednisolone 5mg,(#{lY3T8d8tdFZ.ShAXH8W58Ju}*3)-(#{lY3T8d8tdFZ.dRvK7VxuTSd}+#{u2kwqlDvbiN.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Prothionamide 250mg,S3QArcfK1eD,TB_SCDRR-Qty for resupply_Prothionamide 250mg,(#{IoUEO6cfUFM.ShAXH8W58Ju}*3)-(#{IoUEO6cfUFM.dRvK7VxuTSd}+#{KeVDWqho9hw.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Pyrazinamide 500mg,ijLc6wZKn5L,TB_SCDRR-Qty for resupply_Pyrazinamide 500mg,(#{x9Vob0qwPaE.ShAXH8W58Ju}*3)-(#{x9Vob0qwPaE.dRvK7VxuTSd}+#{knfInTNYGJ4.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Pyridoxine 25mg,sKAtyN0a7W7,TB_SCDRR-Qty for resupply_Pyridoxine 25mg,(#{e3Cuw6ziKyG.ShAXH8W58Ju}*3)-(#{e3Cuw6ziKyG.dRvK7VxuTSd}+#{i47XvoEEK8p.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Pyridoxine 50mg,egXEWqHQyo8,TB_SCDRR-Qty for resupply_Pyridoxine 50mg,(#{BOnG5LlzEuw.ShAXH8W58Ju}*3)-(#{BOnG5LlzEuw.dRvK7VxuTSd}+#{DSiqSvwjfWl.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_R/H 150/75 mg,zHXCo1bCVyJ,TB_SCDRR-Qty for resupply_R/H 150/75 mg,(#{h8dH734G8iX.ShAXH8W58Ju}*3)-(#{h8dH734G8iX.dRvK7VxuTSd}+#{SReftoGTyK1.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_R/H 60/30 mg,y2XtgrncfoP,TB_SCDRR-Qty for resupply_R/H 60/30 mg,(#{MDMlHMkkEOG.ShAXH8W58Ju}*3)-(#{MDMlHMkkEOG.dRvK7VxuTSd}+#{sGgT9iawrWp.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_R/H 60/60 mg,hdaePcqUsrM,TB_SCDRR-Qty for resupply_R/H 60/60 mg,(#{G2yIfsUWhyM.ShAXH8W58Ju}*3)-(#{G2yIfsUWhyM.dRvK7VxuTSd}+#{mGmxyB2ynjC.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_R/H 75/50 mg,h8M8OPv50eC,TB_SCDRR-Qty for resupply_R/H 75/50 mg,(#{L9uipIDbAd1.ShAXH8W58Ju}*3)-(#{L9uipIDbAd1.dRvK7VxuTSd}+#{D25RrfG5JlP.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_R/H/E 150/75/275 mg,P0cTyn32vQv,TB_SCDRR-Qty for resupply_R/H/E 150/75/275 mg,(#{cBFzgnMFJjR.ShAXH8W58Ju}*3)-(#{ae6EBrnahyr.wGSba4uJwJ8}+#{cBFzgnMFJjR.dRvK7VxuTSd}),1
TB_SCDRR-Qty for resupply_R/H/Z 60/30/150 mg,TW4j0XfWYyU,TB_SCDRR-Qty for resupply_R/H/Z 60/30/150 mg,(#{xPQ7dKSqfSz.ShAXH8W58Ju}*3)-(#{xPQ7dKSqfSz.dRvK7VxuTSd}+#{gsSWDJ81fuH.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_R/H/Z 75/50/150 mg,UWxMs18JMYk,TB_SCDRR-Qty for resupply_R/H/Z 75/50/150 mg,(#{MfT3krz1tyl.ShAXH8W58Ju}*3)-(#{MfT3krz1tyl.dRvK7VxuTSd}+#{FFklDDzQwaA.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_R/H/Z/E 150/75/400/275 mg,aZEi1JeeBku,TB_SCDRR-Qty for resupply_R/H/Z/E 150/75/400/275 m,(#{yrbLuCsTfPQ.ShAXH8W58Ju}*3)-(#{Vp6ycWrIssj.wGSba4uJwJ8}+#{yrbLuCsTfPQ.dRvK7VxuTSd}),1
TB_SCDRR-Qty for resupply_Rifampicin 300mg,YBVKsFmgtV8,TB_SCDRR-Qty for resupply_Rifampicin 300mg,(#{qUKbOJARPe8.ShAXH8W58Ju}*3)-(#{qUKbOJARPe8.dRvK7VxuTSd}+#{i7EE0lkzaAo.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Spironolactone 25mg,Cvozi6iSgZv,TB_SCDRR-Qty for resupply_Spironolactone 25mg,(#{jNoTODy1y13.ShAXH8W58Ju}*3)-(#{jNoTODy1y13.dRvK7VxuTSd}+#{mUJAzE9NO9x.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_Spironolactone 50mg,WPY0oLtHL0g,TB_SCDRR-Qty for resupply_Spironolactone 50mg,(#{iql2FvQxQn8.ShAXH8W58Ju}*3)-(#{iql2FvQxQn8.dRvK7VxuTSd}+#{BNGUyEulUtw.wGSba4uJwJ8}),1
TB_SCDRR-Qty for resupply_TB Patient Packs,WyaULCB5KHH,TB_SCDRR-Qty for resupply_TB Patient Packs,(#{ExSwHJiPywn.ShAXH8W58Ju}*3)-(#{i0HKwGrB5sQ.wGSba4uJwJ8}+#{ExSwHJiPywn.dRvK7VxuTSd}),1
TB_SCDRR-Qty for resupply_Valproic acid  (Sodium valproate) 200mg,bXOJBAaZ89x,TB_SCDRR-Qty for resupply_Valproic acid  (Sodium v,(#{Ag7xA8qpU36.ShAXH8W58Ju}*3)-(#{Ag7xA8qpU36.dRvK7VxuTSd}+#{lDWk0wX87gt.wGSba4uJwJ8}),1
TB_SCDRR-ending bal Bedaquiline 100mg,Vhs4Pk6FDDQ,TB_SCDRR-ending bal Bedaquiline 100mg,(#{DZWHKi63Zhz.cK2SyNZElX3}+#{DZWHKi63Zhz.bmfVdmRmt2K}+#{DZWHKi63Zhz.cNxMJ2HZVro})-(#{DZWHKi63Zhz.D0TfJD4FuKO}+#{DZWHKi63Zhz.LaQhI0l2hg8}+#{DZWHKi63Zhz.j247mdtxxTx}),1
TB_SCDRR-ending bal Clofazimine 100mg,GYHXo3OG6a7,TB_SCDRR-ending bal Clofazimine 100mg,(#{YOB7gdu9kE1.cK2SyNZElX3}+#{YOB7gdu9kE1.cNxMJ2HZVro}+#{YOB7gdu9kE1.bmfVdmRmt2K})-(#{YOB7gdu9kE1.LaQhI0l2hg8}+#{YOB7gdu9kE1.D0TfJD4FuKO}+#{YOB7gdu9kE1.j247mdtxxTx}),1
TB_SCDRR-ending bal Delaminid 50mg,xHH35jADygV,TB_SCDRR-ending bal Delaminid 50mg,(#{lvn2UYyzeMP.cK2SyNZElX3}+#{lvn2UYyzeMP.bmfVdmRmt2K}+#{lvn2UYyzeMP.cNxMJ2HZVro})-(#{lvn2UYyzeMP.LaQhI0l2hg8}+#{lvn2UYyzeMP.D0TfJD4FuKO}+#{lvn2UYyzeMP.j247mdtxxTx}),1
TB_SCDRR-ending bal Isoniazid 100mg,sdlqlhWNsaD,TB_SCDRR-ending bal Isoniazid 100mg,(#{GxA30wdyeGY.cK2SyNZElX3}+#{GxA30wdyeGY.bmfVdmRmt2K}+#{GxA30wdyeGY.cNxMJ2HZVro})-(#{GxA30wdyeGY.LaQhI0l2hg8}+#{GxA30wdyeGY.D0TfJD4FuKO}+#{GxA30wdyeGY.j247mdtxxTx}),1
TB_SCDRR-ending bal Isoniazid Syrup 100mg /5ml and pyridoxine 5mg/5ml,z440gMKUBvP,TB_SCDRR-ending bal Isoniazid Syrup 100mg /5ml and,(#{gxcMGiLILNi.cK2SyNZElX3}+#{gxcMGiLILNi.bmfVdmRmt2K}+#{gxcMGiLILNi.cNxMJ2HZVro})-(#{gxcMGiLILNi.D0TfJD4FuKO}+#{gxcMGiLILNi.j247mdtxxTx}+#{gxcMGiLILNi.LaQhI0l2hg8}),1
TB_SCDRR-ending bal Linezolid 600mg,bau7xHObu4M,TB_SCDRR-ending bal Linezolid 600mg,(#{xqQsLyybIw5.cK2SyNZElX3}+#{xqQsLyybIw5.cNxMJ2HZVro}+#{xqQsLyybIw5.bmfVdmRmt2K})-(#{xqQsLyybIw5.LaQhI0l2hg8}+#{xqQsLyybIw5.D0TfJD4FuKO}+#{xqQsLyybIw5.j247mdtxxTx}),1
TB_SCDRR-ending bal MB Adult Blister,pa4ABOXCXgo,TB_SCDRR-ending bal MB Adult Blister,(#{RHyi89GzBr0.cK2SyNZElX3}+#{RHyi89GzBr0.bmfVdmRmt2K}+#{RHyi89GzBr0.cNxMJ2HZVro})-(#{RHyi89GzBr0.LaQhI0l2hg8}+#{RHyi89GzBr0.D0TfJD4FuKO}+#{RHyi89GzBr0.j247mdtxxTx}),1
TB_SCDRR-ending bal MB Child Blister Packs,DX7gPGwYakP,TB_SCDRR-ending bal MB Child Blister Packs,(#{mYOrZTeH8jh.cK2SyNZElX3}+#{mYOrZTeH8jh.bmfVdmRmt2K}+#{mYOrZTeH8jh.cNxMJ2HZVro})-(#{mYOrZTeH8jh.LaQhI0l2hg8}+#{mYOrZTeH8jh.D0TfJD4FuKO}+#{mYOrZTeH8jh.j247mdtxxTx}),1
TB_SCDRR-ending bal PB Adult Blister Packs,JNIqU63xZhZ,TB_SCDRR-ending bal PB Adult Blister Packs,(#{wmWwsojQzKE.cK2SyNZElX3}+#{wmWwsojQzKE.bmfVdmRmt2K}+#{wmWwsojQzKE.cNxMJ2HZVro})-(#{wmWwsojQzKE.LaQhI0l2hg8}+#{wmWwsojQzKE.D0TfJD4FuKO}+#{wmWwsojQzKE.j247mdtxxTx}),1
TB_SCDRR-ending bal PB Child Blister Packs,TQFsNgjLwlV,TB_SCDRR-ending bal PB Child Blister Packs,(#{FF0L8oflr91.cK2SyNZElX3}+#{FF0L8oflr91.bmfVdmRmt2K}+#{FF0L8oflr91.cNxMJ2HZVro})-(#{FF0L8oflr91.LaQhI0l2hg8}+#{FF0L8oflr91.D0TfJD4FuKO}+#{FF0L8oflr91.j247mdtxxTx}),1
TB_SCDRR-ending bal Para-aminosalicylic acid 4mg,aZQ89hgjPZ1,TB_SCDRR-ending bal Para-aminosalicylic acid 4mg,(#{zth75ip3MUd.cK2SyNZElX3}+#{zth75ip3MUd.bmfVdmRmt2K}+#{zth75ip3MUd.cNxMJ2HZVro})-(#{zth75ip3MUd.LaQhI0l2hg8}+#{zth75ip3MUd.D0TfJD4FuKO}+#{zth75ip3MUd.j247mdtxxTx}),1
TB_SCDRR-ending bal Prothionamide 250mg,nxPOyfxUDeY,TB_SCDRR-ending bal Prothionamide 250mg,(#{KeVDWqho9hw.cK2SyNZElX3}+#{KeVDWqho9hw.cNxMJ2HZVro}+#{KeVDWqho9hw.bmfVdmRmt2K})-(#{KeVDWqho9hw.LaQhI0l2hg8}+#{KeVDWqho9hw.D0TfJD4FuKO}+#{KeVDWqho9hw.j247mdtxxTx}),1
TB_SCDRR-ending bal Pyridoxine 25mg,p1dFlW9OH7O,TB_SCDRR-ending bal Pyridoxine 25mg,(#{i47XvoEEK8p.cK2SyNZElX3}+#{i47XvoEEK8p.bmfVdmRmt2K}+#{i47XvoEEK8p.cNxMJ2HZVro})-(#{i47XvoEEK8p.j247mdtxxTx}+#{i47XvoEEK8p.D0TfJD4FuKO}+#{i47XvoEEK8p.LaQhI0l2hg8}),1
TB_SCDRR-ending bal Pyridoxine 50mg,dGyQxXyqym8,TB_SCDRR-ending bal Pyridoxine 50mg,(#{DSiqSvwjfWl.cK2SyNZElX3}+#{DSiqSvwjfWl.bmfVdmRmt2K}+#{DSiqSvwjfWl.cNxMJ2HZVro})-(#{DSiqSvwjfWl.LaQhI0l2hg8}+#{DSiqSvwjfWl.D0TfJD4FuKO}+#{DSiqSvwjfWl.j247mdtxxTx}),1
TB_SCDRR-ending bal soniazid 300mg,kb7hoqh0ORo,TB_SCDRR-ending bal soniazid 300mg,(#{Kkg7QvFUhzq.cK2SyNZElX3}+#{Kkg7QvFUhzq.bmfVdmRmt2K}+#{Kkg7QvFUhzq.cNxMJ2HZVro})-(#{Kkg7QvFUhzq.LaQhI0l2hg8}+#{Kkg7QvFUhzq.D0TfJD4FuKO}+#{Kkg7QvFUhzq.j247mdtxxTx}),1
TB_SCDRR-ending bal soniazid Syrup 50mg /5ml,jcdhymk27uM,TB_SCDRR-ending bal soniazid Syrup 50mg /5ml,(#{PVy2CcHmOHS.cK2SyNZElX3}+#{PVy2CcHmOHS.bmfVdmRmt2K}+#{PVy2CcHmOHS.cNxMJ2HZVro})-(#{PVy2CcHmOHS.LaQhI0l2hg8}+#{PVy2CcHmOHS.D0TfJD4FuKO}+#{PVy2CcHmOHS.j247mdtxxTx}),1
TB_Spironolactone 25mg MoS,gSjLYjn5ktO,TB_Spironolactone 25mg MoS,(#{mUJAzE9NO9x.wGSba4uJwJ8}+#{jNoTODy1y13.dRvK7VxuTSd})/#{jNoTODy1y13.ShAXH8W58Ju},1
TB_Spironolactone 25mg SoH,J9t1Z6iWDcP,TB_Spironolactone 25mg SoH,#{mUJAzE9NO9x.wGSba4uJwJ8}+#{jNoTODy1y13.dRvK7VxuTSd},1
TB_Spironolactone 50mg  SoH,IadsFLbD0Mw,TB_Spironolactone 50mg  SoH,#{BNGUyEulUtw.wGSba4uJwJ8}+#{iql2FvQxQn8.dRvK7VxuTSd},1
TB_Spironolactone 50mg MoS,XdyUQVZuJ4O,TB_Spironolactone 50mg MoS,(#{BNGUyEulUtw.wGSba4uJwJ8}+#{iql2FvQxQn8.dRvK7VxuTSd})/#{iql2FvQxQn8.ShAXH8W58Ju},1
TB_TB Patient Packs MoS,EH8e1gSixd7,TB_TB Patient Packs MoS,(#{i0HKwGrB5sQ.wGSba4uJwJ8}+#{ExSwHJiPywn.dRvK7VxuTSd})/#{ExSwHJiPywn.ShAXH8W58Ju},1
TB_Valproic acid  (Sodium valproate) 200mg MoS,LInAgNYJryH,TB_Valproic acid  (Sodium valproate) 200mg MoS,(#{lDWk0wX87gt.wGSba4uJwJ8}+#{Ag7xA8qpU36.dRvK7VxuTSd})/#{Ag7xA8qpU36.ShAXH8W58Ju},1
"TCP-1 Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases",pzueHVbzQs0,"BC + CD, new and relapse cases",#{z8QuJHnjbnq.Fmwb7qAGS9L} + #{z8QuJHnjbnq.ugrZILDyXFQ} + #{CQNuu86XczN.Fmwb7qAGS9L} + #{CQNuu86XczN.ugrZILDyXFQ} + #{DBa1E1JSJ5K.Fmwb7qAGS9L} + #{DBa1E1JSJ5K.ugrZILDyXFQ},1
"TCP-1⁽ᴹ⁾ Number of notified cases of TB bacteriologically confirmed, new and relapse cases",x1raXnYa2qy,"DSTB BC , new and relapse cases",#{z8QuJHnjbnq.Fmwb7qAGS9L} + #{z8QuJHnjbnq.ugrZILDyXFQ},1
TCP-7a Number of notified TB cases (all forms) contributed by non-national TB program providers – private/non-governmental facilities,HsnWODuYZyu,Contribution by Private and FBO,#{xhQlihiebMH.WwOVo8ccFpn},1
TIBU_CT Death rate(all forms),kgeB3B2SQvP,TIBU_CT Death rate(all forms),#{Z9AVW5bKTaG.rH2x9vLTldI} + #{mb7gNISsJ8b.bfnePhN6SH6} + #{qF3ilXwp479.wyLTTL3nGWQ} + #{YpM2CXCPZbf.Xc27LcZstD5} + #{yEyrFyJryXL.OMQWRyqq6aA} + #{m7BMQu4HYRT.rf6Umm9tJJo} + #{t730XRFI4WL.roiBu39Ry1Y} + #{H61J8pIAjLQ.Lf8OCNIaUZ2},#{Z9AVW5bKTaG.WMEPYZKZ3U0} + #{mb7gNISsJ8b.V3R4ZWKdKqM} + #{qF3ilXwp479.HvzUvIpAwTb} + #{YpM2CXCPZbf.LE9HaeX27pF} + #{yEyrFyJryXL.X5KEYn5r72h} + #{m7BMQu4HYRT.Uhqzn2L1Myf} + #{t730XRFI4WL.Qt6JuWhfM6C} + #{H61J8pIAjLQ.ssDgYPkkLGp}
TIBU_CT Proportion of bacteriologically confirmed TB patients  Cured,p9oZp7KfzTu,TIBU_CT Proportion of bconfirmed TB patients Cured,#{YpM2CXCPZbf.IFFAb0ApZv2} ,#{YpM2CXCPZbf.LE9HaeX27pF}
TIBU_CT TB Lost to follow up rate(All forms),J1o4oarAWu2,TIBU_CT TB Lost to follow up rate(All forms),#{Z9AVW5bKTaG.ZdpyYvlURuy} + #{mb7gNISsJ8b.c8Ryy3r6B1C} + #{qF3ilXwp479.sgKFauzjV4H} + #{YpM2CXCPZbf.CelxNNpkrdt} + #{yEyrFyJryXL.ULjhM25nAxq} + #{m7BMQu4HYRT.KAuNTGdpL0G} + #{t730XRFI4WL.hT10oYsNeSd} + #{H61J8pIAjLQ.BzwDCspO4yg},#{Z9AVW5bKTaG.WMEPYZKZ3U0} + #{mb7gNISsJ8b.V3R4ZWKdKqM} + #{qF3ilXwp479.HvzUvIpAwTb} + #{YpM2CXCPZbf.LE9HaeX27pF} + #{yEyrFyJryXL.X5KEYn5r72h} + #{m7BMQu4HYRT.Uhqzn2L1Myf} + #{t730XRFI4WL.Qt6JuWhfM6C} + #{H61J8pIAjLQ.ssDgYPkkLGp}
TIBU_CT TB treatment failure rate(All forms),Twcfsmg1UzB,TIBU_CT TB treatment failure rate(All forms),#{YpM2CXCPZbf.K8EuYuE8slP} + #{Z9AVW5bKTaG.haXbgY6NAV5} + #{mb7gNISsJ8b.D3dmNB7mm29} + #{qF3ilXwp479.YPfgUxlJKtT},#{Z9AVW5bKTaG.WMEPYZKZ3U0} + #{mb7gNISsJ8b.V3R4ZWKdKqM} + #{qF3ilXwp479.HvzUvIpAwTb} + #{YpM2CXCPZbf.LE9HaeX27pF}
TIBU_CT TB treatment success rate(all forms),n2HlH5rLhy5,TIBU_CT TB treatment success rate(all forms),(#{YpM2CXCPZbf.IFFAb0ApZv2} + #{YpM2CXCPZbf.hucvirG8l9C} + #{qF3ilXwp479.X5RAYt8HhXv} + #{qF3ilXwp479.gXsq6xIk7d3} + #{mb7gNISsJ8b.aOAYLKrsM7D} + #{mb7gNISsJ8b.EuKrcb65hPi} + #{Z9AVW5bKTaG.SjfRUylOCp4} + #{Z9AVW5bKTaG.E6NVZENpm5Y} + #{yEyrFyJryXL.MwiyIzhhKxr} + #{H61J8pIAjLQ.EcxoV9pk3ra} + #{m7BMQu4HYRT.Q9UypR5WreG}+#{t730XRFI4WL.MakbvESH4Ti}),#{Z9AVW5bKTaG.WMEPYZKZ3U0} + #{mb7gNISsJ8b.V3R4ZWKdKqM} + #{qF3ilXwp479.HvzUvIpAwTb} + #{YpM2CXCPZbf.LE9HaeX27pF} + #{yEyrFyJryXL.X5KEYn5r72h} + #{m7BMQu4HYRT.Uhqzn2L1Myf} + #{t730XRFI4WL.Qt6JuWhfM6C} + #{H61J8pIAjLQ.ssDgYPkkLGp}
TOB-Amenity Ward,seXYftDeAC2,TOB-Amenity Ward,#{zTIGTbphtuA.CFyfkW0xUuP},(#{zTIGTbphtuA.fgY5yxfRFHN}+#{zTIGTbphtuA.ERX6phnRjMW})*[days]
TOB-Eye Ward,AWU8aRYtCSN,TOB-Eye Ward,#{bRP7RnMWTK8.CFyfkW0xUuP},(#{bRP7RnMWTK8.fgY5yxfRFHN}+#{bRP7RnMWTK8.ERX6phnRjMW})*[days]
TOB-Gynacology Ward,weEpVVe84V2,TOB-Gynacology Ward,#{zqqP41WTYNk.CFyfkW0xUuP},(#{zqqP41WTYNk.fgY5yxfRFHN}+#{zqqP41WTYNk.ERX6phnRjMW})*[days]
TOB-Isolation Ward,H9pEFAhnVep,TOB-Isolation Ward,#{ndneSgDusqj.CFyfkW0xUuP},(#{ndneSgDusqj.fgY5yxfRFHN}+#{ndneSgDusqj.ERX6phnRjMW})*[days]
TOB-Labour Ward,mAEG1XKkdLR,TOB-Labour Ward,#{KcmpbSvRETO.CFyfkW0xUuP},(#{KcmpbSvRETO.fgY5yxfRFHN}+#{KcmpbSvRETO.ERX6phnRjMW})*[days]
TOB-Maternity Ward,IGWmHhT3lEf,TOB-Maternity Ward,#{C3srxhSBods.CFyfkW0xUuP},(#{C3srxhSBods.fgY5yxfRFHN}+#{C3srxhSBods.ERX6phnRjMW})*[days]
TOB-Medical ward Female,irlWa5CsJ0H,TOB-Medical ward Female,#{S9BU0xS5QRf.CFyfkW0xUuP},(#{S9BU0xS5QRf.fgY5yxfRFHN}+#{S9BU0xS5QRf.ERX6phnRjMW})*[days]
TOB-Medical ward Male,Nj79IRuT2ea,TOB-Medical ward Male,#{OdXZaAsAGRU.CFyfkW0xUuP},(#{OdXZaAsAGRU.fgY5yxfRFHN}+#{OdXZaAsAGRU.ERX6phnRjMW})*[days]
TOB-Nursery/Neonatal Ward,AclEIcJbsT9,TOB-Nursery/Neonatal Ward,#{VuMnNeKMui9.CFyfkW0xUuP},(#{VuMnNeKMui9.fgY5yxfRFHN}+#{VuMnNeKMui9.ERX6phnRjMW})*[days]
TOB-Orthopaedic Ward,Nwgkx8DVgCr,TOB-Orthopaedic Ward,#{Y1sxN73phAf.CFyfkW0xUuP},(#{Y1sxN73phAf.fgY5yxfRFHN}+#{Y1sxN73phAf.ERX6phnRjMW})*[days]
TOB-Paediatric Ward,yylRWuPVIlp,TOB-Paediatric Ward,#{IgnbdUEWMd4.CFyfkW0xUuP},(#{IgnbdUEWMd4.fgY5yxfRFHN}+#{IgnbdUEWMd4.ERX6phnRjMW})*[days]
TOB-Psychastric Ward,znygOszNPmL,TOB-Psychastric Ward,#{BcVftn5I5NL.CFyfkW0xUuP},(#{BcVftn5I5NL.fgY5yxfRFHN}+#{BcVftn5I5NL.ERX6phnRjMW})*[days]
TOB-Surgical Female,H6hrzd6vonM,TOB-Surgical Female,#{rAvVxANpmvq.CFyfkW0xUuP},(#{rAvVxANpmvq.fgY5yxfRFHN}+#{rAvVxANpmvq.ERX6phnRjMW})*[days]
TOB-Surgical Male,CQazAxNNdXv,TOB-Surgical Male,#{slxcaBIJQFz.CFyfkW0xUuP},(#{slxcaBIJQFz.fgY5yxfRFHN}+#{slxcaBIJQFz.ERX6phnRjMW})*[days]
TOB-Surgical Ward,haLtM1O4blf,TOB-Surgical Ward,#{knorevTYX7E.CFyfkW0xUuP},(#{knorevTYX7E.fgY5yxfRFHN}+#{knorevTYX7E.ERX6phnRjMW})*[days]
TOTAL CHECK- Ref Note,nUD5yRYkoP7,TOTAL CHECK- Ref Note,(((#{QokZ5jjGLRz.NhSoXUMPK2K}+#{H5NKPaRikyM.NhSoXUMPK2K}+#{cKGenTODtq8.NhSoXUMPK2K}+#{nspiDhcn12j.NhSoXUMPK2K}+#{zo5v2sL2Pcz.NhSoXUMPK2K}+#{YkVzbDfJKMy.NhSoXUMPK2K}+#{FLT5619aj9V.NhSoXUMPK2K})-(#{jY3JFizFzQN.NhSoXUMPK2K}+#{usMDjlboKn4.NhSoXUMPK2K}+#{WuEJXcFURTY.NhSoXUMPK2K}+#{t75eApxzxfv.NhSoXUMPK2K}+#{q04fFLke4PE.NhSoXUMPK2K}+#{IxfhqZSgGy9.NhSoXUMPK2K}+#{QrHdlGiLTpv.NhSoXUMPK2K}+#{nGagRoo4BzA.NhSoXUMPK2K}+#{RijWww0GNyd.NhSoXUMPK2K}+#{sDEtpJj8IeQ.NhSoXUMPK2K}+#{VV8rxMutqgB.NhSoXUMPK2K}+#{W6kjK1t3oha.NhSoXUMPK2K}+#{DOPHF9sDlCE.NhSoXUMPK2K}+#{uHj0fEYrjTx.NhSoXUMPK2K}+#{Q3Dtz4uTL0J.NhSoXUMPK2K}+#{RIdOyfRqT15.NhSoXUMPK2K}+#{KAVPEvsu7GB.NhSoXUMPK2K}+#{sW1FEKkUlno.NhSoXUMPK2K}+#{JgjYnWEbbXI.NhSoXUMPK2K}+#{GeLsHQnBJSl.NhSoXUMPK2K}+#{Anntg74AWAc.NhSoXUMPK2K}+#{NAWDpCTju9c.NhSoXUMPK2K}+#{uIKFwsGjL8l.NhSoXUMPK2K}+#{zfE43ojuX27.NhSoXUMPK2K}+#{Jm0j7eIJw22.NhSoXUMPK2K}+#{Kvrh6Edh4ux.NhSoXUMPK2K}+#{kZVa4Dfz3oW.NhSoXUMPK2K}+#{ozuOGiiROjR.NhSoXUMPK2K}+#{zq5cC1mHOjZ.NhSoXUMPK2K}+#{kkKxlgb0SIK.NhSoXUMPK2K}+#{eWJI88NUHju.NhSoXUMPK2K}+#{ZL5umjFvNZT.NhSoXUMPK2K}+#{kMyKJqs4tP6.NhSoXUMPK2K}+#{JfMlkDb7sfP.NhSoXUMPK2K}+#{ERUP9jd5kr8.NhSoXUMPK2K}+#{VE7bP4Hd0Y8.NhSoXUMPK2K}+#{G10FiANc4uK.NhSoXUMPK2K}+#{jER1yfrClYQ.NhSoXUMPK2K}+#{zmTKl26bqXb.NhSoXUMPK2K}+#{JqVPN31hItf.NhSoXUMPK2K}+#{FNaQfndi92d.NhSoXUMPK2K}+#{pwYhMY7SObK.NhSoXUMPK2K}+#{T6Zosl4H5TG.NhSoXUMPK2K}+#{W53qF6leiPm.NhSoXUMPK2K}+#{MxceLE1Wgwj.NhSoXUMPK2K}+#{HGfobnG3qSX.NhSoXUMPK2K}+#{WypNzlF1rxb.NhSoXUMPK2K}+#{kltZozM5rkg.NhSoXUMPK2K}+#{SWHhf1eE89t.NhSoXUMPK2K}+#{qLWHhVTIp0l.NhSoXUMPK2K}+#{s2Ha3e0xwwp.NhSoXUMPK2K}+#{RMsgMQj2SBM.NhSoXUMPK2K}+#{X3nuiSHRJJP.NhSoXUMPK2K}+#{bDSQEZM3rtd.NhSoXUMPK2K}+#{dvo26Xu2g3G.NhSoXUMPK2K}+#{ksAM140tLvc.NhSoXUMPK2K}+#{mYIZtgEPa5S.NhSoXUMPK2K}+#{RWwJcCEIcZw.NhSoXUMPK2K}+#{u9TiVtfs3or.NhSoXUMPK2K}+#{BsyP5AnR1pE.NhSoXUMPK2K}+#{p4Vk0aCXUKj.NhSoXUMPK2K}+#{ZysDicYyDxN.NhSoXUMPK2K}+#{aLt2Db8y8VE.NhSoXUMPK2K}+#{Mnz4Ts6dMVo.NhSoXUMPK2K}+#{Mnz4Ts6dMVo.NhSoXUMPK2K}+#{Tpp5Fh9rV07.NhSoXUMPK2K}+#{sDEtpJj8IeQ.NhSoXUMPK2K}+#{DOPHF9sDlCE.NhSoXUMPK2K}+#{uHj0fEYrjTx.NhSoXUMPK2K}))+(#{fKvHjy58Hoe.NhSoXUMPK2K}+#{OheXXPgAdBi.NhSoXUMPK2K}+#{EWCqmXmU1Aj.NhSoXUMPK2K}))-(#{MznPWk9qAwQ.NhSoXUMPK2K}+#{v39gJQo67T2.NhSoXUMPK2K}+#{pW3EqzhIYHf.NhSoXUMPK2K}),1
Tb_R/H/Z 60/30/150 mg SOH,UZHXWlTSVjt,Tb_R/H/Z 60/30/150 mg SOH,#{gsSWDJ81fuH.wGSba4uJwJ8}+#{xPQ7dKSqfSz.dRvK7VxuTSd},1
Test malaria confirmed rate,eTW3k7HmDxV,Test malaria confirmed rate,(#{OoakJhWiyZp.SeDaCnHi3m5} + #{OoakJhWiyZp.lHl2rmXpHse}),#{NLKRV7bYbVy}
Tetanus Toxoid Wastage Rate,MFXYuPg0M2j,Tetanus Wastage Rate,#{HIfJ6JvWQmQ.NhSoXUMPK2K}-#{odmSZSezPsY.NhSoXUMPK2K}-#{au9lav766rM.kHFI1LYOvZF}-#{au9lav766rM.nYnnLevxuXP}-#{au9lav766rM.Qzjct1emaaj}-#{au9lav766rM.J24uZ0lCFVE}-#{au9lav766rM.B4gIWbNNUFc}-#{au9lav766rM.WmSjcUiJumX}-#{aBKk9v6MpWf.kHFI1LYOvZF}-#{aBKk9v6MpWf.nYnnLevxuXP}-#{aBKk9v6MpWf.Qzjct1emaaj}-#{aBKk9v6MpWf.J24uZ0lCFVE}-#{aBKk9v6MpWf.B4gIWbNNUFc}-#{aBKk9v6MpWf.WmSjcUiJumX}+#{siS80Yt4ul4.NhSoXUMPK2K},#{HIfJ6JvWQmQ.NhSoXUMPK2K}+#{siS80Yt4ul4.NhSoXUMPK2K}
"Tetracycline Eye Ointment,1%, 3.5g tube (Tube) MoS",JRnL0o1E7K8,"Tetracycline Eye Ointment,1%, 3.5g tube (Tube)",#{qoEFejcajz1.n8XlCFUpWOG},#{RDb5SFas36A.QvctQfKAQn3}
"Total (Pulmonary, clinically diagnosed)",Zc7H1MW3MAx,"Total (Pulmonary, clinically diagnosed)",#{DBa1E1JSJ5K.WwOVo8ccFpn},1
Total <5years who are Stunted,F3oPUDgoYBn,<5years who are Stunted,#{fGAuIUP6lHC}+#{mnsOAdOfXSi}+#{YloG1P6jXSR},1
Total <5years who are Underweight,jKvZxtHuwLa,<5yrs Underweight,#{AYT1IPxFRZx}+#{uYBa6RU8wUZ}+#{AIduSzrilaz},1
Total ACTs dispensed (Malaria Commodities ),SHSyrJHMnJM,Total ACTs dispensed,#{c0MB4RmVjxk.w77uMi1KzOH} + #{qnZmg5tNSMy.w77uMi1KzOH} + #{gVp1KSFI69G.w77uMi1KzOH} + #{BnGDrFwyQp9.w77uMi1KzOH},1
Total AL Physical Count,Q2Fv9XN8G0C,Total AL Physical Count,#{c0MB4RmVjxk.rPAsF4cpNxm}+#{qnZmg5tNSMy.rPAsF4cpNxm}+#{gVp1KSFI69G.rPAsF4cpNxm}+#{BnGDrFwyQp9.rPAsF4cpNxm},1
Total AL Received,w8wA2IeOkJR,Total AL Received,#{c0MB4RmVjxk.yuvCdaFqdCW}+#{qnZmg5tNSMy.yuvCdaFqdCW}+#{gVp1KSFI69G.yuvCdaFqdCW}+#{BnGDrFwyQp9.yuvCdaFqdCW},1
Total AL doses dispensed,JKDbGwp7vdy,Total AL doses dispensed,#{c0MB4RmVjxk.w77uMi1KzOH}+#{qnZmg5tNSMy.w77uMi1KzOH}+#{gVp1KSFI69G.w77uMi1KzOH}+#{BnGDrFwyQp9.w77uMi1KzOH},1
Total Admissions (MOH 717),OuzGn38bzgA,Total Admissions (MOH 717),(#{cvJuw6Fbuiw})+(#{r7LJ3kCX8EZ}),1
Total BCG Doses used in the month,JmpwdlQlwXb,Total BCG Doses used in the month,(#{d8MsenqQaMv.NhSoXUMPK2K}+#{mRVVnw1KKSL.NhSoXUMPK2K})-#{iIlheePZjCc.NhSoXUMPK2K},1
Total BCG Stock within the Month,DsGk0nzI1g6,Total BCG Stock within the Month,#{mRVVnw1KKSL.NhSoXUMPK2K}+#{d8MsenqQaMv.NhSoXUMPK2K},1
Total BCG doses stocked in the month,wFQGdbJN5AV,Total BCG doses stocked in the month,#{d8MsenqQaMv.NhSoXUMPK2K}+#{mRVVnw1KKSL.NhSoXUMPK2K},1
Total BCG doses used in the month,aAtDRpz8eUn,Total BCG doses used in the month,(#{d8MsenqQaMv.NhSoXUMPK2K}+#{mRVVnw1KKSL.NhSoXUMPK2K})-#{iIlheePZjCc.NhSoXUMPK2K},1
Total BCG doses wasted in the month,bJ5Srq5vbVS,Total BCG doses wasted in the month,((#{d8MsenqQaMv.NhSoXUMPK2K}+#{mRVVnw1KKSL.NhSoXUMPK2K})-#{iIlheePZjCc.NhSoXUMPK2K})-#{O3qECFGrzeF},1
Total Beds and Cots Service Workload,KJuJZ8Z4vna,Beds and Cots,#{K3i0LumP9MU}+#{Q9bZ7fvL0c3},1
Total Children Weight  0-6 Months,BYfoG22kIqx,Total Children Weight  0-6 Months,#{twpy25QKLk9} + #{lvyOQjZaXZ3} + #{QCNHvzgxurQ} + #{ENjll6PbaI8} + #{AIduSzrilaz},#{twpy25QKLk9} + #{lvyOQjZaXZ3} + #{QCNHvzgxurQ} + #{ENjll6PbaI8} + #{AIduSzrilaz}
Total Children attending CWC,D0dZJRB71Sn,Total Children attending CWC,#{EsfvxFcltV0},1
Total Cildren 6-59Months Issued Vit A,iVNPM9pcSDG, 6-59Months Issued Vit A,#{lxEQY7XM7Oy.NhSoXUMPK2K}+#{KXifjlklHaU.NhSoXUMPK2K},1
Total Clients receiving Short acting FP commodities,CfpgknFZbyh,Total Clients receiving Short acting FP commoditie,#{uHM6lzLXDBd.wBWcFk7k1qY}+#{BQmcVE8fex4.wBWcFk7k1qY}+#{paDQStynGGD.wBWcFk7k1qY}+#{yQFyyQBhXQf.wBWcFk7k1qY},1
Total Clients receiving long acting FP commodities,Wo4Hana1TLL,Total Clients receiving long acting FP commodities,#{otgQMOXuyIn.wBWcFk7k1qY}+#{DuBH6qPPdaO.wBWcFk7k1qY},1
Total Close Cash/Bank Balance,NhajbtpQeI7,Total Close Cash/Bank Balance,#{MznPWk9qAwQ.NhSoXUMPK2K}+#{v39gJQo67T2.NhSoXUMPK2K}+#{pW3EqzhIYHf.NhSoXUMPK2K},1
Total Community Deaths,Mte6GyoZ8kz,TotTotal Community Deaths,#{h3V5wA9UYyD.NhSoXUMPK2K}+#{xRYizOQBaUK.NhSoXUMPK2K}+#{QOsI0nmOANI.NhSoXUMPK2K}+#{NR0bPfjNTWT.NhSoXUMPK2K} + #{bWTVzXQoxpt} + #{sXPwrF8r04E} + #{I9yVwu1FWu6} + #{zW17XEoFhAN} + #{jBYvAmDdyfY},1
Total Confirmed malaria cases (<5Years MoH 705A+>5Years MoH 705B),ssmk1hgU4ok,Total Confirmed malaria cases,#{OoakJhWiyZp.lHl2rmXpHse} + #{OoakJhWiyZp.SeDaCnHi3m5},1
Total Covid Vaccinated,au7BKK4Q9ct,Total Covid Vaccinated,#{myQD3R0GBUq} + #{ZWMO83OyDwx} + #{LTJsHtrbyML} + #{jm6G9QtE6Th} + #{gOksPnou3je} + #{NHd2e6QGCkk} + #{UoaXvx7kTB7} + #{pkrY92yugfK} + #{qRQ3LIl7SmG} +#{eXSwuieh7QF},1
Total Covid Vaccinated 1st dose,D7kpRKTBrVI,Total Covid Vaccinated 1st dose,#{myQD3R0GBUq}  + #{LTJsHtrbyML}  + #{gOksPnou3je}  + #{UoaXvx7kTB7} +  #{qRQ3LIl7SmG} +#{eXSwuieh7QF.WsLO6h9a3Uj},1
Total Covid Vaccinated 2nd dose,QhFRQGdSdms,Total Covid Vaccinated 2nd dose, #{ZWMO83OyDwx} +  #{jm6G9QtE6Th} +  #{NHd2e6QGCkk} +  #{pkrY92yugfK}  + #{eXSwuieh7QF.jvfEsvm7slM},1
Total DPT+HIB+HEP B doses wasted in the month,wMWgZlbtTEl,Total DPT+HIB+HEP B doses wasted in the month,((#{s5PaJNvYa6i.NhSoXUMPK2K}+#{byrpD40AkQG.NhSoXUMPK2K})-#{BkGKNzv3Vn6.NhSoXUMPK2K})-(#{jVLQPHARXeN}+#{jCkbf493nG4}+#{yZVDFC7pP3F}),1
Total DPT+HiB+HEP B doses stocked in the month,EoVF9THLyaw,Total DPT+HiB+HEP B doses stocked mnth,#{s5PaJNvYa6i.NhSoXUMPK2K}+#{byrpD40AkQG.NhSoXUMPK2K},1
Total DPT+HiB+HEP B doses used in the month,BjuISQpPupz,Total DPT+HiB+HE doses used in the month,(#{s5PaJNvYa6i.NhSoXUMPK2K}+#{byrpD40AkQG.NhSoXUMPK2K})-#{BkGKNzv3Vn6.NhSoXUMPK2K},1
Total DPT/Hep+HiB doses Administered,VdpqyPb5DLw,Total DPT/Hep+HiB doses Administered,#{ku80YRejJPg} + #{K1Zzhafeukq} + #{OyddF1qflzP},1
Total DR cases managed as MDR tested HIV+,DXtadccMZk3,Total DR cases managed ,#{PZxFOwfXC1u.Muh7KDYkzTH}+#{PZxFOwfXC1u.odIztAzcNdB}+#{PZxFOwfXC1u.HSN3hQ4bcuD}+#{PZxFOwfXC1u.C5Q8JIDVtub}+#{PZxFOwfXC1u.tRCa7spO1vQ}+#{PZxFOwfXC1u.jDmOJlsLXhS}+#{PZxFOwfXC1u.nukr2Si4Bh3}+#{PZxFOwfXC1u.VaoFRK7SyaF},1
Total DR cases managed as MDR tested for HIV,rFN7r4YfOhG,Total DR cases managed a,#{qgh5VZTdydJ.Muh7KDYkzTH}+#{qgh5VZTdydJ.odIztAzcNdB}+#{qgh5VZTdydJ.HSN3hQ4bcuD}+#{qgh5VZTdydJ.C5Q8JIDVtub}+#{qgh5VZTdydJ.tRCa7spO1vQ}+#{qgh5VZTdydJ.jDmOJlsLXhS}+#{qgh5VZTdydJ.nukr2Si4Bh3}+#{qgh5VZTdydJ.VaoFRK7SyaF},1
Total DRTB (Type of resistance),rq53S340Hkm,Total DRTB (Type of resis,#{zVIv5xsY92B.OkitnJWqNwK}+#{zVIv5xsY92B.ZKt9O4laTpl}+#{zVIv5xsY92B.Muh7KDYkzTH}+#{zVIv5xsY92B.lLgSvDGjkQq}+#{zVIv5xsY92B.njpcfJLWMun}+#{zVIv5xsY92B.iMkdsG2hnT3}+#{zVIv5xsY92B.JjXGLDhx7an}+#{zVIv5xsY92B.odIztAzcNdB}+#{zVIv5xsY92B.HSN3hQ4bcuD}+#{zVIv5xsY92B.C5Q8JIDVtub}+#{zVIv5xsY92B.nx4Y45o8oVt}+#{zVIv5xsY92B.tRCa7spO1vQ}+#{zVIv5xsY92B.jDmOJlsLXhS}+#{zVIv5xsY92B.nukr2Si4Bh3}+#{zVIv5xsY92B.VaoFRK7SyaF}+#{zVIv5xsY92B.G9b7SF1c0jV},1
Total DRTB tested HIV+,TcuhxDKGp7Q,Total DRTB tested HIV+,#{PZxFOwfXC1u.OkitnJWqNwK}+#{PZxFOwfXC1u.ZKt9O4laTpl}+#{PZxFOwfXC1u.Muh7KDYkzTH}+#{PZxFOwfXC1u.lLgSvDGjkQq}+#{PZxFOwfXC1u.njpcfJLWMun}+#{PZxFOwfXC1u.iMkdsG2hnT3}+#{PZxFOwfXC1u.JjXGLDhx7an}+#{PZxFOwfXC1u.odIztAzcNdB}+#{PZxFOwfXC1u.HSN3hQ4bcuD}+#{PZxFOwfXC1u.C5Q8JIDVtub}+#{PZxFOwfXC1u.nx4Y45o8oVt}+#{PZxFOwfXC1u.tRCa7spO1vQ}+#{PZxFOwfXC1u.jDmOJlsLXhS}+#{PZxFOwfXC1u.nukr2Si4Bh3}+#{PZxFOwfXC1u.VaoFRK7SyaF}+#{PZxFOwfXC1u.G9b7SF1c0jV},1
Total DRTB tested for HIV,cZBi1CS8pS7,Total DRTB tested for HIV,#{qgh5VZTdydJ.OkitnJWqNwK}+#{qgh5VZTdydJ.ZKt9O4laTpl}+#{qgh5VZTdydJ.Muh7KDYkzTH}+#{qgh5VZTdydJ.lLgSvDGjkQq}+#{qgh5VZTdydJ.njpcfJLWMun}+#{qgh5VZTdydJ.iMkdsG2hnT3}+#{qgh5VZTdydJ.JjXGLDhx7an}+#{qgh5VZTdydJ.odIztAzcNdB}+#{qgh5VZTdydJ.HSN3hQ4bcuD}+#{qgh5VZTdydJ.C5Q8JIDVtub}+#{qgh5VZTdydJ.nx4Y45o8oVt}+#{qgh5VZTdydJ.tRCa7spO1vQ}+#{qgh5VZTdydJ.jDmOJlsLXhS}+#{qgh5VZTdydJ.nukr2Si4Bh3}+#{qgh5VZTdydJ.VaoFRK7SyaF}+#{qgh5VZTdydJ.G9b7SF1c0jV},1
Total Dewormed,oHLFVhJTJ5y,Total Dewormed,#{NXl959cFhDr},1
Total Diarrhoea Cases Under 5 and Over 5 Years,IcZ7WUBrahY,Total Diarrhoea cases,#{JcgMuSM3NnI.lHl2rmXpHse} + #{hGhUdN3KgrK.lHl2rmXpHse} + #{ZI3qZ2mfBER.lHl2rmXpHse} + #{tovFNTW5b9K.lHl2rmXpHse}+#{tovFNTW5b9K.SeDaCnHi3m5},1
Total EPTB  case tested HIV +,ZxtXRbSBHj1,Total EPTB   tested HIV+,#{Vri74blSuoL.G7Yo01Xihi1}+#{Vri74blSuoL.ylAZAGPSH8q},1
Total EPTB  case tested for HIV,uOJpfZvyZJ3,Total EPTB tested  forHIV,#{CQVzChlE9qw.G7Yo01Xihi1}+#{CQVzChlE9qw.ylAZAGPSH8q},1
Total EPTB and are HIV+ out of Tested Total EPTB,OHYkURczD8z,% Total EPTB and are HIV+,#{Vri74blSuoL.G7Yo01Xihi1}+#{Vri74blSuoL.ylAZAGPSH8q},#{CQVzChlE9qw.G7Yo01Xihi1}+#{CQVzChlE9qw.ylAZAGPSH8q}
Total EPTB cases notified,PvoEZKps03y,Total EPTB cases notified,#{CQNuu86XczN.WwOVo8ccFpn},1
Total EPTB tested for HIV out of the registered Total EPTB,zG4vrVBmrnr,% Total EPTB tested,#{CQVzChlE9qw.G7Yo01Xihi1}+#{CQVzChlE9qw.ylAZAGPSH8q},#{MmsSJfunbRu.G7Yo01Xihi1}+#{MmsSJfunbRu.ylAZAGPSH8q}
Total Expenditure,LougEBmdrSC,Total Expenditure,#{kQ4NVgc2MYs.NhSoXUMPK2K}+#{jY3JFizFzQN.NhSoXUMPK2K}+#{usMDjlboKn4.NhSoXUMPK2K}+#{WuEJXcFURTY.NhSoXUMPK2K}+#{KAVPEvsu7GB.NhSoXUMPK2K}+#{sW1FEKkUlno.NhSoXUMPK2K}+#{JgjYnWEbbXI.NhSoXUMPK2K}+#{GeLsHQnBJSl.NhSoXUMPK2K}+#{Anntg74AWAc.NhSoXUMPK2K}+#{NAWDpCTju9c.NhSoXUMPK2K}+#{uIKFwsGjL8l.NhSoXUMPK2K}+#{zfE43ojuX27.NhSoXUMPK2K}+#{Jm0j7eIJw22.NhSoXUMPK2K}+#{Kvrh6Edh4ux.NhSoXUMPK2K}+#{kZVa4Dfz3oW.NhSoXUMPK2K}+#{ozuOGiiROjR.NhSoXUMPK2K}+#{zq5cC1mHOjZ.NhSoXUMPK2K}+#{kkKxlgb0SIK.NhSoXUMPK2K}+#{ChuFUyaFoat.NhSoXUMPK2K}+#{Ta4fC50ws12.NhSoXUMPK2K}+#{pMp1v17OVlZ.NhSoXUMPK2K}+#{ktAiKqEgewS.NhSoXUMPK2K}+#{eWJI88NUHju.NhSoXUMPK2K}+#{ZL5umjFvNZT.NhSoXUMPK2K}+#{kMyKJqs4tP6.NhSoXUMPK2K}+#{JfMlkDb7sfP.NhSoXUMPK2K}+#{ERUP9jd5kr8.NhSoXUMPK2K}+#{VE7bP4Hd0Y8.NhSoXUMPK2K}+#{G10FiANc4uK.NhSoXUMPK2K}+#{jER1yfrClYQ.NhSoXUMPK2K}+#{zmTKl26bqXb.NhSoXUMPK2K}+#{JqVPN31hItf.NhSoXUMPK2K}+#{FNaQfndi92d.NhSoXUMPK2K}+#{pwYhMY7SObK.NhSoXUMPK2K}+#{T6Zosl4H5TG.NhSoXUMPK2K}+#{W53qF6leiPm.NhSoXUMPK2K}+#{MxceLE1Wgwj.NhSoXUMPK2K}+#{HGfobnG3qSX.NhSoXUMPK2K}+#{WypNzlF1rxb.NhSoXUMPK2K}+#{kltZozM5rkg.NhSoXUMPK2K}+#{SWHhf1eE89t.NhSoXUMPK2K}+#{qLWHhVTIp0l.NhSoXUMPK2K}+#{s2Ha3e0xwwp.NhSoXUMPK2K}+#{RMsgMQj2SBM.NhSoXUMPK2K}+#{X3nuiSHRJJP.NhSoXUMPK2K}+#{bDSQEZM3rtd.NhSoXUMPK2K}+#{dvo26Xu2g3G.NhSoXUMPK2K}+#{dvo26Xu2g3G.NhSoXUMPK2K}+#{ksAM140tLvc.NhSoXUMPK2K}+#{mYIZtgEPa5S.NhSoXUMPK2K}+#{RWwJcCEIcZw.NhSoXUMPK2K}+#{u9TiVtfs3or.NhSoXUMPK2K}+#{BsyP5AnR1pE.NhSoXUMPK2K}+#{p4Vk0aCXUKj.NhSoXUMPK2K}+#{ZysDicYyDxN.NhSoXUMPK2K}+#{Mnz4Ts6dMVo.NhSoXUMPK2K},1
Total Female All New PTB+ HIV+,IKcfBWOfy4h,Female All New PTB+ HIV+,#{m9rOYAy4LZT.mShPtMKrbn3}+#{m9rOYAy4LZT.evzSmUUZM1g}+#{m9rOYAy4LZT.WDafWKWrI84}+#{m9rOYAy4LZT.g6eOWUrsZRD}+#{m9rOYAy4LZT.ppw89viJsQm}+#{m9rOYAy4LZT.ePIPTGN08C1}+#{m9rOYAy4LZT.XDU1Bi82Hgl}+#{m9rOYAy4LZT.MlP8UmeTtS7}+#{m9rOYAy4LZT.XIQ1SeOshtt},1
Total Female All New PTB+ Tested,q9Ks0uGFbEC, Female All New PTB+ test,#{NNkcO5xJ4D8.mShPtMKrbn3}+#{NNkcO5xJ4D8.evzSmUUZM1g}+#{NNkcO5xJ4D8.WDafWKWrI84}+#{NNkcO5xJ4D8.g6eOWUrsZRD}+#{NNkcO5xJ4D8.ppw89viJsQm}+#{NNkcO5xJ4D8.ePIPTGN08C1}+#{NNkcO5xJ4D8.XDU1Bi82Hgl}+#{NNkcO5xJ4D8.MlP8UmeTtS7}+#{NNkcO5xJ4D8.XIQ1SeOshtt},1
Total Female MDR DR TB cases,Zixe1HWcxCf,Total Female MDR DR TB ca,#{nc89Tco5Fw2.mShPtMKrbn3}+#{nc89Tco5Fw2.evzSmUUZM1g}+#{nc89Tco5Fw2.WDafWKWrI84}+#{nc89Tco5Fw2.g6eOWUrsZRD}+#{nc89Tco5Fw2.ppw89viJsQm}+#{nc89Tco5Fw2.ePIPTGN08C1}+#{nc89Tco5Fw2.XDU1Bi82Hgl}+#{nc89Tco5Fw2.MlP8UmeTtS7}+#{nc89Tco5Fw2.XIQ1SeOshtt},1
Total Female MDR DR TB cases tested HIV,BCnT1yUJQgj,Female MDR DR TB HIV,#{AyQZFk6xPiX.mShPtMKrbn3}+#{AyQZFk6xPiX.evzSmUUZM1g}+#{AyQZFk6xPiX.WDafWKWrI84}+#{AyQZFk6xPiX.g6eOWUrsZRD}+#{AyQZFk6xPiX.ppw89viJsQm}+#{AyQZFk6xPiX.ePIPTGN08C1}+#{AyQZFk6xPiX.XDU1Bi82Hgl}+#{AyQZFk6xPiX.MlP8UmeTtS7}+#{AyQZFk6xPiX.XIQ1SeOshtt},1
Total Female Mono DR TB cases tested HIV,aWWDvpwDOYB,Female Mono DR TB cases t,#{ohF7EvzReQA.mShPtMKrbn3}+#{ohF7EvzReQA.evzSmUUZM1g}+#{ohF7EvzReQA.WDafWKWrI84}+#{ohF7EvzReQA.g6eOWUrsZRD}+#{ohF7EvzReQA.ppw89viJsQm}+#{ohF7EvzReQA.ePIPTGN08C1}+#{ohF7EvzReQA.XDU1Bi82Hgl}+#{ohF7EvzReQA.MlP8UmeTtS7}+#{ohF7EvzReQA.XIQ1SeOshtt},1
Total Female Mono DR TB cases tested for HIV+,Jei3J7WKnTj,Total Female Mono DR TB ,#{LhBvrJB3yg9.XIQ1SeOshtt}+#{LhBvrJB3yg9.MlP8UmeTtS7}+#{LhBvrJB3yg9.XDU1Bi82Hgl}+#{LhBvrJB3yg9.ePIPTGN08C1}+#{LhBvrJB3yg9.ppw89viJsQm}+#{LhBvrJB3yg9.g6eOWUrsZRD}+#{LhBvrJB3yg9.WDafWKWrI84}+#{LhBvrJB3yg9.evzSmUUZM1g}+#{LhBvrJB3yg9.mShPtMKrbn3},1
Total Female Other Mono DR TB cases,cdmdSsYbMJM,Total Female Other Mono ,#{Tffhpx2GH7c.mShPtMKrbn3}+#{Tffhpx2GH7c.evzSmUUZM1g}+#{Tffhpx2GH7c.WDafWKWrI84}+#{Tffhpx2GH7c.g6eOWUrsZRD}+#{Tffhpx2GH7c.ppw89viJsQm}+#{Tffhpx2GH7c.ePIPTGN08C1}+#{Tffhpx2GH7c.XDU1Bi82Hgl}+#{Tffhpx2GH7c.MlP8UmeTtS7}+#{Tffhpx2GH7c.XIQ1SeOshtt},1
Total Female Other Mono DR TB cases HIV+,UdEYjjhIhYg,Female Other Mono DR TB ,#{BO5msapoyFl.mShPtMKrbn3}+#{BO5msapoyFl.evzSmUUZM1g}+#{BO5msapoyFl.WDafWKWrI84}+#{BO5msapoyFl.g6eOWUrsZRD}+#{BO5msapoyFl.ppw89viJsQm}+#{BO5msapoyFl.ePIPTGN08C1}+#{BO5msapoyFl.XDU1Bi82Hgl}+#{BO5msapoyFl.MlP8UmeTtS7}+#{BO5msapoyFl.XIQ1SeOshtt},1
Total Female Other Mono DR TB cases tested HIV ,KzaBfa9BaQq, Mono DR TB cases tested,#{AZGC3SRp2tj.mShPtMKrbn3}+#{AZGC3SRp2tj.evzSmUUZM1g}+#{AZGC3SRp2tj.WDafWKWrI84}+#{AZGC3SRp2tj.g6eOWUrsZRD}+#{AZGC3SRp2tj.ppw89viJsQm}+#{AZGC3SRp2tj.ePIPTGN08C1}+#{AZGC3SRp2tj.XDU1Bi82Hgl}-#{AZGC3SRp2tj.MlP8UmeTtS7}+#{AZGC3SRp2tj.XIQ1SeOshtt},1
Total Female tested HIV+ (Tested for HIV) (EPTB),yPYq6SAhMxd,% of Total Female te,#{F7BQXT7ExEh.mShPtMKrbn3}+#{F7BQXT7ExEh.XDU1Bi82Hgl}+#{F7BQXT7ExEh.evzSmUUZM1g}+#{F7BQXT7ExEh.WDafWKWrI84}+#{F7BQXT7ExEh.g6eOWUrsZRD}+#{F7BQXT7ExEh.ppw89viJsQm}+#{F7BQXT7ExEh.ePIPTGN08C1}+#{F7BQXT7ExEh.MlP8UmeTtS7}+#{F7BQXT7ExEh.XIQ1SeOshtt},#{tZYhz9UkfxJ.mShPtMKrbn3}+#{tZYhz9UkfxJ.XDU1Bi82Hgl}+#{tZYhz9UkfxJ.evzSmUUZM1g}+#{tZYhz9UkfxJ.WDafWKWrI84}+#{tZYhz9UkfxJ.g6eOWUrsZRD}+#{tZYhz9UkfxJ.ppw89viJsQm}+#{tZYhz9UkfxJ.ePIPTGN08C1}+#{tZYhz9UkfxJ.MlP8UmeTtS7}+#{tZYhz9UkfxJ.XIQ1SeOshtt}
Total Female tested HIV+ (Tested for HIV) (PTB+),GXa5t4AghOG,% of Total Female test,#{m9rOYAy4LZT.mShPtMKrbn3}+#{m9rOYAy4LZT.XDU1Bi82Hgl}+#{m9rOYAy4LZT.evzSmUUZM1g}+#{m9rOYAy4LZT.WDafWKWrI84}+#{m9rOYAy4LZT.g6eOWUrsZRD}+#{m9rOYAy4LZT.ppw89viJsQm}+#{m9rOYAy4LZT.ePIPTGN08C1}+#{m9rOYAy4LZT.MlP8UmeTtS7}+#{m9rOYAy4LZT.XIQ1SeOshtt},#{NNkcO5xJ4D8.mShPtMKrbn3}+#{NNkcO5xJ4D8.XDU1Bi82Hgl}+#{NNkcO5xJ4D8.evzSmUUZM1g}+#{NNkcO5xJ4D8.WDafWKWrI84}+#{NNkcO5xJ4D8.g6eOWUrsZRD}+#{NNkcO5xJ4D8.ppw89viJsQm}+#{NNkcO5xJ4D8.ePIPTGN08C1}+#{NNkcO5xJ4D8.MlP8UmeTtS7}+#{NNkcO5xJ4D8.XIQ1SeOshtt}
Total Female tested HIV+ (Tested for HIV) (PTB-),LEguuvoaYRo,% of Total Female tes,#{pRlwE15DsEF.mShPtMKrbn3}+#{pRlwE15DsEF.XDU1Bi82Hgl}+#{pRlwE15DsEF.evzSmUUZM1g}+#{pRlwE15DsEF.WDafWKWrI84}+#{pRlwE15DsEF.g6eOWUrsZRD}+#{pRlwE15DsEF.ppw89viJsQm}+#{pRlwE15DsEF.ePIPTGN08C1}+#{pRlwE15DsEF.MlP8UmeTtS7}+#{pRlwE15DsEF.XIQ1SeOshtt},#{DGOE9qBg0S9.mShPtMKrbn3}+#{DGOE9qBg0S9.XDU1Bi82Hgl}+#{DGOE9qBg0S9.evzSmUUZM1g}+#{DGOE9qBg0S9.WDafWKWrI84}+#{DGOE9qBg0S9.g6eOWUrsZRD}+#{DGOE9qBg0S9.ppw89viJsQm}+#{DGOE9qBg0S9.ePIPTGN08C1}+#{DGOE9qBg0S9.MlP8UmeTtS7}+#{DGOE9qBg0S9.XIQ1SeOshtt}
Total Female tested for HIV (EPTB),egM2KHXMivL,% of Total Female teste,#{tZYhz9UkfxJ.mShPtMKrbn3}+#{tZYhz9UkfxJ.XDU1Bi82Hgl}+#{tZYhz9UkfxJ.evzSmUUZM1g}+#{tZYhz9UkfxJ.WDafWKWrI84}+#{tZYhz9UkfxJ.g6eOWUrsZRD}+#{tZYhz9UkfxJ.ppw89viJsQm}+#{tZYhz9UkfxJ.ePIPTGN08C1}+#{tZYhz9UkfxJ.MlP8UmeTtS7}+#{tZYhz9UkfxJ.XIQ1SeOshtt},#{jJSUs0JbSra.mShPtMKrbn3}+#{jJSUs0JbSra.XDU1Bi82Hgl}+#{jJSUs0JbSra.evzSmUUZM1g}+#{jJSUs0JbSra.WDafWKWrI84}+#{jJSUs0JbSra.g6eOWUrsZRD}+#{jJSUs0JbSra.ppw89viJsQm}+#{jJSUs0JbSra.ePIPTGN08C1}+#{jJSUs0JbSra.MlP8UmeTtS7}+#{jJSUs0JbSra.XIQ1SeOshtt}
Total Female tested for HIV (PTB+),VgyPwQ1KroJ,% of Total Female tested ,#{NNkcO5xJ4D8.mShPtMKrbn3}+#{NNkcO5xJ4D8.XDU1Bi82Hgl}+#{NNkcO5xJ4D8.evzSmUUZM1g}+#{NNkcO5xJ4D8.WDafWKWrI84}+#{NNkcO5xJ4D8.g6eOWUrsZRD}+#{NNkcO5xJ4D8.ppw89viJsQm}+#{NNkcO5xJ4D8.ePIPTGN08C1}+#{NNkcO5xJ4D8.MlP8UmeTtS7}+#{NNkcO5xJ4D8.XIQ1SeOshtt},#{mYcTFL89KEW.mShPtMKrbn3}+#{mYcTFL89KEW.XDU1Bi82Hgl}+#{mYcTFL89KEW.evzSmUUZM1g}+#{mYcTFL89KEW.WDafWKWrI84}+#{mYcTFL89KEW.g6eOWUrsZRD}+#{mYcTFL89KEW.ppw89viJsQm}+#{mYcTFL89KEW.ePIPTGN08C1}+#{mYcTFL89KEW.MlP8UmeTtS7}+#{mYcTFL89KEW.XIQ1SeOshtt}
Total Female tested for HIV (PTB-),luNjSEf5zOY,% of Total Female tested,#{DGOE9qBg0S9.mShPtMKrbn3}+#{DGOE9qBg0S9.XDU1Bi82Hgl}+#{DGOE9qBg0S9.evzSmUUZM1g}+#{DGOE9qBg0S9.WDafWKWrI84}+#{DGOE9qBg0S9.g6eOWUrsZRD}+#{DGOE9qBg0S9.ppw89viJsQm}+#{DGOE9qBg0S9.ePIPTGN08C1}+#{DGOE9qBg0S9.MlP8UmeTtS7}+#{DGOE9qBg0S9.XIQ1SeOshtt},#{u8dU1LPUUWD.mShPtMKrbn3}+#{u8dU1LPUUWD.XDU1Bi82Hgl}+#{u8dU1LPUUWD.evzSmUUZM1g}+#{u8dU1LPUUWD.WDafWKWrI84}+#{u8dU1LPUUWD.g6eOWUrsZRD}+#{u8dU1LPUUWD.ppw89viJsQm}+#{u8dU1LPUUWD.ePIPTGN08C1}+#{u8dU1LPUUWD.MlP8UmeTtS7}+#{u8dU1LPUUWD.XIQ1SeOshtt}
Total Health Products Amount Received- Non pharmaceuticals,PrpdD8EdyOk,Non pharmaceuticals Recei,#{xgjUzJuRc9y.mkunaICeJrU}+#{xifB1WtH7Ng.mkunaICeJrU}+#{RbeH1QkzW1n.mkunaICeJrU}+#{wvsz8rHyZjm.mkunaICeJrU},1
Total Health Products Amount Received- Pharmaceuticals,uVhtxdvCGDQ,Total Amount Received,#{xgjUzJuRc9y.uatqPaQgSUj}+#{xifB1WtH7Ng.uatqPaQgSUj}+#{RbeH1QkzW1n.uatqPaQgSUj}+#{wvsz8rHyZjm.uatqPaQgSUj},1
Total IPV doses stocked in the month,jSXgJmpmjo3,Total IPV doses stocked in the month,#{MJQFsY7Dp8G.NhSoXUMPK2K}+#{KUNmx9W9U2D.NhSoXUMPK2K},1
Total IPV doses used in the month,cb3lpQrYOzC,Total IPV doses used in the month,(#{MJQFsY7Dp8G.NhSoXUMPK2K}+#{KUNmx9W9U2D.NhSoXUMPK2K})-#{IFQwJq7fgld.NhSoXUMPK2K},1
Total IPV doses wasted in the month,xcj0t30u31W,Total IPV doses wasted in the month,((#{MJQFsY7Dp8G.NhSoXUMPK2K}+#{KUNmx9W9U2D.NhSoXUMPK2K})-#{IFQwJq7fgld.NhSoXUMPK2K})-#{gw4Zog5qvBy},1
Total Income/Revenue,eUbfhvQAZTO,Total Income/Revenue,#{RvNJvXCx4El.NhSoXUMPK2K}+#{zo5v2sL2Pcz.NhSoXUMPK2K}+#{QokZ5jjGLRz.NhSoXUMPK2K}+#{YkVzbDfJKMy.NhSoXUMPK2K}+#{H5NKPaRikyM.NhSoXUMPK2K}+#{FLT5619aj9V.NhSoXUMPK2K}+#{cKGenTODtq8.NhSoXUMPK2K}+#{nspiDhcn12j.NhSoXUMPK2K},1
Total Infant below 6 month exclusive breastfeed,byx90i3WIpR,Total Infant below 6 month exclusive breastfeed,#{QUueF25THDC.a57uWFr3dUy} + #{QUueF25THDC.MJAGUpeHkpn},1
Total LLIN ANC Plus Children < 1yr (711),uT5ryVQQh8A,Total LLIN ANC Plus Children ,#{eIvn8VgI5Zx} + #{adV5ma0IRHU},1
Total MDR TB tested HIV+,zEWxZGGuV6G,Total MDR TB tested HIV+,#{PZxFOwfXC1u.tRCa7spO1vQ}+#{PZxFOwfXC1u.jDmOJlsLXhS}+#{PZxFOwfXC1u.nukr2Si4Bh3}+#{PZxFOwfXC1u.VaoFRK7SyaF},1
Total MDR TB tested for HIV,zbNSBUrK15k,Total MDR TB tested for H, #{qgh5VZTdydJ.tRCa7spO1vQ}+#{qgh5VZTdydJ.jDmOJlsLXhS}+#{qgh5VZTdydJ.nukr2Si4Bh3}+#{qgh5VZTdydJ.VaoFRK7SyaF},1
Total Male All New PTB+ HIV+,rJWRuewWtlX, Male All New PTB+ HiV+,#{m9rOYAy4LZT.k6pLc73EqHg}+#{m9rOYAy4LZT.sp5O3uieiaL}+#{m9rOYAy4LZT.bvvGm4SkxGX}+#{m9rOYAy4LZT.ZlAlLmbVO9k}+#{m9rOYAy4LZT.r5VV8KQkAUG}+#{m9rOYAy4LZT.Bhcon9Mwf1x}+#{m9rOYAy4LZT.ZBKfkjMF8TE}+#{m9rOYAy4LZT.RYmHjCLU2CB}+#{m9rOYAy4LZT.DqxmUcaZ8FL},1
Total Male All New PTB+ Tested,zlKDSaHuJD1,Total Male All New PTB+ T,#{NNkcO5xJ4D8.k6pLc73EqHg}+#{NNkcO5xJ4D8.sp5O3uieiaL}+#{NNkcO5xJ4D8.bvvGm4SkxGX}+#{NNkcO5xJ4D8.ZlAlLmbVO9k}+#{NNkcO5xJ4D8.r5VV8KQkAUG}+#{NNkcO5xJ4D8.Bhcon9Mwf1x}+#{NNkcO5xJ4D8.ZBKfkjMF8TE}+#{NNkcO5xJ4D8.RYmHjCLU2CB}+#{NNkcO5xJ4D8.DqxmUcaZ8FL},1
Total Male MDR DR TB cases tested HIV+,zw9cQacIhbn,Total Male MDR DR TB ca,#{OTDY9KaKpA0.k6pLc73EqHg}+#{OTDY9KaKpA0.sp5O3uieiaL}+#{OTDY9KaKpA0.bvvGm4SkxGX}+#{OTDY9KaKpA0.ZlAlLmbVO9k}+#{OTDY9KaKpA0.r5VV8KQkAUG}+#{OTDY9KaKpA0.Bhcon9Mwf1x}+#{OTDY9KaKpA0.ZBKfkjMF8TE}+#{OTDY9KaKpA0.RYmHjCLU2CB}+#{OTDY9KaKpA0.DqxmUcaZ8FL},1
Total Male Mono DR TB cases,axS9JHNNI71,Total MaleMono DR TB case,#{YX4Zx8WZvbE.k6pLc73EqHg}+#{YX4Zx8WZvbE.sp5O3uieiaL}+#{YX4Zx8WZvbE.bvvGm4SkxGX}+#{YX4Zx8WZvbE.ZlAlLmbVO9k}+#{YX4Zx8WZvbE.r5VV8KQkAUG}+#{YX4Zx8WZvbE.Bhcon9Mwf1x}+#{YX4Zx8WZvbE.ZBKfkjMF8TE}+#{YX4Zx8WZvbE.RYmHjCLU2CB}+#{YX4Zx8WZvbE.DqxmUcaZ8FL},1
Total Male Mono DR TB cases tested HIV,HQ7TcZqPsl3,Total Male Mono DR TB cas,#{ohF7EvzReQA.k6pLc73EqHg}+#{ohF7EvzReQA.sp5O3uieiaL}+#{ohF7EvzReQA.bvvGm4SkxGX}+#{ohF7EvzReQA.ZlAlLmbVO9k}+#{ohF7EvzReQA.r5VV8KQkAUG}+#{ohF7EvzReQA.Bhcon9Mwf1x}+#{ohF7EvzReQA.ZBKfkjMF8TE}+#{ohF7EvzReQA.RYmHjCLU2CB}+#{ohF7EvzReQA.DqxmUcaZ8FL},1
Total Male Mono DR TB cases tested for HIV+,qZ9cNUt7UmN,Mono DR TB cases tested f,#{LhBvrJB3yg9.k6pLc73EqHg}+#{LhBvrJB3yg9.sp5O3uieiaL}+#{LhBvrJB3yg9.bvvGm4SkxGX}+#{LhBvrJB3yg9.ZlAlLmbVO9k}+#{LhBvrJB3yg9.r5VV8KQkAUG}+#{LhBvrJB3yg9.Bhcon9Mwf1x}+#{LhBvrJB3yg9.ZBKfkjMF8TE}+#{LhBvrJB3yg9.RYmHjCLU2CB}+#{LhBvrJB3yg9.DqxmUcaZ8FL},1
Total Male Other Mono DR TB cases,n6033mdLmm4,Total Male Other Mono DR ,#{Tffhpx2GH7c.k6pLc73EqHg}+#{Tffhpx2GH7c.sp5O3uieiaL}+#{Tffhpx2GH7c.bvvGm4SkxGX}+#{Tffhpx2GH7c.ZlAlLmbVO9k}+#{Tffhpx2GH7c.r5VV8KQkAUG}+#{Tffhpx2GH7c.Bhcon9Mwf1x}+#{Tffhpx2GH7c.ZBKfkjMF8TE}+#{Tffhpx2GH7c.RYmHjCLU2CB}+#{Tffhpx2GH7c.DqxmUcaZ8FL},1
Total Male Other Mono DR TB cases HIV+,BBb7j29Dfbx,Male Other Mono DR TB cas,#{BO5msapoyFl.k6pLc73EqHg}+#{BO5msapoyFl.sp5O3uieiaL}+#{BO5msapoyFl.bvvGm4SkxGX}+#{BO5msapoyFl.ZlAlLmbVO9k}+#{BO5msapoyFl.r5VV8KQkAUG}+#{BO5msapoyFl.Bhcon9Mwf1x}+#{BO5msapoyFl.ZBKfkjMF8TE}+#{BO5msapoyFl.RYmHjCLU2CB}+#{BO5msapoyFl.DqxmUcaZ8FL},1
Total Male Other Mono DR TB cases tested HIV ,S9eixwNvjPj, Male Other Mono DR TB,#{AZGC3SRp2tj.k6pLc73EqHg}+#{AZGC3SRp2tj.sp5O3uieiaL}+#{AZGC3SRp2tj.bvvGm4SkxGX}+#{AZGC3SRp2tj.ZlAlLmbVO9k}+#{AZGC3SRp2tj.r5VV8KQkAUG}+#{AZGC3SRp2tj.Bhcon9Mwf1x}+#{AZGC3SRp2tj.ZBKfkjMF8TE}+#{AZGC3SRp2tj.RYmHjCLU2CB}+#{AZGC3SRp2tj.DqxmUcaZ8FL},1
Total Male tested HIV+ (Tested for HIV) (EPTB),So1YA76ni4u,% of Total Male teste,#{F7BQXT7ExEh.k6pLc73EqHg}+#{F7BQXT7ExEh.ZBKfkjMF8TE}+#{F7BQXT7ExEh.sp5O3uieiaL}+#{F7BQXT7ExEh.bvvGm4SkxGX}+#{F7BQXT7ExEh.ZlAlLmbVO9k}+#{F7BQXT7ExEh.r5VV8KQkAUG}+#{F7BQXT7ExEh.Bhcon9Mwf1x}+#{F7BQXT7ExEh.RYmHjCLU2CB}+#{F7BQXT7ExEh.DqxmUcaZ8FL},#{tZYhz9UkfxJ.k6pLc73EqHg}+#{tZYhz9UkfxJ.ZBKfkjMF8TE}+#{tZYhz9UkfxJ.sp5O3uieiaL}+#{tZYhz9UkfxJ.bvvGm4SkxGX}+#{tZYhz9UkfxJ.ZlAlLmbVO9k}+#{tZYhz9UkfxJ.r5VV8KQkAUG}+#{tZYhz9UkfxJ.Bhcon9Mwf1x}+#{tZYhz9UkfxJ.RYmHjCLU2CB}+#{tZYhz9UkfxJ.DqxmUcaZ8FL}
Total Male tested HIV+ (Tested for HIV) (PTB+),ztVHzZWxvM1,% of Total Male tested HI,#{m9rOYAy4LZT.k6pLc73EqHg}+#{m9rOYAy4LZT.ZBKfkjMF8TE}+#{m9rOYAy4LZT.sp5O3uieiaL}+#{m9rOYAy4LZT.bvvGm4SkxGX}+#{m9rOYAy4LZT.ZlAlLmbVO9k}+#{m9rOYAy4LZT.r5VV8KQkAUG}+#{m9rOYAy4LZT.Bhcon9Mwf1x}+#{m9rOYAy4LZT.RYmHjCLU2CB}+#{m9rOYAy4LZT.DqxmUcaZ8FL},#{NNkcO5xJ4D8.k6pLc73EqHg}+#{NNkcO5xJ4D8.ZBKfkjMF8TE}+#{NNkcO5xJ4D8.sp5O3uieiaL}+#{NNkcO5xJ4D8.bvvGm4SkxGX}+#{NNkcO5xJ4D8.ZlAlLmbVO9k}+#{NNkcO5xJ4D8.r5VV8KQkAUG}+#{NNkcO5xJ4D8.Bhcon9Mwf1x}+#{NNkcO5xJ4D8.RYmHjCLU2CB}+#{NNkcO5xJ4D8.DqxmUcaZ8FL}
Total Male tested HIV+ (Tested for HIV) (PTB-),yjjgA1Hsy2q,% of Total Male tested H,#{pRlwE15DsEF.k6pLc73EqHg}+#{pRlwE15DsEF.ZBKfkjMF8TE}+#{pRlwE15DsEF.sp5O3uieiaL}+#{pRlwE15DsEF.bvvGm4SkxGX}+#{pRlwE15DsEF.ZlAlLmbVO9k}+#{pRlwE15DsEF.r5VV8KQkAUG}+#{pRlwE15DsEF.Bhcon9Mwf1x}+#{pRlwE15DsEF.RYmHjCLU2CB}+#{pRlwE15DsEF.DqxmUcaZ8FL},#{DGOE9qBg0S9.k6pLc73EqHg}+#{DGOE9qBg0S9.ZBKfkjMF8TE}+#{DGOE9qBg0S9.sp5O3uieiaL}+#{DGOE9qBg0S9.bvvGm4SkxGX}+#{DGOE9qBg0S9.ZlAlLmbVO9k}+#{DGOE9qBg0S9.r5VV8KQkAUG}+#{DGOE9qBg0S9.Bhcon9Mwf1x}+#{DGOE9qBg0S9.RYmHjCLU2CB}+#{DGOE9qBg0S9.DqxmUcaZ8FL}
Total Male tested for HIV (EPTB),kOW5VAJVvx8,% of Total Male tested ,#{tZYhz9UkfxJ.k6pLc73EqHg}+#{tZYhz9UkfxJ.ZBKfkjMF8TE}+#{tZYhz9UkfxJ.sp5O3uieiaL}+#{tZYhz9UkfxJ.bvvGm4SkxGX}+#{tZYhz9UkfxJ.ZlAlLmbVO9k}+#{tZYhz9UkfxJ.r5VV8KQkAUG}+#{tZYhz9UkfxJ.Bhcon9Mwf1x}+#{tZYhz9UkfxJ.RYmHjCLU2CB}+#{tZYhz9UkfxJ.DqxmUcaZ8FL},#{jJSUs0JbSra.k6pLc73EqHg}+#{jJSUs0JbSra.ZBKfkjMF8TE}+#{jJSUs0JbSra.sp5O3uieiaL}+#{jJSUs0JbSra.bvvGm4SkxGX}+#{jJSUs0JbSra.ZlAlLmbVO9k}+#{jJSUs0JbSra.r5VV8KQkAUG}+#{jJSUs0JbSra.Bhcon9Mwf1x}+#{jJSUs0JbSra.RYmHjCLU2CB}+#{jJSUs0JbSra.DqxmUcaZ8FL}
Total Male tested for HIV (PTB+),Vw9lMKENd72,% of Total Male tested fo,#{NNkcO5xJ4D8.k6pLc73EqHg}+#{NNkcO5xJ4D8.ZBKfkjMF8TE}+#{NNkcO5xJ4D8.sp5O3uieiaL}+#{NNkcO5xJ4D8.bvvGm4SkxGX}+#{NNkcO5xJ4D8.ZlAlLmbVO9k}+#{NNkcO5xJ4D8.r5VV8KQkAUG}+#{NNkcO5xJ4D8.Bhcon9Mwf1x}+#{NNkcO5xJ4D8.RYmHjCLU2CB}+#{NNkcO5xJ4D8.DqxmUcaZ8FL},#{mYcTFL89KEW.k6pLc73EqHg}+#{mYcTFL89KEW.ZBKfkjMF8TE}+#{mYcTFL89KEW.sp5O3uieiaL}+#{mYcTFL89KEW.bvvGm4SkxGX}+#{mYcTFL89KEW.ZlAlLmbVO9k}+#{mYcTFL89KEW.r5VV8KQkAUG}+#{mYcTFL89KEW.Bhcon9Mwf1x}+#{mYcTFL89KEW.RYmHjCLU2CB}+#{mYcTFL89KEW.DqxmUcaZ8FL}
Total Male tested for HIV (PTB-),fVz7KKUzb4a,% of Total Male tested f,#{DGOE9qBg0S9.k6pLc73EqHg}+#{DGOE9qBg0S9.ZBKfkjMF8TE}+#{DGOE9qBg0S9.sp5O3uieiaL}+#{DGOE9qBg0S9.bvvGm4SkxGX}+#{DGOE9qBg0S9.ZlAlLmbVO9k}+#{DGOE9qBg0S9.r5VV8KQkAUG}+#{DGOE9qBg0S9.Bhcon9Mwf1x}+#{DGOE9qBg0S9.RYmHjCLU2CB}+#{DGOE9qBg0S9.DqxmUcaZ8FL},#{u8dU1LPUUWD.k6pLc73EqHg}+#{u8dU1LPUUWD.ZBKfkjMF8TE}+#{u8dU1LPUUWD.sp5O3uieiaL}+#{u8dU1LPUUWD.bvvGm4SkxGX}+#{u8dU1LPUUWD.ZlAlLmbVO9k}+#{u8dU1LPUUWD.r5VV8KQkAUG}+#{u8dU1LPUUWD.Bhcon9Mwf1x}+#{u8dU1LPUUWD.RYmHjCLU2CB}+#{u8dU1LPUUWD.DqxmUcaZ8FL}
Total Maternal Complications,sN1kWXKnyRb,Maternal complications,#{qrTk1w6Y5Bk} + #{JzM8Q9sIc9i} + #{d4KC4RIwpKH} + #{xAAEwRrU8EH}  ,1
Total Measle doses stocked in the month,GYEmLSeWEdF,Total Measle doses stocked in the month,#{AMVejJGpKI9.NhSoXUMPK2K}+#{smag5V5gz0s.NhSoXUMPK2K},1
Total Measles doses used,avCA4B0WQTr,Total Measles doses used,#{AMVejJGpKI9.NhSoXUMPK2K} + #{smag5V5gz0s.NhSoXUMPK2K} - #{Gk6WlfVitbC.NhSoXUMPK2K},1
Total Measles-Rubella Doses Administered ,eENKeR1CeXW,Total Measles-Rubella Doses Administered ,#{sRbqc5gBQhI} + #{ivRgbmpCYTx.NhSoXUMPK2K} + #{Jw3alL29ZEi.NhSoXUMPK2K},1
Total Mono resistance (Type of resistance),MAyY013WO1e,Total Mono resistance (Ty,#{zVIv5xsY92B.OkitnJWqNwK}+#{zVIv5xsY92B.ZKt9O4laTpl}+#{zVIv5xsY92B.Muh7KDYkzTH}+#{zVIv5xsY92B.lLgSvDGjkQq},1
Total New <5years who are weighed,LFygugFZ2Vl,Total New <5years who are weighed,#{U4mo01O7hCY}+#{A0iW2ssADiX}+#{ofVM8O5NzjJ},1
Total New EPTB Female,e1JKusHDjsY,Total New EPTB Female,#{jJSUs0JbSra.mShPtMKrbn3}+#{jJSUs0JbSra.evzSmUUZM1g}+#{jJSUs0JbSra.WDafWKWrI84}+#{jJSUs0JbSra.g6eOWUrsZRD}+#{jJSUs0JbSra.ppw89viJsQm}+#{jJSUs0JbSra.ePIPTGN08C1}+#{jJSUs0JbSra.XDU1Bi82Hgl}+#{jJSUs0JbSra.MlP8UmeTtS7}+#{jJSUs0JbSra.XIQ1SeOshtt},1
Total New EPTB Female tested HIV+,HGaJPk15Ww0,Total New EPTB Female te,#{F7BQXT7ExEh.mShPtMKrbn3}+#{F7BQXT7ExEh.evzSmUUZM1g}+#{F7BQXT7ExEh.WDafWKWrI84}+#{F7BQXT7ExEh.g6eOWUrsZRD}+#{F7BQXT7ExEh.ppw89viJsQm}+#{F7BQXT7ExEh.ePIPTGN08C1}+#{F7BQXT7ExEh.XDU1Bi82Hgl}+#{F7BQXT7ExEh.MlP8UmeTtS7}+#{F7BQXT7ExEh.XIQ1SeOshtt},1
Total New EPTB Female tested for HIV,Wny5nj65Q2f,Total New EPTB Female tes,#{tZYhz9UkfxJ.mShPtMKrbn3}+#{tZYhz9UkfxJ.evzSmUUZM1g}+#{tZYhz9UkfxJ.WDafWKWrI84}+#{tZYhz9UkfxJ.g6eOWUrsZRD}+#{tZYhz9UkfxJ.ppw89viJsQm}+#{tZYhz9UkfxJ.ePIPTGN08C1}+#{tZYhz9UkfxJ.XDU1Bi82Hgl}+#{tZYhz9UkfxJ.MlP8UmeTtS7}+#{tZYhz9UkfxJ.XIQ1SeOshtt},1
Total New EPTB Male,hNeYhVxfMFK,Total New EPTB Male,#{jJSUs0JbSra.k6pLc73EqHg}+#{jJSUs0JbSra.sp5O3uieiaL}+#{jJSUs0JbSra.bvvGm4SkxGX}+#{jJSUs0JbSra.ZlAlLmbVO9k}+#{jJSUs0JbSra.r5VV8KQkAUG}+#{jJSUs0JbSra.Bhcon9Mwf1x}+#{jJSUs0JbSra.ZBKfkjMF8TE}+#{jJSUs0JbSra.RYmHjCLU2CB}+#{jJSUs0JbSra.DqxmUcaZ8FL},1
Total New EPTB Male tested HIV+,NY2VSsqVDso,Total New EPTB Male test,#{F7BQXT7ExEh.k6pLc73EqHg}+#{F7BQXT7ExEh.sp5O3uieiaL}+#{F7BQXT7ExEh.bvvGm4SkxGX}+#{F7BQXT7ExEh.ZlAlLmbVO9k}+#{F7BQXT7ExEh.r5VV8KQkAUG}+#{F7BQXT7ExEh.Bhcon9Mwf1x}+#{F7BQXT7ExEh.ZBKfkjMF8TE}+#{F7BQXT7ExEh.RYmHjCLU2CB}+#{F7BQXT7ExEh.DqxmUcaZ8FL},1
Total New EPTB Male tested for HIV,HG1piKDlrLf,Total New EPTB Male teste,#{tZYhz9UkfxJ.k6pLc73EqHg}+#{tZYhz9UkfxJ.sp5O3uieiaL}+#{tZYhz9UkfxJ.bvvGm4SkxGX}+#{tZYhz9UkfxJ.ZlAlLmbVO9k}+#{tZYhz9UkfxJ.r5VV8KQkAUG}+#{tZYhz9UkfxJ.Bhcon9Mwf1x}+#{tZYhz9UkfxJ.ZBKfkjMF8TE}+#{tZYhz9UkfxJ.RYmHjCLU2CB}+#{tZYhz9UkfxJ.DqxmUcaZ8FL},1
Total New PTB- Female,RhRnCjjOCrI,Total New PTB- Female,#{u8dU1LPUUWD.mShPtMKrbn3}+#{u8dU1LPUUWD.evzSmUUZM1g}+#{u8dU1LPUUWD.WDafWKWrI84}+#{u8dU1LPUUWD.g6eOWUrsZRD}+#{u8dU1LPUUWD.ppw89viJsQm}+#{u8dU1LPUUWD.ePIPTGN08C1}+#{u8dU1LPUUWD.XDU1Bi82Hgl}+#{u8dU1LPUUWD.MlP8UmeTtS7}+#{u8dU1LPUUWD.XIQ1SeOshtt},1
Total New PTB- Female tested HIV+,cGNcgflvHOb,Total New PTB- Female te,#{pRlwE15DsEF.mShPtMKrbn3}+#{pRlwE15DsEF.evzSmUUZM1g}+#{pRlwE15DsEF.WDafWKWrI84}+#{pRlwE15DsEF.g6eOWUrsZRD}+#{pRlwE15DsEF.ppw89viJsQm}+#{pRlwE15DsEF.ePIPTGN08C1}+#{pRlwE15DsEF.XDU1Bi82Hgl}+#{pRlwE15DsEF.MlP8UmeTtS7}+#{pRlwE15DsEF.XIQ1SeOshtt},1
Total New PTB- Female tested for HIV,rePIAcl2g8S,Total New PTB- Female tes,#{DGOE9qBg0S9.mShPtMKrbn3}+#{DGOE9qBg0S9.evzSmUUZM1g}+#{DGOE9qBg0S9.WDafWKWrI84}+#{DGOE9qBg0S9.g6eOWUrsZRD}+#{DGOE9qBg0S9.ppw89viJsQm}+#{DGOE9qBg0S9.ePIPTGN08C1}+#{DGOE9qBg0S9.XDU1Bi82Hgl}+#{DGOE9qBg0S9.MlP8UmeTtS7}+#{DGOE9qBg0S9.XIQ1SeOshtt},1
Total New PTB- Male,yteWd4QIMv8,Total New PTB- Male,#{u8dU1LPUUWD.k6pLc73EqHg}+#{u8dU1LPUUWD.sp5O3uieiaL}+#{u8dU1LPUUWD.bvvGm4SkxGX}+#{u8dU1LPUUWD.ZlAlLmbVO9k}+#{u8dU1LPUUWD.r5VV8KQkAUG}+#{u8dU1LPUUWD.Bhcon9Mwf1x}+#{u8dU1LPUUWD.ZBKfkjMF8TE}+#{u8dU1LPUUWD.RYmHjCLU2CB}+#{u8dU1LPUUWD.DqxmUcaZ8FL},1
Total New PTB- Male tested HIV+,c0UEicUnL03,Total New PTB- Male test,#{pRlwE15DsEF.k6pLc73EqHg}+#{pRlwE15DsEF.sp5O3uieiaL}+#{pRlwE15DsEF.bvvGm4SkxGX}+#{pRlwE15DsEF.ZlAlLmbVO9k}+#{pRlwE15DsEF.r5VV8KQkAUG}+#{pRlwE15DsEF.Bhcon9Mwf1x}+#{pRlwE15DsEF.ZBKfkjMF8TE}+#{pRlwE15DsEF.RYmHjCLU2CB}+#{pRlwE15DsEF.DqxmUcaZ8FL},1
Total New PTB- Male tested for HIV,pAdapgorqjw,Total New PTB- Male teste,#{DGOE9qBg0S9.k6pLc73EqHg}+#{DGOE9qBg0S9.sp5O3uieiaL}+#{DGOE9qBg0S9.bvvGm4SkxGX}+#{DGOE9qBg0S9.ZlAlLmbVO9k}+#{DGOE9qBg0S9.r5VV8KQkAUG}+#{DGOE9qBg0S9.Bhcon9Mwf1x}+#{DGOE9qBg0S9.ZBKfkjMF8TE}+#{DGOE9qBg0S9.RYmHjCLU2CB}+#{DGOE9qBg0S9.DqxmUcaZ8FL},1
Total New TB Cases HIV+,Y2oRhob7SAU,Total New TB Cases HIV+,#{TXJ3QlKmD10} + #{jjXPL4ZIuIU},1
Total Number Adolescent 10-19 years presenting with Pregnancy At 1st ANC Visit,nA83Fw28Lu0,At 1st ANC Visit -Adolescents 10-19years,(#{chMsCa5zcn7} + #{uHBmKxktYk0}),1
Total Number of Blood Smear Positives  MOH706,JXZ3iy1l0lo,Blood Smear Testing (aggregate),#{pacXvg8XEYT.nwpzSJ8o7hD} + #{qi4TilPOx6o.nwpzSJ8o7hD},1
Total Number of Blood Smear Testing Done,jZ98vsruEKs,Total Number of Blood Smear Testing Done,#{pacXvg8XEYT.TZ7UnG134RW} + #{qi4TilPOx6o.TZ7UnG134RW},1
Total Number of Confirmed Malaria cases- IDSR,oF8JRbYCitm,Total Number of Confirmed Malaria cases,#{IYnqoV2vlRq.FIYMDBzdabP} + #{IYnqoV2vlRq.ROXPeIvP89X},1
Total Number of HIV patients screened for TB ,IzGaAw3inLi,Number of HIV patients screened for TB ,#{UIIkCIajLVh} + #{TxR1FNVfzMH} + #{YQGzbNSKQV5} + #{piVmBFjFkfM} + #{cbaDJgQ2X4k} + #{LyNflllos12},1
Total Number of HIV+ clients assessed for nutrition status ,TqVeAiVuXKL, HIV+ clnts assessed for nutrition status ,#{EqhcLCyzn6b} + #{ONFHSFsYoPS},1
Total Number of TB NEW CASES  with TB &HIV ,N8BQEqOXdni,TB NEW CASES  with TB &HIV ,#{TXJ3QlKmD10} + #{jjXPL4ZIuIU},1
Total OPV Doses remaining at the end of the month ,Hvl3TXznK5y,Total OPV Doses remaining at the end Mnt,(#{kuxcnLoB85c.NhSoXUMPK2K}+#{BhPzqSAoc9Y.NhSoXUMPK2K})+#{g2ZhqF3DKMx.NhSoXUMPK2K},1
Total OPV doses stocked in the month,JSYnZZk9QAY,Total OPV doses stocked in the month,#{kuxcnLoB85c.NhSoXUMPK2K}+#{BhPzqSAoc9Y.NhSoXUMPK2K},1
Total OPV doses used in the month,daaFU8dr7lL,Total OPV doses used in the month,(#{kuxcnLoB85c.NhSoXUMPK2K}+#{BhPzqSAoc9Y.NhSoXUMPK2K})-#{g2ZhqF3DKMx.NhSoXUMPK2K},1
Total OPV doses wasted in the month,F5DgoKEz38S,Total OPV doses wasted in the month,((#{kuxcnLoB85c.NhSoXUMPK2K}+#{BhPzqSAoc9Y.NhSoXUMPK2K})-#{g2ZhqF3DKMx.NhSoXUMPK2K})-(#{iX5pEjcJowF}+#{t3QKFZbCf2B}+#{OLlWZUfLtsR}+#{c2Gm5hW3I4i}),1
Total Opening Cash/Bank Balance,bgvCi6hKKnS,Total Opening Cash/Bank Balance,#{fKvHjy58Hoe.NhSoXUMPK2K}+#{OheXXPgAdBi.NhSoXUMPK2K}+#{EWCqmXmU1Aj.NhSoXUMPK2K},1
Total Outpatient attendance Workload,rOqHQZvzoQW,Total Outpatient attendance Workload,#{rIkD2jIDqPh}+#{zXzBILTVJzD}+#{Ha96SBKI06u}+#{F6AwnxbwiK2}+#{x13zGZKuxzs}+#{uTQOSp7rx5h}+#{EsfvxFcltV0}+#{aq64ukEqs2N}+#{JQkE0bN9OTB}+#{d3jNYZueSmn}+#{hAH08l33p9B}+#{JGbmLfjZPEf}+#{SyUQl638r5P}+#{T22hPVk4yGZ}+#{T22hPVk4yGZ}+#{QStt76mU06X}+#{DpR59HXC0jW}+#{GAeKNgKXNDm}+#{WEW9Bjga52F},1
Total PCV 10 (Pneumococcal) doses stocked in the month,CiUcBE47oGm,Total PCV 10 (Pneumococcal) doses stocke,#{BQeaCpVaUYB.NhSoXUMPK2K}+#{XkemTADiLv4.NhSoXUMPK2K},1
Total PDR TB (Type of resistance),IrhIZFYRlXT,Total PDR TB (Type of res,#{zVIv5xsY92B.njpcfJLWMun}+#{zVIv5xsY92B.iMkdsG2hnT3}+#{zVIv5xsY92B.JjXGLDhx7an}+#{zVIv5xsY92B.odIztAzcNdB}+#{zVIv5xsY92B.HSN3hQ4bcuD}+#{zVIv5xsY92B.C5Q8JIDVtub}+#{zVIv5xsY92B.nx4Y45o8oVt},1
Total PDR TB tested HIV+,cVrQeH0tQ1z,Total PDR TB tested HIV+,#{PZxFOwfXC1u.njpcfJLWMun}+#{PZxFOwfXC1u.iMkdsG2hnT3}+#{PZxFOwfXC1u.JjXGLDhx7an}+#{PZxFOwfXC1u.odIztAzcNdB}+#{PZxFOwfXC1u.HSN3hQ4bcuD}+#{PZxFOwfXC1u.C5Q8JIDVtub}+#{PZxFOwfXC1u.nx4Y45o8oVt},1
Total PDR TB tested for HIV,wqzumEGgyzR,Total PDR TB tested for H,#{qgh5VZTdydJ.njpcfJLWMun}+#{qgh5VZTdydJ.iMkdsG2hnT3}+#{qgh5VZTdydJ.JjXGLDhx7an}+#{qgh5VZTdydJ.odIztAzcNdB}+#{qgh5VZTdydJ.HSN3hQ4bcuD}+#{qgh5VZTdydJ.C5Q8JIDVtub}+#{qgh5VZTdydJ.nx4Y45o8oVt},1
Total PTB- and are HIV+ out of Tested Total PTB-,OovpakNdUTv,% Total PTB- and are HIV+,#{Vri74blSuoL.cWPCEmypCYS}+#{Vri74blSuoL.TgiG5Y15JDI},#{CQVzChlE9qw.cWPCEmypCYS}+#{CQVzChlE9qw.TgiG5Y15JDI}
Total PTB- case tested HIV +,LpMxiKGilTe,PTB- case tested HIV +,#{Vri74blSuoL.cWPCEmypCYS}+#{Vri74blSuoL.TgiG5Y15JDI},1
Total PTB- case tested for HIV,E4QznFE6ch9,PTB- case tested for HIV,#{CQVzChlE9qw.cWPCEmypCYS}+#{CQVzChlE9qw.TgiG5Y15JDI},1
Total Partners HIV Status for TB,pqyOli2P9z8,Total Partners HIV Status,#{gwbUMHQwIiu.NhSoXUMPK2K}+#{fqJ6Ugr5cOv.NhSoXUMPK2K}+#{B4UV6oiRgKD.NhSoXUMPK2K}+#{A29H6xTxrrQ.NhSoXUMPK2K},1
Total Perinatal Deaths,kvKvG35IPmd,Total Perinatal deaths,#{rYn8RCcHJg1} + #{wZtDYVBa41h} + #{Sw2AEIBtrFz},1
Total Pneumococal doses stocked in the month,NK6WYR2vG6E,Total Pneumococal doses stocked in the month,#{BQeaCpVaUYB.NhSoXUMPK2K}+#{XkemTADiLv4.NhSoXUMPK2K},1
Total Pneumococal doses used in the month,j5R3Z82gMMv,Total Pneumococal doses used in the month,(#{BQeaCpVaUYB.NhSoXUMPK2K}+#{XkemTADiLv4.NhSoXUMPK2K})-#{VRD05emEwOF.NhSoXUMPK2K},1
Total Pneumococal doses wasted in the month,Eu3O0otJhEP,Total Pneumococal doses wasted in the month,((#{BQeaCpVaUYB.NhSoXUMPK2K}+#{XkemTADiLv4.NhSoXUMPK2K})-#{VRD05emEwOF.NhSoXUMPK2K})-(#{L2dPeH9VkBc}+#{xiaJWeXNYif}+#{h1GlCYbIQvU}),1
Total Population (Male+Female),zPhHcIhpWvl,Total Population (Male+Female),#{Mpv8crmnOzy} + #{w5ltvnNihEZ},1
Total Population Tested for HIV,ddRTLT3VYeF,Total Population Tested for HIV,#{tZYhz9UkfxJ}+#{Du49LE8Qndk.NhSoXUMPK2K}+#{h4pR1wz1JQb.NhSoXUMPK2K},1
Total Positives,ARGMY97u2tS,Number Tested Positive,#{wu0ITFRjUzF} + #{D9YwtS6RhQ1} + #{xMNhnyu7vm1} + #{kLXGWRLzCAw} + #{du5RMT3aecB} + #{oCFXmpol7D8} + #{F9OR49Lc1aR} + #{cBTa1jVzT8f} + #{J4vNm7YEkdj},1
Total RDT Done Community,Ixq1PQ15qQU,Total RDT Tests CU,#{RXgNfdYSJPh} + #{ZAsCMIJLkvj},1
Total RDTs dispensed (Malaria Commodity),fuaOUR9Nstf,Total RDTs dispensed (Malaria Commodity),#{c0MB4RmVjxk.w77uMi1KzOH} + #{qnZmg5tNSMy.w77uMi1KzOH} + #{gVp1KSFI69G.w77uMi1KzOH} + #{BnGDrFwyQp9.w77uMi1KzOH},1
Total Received HIV + Results,ari1nBlW6pr,Total Received HIV + Results,#{c2pgDecBILP} + #{NMWgSKFW6U7} + #{QXQFd2JB10B} + #{RCFqEXIiqed} + #{xN6GhQGgaoI} + #{DBZH3aC9gwQ},1
Total Receiving HIV + Results,jbDjnUU4UKY,Total Receiving HIV + Results,#{QXQFd2JB10B} + #{c2pgDecBILP} + #{NMWgSKFW6U7} + #{DBZH3aC9gwQ} + #{xN6GhQGgaoI}+ #{RCFqEXIiqed},1
Total Retreatment and are HIV+ out of Tested Total Retreatment,mZWDs2Ofzhz,% Total Re-treatment HIV+,#{Vri74blSuoL},#{CQVzChlE9qw}
Total Retreatment out of total TB cases,cN9PGGnOutE,% Total Retreatment ,#{MmsSJfunbRu.tHclu1dgnFD}+#{MmsSJfunbRu.wMCUnTibIsX}+#{MmsSJfunbRu.oAk5orcJaEF}+#{MmsSJfunbRu.yuNHDBNJL9M},#{MmsSJfunbRu}
Total Retreatment tested for HIV of the registered Total Retreatment,d6hN7c1OuW8,% Total Retreatment teste,#{CQVzChlE9qw},#{MmsSJfunbRu}
Total Skilled Deliveries,RsYvCg0aeuZ,Total Skilled Deliveries,#{jaPrPmor6WV} + #{rAZBTMa7Jy3} + #{sMqM8DwiAaj} + #{Kx64gGqaFVq},1
Total Still Births,qEXcjDlSJjv,Total Still Births,#{rYn8RCcHJg1.NhSoXUMPK2K}+#{wZtDYVBa41h.NhSoXUMPK2K},1
Total Suspected malaria cases (<5Years MoH 705A+>5Years MoH 705B),ctjwUeGzbWT,Total Suspected malaria cases,#{Lt0FqtnHraW.lHl2rmXpHse} + #{Lt0FqtnHraW.SeDaCnHi3m5},1
Total TB  case tested HIV +,txR2BhvUvTE,Total TB   tested HIV+,#{Vri74blSuoL},1
Total TB  case tested for HIV ,MOBNZI686n5,Total TB  case tested HIV,#{CQVzChlE9qw},1
Total TB Case Nutritional Support,MKdZOsoA859,Total TB Case Nutritional,#{RwS3Hb7xXmO.NhSoXUMPK2K}+#{T8TVFR9DgLm.NhSoXUMPK2K},1
Total TB case  tested HIV+ during Retreatment,zNZtVtoXMId,Total TB case  tested HIV,#{Vri74blSuoL.tHclu1dgnFD}+#{Vri74blSuoL.wMCUnTibIsX}+#{Vri74blSuoL.oAk5orcJaEF}+#{Vri74blSuoL.yuNHDBNJL9M},1
Total TB cases and are HIV+ out of Tested Total TB cases,pOFX27r2Mdp,% Total TB cases and HIV+,#{Vri74blSuoL},#{CQVzChlE9qw}
Total TB cases detected,jS9QjkV7afy,Total TB cases detected,#{hNsd8cQIYun}+#{VihTrdMMli8}+#{BgFeMs6gQ7E}+#{YDZlFPpGO2W},1
Total TB cases notified to the national program.,JDdS1LRd7Cj,Total TB cases notified,#{xhQlihiebMH.WwOVo8ccFpn},1
Total TB cases on HAART,Rkask9eMi7e,Total TB cases on HAART,#{IOy5jgQqfHU} + #{PIxcR1T5ORh},1
Total TB cases tested for HIV out of the registered Total TB cases,LYwPdcEb7V3,% Total TB cases tested,#{CQVzChlE9qw},#{MmsSJfunbRu}
Total TB registered tested for HIV During retreatment,h1PvP0m3B2i,TB registered tested HIV,#{CQVzChlE9qw.yuNHDBNJL9M}+#{CQVzChlE9qw.oAk5orcJaEF}+#{CQVzChlE9qw.wMCUnTibIsX}+#{CQVzChlE9qw.tHclu1dgnFD},1
Total Tested,F6gxWRewVEy,Total Number Tested,#{gMICOUtzqRb} + #{lj9QYJqS7bN} + #{YXJf27jfkvS} + #{XiRbc0DSMOH} + #{OePJt8CcZ0d} + #{JiuqbydCIcy} + #{pkShOkgNQt2} + #{atSQz5O7e2A} + #{gTkVw97FnQK},1
Total Tested Malaria Cases - Community,LbEVPunJX1W,Total Tested Cases - Community,#{CVHsV294PjK} + #{NeUMw0K561Q} + #{TZHFXJrxbUU} + #{EA3C82Tnftk} + #{vmQj5H8ImG4} + #{nqa34Xgoq3T},1
Total Tetanus Toxoid doses stocked in the month,YcB6yyunMFR,Total Tetanus Toxoid doses stocked Month,#{HIfJ6JvWQmQ.NhSoXUMPK2K}+#{siS80Yt4ul4.NhSoXUMPK2K},1
"Total VITAMIN A 100,000 IU capsules in stocked in the month",clJNRG7uHOx,"VITAMIN A 100,000 IU capsu stocked Month",#{OKXUzudHulV.NhSoXUMPK2K}+#{IWndZVZ3KqT.NhSoXUMPK2K},1
"Total VITAMIN A 200,000 IU capsules in stocked in the month",VIXrXaZl3js,"Total VITAMIN A 200,000 IU capsu stocked",#{whXQzFlRT37.NhSoXUMPK2K}+#{BBD2ipNt4Ro.NhSoXUMPK2K},1
Total WRA received modern Contraceptive methods,n9kuCebQpqc,WRA received modern Contraceptive,#{uHM6lzLXDBd.K4WLOEhtcvC}+#{uHM6lzLXDBd.wBWcFk7k1qY}+#{BQmcVE8fex4.K4WLOEhtcvC}+#{BQmcVE8fex4.wBWcFk7k1qY}+#{yQFyyQBhXQf.wBWcFk7k1qY}+#{yQFyyQBhXQf.K4WLOEhtcvC}+#{otgQMOXuyIn.wBWcFk7k1qY}+#{otgQMOXuyIn.K4WLOEhtcvC}+#{DuBH6qPPdaO.wBWcFk7k1qY}+#{DuBH6qPPdaO.K4WLOEhtcvC}+#{PggNwT09D3U.wBWcFk7k1qY}+#{M9wNpvfC8wb.wBWcFk7k1qY}+#{M9wNpvfC8wb.K4WLOEhtcvC}+ #{paDQStynGGD.wBWcFk7k1qY}+ #{paDQStynGGD.K4WLOEhtcvC},1
Total Yellow Fever doses stocked in the month,ppLnOulaknM,Total Yellow Fever doses stocked Month,#{qEWi8LlojkO.NhSoXUMPK2K}+#{Rk1XnSRNZdC.NhSoXUMPK2K},1
Total clients tested- (VCT&DTC- MOH 711),WzzOqiEdFJg,Total clients tested- (VCT&DTC-MOH 711),#{NeH2XNZ4B78}+#{rxhsRqFckMf}+#{s0Zi5NpklJN},1
Total deliveries,BDsWWkJHuce,Total deliveries,#{jaPrPmor6WV.NhSoXUMPK2K}+#{sMqM8DwiAaj.NhSoXUMPK2K}+#{rAZBTMa7Jy3.NhSoXUMPK2K}+#{Kx64gGqaFVq.NhSoXUMPK2K},1
Total deliveries in facilities,FXeDYp2ATE9,Total HF deliveries,#{jaPrPmor6WV.NhSoXUMPK2K}+#{rAZBTMa7Jy3.NhSoXUMPK2K}+#{sMqM8DwiAaj.NhSoXUMPK2K}+#{Kx64gGqaFVq.NhSoXUMPK2K},1
Total inpatient Deaths (HAA),hC5ScvmQZmn,Total inpatient Deaths,#{zTIGTbphtuA.kVkbqBCZLKg} + #{bRP7RnMWTK8.kVkbqBCZLKg} + #{zqqP41WTYNk.kVkbqBCZLKg} + #{ndneSgDusqj.kVkbqBCZLKg} + #{KcmpbSvRETO.kVkbqBCZLKg} + #{C3srxhSBods.kVkbqBCZLKg} + #{S9BU0xS5QRf.kVkbqBCZLKg} + #{OdXZaAsAGRU.kVkbqBCZLKg} + #{VuMnNeKMui9.kVkbqBCZLKg} + #{Y1sxN73phAf.kVkbqBCZLKg} + #{m43S60pVppf.kVkbqBCZLKg} + #{IgnbdUEWMd4.kVkbqBCZLKg} + #{BcVftn5I5NL.kVkbqBCZLKg} + #{rAvVxANpmvq.kVkbqBCZLKg} + #{slxcaBIJQFz.kVkbqBCZLKg} + #{knorevTYX7E.kVkbqBCZLKg},1
Total malaria  Case (IDSR MOH 505) ,XTIf22yHwrK,Total malaria  Case (IDSR MOH 505) ,#{GJDppyWOYYM.dCd7yKlyqk4} + #{GJDppyWOYYM.PTWBeC1K2HJ} ,1
Total new Outpatients found with high blood pressure,EAMJ1sPvwkF,new OPD high blood pressu,#{lVNKL5UQ8Sb},1
Total new Outpatients with mental health conditions (<5 and >5 Yrs),mpKY5hRBO2Z,new Outpatients with ment,#{HmgfJSVUOOr},1
Total no of Adolescent (10-19yrs) Pregn. At 1st ANC Visit,gvn7RQuZDsh,Total Adolescent (10-19yrs) Pregn. At 1st ANC,#{chMsCa5zcn7} + #{uHBmKxktYk0},1
Total no. on PrEP,YIfDSTwNSFa,Total no. on PrEP,(#{eq4rc07ARwD} + #{AYNAyx4h883} + #{Neqx6RwDm6r}),1
Total number currently on Care,tsC5wHC0588,Total number currently on Care,#{uRhTwUUG8Xc.NhSoXUMPK2K}+#{Sll1gd58DuW.NhSoXUMPK2K}+#{q6Ifdhfa9UZ.NhSoXUMPK2K}+#{m1yNfb8Pk5o.NhSoXUMPK2K},1
Total number currently on Cotrimoxazole,viJJXWP0lqi,Total number currently on Cotrimoxazole,#{Y6x3Qc60cny.NhSoXUMPK2K}+#{KWfnVyJ6csJ.NhSoXUMPK2K}+#{C8xQ25DfJ4c.NhSoXUMPK2K}+#{niVwX6llpwW.NhSoXUMPK2K},1
Total number of <5 diarrhoea reported cases-both community & facility,f5NJmBU7efo,<5 diarrhoea cases-both community & facility,#{V00z4bQRaqe} + #{JcgMuSM3NnI.lHl2rmXpHse} + #{hGhUdN3KgrK.lHl2rmXpHse} + #{ZI3qZ2mfBER.lHl2rmXpHse} + #{tovFNTW5b9K.lHl2rmXpHse},1
Total number of Children under 5 years treated for Malaria ,qDRctnqOdQq,Child <5 treated Malaria,#{Lt0FqtnHraW.lHl2rmXpHse}+#{OoakJhWiyZp.lHl2rmXpHse},1
Total number of HIV-positive pregnant women in facility (New positive & Knwn Positive-MOH731),zTqp9P84HBm,Total number of HIV-positive pregnant,#{TJMdle70A7X.NhSoXUMPK2K}+#{GCAkHwMAWM6.NhSoXUMPK2K},1
Total number of Patients starting ART,GM7jPEFSIa9,Total number of Patients starting ART,(#{mACm1JUzeLT} + #{Hbc2qRi0U5x} + #{jthpt5cVV9c} + #{LC2OqnUC5Sn} + #{DaNcGZnkclz} + #{yWkSi8L3qGm} + #{zNCSlBKbS6d} + #{K59f8nZ5vhy} + #{Nv4OkbdDvmm} + #{SCMKsiNj6c5}),1
Total number of children under 5 years who are weighed,g4nnmGpfRKI,Total weighed under 5,#{uYBa6RU8wUZ} + #{Ype6qUApdlR} + #{twpy25QKLk9} + #{ikI4r8YuZZ0} + #{qoEPwxCNrll} + #{QCNHvzgxurQ} + #{mv0ICssqScK} + #{k3xX4NKJaaY} + #{lvyOQjZaXZ3} + #{PW4W1Fa7b5b} + #{zels3jARvGQ} + #{ENjll6PbaI8} + #{HlZXTFN2B61} + #{AIduSzrilaz} + #{AYT1IPxFRZx},1
Total number of household with Latrine,hqCB7bG2c3D,Total number of household with Latrine,#{Sz30p2DryRZ.NhSoXUMPK2K},1
Total number of malaria tests (RDT + BS) MOH706,r2eCEDoLmpY,Total malaria tests (RDT + BS),#{pacXvg8XEYT.TZ7UnG134RW} + #{qi4TilPOx6o.TZ7UnG134RW} + #{vORT3FUaS6P.TZ7UnG134RW},1
Total number of new clients enrolled in HIV care,pBYxHlN4Cz6,Total no..newly clients enrolled in care,(#{Nj4fdwBMPSv} + #{Qx6MQyeLsbW} + #{voKyCW93y78} + #{fEreYoprpD1} + #{k3XKbFkk2ZR} + #{tCuuWVCan0K} + #{IEPIbqqB7FP} + #{nNE84uVg0xN} + #{LGMBmncr1Qw} + #{FsnRF3p3qVc}),1
Total number of patients currently on ARVs(731),Cl9xy7ceELQ,Currently on ARV(731),#{ISGNo6jMJlI.NhSoXUMPK2K}+#{cbUoZG6mlS7.NhSoXUMPK2K}+#{oTjp04eBIaV.NhSoXUMPK2K}+#{QISrDYwXnMw.NhSoXUMPK2K},1
Total number of patients over 5 years treated for Malaria ,TUreyEFUxYX,Patients >5 Malaria,#{Lt0FqtnHraW.SeDaCnHi3m5}+#{OoakJhWiyZp.SeDaCnHi3m5}+#{gvZmXInRLuD.SeDaCnHi3m5},1
Total tested HIV+ (Tested for HIV) (PTB+),BZYFf0s6iVv,% of Total tested HIV+ (T,#{m9rOYAy4LZT},#{NNkcO5xJ4D8}
Total tested HIV+ (Tested for HIV) (PTB-),wsF30LZ9QDu,% of Total tested HIV+ (,#{pRlwE15DsEF},#{DGOE9qBg0S9}
Total tested for HIV (EPTB),P65MKtVJNPy,% of Total tested for H,#{tZYhz9UkfxJ},#{jJSUs0JbSra}
Total tested for HIV (PTB+),PuKGzgK5Rsf,% of Total tested for HIV,#{NNkcO5xJ4D8},#{mYcTFL89KEW}
Total tested for HIV (PTB-),JUT3RKrbafs,% of Total tested for HI,#{DGOE9qBg0S9},#{u8dU1LPUUWD}
Total tested for Microscopy,F8Fi5ez20jR,Total tested for Microscopy,#{BgXDbyw4TZI.QKy6jjocOLj}+#{TSgMfWzStx6.QKy6jjocOLj},1
Total tested for RDT,eNCCI7mKVCh,Total tested for RDT,#{TSgMfWzStx6.hH6R0ZkxiK0}+#{E64sUrp6DrX.hH6R0ZkxiK0}+#{FJV0d0Ie4Z1.hH6R0ZkxiK0},1
Total under five Diarrhoea cases reported,V0zOOi0jiFU,Total <5Yrs Diarrhoea Cases,#{JcgMuSM3NnI.lHl2rmXpHse} + #{hGhUdN3KgrK.lHl2rmXpHse} + #{ZI3qZ2mfBER.lHl2rmXpHse} + #{tovFNTW5b9K.lHl2rmXpHse},1
Total under five diarrhoea cases reported,B4jH9l9ZRKt,Total under five diarrhoea cases reported,#{JcgMuSM3NnI.lHl2rmXpHse} + #{hGhUdN3KgrK.lHl2rmXpHse} + #{ZI3qZ2mfBER.lHl2rmXpHse} + #{tovFNTW5b9K.lHl2rmXpHse},1
Total under five pneumonia cases reported,OvDwPPIrEnB,Total under five pneumonia cases reported,#{EEVfLW0M8vU.lHl2rmXpHse} + #{QgiADNKtauy.lHl2rmXpHse},1
Total underweight Under 5 Years,N39rY8MeuA0,Total underweight <5Yrs,#{AYT1IPxFRZx}+#{AIduSzrilaz}+#{uYBa6RU8wUZ},1
Total women tested(NASCOP),nxRsboCrOXm,PMTCT_Tests,#{nspwXhqQaAz.NhSoXUMPK2K}+#{cKxrOyX8yfM.NhSoXUMPK2K},1
Treatment Success Rate all TB cases notified,dDjGDDyjgza,Treatment Success Rate all TB cases notified,#{YpM2CXCPZbf.IFFAb0ApZv2} + #{YpM2CXCPZbf.hucvirG8l9C}+#{m7BMQu4HYRT.Q9UypR5WreG} + #{yEyrFyJryXL.MwiyIzhhKxr}+#{H61J8pIAjLQ.EcxoV9pk3ra} + #{Z9AVW5bKTaG.E6NVZENpm5Y} + #{Z9AVW5bKTaG.SjfRUylOCp4},#{YpM2CXCPZbf.oTxLi0v4fb1} + #{m7BMQu4HYRT.W1sDC9IzJ1d} + #{yEyrFyJryXL.ufORzeLtcEl} + #{H61J8pIAjLQ.Z5hHUGiaOh4} + #{Z9AVW5bKTaG.wiD5SVABQHR}
Treatment success rate for MDR TB ,gDgHqIdzHqC,Treatment success rate for MDR TB ,#{dSpjJg77lqe.VCQe5GaW6Qc} + #{dSpjJg77lqe.wkH3A40WUfw},#{dSpjJg77lqe.j0Q6xdnrEuX}
Treatment success rate of RR TB and MDR-TB: Percentage of cases with RR and/or MDR-TB successfully treated,if6mEn3ov6a,TSR-RR/MDR,#{zPllAfgO3ci.W0PYD9w1P7k} + #{zPllAfgO3ci.lBIflLPDyFn} + #{BeOuHKpkCvs.VCQe5GaW6Qc} + #{KrhfD6ODpPd.VCQe5GaW6Qc} + #{xRzPAKLtBKV.VCQe5GaW6Qc} + #{A6IByGxzIEC.VCQe5GaW6Qc} ,#{TFY14Uz8Rbe.qTrLmyDFOy8} +#{rPauQ5IkJx8.qTrLmyDFOy8}
"Treatment success rate of all forms of DSTB - bacteriologically confirmed plus clinically diagnosed, new and relapse cases",WhC790A6JcR,DSTB_TSR (New and Relapse),#{YpM2CXCPZbf.IFFAb0ApZv2} + #{YpM2CXCPZbf.hucvirG8l9C} + #{yEyrFyJryXL.MwiyIzhhKxr} + #{H61J8pIAjLQ.EcxoV9pk3ra} + #{m7BMQu4HYRT.Q9UypR5WreG},#{YpM2CXCPZbf.LE9HaeX27pF} + #{yEyrFyJryXL.X5KEYn5r72h} + #{m7BMQu4HYRT.Uhqzn2L1Myf} + #{H61J8pIAjLQ.ssDgYPkkLGp}
Turnover Interval,HWfy8sk8VEg,Turnover Interval,(#{R6Z03VUZ0YU.JUI7tesx6as}+#{KeluwzeRirR.JUI7tesx6as}+#{R6Z03VUZ0YU.Lj5arkL7GL8}+#{KeluwzeRirR.Lj5arkL7GL8}+#{R6Z03VUZ0YU.ObiJr399QRt}+#{KeluwzeRirR.ObiJr399QRt}+#{R6Z03VUZ0YU.bPNw3Km3Ug7}+#{KeluwzeRirR.bPNw3Km3Ug7})-((#{K3i0LumP9MU.Lj5arkL7GL8}+#{K3i0LumP9MU.JUI7tesx6as}+#{K3i0LumP9MU.bPNw3Km3Ug7}+#{K3i0LumP9MU.ObiJr399QRt}+#{Q9bZ7fvL0c3.Lj5arkL7GL8}+#{Q9bZ7fvL0c3.JUI7tesx6as}+#{Q9bZ7fvL0c3.ObiJr399QRt})*366),#{o6RJFSXIelv.JUI7tesx6as}+#{o6RJFSXIelv.Lj5arkL7GL8}+#{o6RJFSXIelv.ObiJr399QRt}+#{o6RJFSXIelv.bPNw3Km3Ug7}+#{JbfEjiVnE6z.JUI7tesx6as}+#{JbfEjiVnE6z.Lj5arkL7GL8}+#{JbfEjiVnE6z.ObiJr399QRt}+#{JbfEjiVnE6z.bPNw3Km3Ug7}
Turnover per Bed,h3FULPT4PV1,Turnover per Bed,#{o6RJFSXIelv.JUI7tesx6as}+#{o6RJFSXIelv.Lj5arkL7GL8}+#{o6RJFSXIelv.ObiJr399QRt}+#{o6RJFSXIelv.bPNw3Km3Ug7}+#{JbfEjiVnE6z.JUI7tesx6as}+#{JbfEjiVnE6z.Lj5arkL7GL8}+#{JbfEjiVnE6z.ObiJr399QRt}+#{JbfEjiVnE6z.bPNw3Km3Ug7},#{K3i0LumP9MU.Lj5arkL7GL8}+#{K3i0LumP9MU.JUI7tesx6as}+#{K3i0LumP9MU.bPNw3Km3Ug7}+#{K3i0LumP9MU.ObiJr399QRt}+#{Q9bZ7fvL0c3.Lj5arkL7GL8}+#{Q9bZ7fvL0c3.JUI7tesx6as}+#{Q9bZ7fvL0c3.ObiJr399QRt}
Under 15 year population to the total Population,GkD1JTByasu,% Under 15 year of popn,#{iYiM4K22JwD.NhSoXUMPK2K},#{NLKRV7bYbVy.NhSoXUMPK2K}
Under 5 years receiving Vitamin A Performance,zYKgSorp23r,Vit A <5y Perf,#{lxEQY7XM7Oy.NhSoXUMPK2K}+#{KXifjlklHaU.NhSoXUMPK2K},#{iwjbfsWMO6q.ea7VHlwMkhH}
Under 5yrs de-wormed at the health facility,dB17ulRzTHi,Under 5yrs de-wormed,#{NXl959cFhDr},#{KNrK5VWTZkx.NhSoXUMPK2K}
User Fee Accounting rate,peA2XeDqscF,User Fee Accounting rate,#{oMWJpAyAIUh.HOgzR50Zd4h},#{uq2Izs9ZGT7.HOgzR50Zd4h}
User Fee utilization rate,GEsQZHfMalQ,User Fee utilization rate,#{uq2Izs9ZGT7.HOgzR50Zd4h},#{QLC6ejj76za.HOgzR50Zd4h}
Utilization Rate of fund  from Partners,olwqEEGeMwT,Partners Utilization Rate,#{uq2Izs9ZGT7.ho19GFuJL4X},#{QLC6ejj76za.ho19GFuJL4X}
VCT Clients Tested Total,nac0E74gYnw,VCT Clients Tested Total,#{NeH2XNZ4B78}+#{s0Zi5NpklJN}+#{rxhsRqFckMf},1
VMMC Adverse Events (AE) Total Ratio,OtFHdARB9D1,VMMC AE Total ,#{l1u7l9pXRgP.NhSoXUMPK2K}+#{CNpwuOCcP8V.NhSoXUMPK2K},#{dwBgncXjtLi.NhSoXUMPK2K}
VMMC Positivity,zvpFcXn1fts,VMMC Positivity,#{EspuNzhHIJH.NhSoXUMPK2K},#{dwBgncXjtLi.NhSoXUMPK2K}
VMMC_Proportion of MC With Adverse Events,TrXOt6vLEWc,VMMC_Proportion of MC With Adverse Events,(#{KzhBouepg13} + #{zVZywwIJxcR} + #{OseYV3376eB} + #{kzlGNwD5SMc}),(#{ZPcn7zMAZ1V} + #{GGKtWopm7vD} + #{hx68TrqkSh1} + #{i99a9CT4YeV} + #{WyVWHKRa4i8} + #{yivJXC2pAOM})
VSPs % Defaulter referred for ANC,QTvpBQ0CkbK,VSPs % Defaulter referred for ANC,#{oOubBMnQF2r}/#{hxXwYIgT8rI},1
VSPs % Diabetes Cases,uyqUvJcfOP5,VSPs % Diabetes Cases,#{D923dTnerdk}/#{NLKRV7bYbVy},1
VSPs % new referrals for ANC visits,Feva5BMyzhy,VSPs % new referrals for ANC visits,#{f9vesk5d4IY}/(#{f9vesk5d4IY}+#{hxXwYIgT8rI}),1
Vasectomy couple year protection,YJ6wwejMqpS,Vasectomy  CYP,(#{Nqt6rz4tqnm.wBWcFk7k1qY}+#{Nqt6rz4tqnm.K4WLOEhtcvC} + #{q5G4zR4872u} + #{q5G4zR4872u.DTYqflFj4uE} + #{q5G4zR4872u.xiLt33hq7so})*10,1
Vitamin A Coverage for Children 6 - 59 Months,AEwBkehhvpY,Vit A cov. children 6 - 59 Months,#{MAGmTkOIZus.ieuodyY5ybC} + #{UTXjB4dxdrp} + #{Oaysbgtl1gF} + #{lxEQY7XM7Oy} + #{KXifjlklHaU} + #{cPeaV6caNqJ},90 / 100 * #{KNrK5VWTZkx}
Vitamin A Wastage Rate,gVQLE8SFWBr,Vitamin A Wastage Ra,#{OKXUzudHulV.NhSoXUMPK2K}+#{whXQzFlRT37.NhSoXUMPK2K}+#{Vdip0KyoL9f.NhSoXUMPK2K}-#{vOaRpiWvl2K.NhSoXUMPK2K}-#{oACe0uiAmnT.NhSoXUMPK2K}-#{q5vvAyTR1iH.NhSoXUMPK2K}-#{e4E6Mggubur.NhSoXUMPK2K}+#{VpR5yisd68e.NhSoXUMPK2K}+#{KFce5qLpNbI.NhSoXUMPK2K}+#{l82s7ox5T1Y.NhSoXUMPK2K}+#{zhGgJA94UZD.NhSoXUMPK2K}+#{VVMKbm0VD3E.NhSoXUMPK2K}+#{spjzPM5MiXs.NhSoXUMPK2K}+#{lxEQY7XM7Oy.NhSoXUMPK2K}+#{vfyid8wVnVz.NhSoXUMPK2K}+#{KXifjlklHaU.NhSoXUMPK2K}+#{IWndZVZ3KqT.NhSoXUMPK2K}+#{BBD2ipNt4Ro.NhSoXUMPK2K}+#{Axm0HAh8Jwg.NhSoXUMPK2K},#{HIfJ6JvWQmQ.NhSoXUMPK2K}
Vitamin A coverage Children 6-11 months,pE74ouskL6B,Vit. A cov. Children 6-11mt,(#{MAGmTkOIZus} + #{KXifjlklHaU}) * 0.5,#{pMbuvKvH4rg} / 2
WRA ANC Receiving Iron,hKb1MySeHq6,WRA ANC Receiving Iron,#{QgjmGMoIcGu.NhSoXUMPK2K},#{f9vesk5d4IY.NhSoXUMPK2K}+#{hxXwYIgT8rI.NhSoXUMPK2K}
WRA Receiving Iron (general population),Y7oqTyaAz5a,% WRA Recvg Iron-ElPopn,#{QgjmGMoIcGu.NhSoXUMPK2K},#{JOnT3OiMd5o.NhSoXUMPK2K}
WRA receiving FP Commodities (Rev 2020),atCnKnnq9ZW,WRA receiving FP Commodities (Rev 2020),#{uHM6lzLXDBd} + #{paDQStynGGD} + #{BQmcVE8fex4} + #{fYCo4peO0yE} + #{BW2T5DsuZuX} + #{PgQIx7Hq1kp} + #{NMCIxSeGpS3} + #{CJdFYcZ1zOq} + #{TUHzoPGLM3t} + #{Wv02gixbRpT} + #{hRktPfPEegP} + #{g6Wk32DjOez} + #{q5G4zR4872u} + #{OiuBpHJw4kf},#{bPQDV3mud0v}
WRA receiving FP commodities Coverage,Js7Ia8ffGvX,WRA receiving FP Cov,#{uHM6lzLXDBd} + #{paDQStynGGD} + #{BQmcVE8fex4} + #{fYCo4peO0yE} + #{BW2T5DsuZuX} + #{PgQIx7Hq1kp} + #{NMCIxSeGpS3} + #{CJdFYcZ1zOq} + #{TUHzoPGLM3t} + #{Wv02gixbRpT} + #{hRktPfPEegP} + #{g6Wk32DjOez} + #{q5G4zR4872u} + #{OiuBpHJw4kf},#{bPQDV3mud0v.NhSoXUMPK2K}
WRA receiving FP commodities Performance,kIJ4UqqPzvD,WRA rec FP Perf,#{BQmcVE8fex4}+#{uHM6lzLXDBd}+#{yQFyyQBhXQf}+#{DuBH6qPPdaO}+#{otgQMOXuyIn}+#{PggNwT09D3U}+#{Nqt6rz4tqnm}+#{cV4qoKSYiBs}+#{OiuBpHJw4kf}+#{M9wNpvfC8wb},#{Xbpbb2r5jJj.ea7VHlwMkhH}
Women of child bearing age (15 – 49 Years) to the total Population,QFxYxFGKny4,% WRA of Popn,#{bPQDV3mud0v.NhSoXUMPK2K},#{NLKRV7bYbVy.NhSoXUMPK2K}
Yellow Fever  SIA Percentage Vaccinated 5-60 years,Y8vm0gYzZjX,Yellow Fever  SIA % Vaccinated 5-60 years,#{NAnFUhQ3Kjn.YRhgF3hAyyg} + #{NAnFUhQ3Kjn.xpSGpUHupbF} + #{oHmSv0O1UAC.YRhgF3hAyyg} + #{oHmSv0O1UAC.xpSGpUHupbF} + #{jfX1ZzS3D3n.YRhgF3hAyyg} + #{jfX1ZzS3D3n.xpSGpUHupbF},#{cIoBL9mjS2u}
Yellow Fever  SIA Percentage Vaccinated Children (9-59months),SxOzZHrA3np,Yellow Fever % Vaccinated Children (9-59months),#{NAnFUhQ3Kjn.rnXLQXI8eBx} + #{NAnFUhQ3Kjn.XbmEJzMhcRR} + #{oHmSv0O1UAC.rnXLQXI8eBx} + #{oHmSv0O1UAC.XbmEJzMhcRR} + #{jfX1ZzS3D3n.rnXLQXI8eBx} + #{jfX1ZzS3D3n.XbmEJzMhcRR},#{mX8sNKNsO4A}
Yellow Fever  SIA overall Percentage Vaccinated 5-60 years,KGASLJNfyFm,Yellow Fever  SIA overall %Vaccinated 5-60 years,#{NAnFUhQ3Kjn.YRhgF3hAyyg} + #{NAnFUhQ3Kjn.xpSGpUHupbF} + #{oHmSv0O1UAC.YRhgF3hAyyg} + #{oHmSv0O1UAC.xpSGpUHupbF} + #{jfX1ZzS3D3n.YRhgF3hAyyg} + #{jfX1ZzS3D3n.xpSGpUHupbF},#{cIoBL9mjS2u} + #{mX8sNKNsO4A}
Yellow Fever  SIA overall Percentage Vaccinated children (9-59Months),KcVKztBUmw9,Yellow Fever  SIA % Vaccinated children,#{NAnFUhQ3Kjn.rnXLQXI8eBx} + #{NAnFUhQ3Kjn.XbmEJzMhcRR} + #{oHmSv0O1UAC.rnXLQXI8eBx} + #{oHmSv0O1UAC.XbmEJzMhcRR} + #{jfX1ZzS3D3n.rnXLQXI8eBx} + #{jfX1ZzS3D3n.XbmEJzMhcRR},#{cIoBL9mjS2u} + #{mX8sNKNsO4A}
Yellow Fever SIA Target Population,M0tLwvVZpLo,Yellow Fever SIA Target Population,#{mX8sNKNsO4A} + #{cIoBL9mjS2u},1
Yellow Fever SIA Total Vaccinated,OKsQ7n0efFq,Yellow Fever SIA Total Vaccinated,#{NAnFUhQ3Kjn.rnXLQXI8eBx} + #{NAnFUhQ3Kjn.XbmEJzMhcRR} + #{NAnFUhQ3Kjn.YRhgF3hAyyg} + #{NAnFUhQ3Kjn.xpSGpUHupbF} + #{oHmSv0O1UAC.rnXLQXI8eBx} + #{oHmSv0O1UAC.XbmEJzMhcRR} + #{oHmSv0O1UAC.YRhgF3hAyyg} + #{oHmSv0O1UAC.xpSGpUHupbF} + #{jfX1ZzS3D3n.rnXLQXI8eBx} + #{jfX1ZzS3D3n.XbmEJzMhcRR} + #{jfX1ZzS3D3n.YRhgF3hAyyg} + #{jfX1ZzS3D3n.xpSGpUHupbF},1
Yellow Fever SIA Total Vaccinated(Hard to Reach),QsGIQWCggaa,Yellow Fever Total Vaccinated(Hard to Reach),#{oHmSv0O1UAC.rnXLQXI8eBx} + #{oHmSv0O1UAC.XbmEJzMhcRR} + #{oHmSv0O1UAC.YRhgF3hAyyg} + #{oHmSv0O1UAC.xpSGpUHupbF},1
Yellow Fever SIA Total Vaccinated(Static Population),GEycEcTY3rh,Yellow Fever Total Vaccinated(Static Population),#{NAnFUhQ3Kjn.rnXLQXI8eBx} + #{NAnFUhQ3Kjn.XbmEJzMhcRR} + #{NAnFUhQ3Kjn.YRhgF3hAyyg} + #{NAnFUhQ3Kjn.xpSGpUHupbF},1
Yellow Fever SIA Total Vaccinated(Temporary Fixed),sIyXYQGzGSP,Yellow Fever Total Vaccinated(Temporary Fixed),#{jfX1ZzS3D3n.rnXLQXI8eBx} + #{jfX1ZzS3D3n.XbmEJzMhcRR} + #{jfX1ZzS3D3n.YRhgF3hAyyg} + #{jfX1ZzS3D3n.xpSGpUHupbF},1
Yellow Fever Wastage Rate,uQy0newSrjB,Yellow Fever Wastage,#{qEWi8LlojkO.NhSoXUMPK2K}+#{Rk1XnSRNZdC.NhSoXUMPK2K}-#{fN2IogSWRPi.NhSoXUMPK2K}+#{PJCUSyQ6Ahv.bCfwecaPx2W}+#{PJCUSyQ6Ahv.ieuodyY5ybC},#{qEWi8LlojkO.NhSoXUMPK2K}+#{Rk1XnSRNZdC.NhSoXUMPK2K}
covid_vaccine_Healthcare Workers Fully Vaccinated,jW01gPgax43,covid_vaccine_Healthcare Workers Fully Vaccinated,#{HOwROPlBx9f.EKbkjqMMi9J},1
iHRIS Laboratory Staff,jXMH16JJxmN,iHRIS Laboratory Staff,#{UQe25w2sxfL.NhSoXUMPK2K},1
iHRIS Medical Officers Total,iwINwKFxsya,iHRIS Medical Officers Total,#{wL8bTjxwuZ3.NhSoXUMPK2K},1
iHRIS Nurses + IHRIS Med Lab Techs,B35zCLFkO98,iHRIS Nurses + IHRIS Med Lab Techs,#{pfIYHskfyhQ}+#{oGRUr2UiR8E}+#{CGN15kwiEla.NhSoXUMPK2K}+#{qrQRIOl3Y7W}+#{tdkj2HWk7GG}+#{e4SD2TEWunw}+#{aOH63LerJKG}+#{LJVhaEUREt1}+#{YBRNewyiKTG}+#{FheKkDXpzuB}+#{YFJwW8QWT0s}+#{N6JCCDgmijq}+#{D1YK6LDr1uo}+#{yut0lbk8fLZ}+#{v5YHnZPeu3Y}+#{T0ncWxRLsyF}+#{fDNhtWxxkDD}+#{nW6QimezeUY}+#{UQe25w2sxfL.NhSoXUMPK2K},1
iHRIS Nurses + MO,mUF5G3emX0h,iHRIS Nurses + MO,#{wL8bTjxwuZ3.NhSoXUMPK2K}+#{pfIYHskfyhQ}+#{oGRUr2UiR8E}+#{CGN15kwiEla.NhSoXUMPK2K}+#{qrQRIOl3Y7W}+#{tdkj2HWk7GG}+#{e4SD2TEWunw}+#{aOH63LerJKG}+#{LJVhaEUREt1}+#{YBRNewyiKTG}+#{FheKkDXpzuB}+#{YFJwW8QWT0s}+#{N6JCCDgmijq}+#{D1YK6LDr1uo}+#{yut0lbk8fLZ}+#{v5YHnZPeu3Y}+#{T0ncWxRLsyF}+#{fDNhtWxxkDD}+#{nW6QimezeUY},1
iHRIS Total Number of BSN Nurses,cqbvFtDFFMV,BSN Nurses,(#{CGN15kwiEla.NhSoXUMPK2K}+#{y90HxYFJReg.NhSoXUMPK2K}),1
iHRIS Total Number of Clinical Officers,jY9FYiic0g5,iHRIS Total Number of Clinical Officers,#{uAk9AD2NGFv.NhSoXUMPK2K}+#{KRxsqqbdAGH.NhSoXUMPK2K}+#{QWymS3dj4uU.NhSoXUMPK2K}+#{J8mzCuLBAH1.NhSoXUMPK2K}+#{YOMA61T94eU.NhSoXUMPK2K}+#{pjEN2QceKNH.NhSoXUMPK2K}+#{ShtwHIW1rOC.NhSoXUMPK2K}+#{H1dgcVTwWQM.NhSoXUMPK2K}+#{arRbatxU74M.NhSoXUMPK2K}+#{Y0SDd8s2bK4.NhSoXUMPK2K}+#{GpYmbmcP4Oa.NhSoXUMPK2K}+#{RGMaEjZKHk9.NhSoXUMPK2K}+#{gUIhX5nb9V9.NhSoXUMPK2K}+#{uAk9AD2NGFv.NhSoXUMPK2K}+#{KRxsqqbdAGH.NhSoXUMPK2K}+#{UBCpnu7mV2S.NhSoXUMPK2K}+#{QWymS3dj4uU.NhSoXUMPK2K}+#{J8mzCuLBAH1.NhSoXUMPK2K}+#{YOMA61T94eU.NhSoXUMPK2K}+#{pjEN2QceKNH.NhSoXUMPK2K}+#{ShtwHIW1rOC.NhSoXUMPK2K}+#{H1dgcVTwWQM.NhSoXUMPK2K}+#{arRbatxU74M.NhSoXUMPK2K}+#{Y0SDd8s2bK4.NhSoXUMPK2K}+#{GpYmbmcP4Oa.NhSoXUMPK2K},1
iHRIS Total Number of Doctors,XJyhUSQC8TL,iHRIS Total Number of Doctors,"(#{hGQQrwQHpl6.NhSoXUMPK2K}
+#{mdTMtjN91ty.NhSoXUMPK2K}+#{CEotjNMm1sL.NhSoXUMPK2K}+#{pKfgH5i1BOj.NhSoXUMPK2K}+#{z2UWuWGZmky.NhSoXUMPK2K}+#{Y3H9ih4947B.NhSoXUMPK2K}+#{Exfk4go7QAN.NhSoXUMPK2K}+#{X3AKw12zLoy.NhSoXUMPK2K}+#{D2swyDbsACF.NhSoXUMPK2K}+#{rdcY4adVjsT.NhSoXUMPK2K}+#{wL8bTjxwuZ3.NhSoXUMPK2K}+#{xJfjSsinslN.NhSoXUMPK2K}+#{AiH62Ek8tX1.NhSoXUMPK2K}+#{L2hEgD7f7vc.NhSoXUMPK2K}+#{ijmM6BD1bv3.NhSoXUMPK2K}+#{XExx7Tp3GT3.NhSoXUMPK2K}+#{dBXuAWSKwby.NhSoXUMPK2K}+#{Z3fTEDYL0sQ.NhSoXUMPK2K}+#{VNtTqsSmDZj.NhSoXUMPK2K}+#{vQM2DsXKWlk.NhSoXUMPK2K}+#{qC6CzmFEl6N.NhSoXUMPK2K}+#{mZcAwqL8sF5.NhSoXUMPK2K}+#{uc99LmZ1tcE.NhSoXUMPK2K}+#{cpVWHoqhnSD.NhSoXUMPK2K}+#{SRLEdIKhmdN.NhSoXUMPK2K}+#{RBJeSMqxZJb.NhSoXUMPK2K}+#{jcAWqDjKIzu.NhSoXUMPK2K}+#{VGyeD7K7NhU.NhSoXUMPK2K}+#{dsZvZQDOjqe.NhSoXUMPK2K}+#{wGXLcYLdMSz.NhSoXUMPK2K})",1
iHRIS Total Number of Nurses,DQoma6lNWxQ,iHRIS All Nurses,#{YBRNewyiKTG.Lt6CjodPpWZ}+#{YBRNewyiKTG.MJAGUpeHkpn}+#{YFJwW8QWT0s.Lt6CjodPpWZ}+#{YFJwW8QWT0s.MJAGUpeHkpn}+#{KplQtl1zQ6v.Lt6CjodPpWZ}+#{KplQtl1zQ6v.MJAGUpeHkpn},1
ihris COs + MOs,t2OuJDoCAh0,ihris COs + MOs,#{wL8bTjxwuZ3.NhSoXUMPK2K}+#{uAk9AD2NGFv.NhSoXUMPK2K}+#{KRxsqqbdAGH.NhSoXUMPK2K}+#{QWymS3dj4uU.NhSoXUMPK2K}+#{J8mzCuLBAH1.NhSoXUMPK2K}+#{YOMA61T94eU.NhSoXUMPK2K}+#{pjEN2QceKNH.NhSoXUMPK2K}+#{ShtwHIW1rOC.NhSoXUMPK2K}+#{H1dgcVTwWQM.NhSoXUMPK2K}+#{arRbatxU74M.NhSoXUMPK2K}+#{Y0SDd8s2bK4.NhSoXUMPK2K}+#{GpYmbmcP4Oa.NhSoXUMPK2K}+#{RGMaEjZKHk9.NhSoXUMPK2K}+#{gUIhX5nb9V9.NhSoXUMPK2K}+#{uAk9AD2NGFv.NhSoXUMPK2K}+#{KRxsqqbdAGH.NhSoXUMPK2K}+#{UBCpnu7mV2S.NhSoXUMPK2K}+#{QWymS3dj4uU.NhSoXUMPK2K}+#{J8mzCuLBAH1.NhSoXUMPK2K}+#{YOMA61T94eU.NhSoXUMPK2K}+#{pjEN2QceKNH.NhSoXUMPK2K}+#{ShtwHIW1rOC.NhSoXUMPK2K}+#{H1dgcVTwWQM.NhSoXUMPK2K}+#{arRbatxU74M.NhSoXUMPK2K}+#{Y0SDd8s2bK4.NhSoXUMPK2K}+#{GpYmbmcP4Oa.NhSoXUMPK2K},1
new outpatients cases with high blood pressure,cCeRPJYgS0v,% of new OPD HYPertension,#{lVNKL5UQ8Sb},#{NLKRV7bYbVy.NhSoXUMPK2K}
new outpatients with mental health conditions,AA1A2D4itbr,% of new OPD mental,#{HmgfJSVUOOr},#{NLKRV7bYbVy.NhSoXUMPK2K}
proportion  of Pregnant women receiving1st Tetanus Toxoid ,cglYZQvydu8,TT 1 coverage,#{au9lav766rM.nYnnLevxuXP},#{JOnT3OiMd5o.NhSoXUMPK2K}
proportion of monthly ANC visit by pregnant adolescent ,pkrmMArAnOn,prop of monthly ANC visit by preg adolescent ,(#{chMsCa5zcn7} + #{uHBmKxktYk0}),(#{uTQOSp7rx5h.wBWcFk7k1qY} + #{uTQOSp7rx5h.K4WLOEhtcvC})
proportion of under 1 year receiving OPV 1 ,tKGNp1722Hc,OPV 1 Coverage,#{t3QKFZbCf2B.ieuodyY5ybC},#{pMbuvKvH4rg.NhSoXUMPK2K}
proportion of under 1 year receiving OPV 3 ,MI3SdIsA0iU,OPV 3 Coverage,#{c2Gm5hW3I4i.ieuodyY5ybC},#{pMbuvKvH4rg}
proportional of ANC clients tested syphilis,CUsRH39ePGN,proportional of ANC clients tested syphilis,#{uvBuzBj0AbL.NhSoXUMPK2K},"
#{f9vesk5d4IY.NhSoXUMPK2K}"
under 5’s treated for diarrhea,vb6xc8wpCIn,% of under 5’sRX diarrhea,#{tovFNTW5b9K.lHl2rmXpHse},#{KNrK5VWTZkx.NhSoXUMPK2K}
